PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brearley, M				Brearley, M			Teams: lessons from the world of sport	BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Millennium Festival of Medicine Conference	NOV 06-10, 2000	LONDON, ENGLAND								Brearley, M (corresponding author), 20 Provost Rd, London NW3 4ST, England.								0	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1141	1143		10.1136/bmj.321.7269.1141	http://dx.doi.org/10.1136/bmj.321.7269.1141			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061741	Green Published			2022-12-28	WOS:000165219600032
J	Ferguson, T				Ferguson, T			Online patient-helpers and physicians working together: a new partnership for high quality health care	BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Millennium Festival of Medicine Conference	NOV 06-10, 2000	LONDON, ENGLAND						Univ Texas, Hlth Sci Ctr, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston	Ferguson, T (corresponding author), Ferguson Report, 3805 Stevenson Ave, Austin, TX 78703 USA.							Ferguson S., 2020, J ED ONLINE; FERGUSON T, 1999, FERGUSON REPORT; Ferguson T., 1998, JAMA-J AM MED ASSOC, V280, P1261; FERGUSON T, 2000, GUIDED TOUR SELF HEL; Kane B, 1998, J AM MED INFORM ASSN, V5, P104, DOI 10.1136/jamia.1998.0050104; KEENER C, 2000, ONL C ONL HLTH HARV	6	96	96	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1129	1132		10.1136/bmj.321.7269.1129	http://dx.doi.org/10.1136/bmj.321.7269.1129			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061737	Green Published			2022-12-28	WOS:000165219600028
J	Finch, J				Finch, J			Interprofessional education and teamworking: a view from the education providers	BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Millennium Festival of Medicine Conference	NOV 06-10, 2000	LONDON, ENGLAND						Univ Keele, Keele ST5 5BG, Staffs, England	Keele University	Finch, J (corresponding author), Univ Keele, Keele ST5 5BG, Staffs, England.							Barr H, 1996, ED HLTH, V9, P341; *CTR ADV INT ED, 2000, WORK CAIPE; *DEP HLTH, 2000, HLTH SERV ALL TAL DE; Department of Health, 2000, NHS PLAN PLAN INV PL; *GEN MED COUNC, 1998, GUID MAINT GOOD MED; GEORGE C, 2000, TEAMWORKING MED; Leathard A., 1994, GOING INTERPROFESSIO; PITILLO M, 1998, ED HLTH, V11, P285; Ross F, 2000, MED EDUC, V34, P739, DOI 10.1046/j.1365-2923.2000.00626.x; SOOTHILL K, 1995, INTERPROFESSIONAL RE; Wilson T, 2000, MED EDUC, V34, P744	11	58	59	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1138	1140		10.1136/bmj.321.7269.1138	http://dx.doi.org/10.1136/bmj.321.7269.1138			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061740	Green Published			2022-12-28	WOS:000165219600031
J	Manfredini, R; Portaluppi, F; Salmi, R; Martini, A; Gallerani, M				Manfredini, R; Portaluppi, F; Salmi, R; Martini, A; Gallerani, M			Circadian variation in onset of epistaxis: analysis of hospital admissions	BRITISH MEDICAL JOURNAL			English	Article							EVENTS		Univ Ferrara, Sch Med, Dept Clin & Expt Med, Internal Med & Hypertens Unit 1, I-44100 Ferrara, Italy; Univ Ferrara, Sch Med, Dept Ear Nose & Throat, I-44100 Ferrara, Italy; St Anna Gen Hosp, Dept Internal Med, Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna	Manfredini, R (corresponding author), Univ Ferrara, Sch Med, Dept Clin & Expt Med, Internal Med & Hypertens Unit 1, I-44100 Ferrara, Italy.		Manfredini, Roberto/N-3859-2019; Portaluppi, Francesco/H-2206-2012; Manfredini, Roberto/AAJ-5442-2020; Manfredini, Roberto/A-3471-2008; Martini, Alessandro/K-2513-2018	Manfredini, Roberto/0000-0002-8364-2601; Portaluppi, Francesco/0000-0002-2948-1579; Manfredini, Roberto/0000-0002-8364-2601; Martini, Alessandro/0000-0002-2003-6348				Gallerani M, 1996, STROKE, V27, P1793, DOI 10.1161/01.STR.27.10.1793; Manfredini R, 1999, LANCET, V353, P643, DOI 10.1016/S0140-6736(98)05653-0; Manfredini R, 1996, ANN NY ACAD SCI, V783, P141, DOI 10.1111/j.1749-6632.1996.tb26713.x; MOJON A, 1992, CHRONOBIOL INT, V9, P403, DOI 10.3109/07420529209064552; Portaluppi F, 1999, CHRONOBIOL INT, V16, P33, DOI 10.3109/07420529908998710	5	12	13	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1112	1112		10.1136/bmj.321.7269.1112	http://dx.doi.org/10.1136/bmj.321.7269.1112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061731	Green Published, Bronze			2022-12-28	WOS:000165219600023
J	Dupont, PJ; Lightstone, L; Clutterbuck, EJ; Gaskin, G; Pusey, CD; Cook, T; Warrens, AN				Dupont, PJ; Lightstone, L; Clutterbuck, EJ; Gaskin, G; Pusey, CD; Cook, T; Warrens, AN			Lesson of the week - Cholesterol emboli syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RENAL-FAILURE; CRYSTAL EMBOLIZATION; THERAPY		Hammersmith Hosp, Imperial Coll, Sch Med, Renal Sect, London W12 0NN, England; Hammersmith Hosp, Dept Histopathol, London W12 0HS, England	Imperial College London; Imperial College London	Warrens, AN (corresponding author), Hammersmith Hosp, Imperial Coll, Sch Med, Renal Sect, London W12 0NN, England.	a.warrens@ic.ac.uk	Lightstone, Liz/M-4331-2014	Lightstone, Liz/0000-0002-4603-4076				Adorati M, 1998, NEPHROL DIAL TRANSPL, V13, P1262, DOI 10.1093/ndt/13.5.1262; Belenfant X, 1997, PRESSE MED, V26, P1236; Belenfant X, 1999, AM J KIDNEY DIS, V33, P840, DOI 10.1016/S0272-6386(99)70415-4; DAHLBERG PJ, 1989, SURGERY, V105, P737; Ferrari E, 1998, HEART, V79, P133, DOI 10.1136/hrt.79.2.133; GUPTA BK, 1993, AM J KIDNEY DIS, V21, P659, DOI 10.1016/S0272-6386(12)80040-0; LYE WC, 1993, AM J NEPHROL, V13, P489, DOI 10.1159/000168669; MANRIQUE ER, 1998, ARCH INTERN MED, V158, P1575; Mayo RR, 1996, AM J MED, V100, P524, DOI 10.1016/S0002-9343(95)00059-3; Moolenaar W, 1996, ARCH INTERN MED, V156, P653, DOI 10.1001/archinte.156.6.653; Piriou V, 1996, BRIT J ANAESTH, V77, P277, DOI 10.1093/bja/77.2.277; Scolari F, 1996, NEPHROL DIAL TRANSPL, V11, P1607; THADHANI RI, 1995, MEDICINE, V74, P350, DOI 10.1097/00005792-199511000-00005; Woolfson RG, 1998, LANCET, V351, P1331, DOI 10.1016/S0140-6736(05)79058-9	15	20	20	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2000	321	7268					1065	1067		10.1136/bmj.321.7268.1065	http://dx.doi.org/10.1136/bmj.321.7268.1065			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PU	11053182	Green Published			2022-12-28	WOS:000165076800029
J	Segev, I; London, M				Segev, I; London, M			Untangling dendrites with quantitative models	SCIENCE			English	Review							CA1 PYRAMIDAL NEURONS; CEREBELLAR PURKINJE-CELLS; VISUAL INTERNEURONS; NEOCORTICAL NEURONS; SYNAPTIC INPUT; SHUNTING INHIBITION; BACKGROUND ACTIVITY; MOTION INFORMATION; CABLE STRUCTURES; ONE BRANCH	Our understanding of the function of dendrites has been greatly enriched by an inspiring dialogue between theory and experiments. Rather than functionally ignoring dendrites, representing neurons as single summing points, we have realized that dendrites are electrically and chemically distributed nonlinear units and that this has important consequences for interpreting experimental data and for the role of neurons in information processing. Here, we examine the route to unraveling some of the enigmas of dendrites and highlight the main insights that have been gained. Future directions are discussed that will enable theory and models to keep shedding Light on dendrites, where the most fundamental input-output adaptive processes take place.	Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Segev, I (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel.		London, Michael/B-4175-2010	London, Michael/0000-0001-5137-1707; Segev, Idan/0000-0001-7279-9630				Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; AGMONSNIR H, 1993, J NEUROPHYSIOL, V70, P2066, DOI 10.1152/jn.1993.70.5.2066; Anderson JC, 1999, NAT NEUROSCI, V2, P820, DOI 10.1038/12194; [Anonymous], [No title captured]; Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Borg-Graham LJ, 2000, J COMPUT NEUROSCI, V8, P209, DOI 10.1023/A:1008945925865; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Borst A, 1996, ACTA PHYSIOL SCAND, V157, P403, DOI 10.1046/j.1365-201X.1996.30250000.x; BORST A, 1992, P NATL ACAD SCI USA, V89, P4139, DOI 10.1073/pnas.89.9.4139; Bower JM, 1998, BOOK GENESIS EXPLORI; BURKE RE, 1971, J PHYSIOL-LONDON, V212, P1; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Cook EP, 1999, J NEUROPHYSIOL, V81, P535, DOI 10.1152/jn.1999.81.2.535; Copeland BJ, 1996, SYNTHESE, V108, P335, DOI 10.1007/BF00413693; DEFELICE LJ, 1975, FED PROC, V34, P1338; DESCHUTTER E, 1994, P NATL ACAD SCI USA, V91, P4736, DOI 10.1073/pnas.91.11.4736; DOUGLAS RJ, 1988, NATURE, V332, P642, DOI 10.1038/332642a0; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FUJITA Y, 1968, J NEUROPHYSIOL, V31, P131, DOI 10.1152/jn.1968.31.2.131; GAMBLE E, 1987, SCIENCE, V236, P1311, DOI 10.1126/science.3495885; Haag J, 1997, J NEUROSCI, V17, P4809; HAAG J, 1992, NEUROSCI LETT, V140, P173, DOI 10.1016/0304-3940(92)90095-O; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1946, PROC R SOC SER B-BIO, V133, P444, DOI 10.1098/rspb.1946.0024; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; HOLMES WR, 1986, BIOL CYBERN, V55, P115; HOPFIELD JJ, 1994, PHYS TODAY, V47, P40, DOI 10.1063/1.881412; Jack J, 1983, ELECT CURRENT FLOW E; JACK JJB, 1971, J PHYSIOL-LONDON, V215, P283, DOI 10.1113/jphysiol.1971.sp009472; Kamondi A, 1998, J NEUROSCI, V18, P3919; KOCH C, 1984, BIOL CYBERN, V50, P15, DOI 10.1007/BF00317936; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; KOCH C, IN PRESS NATURE NEUR; LAURENT G, 1993, J NEUROPHYSIOL, V69, P1484, DOI 10.1152/jn.1993.69.5.1484; London M, 1999, J NEUROSCI, V19, P8219; LONDON M, 2000, SOC NEUR ABSTR 1, V26, P1118; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1998, J NEUROSCI, V18, P7613; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Manwani A, 1999, NEURAL COMPUT, V11, P1797, DOI 10.1162/089976699300015972; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MEL BW, 1992, NEURAL COMPUT, V4, P502, DOI 10.1162/neco.1992.4.4.502; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Mel BW, 1998, J NEUROSCI, V18, P4325; MEUNIER C, IN PRESS HDB BIOL PH; NICHOLSON C, 1971, J NEUROPHYSIOL, V34, P509, DOI 10.1152/jn.1971.34.4.509; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; RALL W, 1969, BIOPHYS J, V9, P1509, DOI 10.1016/S0006-3495(69)86468-4; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; RALL W, 1959, EXP NEUROL, V1, P491, DOI 10.1016/0014-4886(59)90046-9; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Rall W., 1974, CELLULAR MECH SUBSER, P13; Rall W, 1964, NEURAL THEORY MODELI, P73; RAPP M, 1992, NEURAL COMPUT, V4, P518, DOI 10.1162/neco.1992.4.4.518; RAPP M, 1997, THESIS HEBREW U JERU; REDMAN S, 1983, J PHYSIOL-LONDON, V343, P117, DOI 10.1113/jphysiol.1983.sp014884; REYES AD, 1994, J NEUROSCI, V14, P5352; RIEKE F, 1996, SPIKES EXPLORING LAN; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; SCHWINDT PC, 1995, J NEUROPHYSIOL, V74, P2220, DOI 10.1152/jn.1995.74.5.2220; SEGEV I, 1988, J NEUROPHYSIOL, V60, P499, DOI 10.1152/jn.1988.60.2.499; Segev I, 1998, TRENDS NEUROSCI, V21, P453, DOI 10.1016/S0166-2236(98)01327-7; Segev I, 1998, METHODS NEURONAL MOD, P93; SEGEV I, 1999, DENDRITES, P205; Shepherd G.M., 1995, THEORETICAL FDN DEND; SHEPHERD GM, 1985, P NATL ACAD SCI USA, V82, P2192, DOI 10.1073/pnas.82.7.2192; Shepherd GM, 1996, J NEUROPHYSIOL, V75, P2197, DOI 10.1152/jn.1996.75.6.2197; SIEGEL M, 1994, P NATL ACAD SCI USA, V91, P11308, DOI 10.1073/pnas.91.24.11308; Single S, 1997, J NEUROSCI, V17, P6023; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; STRATFORD RD, 1989, COMPUTING NEURON; STUART G, 1995, CURR OPIN NEUROBIOL, V5, P389, DOI 10.1016/0959-4388(95)80053-0; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Tuckwell H. C., 1988, INTRO THEORETICAL NE, V1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Ulrich D, 2000, J NEUROPHYSIOL, V84, P1445, DOI 10.1152/jn.2000.84.3.1445; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; WILSON CJ, 1995, J COMPUT NEUROSCI, V2, P91, DOI 10.1007/BF00961882; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Zador AM, 1996, NEURAL COMPUT, V8, P611, DOI 10.1162/neco.1996.8.3.611	94	211	220	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					744	750		10.1126/science.290.5492.744	http://dx.doi.org/10.1126/science.290.5492.744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052930				2022-12-28	WOS:000090067600035
J	Brahams, D				Brahams, D			UK: impact of European human rights law	LANCET			English	Article								The UK's Human Rights Act 1998, which incorporates into that country's law the European Convention on Rights and Freedoms, came into full operation on Oct 2, 2000. The Act imposes duties on public authorities, who must now justify their position if that is in conflict with a Convention right. Four Articles in the Convention are potential flashpoints in respect of health cases, examples being patients' rights to receive expensive life-saving treatment and disciplinary procedures, including those of the General Medical Council and National Health Service trusts.	Old Sq Chambers, London WC1R 5LQ, England		Brahams, D (corresponding author), Old Sq Chambers, Grays Inn, London WC1R 5LQ, England.							Brahams D, 2000, LANCET, V356, P145, DOI 10.1016/S0140-6736(05)73164-0; GUMBEL EA, 2000, CLIN RISK, V6, P43; HAVERS P, POWERS HARRIS CLIN N, P27; Horton R, 2000, LANCET, V356, P1186, DOI 10.1016/S0140-6736(00)02771-9; Winstone H, 1999, Med Leg J, V67, P35	5	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1433	1434		10.1016/S0140-6736(00)02856-7	http://dx.doi.org/10.1016/S0140-6736(00)02856-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052599				2022-12-28	WOS:000089976100044
J	Griffith, CA; Hall, JL; Geballe, TR				Griffith, CA; Hall, JL; Geballe, TR			Detection of daily clouds on Titan	SCIENCE			English	Article							SURFACE; ATMOSPHERE; TROPOSPHERE; METHANE; TEMPERATURE; REANALYSIS; OCEAN	We have discovered frequent variations in the near-infrared spectrum of Titan, Saturn's largest moon, which are indicative of the daily presence of sparse clouds covering less than 1% of the area of the satellite. The thermodynamics of Titan's atmosphere and the clouds' altitudes suggest that convection governs their evolutions. Their short lives point to the presence of rain. We propose that Titan's atmosphere resembles Earth's, with clouds, rain, and an active weather cycle, driven by latent heat release from the primary condensible species.	No Arizona Univ, Dept Phys & Astron, Flagstaff, AZ 86011 USA; Gemini Observ, Hilo, HI 96720 USA	Northern Arizona University	Griffith, CA (corresponding author), No Arizona Univ, Dept Phys & Astron, Flagstaff, AZ 86011 USA.							AWAL M, 1994, GEOPHYS RES LETT, V21, P2491, DOI 10.1029/94GL01707; Combes M, 1997, ICARUS, V129, P482, DOI 10.1006/icar.1997.5772; COURTIN R, 1995, ICARUS, V114, P144, DOI 10.1006/icar.1995.1050; COUSTENIS A, 1995, ICARUS, V118, P87, DOI 10.1006/icar.1995.1179; ESHLEMAN VR, 1983, SCIENCE, V221, P53, DOI 10.1126/science.221.4605.53; FLASAR FM, 1983, SCIENCE, V221, P55, DOI 10.1126/science.221.4605.55; FLASAR FM, 1981, NATURE, V292, P693, DOI 10.1038/292693a0; GIER HT, 1970, TESTIS, V1, P1; Goody R.M., 1989, ATMOSPHERIC RAD THEO, Vsecond, DOI [10.1093/OSO/9780195051346.001.0001, DOI 10.1093/OSO/9780195051346.001.0001]; GRIFFITH CA, 1993, NATURE, V364, P511, DOI 10.1038/364511a0; GRIFFITH CA, 1991, ICARUS, V93, P362, DOI 10.1016/0019-1035(91)90219-J; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; HOLTON JR, 1992, INTRO DYNAMICAL METE; Hunten D.M, 1984, SATURN, P671; LELLOUCH E, 1989, ICARUS, V79, P328, DOI 10.1016/0019-1035(89)90081-X; LEMMON MT, 1995, ICARUS, V113, P27, DOI 10.1006/icar.1995.1003; LEMMON MT, 1993, ICARUS, V103, P329, DOI 10.1006/icar.1993.1074; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; McKay CP, 1997, ICARUS, V129, P498, DOI 10.1006/icar.1997.5751; Samuelson RE, 1997, PLANET SPACE SCI, V45, P959, DOI 10.1016/S0032-0633(97)00090-1; SIMPSON J, 1967, J ATMOS SCI, V24, P508, DOI 10.1175/1520-0469(1967)024<0508:SCSESA>2.0.CO;2; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023; STOMMEL H, 1947, J METEOROL, V4, P91, DOI 10.1175/1520-0469(1947)004<0091:EOAIAC>2.0.CO;2; TOON OB, 1988, ICARUS, V75, P255, DOI 10.1016/0019-1035(88)90005-X	24	124	124	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					509	513		10.1126/science.290.5491.509	http://dx.doi.org/10.1126/science.290.5491.509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039930				2022-12-28	WOS:000089946000049
J	Kim, CH; Oda, T; Itoh, M; Jiang, D; Artinger, KB; Chandrasekharappa, SC; Driever, W; Chitnis, AB				Kim, CH; Oda, T; Itoh, M; Jiang, D; Artinger, KB; Chandrasekharappa, SC; Driever, W; Chitnis, AB			Repressor activity of headless/Tcf3 is essential for vertebrate head formation	NATURE			English	Article							HOMEOBOX GENE; SPEMANN ORGANIZER; XENOPUS EMBRYOS; BETA-CATENIN; ZEBRAFISH; WNT; LOCALIZATION; EXPRESSION; ANTAGONIST; INDUCTION	The vertebrate organizer can induce a complete body axis when transplanted to the ventral side of a host embryo(1) by virtue of its distinct head and trunk inducing properties. Wingless/Wnt antagonists secreted by the organizer have been identified as head inducers(2-4). Their ectopic expression can promote head formation, whereas ectopic activation of Wnt signalling during early gastrulation blocks head formation(5-7). These observations suggest that the ability of head inducers to inhibit Wnt signalling during formation of anterior structures is what distinguishes them from trunk inducers that permit the operation of posteriorizing Wnt signals(8). Here we describe the zebrarsh headless (hdl) mutant and show that its severe head defects are due to a mutation in T-cell factor-3 (Tcf3), a member of the Tcf/Lef family(9,10). Loss of Tcf3 function in the hdl mutant reveals that hdl represses Wnt target genes. We provide genetic evidence that a component of the Wnt signalling pathway is essential in vertebrate head formation and patterning.	NICHD, Genet Mol Lab, NIH, Bethesda, MD 20892 USA; NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Freiburg, Inst Zool, D-79104 Freiburg, Germany	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Harvard Medical School; University of Freiburg	Chitnis, AB (corresponding author), NICHD, Genet Mol Lab, NIH, Bethesda, MD 20892 USA.			Driever, Wolfgang/0000-0002-9551-9141; Kim, Cheol-Hee/0000-0002-3019-0699	NICHD NIH HHS [F32 HD008209-04, F32 HD008209] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001012, F32HD008209] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Artinger KB, 1999, DEVELOPMENT, V126, P3969; BADIANI P, 1994, GENE DEV, V8, P770, DOI 10.1101/gad.8.7.770; Brannon M, 1999, DEVELOPMENT, V126, P3159; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Gates MA, 1999, GENOME RES, V9, P334; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kobayashi M, 1998, DEVELOPMENT, V125, P2973; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; McGrew LL, 1999, MECH DEVELOP, V87, P21, DOI 10.1016/S0925-4773(99)00136-7; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Nieto MA, 1999, CELL, V98, P417, DOI 10.1016/S0092-8674(00)81971-6; Pelegri F, 1998, MECH DEVELOP, V77, P63, DOI 10.1016/S0925-4773(98)00132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; VANDEWETERING M, 1992, J BIOL CHEM, V267, P8530; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X	29	315	326	2	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					913	916		10.1038/35038097	http://dx.doi.org/10.1038/35038097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057671	Green Accepted			2022-12-28	WOS:000089901900054
J	Spurgeon, D				Spurgeon, D			Canada plans reduction in greenhouse-gas emissions	NATURE			English	News Item																			0	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					824	824		10.1038/35038226	http://dx.doi.org/10.1038/35038226			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057633	Bronze			2022-12-28	WOS:000089901900010
J	Corset, V; Nguyen-ba-Charvet, KT; Forcet, C; Moyse, E; Chedotal, A; Mehlen, P				Corset, V; Nguyen-ba-Charvet, KT; Forcet, C; Moyse, E; Chedotal, A; Mehlen, P			Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor	NATURE			English	Article							COLORECTAL-CANCER DCC; GROWTH CONE GUIDANCE; NETRIN RECEPTOR; A(2B) RECEPTORS; NERVOUS-SYSTEM; MAST-CELLS; BINDING; ATTRACTION; MECHANISM; REPULSION	The netrins, a family of laminin-related secreted proteins, are critical in controlling axon elongation and pathfinding(1-4). The DCC (for deleted in colorectal cancer) protein was proposed as a receptor for netrin-1 in the light of many observations including the inhibition of netrin-1-mediated axon outgrowth and attraction in the presence of an anti-DCC antiserum(5-7), the similitude of nervous system defects in DCC and netrin-1 knockout mice(4,8) and the results of receptor swapping experiments(9). Previous studies have failed to show a direct interaction of DCC with netrin-1 (ref. 10), suggesting the possibility of an additional receptor or coreceptor. Here we show that DCC interacts with the membrane-associated adenosine A2b receptor, a G-protein-coupled receptor that induces cAMP accumulation on binding adenosine(11). We show that A2b is actually a netrin-1 receptor and induces cAMP accumulation on binding netrin-1. Finally, we show that netrin-1-dependent outgrowth of dorsal spinal cord axons directly involves A2b. Together our results indicate that the growth-promoting function of netrin-1 may require a receptor complex containing DCC and A2b.	Univ Lyon 1, Ctr Genet Mol & Cellulaire, Lab Apoptose & Differenciat, Label Ligue,CNRS,UMR 5534, F-69622 Villeurbanne, France; Hop La Pitie Salpetriere, INSERM, U106, F-75651 Paris 13, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Mehlen, P (corresponding author), Univ Lyon 1, Ctr Genet Mol & Cellulaire, Lab Apoptose & Differenciat, Label Ligue,CNRS,UMR 5534, F-69622 Villeurbanne, France.		Chedotal, Alain/F-2750-2017; Nguyen-Ba-Charvet, Kim/J-3507-2017; MOYSE, Emmanuel/ABE-1819-2021	Chedotal, Alain/0000-0001-7577-3794; Nguyen-Ba-Charvet, Kim/0000-0001-5398-0872; MOYSE, Emmanuel/0000-0002-9590-1367				Bennett KL, 1997, J BIOL CHEM, V272, P26940, DOI 10.1074/jbc.272.43.26940; Boileau AJ, 1999, J NEUROSCI, V19, P4847; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999; de Castro F, 1999, J NEUROSCI, V19, P4428; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEOKTISTOV I, 1993, MOL PHARMACOL, V43, P909; FEOKTISTOV I, 1995, J CLIN INVEST, V96, P1979, DOI 10.1172/JCI118245; Feoktistov I, 1997, PHARMACOL REV, V49, P381; FORCET C, UNPUB P NATL ACAD SC; FREDHOLM BB, 1982, EUR J PHARMACOL, V81, P673, DOI 10.1016/0014-2999(82)90359-4; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Linden J, 1999, MOL PHARMACOL, V56, P705; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Meyerhardt JA, 1999, CELL GROWTH DIFFER, V10, P35; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ralevic V, 1998, PHARMACOL REV, V50, P413; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Squires RF, 1999, NEUROCHEM RES, V24, P1593, DOI 10.1023/A:1021116502548; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; YAKEL JL, 1993, MOL PHARMACOL, V43, P277	29	168	175	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					747	750		10.1038/35037600	http://dx.doi.org/10.1038/35037600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048721				2022-12-28	WOS:000089773900043
J	Ghahramani, Z				Ghahramani, Z			Computational neuroscience - Building blocks of movement	NATURE			English	Editorial Material							MOTOR		UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England	University of London; University College London	Ghahramani, Z (corresponding author), UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England.							Bernstein N, 1967, COORDINATION REGULAT; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Loeb GE, 1999, PROG BRAIN RES, V123, P405, DOI 10.1016/S0079-6123(08)62875-7; MORASSO P, 1982, BIOL CYBERN, V45, P131, DOI 10.1007/BF00335240; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964	9	8	8	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					682	683		10.1038/35037690	http://dx.doi.org/10.1038/35037690			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048700				2022-12-28	WOS:000089773900021
J	Yoo, HI; Barsoum, MW; El-Raghy, T				Yoo, HI; Barsoum, MW; El-Raghy, T			Materials science - Ti3SiC2 has negligible thermopower	NATURE			English	Article									Seoul Natl Univ, Sch Mat Sci & Engn, Seoul 151742, South Korea; Drexel Univ, Dept Mat Engn, Philadelphia, PA 19104 USA	Seoul National University (SNU); Drexel University	Yoo, HI (corresponding author), Seoul Natl Univ, Sch Mat Sci & Engn, Seoul 151742, South Korea.		Gogotsi, Yury/B-2167-2008	Gogotsi, Yury/0000-0001-9423-4032				Barsoum MW, 1997, J MATER SYNTH PROCES, V5, P197; Barsoum MW, 1997, J ELECTROCHEM SOC, V144, P2508, DOI 10.1149/1.1837846; Barsoum MW, 1999, J PHYS CHEM SOLIDS, V60, P429, DOI 10.1016/S0022-3697(98)00313-8; Barsoum MW, 1996, J AM CERAM SOC, V79, P1953, DOI 10.1111/j.1151-2916.1996.tb08018.x; BARSOUM MW, IN PRESS PHYS REV B; BERLINCOURT TG, 1959, PHYS REV, V114, P969, DOI 10.1103/PhysRev.114.969; CUSACK N, 1958, P PHYS SOC LOND, V72, P898, DOI 10.1088/0370-1328/72/5/429; Gilbert CJ, 2000, SCRIPTA MATER, V42, P761, DOI 10.1016/S1359-6462(99)00427-3; Mott N. F., 1958, THEORY PROPERTIES ME; WORNER HW, 1951, AUST J SCI RES SER A, V4, P62, DOI 10.1071/CH9510062; YOO HI, 1992, SOLID STATE IONICS, V53, P583, DOI 10.1016/0167-2738(92)90433-P; YOO HI, 1992, J PHYS CHEM SOLIDS, V53, P973, DOI 10.1016/0022-3697(92)90126-X	12	154	156	0	53	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					581	582		10.1038/35036686	http://dx.doi.org/10.1038/35036686			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034196				2022-12-28	WOS:000089772800032
J	Numano, F; Okawara, M; Inomata, H; Kobayashi, Y				Numano, F; Okawara, M; Inomata, H; Kobayashi, Y			Takayasu's arteritis	LANCET			English	Article									Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Numano, F (corresponding author), Tokyo Med & Dent Univ, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	numano.med3@tmd.ac.jp	Rosenstein, Elliot D/N-1666-2013	Rosenstein, Elliot D/0000-0001-7681-4615				Dabague J, 1996, INT J CARDIOL, V54, pS103, DOI 10.1016/S0167-5273(96)88779-1; Deyu Z, 1997, HEART VESSELS, V7, P32; Jain S, 1996, INT J CARDIOL, V54, pS111, DOI 10.1016/S0167-5273(96)88780-8; KIMURA A, 1998, INT J CARDIOL S, V54, pS65; Koide K, 1992, Heart Vessels Suppl, V7, P48, DOI 10.1007/BF01744544; Numano F, 1999, INTERNAL MED, V38, P226, DOI 10.2169/internalmedicine.38.226; Numano F, 1998, INT J CARDIOL, V66, pS5; Numano F, 2000, ANN NY ACAD SCI, V902, P65; NUMANO F, IN PRESS VASCULAR MA; Numano F, 1996, INT J CARDIOL, V54, pS1; Numano Fujio, 1997, Current Opinion in Rheumatology, V9, P12, DOI 10.1097/00002281-199701000-00003; Park Y B, 1992, Heart Vessels Suppl, V7, P55, DOI 10.1007/BF01744545; Rosenthal T, 1992, Heart Vessels Suppl, V7, P44, DOI 10.1007/BF01744543; Sato EI, 1998, INT J CARDIOL, V66, pS67, DOI 10.1016/S0167-5273(98)00152-1; Suwanwela N, 1996, INT J CARDIOL, V54, pS117, DOI 10.1016/S0167-5273(96)88781-X; Turkoglu C, 1996, INT J CARDIOL, V54, pS135	16	204	233	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2000	356	9234					1023	1025		10.1016/S0140-6736(00)02701-X	http://dx.doi.org/10.1016/S0140-6736(00)02701-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041416				2022-12-28	WOS:000089293600041
J	Marmot, M; Bobak, M				Marmot, M; Bobak, M			International comparators and poverty and health in Europe	BMJ-BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Millennium Festival of Medicine Conference	NOV 06-10, 2000	LONDON, ENGLAND				CORONARY HEART-DISEASE; PSYCHOSOCIAL FACTORS; PROSPECTIVE COHORT; CIVIL-SERVANTS; WHITEHALL-II; JOB CONTROL; MORTALITY; INEQUALITIES; RISK; EXPLANATIONS		UCL, Dept Epidemiol & Publ Hlth, Int Ctr Hlth & Soc, London WC1E 6BT, England	University of London; University College London	Marmot, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Int Ctr Hlth & Soc, Mortimer St, London WC1E 6BT, England.	M.Marmot@.ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419; Bobak, Martin/0000-0002-2633-6851	Medical Research Council [G8802774, G19/35] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Acheson D., 1998, INDEPENDENT INQUIRY; [Anonymous], 1993, WORLD DEV REP 1993; Atkinson A B, 1992, EC TRANSFORMATION EE; Bartley M, 1999, SOC SCI MED, V49, P831, DOI 10.1016/S0277-9536(99)00192-6; BLAZCK J, 2000, MORTALITY CRISIS TRA; BOBAK M, 1994, AM J PUBLIC HEALTH, V84, P1167, DOI 10.2105/AJPH.84.7.1167; Bobak M, 1996, BRIT MED J, V312, P421; Bobak M, 2000, J EPIDEMIOL COMMUN H, V54, P91, DOI 10.1136/jech.54.2.91; Bobak M, 1998, EPIDEMIOLOGY, V9, P43, DOI 10.1097/00001648-199801000-00010; Bobak M, 2000, SOC SCI MED, V51, P1343, DOI 10.1016/S0277-9536(00)00096-4; Bosma H, 1997, BRIT MED J, V314, P558, DOI 10.1136/bmj.314.7080.558; Carlson P, 1998, SOC SCI MED, V46, P1355, DOI 10.1016/S0277-9536(97)10093-4; Hajdu P., 1995, EUR J PUBLIC HEALTH, V5, P259, DOI [DOI 10.1093/EURPUB/5.4.259, 10.1093/eurpub/5.4.259]; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jozan P, 1999, BRIT MED J, V318, P914, DOI 10.1136/bmj.318.7188.914; Koupilova I, 1998, AM J PUBLIC HEALTH, V88, P1343, DOI 10.2105/AJPH.88.9.1343; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Marmot M, 2006, SOCIAL DETERMINANTS; MARMOT M, 1999, SOCIAL EPIDEMIOLOGY; Marmot MG, 1996, BRIT MED J, V313, P1177, DOI 10.1136/bmj.313.7066.1177; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1984, LANCET, V1, P1003; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; PIKHART H, 2000, THESIS U COLL LONDON; SEN A, 1999, DEV FREEDOM, P104; Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; *UN INT CHILD DEV, 1998, 5 MONEE UN INT CHILD; van Rossum CTM, 2000, J EPIDEMIOL COMMUN H, V54, P178, DOI 10.1136/jech.54.3.178; WATSON P, 1995, SOC SCI MED, V41, P923, DOI 10.1016/0277-9536(94)00405-I; *WHO, 2000, HLTH ALL; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC	33	119	121	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2000	321	7269					1124	1128		10.1136/bmj.321.7269.1124	http://dx.doi.org/10.1136/bmj.321.7269.1124			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	372DT	11061736	Green Submitted, Green Published			2022-12-28	WOS:000165219600027
J	Mason, J; Young, P; Freemantle, N; Hobbs, R				Mason, J; Young, P; Freemantle, N; Hobbs, R			Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction	BRITISH MEDICAL JOURNAL			English	Article							MANAGEMENT	Objective To estimate the costs and consequences of diagnosing symptomatic heart failure with left ventricular systolic dysfunction and initiating angiotensin converting enzyme inhibitors in primary care. Design Analysis of individual patient data from studies of left ventricular dysfunction (SOLVD) to identify complications during test dose and titration phases. Setting Two randomised controlled trials in secondary care. Participants 7487 patients taking a test dose of enalapril at enrolment to the treatment and prevention trials; 2569 patients with clinical signs of heart failure and established left ventricular dysfunction entered the treatment trial. Main outcome measures Discontinuation during the test dose period. Discontinuation or reduction of dose during the first year of treatment for heart failure. Costs of diagnosis and titration of treatment. Results During the test dose phase, 585 patients (7.8%) reported side effects; 136 (1.8%) of these discontinued because of severe side effects. During the titration phase, compared with placebo, enalapril was associated with an increased risk of dose reduction due to hypotension (odds ratio 2.09, 95% confidence interval 1.15 to 3.82). However, overall, there was no difference in the rates of side effects leading to dose reduction or withdrawal between the enalapril and placebo groups. The costs of diagnosing heart failure with left ventricular systolic dysfunction and initiating and titrating an angiotensin converting enzyme inhibitor in primary care are pound 300 to pound 400. Conclusions Treatment with angiotensin converting enzyme inhibitors can be safely started for patients with heart failure and left ventricular systolic dysfunction in primary care.	Univ York, Ctr Hlth Econ, Med Evaluat Grp, York YO10 5DD, N Yorkshire, England; Univ Birmingham, Sch Med, Div Primary Care Publ & Occupat Hlth, Birmingham B15 2TT, W Midlands, England	University of York - UK; University of Birmingham	Mason, J (corresponding author), Univ York, Ctr Hlth Econ, Med Evaluat Grp, York YO10 5DD, N Yorkshire, England.		Mason, James M/D-9904-2011; Young, Philip/ABI-1480-2020	Mason, James M/0000-0001-9210-4082; Young, Philip/0000-0003-0201-9277; Freemantle, Nick/0000-0001-5807-5740; hobbs, richard/0000-0001-7976-7172				*AG HLTH CAR POL R, 1994, CLIN PRACT GUID, V11; *BRIT MED ASS, 1999, BRIT NAT FORM; CLARKE KW, 1994, BRIT HEART J, V71, P584; CLELAND JG, 1995, EUR HEART J, V16, P741; Cleland JGF, 1999, BRIT MED J, V318, P824, DOI 10.1136/bmj.318.7187.824; Davie AP, 1996, BRIT MED J, V312, P222; Eccles M, 1998, BMJ-BRIT MED J, V316, P1369, DOI 10.1136/bmj.316.7141.1369; FRANK GJ, 1989, CARDIOLOGY, V76, P56, DOI 10.1159/000174560; Hjalmarson A, 1999, LANCET, V353, P2001; HOBBS FDR, IN PRESS EUR HEART J; Houghton AR, 1997, INT J CARDIOL, V59, P7, DOI 10.1016/S0167-5273(96)02904-X; Lechat P, 1999, LANCET, V353, P9; Lightowlers S, 1998, STROKE, V29, P1827, DOI 10.1161/01.STR.29.9.1827; Mair FS, 1996, BRIT J GEN PRACT, V46, P77; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Netten A, 1999, UNIT COSTS HLTH SOCI; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; ONEILL CJA, 1988, EUR J CLIN PHARMACOL, V35, P143, DOI 10.1007/BF00609243; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Poole-Wilson P, 1998, EUR HEART J, V19, P481; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; SAS Institute, 1990, SAS STAT US GUID VER; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; WEELDON NM, 1993, Q J MED, V86, P17; WHEELDON NM, 1993, Q J MED, V86, P17; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2000, NEW ENGL J MED, V342, P145; YUSUF S, 1990, AM J CARDIOL, V66, P315	28	15	15	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1113	1116		10.1136/bmj.321.7269.1113	http://dx.doi.org/10.1136/bmj.321.7269.1113			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061732	Green Published, Bronze			2022-12-28	WOS:000165219600024
J	Kravitz, RL				Kravitz, RL			Direct-to-consumer advertising of prescription drugs: Implications for the patient-physician relationship	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif Davis, Ctr Hlth Serv Res Primary Care, Davis, CA 95616 USA	University of California System; University of California Davis	Kravitz, RL (corresponding author), Univ Calif Davis, Ctr Hlth Serv Res Primary Care, Davis, CA 95616 USA.		Kravitz, Richard/AAF-7425-2021	Kravitz, Richard/0000-0001-5575-529X				Bell RA, 1999, J FAM PRACTICE, V48, P446; EVERETT SE, 1991, J ADVERTISING RES, V31, P43; Hoffman JR, 1999, BRIT MED J, V318, P1301, DOI 10.1136/bmj.318.7194.1301; Holmer AF, 1999, JAMA-J AM MED ASSOC, V281, P380, DOI 10.1001/jama.281.4.380; Lipsky MS, 1997, J FAM PRACTICE, V45, P495; MAGUIRE P, 1999, ACP ASIM OBSERVER, P1; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110	7	26	26	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2244	2244		10.1001/jama.284.17.2244	http://dx.doi.org/10.1001/jama.284.17.2244			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	367GD	11056603	hybrid			2022-12-28	WOS:000090052600039
J	Gore, A				Gore, A			Ensuring access to health care - The Gore plan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2110	2111		10.1001/jama.284.16.2110	http://dx.doi.org/10.1001/jama.284.16.2110			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364QA	11042761				2022-12-28	WOS:000089902100033
J	Holt, RD				Holt, RD			Evolutionary biology - Use it or lose it	NATURE			English	Editorial Material							ECOLOGICAL SPECIALIZATION; POPULATIONS		Univ Kansas, Museum Nat Hist, Lawrence, KS 66045 USA; Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA; Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	University of Kansas; University of Kansas; University of Kansas	Holt, RD (corresponding author), Univ Kansas, Museum Nat Hist, Lawrence, KS 66045 USA.	predator@ukans.edu						Agrawal AA, 2000, ECOLOGY, V81, P500, DOI 10.1890/0012-9658(2000)081[0500:HREAAT]2.0.CO;2; [Anonymous], 1995, ADAPTATION NATURAL S, DOI DOI 10.4159/HARVARD.9780674419070; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Culver D. C., 1982, CAVE LIFE; FURCHAIN P, 2000, GENETICS, V154, P959; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Holt RD, 1996, EVOL ECOL, V10, P1, DOI 10.1007/BF01239342; KAWECKI TJ, 1995, EVOL ECOL, V9, P38, DOI 10.1007/BF01237695; Kawecki TJ, 1997, J EVOLUTION BIOL, V10, P407, DOI 10.1007/s000360050032; Kelley ST, 1998, EVOLUTION, V52, P1731, DOI [10.2307/2411346, 10.1111/j.1558-5646.1998.tb02253.x]; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002	12	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					689	690		10.1038/35037703	http://dx.doi.org/10.1038/35037703			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048704				2022-12-28	WOS:000089773900025
J	Krammer, PH				Krammer, PH			CD95's deadly mission in the immune system	NATURE			English	Review							TUMOR-NECROSIS-FACTOR; T-CELL APOPTOSIS; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; FAS-MEDIATED APOPTOSIS; HUMAN DENDRITIC CELLS; HUMAN B-CELLS; IN-VIVO; ANTIGEN RECEPTOR; SURFACE-IMMUNOGLOBULIN; NEGATIVE SELECTION	Apoptosis in the immune system is a fundamental process regulating lymphocyte maturation, receptor repertoire selection and homeostasis. Thus, death by apoptosis is as essential for the function of lymphocytes as growth and differentiation. This article focuses on death receptor-associated apoptosis and the role of CD95 (Apo-1/Fas)- mediated signalling in T-cell and B-cell development and during the course of an immune response. Gaining an insight into these processes improves our understanding of the pathogenesis of diseases such as cancer, autoimmunity and AIDS, and opens new approaches to rational treatment strategies.	German Canc Res Ctr, Tumorimmunol Program, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Krammer, PH (corresponding author), German Canc Res Ctr, Tumorimmunol Program, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.							Adams JM, 1999, ONCOGENE, V18, P5268, DOI 10.1038/sj.onc.1202997; Aiello S, 2000, J IMMUNOL, V164, P4649, DOI 10.4049/jimmunol.164.9.4649; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Amsen D, 1998, IMMUNOL REV, V165, P209, DOI 10.1111/j.1600-065X.1998.tb01241.x; Ashany D, 1999, J IMMUNOL, V163, P5303; Baumler CB, 1996, BLOOD, V88, P1741; Berard R, 1999, J IMMUNOL, V163, P4655; Berndt C, 1998, P NATL ACAD SCI USA, V95, P12556, DOI 10.1073/pnas.95.21.12556; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; Berzins SP, 1999, P NATL ACAD SCI USA, V96, P9787, DOI 10.1073/pnas.96.17.9787; Bjorck P, 1997, INT IMMUNOL, V9, P365, DOI 10.1093/intimm/9.3.365; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; BOISE LH, 1995, CURR OPIN IMMUNOL, V7, P620, DOI 10.1016/0952-7915(95)80067-0; Bouchon A, 2000, EUR J IMMUNOL, V30, P69, DOI 10.1002/1521-4141(200001)30:1<69::AID-IMMU69>3.0.CO;2-#; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CASCINO I, 1995, J IMMUNOL, V154, P2706; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; CHEN WF, 1983, THYMUS, V5, P179; Craxton A, 1999, ADV IMMUNOL, V73, P79, DOI 10.1016/S0065-2776(08)60786-5; DEBATIN KM, 1994, BLOOD, V83, P3101, DOI 10.1182/blood.V83.10.3101a.3101a; Debatin KM, 1999, ADV EXP MED BIOL, V457, P237; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DosReis GA, 1998, IMMUNOL TODAY, V19, P587, DOI 10.1016/S0167-5699(98)01369-3; Drakesmith H, 2000, IMMUNOL TODAY, V21, P214, DOI 10.1016/S0167-5699(00)01610-8; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Foote LC, 1998, J EXP MED, V187, P847, DOI 10.1084/jem.187.6.847; Golstein P, 1997, SCIENCE, V275, P1081, DOI 10.1126/science.275.5303.1081; Gougeon ML, 1999, ANN NY ACAD SCI, V887, P199, DOI 10.1111/j.1749-6632.1999.tb07934.x; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hu SM, 1997, J BIOL CHEM, V272, P9621; Igney FH, 2000, EUR J IMMUNOL, V30, P725, DOI 10.1002/1521-4141(200003)30:3<725::AID-IMMU725>3.3.CO;2-4; Inaba M, 1999, J IMMUNOL, V163, P1315; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KIRCHHOFF S, IN PRESS EUR J IMMUN; KIRCHHOFF S, IN PRESS J IMMUNOL; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; Kishimoto H, 2000, CLIN IMMUNOL, V95, pS3, DOI 10.1006/clim.1999.4818; KLAS C, 1993, INT IMMUNOL, V5, P625, DOI 10.1093/intimm/5.6.625; Knodel M, 1999, EUR J IMMUNOL, V29, P2988; Krammer P H, 1999, Adv Immunol, V71, P163; KRAMMER P H, 1992, Current Biology, V2, P383, DOI 10.1016/0960-9822(92)90084-N; KRAMMER PH, 1994, IMMUNOL REV, V142, P175, DOI 10.1111/j.1600-065X.1994.tb00889.x; KROEMER G, 1995, ADV IMMUNOL, V58, P211, DOI 10.1016/S0065-2776(08)60621-5; Lagresle C, 1996, J EXP MED, V183, P1377, DOI 10.1084/jem.183.4.1377; Lam KP, 1998, P NATL ACAD SCI USA, V95, P13171, DOI 10.1073/pnas.95.22.13171; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; LEITHAUSER F, 1993, LAB INVEST, V69, P415; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li JH, 1998, J IMMUNOL, V161, P3943; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MARIANI SM, 1995, EUR J IMMUNOL, V25, P2303, DOI 10.1002/eji.1830250828; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; Medema JP, 1997, EUR J IMMUNOL, V27, P3492, DOI 10.1002/eji.1830271250; Merville P, 1996, J EXP MED, V183, P227, DOI 10.1084/jem.183.1.227; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1998, J HUM GENET, V43, P2, DOI 10.1007/s100380050029; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; PETER ME, 1998, APOPTOSIS PROBLEMS D, P25; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Spaner D, 1999, J IMMUNOL, V162, P1192; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; Tanaka M, 1996, NAT MED, V2, P317, DOI 10.1038/nm0396-317; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Van Parijs L, 1999, IMMUNITY, V11, P763, DOI 10.1016/S1074-7613(00)80150-8; VanParijs L, 1996, IMMUNITY, V4, P321, DOI 10.1016/S1074-7613(00)80440-9; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; YAGITA H, 1995, IMMUNOL REV, V146, P223, DOI 10.1111/j.1600-065X.1995.tb00691.x; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zhou T, 1999, NAT MED, V5, P42, DOI 10.1038/4723; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367	98	1319	1387	1	57	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					789	795		10.1038/35037728	http://dx.doi.org/10.1038/35037728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048730				2022-12-28	WOS:000089773900054
J	Thoroughman, KA; Shadmehr, R				Thoroughman, KA; Shadmehr, R			Learning of action through adaptive combination of motor primitives	NATURE			English	Article							REACHING MOVEMENTS; ARM; REPRESENTATION; DIRECTION; DYNAMICS; MODEL	Understanding how the brain constructs movements remains a fundamental challenge in neuroscience. The brain may control complex movements through flexible combination of motor primitives(1), where each primitive is an element of computation in the sensorimotor map that transforms desired limb trajectories into motor commands. Theoretical studies have shown that a system's ability to learn action depends on the shape of its primitives(2). Using a time-series analysis of error patterns, here we show that humans learn the dynamics of reaching movements through a flexible combination of primitives that have gaussian-like tuning functions encoding hand velocity. The wide tuning of the inferred primitives predicts limitations on the brain's ability to represent viscous dynamics. We find close agreement between the predicted limitations and the subjects' adaptation to new force fields. The mathematical properties of the derived primitives resemble the tuning curves of Purkinje cells in the cerebellum. The activity of these cells may encode primitives that underlie the learning of dynamics.	Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University	Shadmehr, R (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037422] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007057] Funding Source: Medline; NINDS NIH HHS [R01 NS037422-02, R01 NS037422] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amirikian B, 2000, NEUROSCI RES, V36, P73, DOI 10.1016/S0168-0102(99)00112-1; Bastian AJ, 1996, J NEUROPHYSIOL, V76, P492, DOI 10.1152/jn.1996.76.1.492; Bhushan N, 1999, BIOL CYBERN, V81, P39, DOI 10.1007/s004220050543; Coltz JD, 1999, J NEUROSCI, V19, P1782; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; CONRAD B, 1974, BRAIN RES, V71, P507, DOI 10.1016/0006-8993(74)90994-9; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Ghez C., 2000, NEW COGNITIVE NEUROS, P501; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Goodkin H. P., 1993, Canadian Journal of Neurological Sciences, V20, pS93; Holdefer RN, 2000, J NEUROPHYSIOL, V84, P585, DOI 10.1152/jn.2000.84.1.585; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; KAWATO M, 1989, ADV ROBOTICS, V3, P229; Lang CE, 1999, J NEUROPHYSIOL, V82, P2108, DOI 10.1152/jn.1999.82.5.2108; Martin JH, 2000, J NEUROPHYSIOL, V83, P1886, DOI 10.1152/jn.2000.83.4.1886; MATSOUKA Y, 1998, THESIS MIT; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Nezafat R., 1999, Society for Neuroscience Abstracts, V25, P2178; Sanner RM, 1999, BIOL CYBERN, V80, P369, DOI 10.1007/s004220050532; Schaal S, 1998, NEURAL COMPUT, V10, P2047, DOI 10.1162/089976698300016963; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Spoelstra J, 2000, BIOL CYBERN, V82, P321, DOI 10.1007/s004220050586; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	30	647	678	5	62	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					742	747		10.1038/35037588	http://dx.doi.org/10.1038/35037588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048720	Green Accepted			2022-12-28	WOS:000089773900042
J	Chapman, CR				Chapman, CR			Meteorites - The long trip to Earth	NATURE			English	Editorial Material									SW Res Inst, Boulder, CO 80302 USA		Chapman, CR (corresponding author), SW Res Inst, Suite 426,1050 Walnut St, Boulder, CO 80302 USA.							Farinella P, 1998, ICARUS, V132, P378, DOI 10.1006/icar.1997.5872; Gladman BJ, 1997, SCIENCE, V277, P197, DOI 10.1126/science.277.5323.197; PETERSON C, 1976, ICARUS, V29, P91, DOI 10.1016/0019-1035(76)90105-6; Vokrouhlicky D, 2000, NATURE, V407, P606, DOI 10.1038/35036528; WISDOM J, 1985, NATURE, V315, P731, DOI 10.1038/315731a0	6	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					573	576		10.1038/35036666	http://dx.doi.org/10.1038/35036666			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034191				2022-12-28	WOS:000089772800026
J	Macilwain, C				Macilwain, C			US considers moves to relieve morale crisis at energy labs	NATURE			English	News Item																		Pines D, 2000, NATURE, V407, P447, DOI 10.1038/35035219; 1999, NATURE, V402, P449	2	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					547	548		10.1038/35036708	http://dx.doi.org/10.1038/35036708			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034171	Bronze			2022-12-28	WOS:000089772800003
J	Martin, J				Martin, J			The idea is more important than the experiment	LANCET			English	Editorial Material									UCL, Dept Med, British Heart Fdn Labs, London WC1E 6JJ, England	University of London; University College London	Martin, J (corresponding author), UCL, Dept Med, British Heart Fdn Labs, Torrington Pl, London WC1E 6JJ, England.								0	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					934	937		10.1016/S0140-6736(00)02691-X	http://dx.doi.org/10.1016/S0140-6736(00)02691-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036911				2022-12-28	WOS:000089259800040
J	Busse, WW				Busse, WW			A 47-year-old woman with severe asthma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AIRWAY HYPERRESPONSIVENESS; ADULT PATIENTS; HAY-FEVER; LIFE; ALLERGEN; CHILDREN; INFLAMMATION; BUDESONIDE; PREVALENCE; IMMUNOTHERAPY		Univ Wisconsin, Sch Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Busse, WW (corresponding author), Care of Hartman EE, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,LY318, Boston, MA 02215 USA.							ABRAMSON MJ, 1995, AM J RESP CRIT CARE, V151, P969; ADELROTH E, 1986, AM REV RESPIR DIS, V134, P704; Alm JS, 1999, LANCET, V353, P1485, DOI 10.1016/S0140-6736(98)09344-1; *AM OR SOC, 1991, AM REV RESPIR DIS, V144, P1202; APPEL D, 1989, J ALLERGY CLIN IMMUN, V84, P90, DOI 10.1016/0091-6749(89)90182-6; BEASLEY R, 1993, J ALLERGY CLIN IMMUN, V92, P148, DOI 10.1016/0091-6749(93)90097-Y; Britton J, 1998, BMJ-BRIT MED J, V317, P227, DOI 10.1136/bmj.317.7153.227; Busse WW, 1998, J ALLERGY CLIN IMMUN, V101, P457, DOI 10.1016/S0091-6749(98)70353-7; CHRISTOPHER KL, 1983, NEW ENGL J MED, V308, P1566, DOI 10.1056/NEJM198306303082605; COULTAS DB, 1993, AM J RESP CRIT CARE, V149, pS94; Creticos PS, 1996, NEW ENGL J MED, V334, P501, DOI 10.1056/NEJM199602223340804; DJUKANOVIC R, 1992, AM REV RESPIR DIS, V145, P669, DOI 10.1164/ajrccm/145.3.669; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; Evans DJ, 1997, NEW ENGL J MED, V337, P1412, DOI 10.1056/NEJM199711133372002; Folkerts G, 1998, AM J RESP CRIT CARE, V157, P1708, DOI 10.1164/ajrccm.157.6.9707163; Gern JE, 1999, J CLIN INVEST, V104, P837, DOI 10.1172/JCI8272; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; Habbick BF, 1999, CAN MED ASSOC J, V160, P1824; Harding SM, 1999, J ALLERGY CLIN IMMUN, V104, P251, DOI 10.1016/S0091-6749(99)70360-X; Horwitz RJ, 1998, AM J RESP CRIT CARE, V157, P1363, DOI 10.1164/ajrccm.157.5.9706059; Jarjour NN, 1998, AM J RESP CRIT CARE, V157, P692, DOI 10.1164/ajrccm.157.3.9705020; LANG DM, 1994, NEW ENGL J MED, V331, P1542, DOI 10.1056/NEJM199412083312302; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Laviolette M, 1999, AM J RESP CRIT CARE, V160, P1862, DOI 10.1164/ajrccm.160.6.9803042; Lewis SA, 1998, CLIN EXP ALLERGY, V28, P1493; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Mattes J, 1999, CLIN EXP ALLERGY, V29, P729; Murray MD, 1997, J CLIN EPIDEMIOL, V50, P167, DOI 10.1016/S0895-4356(96)00333-2; *NAT ASTHM ED PROG, 1997, NIH PUBL; *NAT HEART LUNG BL, 1997, NIH PUBL; OBYRNE PM, 1986, CHEST, V90, P575, DOI 10.1378/chest.90.4.575; Panhuysen CIM, 1997, AM J RESP CRIT CARE, V155, P1267, DOI 10.1164/ajrccm.155.4.9105065; Peat JK, 1999, J ALLERGY CLIN IMMUN, V103, P1, DOI 10.1016/S0091-6749(99)70517-8; PLATTSMILLS TAE, 1982, LANCET, V2, P675; Ponsonby AL, 1999, THORAX, V54, P664, DOI 10.1136/thx.54.8.664; RACHELEFSKY GS, 1984, PEDIATRICS, V73, P526; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Shaheen SO, 1996, BRIT MED J, V313, P969, DOI 10.1136/bmj.313.7063.969; SHIM CS, 1983, ARCH INTERN MED, V143, P890, DOI 10.1001/archinte.143.5.890; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Sullivan S, 1996, AM J RESP CRIT CARE, V154, pS84, DOI 10.1164/ajrccm/154.3_Pt_2.S84; Von Ehrenstein OS, 2000, CLIN EXP ALLERGY, V30, P187, DOI 10.1046/j.1365-2222.2000.00801.x; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046; WIESCH DG, 1998, ALLERGY PRINCIPLES P, P799; WILSON SR, 1993, AM J MED, V94, P564, DOI 10.1016/0002-9343(93)90206-5; Woolcock A, 1996, AM J RESP CRIT CARE, V153, P1481, DOI 10.1164/ajrccm.153.5.8630590; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	52	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2225	2233		10.1001/jama.284.17.2225	http://dx.doi.org/10.1001/jama.284.17.2225			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056595				2022-12-28	WOS:000090052600032
J	Mittra, I; Baum, M; Thornton, H; Houghton, J				Mittra, I; Baum, M; Thornton, H; Houghton, J			Is clinical breast examination an acceptable alternative to mammographic screening?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERVAL CANCERS; AGGRESSIVENESS; PROGRAM		UCL, Sch Med, Dept Surg, London W1P 7LD, England; Tata Mem Hosp, Dept Surg Oncol, Mumbai 400012, India; Saionara, Colchester CO5 7EA, Essex, England; Royal Free & UCL Med Sch, CRC & UCL Canc Trials Ctr, CRC Unit, London W1A 8AN, England	University of London; University College London; UCL Medical School; Tata Memorial Centre (TMC); Tata Memorial Hospital; University of London; University College London	Baum, M (corresponding author), UCL, Sch Med, Dept Surg, London W1P 7LD, England.	m.baum@ucl.ac.uk		Mittra, Indraneel/0000-0002-5768-3821				BAINES CJ, 1989, CANCER, V63, P1816; BEAHRS OH, 1979, JNCI-J NATL CANCER I, V62, P639; Day N, 1995, J Med Screen, V2, P180; FLETCHER SW, 1993, J NATL CANCER I, V85, P1644, DOI 10.1093/jnci/85.20.1644; General Medical Council (UK), 1998, SEEK PAT CONS ETH CO; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; HAKAMA M, 1995, LANCET, V345, P221; JOENSUU H, 1991, BRIT J CANCER, V64, P588, DOI 10.1038/bjc.1991.355; KLEMI PJ, 1992, BRIT MED J, V304, P467, DOI 10.1136/bmj.304.6825.467; KOPANS DB, 1990, AM J ROENTGENOL, V155, P748, DOI 10.2214/ajr.155.4.ajronline_155_4_001; Kuroishi T, 2000, Breast Cancer, V7, P1, DOI 10.1007/BF02967181; Miller A B, 1997, J Natl Cancer Inst Monogr, P37; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; MILLER AB, 1991, LANCET, V338, P113, DOI 10.1016/0140-6736(91)90103-V; MILLER AB, 1990, AM J ROENTGENOL, V155, P1133, DOI 10.2214/ajr.155.5.2120947; MITTRA I, 1999, CANC STRATEGY, V1, P152; MITTRA I, 1997, BREAST CANC SCREENIN, P97; PATNICK J, 1998, 98 REV NHS BREAST SC; SEMIGLAZOV VF, 1993, EUR J CANCER, V29A, P2039; Skrabanek P, 1989, Int J Technol Assess Health Care, V5, P423; Sylvester PA, 1997, ANN ROY COLL SURG, V79, P276; Thomas DB, 1997, JNCI-J NATL CANCER I, V89, P355, DOI 10.1093/jnci/89.5.355; WOODMAN CBJ, 1995, BRIT MED J, V310, P224, DOI 10.1136/bmj.310.6974.224; 1992, LANCET, V339, P1473	24	41	44	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2000	321	7268					1071	1073		10.1136/bmj.321.7268.1071	http://dx.doi.org/10.1136/bmj.321.7268.1071			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PU	11053185	Green Published			2022-12-28	WOS:000165076800031
J	de la Iglesia, HO; Meyer, J; Carpino, A; Schwartz, WJ				de la Iglesia, HO; Meyer, J; Carpino, A; Schwartz, WJ			Antiphase oscillation of the left and right suprachiasmatic nuclei	SCIENCE			English	Article							ACTIVITY RHYTHMS; CIRCADIAN OSCILLATORS; GOLDEN-HAMSTER; INTERNAL DESYNCHRONIZATION; UNILATERAL LESIONS; FIRING RHYTHMS; DARK PULSES; EXPRESSION; LIGHT; CLOCK	An unusual property of the circadian timekeeping systems of animals is rhythm "splitting," in which a single daily period of physical activity (usually measured as wheel running) dissociates into two stably coupled components about 12 hours apart; this behavior has been ascribed to a clock composed of two circadian oscillators cycling in antiphase. We analyzed gene expression in the hypothalamic circadian clock, the suprachiasmatic nucleus (SCN), of behaviorally "split" hamsters housed in constant Light. The results show that the two oscillators underlying the split condition correspond to the Left and right sides of the bilaterally paired SCN.	Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	de la Iglesia, HO (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, 55 Lake Ave N, Worcester, MA 01655 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NINDS NIH HHS [R01 NS24542] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024542] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; BOULOS Z, 1986, J BIOL RHYTHM, V1, P1; CHAMBILLE I, 1993, BRAIN RES, V612, P138, DOI 10.1016/0006-8993(93)91654-B; DAAN S, 1978, J THEOR BIOL, V70, P297, DOI 10.1016/0022-5193(78)90378-8; Davis FC, 1996, J BIOL RHYTHM, V11, P291, DOI 10.1177/074873049601100402; DAVIS FC, 1984, J COMP PHYSIOL, V154, P221, DOI 10.1007/BF00604987; Guido ME, 1999, NEUROSCIENCE, V90, P555, DOI 10.1016/S0306-4522(98)00467-9; HARRINGTON ME, 1990, BRAIN RES BULL, V24, P593, DOI 10.1016/0361-9230(90)90164-U; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; HUDSON DJ, 1980, BRAIN RES, V183, P481, DOI 10.1016/0006-8993(80)90485-0; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KALSBEEK A, 1993, J COMP NEUROL, V332, P293, DOI 10.1002/cne.903320304; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KOEHLER WK, 1978, NATURE, V274, P708, DOI 10.1038/274708a0; LEES JG, 1983, J COMP PHYSIOL, V153, P123, DOI 10.1007/BF00610349; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; MEIJER JH, 1990, J BIOL RHYTHM, V5, P1, DOI 10.1177/074873049000500101; PAGE TL, 1978, J COMP PHYSIOL, V124, P225, DOI 10.1007/BF00657054; Palmer JD, 2000, BIOESSAYS, V22, P32, DOI 10.1002/(SICI)1521-1878(200001)22:1<32::AID-BIES7>3.3.CO;2-L; PICKARD GE, 1984, PHYSIOL BEHAV, V32, P763, DOI 10.1016/0031-9384(84)90191-4; PICKARD GE, 1982, SCIENCE, V215, P1119, DOI 10.1126/science.7063843; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; REPPERT SM, 1987, TRENDS NEUROSCI, V10, P76, DOI 10.1016/0166-2236(87)90029-4; Schwartz WJ, 2000, NEUROSCIENCE, V98, P535, DOI 10.1016/S0306-4522(00)00140-8; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; SHIBUYA CA, 1980, NATURWISSENSCHAFTEN, V67, P45, DOI 10.1007/BF00424511; Sumova A, 1998, AM J PHYSIOL-REG I, V274, pR857, DOI 10.1152/ajpregu.1998.274.3.R857; SWANN JM, 1985, SCIENCE, V228, P898, DOI 10.1126/science.4001926; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; WIEDENMANN G, 1983, J COMP PHYSIOL, V150, P51, DOI 10.1007/BF00605287; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; ZLOMANCZUK P, 1991, BRAIN RES, V559, P94, DOI 10.1016/0006-8993(91)90291-3	36	223	228	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					799	801		10.1126/science.290.5492.799	http://dx.doi.org/10.1126/science.290.5492.799			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052942				2022-12-28	WOS:000090067600047
J	van der Wal, CH; ter Haar, ACJ; Wilhelm, FK; Schouten, RN; Harmans, CJPM; Orlando, TP; Lloyd, S; Mooij, JE				van der Wal, CH; ter Haar, ACJ; Wilhelm, FK; Schouten, RN; Harmans, CJPM; Orlando, TP; Lloyd, S; Mooij, JE			Quantum superposition of macroscopic persistent-current states	SCIENCE			English	Article							SPECTROSCOPY; SYSTEM	Microwave spectroscopy experiments have been performed on two quantum Levels of a macroscopic superconducting Loop with three Josephson junctions. Level repulsion of the ground state and first excited state is found where two classical persistent-current states with opposite polarity are degenerate, indicating symmetric and antisymmetric quantum superpositions of macroscopic states. The two classical states have persistent currents of 0.5 microampere and correspond to the center-of-mass motion of millions of Cooper pairs.	Delft Univ Technol, Dept Appl Phys, NL-2600 GA Delft, Netherlands; Delft Inst Microelect & Submicron Technol, NL-2600 GA Delft, Netherlands; MIT, Dept Mech Engn, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Delft University of Technology; Delft University of Technology; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	van der Wal, CH (corresponding author), Delft Univ Technol, Dept Appl Phys, POB 5046, NL-2600 GA Delft, Netherlands.	caspar@qt.tn.tudelft.nl	van der Wal, Caspar H./D-9206-2013; Mooij, Johan/B-1371-2012; Wilhelm, Frank/G-2162-2010; Wilhelm, Frank/F-7944-2017	van der Wal, Caspar H./0000-0002-9843-3220; Wilhelm, Frank/0000-0003-1034-8476				ABRAGAM A, 1961, PRINCIPLES NUCLEAR M, P39; Anderson P.W., 1964, LECT MANY BODY PROBL, V2, P113, DOI DOI 10.1140/EPJST/E2010-01303-3; Arndt M, 1999, NATURE, V401, P680, DOI 10.1038/44348; Bocko MF, 1997, IEEE T APPL SUPERCON, V7, P3638, DOI 10.1109/77.622206; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; COHENTANNOUDJI C, 1977, QUANTUM MECH, V1, P443; Cosmelli C, 1999, PHYS REV LETT, V82, P5357, DOI 10.1103/PhysRevLett.82.5357; del Barco E, 1999, EUROPHYS LETT, V47, P722, DOI 10.1209/epl/i1999-00450-8; Flees DJ, 1999, J SUPERCOND, V12, P813, DOI 10.1023/A:1007797329201; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; Grifoni M, 1998, PHYS REP, V304, P229, DOI 10.1016/S0370-1573(98)00022-2; GRIFONI M, 1998, QUANTUM MEASUREMENT, P1; Han SY, 1996, PHYS REV LETT, V76, P3404, DOI 10.1103/PhysRevLett.76.3404; Han SY, 2000, PHYS REV LETT, V84, P1300, DOI 10.1103/PhysRevLett.84.1300; Ioffe LB, 1999, NATURE, V398, P679, DOI 10.1038/19464; Leggett A J, 1980, PROG THEOR PHYS SUPP, V69, P80; Leggett AJ, 1999, J SUPERCOND, V12, P683, DOI 10.1023/A:1007712405094; LEGGETT AJ, 1985, PHYS REV LETT, V54, P857, DOI 10.1103/PhysRevLett.54.857; LEGGETT AJ, 1987, REV MOD PHYS, V59, P1, DOI 10.1103/RevModPhys.59.1; Likharev K. K., 1983, SOV PHYS USP, V26, P87; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Nakamura Y, 1997, PHYS REV LETT, V79, P2328, DOI 10.1103/PhysRevLett.79.2328; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Oosterkamp TH, 1998, NATURE, V395, P873, DOI 10.1038/27617; Orlando TP, 1999, PHYS REV B, V60, P15398, DOI 10.1103/PhysRevB.60.15398; Prokof'ev NV, 2000, REP PROG PHYS, V63, P669, DOI 10.1088/0034-4885/63/4/204; ROUSE R, 1995, PHYS REV LETT, V75, P1614, DOI 10.1103/PhysRevLett.75.1614; TIAN L, IN PRESS QUANTUM MES; TINKHAM M, 1996, INTRO SUPERCONDUCTIV, P196; van der Wal CH, 1999, J SUPERCOND, V12, P807, DOI 10.1023/A:1007745312363; Wernsdorfer W, 1999, SCIENCE, V284, P133, DOI 10.1126/science.284.5411.133	32	792	807	2	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2000	290	5492					773	777		10.1126/science.290.5492.773	http://dx.doi.org/10.1126/science.290.5492.773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052934	Green Submitted			2022-12-28	WOS:000090067600039
J	Loff, B; Gruskin, S				Loff, B; Gruskin, S			Getting serious about the right to health	LANCET			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02115 USA; Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Harvard University; Harvard T.H. Chan School of Public Health; Monash University	Loff, B (corresponding author), Harvard Univ, Sch Publ Hlth, Francois Xavier Bagnoud Ctr Hlth & Human Rights, 665 Huntington Ave, Boston, MA 02115 USA.		Loff, Bebe/G-9241-2014	Loff, Bebe/0000-0003-1963-6503					0	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1435	1435		10.1016/S0140-6736(05)74070-8	http://dx.doi.org/10.1016/S0140-6736(05)74070-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052602				2022-12-28	WOS:000089976100047
J	Iwamoto, T; Tamura, M; Kabuto, C; Kira, M				Iwamoto, T; Tamura, M; Kabuto, C; Kira, M			A stable bicyclic compound with two Si = Si double bonds	SCIENCE			English	Article							SI DOUBLE-BONDS; SILICON; AROMATICITY	In contrast to carbon, silicon does not readily form double bonds, and compounds containing silicon-silicon double bonds can usually be stabilized only by protection with bulky substituents. We have isolated a silicon analog of spiropentadiene 1, a carbon double-ring compound that has not been isolated to date. In the crystal structure of tetrakis[tri(t-butyldimethylsilyl)silyl]spiropentasiladiene 2, a substantial deviation from the perpendicular arrangement of the two rings is observed, and the silicon-silicon double bonds are shown to be distorted. Spectroscopic data indicate pronounced interaction between two remote silicon-silicon double bonds in the molecule. Silicon-silicon bonds may be more accessible to synthesis than previously assumed.	Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Kira, M (corresponding author), Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan.		Iwamoto, Takeaki/C-5131-2009	Iwamoto, Takeaki/0000-0002-8556-5785				BILLUPS WE, 1991, J AM CHEM SOC, V113, P5084, DOI 10.1021/ja00013a067; BOOUDJOUK P, 1984, J CHEM SOC CHEM COMM, P777; FRISCH MJ, 1998, GAUSSIAN 98 REV A 7; GEORGE P, 1976, TETRAHEDRON, V32, P317, DOI 10.1016/0040-4020(76)80043-9; Goller A, 1996, J ORG CHEM, V61, P5840, DOI 10.1021/jo960387h; Grybat A, 1999, ANGEW CHEM INT EDIT, V38, P2010, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<2010::AID-ANIE2010>3.0.CO;2-T; HOFFMANN R, 1967, J AM CHEM SOC, V89, P5215, DOI 10.1021/ja00996a023; Ichinohe M, 1999, ANGEW CHEM INT EDIT, V38, P2194, DOI 10.1002/(SICI)1521-3773(19990802)38:15<2194::AID-ANIE2194>3.0.CO;2-L; Iwamoto T, 1999, J AM CHEM SOC, V121, P886, DOI 10.1021/ja983623+; KAO J, 1978, J AM CHEM SOC, V100, P766; Kira M, 1996, J AM CHEM SOC, V118, P10303, DOI 10.1021/ja961913p; Nyulaszi L, 1999, J AM CHEM SOC, V121, P6872, DOI 10.1021/ja983113f; Okazaki R., 1996, ADV ORGANOMET CHEM, V39, P231, DOI DOI 10.1016/S0065-3055(08)60469-4; Raabe G., 1989, CHEM ORGANIC SILICON; Saini RK, 1999, TETRAHEDRON LETT, V40, P6157, DOI 10.1016/S0040-4039(99)01293-9; SIMMONS HE, 1967, J AM CHEM SOC, V89, P5208, DOI 10.1021/ja00996a022; TSUMURAYA T, 1991, ANGEW CHEM INT EDIT, V30, P902, DOI 10.1002/anie.199109021; Tsutsui S, 1998, ORGANOMETALLICS, V17, P3819, DOI 10.1021/om980207p; Weidenbruch M, 1997, ANGEW CHEM INT EDIT, V36, P2503, DOI 10.1002/anie.199725031; West R, 1997, J AM CHEM SOC, V119, P4972, DOI 10.1021/ja963921b; WEST R, 1981, SCIENCE, V214, P1343, DOI 10.1126/science.214.4527.1343; Wiberg N, 1998, ANGEW CHEM INT EDIT, V37, P2869, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2869::AID-ANIE2869>3.0.CO;2-2	22	78	78	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					504	506		10.1126/science.290.5491.504	http://dx.doi.org/10.1126/science.290.5491.504			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039928				2022-12-28	WOS:000089946000047
J	Yan, MH; Wang, LC; Hymowitz, SG; Schilbach, S; Lee, J; Goddard, A; de Vos, AM; Gao, WQ; Dixit, VM				Yan, MH; Wang, LC; Hymowitz, SG; Schilbach, S; Lee, J; Goddard, A; de Vos, AM; Gao, WQ; Dixit, VM			Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors	SCIENCE			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; ECTODYSPLASIN-A; EDA GENE; PROTEIN; HOMOLOG; RESOLUTION; MUTATIONS; MEMBRANE; ENCODES; DOMAIN	Ectodysplasin, a member of the tumor necrosis factor family, is encoded by the anhidrotic ectodermal dysplasia (EDA) gene. Mutations in EDA give rise to a clinical syndrome characterized by loss of hair, sweat glands, and teeth. EDA-A1 and EDA-A2 are two isoforms of ectodysplasin that differ only by an insertion of two amino acids. This insertion functions to determine receptor binding specificity, such that EDA-A1 binds only the receptor EDAR, whereas EDA-A2 binds only the related, but distinct, X-linked ectodysplasin-A2 receptor (XEDAR). In situ binding and organ culture studies indicate that EDA-A1 and EDA-A2 are differentially expressed and play a role in epidermal morphogenesis.	Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, S San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, S San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, S San Francisco, CA 94080 USA.		dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; ECK MJ, 1992, J BIOL CHEM, V267, P2119; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Freire-Maia N, 1988, Birth Defects Orig Artic Ser, V24, P3; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Mikkola ML, 1999, MECH DEVELOP, V88, P133, DOI 10.1016/S0925-4773(99)00180-X; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Wang LC, 2000, J NEUROSCI RES, V61, P1; WILSONRAWLS J, 1994, VIROLOGY, V201, P66, DOI 10.1006/viro.1994.1266; Yan M., UNPUB; ZONANA J, 1992, AM J HUM GENET, V51, P1036	20	223	364	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					523	527		10.1126/science.290.5491.523	http://dx.doi.org/10.1126/science.290.5491.523			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039935				2022-12-28	WOS:000089946000054
J	Chan, TM; Li, FK; Tang, CSO; Wong, RWS; Fang, GX; Ji, YL; Lau, CS; Wong, AKM; Tong, MKL; Chan, KW; Lai, KN				Chan, TM; Li, FK; Tang, CSO; Wong, RWS; Fang, GX; Ji, YL; Lau, CS; Wong, AKM; Tong, MKL; Chan, KW; Lai, KN		Hong Kong-Guangzhou Nephrol Study Grp	Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTROLLED TRIAL; THERAPY; CYCLOPHOSPHAMIDE; ERYTHEMATOSUS; PREDNISONE	Background: The combination of cyclophosphamide and prednisolone is effective for the treatment of severe lupus nephritis but has serious adverse effects. Whether mycophenolate mofetil can be substituted for cyclophosphamide is not known. Methods: In 42 patients with diffuse proliferative lupus nephritis we compared the efficacy and side effects of a regimen of prednisolone and mycophenolate mofetil given for 12 months with those of a regimen of prednisolone and cyclophosphamide given for 6 months, followed by prednisolone and azathioprine for 6 months. Complete remission was defined as a value for urinary protein excretion that was less than 0.3 g per 24 hours, with normal urinary sediment, a normal serum albumin concentration, and values for serum creatinine and creatinine clearance that were no more than 15 percent above the base-line values. Partial remission was defined as a value for urinary protein excretion that was between 0.3 and 2.9 g per 24 hours, with a serum albumin concentration of at least 3.0 g per deciliter. Results: Eighty-one percent of the 21 patients treated with mycophenolate mofetil and prednisolone (group 1) had a complete remission, and 14 percent had a partial remission, as compared with 76 percent and 14 percent, respectively, of the 21 patients treated with cyclophosphamide and prednisolone followed by azathioprine and prednisolone (group 2). The improvements in the degree of proteinuria and the serum albumin and creatinine concentrations were similar in the two groups. One patient in each group discontinued treatment because of side effects. Infections were noted in 19 percent of the patients in group 1 and in 33 percent of those in group 2 (P=0.29). Other adverse effects occurred only in group 2; they included amenorrhea (in 23 percent of the patients), hair loss (19 percent), leukopenia (10 percent), and death (10 percent). The rates of relapse were 15 percent and 11 percent, respectively. Conclusions: For the treatment of diffuse proliferative lupus nephritis, the combination of mycophenolate mofetil and prednisolone is as effective as a regimen of cyclophosphamide and prednisolone followed by azathioprine and prednisolone. (N Engl J Med 2000;343:1156-62.) (C) 2000 Massachusetts Medical Society.	Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Nephrol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chan, TM (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Nephrol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.			Lau, Wallace Chak Sing/0000-0001-6698-8355; Chan, Tak Mao/0000-0002-3495-4051				Allison AC, 1996, CLIN TRANSPLANT, V10, P77; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; AUSTIN HA, 1986, NEW ENGL J MED, V314, P614, DOI 10.1056/NEJM198603063141004; BOUMPAS DT, 1992, LANCET, V340, P741, DOI 10.1016/0140-6736(92)92292-N; CHAN TM, 1995, NEPHRON, V71, P321, DOI 10.1159/000188739; Churg J., 1982, RENAL DIS CLASSIFICA; DONADIO JV, 1978, NEW ENGL J MED, V299, P1151, DOI 10.1056/NEJM197811232992102; Dooley MA, 1999, J AM SOC NEPHROL, V10, P833; Glicklich D, 1998, AM J KIDNEY DIS, V32, P318, DOI 10.1053/ajkd.1998.v32.pm9708620; GRINYO J, 1995, LANCET, V345, P1321; Halloran P, 1997, TRANSPLANTATION, V63, P618; Jonsson CA, 1999, CLIN EXP IMMUNOL, V116, P534; LEWIS EJ, 1992, NEW ENGL J MED, V326, P1373, DOI 10.1056/NEJM199205213262101; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; van Bruggen MCJ, 1998, J AM SOC NEPHROL, V9, P1407	15	738	799	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2000	343	16					1156	1162		10.1056/NEJM200010193431604	http://dx.doi.org/10.1056/NEJM200010193431604			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364FY	11036121	Green Published			2022-12-28	WOS:000089882800004
J	[Anonymous]				[Anonymous]			Desperately seeking a syndrome	NATURE			English	Editorial Material																		Wadman M, 2000, NATURE, V407, P121, DOI 10.1038/35025263; Wadman M, 1997, NATURE, V385, P187, DOI 10.1038/385187a0	2	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					819	819						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057624				2022-12-28	WOS:000089901900001
J	Gostin, LO				Gostin, LO			A proposed national policy on health care workers living with HIV/AIDS and other blood-borne pathogens	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-B VIRUS; HIV TRANSMISSION; PATIENT; PROVIDER; SURGEON; DISCRIMINATION; INFECTION	In 1991, scientific uncertainty about the risk of transmission of human immunodeficiency virus or hepatitis B virus (hepatitis B e antigen [HBeAg]-positive) led the Centers for Disease Control and Prevention to recommend that infected health care workers (HCWs) be reviewed by an expert panel and inform patients of their serologic status before engaging in exposure-prone procedures. The data demonstrate that risks of transmission in the health care setting are exceedingly low, suggesting that the national policy should be reformed. Implementation of the current national policy at the local level poses significant human rights burdens on HCWs. but does not improve patient safety. A new national policy should focus on the management of the workplace environment and injury prevention by creating a program to prevent blood-borne pathogen transmission; by encouraging infected HCWs to promote their own health and well-being; by discontinuing expert review panels and special restrictions for exposure-prone procedures, which stigmatize HCWs; by discontinuing mandatory disclosure of a HCW's infection status in low-level risk procedures; and by imposing practice restrictions to avert significant risks to patients. Inclusion of these principles would achieve high levels of patient safety without discrimination and invasion of privacy.	Georgetown Univ, Ctr Law, Washington, DC 20001 USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA	Georgetown University; Johns Hopkins University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						*AM COLL SURG, 1999, B AM COLL SURG, V84, P21; *AM COLL SURG, 1998, B AM COLL SURG, V83, P27; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; BEEKMANN SE, 1994, CLIN INFECT DIS, V18, P562, DOI 10.1093/clinids/18.4.562; BELL DM, 1995, SURG CLIN N AM, V75, P1189; Blanchard A, 1998, J VIROL, V72, P4537, DOI 10.1128/JVI.72.5.4537-4540.1998; *CDCP, 2000, SURV HLTH CAR WORK H; CIESIELSKI CA, 1994, ANN INTERN MED, V121, P886, DOI 10.7326/0003-4819-121-11-199412010-00011; DANIELS N, 1992, JAMA-J AM MED ASSOC, V267, P1368, DOI 10.1001/jama.267.10.1368; Donnelly M, 1999, Commun Dis Public Health, V2, P126; Duckworth G J, 1999, Commun Dis Public Health, V2, P188; Esteban JI, 1996, NEW ENGL J MED, V334, P555, DOI 10.1056/NEJM199602293340902; FISHER ES, 1997, TORT INSUR LAW J, V33, P169; FRIEDLAND GH, 1987, NEW ENGL J MED, V317, P1125, DOI 10.1056/NEJM198710293171806; Garner Julia S., 1996, Infection Control and Hospital Epidemiology, V17, P53; Gerberding J, 1999, ANN INTERN MED, V130, P64, DOI 10.7326/0003-4819-130-1-199901050-00012; Gerberding JL, 1996, NEW ENGL J MED, V334, P594, DOI 10.1056/NEJM199602293340909; GOSTIN L, 1991, ARCH INTERN MED, V151, P663, DOI 10.1001/archinte.151.4.663; Gostin L, 1991, Law Med Health Care, V19, P140; Gostin LO, 1999, JAMA-J AM MED ASSOC, V281, P745, DOI 10.1001/jama.281.8.745; GOSTIN LO, 1996, COMMUNICATION   0626; Goujon CP, 2000, J VIROL, V74, P2525, DOI 10.1128/JVI.74.6.2525-2532.2000; Harpaz R, 1996, NEW ENGL J MED, V334, P549, DOI 10.1056/NEJM199602293340901; Henderson DK, 1997, INFECT CONT HOSP EP, V18, P349; Heptonstall J, 1997, NEW ENGL J MED, V336, P178, DOI 10.1056/NEJM199701163360304; Hutin YJF, 1999, INFECT CONT HOSP EP, V20, P731, DOI 10.1086/501573; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; LO B, 1992, JAMA-J AM MED ASSOC, V267, P1100, DOI 10.1001/jama.267.8.1100; Lot F, 1999, ANN INTERN MED, V130, P1, DOI 10.7326/0003-4819-130-1-199901050-00002; McIntosh P L, 1996, Univ Kans Law Rev, V44, P315; Ngui SL, 2000, J INFECT DIS, V181, P838, DOI 10.1086/315313; Noble A, 1998, J Eval Clin Pract, V4, P49, DOI 10.1046/j.1365-2753.1998.t01-1-00005.x; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; RHODES RS, 1995, SURG CLIN N AM, V75, P1205; ROBERT LM, 1995, ANN INTERN MED, V122, P653, DOI 10.7326/0003-4819-122-9-199505010-00002; Robinson EN, 1996, MED DECIS MAKING, V16, P86, DOI 10.1177/0272989X9601600117; RODGERS AS, 1993, JAMA-J AM MED ASSOC, V269, P1795; ROPER WL, 1992, COMMUNICATION   0616; Ross RS, 1999, LANCET, V353, P324, DOI 10.1016/S0140-6736(05)74903-5; Ross RS, 2000, ARCH INTERN MED, V160, P2313, DOI 10.1001/archinte.160.15.2313; Saag MS, 1996, NAT MED, V2, P625, DOI 10.1038/nm0696-625; Schatz B, 1995, B NEW YORK ACAD MED, V72, P263; Van Detta JA, 1999, HARVARD J LAW PUBL P, V22, P849; WEBBER DW, 1997, AIDS LAW; Wilfert CM, 1999, PEDIATRICS, V104, P318, DOI 10.1542/peds.104.2.318; 1991, MMWR MORB MORTAL WKL, V40, P33; 1990, MMWR MORB MORTAL WKL, V39, P489; 1995, COMMUN DIS REP CDR W, V5, P121; 1991, MMWR MORB MORTAL WKL, V40, P21; 1993, MMWR MORB MORTAL WKL, V42, P337; 1993, MMWR MORB MORTAL WKL, V42, P329; 1991, MMWR MORB MORTAL WKL, V40, P377	53	29	30	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1965	1970		10.1001/jama.284.15.1965	http://dx.doi.org/10.1001/jama.284.15.1965			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362JC	11035894				2022-12-28	WOS:000089774000030
J	Ye, K; Cong, BL; Ye, DI				Ye, K; Cong, BL; Ye, DI			The possible subduction of continental material to depths greater than 200 km	NATURE			English	Article							HIGH-PRESSURE; 300 KILOMETERS; EASTERN CHINA; ALPE-ARAMI; ECLOGITE; TRANSFORMATION; PERIDOTITE; ISOTOPE; GARNETS; DIAMOND	Determining the depth to which continental lithosphere can be subducted into the mantle at convergent plate boundaries is of importance for understanding the long-term growth of supercontinents as well as the dynamic processes that shape such margins. Recent discoveries of coesite and diamond in regional ultrahigh-pressure (UHP) metamorphic rocks has demonstrated that continental material can be subducted to depths of at least 120 km (ref. 1), and subduction to depths of 150-300 km has been inferred from garnet peridotites in orogenic UHP belts based on several indirect observations(2-5). But continental subduction to such depths is difficult to trace directly in natural UHP metamorphic crustal rocks by conventional mineralogical and petrological methods because of extensive late-stage recrystallization and the lack of a suitable pressure indicator. It has been predicted from experimental work, however, that solid-state dissolution of pyroxene should occur in garnet at depths greater than 150 km (refs 6-8). Here we report the observation of high concentrations of clinopyroxene, rutile and apatite exsolutions in garnet within eclogites from Yangkou in the Sulu UHP metamorphic belt, China. We interpret these data as resulting from the high-pressure formation of pyroxene solid solutions in subducted continental material. Appropriate conditions for the Na2O concentrations and octahedral silicon observed in these samples are met at depths greater than 200 km.	Chinese Acad Sci, Inst Geol & Geophys, Lab Lithosphere Tecton Evolut, Beijing 100029, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS	Ye, K (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Lab Lithosphere Tecton Evolut, POB 9825, Beijing 100029, Peoples R China.							AMES L, 1993, GEOLOGY, V21, P339, DOI 10.1130/0091-7613(1993)021<0339:TOCOTS>2.3.CO;2; AMSTRONG RL, 1981, PHIL T R SOC LOND A, V301, P443; ANDERSSON S, 1977, NATURE, V267, P605, DOI 10.1038/267605b0; Bozhilov KN, 1999, SCIENCE, V284, P128, DOI 10.1126/science.284.5411.128; Chopin C., 1995, ULTRAHIGH PRESSURE M, P96, DOI DOI 10.1017/CB09780511573088.004; Cong BL., 1996, ULTRAHIGH PRESSURE M, p224 pp; Dobrzhinetskaya L, 1996, SCIENCE, V271, P1841, DOI 10.1126/science.271.5257.1841; DUPRE B, 1983, NATURE, V303, P142, DOI 10.1038/303142a0; Green HW, 1997, SCIENCE, V278, P704; HAGGERTY SE, 1990, SCIENCE, V248, P993, DOI 10.1126/science.248.4958.993; IRIFUNE T, 1986, EARTH PLANET SC LETT, V77, P245, DOI 10.1016/0012-821X(86)90165-2; IRIFUNE T, 1994, EARTH PLANET SC LETT, V126, P351, DOI 10.1016/0012-821X(94)90117-1; LOUBET M, 1988, EARTH PLANET SC LETT, V89, P299, DOI 10.1016/0012-821X(88)90118-5; MOORE RO, 1985, NATURE, V318, P553, DOI 10.1038/318553a0; Okamoto K, 1998, ISL ARC, V7, P52, DOI 10.1046/j.1440-1738.1998.00179.x; Ono S, 1996, PHYS EARTH PLANET IN, V96, P171, DOI 10.1016/0031-9201(96)03149-4; RINGWOOD AE, 1971, EARTH PLANET SC LETT, V12, P411, DOI 10.1016/0012-821X(71)90026-4; RINGWOOD AE, 1970, EARTH PLANET SC LETT, V7, P371, DOI 10.1016/0012-821X(69)90052-1; SCHERTL HP, 1991, CONTRIB MINERAL PETR, V108, P1, DOI 10.1007/BF00307322; SOBOLEV NV, 1971, CONTRIB MINERAL PETR, V31, P1, DOI 10.1007/BF00373387; TOMPSON RN, 1975, EARTH PLANET SC LETT, V26, P417; van Roermund H.L.M., 1998, EOS, V79, pF971; Wallis SR, 1997, J GEOL SOC LONDON, V154, P45, DOI 10.1144/gsjgs.154.1.0045; Widiyantoro S, 1996, SCIENCE, V271, P1566, DOI 10.1126/science.271.5255.1566; YANG JJ, 1993, J GEOL, V101, P541, DOI 10.1086/648248; Ye K, 2000, LITHOS, V52, P157, DOI 10.1016/S0024-4937(99)00089-4; ZHANG RY, 1994, J METAMORPH GEOL, V12, P169, DOI 10.1111/j.1525-1314.1994.tb00012.x; Zhang RY, 1997, J METAMORPH GEOL, V15, P183, DOI 10.1111/j.1525-1314.1997.00012.x	28	532	667	3	105	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					734	736		10.1038/35037566	http://dx.doi.org/10.1038/35037566			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048717				2022-12-28	WOS:000089773900039
J	Voinnet, O; Lederer, C; Baulcombe, DC				Voinnet, O; Lederer, C; Baulcombe, DC			A viral movement protein prevents spread of the gene silencing signal in Nicotiana benthamiana	CELL			English	Article							PLANTS; VIRUSES; RNA; DNA; SUPPRESSION; STRATEGY; CELL	In plants, viruses induce an RNA-mediated defense that is similar to posttranscriptional gene silencing (PTGS) of transgenes. Here we demonstrate with potato virus X (PVX) that PTGS operates as a systemic, sequence-specific defense system. However, in grafting experiments or with movement defective forms of PVX, we could not detect systemic silencing unless the 25 kDa viral movement protein (p25) was made nonfunctional. Investigation of p25 revealed two branches to the PTGS pathway that converge in the production of 25 nucleotide RNAs corresponding to the target RNA. One of these branches is unique to virus-induced PTGS and is not affected by p25. The second branch is common to both virus- and transgene-induced PTGS, is blocked by p25, and is likely to generate the systemic silencing signal.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Baulcombe, DC (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	david.baulcombe@bbsrc.ac.uk	Lederer, Carsten W./GXN-3171-2022	Voinnet, Olivier/0000-0001-6982-9544; Baulcombe, David/0000-0003-0780-6878				Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Angell SM, 1996, VIROLOGY, V216, P197, DOI 10.1006/viro.1996.0046; Atabekov J G, 1990, Adv Virus Res, V38, P201, DOI 10.1016/S0065-3527(08)60863-5; Baulcombe D, 1999, ARCH VIROL, P189; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Carrington JC, 1999, TRENDS MICROBIOL, V7, P312, DOI 10.1016/S0966-842X(99)01559-0; Carrington JC, 1996, PLANT CELL, V8, P1669, DOI 10.1105/tpc.8.10.1669; Chisholm ST, 2000, P NATL ACAD SCI USA, V97, P489, DOI 10.1073/pnas.97.1.489; Covey SN, 1997, NATURE, V385, P781, DOI 10.1038/385781a0; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Jorgensen RA, 1998, SCIENCE, V279, P1486, DOI 10.1126/science.279.5356.1486; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Lucas WJ, 1999, CURR OPIN PLANT BIOL, V2, P192, DOI 10.1016/S1369-5266(99)80035-1; Matthews REF., 2002, PLANT VIROLOGY; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Ruiz F, 1998, MOL BIOL CELL, V9, P931, DOI 10.1091/mbc.9.4.931; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; Verchot J, 1998, J VIROL, V72, P8316, DOI 10.1128/JVI.72.10.8316-8320.1998; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Whitham SA, 1999, P NATL ACAD SCI USA, V96, P772, DOI 10.1073/pnas.96.2.772; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	33	512	573	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 29	2000	103	1					157	167		10.1016/S0092-8674(00)00095-7	http://dx.doi.org/10.1016/S0092-8674(00)00095-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051555	Bronze			2022-12-28	WOS:000089636400016
J	Apfel, SC; Schwartz, S; Adornato, BT; Freeman, R; Biton, V; Rendell, M; Vinik, A; Giuliani, M; Stevens, JC; Barbano, R; Dyck, PJ				Apfel, SC; Schwartz, S; Adornato, BT; Freeman, R; Biton, V; Rendell, M; Vinik, A; Giuliani, M; Stevens, JC; Barbano, R; Dyck, PJ		rhNGF Clin Investigator Grp	Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy - A randomized controled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RETROGRADE AXONAL-TRANSPORT; DETECTION THRESHOLDS; FACTOR NGF; NEUROPATHY; SKIN; RATS	Context Nerve growth factor is a neurotrophic factor that promotes the survival of small fiber sensory neurons and sympathetic neurons in the peripheral nervous system. Recombinant human nerve growth factor (rhNGF) has demonstrated efficacy as treatment for peripheral neuropathy in experimental models and phase 2 clinical trials. Objective To evaluate the efficacy and safety of a 12-month regimen of rhNGF in patients with diabetic polyneuropathy. Design Randomized, double-blind, placebo-controlled phase 3 trial conducted from July 1997 through May 1999, Setting Eighty-four outpatient centers throughout the United States. Patients A total of 1019 men and women aged 18 to 74 years with either type 1 or type 2 diabetes and a sensory polyneuropathy attributable to diabetes. Interventions Patients were randomly assigned to receive either rhNGF, 0.1 mug/kg (n = 504), or placebo (n = 515) by subcutaneous injection 3 times per week for 48 weeks. Patients were assessed at baseline, 12 weeks, 24 weeks, and 48 weeks. Main Outcome Measures The primary outcome measure was a change in neuropathy between baseline and week 48, demonstrated by the Neuropathy Impairment Score for the Lower Limbs, compared between the 2 groups. Secondary outcome measures included quantitative sensory tests using the CASE IV System, the Neuropathy Symptom and Change questionnaire, the Patient Benefit Questionnaire (PBQ), and a global symptom assessment, as well as nerve conduction studies and occurrence of new plantar foot ulcers. Patients also were evaluated for presence of adverse events. Results Among patients who received rhNGF, 418 (83%) completed the regimen compared with 461 (90%) who received placebo. Administration of rhNGF was safe, with few adverse events attributed to treatment apart from injection site pain/ hyperalgesia and other pain syndromes. However, neither the primary end point (P=.25) nor most of the secondary end points demonstrated a significant benefit of rhNGF. Exceptions were the global symptom assessment (P=.03) and 2 of 32 comparisons within the PBQ, which showed a modest but significant benefit of rhNGF (P=.05 for severity of pain in the legs and P=.003 for 6-month symptoms in the feet and legs). Conclusion Unlike previous phase 2 trials, this phase 3 clinical trial failed to demonstrate a significant beneficial effect of rhNGF on diabetic polyneuropathy.	Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; Diabet & Glandular Dis Clin, San Antonio, TX USA; Diabet & Glandular Dis Clin, Palo Alto, CA USA; Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Arkansas Res Program, Little Rock, AR USA; Creighton Univ, Sch Med, Creighton Diabet Ctr, Omaha, NE USA; Eastern Virginia Med Sch, Inst Diabet, Norfolk, VA 23501 USA; Univ Pittsburgh, Med Ctr, Div Neuromuscular Dis, Pittsburgh, PA USA; Mayo Clin, Dept Neurol, Scottsdale, AZ USA; Univ Rochester, Dept Neurol, Rochester, NY USA; Mayo Clin & Mayo Fdn, Mayo Med Sch, Peripheral Neuropathy Ctr, Rochester, MN 55905 USA	Yeshiva University; Albert Einstein College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Creighton University; Eastern Virginia Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; Mayo Clinic Phoenix; University of Rochester; Mayo Clinic	Apfel, SC (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Kennedy Ctr 401, 1300 Morris Pk Ave, Bronx, NY 10461 USA.							ALBERS JW, 1995, ANN NEUROL, V38, P478; Anand P, 1996, NAT MED, V2, P703, DOI 10.1038/nm0696-703; APFEL SC, 1991, ANN NEUROL, V29, P87, DOI 10.1002/ana.410290115; APFEL SC, 1992, ANN NEUROL, V31, P76, DOI 10.1002/ana.410310114; Apfel SC, 1998, NEUROLOGY, V51, P695, DOI 10.1212/WNL.51.3.695; APFEL SC, 1994, BRAIN RES, V634, P7, DOI 10.1016/0006-8993(94)90252-6; APFEL SC, 1997, CLIN APPL NEUROTROPH; COHEN S, 1954, P NATL ACAD SCI USA, V40, P1014, DOI 10.1073/pnas.40.10.1014; DIAMOND J, 1992, J NEUROSCI, V12, P1454; Dyck PJ, 1997, NEUROLOGY, V49, P229, DOI 10.1212/WNL.49.1.229; Dyck PJ, 1996, J NEUROL SCI, V136, P54, DOI 10.1016/0022-510X(95)00277-9; DYCK PJ, 1987, DIABETES CARE, V10, P432, DOI 10.2337/diacare.10.4.432; DYCK PJ, 1993, NEUROLOGY, V43, P1500, DOI 10.1212/WNL.43.8.1500; DYCK PJ, 1993, NEUROLOGY, V43, P1508, DOI 10.1212/WNL.43.8.1508; FERNYHOUGH P, 1994, NEUROSCIENCE, V62, P337, DOI 10.1016/0306-4522(94)90368-9; GRUENER G, 1994, J CLIN NEUROPHYSIOL, V11, P568, DOI 10.1097/00004691-199411000-00004; HELLWEG R, 1994, EXP NEUROL, V130, P24, DOI 10.1006/exnr.1994.1181; JACKSON GR, 1990, J NEUROSCI RES, V25, P360, DOI 10.1002/jnr.490250313; JAKOBSEN J, 1981, DIABETES, V30, P797, DOI 10.2337/diab.30.10.797; KESSLER JA, 1980, P NATL ACAD SCI USA, V77, P113; MACLEAN DB, 1989, BRAIN RES, V478, P349, DOI 10.1016/0006-8993(89)91515-1; McArthur JC, 2000, NEUROLOGY, V54, P1080, DOI 10.1212/WNL.54.5.1080; PETTY BG, 1994, ANN NEUROL, V36, P244, DOI 10.1002/ana.410360221; ROHRER H, 1988, DEV BIOL, V128, P240, DOI 10.1016/0012-1606(88)90286-2; SCHMIDT RE, 1986, BRAIN RES, V378, P325, DOI 10.1016/0006-8993(86)90936-4	25	256	277	1	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2215	2221		10.1001/jama.284.17.2215	http://dx.doi.org/10.1001/jama.284.17.2215			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056593	Bronze			2022-12-28	WOS:000090052600030
J	Dave, AS; Margoliash, D				Dave, AS; Margoliash, D			Song replay during sleep and computational rules for sensorimotor vocal learning	SCIENCE			English	Article							TIME-COMPARISON CIRCUIT; ELECTRIC FISH MIDBRAIN; MODEL; SEQUENCES; NETWORK; HIPPOCAMPUS; BEHAVIOR; SYSTEM; OWL	Songbirds Learn a correspondence between vocal-motor output and auditory feedback during development. For neurons in a motor cortex analog of adult zebra finches, we show that the timing and structure of activity elicited by the playback of song during sleep matches activity during daytime singing. The motor activity leads syllables, and the matching sensory response depends on a sequence of typically up to three of the preceding syllables. Thus, sensorimotor correspondence is reflected in temporally precise activity patterns of single neurons that use Long sensory memories to predict syllable sequences. Additionally, "spontaneous" activity of these neurons during sleep matches their sensorimotor activity, a form of song "replay," These data suggest a model whereby sensorimotor correspondences are stored during singing but do not modify behavior, and off-line comparison (e,g., during sleep) of rehearsed motor output and predicted sensory feedback is used to adaptively shape motor output.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Margoliash, D (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.		Galantucci, Bruno/E-5770-2010		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060276, F31MH011615] Funding Source: NIH RePORTER; NIMH NIH HHS [MH11615, MH59831, MH60276] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Beiser DG, 1998, J NEUROPHYSIOL, V79, P3168, DOI 10.1152/jn.1998.79.6.3168; Berns GS, 1998, J COGNITIVE NEUROSCI, V10, P108, DOI 10.1162/089892998563815; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Brown J, 1999, J NEUROSCI, V19, P10502; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CARR CE, 1986, J NEUROSCI, V6, P1372; CARR CE, 1986, J NEUROSCI, V6, P107; CARR CE, 1990, J NEUROSCI, V10, P3227; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Engel AK, 1997, CEREB CORTEX, V7, P571, DOI 10.1093/cercor/7.6.571; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Laurent G, 1996, J NEUROSCI, V16, P3837; Luo MM, 1999, J NEUROSCI, V19, P6700; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Suri RE, 1998, EXP BRAIN RES, V121, P350, DOI 10.1007/s002210050467; Sutton R. S., 1999, REINFORCEMENT LEARNI; VU ET, 1994, J NEUROSCI, V14, P6924; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	24	318	322	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					812	816		10.1126/science.290.5492.812	http://dx.doi.org/10.1126/science.290.5492.812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052946				2022-12-28	WOS:000090067600051
J	Lumley, J				Lumley, J			Any room left for disagreement about assisting breech births at term?	LANCET			English	Editorial Material							RANDOMIZED MANAGEMENT		La Trobe Univ, Ctr Study Mothers & Childrens Hlth, Melbourne, Vic 3153, Australia	La Trobe University	Lumley, J (corresponding author), La Trobe Univ, Ctr Study Mothers & Childrens Hlth, Melbourne, Vic 3153, Australia.							[Anonymous], 1994, J SOGC, V16, P1839; COLLEA JV, 1980, AM J OBSTET GYNECOL, V137, P235, DOI 10.1016/0002-9378(80)90780-2; GIMOVSKY ML, 1983, AM J OBSTET GYNECOL, V146, P34, DOI 10.1016/0002-9378(83)90923-7; HANNAH ME, 1992, NEW ENGL J MED, V326, P1587, DOI 10.1056/NEJM199206113262402	4	21	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1368	1369		10.1016/S0140-6736(00)02833-6	http://dx.doi.org/10.1016/S0140-6736(00)02833-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052572				2022-12-28	WOS:000089976100002
J	Barouch, DH; Santra, S; Schmitz, JE; Kuroda, MJ; Fu, TM; Wagner, W; Bilska, M; Craiu, A; Zheng, XX; Krivulka, GR; Beaudry, K; Lifton, MA; Nickerson, CE; Trigona, WL; Punt, K; Freed, DC; Guan, LM; Dubey, S; Casimiro, D; Simon, A; Davies, ME; Chastain, M; Strom, TB; Gelman, RS; Montefiori, DC; Lewis, MG; Emini, EA; Shiver, JW; Letvin, NL				Barouch, DH; Santra, S; Schmitz, JE; Kuroda, MJ; Fu, TM; Wagner, W; Bilska, M; Craiu, A; Zheng, XX; Krivulka, GR; Beaudry, K; Lifton, MA; Nickerson, CE; Trigona, WL; Punt, K; Freed, DC; Guan, LM; Dubey, S; Casimiro, D; Simon, A; Davies, ME; Chastain, M; Strom, TB; Gelman, RS; Montefiori, DC; Lewis, MG; Emini, EA; Shiver, JW; Letvin, NL			Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; IMMUNE-RESPONSES; CELL RESPONSES; DISEASE PROGRESSION; PROTECTION; INFECTION; MACAQUES; PROTEIN; HIV-1	With accumulating evidence indicating the importance of cytotoxic T Lymphocytes (CTLs) in containing human immunodeficiency virus-1 (HIV-1) replication in infected individuals, strategies are being pursued to elicit virus-specific CTLs with prototype HIV-1 vaccines. Here, we report the protective efficacy of vaccine-elicited immune responses against a pathogenic SHIV-89.6P challenge in rhesus monkeys. Immune responses were elicited by DNA vaccines expressing SIVmac239 Gag and HIV-1 89.6P Env, augmented by the administration of the purified fusion protein IL-2/Ig, consisting of interleukin-2 (IL-2) and the Fc portion of immunoglobulin G (IgG), or a plasmid encoding IL-2/Ig. After SHIV-89.6P infection, sham-vaccinated monkeys developed weak CTL responses, rapid Loss of CD4(+) T cells, no virus-specific CD4(+) T cell responses, high setpoint viral loads, significant clinical disease progression, and death in half of the animals by day 140 after challenge. in contrast, all monkeys that received the DNA vaccines augmented with IL-2/Ig were infected, but demonstrated potent secondary CTL responses, stable CD4(+) T cell counts, preserved virus-specific CD4(+) T cell responses, Low to undetectable setpoint viral Loads, and no evidence of clinical disease or mortality by day 140 after challenge.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Merck Res Labs, West Point, PA 19486 USA; So Res Inst, Frederick, MD 21701 USA; Duke Univ, Med Ctr, Durham, NC 27710 USA; Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Merck & Company; Duke University; Harvard University; Dana-Farber Cancer Institute	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, 330 Brookline Ave, Boston, MA 02215 USA.	dan_barouch@hotmail.com	Barouch, Dan/Y-3918-2019; Schmitz, Joern/A-4929-2018	Schmitz, Joern/0000-0001-8803-0922	NATIONAL CANCER INSTITUTE [R01CA050139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085343, P01AI041521] Funding Source: NIH RePORTER; NCI NIH HHS [CA-50139, R01 CA050139] Funding Source: Medline; NIAID NIH HHS [P01 AI041521, AI-65301, AI-85343] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; Allen TM, 1998, J IMMUNOL, V160, P6062; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Barouch DH, 2000, P NATL ACAD SCI USA, V97, P4192, DOI 10.1073/pnas.050417697; Barouch DH, 1998, J IMMUNOL, V161, P1875; BAROUCH DH, UNPUB; Boyer JD, 1997, NAT MED, V3, P526, DOI 10.1038/nm0597-526; CHEN ZW, 1995, J EXP MED, V182, P21, DOI 10.1084/jem.182.1.21; Chow YH, 1997, J VIROL, V71, P169, DOI 10.1128/JVI.71.1.169-178.1997; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; Egan MA, 2000, J VIROL, V74, P7485, DOI 10.1128/JVI.74.16.7485-7495.2000; Egan MA, 1999, J VIROL, V73, P5466, DOI 10.1128/JVI.73.7.5466-5472.1999; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Geissler M, 1997, J IMMUNOL, V158, P1231; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kent SJ, 1998, J VIROL, V72, P10180, DOI 10.1128/JVI.72.12.10180-10188.1998; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; LANDOLFI NF, 1991, J IMMUNOL, V146, P915; Letvin NL, 1997, P NATL ACAD SCI USA, V94, P9378, DOI 10.1073/pnas.94.17.9378; Lu S, 1996, J VIROL, V70, P3978, DOI 10.1128/JVI.70.6.3978-3991.1996; McMichael A, 1998, CELL, V93, P673, DOI 10.1016/S0092-8674(00)81428-2; MILLER MD, 1991, J IMMUNOL, V147, P320; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Nickerson P, 1996, Transpl Immunol, V4, P81, DOI 10.1016/S0966-3274(96)80043-8; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Reimann KA, 1999, VIROLOGY, V256, P15, DOI 10.1006/viro.1999.9632; Reimann KA, 1996, J VIROL, V70, P3198, DOI 10.1128/JVI.70.5.3198-3206.1996; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Robinson HL, 1999, NAT MED, V5, P526, DOI 10.1038/8406; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seth A, 2000, J VIROL, V74, P2502, DOI 10.1128/JVI.74.6.2502-2509.2000; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Xin KQ, 1998, IMMUNOLOGY, V94, P438, DOI 10.1046/j.1365-2567.1998.00533.x	41	787	832	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2000	290	5491					486	492		10.1126/science.290.5491.486	http://dx.doi.org/10.1126/science.290.5491.486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039923				2022-12-28	WOS:000089946000042
J	Kip, D; Soljacic, M; Segev, M; Eugenieva, E; Christodoulides, DN				Kip, D; Soljacic, M; Segev, M; Eugenieva, E; Christodoulides, DN			Modulation instability and pattern formation in spatially incoherent light beams	SCIENCE			English	Article							SCREENING SOLITONS; STATE; MEDIA; FIELD; WAVE; DARK	We report on the experimental observation of modulation instability of partially spatially incoherent light beams in noninstantaneous nonlinear media and show that in such systems patterns can form spontaneously from noise. Incoherent modulation instability occurs above a specific threshold that depends on the coherence properties (correlation distance) of the wave packet and leads to a periodic train of one-dimensional filaments. At a higher value of nonlinearity, the incoherent one-dimensional filaments display a two-dimensional instability and break up into self-ordered arrays of light spots. This discovery of incoherent pattern formation reflects on many other nonlinear systems beyond optics. It implies that patterns can form spontaneously (from noise) in diverse nonlinear many-body systems involving weakly correlated particles, such as atomic gases at (or near) Bose-Einstein condensation temperatures and electrons in semiconductors at the vicinity of the quantum Hall regime.	Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Inst Solid State, IL-32000 Haifa, Israel; Univ Osnabruck, Dept Phys, D-49069 Osnabruck, Germany; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; Lehigh Univ, Dept Elect Engn & Comp Sci, Bethlehem, PA 18015 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; University Osnabruck; Princeton University; Princeton University; Lehigh University	Segev, M (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.		Kip, Detlef/C-7021-2013; Soljacic, Marin/AAA-4868-2019	Kip, Detlef/0000-0001-7923-0113; 				AGRAWAL GP, 1995, NONLINEAR FIBER OPTI, pCH5; Akhmediev N, 1998, PHYS REV LETT, V81, P4632, DOI 10.1103/PhysRevLett.81.4632; BESPALOV VI, 1966, JETP LETT-USSR, V3, P307; Busch T, 2000, PHYS REV LETT, V84, P2298, DOI 10.1103/PhysRevLett.84.2298; Carvalho MI, 1996, OPT COMMUN, V126, P167, DOI 10.1016/0030-4018(95)00743-1; Chen ZG, 1998, SCIENCE, V280, P889, DOI 10.1126/science.280.5365.889; CHRISTODOULIDES DN, 1995, J OPT SOC AM B, V12, P1628, DOI 10.1364/JOSAB.12.001628; Christodoulides DN, 1998, PHYS REV LETT, V80, P5113, DOI 10.1103/PhysRevLett.80.5113; Clausen CB, 1999, PHYS REV LETT, V83, P4740, DOI 10.1103/PhysRevLett.83.4740; Cornish SL, 2000, PHYS REV LETT, V85, P1795, DOI 10.1103/PhysRevLett.85.1795; Coskun TH, 2000, PHYS REV LETT, V84, P2374, DOI 10.1103/PhysRevLett.84.2374; HASEGAWA A, 1980, IEEE J QUANTUM ELECT, V16, P694, DOI 10.1109/JQE.1980.1070554; ITURBECASTILLO MD, 1995, OPT LETT, V20, P1853, DOI 10.1364/OL.20.001853; KARPMAN VI, 1967, JETP LETT-USSR, V6, P277; Lilly MP, 1999, PHYS REV LETT, V82, P394, DOI 10.1103/PhysRevLett.82.394; MacDonald AH, 2000, PHYS REV B, V61, P5724, DOI 10.1103/PhysRevB.61.5724; Mitchell M, 1997, NATURE, V387, P880, DOI 10.1038/43079; Mitchell M, 1996, PHYS REV LETT, V77, P490, DOI 10.1103/PhysRevLett.77.490; Mitchell M, 1997, PHYS REV LETT, V79, P4990, DOI 10.1103/PhysRevLett.79.4990; Sackett CA, 1999, PHYS REV LETT, V82, P876, DOI 10.1103/PhysRevLett.82.876; SEGEV M, 1994, PHYS REV LETT, V73, P3211, DOI 10.1103/PhysRevLett.73.3211; SHIH MF, 1995, ELECTRON LETT, V31, P826, DOI 10.1049/el:19950570; Shkunov VV, 1998, PHYS REV LETT, V81, P2683, DOI 10.1103/PhysRevLett.81.2683; Snyder AW, 1998, PHYS REV LETT, V80, P1422, DOI 10.1103/PhysRevLett.80.1422; Soljacic M, 2000, PHYS REV LETT, V84, P467, DOI 10.1103/PhysRevLett.84.467; Stegeman GI, 1999, SCIENCE, V286, P1518, DOI 10.1126/science.286.5444.1518	28	249	254	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					495	498		10.1126/science.290.5491.495	http://dx.doi.org/10.1126/science.290.5491.495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039925	Green Submitted			2022-12-28	WOS:000089946000044
J	Sigman, DM; Boyle, EA				Sigman, DM; Boyle, EA			Glacial/interglacial variations in atmospheric carbon dioxide	NATURE			English	Review							LAST GLACIAL MAXIMUM; EASTERN EQUATORIAL PACIFIC; VOSTOK ICE CORE; SOUTHERN-OCEAN; NITROGEN-FIXATION; DEEP-SEA; ISOTOPIC COMPOSITION; CALCITE LYSOCLINE; NORTH-ATLANTIC; SEDIMENT TRAPS	Twenty years ago, measurements on ice cores showed that the concentration of carbon dioxide in the atmosphere was lower during ice ages than it is today. As yet, there is no broadly accepted explanation for this difference. Current investigations focus on the ocean's 'biological pump', the sequestration of carbon in the ocean interior by the rain of organic carbon out of the surface ocean, and its effect on the burial of calcium carbonate in marine sediments. Some researchers surmise that the whole-ocean reservoir of algal nutrients was larger during glacial times, strengthening the biological pump at low latitudes, where these nutrients are currently limiting. Others propose that the biological pump was more efficient during glacial times because of more complete utilization of nutrients at high latitudes, where much of the nutrient supply currently goes unused. We present a version of the latter hypothesis that focuses on the open ocean surrounding Antarctica, involving both the biology and physics of that region.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Princeton University; Massachusetts Institute of Technology (MIT)	Sigman, DM (corresponding author), Princeton Univ, Dept Geosci, Guyot Hall, Princeton, NJ 08544 USA.		Sigman, Daniel M/A-2649-2008	Sigman, Daniel M/0000-0002-7923-1973				ADAMS JM, 1990, NATURE, V348, P711, DOI 10.1038/348711a0; ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; ARCHER D, 1991, J GEOPHYS RES-OCEANS, V96, P17037, DOI 10.1029/91JC01812; ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; BARNOLA JM, 1987, NATURE, V329, P408, DOI 10.1038/329408a0; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; Behl RJ, 1996, NATURE, V379, P243, DOI 10.1038/379243a0; Berger A.L., 1984, MILANKOVITCH CLIMATE; BERGER WH, 1970, MAR GEOL, V8, P111, DOI 10.1016/0025-3227(70)90001-0; BERGER WH, 1982, NATURWISSENSCHAFTEN, V69, P87, DOI 10.1007/BF00441228; BERGER WH, 1994, CARBON CYCLING GLACI, P385; BIRD MI, 1994, NATURE, V371, P566, DOI 10.1038/371566a0; BOYLE EA, 1988, J GEOPHYS RES-OCEANS, V93, P15701, DOI 10.1029/JC093iC12p15701; BOYLE EA, 1982, SCIENCE, V218, P784, DOI 10.1126/science.218.4574.784; Boyle EA, 1988, PALEOCEANOGRAPHY, V3, P471, DOI 10.1029/PA003i004p00471; Broecker W, 1999, GLOBAL BIOGEOCHEM CY, V13, P817, DOI 10.1029/1999GB900050; Broecker W.S., 1971, LATE CENOZOIC ICE AG, P239; Broecker W.S., 1982, TRACERS SEA; Broecker WS, 1992, GLOBAL BIOGEOCHEM CY, V6, P315, DOI 10.1029/92GB01672; Broecker WS, 1989, GLOBAL BIOGEOCHEM CY, V3, P215, DOI 10.1029/GB003i003p00215; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; BROECKER WS, 1978, DEEP-SEA RES, V25, P65; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; BROECKER WS, 1987, PALEOCEANOGRAPHY, V3, P1; Catubig NR, 1998, PALEOCEANOGRAPHY, V13, P298, DOI 10.1029/98PA00609; CHARLES CD, 1988, GEOLOGICAL HIST POLA, P519; CHISHOLM SW, 1991, LIMNOL OCEANOGR, V36, pU1507; CLIMAP PM, 1976, SCIENCE, V191, P1131, DOI DOI 10.1126/SCIENCE.191.4232.1131; CROWLEY TJ, 1995, GLOBAL BIOGEOCHEM CY, V9, P377, DOI 10.1029/95GB01107; Curry WB, 1988, PALEOCEANOGRAPHY, V3, P317, DOI 10.1029/PA003i003p00317; De La Rocha CL, 1998, NATURE, V395, P680, DOI 10.1038/27174; DiTullio GR, 2000, NATURE, V404, P595, DOI 10.1038/35007061; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; DYMOND J, 1985, LIMNOL OCEANOGR, V30, P699, DOI 10.4319/lo.1985.30.4.0699; EDMOND JM, 1979, EARTH PLANET SC LETT, V46, P1, DOI 10.1016/0012-821X(79)90061-X; Elderfield H, 2000, NATURE, V405, P305, DOI 10.1038/35012507; EMERSON S, 1981, J MAR RES, V39, P139; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; FARRELL JW, 1995, NATURE, V377, P514, DOI 10.1038/377514a0; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Gnanadesikan A, 1999, SCIENCE, V283, P2077, DOI 10.1126/science.283.5410.2077; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; Hales B, 1997, GEOCHIM COSMOCHIM AC, V61, P501, DOI 10.1016/S0016-7037(96)00366-3; Haug GH, 1998, PALEOCEANOGRAPHY, V13, P427, DOI 10.1029/98PA01976; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Herguera JC, 1992, PALEOCEANOGRAPHY, V7, P273, DOI 10.1029/92PA00869; Holmen K., 1992, GLOBAL BIOGEOCHEMICA, V50, P239; HONJO S, 1996, PARTICLE FLUX OCEAN; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Keigwin LD, 1998, PALEOCEANOGRAPHY, V13, P323, DOI 10.1029/98PA00874; KEIGWIN LD, 1989, PALAEOGEOGR PALAEOCL, V73, P85, DOI 10.1016/0031-0182(89)90047-3; Keir RS, 1988, PALEOCEANOGRAPHY, V3, P413, DOI 10.1029/PA003i004p00413; KEIR RS, 1995, PALEOCEANOGRAPHY, V10, P871, DOI 10.1029/95PA02177; KNOX F, 1984, J GEOPHYS RES-ATMOS, V89, P4629, DOI 10.1029/JD089iD03p04629; Kohfeld KE, 1996, PALEOCEANOGRAPHY, V11, P679, DOI 10.1029/96PA02617; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; LEUENBERGER M, 1992, NATURE, V357, P488, DOI 10.1038/357488a0; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; MARINO BD, 1991, NATURE, V349, P127, DOI 10.1038/349127a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MCCORKLE DC, 1995, PALEOCEANOGRAPHY, V10, P699, DOI 10.1029/95PA01427; MCELROY MB, 1983, NATURE, V302, P328, DOI 10.1038/302328a0; Milliman J. D., 1974, MARINE CARBONATES; Moore JK, 2000, GLOBAL BIOGEOCHEM CY, V14, P455, DOI 10.1029/1999GB900051; MORLEY JJ, 1983, EARTH PLANET SC LETT, V66, P63, DOI 10.1016/0012-821X(83)90126-7; MORTLOCK RA, 1991, NATURE, V351, P220, DOI 10.1038/351220a0; OPPO DW, 1993, SCIENCE, V259, P1148, DOI 10.1126/science.259.5098.1148; PEDERSEN TF, 1983, GEOLOGY, V11, P16, DOI 10.1130/0091-7613(1983)11<16:IPITEE>2.0.CO;2; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pride C, 1999, PALEOCEANOGRAPHY, V14, P397, DOI 10.1029/1999PA900004; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Rosenthal Y, 1997, PALEOCEANOGRAPHY, V12, P787, DOI 10.1029/97PA02508; Rosenthal Y, 2000, PALEOCEANOGRAPHY, V15, P65, DOI 10.1029/1999PA000369; RUTTENBERG KC, 1993, CHEM GEOL, V107, P405, DOI 10.1016/0009-2541(93)90220-D; Sanyal A, 1997, GLOBAL BIOGEOCHEM CY, V11, P125, DOI 10.1029/97GB00223; SARMIENTO JL, 1991, LIMNOL OCEANOGR, V36, P1928, DOI 10.4319/lo.1991.36.8.1928; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; SAYLES FL, 1977, GEOCHIM COSMOCHIM AC, V41, P951, DOI 10.1016/0016-7037(77)90154-5; SHACKLETON NJ, 1977, FATE FOSSIL FUEL OCE; SIEGENTHALER U, 1984, NATURE, V308, P624, DOI 10.1038/308624a0; Sigman DM, 1999, PALEOCEANOGRAPHY, V14, P118, DOI 10.1029/1998PA900018; Sigman DM, 1998, GLOBAL BIOGEOCHEM CY, V12, P409, DOI 10.1029/98GB01184; Sigman DM, 1999, GLOBAL BIOGEOCHEM CY, V13, P1149, DOI 10.1029/1999GB900038; Smith HJ, 1999, NATURE, V400, P248, DOI 10.1038/22291; SOWERS T, 1995, SCIENCE, V269, P210, DOI 10.1126/science.269.5221.210; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; TOGGWEILER JR, 1995, DEEP-SEA RES PT I, V42, P477, DOI 10.1016/0967-0637(95)00012-U; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; TOGGWEILER JR, 1999, EOS, V80, pOS286; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Webb RS, 1997, NATURE, V385, P695, DOI 10.1038/385695a0	100	874	924	13	334	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					859	869		10.1038/35038000	http://dx.doi.org/10.1038/35038000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057657				2022-12-28	WOS:000089901900040
J	Pinto-Sietsma, SJ; Mulder, J; Janssen, WMT; Hillege, HL; de Zeeuw, D; de Jong, PE				Pinto-Sietsma, SJ; Mulder, J; Janssen, WMT; Hillege, HL; de Zeeuw, D; de Jong, PE			Smoking is related to albuminuria and abnormal renal function in nondiabetic persons	ANNALS OF INTERNAL MEDICINE			English	Article							GLYCOSYLATION END-PRODUCTS; INSULIN-RESISTANCE SYNDROME; CIGARETTE-SMOKING; MANIFEST NEPHROPATHY; DIABETES-MELLITUS; TREATED DIABETICS; SMOKERS; MICROALBUMINURIA; IMPAIRMENT; POPULATION	Background: smoking induces albuminuria and accelerates progression to renal failure in persons with diabetes, but little is known about the relation between smoking and renal function in nondiabetic persons. Objective: To investigate whether smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Design: cross-sectional study. Setting: Groningen, The Netherlands. Participants: 7476 participants in the PREVEND (Prevention of REnal and Vascular ENd stage Disease) Study. Measurements: Microalbuminuria and high normal albuminuria were defined as urinary albumin excretion of 30 to 300 mg/24 h and 15 to 30 mg/24 h, respectively. Elevated or decreased glomerular filtration rate (GFR) was defined as a creatinine clearance that exceeded or was less than two times the standard deviation of the mean value in nondiabetic, nonsmoking participants who had an albumin excretion of 0 to 15 mg/24 h, adjusted for age and sex. Results: current smokers had a higher median albumin excretion than nonsmokers and were more likely to have microalbuminuria and high normal albuminuria with elevated or decreased GFR. After adjustment for several potential confounding factors, persons who smoked 20 or fewer cigarettes/d and persons who smoked more than 20 cigarettes/d, respectively, showed a dose-dependent association between smoking and high normal albuminuria (relative risk, 1.33 [95% CI, 1.10 to 1.61] and 1.98 [CI, 1.49 to 2.64]), microalbuminuria (relative risk, 1.92 [CI, 1.54 to 2.39] and 2.15 [CI, 1.52 to 3.03]), elevated GFR (relative risk, 1.82 [CI, 1.31 to 2.53] and 1.84 [CI, 1.12 to 3.02]), and decreased GFR (relative risk, 1.53 [CI, 1.04 to 2.24] and 1.83 [CI, 1.05 to 3.20]), respectively. Quitting smoking was associated only with microalbuminuria. Conclusions: Smoking is associated with albuminuria and abnormal renal function. However, these associations are less pronounced or absent in former smokers.	Univ Groningen Hosp, Dept Internal Med, Div Nephrol, NL-9713 GZ Groningen, Netherlands; Univ Groningen, Inst Drug Explorat, Groningen, Netherlands	University of Groningen; University of Groningen	Pinto-Sietsma, SJ (corresponding author), Univ Groningen Hosp, Dept Internal Med, Div Nephrol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.		SJ, Pinto-Sietsma/AAI-3207-2021; de Zeeuw, Dick/E-9080-2014	de Zeeuw, Dick/0000-0003-3434-7777; Mulder, Jaap/0000-0001-5404-9203				ATTVALL S, 1993, J INTERN MED, V233, P327, DOI 10.1111/j.1365-2796.1993.tb00680.x; BIESENBACH G, 1994, NEPHROL DIAL TRANSPL, V9, P1097, DOI 10.1093/ndt/9.8.1097; BLACK HR, 1983, NEPHRON, V34, P173, DOI 10.1159/000183005; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Christiansen J S, 1978, Diabetes Care, V1, P146, DOI 10.2337/diacare.1.3.146; Cirillo M, 1998, ARCH INTERN MED, V158, P1933, DOI 10.1001/archinte.158.17.1933; COUPER JJ, 1994, DIABETIC MED, V11, P666, DOI 10.1111/j.1464-5491.1994.tb00330.x; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; EKBERG G, 1991, J INTERN MED, V230, P435, DOI 10.1111/j.1365-2796.1991.tb00469.x; EKBERG G, 1990, J INTERN MED, V228, P211; ELIASSON B, 1994, ARTERIOSCLER THROMB, V14, P1946, DOI 10.1161/01.ATV.14.12.1946; ESPOSITO C, 1989, J EXP MED, V170, P1387, DOI 10.1084/jem.170.4.1387; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Fliser D, 1998, KIDNEY INT, V53, P1343, DOI 10.1046/j.1523-1755.1998.00898.x; FORSBLOM CM, 1995, DIABETOLOGIA, V38, P363, DOI 10.1007/s001250050294; Gambaro G, 1998, J AM SOC NEPHROL, V9, P562; HAFFNER SM, 1993, DIABETOLOGIA, V36, P1002, DOI 10.1007/BF02374491; HAMMOND EC, 1966, EPIDEMIOLOGICAL APPR, P127; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; JANZON L, 1983, DIABETOLOGIA, V25, P86; Jarrett R J, 1984, Diabet Med, V1, P17; Karter AJ, 1996, DIABETES, V45, P1547, DOI 10.2337/diabetes.45.11.1547; KIOWSKI W, 1994, CIRCULATION, V90, P27, DOI 10.1161/01.CIR.90.1.27; Kubo M, 1999, KIDNEY INT, V55, P2450, DOI 10.1046/j.1523-1755.1999.00458.x; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; MAKITA Z, 1994, LANCET, V343, P1519, DOI 10.1016/S0140-6736(94)92935-1; METCALF PA, 1993, CLIN CHEM, V39, P1793; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; MUHLHAUSER I, 1986, DIABETOLOGIA, V29, P500, DOI 10.1007/BF00453501; NITENBERG A, 1993, AM J MED, V95, P71, DOI 10.1016/0002-9343(93)90234-G; Orth SR, 1997, KIDNEY INT, V51, P1669, DOI 10.1038/ki.1997.232; Park Sung Kwang, 1995, Korean Journal of Internal Medicine (English Edition), V10, P48; PINTOSIETSMA SJ, 2000, IN PRESS J AM SOC NE, V11; Remuzzi G, 1999, AM J KIDNEY DIS, V33, P807, DOI 10.1016/S0272-6386(99)70241-6; Ritz E, 1998, J AM SOC NEPHROL, V9, P1798; SELL DR, 1990, J CLIN INVEST, V85, P380, DOI 10.1172/JCI114449; TELMER S, 1984, ACTA MED SCAND, V215, P63; *US DHEW, 1973, PHS PUBL; VLASSARA H, 1992, P NATL ACAD SCI USA, V89, P12043, DOI 10.1073/pnas.89.24.12043; VORA JP, 1992, KIDNEY INT, V41, P829, DOI 10.1038/ki.1992.127	42	213	232	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					585	591		10.7326/0003-4819-133-8-200010170-00008	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033585				2022-12-28	WOS:000089906300002
J	Cho, KO; Chern, J; Izaddoost, S; Choi, KW				Cho, KO; Chern, J; Izaddoost, S; Choi, KW			Novel signaling from the peripodial membrane is essential for eye disc patterning in Drosophila	CELL			English	Article							SEGMENT POLARITY GENE; RETINAL DIFFERENTIATION; MORPHOGENETIC FURROW; IMAGINAL DISKS; ADULT HEAD; WINGLESS; HEDGEHOG; MELANOGASTER; EXPRESSION; INDUCTION	The Drosophila eye disc is a sac of single layer epithelium with two opposing sides, the peripodial membrane (PM) and the disc proper (DP). Retinal morphogenesis is organized by Notch signaling at the dorsoventral (DV) boundary in the DP. Functions of the PM in coordinating growth and patterning of the DP are unknown. We show that the secreted proteins, Hedgehog, Wingless, and Decapentaplegic, are expressed in the PM, yet they control DP expression of Notch ligands, Delta and Serrate. Peripodial clones expressing Hedgehog induce Serrate in the DP while loss of peripodial Hedgehog disrupts disc growth. Furthermore, PM cells extend cellular processes to the DP. Therefore, peripodial signaling is critical for eye pattern formation and may be mediated by peripodial processes.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Choi, KW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.		Cho, Kyung-Ok/C-1705-2011; Choi, Kwang-Wook/C-1707-2011	Choi, Kwang-Wook/0000-0002-8997-3065; Cho, Kyung-Ok/0000-0002-0760-2560				Agnes F, 1999, DEVELOPMENT, V126, P5453; BAKER NE, 1987, EMBO J, V6, P1765, DOI 10.1002/j.1460-2075.1987.tb02429.x; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Brennan CA, 2000, CELL MOL LIFE SCI, V57, P195, DOI 10.1007/PL00000684; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; BROWER DL, 1987, DEVELOPMENT, V101, P83; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; BRYANT PJ, 1975, J EXP ZOOL, V193, P49, DOI 10.1002/jez.1401930106; CARROLL SB, 1989, GENE DEV, V3, P905, DOI 10.1101/gad.3.6.905; Cavodeassi F, 1999, DEVELOPMENT, V126, P4933; Chen HX, 1999, CELL TISSUE RES, V296, P67, DOI 10.1007/s004410051267; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Cohen Stephen M., 1993, P747; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dominguez M, 1997, GENE DEV, V11, P3254, DOI 10.1101/gad.11.23.3254; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Fristrom Dianne, 1993, P843; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Gibson MC, 2000, CELL, V103, P343, DOI 10.1016/S0092-8674(00)00125-2; Gibson MC, 1999, DEVELOPMENT, V126, P1591; HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; Heberlein U, 1998, DEVELOPMENT, V125, P567; HEBERLEIN U, 1995, NATURE, V373, P709, DOI 10.1038/373709a0; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; JACOBSON AG, 1988, DEVELOPMENT, V104, P341; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; Ju BG, 2000, NATURE, V405, P191, DOI 10.1038/35012090; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KASSIS JA, 1992, P NATL ACAD SCI USA, V89, P1919, DOI 10.1073/pnas.89.5.1919; Kehl BT, 1998, DEVELOPMENT, V125, P1217; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; MA CY, 1995, DEVELOPMENT, V121, P2279; McNeill H, 1997, GENE DEV, V11, P1073, DOI 10.1101/gad.11.8.1073; MILNER M J, 1984, Wilhelm Roux's Archives of Developmental Biology, V193, P406, DOI 10.1007/BF00848232; MILNER M J, 1983, Wilhelm Roux's Archives of Developmental Biology, V192, P164, DOI 10.1007/BF00848686; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Murone M, 1999, EXP CELL RES, V253, P25, DOI 10.1006/excr.1999.4676; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Netter S, 1998, GENETICS, V149, P257; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; Obara-Ishihara T, 1999, DEVELOPMENT, V126, P1103; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; PARKS AL, 1995, MECH DEVELOP, V50, P201, DOI 10.1016/0925-4773(94)00336-L; Penton A, 1996, NATURE, V382, P162, DOI 10.1038/382162a0; Pignoni F, 1997, DEVELOPMENT, V124, P271; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Reifegerste R, 1999, BIOESSAYS, V21, P275, DOI 10.1002/(SICI)1521-1878(199904)21:4<275::AID-BIES3>3.0.CO;2-5; Royet J, 1997, DEVELOPMENT, V124, P4793; Royet J, 1996, DEVELOPMENT, V122, P1849; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; STJOHNSTON RD, 1990, GENE DEV, V4, P1114, DOI 10.1101/gad.4.7.1114; Theisen H, 1996, DEVELOPMENT, V122, P3939; Treisman JE, 1998, CURR TOP DEV BIOL, V39, P119, DOI 10.1016/S0070-2153(08)60454-8; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 1999, DEVELOPMENT, V126, P5857; Yuan YP, 1997, CELL, V88, P9, DOI 10.1016/S0092-8674(00)81852-8	65	100	103	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 13	2000	103	2					331	342		10.1016/S0092-8674(00)00124-0	http://dx.doi.org/10.1016/S0092-8674(00)00124-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057905	Bronze			2022-12-28	WOS:000089864300016
J	Hampshire, V				Hampshire, V			Poorly conducted (or reported) animal tests put humans at risk	NATURE			English	Letter									Adv Vet Applicat, Bethesda, MD 20817 USA		Hampshire, V (corresponding author), Adv Vet Applicat, 7307 Nevis Rd, Bethesda, MD 20817 USA.							Lazarous DF, 1999, CARDIOVASC RES, V44, P294, DOI 10.1016/S0008-6363(99)00203-5; Nunes FA, 1999, HUM GENE THER, V10, P2515, DOI 10.1089/10430349950016852; 1999, US TODAY        1103; 2000, WASHINGTON POST 0712	4	2	2	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					671	671		10.1038/35037798	http://dx.doi.org/10.1038/35037798			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048694				2022-12-28	WOS:000089773900012
J	Meier, P; Finch, A; Evan, G				Meier, P; Finch, A; Evan, G			Apoptosis in development	NATURE			English	Review							PROGRAMMED CELL-DEATH; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; DROSOPHILA HOMOLOG; GENETIC-CONTROL; CASPASE; SURVIVAL; ACTIVATION; EXPRESSION; PROTEASES	Essential to the construction, maintenance and repair of tissues is the ability to induce suicide of supernumerary, misplaced or damaged cells with high specificity and efficiency. Study of three principal organisms - the nematode, fruitfly and mouse - indicate that cell suicide is implemented through the activation of an evolutionarily conserved molecular programme intrinsic to all metazoan cells. Dysfunctions in the regulation or execution of cell suicide are implicated in a wide range of developmental abnormalities and diseases.	Imperial Canc Res Fund, Signal Transduct Lab, London WC2A 3PX, England; Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA	Cancer Research UK; University of California System; University of California San Francisco	Meier, P (corresponding author), Inst Canc Res, Chester Beatty Labs, Breakthrough Toby Robins Breast Canc Res Ctr, Fulham Rd, London SW3 6JB, England.			Meier, Pascal/0000-0003-2760-6523				Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; Bergmann A, 1998, ONCOGENE, V17, P3215, DOI 10.1038/sj.onc.1202586; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Brachmann CB, 2000, CURR BIOL, V10, P547, DOI 10.1016/S0960-9822(00)00474-7; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; Chen P, 2000, J CELL BIOL, V148, P625, DOI 10.1083/jcb.148.4.625; Colussi PA, 2000, J CELL BIOL, V148, P703, DOI 10.1083/jcb.148.4.703; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Foley K, 1998, DEVELOPMENT, V125, P1075; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hengartner M, 1998, SCIENCE, V281, P1298, DOI 10.1126/science.281.5381.1298; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; HU S, IN PRESS J BIOL CHEM; Igaki T, 2000, P NATL ACAD SCI USA, V97, P662, DOI 10.1073/pnas.97.2.662; Inaba T, 1996, NATURE, V382, P541, DOI 10.1038/382541a0; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jiang CG, 1997, DEVELOPMENT, V124, P4673; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kiess W, 1998, EUR J ENDOCRINOL, V138, P482, DOI 10.1530/eje.0.1380482; Kondo T, 1997, P NATL ACAD SCI USA, V94, P11951, DOI 10.1073/pnas.94.22.11951; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; McCall K, 1998, SCIENCE, V279, P230, DOI 10.1126/science.279.5348.230; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Merino R, 1999, ANN NY ACAD SCI, V887, P120, DOI 10.1111/j.1749-6632.1999.tb07927.x; MERRITT AJ, 1995, J CELL SCI, V108, P2261; Metzstein MM, 1999, MOL CELL, V4, P309, DOI 10.1016/S1097-2765(00)80333-0; Metzstein MM, 1996, NATURE, V382, P545, DOI 10.1038/382545a0; Middleton G, 2000, EUR J NEUROSCI, V12, P819, DOI 10.1046/j.1460-9568.2000.00966.x; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Namba R, 1997, DEVELOPMENT, V124, P1393; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Pena JC, 1997, CELL GROWTH DIFFER, V8, P619; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Saxen L., 1987, ORGANOGENESIS KIDNEY; Shaham S, 1998, J BIOL CHEM, V273, P35109, DOI 10.1074/jbc.273.52.35109; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Song ZW, 2000, MOL CELL BIOL, V20, P2907, DOI 10.1128/MCB.20.8.2907-2914.2000; TATA JR, 1966, DEV BIOL, V13, P77, DOI 10.1016/0012-1606(66)90050-9; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Varkey J, 1999, J CELL BIOL, V144, P701, DOI 10.1083/jcb.144.4.701; VAUX DL, 1992, SCIENCE, V258, P1955, DOI 10.1126/science.1470921; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang J, 2000, J CELL SCI, V113, P753; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Weil M, 1997, CURR BIOL, V7, P281, DOI 10.1016/S0960-9822(06)00125-4; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yeh WC, 1999, IMMUNOL REV, V169, P283, DOI 10.1111/j.1600-065X.1999.tb01323.x; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhang H, 2000, J BIOL CHEM, V275, P27303; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593; Zhou L, 1999, MOL CELL, V4, P745, DOI 10.1016/S1097-2765(00)80385-8; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	74	742	813	1	54	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					796	801		10.1038/35037734	http://dx.doi.org/10.1038/35037734			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048731				2022-12-28	WOS:000089773900055
J	Johansson, LC; Norberg, UML				Johansson, LC; Norberg, UML			Biomechanics - Asymmetric toes aid underwater swimming	NATURE			English	Article									Gothenburg Univ, Dept Zool, S-41390 Gothenburg, Sweden	University of Gothenburg	Johansson, LC (corresponding author), Gothenburg Univ, Dept Zool, S-41390 Gothenburg, Sweden.		Johansson, Christoffer/B-2189-2013	Johansson, Christoffer/0000-0002-1851-3635				Braun J., 1985, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V169, P307; EBB P, 1985, FUNCTIONAL VERTEBRAT, P110; NORBERG RA, 1973, BIOL REV, V48, P561, DOI 10.1111/j.1469-185X.1973.tb01569.x; NORBERG RA, 1985, BEGINNINGS BIRDS; Norberg UML, 1990, VERTEBRATE FLIGHT; Smith A. M. O., 1975, J AIRCRAFT, V12, P501, DOI [10.2514/3.59830, DOI 10.2514/3.59830]; [No title captured]	7	18	18	15	75	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					582	583		10.1038/35036689	http://dx.doi.org/10.1038/35036689			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034197				2022-12-28	WOS:000089772800033
J	Okuda, M; Horn, HF; Tarapore, P; Tokuyama, Y; Smulian, AG; Chan, PK; Knudsen, ES; Hofmann, IA; Snyder, JD; Bove, KE; Fukasawa, K				Okuda, M; Horn, HF; Tarapore, P; Tokuyama, Y; Smulian, AG; Chan, PK; Knudsen, ES; Hofmann, IA; Snyder, JD; Bove, KE; Fukasawa, K			Nucleophosmin/B23 is a target of CDK2/Cyclin E in centrosome duplication	CELL			English	Article							CELL-CYCLE; MAMMALIAN-CELLS; MOS ONCOGENE; S-PHASE; PROTEINS; B23; OVEREXPRESSION; INSTABILITY; ACTIVATION; KINASES	In animal cells, duplication of centrosomes and DNA is coordinated. Since CDK2/cyclin E triggers initiation of both events, activation of CDK2/cyclin E is thought to link these two events. We identified nucleophosmin (NPM/B23) as a substrate of CDK2/cyclin E in centrosome duplication. NPM/B23 associates specifically with unduplicated centrosomes, and NPM/B23 dissociates from centrosomes by CDK2/cyclin E-mediated phosphorylation. An anti-NPM/B23 antibody, which blocks this phosphorylation, suppresses the initiation of centrosome duplication in vivo. Moreover, expression of a nonphosphorylatable mutant NPM/ B23 in cells effectively blocks centrosome duplication. Thus, NPM/B23 is a target of CDK2/cyclin E in the initiation of centrosome duplication.	Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Div Infect Dis, Cincinnati, OH 45267 USA; Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; Childrens Hosp Res Fdn, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Fukasawa, K (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA.	kenji.fukasawa@uc.edu	Tarapore, Pheruza/A-8876-2013	Tarapore, Pheruza/0000-0003-0911-3661; Horn, Henning/0000-0002-5885-8996; Okuda, Masaru/0000-0003-4690-8244	NATIONAL CANCER INSTITUTE [R01CA090522] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA090522-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Brinkley BR, 1998, CELL MOTIL CYTOSKEL, V41, P281, DOI 10.1002/(SICI)1097-0169(1998)41:4<281::AID-CM1>3.0.CO;2-C; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; CHAN WY, 1989, BIOCHEMISTRY-US, V28, P1033, DOI 10.1021/bi00429a017; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FUKASAWA K, 1995, ONCOGENE, V10, P1; FUKASAWA K, 1994, CELL GROWTH DIFFER, V5, P1093; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; HEICHMAN KA, 1994, CELL, V79, P557, DOI 10.1016/0092-8674(94)90541-X; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; JOSHI HC, 1994, CURR OPIN CELL BIOL, V6, P55, DOI 10.1016/0955-0674(94)90116-3; Keryer G, 1995, BIOL CELL, V84, P155, DOI 10.1016/0248-4900(96)89425-1; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Lange BMH, 1996, TRENDS CELL BIOL, V6, P348, DOI 10.1016/0962-8924(96)10033-7; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; Moudjou M, 1996, J CELL SCI, V109, P875; MOUDJOU M, 1994, METHOD CENTROSOME IS; Mussman JG, 2000, ONCOGENE, V19, P1635, DOI 10.1038/sj.onc.1203460; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Nigg E A, 1988, Int Rev Cytol, V110, P27; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Pihan GA, 1998, CANCER RES, V58, P3974; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; SPECTOR DL, 1984, CHROMOSOMA, V90, P139, DOI 10.1007/BF00292451; Szebeni A, 1999, PROTEIN SCI, V8, P905; TOURNIER F, 1994, CELL CYCLE REGULATIO; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; VANDRE DD, 1989, CENTROSOME CYCLE ANI; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; YUNG BYM, 1985, BIOCHIM BIOPHYS ACTA, V826, P167, DOI 10.1016/0167-4781(85)90002-8; Zatsepina OV, 1999, J CELL SCI, V112, P455	38	545	563	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 29	2000	103	1					127	140		10.1016/S0092-8674(00)00093-3	http://dx.doi.org/10.1016/S0092-8674(00)00093-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051553	Bronze			2022-12-28	WOS:000089636400014
J	Simon, MA				Simon, MA			Receptor tyrosine kinases: Specific outcomes from general signals	CELL			English	Review							DROSOPHILA EYE; CELL FATE; PATHWAY; ACTIVATION; DIFFERENTIATION; ELEGANS; ROUGH		Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Simon, MA (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							BASLER K, 1990, GENE DEV, V4, P728, DOI 10.1101/gad.4.5.728; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Greenwood S, 1997, DEVELOPMENT, V124, P4879; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Maloof JN, 1998, DEVELOPMENT, V125, P181; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Tan PBO, 1999, TRENDS GENET, V15, P145, DOI 10.1016/S0168-9525(99)01694-7; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	18	131	133	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					13	15		10.1016/S0092-8674(00)00100-8	http://dx.doi.org/10.1016/S0092-8674(00)00100-8			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051543	Bronze			2022-12-28	WOS:000089636400004
J	Pittet, D; Bonten, MJM				Pittet, D; Bonten, MJM			Towards invasive diagnostic techniques as standard management of ventilator-associated pneumonia	LANCET			English	Editorial Material									Univ Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland; Univ Utrecht Hosp, Dept Internal Med, Utrecht, Netherlands	University of Geneva; Utrecht University; Utrecht University Medical Center	Pittet, D (corresponding author), Univ Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland.							Bonten MJM, 1997, AM J RESP CRIT CARE, V156, P1820, DOI 10.1164/ajrccm.156.6.9610117; Campbell GD, 1996, AM J RESP CRIT CARE, V153, P1711; CHASTRE J, 1994, AM J RESP CRIT CARE, V150, P570, DOI 10.1164/ajrccm.150.2.8049850; Fagon JY, 2000, ANN INTERN MED, V132, P621, DOI 10.7326/0003-4819-132-8-200004180-00004; FAGON JY, 1993, AM J MED, V94, P281, DOI 10.1016/0002-9343(93)90060-3; KOLLEF MH, 1995, ANN INTERN MED, V122, P743, DOI 10.7326/0003-4819-122-10-199505150-00002; NIEDERMAN MS, 1994, AM J RESP CRIT CARE, V150, P565, DOI 10.1164/ajrccm.150.2.8049849; Pittet D, 1998, LANCET, V352, P83, DOI 10.1016/S0140-6736(98)85005-8; Sanchez-Nieto JM, 1998, AM J RESP CRIT CARE, V157, P371, DOI 10.1164/ajrccm.157.2.97-02039; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639	10	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					874	874		10.1016/S0140-6736(00)02675-1	http://dx.doi.org/10.1016/S0140-6736(00)02675-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036890				2022-12-28	WOS:000089259800007
J	Angel, C; Johnson, A				Angel, C; Johnson, A			Broadening access to undergraduate medical education	BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Millennium Festival of Medicine Conference	NOV 06-10, 2000	LONDON, ENGLAND						Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England; Univ Sheffield, Recruitment & Admiss Off, Sheffield S3 7QX, S Yorkshire, England	University of Sheffield; University of Sheffield	Angel, C (corresponding author), Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England.							*COUNC HEADS MED S, 2000, MED ED RES CHMS STAT; *HIGH ED FUND COUN, 1997, M897 HEFCE; *HIGH ED FUND COUN, 1996, M996 HEFCE; McManus IC, 1998, BRIT MED J, V317, P1111	4	26	26	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1136	1138		10.1136/bmj.321.7269.1136	http://dx.doi.org/10.1136/bmj.321.7269.1136			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061739	Green Published			2022-12-28	WOS:000165219600030
J	Henney, JE				Henney, JE			Challenges in regulating direct-to-consumer advertising	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									US FDA, Washington, DC 20204 USA	US Food & Drug Administration (FDA)	Henney, JE (corresponding author), US FDA, Washington, DC 20204 USA.							Bradley LR, 1997, MED CARE, V35, P86, DOI 10.1097/00005650-199701000-00008; Food and Drug Administration Center for Drug Evaluation and Research (CDER), 1999, FED REG, V64, P43197; *FOOD DRUG ADM, 1997, DRAFT GUID IND CONS; *FOOD DRUG ADM, 1984, PRESCR DRUG ADV CONS; WILES MS, 2000, HLTH AFF MILLWOOD, V10, P110; 1999, FED REG, V50, P36677	6	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2242	2242		10.1001/jama.284.17.2242	http://dx.doi.org/10.1001/jama.284.17.2242			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056601	hybrid			2022-12-28	WOS:000090052600037
J	Feder, G; Cryer, C; Donovan, S; Carter, Y				Feder, G; Cryer, C; Donovan, S; Carter, Y		Guidelines Dev Grp	Guidelines for the prevention of falls in people over 65	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIAL; OLDER ADULTS; HIP PROTECTORS; HOME RESIDENTS; ELDERLY PEOPLE; REDUCE FALLS; EXERCISE; PROGRAM; COMMUNITY; BALANCE		Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Med Sch, Dept Gen Practice & Primary Care, London E1 4NS, England; Univ Kent, Ctr Hlth Serv Studies, Tunbridge Wells TN3 0TG, Kent, England	University of London; Queen Mary University London; University of Kent	Feder, G (corresponding author), Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Med Sch, Dept Gen Practice & Primary Care, London E1 4NS, England.			Feder, Gene/0000-0002-7890-3926				Buchner DM, 1997, J GERONTOL A-BIOL, V52, pM218, DOI 10.1093/gerona/52A.4.M218; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; CARPENTER GI, 1990, BRIT MED J, V300, P253; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; *CONS AFF DIR, 1999, HOM ACC SURV SYST IN; Ebrahim S, 1997, AGE AGEING, V26, P253, DOI 10.1093/ageing/26.4.253; Eccles M, 1998, BRIT MED J, V316, P1232, DOI 10.1136/bmj.316.7139.1232; El-Faizy Marjan, 1994, Physical and Occupational Therapy in Geriatrics, V12, P33; FABACHER D, 1994, J AM GERIATR SOC, V42, P630, DOI 10.1111/j.1532-5415.1994.tb06862.x; Gallagher EM, 1996, CAN J AGING, V15, P84, DOI 10.1017/S0714980800013301; GILLESPIE LD, 1997, COCHRANE LIBRARY; HORNBROOK MC, 1994, GERONTOLOGIST, V34, P16, DOI 10.1093/geront/34.1.16; LAURITZEN JB, 1993, LANCET, V341, P11, DOI 10.1016/0140-6736(93)92480-H; LAURITZEN JB, 1996, NORD MED, V11, P340; LORD SR, 1995, J AM GERIATR SOC, V43, P1198, DOI 10.1111/j.1532-5415.1995.tb07394.x; McMurdo MET, 1997, BRIT MED J, V314, P569, DOI 10.1136/bmj.314.7080.569; Means KM, 1996, ARCH PHYS MED REHAB, V77, P1030, DOI 10.1016/S0003-9993(96)90064-7; MULROW CD, 1994, JAMA-J AM MED ASSOC, V271, P519, DOI 10.1001/jama.271.7.519; PROVINCE MA, 1995, JAMA-J AM MED ASSOC, V273, P1341, DOI 10.1001/jama.273.17.1341; Ray WA, 1997, JAMA-J AM MED ASSOC, V278, P557, DOI 10.1001/jama.278.7.557; REINSCH S, 1992, GERONTOLOGIST, V32, P450, DOI 10.1093/geront/32.4.450; *ROYAL COLL GEN PR, 1996, CLIN GUID MAN AC LOW; RUBENSTEIN LZ, 1990, ANN INTERN MED, V113, P308, DOI 10.7326/0003-4819-113-4-308; Shaw FE, 1998, AGE AGEING, V27, P7, DOI 10.1093/ageing/27.1.7; Skelton Dawn A., 1999, Physiotherapy Theory and Practice, V15, P105, DOI 10.1080/095939899307801; Tinetti M., 1997, REDUCING RISK FALLS; Tinetti ME, 1996, AM J EPIDEMIOL, V144, P389; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; VETTER NJ, 1992, BMJ-BRIT MED J, V304, P888, DOI 10.1136/bmj.304.6831.888; Villar MTA, 1998, AGE AGEING, V27, P195, DOI 10.1093/ageing/27.2.195; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x; 1996, EFFECT HLTH CARE B, V2, P1	33	182	203	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 21	2000	321	7267					1007	1011		10.1136/bmj.321.7267.1007	http://dx.doi.org/10.1136/bmj.321.7267.1007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	366ZF	11039974	Green Published			2022-12-28	WOS:000090035600032
J	Hannah, ME; Hannah, WJ; Hewson, SA; Hodnett, ED; Saigal, S; Willan, AR				Hannah, ME; Hannah, WJ; Hewson, SA; Hodnett, ED; Saigal, S; Willan, AR		Term Breech Trial Collaborative Gr	Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial	LANCET			English	Article							ELECTIVE CESAREAN-SECTION; DELIVERY; FETUSES	Background For 3-4% of pregnancies, the fetus will be in the breech presentation at term. For most of these women, the approach to delivery is controversial. We did randomised trial to compare a policy of planned caesarean section with a policy of planned Vaginal birth for selected breech-presentation pregnancies. Methods At 121 centres in 26 countries, 2088 women with a singleton fetus in a frank or complete breech presentation were randomly assigned planned caesarean section or planned vaginal birth. Women having a vaginal breech delivery bad an experienced clinician at the birth. Mothers and infants were followed-up to 6 weeks post partum. The primary outcomes were perinatal mortality, neonatal mortality, or serious neonatal morbidity; and maternal mortality or serious maternal morbidity. Analysis was by intention to treat. Findings Data were received for 2083 women. Of the 1041 women assigned planned caesarean section. 941 (90.4%) were delivered by caesarean section. Of the 1042 women assigned planned vaginal birth, 591 (56.7%) delivered vaginally. Perinatal mortality, neonatal mortality, or serious neonatal morbidity was significantly lower for the planned caesarean section group than for the planned vaginal birth group (17 of 1039 [1.6%] vs 52 of 1039 [5.0%]; relative risk 0.33 [95% CI 0.19-0.56]; p<0.0001). There were no differences between groups in terms of maternal mortality or serious maternal morbidity (41 of 1041 [3.9%] vs 33 of 1042 [3.2%]; 1.24 [0.79-1.95]; p=0.35). Interpretation Planned caesarean section is better than planned vaginal birth for the term fetus in the breech presentation; serious maternal complications are similar between the groups.	Univ Toronto, Maternal Infant & Reprod Hlth Res Unit, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada; Univ Toronto, Sunnybrook Womens Coll, Hlth Sci Ctr, Dept Obstet & Gynaecol, Toronto, ON M5G 1N8, Canada; Univ Toronto, Fac Nursing, Toronto, ON M5G 1N8, Canada; McMaster Univ, Dept Paediat, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; McMaster University; McMaster University	Hannah, ME (corresponding author), Univ Toronto, Maternal Infant & Reprod Hlth Res Unit, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada.		abdelaleem, mahmoud/B-6567-2015	abdelaleem, mahmoud/0000-0003-3942-9325				Albrechtsen S, 1997, AM J OBSTET GYNECOL, V177, P586, DOI 10.1016/S0002-9378(97)70150-9; [Anonymous], 1994, J SOGC, V16, P1839; CHENG M, 1993, OBSTET GYNECOL, V82, P605; COLLEA JV, 1980, AM J OBSTET GYNECOL, V137, P235, DOI 10.1016/0002-9378(80)90780-2; Danielian PJ, 1996, BRIT MED J, V312, P1451, DOI 10.1136/bmj.312.7044.1451; GIFFORD DS, 1995, OBSTET GYNECOL, V85, P1047, DOI 10.1016/0029-7844(95)00053-T; GIMOVSKY ML, 1983, AM J OBSTET GYNECOL, V146, P34, DOI 10.1016/0002-9378(83)90923-7; HANNAH ME, 1992, NEW ENGL J MED, V326, P1587, DOI 10.1056/NEJM199206113262402; HICKOK DE, 1992, AM J OBSTET GYNECOL, V166, P851, DOI 10.1016/0002-9378(92)91347-D; Hofmeyr GJ, 2000, COCHRANE LIB; Irion O, 1998, BRIT J OBSTET GYNAEC, V105, P710, DOI 10.1111/j.1471-0528.1998.tb10200.x; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2; Penkin P, 1996, J SOGC, V18, P233; StSaunders NJ, 1996, J PERINAT MED, V24, P545; World Health Organization, 1996, WHOFRHMSM967	15	1206	1237	1	53	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1375	1383		10.1016/S0140-6736(00)02840-3	http://dx.doi.org/10.1016/S0140-6736(00)02840-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052579				2022-12-28	WOS:000089976100010
J	Pross, C				Pross, C			The police medical service of Berlin: doctors or agents of the State?	LANCET			English	Editorial Material									Berlin Ctr Treatment Torture Victims, D-14050 Berlin, Germany		Pross, C (corresponding author), Berlin Ctr Treatment Torture Victims, D-14050 Berlin, Germany.								0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1435	1436		10.1016/S0140-6736(00)03143-3	http://dx.doi.org/10.1016/S0140-6736(00)03143-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052601				2022-12-28	WOS:000089976100046
J	Thompson, SA; Duncan, JS; Smith, SJM				Thompson, SA; Duncan, JS; Smith, SJM			Partial seizures presenting as panic attacks	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LOBE SEIZURES; EPILEPSY; PREVALENCE; DIAGNOSIS; DISORDERS		MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Thompson, SA (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England.	SianAT@aol.com		Duncan, John S/0000-0002-1373-0681				ALEMAYEHU S, 1995, EPILEPSIA, V36, P824, DOI 10.1111/j.1528-1157.1995.tb01621.x; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P393; Duncan JS, 1995, CLIN EPILEPSY, P29; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; KERANEN T, 1988, EPILEPSIA, V29, P1, DOI 10.1111/j.1528-1157.1988.tb05089.x; Lagerlund TD, 1996, MAYO CLIN PROC, V71, P1000; LAIDLAW JDD, 1993, BRIT MED J, V306, P709, DOI 10.1136/bmj.306.6879.709; LOGAR C, 1994, EUR NEUROL, V34, P29, DOI 10.1159/000119506; ROBINS LN, 1984, ARCH GEN PSYCHIAT, V41, P949; STAHL SM, 1995, SEMIN NEUROL, V15, P126, DOI 10.1055/s-2008-1041016; YOUNG GB, 1995, J NEUROPSYCH CLIN N, V7, P352	11	36	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2000	321	7267					1002	1003		10.1136/bmj.321.7267.1002	http://dx.doi.org/10.1136/bmj.321.7267.1002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366ZF	11039971	Green Published			2022-12-28	WOS:000090035600030
J	Toker, A; Newton, AC				Toker, A; Newton, AC			Cellular signaling: Pivoting around PDK-1	CELL			English	Review							PROTEIN-KINASE-B; PHOSPHORYLATION; ACTIVATION		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Diego	Toker, A (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA.							Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Prasad N, 2000, BIOCHEMISTRY-US, V39, P6929, DOI 10.1021/bi000387i; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Ziegler WH, 1999, CURR BIOL, V9, P522, DOI 10.1016/S0960-9822(99)80236-X	17	352	357	1	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 13	2000	103	2					185	188		10.1016/S0092-8674(00)00110-0	http://dx.doi.org/10.1016/S0092-8674(00)00110-0			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057891	Bronze			2022-12-28	WOS:000089864300002
J	Choi, SB; Wang, CL; Muench, DG; Ozawa, K; Franceschi, VR; Wu, YJ; Okita, TW				Choi, SB; Wang, CL; Muench, DG; Ozawa, K; Franceschi, VR; Wu, YJ; Okita, TW			Messenger RNA targeting of rice seed storage proteins to specific ER subdomains	NATURE			English	Article							EXPRESSION; ENDOSPERM; CELLS; LOCALIZATION	Rice seeds, a rich reserve of starch and protein, are a major food source in many countries. Unlike the seeds of other plants, which typically accumulate one major type of storage protein, rice seeds use two major classes, prolamines and globulin-like glutelins. Both storage proteins are synthesized on the endoplasmic reticulum (ER) and translocated to the ER lumen, but are then sorted into separate intracellular compartments(1,2). Prolamines are retained in the ER lumen as protein bodies whereas glutelins are transported and stored in protein storage vacuoles. Mechanisms responsible for the retention of prolamines within the ER lumen and their assembly into intracisternal inclusion granules are unknown, but the involvement of RNA localization has been suggested(3). Here we show that the storage protein RNAs are localized to distinct ER membranes and that prolamine RNAs are targeted to the prolamine protein bodies by a mechanism based on RNA signal(s), a process that also requires a translation initiation codon. Our results indicate that the ER may be composed of subdomains that specialize in the synthesis of proteins directed to different compartments of the plant endomembrane system.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Natl Inst Agrobiol Resources, Tsukuba, Ibaraki 3058602, Japan	Washington State University; Washington State University; University of Calgary; National Institute of Agrobiological Sciences - Japan	Okita, TW (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.			Okita, Tom/0000-0002-2246-0599				Bassell GJ, 1999, FASEB J, V13, P447, DOI 10.1096/fasebj.13.3.447; Dalgleish GD, 1999, NUCLEIC ACIDS RES, V27, P4363, DOI 10.1093/nar/27.22.4363; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Jansen RP, 1999, FASEB J, V13, P455, DOI 10.1096/fasebj.13.3.455; KIM WT, 1988, PLANT PHYSIOL, V88, P649, DOI 10.1104/pp.88.3.649; KIM WT, 1993, PLANT CELL PHYSIOL, V34, P595; KRISHNAN HB, 1986, PLANTA, V169, P471, DOI 10.1007/BF00392095; LI XX, 1993, CELL, V72, P869, DOI 10.1016/0092-8674(93)90576-C; LI XX, 1993, SCIENCE, V262, P1054, DOI 10.1126/science.8235623; MITSUKAWA N, 1991, RICE GENETICS, V2, P503; Muench DG, 1997, PLANT CELL PHYSIOL, V38, P404, DOI 10.1093/oxfordjournals.pcp.a029183; Muench DG, 2000, PLANTA, V211, P227, DOI 10.1007/PL00008159; Okita TW, 1996, ANNU REV PLANT PHYS, V47, P327, DOI 10.1146/annurev.arplant.47.1.327; YAMAGATA H, 1986, PLANT CELL PHYSIOL, V27, P135; YAMAGATA H, 1986, PLANT CELL PHYSIOL, V27, P1419, DOI 10.1093/oxfordjournals.pcp.a077240	15	143	150	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					765	767		10.1038/35037633	http://dx.doi.org/10.1038/35037633			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048726				2022-12-28	WOS:000089773900048
J	Christians, E; Davis, AA; Thomas, SD; Benjamin, IJ				Christians, E; Davis, AA; Thomas, SD; Benjamin, IJ			Embryonic development - Maternal effect of Hsf1 on reproductive success	NATURE			English	Article							MOUSE EMBRYO; GENE; TRANSCRIPTION; EXPRESSION; ACTIVATION; PROTECTION; FACTOR-1; MICE		Univ Liege, Fac Vet Med, Dept Histol & Embryol, B-4000 Liege, Belgium; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Div Cell & Mol Biol, Dallas, TX 75390 USA	University of Liege; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Christians, E (corresponding author), Univ Liege, Fac Vet Med, Dept Histol & Embryol, 20 Blvd Colonster, B-4000 Liege, Belgium.	ivor.benjamin@utsouthwestern.edu						BENSAUDE O, 1983, NATURE, V305, P331, DOI 10.1038/305331a0; Bevilacqua A, 2000, DEVELOPMENT, V127, P1541; Christians E, 1997, MOL CELL BIOL, V17, P778, DOI 10.1128/MCB.17.2.778; CHRISTIANS E, 1995, DEVELOPMENT, V121, P113; Davis W, 2000, DEV BIOL, V218, P275, DOI 10.1006/dbio.1999.9486; Greenhouse S, 1998, AM J HUM GENET, V62, P1282, DOI 10.1086/301893; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; LATHAM KE, 1991, DEVELOPMENT, V112, P921; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; SCHUPBACH T, 1989, GENETICS, V121, P101; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943	12	215	230	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					693	694		10.1038/35037669	http://dx.doi.org/10.1038/35037669			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048707				2022-12-28	WOS:000089773900028
J	Gupta, S				Gupta, S			A victim of truth	NATURE			English	Editorial Material									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Gupta, S (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.								0	4	4	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					677	677		10.1038/35037708	http://dx.doi.org/10.1038/35037708			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048697				2022-12-28	WOS:000089773900018
J	Savill, J; Fadok, V				Savill, J; Fadok, V			Corpse clearance defines the meaning of cell death	NATURE			English	Article							APOPTOTIC CELLS; MACROPHAGE RECOGNITION; DENDRITIC CELLS; MEMBRANE PHOSPHATIDYLSERINE; CUTTING EDGE; PHAGOCYTOSIS; BODIES; LEUKOCYTES; ENGULFMENT; ANTIBODIES	While philosophers seek the meaning of life, cell biologists are becoming ever more interested in the meaning of death. Apoptosis marks unwanted cells with 'eat me' signals that direct recognition, engulfment and degradation by phagocytes. Far from being the end of the story, these clearance events allow scavenger cells to confer meaning upon cell death. But if the phagocytic 'spin doctors' receive or transmit the wrong messages, trouble ensues.	Univ Edinburgh, Royal Infirm, Dept Clin & Surg Sci Internal Med, MRC,Ctr Inflammat Res, Edinburgh EH3 9YW, Midlothian, Scotland; Natl Jewish Med & Res Ctr, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA	Royal Infirmary of Edinburgh; University of Edinburgh; National Jewish Health	Savill, J (corresponding author), Univ Edinburgh, Royal Infirm, Dept Clin & Surg Sci Internal Med, MRC,Ctr Inflammat Res, Edinburgh EH3 9YW, Midlothian, Scotland.	j.savill@ed.ac.uk						Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; ALBERT ML, IN PRESS NATURE CELL; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; Bellone M, 1997, J IMMUNOL, V159, P5391; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Brown SB, 1999, J IMMUNOL, V162, P480; CASCIOLAROSEN LA, 1995, J EXP MED, V182, P1625, DOI 10.1084/jem.182.6.1625; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Dini L, 1999, ITAL J ZOOL, V66, P317, DOI 10.1080/11250009909356271; Duffield JS, 2000, J IMMUNOL, V164, P2110, DOI 10.4049/jimmunol.164.4.2110; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Liu YQ, 1999, J IMMUNOL, V162, P3639; LUI QA, 1998, CELL, V93, P961; Manfredi AA, 1998, ARTHRITIS RHEUM-US, V41, P205; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; MEAGHER LC, 1992, J LEUKOCYTE BIOL, V52, P269, DOI 10.1002/jlb.52.3.269; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Moffatt OD, 1999, J IMMUNOL, V162, P6800; Nakamura K, 1999, CELL IMMUNOL, V193, P147, DOI 10.1006/cimm.1999.1459; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Platt N, 2000, J IMMUNOL, V164, P4861, DOI 10.4049/jimmunol.164.9.4861; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Reiter I, 1999, J IMMUNOL, V163, P1730; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; Rovere P, 1998, J IMMUNOL, V161, P4467; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; Savill J, 1998, NATURE, V392, P442, DOI 10.1038/33025; Smits E, 1999, CURR BIOL, V9, P1351, DOI 10.1016/S0960-9822(00)80062-7; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stern M, 1996, AM J PATHOL, V149, P911; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5	50	1146	1204	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					784	788		10.1038/35037722	http://dx.doi.org/10.1038/35037722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048729				2022-12-28	WOS:000089773900053
J	Boetius, A; Ravenschlag, K; Schubert, CJ; Rickert, D; Widdel, F; Gieseke, A; Amann, R; Jorgensen, BB; Witte, U; Pfannkuche, O				Boetius, A; Ravenschlag, K; Schubert, CJ; Rickert, D; Widdel, F; Gieseke, A; Amann, R; Jorgensen, BB; Witte, U; Pfannkuche, O			A marine microbial consortium apparently mediating anaerobic oxidation of methane	NATURE			English	Article							SULFATE-REDUCING BACTERIA; SPATIAL-ORGANIZATION; ACTIVATED-SLUDGE; SEDIMENTS; PROBES; ABUNDANCE; FLOW	A large fraction of globally produced methane is converted to CO2 by anaerobic oxidation in marine sediments(1). Strong geochemical evidence for net methane consumption in anoxic sediments is based on methane profiles(2), radiotracer experiments(3) and stable carbon isotope data(4). But the elusive microorganisms mediating this reaction have not yet been isolated, and the pathway of anaerobic oxidation of methane is insufficiently understood. Recent data suggest that certain archaea reverse the process of methanogenesis by interaction with sulphate-reducing bacteria(5-7). Here we provide microscopic evidence for a structured consortium of archaea and sulphate-reducing bacteria, which we identified by fluorescence in situ hybridization using specific 16S rRNA-targeted oligonucleotide probes. In this example of a structured archaeal-bacterial symbiosis, the archaea grow in dense aggregates of about 100 cells and are surrounded by sulphate-reducing bacteria. These aggregates were abundant in gas-hydrate-rich sediments with extremely high rates of methane-based sulphate reduction, and apparently mediate anaerobic oxidation of methane.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; GEOMAR Res Ctr Marine Geosci, D-24148 Kiel, Germany	Max Planck Society; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Boetius, A (corresponding author), Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany.	aboetius@mpi-bremen.de	Jorgensen, Bo B/C-2214-2013; Amann, Rudolf I/C-6534-2014; Schubert, Carsten/GQQ-1673-2022; Boetius, Antje/D-5459-2013	Jorgensen, Bo B/0000-0001-9398-8027; Amann, Rudolf I/0000-0002-0846-7372; Boetius, Antje/0000-0003-2117-4176				Aharon P, 2000, GEOCHIM COSMOCHIM AC, V64, P233, DOI 10.1016/S0016-7037(99)00292-6; Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; BOHRMANN G, 2000, GEOMAR REP, V93; BOONE DR, 1989, APPL ENVIRON MICROB, V55, P1735, DOI 10.1128/AEM.55.7.1735-1741.1989; DEVEREUX R, 1992, SYST APPL MICROBIOL, V15, P601, DOI 10.1016/S0723-2020(11)80122-0; Elvert M, 1999, NATURWISSENSCHAFTEN, V86, P295, DOI 10.1007/s001140050619; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; Hansen LB, 1998, AQUAT MICROB ECOL, V14, P195, DOI 10.3354/ame014195; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; IVERSEN N, 1985, LIMNOL OCEANOGR, V30, P944, DOI 10.4319/lo.1985.30.5.0944; Koga Y, 1998, BIOSCI BIOTECH BIOCH, V62, P230, DOI 10.1271/bbb.62.230; LINKE P, 1994, DEEP-SEA RES PT I, V41, P721, DOI 10.1016/0967-0637(94)90051-5; Manz W, 1998, FEMS MICROBIOL ECOL, V25, P43; MARTENS CS, 1977, LIMNOL OCEANOGR, V22, P10, DOI 10.4319/lo.1977.22.1.0010; Mobarry BK, 1996, APPL ENVIRON MICROB, V62, P2156, DOI 10.1128/AEM.62.6.2156-2162.1996; Pancost RD, 2000, APPL ENVIRON MICROB, V66, P1126, DOI 10.1128/AEM.66.3.1126-1132.2000; PREUSS A, 1989, Z NATURFORSCH C, V44, P397; Rabus R, 2000, PROKARYOTES EVOLVING; Ravenschlag K, 2000, APPL ENVIRON MICROB, V66, P3592, DOI 10.1128/AEM.66.8.3592-3602.2000; Reerburgh W.S., 1982, DYNAMIC ENV OCEAN FL, P203; Sahm K, 1999, APPL ENVIRON MICROB, V65, P3976; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Stumm W., 1981, AQUATIC CHEM; Suess E, 1999, EARTH PLANET SC LETT, V170, P1, DOI 10.1016/S0012-821X(99)00092-8; Thiel V, 1999, GEOCHIM COSMOCHIM AC, V63, P3959, DOI 10.1016/S0016-7037(99)00177-5; VALENTINE DL, IN PRESS ENV MICROB, V2	29	2055	2238	37	986	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2000	407	6804					623	626		10.1038/35036572	http://dx.doi.org/10.1038/35036572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034209				2022-12-28	WOS:000089772800045
J	Lasorella, A; Noseda, M; Beyna, M; Iavarone, A				Lasorella, A; Noseda, M; Beyna, M; Iavarone, A			Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins	NATURE			English	Article							CELL-CYCLE ARREST; C-MYC; HUMAN NEUROBLASTOMA; REGULATORY PATHWAY; GENE; EXPRESSION; FAMILY; MOUSE; PROLIFERATION; GROWTH	In mammalian cells, Id proteins coordinate proliferation and differentiation. Id2 is a dominant-negative antagonist of basic helix- loop-helix transcription factors and proteins of the retinoblastoma (Rb) family. Here we show that Id2-Rb double knockout embryos survive to term with minimal or no defects in neurogenesis and haematopoiesis, but they die at birth from severe reduction of muscle tissue. In neuroblastoma, an embryonal tumour derived from the neural crest, Id2 is overexpressed in cells carrying extra copies of the N-myc gene. In these cells, Id2 is in molar excess of the active form of Rb. The overexpression of Id2 results from transcriptional activation by oncoproteins of the Myc family. Cell-cycle progression induced by Myc oncoproteins requires inactivation of Rb by Id2. Thus, a dual connection links Id2 and Rb: during normal cell-cycle, Rb prohibits the action of Id2 on its natural targets, but oncogenic activation of the Myc-Id2 transcriptional pathway overrides the tumour-suppressor function of Rb.	Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Ctr Comprehens Canc, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Iavarone, A (corresponding author), Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA.		Califano, Andrea/F-7239-2012	Beyna, Mercedes/0000-0003-0603-3981; Noseda, Michela/0000-0002-9553-5029				Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Amati B, 1998, FRONT BIOSCI, V3, pd250, DOI [10.2741/a239, DOI 10.2741/A239]; BELTINGER CP, 1995, CANCER RES, V55, P2053; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Castresana JS, 1997, MOL CARCINOGEN, V18, P129, DOI 10.1002/(SICI)1098-2744(199703)18:3<129::AID-MC1>3.0.CO;2-A; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Cooper CL, 1997, BLOOD, V89, P3155, DOI 10.1182/blood.V89.9.3155; Diccianni MB, 1996, CANCER LETT, V104, P183, DOI 10.1016/0304-3835(96)04250-4; Diccianni MB, 1999, INT J CANCER, V80, P145, DOI 10.1002/(SICI)1097-0215(19990105)80:1<145::AID-IJC26>3.3.CO;2-7; Easton J, 1998, CANCER RES, V58, P2624; Fan X, 1999, ONCOL REP, V6, P647; Florio M, 1998, MOL CELL BIOL, V18, P5435, DOI 10.1128/MCB.18.9.5435; GOODRICH DW, 1992, NATURE, V360, P177, DOI 10.1038/360177a0; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Iavarone A, 1997, NATURE, V387, P417; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jen Y, 1996, DEV DYNAM, V207, P235; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; Kawamata N, 1996, CANCER, V77, P570; Lasorella A, 1996, MOL CELL BIOL, V16, P2570; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; LUFKIN T, 1992, NATURE, V359, P835, DOI 10.1038/359835a0; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Martinsen BJ, 1998, SCIENCE, V281, P988, DOI 10.1126/science.281.5379.988; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Morrow MA, 1999, MOL IMMUNOL, V36, P491, DOI 10.1016/S0161-5890(99)00071-1; NEUMAN K, 1995, FEBS LETT, V374, P279, DOI 10.1016/0014-5793(95)01128-2; NEUMAN T, 1993, DEV BIOL, V160, P186, DOI 10.1006/dbio.1993.1297; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; ZHU WJ, 1995, MOL BRAIN RES, V30, P312, DOI 10.1016/0169-328X(95)00017-M	41	417	429	1	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					592	598		10.1038/35036504	http://dx.doi.org/10.1038/35036504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034201				2022-12-28	WOS:000089772800037
J	Simmonds, P; Best, L; Baughan, C; Buchanan, R; Davis, C; Fentiman, I; George, S; Gosney, M; Northover, J; Williams, C; Amato, A; Arbman, G; Arenal, JJ; Barillari, P; Benhamiche-Bouvier, AM; Bjerkeset, T; Braun, L; Carlsen, E; Coco, C; Fielding, LP; Franklin, ME; Hermanek, P; de la Fuente, FH; Hohenberger, W; Kingston, RD; Komborozos, VA; Lau, WY; Marks, CG; Navarro-Pomares, A; Pigot, F; Carraro, PS; Smith, J; Stamatakis, JD; Sugihara, K; Tagliacozzo, S; Tartter, P; Verschueren, RCJ; Violi, V				Simmonds, P; Best, L; Baughan, C; Buchanan, R; Davis, C; Fentiman, I; George, S; Gosney, M; Northover, J; Williams, C; Amato, A; Arbman, G; Arenal, JJ; Barillari, P; Benhamiche-Bouvier, AM; Bjerkeset, T; Braun, L; Carlsen, E; Coco, C; Fielding, LP; Franklin, ME; Hermanek, P; de la Fuente, FH; Hohenberger, W; Kingston, RD; Komborozos, VA; Lau, WY; Marks, CG; Navarro-Pomares, A; Pigot, F; Carraro, PS; Smith, J; Stamatakis, JD; Sugihara, K; Tagliacozzo, S; Tartter, P; Verschueren, RCJ; Violi, V		Colorectal Canc Collaborative Grp	Surgery for colorectal cancer in elderly patients: a systematic review	LANCET			English	Article							RECTAL-CANCER; ANTERIOR RESECTION; SURGICAL-TREATMENT; LOCAL RECURRENCE; HEALTH-CARE; SURVIVAL; CARCINOMA; MORTALITY; AGE; OLDER	Background The effectiveness of surgery for colorectal cancer depends on it being carried out safely, which allows most patients to return to productive lives, with an improved postoperative life expectancy, or at least one that is not diminished by the surgery. Because colorectal cancer is a major cause of morbidity and mortality in elderly people, we have examined how the outcomes of surgery in elderly patients differ from those in younger patients. Methods We did a systematic review of published and aggregate data provided by investigators. Studies were identified by computerised and manual searches of published and unpublished reports, scanning references, and contacting investigators. Within each study, outcomes for patients aged 65-74 years, 75-84 years, and 85+ years were expressed in relation to those aged less than 65 years. Findings From 28 independent studies, and a total of 34 194 patients, we found that elderly patients had an increased frequency of comorbid conditions, were more likely to present with later-stage disease and undergo emergency surgery, and less likely to have curative surgery than younger patients. The incidence of postoperative morbidity and mortality increased progressively with advancing age. Overall survival was reduced in elderly patients, but for cancer specific survival age-related differences were much less striking. Interpretation The relation between age and outcomes from colorectal cancer surgery is complex and may be confounded by differences in stage at presentation, tumour site, pre-existing comorbidities, and type of treatment received. However, selected elderly patients benefit from surgery since a large proportion survive for 2 or more years, irrespective of their age.	Southampton Gen Hosp, CRC, Wessex Med Oncol Unit, Southampton SO16 6YD, Hants, England; Southampton Gen Hosp, Hlth Care Res Unit, Southampton SO16 6YD, Hants, England; Royal S Hants Hosp, Wessex Radiotherapy Ctr, Southampton SO9 4PE, Hants, England; Countess Mountbatten House, Southampton, Hants, England; Guys Hosp, Hedley Atkins Breast Unit, London, England; Univ Liverpool, Liverpool L69 3BX, Merseyside, England; St Marks Hosp, Harrow, Middx, England; Inst Hlth Sci, Cochrane Canc Network, Oxford, England	University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal South Hants Hospital; Guy's & St Thomas' NHS Foundation Trust; University of Liverpool; Imperial College London; University of Oxford	Simmonds, P (corresponding author), Southampton Gen Hosp, CRC, Wessex Med Oncol Unit, Southampton SO16 6YD, Hants, England.	pds1@soton.ac.uk	Fentiman, Ian S/I-7644-2019; Fentiman, Ian/AAB-9886-2020	Turner, Lesley/0000-0003-1489-3471				Amato A, 1998, BRIT J SURG, V85, P13; ARBMAN G, 1995, DIS COLON RECTUM, V38, P645, DOI 10.1007/BF02054127; ARENAL JJ, 1997, BR J SURG S2, V84, P24; Arveux I, 1997, BRIT J CANCER, V76, P963, DOI 10.1038/bjc.1997.492; BARILLARI P, 1989, EUR J SURG ONCOL, V15, P441; Bjerkeset T, 1996, EUR J SURG, V162, P643; BRAUN L, 1991, ZBL CHIR, V116, P453; BUHRE LMD, 1994, BRIT J SURG, V81, P1227, DOI 10.1002/bjs.1800810851; Carlsen E, 1998, BRIT J SURG, V85, P526; COCO C, 1996, BR J SURG S2, V83, P25; Coleman M, 1996, BR J SURG S1, V83, P22; DELAFUENTE EH, 1993, REV ESP ENFERM DIG, V84, P17; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Faivre J, 1996, DIS COLON RECTUM, V39, P270, DOI 10.1007/BF02049467; FIELDING LP, 1989, LANCET, V1, P595; Franklin ME, 1996, DIS COLON RECTUM, V39, pS35, DOI 10.1007/BF02053804; Goodwin JS, 1996, JNCI-J NATL CANCER I, V88, P1031, DOI 10.1093/jnci/88.15.1031; *GREAT BRIT OFF NA, 1998, CANC STAT REG ENGL W; GREENFIELD S, 1987, JAMA-J AM MED ASSOC, V257, P2766, DOI 10.1001/jama.257.20.2766; HOSKING MP, 1989, JAMA-J AM MED ASSOC, V261, P1909; IRVIN TT, 1988, BRIT J SURG, V75, P419, DOI 10.1002/bjs.1800750508; Iscoe N, 1998, ANN ONCOL, V9, P74; KESSLER H, 1993, INT J COLORECTAL DIS, V8, P158, DOI 10.1007/BF00341191; Kingston R D, 1992, J R Coll Surg Edinb, V37, P235; Kockerling F, 1998, J CLIN ONCOL, V16, P324; KOMBOROZOS VA, 1995, HELL J GASTROENTEROL, V8, P55; Koruda M J, 1991, Adv Surg, V24, P293; Kwok SPY, 1996, ANN SURG, V223, P170, DOI 10.1097/00000658-199602000-00009; Mella J, 1997, BRIT J SURG, V84, P1731; Monfardini S, 1999, EUR J CANCER, V35, P1771, DOI 10.1016/S0959-8049(99)00227-0; NAVARROPOMARES A, 1994, BR J SURG S, V81, P33; NEWCOMB PA, 1993, J NATL CANCER I, V85, P1580, DOI 10.1093/jnci/85.19.1580; PHILLIPS RKS, 1985, BRIT J SURG, V72, P296, DOI 10.1002/bjs.1800720417; RUNKEL NS, 1991, BRIT J SURG, V78, P183, DOI 10.1002/bjs.1800780216; SAMET J, 1986, JAMA-J AM MED ASSOC, V255, P3385, DOI 10.1001/jama.255.24.3385; Setti Carraro P., 1995, Annali Italiani di Chirurgia, V66, P685; SINGH S, 1995, BRIT J SURG, V82, P1486, DOI 10.1002/bjs.1800821112; Sugihara K, 1996, CANCER-AM CANCER SOC, V78, P1871, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1871::AID-CNCR5>3.3.CO;2-9; TAGLIACOZZO S, 1992, INT J COLORECTAL DIS, V7, P135, DOI 10.1007/BF00360353; Tartter P, 1996, ANN SURG, V223, P351, DOI 10.1097/00000658-199604000-00002; TURNBULL RB, 1967, ANN SURG, V166, P420; Violi V, 1998, DIS COLON RECTUM, V41, P291, DOI 10.1007/BF02237482; WALDRON RP, 1986, BRIT J SURG, V73, P214, DOI 10.1002/bjs.1800730320; *WESS COL CANC AUD, 1997, 4 WESS COL CANC AUD; WILLIAMS NS, 1995, OXFORD TXB ONCOLOGY, P1133; YANCIK R, 1994, CANCER, V74, P1995, DOI 10.1002/1097-0142(19941001)74:7+<1995::AID-CNCR2820741702>3.0.CO;2-Y	46	447	459	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2000	356	9234					968	974		10.1016/S0140-6736(00)02713-6	http://dx.doi.org/10.1016/S0140-6736(00)02713-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041397				2022-12-28	WOS:000089293600010
J	Eisenberg, JM; Power, EJ				Eisenberg, JM; Power, EJ			Transforming insurance coverage into quality health care - Voltage drops from potential to delivered quality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Commonwealth Funds Ditchley Conference	MAY 22-23, 1999	OXFORD, ENGLAND				RANDOMIZED CONTROLLED TRIAL; PATIENT SATISFACTION; PREVENTIVE SERVICES; CHILDREN; ACCESS; STATE; COST; MORTALITY; PHYSICIAN; HOSPITALS	Although the US health care system is often touted as one of the best in the world, disparities exist in quality of care received by different: populations, in different regions, and across different institutions and clinicians, Initiatives to provide access to health insurance have been a major policy tool to ensure that Americans receive high-quality health care. However, availability of insurance coverage does not automatically lead to high-quality care. This article explores points of vulnerability in the US health cave system at which the potential to achieve high-quality care can be lost: (1) access to insurance coverage; (2) enrollment in available insurance plans; (3) access to covered services, clinicians, and health care institutions; (4) choice of plans, clinicians, and health care institutions; (5) access to a consistent source of primary care; (6) access to referral services; and (7) delivery of high-quality health care services, Ensuring high-quality health care requires that each of these "voltage drops" be recognized and addressed.	US Dept HHS, Agcy Hlth Care Policy & Res, Rockville, MD 20852 USA; Natl Forum Healthcare Qual Measurement & Reportin, Washington, DC USA	Agency for Healthcare Research & Quality	Eisenberg, JM (corresponding author), US Dept HHS, Agcy Hlth Care Policy & Res, 2101 E Jefferson St, Rockville, MD 20852 USA.							Abrams M., 1997, COMMONWEALTH FUND SU; American College of Physicians-American Society of Internal Medicine, 1999, NO HLTH INS ITS EN M; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; BALAS EA, 1999, RURAL RESIDENTS NEED; Bindman AB, 1996, J GEN INTERN MED, V11, P269, DOI 10.1007/BF02598266; Burstin HR, 1998, INQUIRY-J HEALTH CAR, V35, P389; BURSTIN HR, 1992, JAMA-J AM MED ASSOC, V268, P2383, DOI 10.1001/jama.268.17.2383; Cooper PF, 1997, HEALTH AFFAIR, V16, P142, DOI 10.1377/hlthaff.16.6.142; CRECO PJ, 1993, NEW ENGL J MED, V329, P1271; Crofton C, 1999, MED CARE, V37, pMS1, DOI 10.1097/00005650-199903001-00001; CUNNINGHAM PJ, 1999, WHO DECLINES EMPLOYE; Davis M, 1999, HEALTH AFFAIR, V18, P231, DOI 10.1377/hlthaff.18.1.231; *DEP HLTH HUM SERV, 2000, SEL STAT HLTH PROF S; Donelan K, 1999, HEALTH AFFAIR, V18, P206, DOI 10.1377/hlthaff.18.3.206; Eisenberg JM, 1999, JAMA-J AM MED ASSOC, V282, P1865, DOI 10.1001/jama.282.19.1865; Ettner SL, 1996, AM J PUBLIC HEALTH, V86, P1748, DOI 10.2105/AJPH.86.12.1748; FRANKS P, 1993, JAMA-J AM MED ASSOC, V270, P737, DOI 10.1001/jama.270.6.737; Fraser I, 1999, HEALTH AFFAIR, V18, P158, DOI 10.1377/hlthaff.18.6.158; Gross DJ, 1999, HEALTH SERV RES, V34, P241; Grumbach K, 1999, JAMA-J AM MED ASSOC, V282, P261, DOI 10.1001/jama.282.3.261; Guidry J J, 1998, J Cancer Educ, V13, P43; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; Hillner BE, 1996, BREAST CANCER RES TR, V40, P75, DOI 10.1007/BF01806004; *HLTH CAR FIN ADM, 1999, CHILDR HLTH INS PROG; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; HUNT KA, 1997, HLTH AFF MILLWOOD, V16, P151; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; *J LEHR KAIS FAM F, 2000, NAT SURV UN; *KAIS FAM FDN, 2000, SURV PHYS NURS; Kapphahn CJ, 1999, J ADOLESCENT HEALTH, V25, P131, DOI 10.1016/S1054-139X(99)00050-6; *KPMG PEAT MARW, 1998, SOURC BOOK HLTH INS; Leviton LC, 1999, JAMA-J AM MED ASSOC, V281, P46, DOI 10.1001/jama.281.1.46; LOHR KN, 1986, R3469HHS RAND CORP; LONG SH, 1998, WIDESPREAD IS MANAGE, V12; MEYER JA, 1997, AHCPR PUBLICATION; MIROWSKY J, 1983, SOC SCI MED, V17, P1353, DOI 10.1016/0277-9536(83)90195-8; MITCHELL JB, 1998, EVALUATION OREGON ME; Monheit AC, 1999, INQUIRY-J HEALTH CAR, V36, P12; MOY E, 1995, ARCH INTERN MED, V155, P1497, DOI 10.1001/archinte.155.14.1497; *NAT EC COUNC DOM, 1999, DIST TRUTHS DANG TRE; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; RHODES J, 1999, PUBL AG HLTH CAR POL; Robinson S, 1997, JOINT COMM J QUAL IM, V23, P239, DOI 10.1016/S1070-3241(16)30313-3; Schmittdiel J, 1997, JAMA-J AM MED ASSOC, V278, P1596, DOI 10.1001/jama.278.19.1596; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Selden TM, 1998, HEALTH AFFAIR, V17, P192, DOI 10.1377/hlthaff.17.3.192; Selden TM, 1999, HEALTH AFFAIR, V18, P126, DOI 10.1377/hlthaff.18.2.126; SHAPIRO MF, 1986, ANN INTERN MED, V104, P246, DOI 10.7326/0003-4819-104-2-246; SIU AL, 1986, NEW ENGL J MED, V315, P1259, DOI 10.1056/NEJM198611133152005; SMITH V, 1999, KAISER FAMILY FDN PU, V2153; Solanki G, 2000, HEALTH SERV RES, V34, P1331; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; SOUMERAI SB, 1993, MILBANK Q, V71, P217, DOI 10.2307/3350399; Steiner CA, 1997, MED CARE, V35, P472, DOI 10.1097/00005650-199705000-00005; Thorpe KE, 1999, HEALTH AFFAIR, V18, P213, DOI 10.1377/hlthaff.18.2.213; *US ADV COMM CONS, 1998, QUAL 1 BETT HLTH CAR; *US C OFF TECHN AS, 1992, DOES HLTH INS MAK DI; *US GAO, 1999, MED ENR AM DECL STAT; Weinick RM, 1999, MED CARE RES REV, V56, P55, DOI 10.1177/107755879905600104; WEINICK RM, 1996, AHCPR PUBLICATION; Wickizer TM, 1999, AM J PUBLIC HEALTH, V89, P1353, DOI 10.2105/AJPH.89.9.1353; Zuvekas SH, 1999, HEALTH SERV RES, V34, P271; 1999, FED REG, V64, P22619; 2000, FED REG, V65, P31124	66	113	113	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2100	2107		10.1001/jama.284.16.2100	http://dx.doi.org/10.1001/jama.284.16.2100			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	364QA	11042759				2022-12-28	WOS:000089902100031
J	Grad, R				Grad, R			Risk of asthma in children with exposure to mite and cat allergens	LANCET			English	Editorial Material							SENSITIZATION		Univ Alabama, Sch Med, Dept Pediat, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham	Grad, R (corresponding author), Univ Alabama, Sch Med, Dept Pediat, Birmingham, AL 35233 USA.							BURR ML, 1993, ARCH DIS CHILD, V68, P724, DOI 10.1136/adc.68.6.724; Leung R, 1997, J ALLERGY CLIN IMMUN, V99, P594, DOI 10.1016/S0091-6749(97)70018-6; Lindfors A, 1999, J ALLERGY CLIN IMMUN, V104, P755, DOI 10.1016/S0091-6749(99)70284-8; Pearce N, 2000, THORAX, V55, P424, DOI 10.1136/thorax.55.5.424; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Strand V, 1998, EUR RESPIR J, V12, P6, DOI 10.1183/09031936.98.12010006; vonMutius E, 1996, BRIT MED J, V312, P1448, DOI 10.1136/bmj.312.7044.1448	7	15	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1369	1370		10.1016/S0140-6736(00)02834-8	http://dx.doi.org/10.1016/S0140-6736(00)02834-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052573				2022-12-28	WOS:000089976100003
J	Koschyk, D; Munzel, T; Brockhoff, C; Meinertz, T				Koschyk, D; Munzel, T; Brockhoff, C; Meinertz, T			Prinzmetal angina	LANCET			English	Article									Univ Hamburg, Hosp Eppendorf, Dept Cardiol, D-20246 Hamburg, Germany	University of Hamburg	Koschyk, D (corresponding author), Univ Hamburg, Hosp Eppendorf, Dept Cardiol, Martinistr 52, D-20246 Hamburg, Germany.								0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1434	1434		10.1016/S0140-6736(00)03142-1	http://dx.doi.org/10.1016/S0140-6736(00)03142-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052600				2022-12-28	WOS:000089976100045
J	Alard, O; Griffin, WL; Lorand, JP; Jackson, SE; O'Reilly, SY				Alard, O; Griffin, WL; Lorand, JP; Jackson, SE; O'Reilly, SY			Non-chondritic distribution of the highly siderophile elements in mantle sulphides	NATURE			English	Article							PLATINUM-GROUP ELEMENTS; SPINEL-LHERZOLITE; SOLID-SOLUTION; PALLADIUM; ORIGIN; EARTH; XENOLITHS; SULFIDES; IRIDIUM; GEOCHEMISTRY	The abundances of highly siderophile (iron-loving) elements (HSEs) in the Earth's mantle provide important constraints on models of the Earth's early evolution. It has long been assumed that the relative abundances of HSEs should reflect the composition of chondritic meteorites-which are thought to represent the primordial material from which the Earth was formed. But the non-chondritic abundance ratios recently found in several types of rock derived from the Earth's mantle(1-3) have been difficult to reconcile with standard models of the Earth's accretion(4-9), and have been interpreted as having arisen from the addition to the primitive mantle of either non-chondritic extraterrestrial material or differentiated material from the Earth's core. Here we report in situ laser-ablation analyses of sulphides in mantle-derived rocks which show that these sulphides do not have chondritic HSE patterns, but that different generations of sulphide within single samples show extreme variability in the relative abundances of HSEs. Sulphides enclosed in silicate phases have high osmium and iridium abundances but low Pd/Ir ratios, whereas pentlandite-dominated interstitial sulphides show low osmium and iridium abundances and high Pd/Ir ratios. We interpret the silicate-enclosed sulphides as the residues of melting processes and interstitial sulphides as the crystallization products of sulphide-bearing (metasomatic) fluids. We suggest that non-chondritic HSE patterns directly reflect processes occurring in the upper mantle-that is, melting and sulphide addition via metasomatism-and are not evidence for the addition of core material or of 'exotic' meteoritic components.	Macquarie Univ, Dept Earth & Planetary Sci, GEMOC, Sydney, NSW 2109, Australia; CSIRO Explorat & Min, N Ryde, NSW 1670, Australia; Museum Natl Hist Nat Paris, Lab Mineral, CNRS, Unite ESA 7058, F-75005 Paris, France	Macquarie University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN)	Alard, O (corresponding author), Macquarie Univ, Dept Earth & Planetary Sci, GEMOC, Sydney, NSW 2109, Australia.	oalard@laurel.ocs.mq.edu.au	ALARD, Olivier/A-7128-2008; O'Reilly, Suzanne Y/A-1315-2008; ALARD, Olivier/R-7755-2016; GAU, geochemist/H-1985-2016; ALARD, Olivier/AAV-8846-2020; Griffin, W.L./F-7713-2011	ALARD, Olivier/0000-0002-0832-6625; O'Reilly, Suzanne Y/0000-0002-3883-5498; ALARD, Olivier/0000-0002-0832-6625; Griffin, W.L./0000-0002-0980-2566				ALARD O, 2000, 2000 NEW FRONTIERS I, P1; Ballhaus C, 1995, CONTRIB MINERAL PETR, V122, P241, DOI 10.1007/s004100050124; Ballhaus C, 2000, J PETROL, V41, P545, DOI 10.1093/petrology/41.4.545; BORISOV A, 1994, GEOCHIM COSMOCHIM AC, V58, P705, DOI 10.1016/0016-7037(94)90500-2; Bulanova GP, 1996, CONTRIB MINERAL PETR, V124, P111, DOI 10.1007/s004100050179; Burton KW, 1999, EARTH PLANET SC LETT, V172, P311, DOI 10.1016/S0012-821X(99)00207-1; Dromgoole E.L., 1987, GEOL SOC AM SPEC PAP, V215, P25; Fleet ME, 1999, LITHOS, V47, P127, DOI 10.1016/S0024-4937(99)00011-0; Guo JF, 1999, J PETROL, V40, P1125; HART SR, 1996, READING ISOTOPIC COD, P123; Jagoutz E., 1979, P LUNAR PLANET SCI, V2, P2031; Kullerud G., 1969, EC GEOLOGY MONOGRAPH, V4, P323, DOI [10.1016/j.lithos.2014.10.001, DOI 10.1016/J.LITHOS.2014.10.001]; Li C, 1996, GEOCHIM COSMOCHIM AC, V60, P1231, DOI 10.1016/0016-7037(96)00009-9; LORAND JP, 1990, GEOCHIM COSMOCHIM AC, V54, P1487, DOI 10.1016/0016-7037(90)90173-I; LORAND JP, 1983, B MINERAL, V106, P585, DOI 10.3406/bulmi.1983.7737; Lorand JP, 1999, J PETROL, V40, P957, DOI 10.1093/petroj/40.6.957; Luguet A, 1999, CR ACAD SCI II A, V329, P637, DOI 10.1016/S1251-8050(00)87640-5; Makovicky M., 1986, METALLOGENY BASIC UL, P415; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Meisel T, 1996, NATURE, V383, P517, DOI 10.1038/383517a0; MITCHELL RH, 1981, GEOCHIM COSMOCHIM AC, V45, P2425, DOI 10.1016/0016-7037(81)90096-X; MORGAN JW, 1986, J GEOPHYS RES-SOLID, V91, P2375, DOI 10.1029/JB091iB12p12375; Pattou L, 1996, NATURE, V379, P712, DOI 10.1038/379712a0; PEACH CL, 1994, CHEM GEOL, V117, P361, DOI 10.1016/0009-2541(94)90138-4; Rehkamper M, 1999, EARTH PLANET SC LETT, V172, P65, DOI 10.1016/S0012-821X(99)00193-4; Shirey SB, 1998, ANNU REV EARTH PL SC, V26, P423, DOI 10.1146/annurev.earth.26.1.423; Snow JE, 1998, NATURE, V391, P166, DOI 10.1038/34396; SZABO C, 1995, GEOCHIM COSMOCHIM AC, V59, P3917, DOI 10.1016/0016-7037(95)00265-2	29	392	417	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					891	894		10.1038/35038049	http://dx.doi.org/10.1038/35038049			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057664				2022-12-28	WOS:000089901900047
J	Keeling, MJ; Gilligan, CA				Keeling, MJ; Gilligan, CA			Metapopulation dynamics of bubonic plague	NATURE			English	Article							INFECTIOUS-DISEASES	Bubonic plague is widely regarded as a disease of mainly historical importance; however, with increasing reports of incidence(1-3) and the discovery of antibiotic-resistant strains of the plague bacterium Yersinia pestis(4), it is re-emerging as a significant health concern(5,6). Here we bypass the conventional human-disease models, and propose that bubonic plague is driven by the dynamics of the disease in the rat population. Using a stochastic, spatial metapopulation model, we show that bubonic plague can persist in relatively small rodent populations from which occasional human epidemics arise, without the need for external imports. This explains why historically the plague persisted despite long disease-free periods, and how the disease re-occurred in cities with tight quarantine control. In a contemporary setting, we show that human vaccination cannot eradicate the plague, and that culling of rats may prevent or exacerbate human epidemics, depending on the timing of the cull. The existence of plague reservoirs in wild rodent populations has important public-health implications for the transmission to urban rats and the subsequent risk of human outbreaks.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge; University of Cambridge	Keeling, MJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	matt@zoo.cam.ac.uk	Keeling, Matt J/J-9280-2012	Keeling, Matt J/0000-0003-4639-4765				ANDERSON R M, 1991; APPLEBY AB, 1980, ECON HIST REV, V33, P161; BACOT AW, 1915, J HYG, V6, P770; BARRETO A, 1995, LANCET, V345, P983, DOI 10.1016/S0140-6736(95)90730-0; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Boisier P, 1997, TROP MED INT HEALTH, V2, P422, DOI 10.1046/j.1365-3156.1997.d01-292.x; BOLKER B, 1995, PHILOS T R SOC B, V348, P309, DOI 10.1098/rstb.1995.0070; Buckle AP, 1994, RODENT PESTS THEIR C; Busvine JR, 1993, DIS TRANSMISSION INS; CURSON P, 1986, PLAGUE SYDNEY ANATOM; FOX JP, 1971, AM J EPIDEMIOL, V94, P179, DOI 10.1093/oxfordjournals.aje.a121310; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; GRAUNT J, 1996, NATURAL POLITICAL OB; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; HANSKI I, 1997, METAPOPULATION BIOL; Hirst L.F., 1938, BRIT ENCY MEDICAL PR, P675; Keeling MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2219, DOI 10.1098/rspb.2000.1272; Keeling MJ, 1997, TRENDS MICROBIOL, V5, P513, DOI 10.1016/S0966-842X(97)01147-5; KUMAR S, 1995, LANCET, V345, P714, DOI 10.1016/S0140-6736(95)90876-5; Macchiavello A., 1954, J TROP MED HYG, V57, P1; McCormick JB, 1998, CURR OPIN MICROBIOL, V1, P125, DOI 10.1016/S1369-5274(98)80152-5; NOBLE JV, 1974, NATURE, V250, P726, DOI 10.1038/250726a0; Pinner RW, 1996, AM J MED SCI, V311, P3, DOI 10.1097/00000441-199601000-00002; Poland J. D., 1979, CRC Handbook Series in Zoonoses. Section A: bacterial, rickettsial, and mycotic diseases. Volume I., P515; Raggett GF., 1982, IMA J, V18, P221; Renshaw E., 1991, MODELLING BIOL POPUL, DOI 10.1017/CBO9780511624094; Scott S, 1996, ANN HUM BIOL, V23, P1, DOI 10.1080/03014469600004232; Shrewsbury JFD, 1970, HIST BUBONIC PLAGUE; SLACK P, 1981, ECON HIST REV, V34, P469	30	176	180	2	62	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					903	906		10.1038/35038073	http://dx.doi.org/10.1038/35038073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057668				2022-12-28	WOS:000089901900051
J	Fesik, SW				Fesik, SW			Insights into programmed cell death through structural biology	CELL			English	Review							TUMOR-NECROSIS-FACTOR; CASPASE RECRUITMENT DOMAIN; APOPTOSIS PROTEIN XIAP; NMR STRUCTURE; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; ION-CHANNEL; INHIBITOR; COMPLEX; BCL-2		Abbott Labs, Abbott Pk, IL 60064 USA	Abbott Laboratories	Fesik, SW (corresponding author), Abbott Labs, Abbott Pk, IL 60064 USA.							Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Day CL, 1999, CELL DEATH DIFFER, V6, P1125, DOI 10.1038/sj.cdd.4400584; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Hinds MG, 1999, NAT STRUCT BIOL, V6, P648; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; LONDON E, 1992, BIOCHIM BIOPHYS ACTA, V1113, P25, DOI 10.1016/0304-4157(92)90033-7; Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v; Lugovskoy AA, 1999, CELL, V99, P747, DOI 10.1016/S0092-8674(00)81672-4; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Straus SE, 1999, ANN INTERN MED, V130, P591, DOI 10.7326/0003-4819-130-7-199904060-00020; SUN C, 2000, IN PRESS J BIOL CHEM; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Uren AG, 1998, TRENDS BIOCHEM SCI, V23, P159, DOI 10.1016/S0968-0004(98)01198-0; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Vaughn DE, 1999, J MOL BIOL, V293, P439, DOI 10.1006/jmbi.1999.3177; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	70	233	243	2	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 13	2000	103	2					273	282		10.1016/S0092-8674(00)00119-7	http://dx.doi.org/10.1016/S0092-8674(00)00119-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057900	Bronze			2022-12-28	WOS:000089864300011
J	Wang, SS; Yue, HW; Derin, RB; Guggino, WB; Lit, M				Wang, SS; Yue, HW; Derin, RB; Guggino, WB; Lit, M			Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; ELECTRON-MICROSCOPY; EPITHELIAL-CELLS; PDZ DOMAINS; IDENTIFICATION; LOCALIZATION; EXPRESSION; BINDING; FAMILY	The cystic fibrosis transmembrane conductance regulator (CFTR) gene encodes a chloride channel protein that belongs to the superfamily of ATP binding cassette (ABC) transporters. Phosphorylation by protein kinase A in the presence of ATP activates the CFTR-mediated chloride conductance of the apical membranes. We have identified a novel hydrophilic CFTR binding protein, CAP70, which is also concentrated on the apical surfaces. CAP70 consists of four PDZ domains, three of which are capable of binding to the CFTR C terminus. Linking at least two CFTR molecules via cytoplasmic C-terminal binding by either multivalent CAP70 ora bivalent monoclonal antibody potentiates the CFTR chloride channel activity. Thus, the CFTR channel can be switched to a more active conducting state via a modification of intermolecular CFTR-CFTR contact that is enhanced by an accessory protein.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Lit, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	minli@jhmi.edu	Eckhardt, Erik/G-1567-2010					ALAWQATI Q, 1995, SCIENCE, V269, P805, DOI 10.1126/science.7543697; ARMSTRONG S, 1998, PEDIAT PULMONOL, V17, P91; AUSUBEL FM, 1993, CURRENT PROTOCOLS MO, V8; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; Devidas S, 1998, J BIOL CHEM, V273, P29373, DOI 10.1074/jbc.273.45.29373; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; GADSBY DC, 1995, ANNU REV PHYSIOL, V57, P387; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kocher O, 1998, LAB INVEST, V78, P117; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; MARSHALL J, 1994, J BIOL CHEM, V269, P2987; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wine JJ, 1995, CURR BIOL, V5, P1357, DOI 10.1016/S0960-9822(95)00269-7; Zerhusen B, 1999, J BIOL CHEM, V274, P7627, DOI 10.1074/jbc.274.12.7627; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	33	248	255	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 29	2000	103	1					169	179		10.1016/S0092-8674(00)00096-9	http://dx.doi.org/10.1016/S0092-8674(00)00096-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051556	Bronze			2022-12-28	WOS:000089636400017
J	Lanza, GA; Sciahbasi, A; Sestito, A; Maseri, A				Lanza, GA; Sciahbasi, A; Sestito, A; Maseri, A			Angina pectoris: a headache	LANCET			English	Article									Univ Cattolica Sacro Cuore, Ist Cardiol, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Lanza, GA (corresponding author), Univ Cattolica Sacro Cuore, Ist Cardiol, I-00168 Rome, Italy.		Lanza, Gaetano Antonio/AAC-2660-2019; Sciahbasi, Alessandro/W-8635-2019	Sciahbasi, Alessandro/0000-0002-7964-4479				Ishida A, 1996, JPN HEART J, V37, P261; LEFKOWITZ D, 1982, ARCH NEUROL-CHICAGO, V39, P130, DOI 10.1001/archneur.1982.00510140064019; Lipton RB, 1997, NEUROLOGY, V49, P813, DOI 10.1212/WNL.49.3.813; MELLER ST, 1992, NEUROSCIENCE, V48, P501, DOI 10.1016/0306-4522(92)90398-L; TAKAYANAGI K, 1990, JPN HEART J, V31, P503	5	20	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					998	998		10.1016/S0140-6736(00)02718-5	http://dx.doi.org/10.1016/S0140-6736(00)02718-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041402				2022-12-28	WOS:000089293600015
J	Kalra, L; Evans, A; Perez, I; Knapp, M; Donaldson, N; Swift, CG				Kalra, L; Evans, A; Perez, I; Knapp, M; Donaldson, N; Swift, CG			Alternative strategies for stroke care: a prospective randomised controlled trial	LANCET			English	Article							ACUTE ISCHEMIC STROKE; NATURAL-HISTORY; HOME-CARE; REHABILITATION; MANAGEMENT; OUTCOMES; THERAPY; UNITS	Background Organised specialist care for stroke improves outcome, but the merits of different methods of organisation are in doubt. This study compares the efficacy of stroke unit with stroke team or domiciliary care. Methods A single-blind, randomised, controlled trial was undertaken in 457 acute-stroke patients (average age 76 years, 48% women) randomly assigned to stroke unit, general wards with stroke team support, or domiciliary stroke care, within 72 h of stroke onset. Outcome was assessed at 3, 6, and 12 months. The primary outcome measure was death or institutionalisation at 12 months. Analyses were by intention to treat. Findings 152 patients were allocated to the stroke unit, 152 to stroke team, and 153 to domiciliary stroke care. 51 (34%) patients in the domiciliary group were admitted to hospital after randomisation. Mortality or institutionalisation at 1 year were lower in patients on a stroke unit than for those receiving care from a stroke team (21/152 [14%] vs 45/149 [30%]; p<0.001) or domiciliary care (21/152 [14%] vs 34/144 [24%]; p=0.03), mainly as a result of reduction in mortality. The proportion of patients alive without severe disability at 1 year was also significantly higher on the stroke unit compared with stroke team (129/152 [85%] vs 99/149 [66%]; p<0.001) or domiciliary care (129/152 [85%] vs 102/144 [71%]; p=0.002). These differences were present at 3 and 6 months after stroke. Interpretation Stroke units are more effective than a specialist stroke team or specialist domiciliary care in reducing mortality, institutionalisation, and dependence after stroke.	Guys Kings & St Thomass Sch Med, Dept Med, London SE5 9PJ, England; Guys Kings & St Thomass Sch Med, Dept Hlth Care Elderly, London SE5 9PJ, England; Inst Psychiat, Ctr Econ Mental Hlth, London, England; Kings Coll Hosp London, Dept Res & Dev, Biostat Unit, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Kalra, L (corresponding author), Guys Kings & St Thomass Sch Med, Dept Med, Denmark Hill Campus, London SE5 9PJ, England.	lalit.kalra@kcl.ac.uk	Knapp, Martin RJ/G-3011-2011	Knapp, Martin/0000-0003-1427-0215				Aboderin I, 1996, J INTERN MED, V240, P173, DOI 10.1046/j.1365-2796.1996.39861000.x; ADAMS HP, 1994, STROKE, V25, P1901, DOI 10.1161/01.STR.25.9.1901; [Anonymous], 1989, STROKE, V20, P1407; Asplund K, 1997, BMJ-BRIT MED J, V314, P1151; Asplund K, 1997, STROKE, V28, P2139, DOI 10.1161/01.STR.28.11.2139; BAMFORD J, 1986, BRIT MED J, V292, P1369, DOI 10.1136/bmj.292.6532.1369; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Collin C, 1988, Int Disabil Stud, V10, P61; DeDeyn PP, 1997, STROKE, V28, P2347, DOI 10.1161/01.STR.28.12.2347; Forster A, 1996, BRIT MED J, V312, P1642, DOI 10.1136/bmj.312.7047.1642; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Hacke W, 1998, STROKE, V29, P2073, DOI 10.1161/01.STR.29.10.2073; Hallan S, 1999, J INTERN MED, V246, P309, DOI 10.1046/j.1365-2796.1999.00531.x; Hankey GJ, 1999, LANCET, V354, P1457, DOI 10.1016/S0140-6736(99)04407-4; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; KALRA L, 1995, STROKE, V26, P2031, DOI 10.1161/01.STR.26.11.2031; KALRA L, 1993, J AM GERIATR SOC, V41, P396, DOI 10.1111/j.1532-5415.1993.tb06947.x; MALMGREN R, 1987, LANCET, V2, P1196; Mohr JP, 2000, JAMA-J AM MED ASSOC, V283, P1189, DOI 10.1001/jama.283.9.1189; Ronning OM, 1998, STROKE, V29, P58, DOI 10.1161/01.STR.29.1.58; Rudd AG, 1997, BMJ-BRIT MED J, V315, P1039, DOI 10.1136/bmj.315.7115.1039; SANDERCOCK PAG, 1991, Q J MED, V78, P101; SHAH E, 1999, ACUTE MANAGEMENT ADM; Shepperd S, 1998, BRIT MED J, V316, P1786, DOI 10.1136/bmj.316.7147.1786; SHEPPERD S, 1999, COCHRANE LIB; WADE DT, 1985, LANCET, V1, P323; WADE DT, 1983, LANCET, V1, P807; WADE DT, 1987, J NEUROL NEUROSUR PS, V50, P177, DOI 10.1136/jnnp.50.2.177; WADE DT, 1999, INTERCOLLEGIATE WORK; WADE DT, 1992, EPIDEMIOLOGICALLY BA; Walker MF, 1999, LANCET, V354, P278, DOI 10.1016/S0140-6736(98)11128-5; Widen Homqvist L, 1998, STROKE, V29, P591; WOODDAUPHINEE S, 1984, STROKE, V15, P864, DOI 10.1161/01.STR.15.5.864	33	138	142	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2000	356	9233					894	899		10.1016/S0140-6736(00)02679-9	http://dx.doi.org/10.1016/S0140-6736(00)02679-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036894				2022-12-28	WOS:000089259800011
J	Satterthwaite, D				Satterthwaite, D			Will most people live in cities?	BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Millennium Festival of Medicine Conference	NOV 06-10, 2000	LONDON, ENGLAND						IIED, London WC1H 0DD, England		Satterthwaite, D (corresponding author), IIED, London WC1H 0DD, England.		Satterthwaite, David E/A-6277-2009	Satterthwaite, David E/0000-0002-0077-1353				FOLLEGATTI JLL, 1998, ENVIRON URBAN, V11, P181; HARDOY JE, IN PRESS ENV PROBLEM; MCGEE TG, 1987, URBANIZATION KOTADES; Menegat R, 1998, ATLAS AMBIENTAL PORT; Tacoli C., 1998, GATEKEEPER SERIES, V77; *UN, 2000, ESAPWP161 UN POP DIV; UN Centre for Human Settlements, 1996, URB WORLD GLOB REP H; Velasquez LS, 1998, ENVIRON URBAN, V10, P9, DOI 10.1630/095624798101284608; *WORLD BANK, 1999, ENT 21 CENT WORLD DE	9	23	25	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1143	1145		10.1136/bmj.321.7269.1143	http://dx.doi.org/10.1136/bmj.321.7269.1143			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061742	Green Published			2022-12-28	WOS:000165219600033
J	Korn, D				Korn, D			Conflicts of interest in biomedical research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Assoc Amer Med Coll, Div Biomed & Hlth Sci Res, Washington, DC 20037 USA	Association of American Medical Colleges	Korn, D (corresponding author), Assoc Amer Med Coll, Div Biomed & Hlth Sci Res, 2450 N St NW, Washington, DC 20037 USA.							AGNEW B, 2000, WASHINGTON FAX  0720; *AM ASS U PROF, 1954, B AM ASS UPROF, V40; Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; *ASS AC HLTH CTR, 1990, CONFL INT AC HLTH CT; *ASS AC HLTH CTR, 1994, CONFL INT I DEC MAK; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; *COMM GOV OP, 1990, 19 COMM GOV OP; KOWALCZYK L, 2000, BOSTON GLOBE    0525, pC1; MARCUS AD, 1999, WALL STREET J   0624, pA1; Mervis J, 2000, SCIENCE, V289, P31, DOI 10.1126/science.289.5476.31; Narin F, 1997, RES POLICY, V26, P317, DOI 10.1016/S0048-7333(97)00013-9; *NIH, 1989, NIH GUID GRANTS CONT, P32; PRESS E, 2000, ATLANTIC MONTHLY, V285, P39; SALTUS R, 2000, BOSTON GLOBE    0829, pA13; Shalala D, 2000, NEW ENGL J MED, V343, P808, DOI 10.1056/NEJM200009143431112; Stolberg S G, 2000, N Y Times Web, pA15; VERGANO D, 2000, US TODAY        0808, pC9; Weatherall D, 2000, LANCET, V355, P1574, DOI 10.1016/S0140-6736(00)02211-X; 2000, CHI RES NEWSLETTER, V8, P1	19	107	109	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2234	2237		10.1001/jama.284.17.2234	http://dx.doi.org/10.1001/jama.284.17.2234			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056596				2022-12-28	WOS:000090052600033
J	Harrington, R; Peters, S; Green, J; Byford, S; Woods, J; McGowan, R				Harrington, R; Peters, S; Green, J; Byford, S; Woods, J; McGowan, R			Randomised comparison of the effectiveness and costs of community and hospital based mental health services for children with behavioural disorders	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONTROLLED TRIALS; PRESCHOOLERS; VALIDATION; PROGRAMS; FAMILIES; MOTHERS	Objective To test the hypothesis that a community based intervention by secondary child and adolescent mental health services would be significantly more effective and less costly than a hospital based intervention. Design Open study with two randomised parallel groups. Setting Two health districts in the north of England. Participants Parents of 3 to 10 year old children with behavioural disorder who had been referred to child and adolescent mental health services. Intervention Parental education groups. Main outcome measures Parents' and teachers' reports of the child's behaviour, parental depression, parental criticism of the child, impact of the child's behaviour on the family. Results 141 subjects were randomised to community (n = 72) or hospital (n = 69) treatment. Primary outcome data were obtained on 115 (82%) cases a year later. Intention to treat analyses showed no significant differences between the community and hospital based groups on any of the outcome measures, or on costs, Parental depression was common and predicted the child's outcome. Conclusions Location of child mental health services may be less important than the range of services that they provide, which should include effective treatment for parents' mental health problems.	Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England; Univ Manchester, Dept Child & Adolescent Psychiat, Manchester M27 4HA, Lancs, England	University of York - UK; University of Manchester	Harrington, R (corresponding author), Univ Manchester, Royal Manchester Childrens Hosp, Dept Child & Adolescent Psychiat, Manchester M27 4HA, Lancs, England.	R.C.Harrington@man.ac.uk	Byford, Sarah/D-1699-2010	Byford, Sarah/0000-0001-7084-1495; Green, Jonathan/0000-0002-0143-181X				Ablow JC, 1999, J AM ACAD CHILD PSY, V38, P1580, DOI 10.1097/00004583-199912000-00020; Arnold D.S., 1993, PSYCHOL ASSESSMENT, V9, P137, DOI [10.1037/1040-3590.5.2.137, DOI 10.1037/1040-3590.5.2.137]; Barber JA, 1998, BRIT MED J, V317, P1195, DOI 10.1136/bmj.317.7167.1195; Beck A.T., 1967, DEPRESSION CLIN EXPT; Byford S, 1999, BRIT J PSYCHIAT, V174, P56, DOI 10.1192/bjp.174.1.56; *CHART I PUBL FIN, 1998, HLTH SERVICE FINANCI; *CHART I PUBL FIN, 1998, HLTH SERV FIN DAT 19; COX AD, 1993, BRIT J PSYCHIAT, V163, P6, DOI 10.1192/bjp.163.1.6; CUNNINGHAM CE, 1995, J CHILD PSYCHOL PSYC, V36, P1141, DOI 10.1111/j.1469-7610.1995.tb01362.x; Davis H, 1998, J CHILD PSYCHOL PSYC, V39, P365, DOI 10.1111/1469-7610.00332; EYBERG SM, 1978, J CLIN CHILD PSYCHOL, V7, P113, DOI 10.1080/15374417809532835; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; KAZDIN AE, 1994, J CONSULT CLIN PSYCH, V62, P1069, DOI 10.1037/0022-006X.62.5.1069; KOLVIN I, 1990, CHILD ADOLESCENT PSY, P113; Machin D., 1987, STAT TABLES DESIGN C; MAGANA AB, 1986, PSYCHIAT RES, V17, P203, DOI 10.1016/0165-1781(86)90049-1; Marks I. M, 1981, CURE CARE NEUROSES; Meltzer H., 2000, MENTAL HLTH CHILDREN; Netten A, 1999, UNIT COSTS HLTH SOCI; NICOL R, 1994, CHILD ADOL PSYCH CL, P1040; PARRYJONES WLI, 1990, CHILD ADOL PSYCH CL, P83; ROUTH CP, 1995, J CHILD PSYCHOL PSYC, V36, P1179, DOI 10.1111/j.1469-7610.1995.tb01364.x; WEBSTERSTRATTON C, 1985, J CHILD PSYCHOL PSYC, V26, P801, DOI 10.1111/j.1469-7610.1985.tb00593.x; WEBSTERSTRATTON C, 1984, J CONSULT CLIN PSYCH, V52, P666, DOI 10.1037/0022-006X.52.4.666; White C, 1998, BRIT J CLIN PSYCHOL, V37, P385, DOI 10.1111/j.2044-8260.1998.tb01396.x; WHO, 1993, ICD 10 CLASS MENT BE	27	44	44	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2000	321	7268					1047	1050A		10.1136/bmj.321.7268.1047	http://dx.doi.org/10.1136/bmj.321.7268.1047			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	369PU	11053174	Bronze, Green Published			2022-12-28	WOS:000165076800023
J	Kordower, JH; Emborg, ME; Bloch, J; Ma, SY; Chu, YP; Leventhal, L; McBride, J; Chen, EY; Palfi, S; Roitberg, BZ; Brown, WD; Holden, JE; Pyzalski, R; Taylor, MD; Carvey, P; Ling, ZD; Trono, D; Hantraye, P; Deglon, N; Aebischer, P				Kordower, JH; Emborg, ME; Bloch, J; Ma, SY; Chu, YP; Leventhal, L; McBride, J; Chen, EY; Palfi, S; Roitberg, BZ; Brown, WD; Holden, JE; Pyzalski, R; Taylor, MD; Carvey, P; Ling, ZD; Trono, D; Hantraye, P; Deglon, N; Aebischer, P			Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease	SCIENCE			English	Article							NEUROTROPHIC FACTOR; GENE-TRANSFER; IN-VIVO; DOPAMINE; NEURONS; MONKEYS; DEGENERATION; BRAIN	Lentiviral delivery of glial cell Line-derived neurotrophic factor (Lenti-GDNF) was tested for its trophic effects upon degenerating nigrostriatal neurons in nonhuman primate models of Parkinson's disease (PD). We injected lenti-GDNF into the striatum and substantia nigra of nonlesioned aged rhesus monkeys or young adult rhesus monkeys treated 1 week prior with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Extensive GDNF expression with anterograde and retrograde transport was seen in all animals. In aged monkeys, Lenti-GDNF augmented dopaminergic function. In MPTP-treated monkeys, lenti-GDNF reversed functional deficits and completely prevented nigrostriatal degeneration. Additionally, Lenti-GDNF injections to intact rhesus monkeys revealed Long-term gene expression (8 months). In MPTP-treated monkeys, lenti-GDNF treatment reversed motor deficits in a hand-reach task. These data indicate that GDNF delivery using a Lentiviral vector system can prevent nigrostriatal degeneration and induce regeneration in primate models of PD and might be a viable therapeutic strategy for PD patients.	Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA; Univ Lausanne, Sch Med, Div Surg Res, Lausanne, Switzerland; Univ Lausanne, Sch Med, Gene Therapy Ctr, Lausanne, Switzerland; Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; Univ Geneva, Fac Med, Dept Genet & Microbiol, Geneva, Switzerland; Serv Hosp Frederic Joliot, CEA, Dept Rech Med, Direct Rech Med,CNRS,Unite Rech Associe 2210, Orsay, France; Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, CH-1015 Lausanne, Switzerland	Rush University; Rush University; University of Lausanne; University of Lausanne; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Geneva; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Kordower, JH (corresponding author), Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, 1653 W Congress Pkwy, Chicago, IL 60612 USA.	jkordowe@rush.edu	Bloch, Jocelyne/A-9668-2017; Brown, William/GXN-2777-2022; Aebischer, Patrick/E-1387-2013; Deglon, Nicole/A-2265-2012; McBride, Jodi/C-4494-2016	Bloch, Jocelyne/0000-0002-6405-1590; Deglon, Nicole/0000-0003-4475-9476; McBride, Jodi/0000-0002-4816-7569	NINDS NIH HHS [NS40578] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040578] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bjorklund A, 1997, NEUROBIOL DIS, V4, P186, DOI 10.1006/nbdi.1997.0151; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Connor B, 1999, GENE THER, V6, P1936, DOI 10.1038/sj.gt.3301033; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Eberling JL, 1999, BRAIN RES, V832, P184, DOI 10.1016/S0006-8993(99)01491-2; Emborg ME, 1998, J COMP NEUROL, V401, P253; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; GASH DM, 1998, ADV PHARMACOL, V42, P11; Honey C, 1999, CAN J NEUROL SCI, V26, pS45, DOI 10.1017/S0317167100000093; KASTNER A, 1993, BRAIN RES, V606, P341, DOI 10.1016/0006-8993(93)91005-D; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; KORDOWER JH, 1995, CELL TRANSPLANT, V4, P155, DOI 10.1016/0963-6897(95)90031-4; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Kordower JH, 1999, EXP NEUROL, V160, P1, DOI 10.1006/exnr.1999.7178; KOZLOWSKI DA, 2000, ASNTR ABSTR, V7, P25; Lapchak PA, 1997, EXP NEUROL, V144, P29, DOI 10.1006/exnr.1996.6384; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Rosenblad C, 2000, EXP NEUROL, V161, P503, DOI 10.1006/exnr.1999.7296; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; Tseng JL, 1997, J NEUROSCI, V17, P325, DOI 10.1523/JNEUROSCI.17-01-00325.1997; Wang GS, 1999, J CLIN INVEST, V104, pR55, DOI 10.1172/JCI8390	23	997	1063	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2000	290	5492					767	773		10.1126/science.290.5492.767	http://dx.doi.org/10.1126/science.290.5492.767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052933				2022-12-28	WOS:000090067600038
J	Morgan, JF				Morgan, JF			From Charles Atlas to Adonis complex - fat is more than a feminist issue	LANCET			English	Editorial Material							BODY		Univ London St Georges Hosp, Sch Med, Dept Psychiat, London SW17 0RE, England	St Georges University London	Morgan, JF (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Psychiat, London SW17 0RE, England.							BROWNELL KD, 1995, INT J EAT DISORDER, V18, P295, DOI 10.1002/1098-108X(199511)18:3<295::AID-EAT2260180313>3.0.CO;2-R; *EAT DIS ASS, 2000, EAT DIS UK REV PROV; FALLON AE, 1985, J ABNORM PSYCHOL, V94, P102, DOI 10.1037/0021-843X.94.1.102; Morant H, 2000, BRIT MED J, V320, P1495, DOI 10.1136/bmj.320.7248.1495; Morgan JF, 1998, INT J EAT DISORDER, V24, P107; Olivardia R, 2000, AM J PSYCHIAT, V157, P1291, DOI 10.1176/appi.ajp.157.8.1291; Pope H., 2000, THE ADONIS COMPLEX; Pope HG, 1999, INT J EAT DISORDER, V26, P65, DOI 10.1002/(SICI)1098-108X(199907)26:1<65::AID-EAT8>3.3.CO;2-4; Pope HG, 2000, AM J PSYCHIAT, V157, P1297, DOI 10.1176/appi.ajp.157.8.1297; Pope HG, 1997, PSYCHOSOMATICS, V38, P548, DOI 10.1016/S0033-3182(97)71400-2; RAPHAEL FJ, 1992, ANN MED, V24, P293, DOI 10.3109/07853899209149957; SLATER E, 1969, CLIN PSYCHIATR, P143	12	13	13	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1372	1373		10.1016/S0140-6736(05)74051-4	http://dx.doi.org/10.1016/S0140-6736(05)74051-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	365XQ	11052576				2022-12-28	WOS:000089976100006
J	Barnham, KWJ; Nelson, J; Stevens, RA				Barnham, KWJ; Nelson, J; Stevens, RA			Did civil reactors supply plutonium for weapons?	NATURE			English	Letter									Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2BW, England; Join Syst, Menlo Park, CA 94025 USA	Imperial College London	Barnham, KWJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2BW, England.		Nelson, Jenny/CAF-2009-2022	Nelson, Jenny/0000-0003-1048-1330				Barnham KWJ, 1998, NATURE, V395, P739, DOI 10.1038/27304; BARNHAM KWJ, 1985, NATURE, V317, P213, DOI 10.1038/317213a0; *DEP EN, 1996, PLUTONIUM 1 50 YEARS; LAYFIELD F, 1987, SIZEWELL B PUBLIC IN; *MIN DEF, 2000, PLUTONIUM ALDERMASTO; *MIN DEF, 2000, HIST ACC PLUT	6	2	2	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					833	834		10.1038/35038256	http://dx.doi.org/10.1038/35038256			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057640	Bronze			2022-12-28	WOS:000089901900017
J	Smaglik, P				Smaglik, P			Tissue donors use their influence in deal over gene patent terms	NATURE			English	News Item																		Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Smaglik P, 2000, NATURE, V404, P912, DOI 10.1038/35010224; 2000, NATURE, V403, P237	3	15	15	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					821	821		10.1038/35038209	http://dx.doi.org/10.1038/35038209			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057626	Bronze			2022-12-28	WOS:000089901900003
J	Aurbach, D; Lu, Z; Schechter, A; Gofer, Y; Gizbar, H; Turgeman, R; Cohen, Y; Moshkovich, M; Levi, E				Aurbach, D; Lu, Z; Schechter, A; Gofer, Y; Gizbar, H; Turgeman, R; Cohen, Y; Moshkovich, M; Levi, E			Prototype systems for rechargeable magnesium batteries	NATURE			English	Article							ELECTROLYTE-SOLUTIONS; NONAQUEOUS BATTERIES; LITHIUM; DEPOSITION; BEHAVIOR; PHASES	The thermodynamic properties of magnesium make it a natural choice for use as an anode material in rechargeable batteries, because it may provide a considerably higher energy density than the commonly used lead-acid and nickel-cadmium systems. Moreover, in contrast to lead and cadmium, magnesium is inexpensive, environmentally friendly and safe to handle. But the development of Mg batteries has been hindered by two problems. First, owing to the chemical activity of Mg, only solutions that neither donate nor accept protons are suitable as electrolytes; but most of these solutions allow the growth of passivating surface films, which inhibit any electrochemical reaction(1-3). Second, the choice of cathode materials has been limited by the difficulty of intercalating Mg ions in many hosts(4). Following previous studies of the electrochemistry of Mg electrodes in various non-aqueous solutions(1,5), and of a variety of intercalation electrodes(6,7), we have now developed rechargeable Mg battery systems that show promise for applications. The systems comprise electrolyte solutions based on Mg organohaloaluminate salts, and MgxMo3S4 cathodes, into which Mg ions can be intercalated reversibly, and with relatively fast kinetics. We expect that further improvements in the energy density will make these batteries a viable alternative to existing systems.	Bar Ilan Univ, Dept Chem, IL-52900 Ramat Gan, Israel	Bar Ilan University	Aurbach, D (corresponding author), Bar Ilan Univ, Dept Chem, IL-52900 Ramat Gan, Israel.	aurbach@mail.biu.ac.il		Cohen, Yair/0000-0002-9199-261X				Aurbach D, 1998, J ELECTROCHEM SOC, V145, P3024, DOI 10.1149/1.1838758; Aurbach D, 1999, J POWER SOURCES, V81, P95, DOI 10.1016/S0378-7753(99)00187-1; Aurbach D, 1998, J ELECTROCHEM SOC, V145, P2629, DOI 10.1149/1.1838692; Aurbach D, 2000, ELECTROCHEM SOLID ST, V3, P31; Aurbach D, 1996, LANGMUIR, V12, P3991, DOI 10.1021/la9600762; Blomgren GE, 1999, NONAQUEOUS ELECTROCHEMISTRY, P53; BROWN OR, 1985, ELECTROCHIM ACTA, V30, P627, DOI 10.1016/0013-4686(85)80104-3; CHEVREL R, 1971, J SOLID STATE CHEM, V3, P515, DOI 10.1016/0022-4596(71)90095-8; Cohen Y, 1999, REV SCI INSTRUM, V70, P4668, DOI 10.1063/1.1150130; CONNOR JH, 1957, J ELECTROCHEM SOC, V104, P38, DOI 10.1149/1.2428492; GENDERS JD, 1986, J ELECTROANAL CHEM, V199, P93, DOI 10.1016/0022-0728(86)87044-9; GOREN E, 1991, J ELECTROCHEM SOC, V138, pL6, DOI 10.1149/1.2085828; GREGORY TD, 1990, J ELECTROCHEM SOC, V137, P775, DOI 10.1149/1.2086553; Liebenow C, 1997, J APPL ELECTROCHEM, V27, P221, DOI 10.1023/A:1018464210084; LINDER CR, 1994, MOL ECOL, V3, P23, DOI 10.1111/j.1365-294X.1994.tb00038.x; Lu Z, 1999, J ELECTROANAL CHEM, V466, P203, DOI 10.1016/S0022-0728(99)00146-1; Novak P, 1999, ELECTROCHIM ACTA, V45, P351, DOI 10.1016/S0013-4686(99)00216-9; RITTER C, 1992, MATER RES BULL, V27, P1217, DOI 10.1016/0025-5408(92)90229-S; YVON K, 1979, CURRENT TOPICS MAT S, V0003, P00053	19	1655	1723	48	1569	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					724	727		10.1038/35037553	http://dx.doi.org/10.1038/35037553			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048714				2022-12-28	WOS:000089773900036
J	Macilwain, C				Macilwain, C			Gore and Bush back rise in science spending	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					663	663						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048688				2022-12-28	WOS:000089773900006
J	Nadis, S				Nadis, S			Science for art's sake	NATURE			English	News Item																			0	9	10	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					668	670		10.1038/35037788	http://dx.doi.org/10.1038/35037788			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048693				2022-12-28	WOS:000089773900011
J	Wagner, FE; Haslbeck, S; Stievano, L; Calogero, S; Pankhurst, QA; Martinek, P				Wagner, FE; Haslbeck, S; Stievano, L; Calogero, S; Pankhurst, QA; Martinek, P			Before striking gold in gold-ruby glass	NATURE			English	Article									Tech Univ Munich, Phys Dept E15, D-85748 Garching, Germany; Univ Ca Foscari, Dipartimento Chim Fis, I-30123 Venice, Italy; UCL, Dept Phys & Astron, London WC1E 6BT, England; FX Nachtmann Bleikristallwerke GmbH, D-94566 Riedelhutte, Germany	Technical University of Munich; Universita Ca Foscari Venezia; University of London; University College London	Wagner, FE (corresponding author), Tech Univ Munich, Phys Dept E15, D-85748 Garching, Germany.		Stievano, Lorenzo/B-7801-2010	Stievano, Lorenzo/0000-0001-8548-0231; Martinek, Klaus-Peter/0000-0001-9321-7898				BADGER AE, 1939, GLASS IND, V20, P407; BARBER DJ, 1990, ARCHAEOMETRY, V32, P33, DOI 10.1111/j.1475-4754.1990.tb01079.x; FALTENS MO, 1970, J CHEM PHYS, V53, P4249, DOI 10.1063/1.1673931; FRANK S, 1984, GLASS TECHNOL, V25, P47; PARISH RV, 1984, MOSSBAUER SPECTROSCO, V1, P577; Rao P, 1996, J NON-CRYST SOLIDS, V203, P202, DOI 10.1016/0022-3093(96)00483-8; STOOKEY SD, 1949, J AM CERAM SOC, V32, P246, DOI 10.1111/j.1151-2916.1949.tb18957.x; WAGNER G, 1987, Z ANORG ALLG CHEM, V549, P26, DOI 10.1002/zaac.19875490604; WASELNIELEN HD, 1968, Z ANORG ALLG CHEM, V359, P36, DOI 10.1002/zaac.19683590105; Weyl W.A., 1951, COLOURED GLASSES, P380; WILLIAMS JA, 1981, J AM CERAM SOC, V64, P709, DOI 10.1111/j.1151-2916.1981.tb15891.x	11	115	117	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					691	692		10.1038/35037661	http://dx.doi.org/10.1038/35037661			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048705				2022-12-28	WOS:000089773900026
J	Fukada-Tanaka, S; Inagaki, Y; Yamaguchi, T; Saito, N; Iida, S				Fukada-Tanaka, S; Inagaki, Y; Yamaguchi, T; Saito, N; Iida, S			Colour-enhancing protein in blue petals - Spectacular morning glory blooms rely on a behind-the-scenes proton exchanger.	NATURE			English	Article									Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan; Meiji Gakuin Univ, Chem Lab, Yokohama, Kanagawa 2448539, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Fukada-Tanaka, S (corresponding author), Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan.		INAGAKI, Yoshishige/B-1458-2011					Fukuda A, 1999, BBA-GENE STRUCT EXPR, V1446, P149, DOI 10.1016/S0167-4781(99)00065-2; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Iida S, 1999, ANN NY ACAD SCI, V870, P265, DOI 10.1111/j.1749-6632.1999.tb08887.x; IMAI YOSHITAKA, 1934, JOUR COLL AGRIC IMP UNIV TOKYO, V12, P479; LU TS, 1992, PHYTOCHEMISTRY, V31, P659, DOI 10.1016/0031-9422(92)90069-3; Maes T, 1999, TRENDS PLANT SCI, V4, P90, DOI 10.1016/S1360-1385(99)01375-8; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; YOSHIDA K, 1995, NATURE, V373, P291, DOI 10.1038/373291a0	8	126	144	4	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					581	581		10.1038/35036683	http://dx.doi.org/10.1038/35036683			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034195				2022-12-28	WOS:000089772800031
J	Stutzmann, N; Tervoort, TA; Bastiaansen, K; Smith, P				Stutzmann, N; Tervoort, TA; Bastiaansen, K; Smith, P			Patterning of polymer-supported metal films by microcutting	NATURE			English	Article							CENTIMETER	The ability to micropattern materials is of great importance for manufacturing advanced electronic, optical and mechanical devices ranging from displays to biosensors(1-6). For this purpose a variety of methods have been developed, including X-ray, electron-beam and photo-lithography(7,8), microcontact printing(9), embossing(10,11), micromoulding(8,12) and cold welding(13). But these techniques are often of restricted applicability, involve a multitude of elaborate and cumbersome processing steps, or require aggressive chemistry. Here we describe a simple and versatile way to create well resolved metallic structures on polymer substrates, which is based on solid-state embossing of metal-coated polymer films. Ductility of both the metal layer and the polymer substrate permits the metal to be cut into surprisingly regular, micrometre-size structures. We illustrate the method by preparing patterned electrically conducting structures, highly efficient infrared polarizers and polarization-dependent colour filters.	ETH Zentrum, Dept Mat, CH-8092 Zurich, Switzerland; Eindhoven Univ Technol, Eindhoven Polymer Labs, NL-5600 MB Eindhoven, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Eindhoven University of Technology	Tervoort, TA (corresponding author), ETH Zentrum, Dept Mat, UNO-C15, CH-8092 Zurich, Switzerland.	tervoort@ifp.mat.ethz.ch	Stingelin, Natalie/D-6745-2016	Stingelin, Natalie/0000-0002-1414-4545; Tervoort, Theo/0000-0002-4962-9841				AUTON JP, 1967, APPL OPTICS, V6, P1023, DOI 10.1364/AO.6.001023; BENNETT JM, 1978, HDB OPTICS, pCH10; BRATEN T, 1978, J MICROSC-OXFORD, V113, P53, DOI 10.1111/j.1365-2818.1978.tb00093.x; Chan VZH, 1999, SCIENCE, V286, P1716, DOI 10.1126/science.286.5445.1716; CHECHENIN NG, 1995, THIN SOLID FILMS, V261, P228, DOI 10.1016/S0040-6090(94)06494-6; Dirix Y, 1999, ADV MATER, V11, P223, DOI 10.1002/(SICI)1521-4095(199903)11:3<223::AID-ADMA223>3.0.CO;2-J; DIRIX Y, 1995, MACROMOLECULES, V28, P486, DOI 10.1021/ma00106a011; Dirix Y, 1997, MACROMOLECULES, V30, P2175, DOI 10.1021/ma960808x; ECHLIN P, 1981, SCANNING ELECT MICRO, V14, P79; Gale MT, 1997, J IMAGING SCI TECHN, V41, P211; GALEY WR, 1978, J MEMBRANE SCI, V4, P41, DOI 10.1016/S0376-7388(00)83283-4; Gau H, 1999, SCIENCE, V283, P46, DOI 10.1126/science.283.5398.46; GERENSER LJ, 1990, ACS SYM SER, V440, P433; GERENSER LJ, 1993, METALLIZED PLASTICS, P113; HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; HILL R, 1947, PROC R SOC LON SER-A, V188, P273, DOI 10.1098/rspa.1947.0009; Kataoka DE, 1999, NATURE, V402, P794, DOI 10.1038/45521; Kim C, 2000, SCIENCE, V288, P831, DOI 10.1126/science.288.5467.831; KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0; KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628; Madou M., 1997, FUNDAMENTALS MICROFA; Moreau W.M., 1988, SEMICONDUCTOR LITHOG; PETCH NJ, 1953, J IRON STEEL I, V174, P25; PIVIN JC, 1989, J PHYS D APPL PHYS, V22, P1443, DOI 10.1088/0022-3727/22/10/005; Rogers JA, 1998, APPL PHYS LETT, V72, P2716, DOI 10.1063/1.121109; SACHER E, 1990, ACS SYM SER, V440, P1; Stutzmann N, 2000, ADV MATER, V12, P557, DOI 10.1002/(SICI)1521-4095(200004)12:8<557::AID-ADMA557>3.0.CO;2-W	27	69	74	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2000	407	6804					613	616		10.1038/35036545	http://dx.doi.org/10.1038/35036545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034206				2022-12-28	WOS:000089772800042
J	Triendl, R				Triendl, R			Reactor refit ignites debate on Japan's fusion strategy	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					549	549		10.1038/35036717	http://dx.doi.org/10.1038/35036717			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034174	Bronze			2022-12-28	WOS:000089772800006
J	Griffiths, R; Stacey, TE; Struthers, J				Griffiths, R; Stacey, TE; Struthers, J			Commentary: Response from members of the Griffiths inquiry	BRITISH MEDICAL JOURNAL			English	Editorial Material									NHS Execut, W Midlands Reg Off, Birmingham B16 9PA, W Midlands, England; NHS Execut, SE Reg Off, London W2 3QR, England; Assoc Community Hlth Councils England & Wales, London N5 1PB, England		Griffiths, R (corresponding author), NHS Execut, W Midlands Reg Off, Birmingham B16 9PA, W Midlands, England.							Samuels MP, 1996, PEDIATRICS, V98, P1154; SOUTHALL D, 2000, RESPONSE GRIFFITHS R	2	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 23	2000	321	7263					755	756						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	11041636				2022-12-28	WOS:000089546600033
J	Kollef, MH				Kollef, MH			Non-invasive ventilation for chronic obstructive pulmonary disease	LANCET			English	Editorial Material							POSITIVE PRESSURE VENTILATION; MECHANICAL VENTILATION; TRIAL		Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Kollef, MH (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.							Burdet L, 1997, AM J RESP CRIT CARE, V156, P1800, DOI 10.1164/ajrccm.156.6.9704142; Fridkin SK, 1996, INFECT CONT HOSP EP, V17, P150; Kollef MH, 1999, NEW ENGL J MED, V340, P627, DOI 10.1056/NEJM199902253400807; Kollef MH, 1997, CRIT CARE MED, V25, P567, DOI 10.1097/00003246-199704000-00004; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; SHAPIRO SH, 1992, LANCET, V340, P1425, DOI 10.1016/0140-6736(92)92620-U; THORENS JB, 1995, CRIT CARE MED, V23, P1807, DOI 10.1097/00003246-199511000-00004; Wood KA, 1998, CHEST, V113, P1339, DOI 10.1378/chest.113.5.1339	11	3	3	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					956	957		10.1016/S0140-6736(00)02708-2	http://dx.doi.org/10.1016/S0140-6736(00)02708-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041392				2022-12-28	WOS:000089293600005
J	Sandberg, S; Paton, JY; Ahola, S; McCann, DC; McGuinness, D; Hillary, CR; Oja, H				Sandberg, S; Paton, JY; Ahola, S; McCann, DC; McGuinness, D; Hillary, CR; Oja, H			The role of acute and chronic stress in asthma attacks in children	LANCET			English	Article							LIFE EVENTS; COMMON COLD; BRONCHIAL REACTIVITY; PSYCHOLOGICAL STRESS; PSYCHOSOCIAL STRESS; SUSCEPTIBILITY; CHILDHOOD; SEVERITY; ILLNESS; DISEASE	Background High levels of stress have been shown to predict the onset of asthma in children genetically at risk, and to correlate with higher asthma morbidity. Our study set out to examine whether stressful experiences actually provoke new exacerbations in children who already have asthma. Methods A group of child patients with verified chronic asthma were prospectively followed up for 18 months. We used continuous monitoring of asthma by the use of diaries and daily peak-flow values, accompanied by repeated interview assessments of life events and psychosocial experiences. The key measures included asthma exacerbations, severely negative life events, and chronic stressors. Findings Severe events, both on their own and in conjunction with high chronic stress, significantly increased the risk of new asthma attacks. The effect of severe events without accompanying chronic stress involved a small delay; they had no effect within the first 2 weeks, but significantly increased the risk in the subsequent 4 weeks (odds ratio 1.71 [95% CI 1.04-2.82], p less than or equal to 0.05 for weeks 2-4 and 2.17 [1.32-3.57], p less than or equal to 0.01 for weeks 4-6). When severe events occurred against the backdrop of high chronic stress, the risk increased sharply and almost immediately within the first fortnight (2.98 [1.20-7.38], p less than or equal to 0.05). The overall attack frequency was affected by several factors, some related to asthma and some to child characteristics. Female sex, higher baseline illness severity, three or more attacks within 6 months, autumn to winter season, and parental smoking were all related to increased risk of new exacerbations; social class and chronic stress were not. Interpretation Severely negative life events increase the risk of children's asthma attacks over the coming few weeks. This risk is magnified and brought forward in time if the child's life situation is also characterised by multiple chronic stressors.	Univ Helsinki, Hosp Children & Adolescents, FIN-00014 Helsinki, Finland; Univ Jyvaskyla, Dept Stat, SF-40351 Jyvaskyla, Finland; Univ Glasgow, Dept Child Hlth, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Dept Child & Adolescent Psychiat, Glasgow G12 8QQ, Lanark, Scotland; Univ Southampton, Dept Child Hlth, Div Allergies & Inflammat Sci, Southampton SO9 5NH, Hants, England	University of Helsinki; University of Jyvaskyla; University of Glasgow; University of Glasgow; University of Southampton	Sandberg, S (corresponding author), HYKS Inst, Tukholmankatu 8F,POB 106, FIN-00029 Helsinki, Finland.		Paton, James/B-9541-2008; Taskinen, Sara/AAD-7967-2019	Taskinen, Sara/0000-0001-9470-7258				Asher MI, 1998, EUR RESPIR J, V12, P315; AVITAL A, 1991, AM REV RESPIR DIS, V144, P36, DOI 10.1164/ajrccm/144.1.36; BOYCE WT, 1995, PSYCHOSOM MED, V57, P411, DOI 10.1097/00006842-199509000-00001; Brown GW, 1989, LIFE EVENTS ILLNESS; Clark NM, 1999, ENVIRON HEALTH PERSP, V107, P421, DOI 10.1289/ehp.99107s3421; CLOUGH JB, 1994, AM J RESP CRIT CARE, V150, P48, DOI 10.1164/ajrccm.150.1.8025771; Cobb JMT, 1996, PSYCHOSOM MED, V58, P404, DOI 10.1097/00006842-199609000-00003; Cobb JMT, 1998, J PSYCHOSOM RES, V45, P319, DOI 10.1016/S0022-3999(97)00311-5; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; Cohen S, 1999, PSYCHOSOM MED, V61, P175, DOI 10.1097/00006842-199903000-00009; COHEN S, 1993, J PERS SOC PSYCHOL, V64, P131, DOI 10.1037/0022-3514.64.1.131; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cohen S, 1998, HEALTH PSYCHOL, V17, P214, DOI 10.1037/0278-6133.17.3.214; Drummond PD, 1997, J PSYCHOSOM RES, V43, P271, DOI 10.1016/S0022-3999(97)00002-0; EISER C, 1990, J CHILD PSYCHOL PSYC, V31, P85, DOI 10.1111/j.1469-7610.1990.tb02274.x; Grey M, 1993, J Pediatr Nurs, V8, P85; Haavet Ole Rikard, 1997, Tidsskrift for den Norske Laegeforening, V117, P3644; HEISEL JS, 1973, BEHAVIORAL PEDIATRIC, V83, P119; JACOBS TJ, 1980, PSYCHOSOM MED, V42, P11, DOI 10.1097/00006842-198001000-00002; MARRIE TJ, 1993, THORAX, V48, P1, DOI 10.1136/thx.48.1.1; Mishoe SC, 1998, J ASTHMA, V35, P553, DOI 10.3109/02770909809048958; Mrazek DA, 1999, PEDIATR PULM, V27, P85, DOI 10.1002/(SICI)1099-0496(199902)27:2<85::AID-PPUL4>3.0.CO;2-B; Office of Population Censuses and Surveys, 1980, CLASS OCC; Randolph C, 1999, Curr Probl Pediatr, V29, P82, DOI 10.1016/S0045-9380(99)80041-3; SANDBERG S, 1993, J CHILD PSYCHOL PSYC, V34, P879, DOI 10.1111/j.1469-7610.1993.tb01096.x; Sarafino EP, 1998, J ASTHMA, V35, P497, DOI 10.3109/02770909809071003; SONINO N, 1993, ACTA ENDOCRINOL-COP, V128, P293, DOI 10.1530/acta.0.1280293; SONINO N, 1993, CLIN ENDOCRINOL, V38, P261, DOI 10.1111/j.1365-2265.1993.tb01004.x; Wade S, 1997, PEDIATR PULM, V24, P263, DOI 10.1002/(SICI)1099-0496(199710)24:4<263::AID-PPUL5>3.0.CO;2-L; Wright AL, 1998, EUR RESPIR J, V12, p17S	30	304	312	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2000	356	9234					982	987		10.1016/S0140-6736(00)02715-X	http://dx.doi.org/10.1016/S0140-6736(00)02715-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	353UJ	11041399	Green Accepted			2022-12-28	WOS:000089293600012
J	Gelmon, K				Gelmon, K			One step forward or one step back with tamoxifen?	LANCET			English	Editorial Material							SURGICAL-ADJUVANT-BREAST; ENDOMETRIAL CANCER; RISK		British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada	British Columbia Cancer Agency	Gelmon, K (corresponding author), British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada.							Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Bernstein L, 1999, J NATL CANCER I, V91, P1654, DOI 10.1093/jnci/91.19.1654; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; Mignotte H, 1998, INT J CANCER, V76, P325, DOI 10.1002/(SICI)1097-0215(19980504)76:3<325::AID-IJC7>3.0.CO;2-X; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485	7	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					868	869		10.1016/S0140-6736(00)02670-2	http://dx.doi.org/10.1016/S0140-6736(00)02670-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036885				2022-12-28	WOS:000089259800002
J	Ernst, E				Ernst, E			The role of complementary and alternative medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Millennium Festival of Medicine Conference	NOV 06-10, 2000	LONDON, ENGLAND				METAANALYSIS; THERAPY		Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Complementary Med, Exeter EX2 4NT, Devon, England	University of Exeter	Ernst, E (corresponding author), Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Complementary Med, Exeter EX2 4NT, Devon, England.	E.Ernst@ex.ac.uk						Astin JA, 2000, ANN INTERN MED, V132, P903, DOI 10.7326/0003-4819-132-11-200006060-00009; Bronfort G, 1999, NEUROL CLIN, V17, P91, DOI 10.1016/S0733-8619(05)70116-X; Cooke B, 2000, BRIT J GEN PRACT, V50, P493; Ernst E, 2000, COMPLEMENT THER MED, V8, P32, DOI 10.1016/S0965-2299(00)90833-1; Ernst E, 2000, BRIT MED J, V321, P707; Ernst E, 1997, CIRCULATION, V96, P1031; Ernst E, 1999, J PAIN SYMPTOM MANAG, V17, P65, DOI 10.1016/S0885-3924(98)00129-8; ERNST E, 1995, BRIT J GEN PRACT, V45, P506; Ernst E, 1999, ANN INTERN MED, V131, P230, DOI 10.7326/0003-4819-131-3-199908030-00021; Ernst E, 2000, ARCH OPHTHALMOL-CHIC, V118, P120; Ernst E, 1999, Complement Ther Med, V7, P250, DOI 10.1016/S0965-2299(99)80011-9; ERNST E, IN PRESS COMPLEMENTA; ERNST E, 1997, EUR J GEN PRACT, V3, P52; Ezzo J, 2000, PAIN, V86, P217, DOI 10.1016/S0304-3959(99)00304-8; Lee A, 1999, ANESTH ANALG, V88, P1362, DOI 10.1097/00000539-199906000-00031; Linde K, 1997, LANCET, V350, P834, DOI 10.1016/S0140-6736(97)02293-9; LINDE K, 1997, COCHRANE LIB; LINDE K, 2000, COCHRANE LIB; Pittler MH, 2000, AM J MED, V108, P276, DOI 10.1016/S0002-9343(99)00454-4; Vickers A, 2000, BRIT J GEN PRACT, V50, P444; Vickers A, 1997, INT J TECHNOL ASSESS, V13, P111, DOI 10.1017/S0266462300010278; White AR, 2000, COMPLEMENT THER MED, V8, P111, DOI 10.1054/ctim.2000.0356; WHITE AR, 1997, COMPLEMENT THER MED, V5, P210; Williams JW, 2000, ANN INTERN MED, V132, P743, DOI 10.7326/0003-4819-132-9-200005020-00011	24	152	156	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2000	321	7269					1133	1135		10.1136/bmj.321.7269.1133	http://dx.doi.org/10.1136/bmj.321.7269.1133			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	372DT	11061738	Green Published			2022-12-28	WOS:000165219600029
J	Gottlieb, S				Gottlieb, S			Early exposure to cows' milk raises risk of diabetes in high risk children	BRITISH MEDICAL JOURNAL			English	News Item																		Paronen J, 2000, DIABETES, V49, P1657, DOI 10.2337/diabetes.49.10.1657	1	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 28	2000	321	7268					1040	1040						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PU	11053167				2022-12-28	WOS:000165076800016
J	Deck, DD; McFarland, BH; Titus, JM; Laws, KE; Gabriel, RM				Deck, DD; McFarland, BH; Titus, JM; Laws, KE; Gabriel, RM			Access to substance abuse treatment services under the Oregon Health Plan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MENTAL-HEALTH; CARE; PATTERNS; MEDICAID; STATES	Context The shift to Medicaid managed care has raised numerous concerns about access to publicly funded substance abuse treatment. The implementation of a capitated chemical dependency benefit within the Oregon Health Plan in 1995 provided an opportunity to study the impact of funding mechanisms on access. Objectives To determine to what extent access to publicly funded substance abuse treatment changed following the shift to managed care in Oregon and to examine factors associated with that change. Design Analysis of statewide treatment and Medicaid eligibility data. Setting and Patients All Medicaid-eligible persons aged 12 to 64 years who were enrolled in the Oregon Health Plan during 1994 (88320), 1996 (170387), 1997 (160929), or 1998 (149877). Main Outcome Measures Access rates (the number of unique individuals admitted to treatment during a calendar year divided by the average number of enrolled members) computed before (1994) and after (1997) implementation of the capitated benefit. Analyses were replicated with data for 1996 and 1998. Results The percentage of Medicaid-eligible persons admitted to substance abuse treatment programs during a calendar year increased from 5.5% of the average number of enrolled members per month in 1994 to 7.7% in 1997, following the shift to managed care. For 1996 and 1998, the rates were 6.9% and 7.7%, respectively. Access rates varied considerably among the 7 largest prepaid health plans after adjusting for case mix. Operating characteristics of these prepaid health plans, such as the method of reimbursing treatment providers, were significant predictors of access after controlling for member characteristics. Conclusion According to our analyses, Medicaid-eligible persons in Oregon observed an increase in access to substance abuse treatment after a shift to managed care.	RMC Res Corp, Portland, OR 97204 USA; Oregon Hlth Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Deck, DD (corresponding author), RMC Res Corp, 522 SW 5th Ave,Suite 1407, Portland, OR 97204 USA.			McFarland, Bentson/0000-0001-9149-5616	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K02AA000281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011970] Funding Source: NIH RePORTER; NIAAA NIH HHS [K02 AA00281] Funding Source: Medline; NIDA NIH HHS [R01 DA11970] Funding Source: Medline; CSAT SAMHSA HHS [1 UR7TI1129401] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CSAT SAMHSA HHS		*AM SOC ADD MED, 1999, IMP MAN CAR SUBST AB; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Barron N, 1999, J PSYCHOACTIVE DRUGS, V31, P241, DOI 10.1080/02791072.1999.10471753; BERGMAN GT, 1999, MANAGED BEHAV HEALTH, V1, P1; Chang CF, 1998, JAMA-J AM MED ASSOC, V279, P864, DOI 10.1001/jama.279.11.864; CUTLER DL, 1992, COMMUNITY MENT HLT J, V28, P121, DOI 10.1007/BF00754279; Cutler DL, 1998, ADM POLICY MENT HLTH, V25, P361, DOI 10.1023/A:1022249606959; DECK DD, 1999, ANN M ASS HLTH SERV; FEYERHERM W, 1995, OREGON HOUSEHOLD TRE; GABRIEL RM, 1998, ANN M AM PUBL HLTH A; GOLD M, 1995, MANAGED CARE LOW INC; GOLD M, 1997, J HLTH POLIT, V22, P631; *HLTH CAR FIN ADM, 1998, MED STAT PROGR FIN S; Iglehart JK, 1999, NEW ENGL J MED, V340, P403, DOI 10.1056/NEJM199902043400525; IGLEHART JK, 1994, NEW ENGL J MED, V330, P75, DOI 10.1056/NEJM199401063300128; KIRBY K, 1999, INTEGRATING ALCOHOL; MARK T, 1998, PUBL US DEP HHS; McCaughrin WC, 1996, J SUBST ABUSE, V8, P403, DOI 10.1016/S0899-3289(96)90002-4; MCFARLAND BH, 1994, COMMUNITY MENT HLT J, V30, P221, DOI 10.1007/BF02188884; McFarland BH, 1997, PSYCHIATR SERV, V48, P191; McKusick D, 1998, HEALTH AFFAIR, V17, P147, DOI 10.1377/hlthaff.17.5.147; MECHANIC D, 1995, MILBANK Q, V73, P19, DOI 10.2307/3350312; Mechanic D, 1998, ARCH GEN PSYCHIAT, V55, P785, DOI 10.1001/archpsyc.55.9.785; *OFF MED ASS PROGR, 1994, OR MED REF DEM WAIV; RAY B, 1997, NATL ADM SUBSTANCE A; ROBINSON GK, 1998, PUBL US DEP HHS; ROSS KV, 2000, NEW DIRECTIONS MENTA, V85; Warner R, 1998, PSYCHIATR SERV, V49, P802, DOI 10.1176/ps.49.6.802	29	35	35	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2093	2099		10.1001/jama.284.16.2093	http://dx.doi.org/10.1001/jama.284.16.2093			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	364QA	11042758	Bronze			2022-12-28	WOS:000089902100030
J	Grumbach, K				Grumbach, K			Insuring the uninsured - Time to end the aura of invisibility	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE-REFORM; INEVITABILITY; MANAGEMENT		Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Grumbach, K (corresponding author), San Francisco Gen Hosp, Ward 83,1001 Potrero Ave, San Francisco, CA 94110 USA.		Grumbach, Kevin/L-9222-2016					Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Blendon RJ, 1999, HEALTH AFFAIR, V18, P203, DOI 10.1377/hlthaff.18.6.203; Blendon RJ, 2000, HEALTH AFFAIR, V19, P210, DOI 10.1377/hlthaff.19.4.210; Broyles RS, 2000, JAMA-J AM MED ASSOC, V284, P2070, DOI 10.1001/jama.284.16.2070; Cunningham PJ, 1999, JAMA-J AM MED ASSOC, V281, P1087, DOI 10.1001/jama.281.12.1087; CUNNINGHAM PJ, 2000, 29 CTR STUD HLTH SYS; Eisenberg JM, 2000, JAMA-J AM MED ASSOC, V284, P2100, DOI 10.1001/jama.284.16.2100; Farey K, 1996, J PUBLIC HEALTH POL, V17, P133, DOI 10.2307/3342694; Forrest CB, 2000, JAMA-J AM MED ASSOC, V284, P2077, DOI 10.1001/jama.284.16.2077; Lewin ME, 2000, AM HLTH CARE SAFETY; LUNDBERG GD, 1991, JAMA-J AM MED ASSOC, V265, P2566; LUNDBERG GD, 1993, JAMA-J AM MED ASSOC, V269, P2554, DOI 10.1001/jama.269.19.2554; LUNDBERG GD, 1992, JAMA-J AM MED ASSOC, V267, P2521; Pincus T, 1998, ANN INTERN MED, V129, P406, DOI 10.7326/0003-4819-129-5-199809010-00011; SKOCPOL T, 1995, HEALTH AFFAIR, V14, P66, DOI 10.1377/hlthaff.14.1.66; Skolnick AA, 1996, JAMA-J AM MED ASSOC, V276, P931; SMITH AD, 1994, TWILLIGHT LOS ANGELE; *US CENS BUR, 2000, HLTH INS COV; *US CENS BUR, 2000, HLTH INS HIST TABL 2	19	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2114	2116		10.1001/jama.284.16.2114	http://dx.doi.org/10.1001/jama.284.16.2114			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	364QA	11042763				2022-12-28	WOS:000089902100035
J	Lurie, N				Lurie, N			Strengthening the US health care safety net	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US Dept HHS, Washington, DC 20201 USA		Lurie, N (corresponding author), US Dept HHS, 200 Independence Ave SW,Room 716-G, Washington, DC 20201 USA.							*ASS AM MED COLL D, 2000, MIN GRAD US MED COLL; Barzansky B, 2000, JAMA-J AM MED ASSOC, V284, P1114, DOI 10.1001/jama.284.9.1114; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; *DEP HLTH HUM SERV, 2000, SEL STAT HLTH PROF S; *HLTH CAR FIN ADM, 1999, STAT CHILDR HLTH INS; *HLTH RES SERV ADM, 2000, VIS FUT PRIM HLTH CA; Holahan J, 2000, HEALTH AFFAIR, V19, P188, DOI 10.1377/hlthaff.19.4.188; Lewin ME, 2000, AM HLTH CARE SAFETY; Lurie N, 1997, J GEN INTERN MED, V12, P34; MAYBERRY RM, 2000, KAISER J FAMILY  OCT; *OFF MIN HLTH DEP, 2000, CLOS GAP; Pathman DE, 2000, JAMA-J AM MED ASSOC, V284, P2084, DOI 10.1001/jama.284.16.2084; RHOADES J, 2000, HLTH INSURANCE STATU; Saha S, 2000, HEALTH AFFAIR, V19, P76, DOI 10.1377/hlthaff.19.4.76; U.S.) C on GME, DHHSPUBL 1998 HRSA, V97, P53; 2000, FED REG, V65, P52762	16	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2112	2114		10.1001/jama.284.16.2112	http://dx.doi.org/10.1001/jama.284.16.2112			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364QA	11042762				2022-12-28	WOS:000089902100034
J	Brand, JG				Brand, JG			Within reach of an end to unnecessary bitterness?	LANCET			English	Editorial Material							TASTE; GUSTDUCIN		Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; Vet Affairs Med Ctr, Philadelphia, PA USA; Univ Penn, Philadelphia, PA 19104 USA	Monell Chemical Senses Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Brand, JG (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.							Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Barlow LA, 1999, NEURON, V22, P209, DOI 10.1016/S0896-6273(00)81081-8; Brand JG, 2000, J NUTR, V130, p942S, DOI 10.1093/jn/130.4.942S; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Hoffman HJ, 1998, ANN NY ACAD SCI, V855, P716, DOI 10.1111/j.1749-6632.1998.tb10650.x; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Krizhanovsky V, 2000, AM J PHYSIOL-CELL PH, V279, pC120, DOI 10.1152/ajpcell.2000.279.1.C120; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Peri I, 2000, AM J PHYSIOL-CELL PH, V278, pC17, DOI 10.1152/ajpcell.2000.278.1.C17; Rossler P, 2000, CHEM SENSES, V25, P413, DOI 10.1093/chemse/25.4.413; Spielman AI, 1996, AM J PHYSIOL-CELL PH, V270, pC926, DOI 10.1152/ajpcell.1996.270.3.C926; SPIELMAN AI, 1992, SOC GEN PHY, V47, P307; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; YAN W, 1999, CHEM SENSES, V24, P595; YEE KK, IN PRESS DEV BRAIN R	20	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2000	356	9239					1371	1372		10.1016/S0140-6736(00)02836-1	http://dx.doi.org/10.1016/S0140-6736(00)02836-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052575				2022-12-28	WOS:000089976100005
J	Thomas, SR; Jamieson, DRS; Muir, KW				Thomas, SR; Jamieson, DRS; Muir, KW			Randomised con trolled trial of atraumatic versus standard needles for diagnostic lumbar puncture	BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIAL; DOUBLE-BLIND; HEADACHE; COMPLICATIONS	Objective To compare the ease of use of atraumatic needles with standard needles for diagnostic lumbar puncture and the incidence of headache after their use. Design Double blind, randomised controlled trial. Setting Investigation ward of a neurology unit in a university hospital. Participants 116 patients requiring elective diagnostic lumbar puncture. Interventions Standardised protocol for lumbar puncture with 20 gauge atraumatic or standard needles. Outcome measures The primary end point was intention to treat analysis of incidence of moderate to severe headache, assessed at one week by telephone interview. Secondary end points were incidence of headache at one week analysed by needle type, ease of use by operator according to a visual analogue scale, incidence of backache, and failure rate of puncture. Results Valid outcome data were available for 97 of 101 patients randomised. Baseline characteristics were matched except for higher body mass index in the standard needle group. By an intention to treat analysis the absolute risk of moderate to severe headache with atraumatic needles was reduced by 26% (95% confidence interval 6% to 45%) compared with standard needles, but there tvas a non-significantly greater absolute risk of multiple attempts at lumbar puncture (14%, - 4% to 32%), Higher body mass index was associated with an increased failure rate with atraumatic needles, but the reduced incidence of headache was maintained. The need for medical interventions was reduced by 20% (1% to 40%). Conclusions Atraumatic needles significantly reduced the incidence of moderate to severe headache and the need for medical interventions after diagnostic need for medical interventions after diagnostic lumbar punctures, but they were associated with a higher failure rate than standard needles.	So Gen Hosp, Inst Neurol Sci, Dept Neurol, Glasgow G51 4TF, Lanark, Scotland; Leeds Gen Infirm, Dept Neurol, Leeds LS1 3EX, W Yorkshire, England	University of Glasgow; Leeds General Infirmary; University of Leeds	Muir, KW (corresponding author), So Gen Hosp, Inst Neurol Sci, Dept Neurol, Glasgow G51 4TF, Lanark, Scotland.		Muir, Keith W/A-7670-2011	Muir, Keith W/0000-0001-9535-022X				BRAUNE HJ, 1992, ACTA NEUROL SCAND, V86, P50, DOI 10.1111/j.1600-0404.1992.tb08053.x; Carson D, 1996, NEUROLOGY, V47, P33, DOI 10.1212/WNL.47.1.33; Evans RW, 1998, NEUROL CLIN, V16, P83, DOI 10.1016/S0733-8619(05)70368-6; Flaatten H, 1998, ACTA NEUROL SCAND, V98, P445, DOI 10.1111/j.1600-0404.1998.tb07328.x; GRANT R, 1991, J NEUROL NEUROSUR PS, V54, P440, DOI 10.1136/jnnp.54.5.440; Greene HM, 1926, J AMER MED ASSOC, V86, P391, DOI 10.1001/jama.1926.02670320005002; Kleyweg RP, 1998, CEPHALALGIA, V18, P635, DOI 10.1046/j.1468-2982.1998.1809635.x; KUNTZ KM, 1992, NEUROLOGY, V42, P1884, DOI 10.1212/WNL.42.10.1884; LYBECKER H, 1990, ANESTH ANALG, V70, P389; MULLER B, 1994, J NEUROL, V241, P376, DOI 10.1007/BF02033354; Strupp M, 1998, J NEUROL, V245, P589, DOI 10.1007/s004150050250	11	62	65	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 21	2000	321	7267					986	990		10.1136/bmj.321.7267.986	http://dx.doi.org/10.1136/bmj.321.7267.986			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366ZF	11039963	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000090035600024
J	Lindahl, B; Toss, H; Siegbahn, A; Venge, P; Wallentin, L				Lindahl, B; Toss, H; Siegbahn, A; Venge, P; Wallentin, L		FRISC Study Grp	Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; EARLY RISK STRATIFICATION; CARDIAC TROPONIN-T; AMYLOID-A-PROTEIN; PROGNOSTIC VALUE; PLASMA-FIBRINOGEN; ANGINA-PECTORIS; HEART-DISEASE; INFARCTION; EVENTS	Background In patients with unstable coronary artery disease, there is a relation between the short-term risk of death and blood levels of troponin T ( a marker of myocardial damage) and C-reactive protein and fibrinogen ( markers of inflammation). Using information obtained during an extension of the follow-up period in the Fragmin during Instability in Coronary Artery Disease trial, we evaluated the usefulness of troponin T, C-reactive protein, and fibrinogen levels and other indicators of risk as predictors of the longterm risk of death from cardiac causes. Methods Levels of C-reactive protein and fibrinogen at enrollment and the maximal level of troponin T during the first 24 hours after enrollment were analyzed in 917 patients included in a clinical trial of low-molecular-weight heparin in unstable coronary artery disease. The patients were followed for a mean of 37.0 months ( range, 1.6 to 50.6). Results During follow-up, 1.2 percent of the 173 patients with maximal blood troponin T levels of less than 0.06 mu g per liter died of cardiac causes, as compared with 8.7 percent of the 367 patients with levels of 0.06 to 0.59 mu g per liter and 15.4 percent of the 377 patients with levels of at least 0.60 mu g per liter (P = 0.007 and P = 0.001, respectively). The rates of death from cardiac causes were 5.7 percent among the 314 patients with blood C-reactive protein levels of less than 2 mg per liter, 7.8 percent among the 294 with levels of 2 to 10 mg per liter, and 16.5 percent among the 309 with levels of more than 10 mg per liter (P = 0.29 and P = 0.001, respectively). The rates of death from cardiac causes were 5.4 percent among the 314 patients with blood fibrinogen levels of less than 3.4 g per liter, 12.0 percent among the 300 with levels of 3.4 to 3.9 g per liter, and 12.9 percent among the 303 with levels of at least 4.0 g per liter (P = 0.004 and P = 0.69, respectively). In a multivariate analysis, levels of troponin T and C-reactive protein were independent predictors of the risk of death from cardiac causes. Conclusions In unstable coronary artery disease, elevated levels of troponin T and C-reactive protein are strongly related to the long-term risk of death from cardiac causes. These markers are independent risk factors, and their effects are additive with respect to each other and other clinical indicators of risk. (N Engl J ed 2000; 343:1139- 47.) (C) 2000, Massachusetts Medical Society.Background: In patients with unstable coronary artery disease, there is a relation between the short-term risk of death and blood levels of troponin T (a marker of myocardial damage) and C-reactive protein and fibrinogen (markers of inflammation). Using information obtained during an extension of the follow-up period in the Fragmin during Instability in Coronary Artery Disease trial, we evaluated the usefulness of troponin T, C-reactive protein, and fibrinogen levels and other indicators of risk as predictors of the long-term risk of death from cardiac causes. Methods: Levels of C-reactive protein and fibrinogen at enrollment and the maximal level of troponin T during the first 24 hours after enrollment were analyzed in 917 patients included in a clinical trial of low-molecular-weight heparin in unstable coronary artery disease. The patients were followed for a mean of 37.0 months (range, 1.6 to 50.6). Results: During follow-up, 1.2 percent of the 173 patients with maximal blood troponin T levels of less than 0.06 microg per liter died of cardiac causes, as compared with 8.7 percent of the 367 patients with levels of 0.06 to 0.59 microg per liter and 15.4 percent of the 377 patients with levels of at least 0.60 microg per liter (P=0.007 and P=0.001, respectively). The rates of death from cardiac causes were 5.7 percent among the 314 patients with blood C-reactive protein levels of less than 2 mg per liter, 7.8 percent among the 294 with levels of 2 to 10 mg per liter, and 16.5 percent among the 309 with levels of more than 10 mg per liter (P=0.29 and P=0.001, respectively). The rates of death from cardiac causes were 5.4 percent among the 314 patients with blood fibrinogen levels of less than 3.4 g per liter, 12.0 percent among the 300 with levels of 3.4 to 3.9 g per liter, and 12.9 percent among the 303 with levels of at least 4.0 g per liter (P=0.004 and P=0.69, respectively). In a multivariate analysis, levels of troponin T and C-reactive protein were independent predictors of the risk of death from cardiac causes. Conclusions: In unstable coronary artery disease, elevated levels of troponin T and C-reactive protein are strongly related to the long-term risk of death from cardiac causes. These markers are independent risk factors, and their effects are additive with respect to each other and other clinical indicators of risk. (N Engl J Med 2000;343:1139-47.)	Uppsala Univ, Dept Cardiol, Uppsala, Sweden; Uppsala Univ, Dept Clin Chem, Uppsala, Sweden	Uppsala University; Uppsala University	Lindahl, B (corresponding author), Univ Uppsala Hosp, Dept Cardiol, S-75185 Uppsala, Sweden.	bertil.lindahl@card.uas.lul.se						Andersen K, 1996, CORONARY ARTERY DIS, V7, P753, DOI 10.1097/00019501-199610000-00008; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Becker RC, 1996, AM J CARDIOL, V78, P142, DOI 10.1016/S0002-9149(96)90386-0; Benamer H, 1999, AM HEART J, V137, P815, DOI 10.1016/S0002-8703(99)70404-7; Benamer H, 1998, AM J CARDIOL, V82, P845, DOI 10.1016/S0002-9149(98)00490-1; Biasucci LM, 1999, CIRCULATION, V99, P855, DOI 10.1161/01.CIR.99.7.855; BLOTH B, 1976, ACTA MED SCAND, V200, P281; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; de Winter RJ, 1999, CARDIOVASC RES, V42, P240, DOI 10.1016/S0008-6363(99)00018-8; GERHARDT W, 1993, CLIN BIOCHEM, V26, P231, DOI 10.1016/0009-9120(93)90122-M; Hamm CW, 1999, NEW ENGL J MED, V341, P548; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Heeschen C, 1999, CIRCULATION, V100, P1509, DOI 10.1161/01.CIR.100.14.1509; Holmvang L, 1999, AM HEART J, V137, P24, DOI 10.1016/S0002-8703(99)70456-4; Holmvang L, 1998, CIRCULATION, V98, P2004, DOI 10.1161/01.CIR.98.19.2004; Jernberg T, 1999, J AM COLL CARDIOL, V34, P1413, DOI 10.1016/S0735-1097(99)00370-8; KROBOT K, 1992, ARTERIOSCLER THROMB, V12, P780, DOI 10.1161/01.ATV.12.7.780; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Lindahl B, 1997, J AM COLL CARDIOL, V29, P43, DOI 10.1016/S0735-1097(96)00447-0; Lindahl B, 1996, CIRCULATION, V93, P1651, DOI 10.1161/01.CIR.93.9.1651; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Luscher MS, 1997, CIRCULATION, V96, P2578, DOI 10.1161/01.CIR.96.8.2578; Maseri A, 1999, HEART, V82, pI2, DOI 10.1136/hrt.82.2008.i2; MEADE TW, 1995, EUR HEART J, V16, P31, DOI 10.1093/eurheartj/16.suppl_A.31; Mendall MA, 1996, BRIT MED J, V312, P1061; Mohler ER, 1998, AM HEART J, V135, P253, DOI 10.1016/S0002-8703(98)70090-0; Morrow DA, 1998, J AM COLL CARDIOL, V31, P1460, DOI 10.1016/S0735-1097(98)00136-3; MullerBardorff M, 1997, CLIN CHEM, V43, P458; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Rao ACR, 1998, HEART, V80, P223, DOI 10.1136/hrt.80.3.223; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Savonitto S, 1999, JAMA-J AM MED ASSOC, V281, P707, DOI 10.1001/jama.281.8.707; Stubbs P, 1996, BRIT MED J, V313, P262, DOI 10.1136/bmj.313.7052.262; SUTTON MS, 1994, CIRCULATION, V89, P68, DOI 10.1161/01.CIR.89.1.68; Terres W, 1998, AM HEART J, V135, P281, DOI 10.1016/S0002-8703(98)70094-8; Toss H, 1997, CIRCULATION, V96, P4204; VOLPI A, 1993, CIRCULATION, V88, P416, DOI 10.1161/01.CIR.88.2.416; Wallentin L, 1996, LANCET, V347, P561	42	926	993	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2000	343	16					1139	1147		10.1056/NEJM200010193431602	http://dx.doi.org/10.1056/NEJM200010193431602			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364FY	11036119	Bronze			2022-12-28	WOS:000089882800002
J	Mehta, SH; Brancati, FL; Sulkowski, MS; Strathdee, SA; Szklo, M; Thomas, DL				Mehta, SH; Brancati, FL; Sulkowski, MS; Strathdee, SA; Szklo, M; Thomas, DL			Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							ASSOCIATION; GLUCOSE; CIRRHOSIS	Background: Hepatitis C virus (HCV) infection may contribute to the development of diabetes mellitus. This relationship has not been investigated at the population level, and its biological mechanism remains unknown. Objective: To examine the prevalence of type 2 diabetes among persons with HCV infection in a representative sample of the general adult population of the United States. Design: Cross-sectional national survey. Setting: The Third National Health and Nutrition Examination Survey, 1988-1994. Participants: 9841 persons older than 20 years of age for whom data on HCV infection and diabetes were complete. Measurements: The presence of diabetes was ascertained by using American Diabetes Association guidelines based on fasting plasma glucose measurement and medication history. Presence of HCV infection was assessed by testing for serum HCV-specific antibodies (anti-HCV). Results: of the 9841 persons evaluated, 8.4% had type 2 diabetes and 2.1% were anti-HCV positive. Type 2 diabetes occurred more often in persons who were older, were nonwhite, had a high body mass index, and had low socioeconomic status. Type 2 diabetes was less common in persons who acknowledged previous illicit drug use. After adjustment for these factors, persons 40 years of age or older with HCV infection were more than three times more likely than those without HCV infection to have type 2 diabetes (adjusted odds ratio, 3.77 [95% CI, 1.80 to 7.87]). None of the 19 persons with type 1 diabetes were anti-HCV positive. Conclusion: In the United States, type 2 diabetes occurs more often in persons with HCV infection who are older than 40 years of age.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Thomas, DL (corresponding author), Johns Hopkins Med Inst, 1147 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.		Strathdee, Steffanie A/B-9042-2009	Szklo, Moyses/0000-0001-9433-6266	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010627, F31DA006007] Funding Source: NIH RePORTER; NIDA NIH HHS [1 F31 DA06007, 1 R01 DA10627] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ALLISON MED, 1994, J HEPATOL, V21, P1135, DOI 10.1016/S0168-8278(05)80631-2; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bonkovsky HL, 1998, HEPATOLOGY, V27, P1661, DOI 10.1002/hep.510270627; Caronia S, 1999, HEPATOLOGY, V30, P1059, DOI 10.1002/hep.510300416; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; GRAY H, 1995, DIABETIC MED, V12, P244, DOI 10.1111/j.1464-5491.1995.tb00466.x; Grimbert S, 1996, GASTROEN CLIN BIOL, V20, P544; Haffner SM, 1998, DIABETES CARE, V21, pC3, DOI 10.2337/diacare.21.3.C3; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Knobler H, 1998, J CLIN GASTROENTEROL, V26, P30, DOI 10.1097/00004836-199801000-00009; Mangia A, 1998, AM J GASTROENTEROL, V93, P2363, DOI 10.1111/j.1572-0241.1998.00688.x; Mason AL, 1999, HEPATOLOGY, V29, P328, DOI 10.1002/hep.510290235; Merli M, 1999, HEPATOLOGY, V30, P649, DOI 10.1002/hep.510300306; *NAT CTR HLTH STAT, 1994, DHHS PUBL; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; NELSON KE, 1991, JAMA-J AM MED ASSOC, V266, P2259, DOI 10.1001/jama.266.16.2259; Ozyilkan E, 1996, AM J GASTROENTEROL, V91, P1480; PETRIDES AS, 1989, J HEPATOL, V8, P107, DOI 10.1016/0168-8278(89)90169-4; Prior M J, 1993, Ann Epidemiol, V3, P9; Simo R, 1996, DIABETES CARE, V19, P998, DOI 10.2337/diacare.19.9.998; Strassburg CP, 1996, J VIRAL HEPATITIS, V3, P49, DOI 10.1111/j.1365-2893.1996.tb00081.x; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; TRAN A, 1993, HEPATOLOGY, V18, P253, DOI 10.1002/hep.1840180205	26	531	545	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					592	599		10.7326/0003-4819-133-8-200010170-00009	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033586				2022-12-28	WOS:000089906300003
J	Adam, D				Adam, D			Plastics that conduct win inventors chemistry prize	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					662	662		10.1038/35037767	http://dx.doi.org/10.1038/35037767			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048687	Bronze			2022-12-28	WOS:000089773900005
J	Filchak, KE; Roethele, JB; Feder, JL				Filchak, KE; Roethele, JB; Feder, JL			Natural selection and sympatric divergence in the apple maggot Rhagoletis pomonella	NATURE			English	Article							HOST RACES; TRADE-OFFS; FIELD-TEST; FLY; TEPHRITIDAE; DIPTERA; SPECIATION; FLIES	In On the Origin of Species, Darwin proposed that natural selection had a fundamental role in speciation(1). But this view receded during the Modern Synthesis when allopatric (geographic) models of speciation were integrated with genetic studies of hybrid sterility and inviability(2,3). The sympatric hypothesis posits that ecological specialization after a host shift can result in speciation in the absence of complete geographic isolation(4,5). The apple maggot, Rhagoletis pomonella, is a model for sympatric speciation in progress(4,5). Hawthorn (Crataegus spp.) is the native host for R. pomonella in N. America(5). But in the mid-1800s, a new population formed on introduced, domesticated apple (Malus pumila)(4,5). Recent studies(6-10) have conferred `host race' status on apple flies as a potentially incipient species, partially isolated from haw flies owing to host-related adaptation. However, the source of selection that differentiates apple and haw flies is unresolved. Here we document a gene-environment interaction (fitness trade-off) that is related to host phenology and that genetically differentiates the races.	Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr, Notre Dame, IN 46556 USA	University of Notre Dame	Filchak, KE (corresponding author), Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr, Notre Dame, IN 46556 USA.							ABRAHAMSON WG, 1994, GALL FORMING INSECTS, P208; [Anonymous], 1861, ORIGIN SPECIES MEANS; Bush G.L., 1975, P187; Bush G. L., 1966, TAXONOMY CYTOLOGY EV; Craig TP, 1997, EVOLUTION, V51, P1552, DOI 10.1111/j.1558-5646.1997.tb01478.x; Dobzhansky T., 1937, GENETICS ORIGINS SPE; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; FEDER JL, 1995, ECOLOGY, V76, P801, DOI 10.2307/1939346; FEDER JL, 1989, EVOLUTION, V43, P1813, DOI [10.2307/2409398, 10.1111/j.1558-5646.1989.tb02632.x]; Feder JL, 1999, ENTOMOL EXP APPL, V91, P211, DOI 10.1023/A:1003603918154; FEDER JL, 1988, NATURE, V336, P61, DOI 10.1038/336061a0; Feder JL, 1998, ENDLESS FORMS, P130; Filchak KE, 1999, EVOLUTION, V53, P187, DOI 10.1111/j.1558-5646.1999.tb05344.x; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; LATHROP FH, 1932, TECH B USDA, V275; Mayr E, 1942, SYSTEMATICS ORIGIN S; MCPHERON BA, 1988, NATURE, V336, P64, DOI 10.1038/336064a0; PROKOPY RJ, 1988, OECOLOGIA, V76, P138, DOI 10.1007/BF00379612; PROKOPY RJ, 1971, CAN ENTOMOL, V103, P1405, DOI 10.4039/Ent1031405-10; REID JA, 1976, P ENT SOC ONTARIO, V197, P19; Roethele JB, 1997, ANN ENTOMOL SOC AM, V90, P470, DOI 10.1093/aesa/90.4.470; Tauber C.A., 1989, P307; Thompson JD., 1994, COEVOLUTIONARY PROCE; Via Sara, 1994, P58; WOOD TK, 1990, EVOLUTION, V44, P619, DOI 10.1111/j.1558-5646.1990.tb05942.x	26	292	298	0	163	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					739	742		10.1038/35037578	http://dx.doi.org/10.1038/35037578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048719				2022-12-28	WOS:000089773900041
J	Wosten, MMSM; Kox, LFF; Chamnongpol, S; Soncini, FC; Groisman, EA				Wosten, MMSM; Kox, LFF; Chamnongpol, S; Soncini, FC; Groisman, EA			A signal transduction system that responds to extracellular iron	CELL			English	Article							2-COMPONENT REGULATORY SYSTEM; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; LIPID-A; POLYMYXIN RESISTANCE; METAL-CATIONS; PMRA MUTANTS; LIPOPOLYSACCHARIDE; TRANSPORT; GENES	Iron is essential for all organisms but can be toxic in excess. Iron homeostasis is typically regulated by cytoplasmic iron binding proteins, but here we describe a signal transduction system (PmrA/PmrB) that responds to extracytoplasmic ferric iron. Iron promoted transcription of PmrA-activated genes and resistance to the antibiotic polymyxin in Salmonella. The PmrB protein bound iron via its periplasmic domain which harbors two copies of the sequence ExxE, a motif present in the Saccharomyces FTR1 iron transporter and in mammalian ferritin light chain. A pmrA mutant was hypersensitive to killing by iron but displayed wild-type resistance to a variety of oxidants, suggesting PmrA/PmrB controls a novel pathway mediating the avoidance of iron toxicity.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Groisman, EA (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA.	groisman@borcim.wustl.edu		Soncini, Fernando/0000-0002-8925-7763; Wosten, Marc/0000-0002-7464-7232	NIAID NIH HHS [AI42236] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042236] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Askwith C, 1998, TRENDS BIOCHEM SCI, V23, P135, DOI 10.1016/S0968-0004(98)01192-X; Askwith CC, 1996, MOL MICROBIOL, V20, P27, DOI 10.1111/j.1365-2958.1996.tb02485.x; Braun V, 1997, ARCH MICROBIOL, V167, P325, DOI 10.1007/s002030050451; Braun V, 1997, BIOL CHEM, V378, P779; BREUER W, 1995, J BIOL CHEM, V270, P24209, DOI 10.1074/jbc.270.41.24209; Cammack R, 1990, IRON TRANSPORT STORA, P17; Davies RH, 1996, J VET MED B, V43, P119, DOI 10.1111/j.1439-0450.1996.tb00295.x; Davis R., 1980, ADV BACTERIAL GENETI; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Dunning JC, 1998, APPL ENVIRON MICROB, V64, P27; ETTNER N, 1995, BIOCHEMISTRY-US, V34, P22, DOI 10.1021/bi00001a004; Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999; FERRIS FG, 1986, CAN J MICROBIOL, V32, P52, DOI 10.1139/m86-010; FOSTER JW, 1992, J BACTERIOL, V174, P4317, DOI 10.1128/JB.174.13.4317-4323.1992; Goddard WP, 1997, J NUTR, V127, P177, DOI 10.1093/jn/127.1.177; Godson GN, 2000, BIOCHEMISTRY-US, V39, P332, DOI 10.1021/bi9916628; GROISMAN EA, 1993, P NATL ACAD SCI USA, V90, P1033, DOI 10.1073/pnas.90.3.1033; GROISMAN EA, 1992, J BACTERIOL, V174, P486, DOI 10.1128/jb.174.2.486-491.1992; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Gunn JS, 1998, MICROB PATHOGENESIS, V25, P77, DOI 10.1006/mpat.1998.0217; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Halliwell B., 1991, FREE RADICALS BIOL M; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HASIN M, 1982, J BIOL CHEM, V257, P2475; Heithoff DM, 1999, J BACTERIOL, V181, P799, DOI 10.1128/JB.181.3.799-807.1999; HELANDER IM, 1994, MOL MICROBIOL, V11, P481, DOI 10.1111/j.1365-2958.1994.tb00329.x; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hoch JA, 1995, 2 COMPONENT SIGNAL T; JOSHI J G, 1988, Biofactors, V1, P207; Kaplan J, 1996, SCIENCE, V271, P1510, DOI 10.1126/science.271.5255.1510; KARLIN KD, 1993, SCIENCE, V261, P701, DOI 10.1126/science.7688141; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; Langley S, 1999, APPL ENVIRON MICROB, V65, P489; Lucassen ECHET, 2000, AQUAT BOT, V66, P321, DOI 10.1016/S0304-3770(99)00083-2; MAKELA PH, 1978, FEMS MICROBIOL LETT, V3, P323; MILLER DD, 1989, BIOL TRACE ELEM RES, V19, P11, DOI 10.1007/BF02925446; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; MUSZYNSKA G, 1992, J CHROMATOGR, V604, P19, DOI 10.1016/0021-9673(92)85524-W; Nelson N, 1999, EMBO J, V18, P4361, DOI 10.1093/emboj/18.16.4361; NIEDERHOFFER EC, 1990, J BACTERIOL, V172, P1930, DOI 10.1128/jb.172.4.1930-1938.1990; Ramanan N, 2000, SCIENCE, V288, P1062, DOI 10.1126/science.288.5468.1062; Ratering S, 2000, BIOGEOCHEMISTRY, V48, P341, DOI 10.1023/A:1006252315427; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANDERSON KE, 1995, MICROBIOL REV, V59, P241, DOI 10.1128/MMBR.59.2.241-303.1995; SHAFER WM, 1984, INFECT IMMUN, V43, P834, DOI 10.1128/IAI.43.3.834-838.1984; SHAFER WM, 1986, INFECT IMMUN, V53, P651, DOI 10.1128/IAI.53.3.651-655.1986; SIMPSON RJ, 1990, BRIT J NUTR, V63, P79, DOI 10.1079/BJN19900093; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; Soncini FC, 1996, J BACTERIOL, V178, P6796, DOI 10.1128/jb.178.23.6796-6801.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Sparling DW, 1996, REV ENVIRON CONTAM T, V145, P1; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; STORM DR, 1977, ANNU REV BIOCHEM, V46, P723, DOI 10.1146/annurev.bi.46.070177.003451; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; TRIKHA J, 1995, J MOL BIOL, V248, P949, DOI 10.1006/jmbi.1995.0274; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Wosten MMSM, 1999, J BIOL CHEM, V274, P27185, DOI 10.1074/jbc.274.38.27185; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999	66	273	278	4	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 29	2000	103	1					113	125		10.1016/S0092-8674(00)00092-1	http://dx.doi.org/10.1016/S0092-8674(00)00092-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051552	Bronze			2022-12-28	WOS:000089636400013
J	Joazeiro, CAP; Hunter, T				Joazeiro, CAP; Hunter, T			Ubiquitination - More than two to tango	SCIENCE			English	Article							C-CBL; LIGASE; RBX1; SCF; PROTEIN; SUBUNIT; ENZYME		Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA	Salk Institute	Joazeiro, CAP (corresponding author), Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA.							Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Huang HK, 2000, J BIOL CHEM, V275, P26661; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	15	35	35	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2061	2062		10.1126/science.289.5487.2061	http://dx.doi.org/10.1126/science.289.5487.2061			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11032556				2022-12-28	WOS:000089430900028
J	Schulze, ED; Wirth, C; Heimann, M				Schulze, ED; Wirth, C; Heimann, M			Climate change - managing forests after Kyoto	SCIENCE			English	Article							CARBON SINK; CO2		Max Planck Inst Biogeochem, D-07701 Jena, Germany	Max Planck Society	Schulze, ED (corresponding author), Max Planck Inst Biogeochem, POB 100164, D-07701 Jena, Germany.	Detlef.Schulze@bgc-jena.mpg.de	Schulze, Ernst-Detlef/K-9627-2014; Wirth, Christian/A-4446-2016; Heimann, Martin/H-7807-2016	Heimann, Martin/0000-0001-6296-5113				Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; Bousquet P, 1999, J GEOPHYS RES-ATMOS, V104, P26161, DOI 10.1029/1999JD900342; Buchmann N, 1999, GLOBAL BIOGEOCHEM CY, V13, P751, DOI 10.1029/1999GB900016; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; Martin PH, 1998, AMBIO, V27, P582; MELILLO J, 1996, IPCC, P445; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; SCHIMEL D, 1996, IPCC WGI, P65; Schulze E.D., 1998, IGBP SERIES, P145; Schulze ED, 1999, GLOBAL CHANGE BIOL, V5, P703, DOI 10.1046/j.1365-2486.1999.00266.x; Schulze ED, 2000, ECOL STU AN, V142, P468; SHVIDENKO A, 1994, AMBIO, V23, P396; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; WIRTH C, IN PRESS PLANT SOIL; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314	16	313	356	9	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2000	289	5487					2058	2059		10.1126/science.289.5487.2058	http://dx.doi.org/10.1126/science.289.5487.2058			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11032555				2022-12-28	WOS:000089430900027
J	Cho, MK; Shohara, R; Schissel, A; Rennie, D				Cho, MK; Shohara, R; Schissel, A; Rennie, D			Policies on faculty conflicts of interest at US universities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIFE-SCIENCE; OF-INTEREST; QUALITY; DRUG	Context Despite federal regulations on faculty conflicts of interest in federally funded research, academic-industry ties are common, and evidence exists that financial considerations bias the research record. Public scrutiny of these ties is increasing, especially in cases where researchers have financial interests in the corporate sponsors of their clinical research. Objective To review policies on conflict of interest at major biomedical research institutions in the United,States. Design Cross-sectional survey and content analysis study conducted from August 1998 to February 2000. Setting and Participants The 100 US institutions with the most funding from the National Institutes of Health in 1998 were initially sampled; policies from 89 institutions were available and included in the analysis. Main Outcome Measures Process for disclosure, review, and management of conflicts of interest and specified management strategies or limitations, according to the institutions' faculty/staff conflict of interest policies. Results Content of the conflict of interest policies varied widely across institutions. Fifty-five percent of policies (n=49) required disclosures from all faculty while 45% (n =40) required them only from principal investigators or those conducting research. Nineteen percent of policies (n=17) specified limits on faculty financial interests in corporate sponsors of research, 12% (n=11) specified limits on permissible delays in publication, and 4% (n=4) prohibited student involvement in work sponsored by a company in which the faculty mentor had a financial interest. Conclusions Most policies on conflict of interest in our sample of major research institutions in the United States lack specificity about the kinds of relationships with industry that are permitted or prohibited. Wide variation in management of conflicts of interest among institutions may cause unnecessary confusion among potential industrial partners or competition among universities for corporate sponsorship that could erode academic standards. It is in the long-term interest of institutions to develop widely agreed-on, clear, specific, and credible policies on conflicts of interest.	Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; NYU, Sch Law, New York, NY 10003 USA	Stanford University; University of California System; University of California San Francisco; New York University	Cho, MK (corresponding author), Stanford Univ, Ctr Biomed Eth, 701 Welch Rd,Suite 1105, Palo Alto, CA 94304 USA.	micho@ieland.staniord.edu						Bero LA, 1996, INT J TECHNOL ASSESS, V12, P209, DOI 10.1017/S0266462300009582; BERO LA, 1992, NEW ENGL J MED, V327, P1135, DOI 10.1056/NEJM199210153271606; Blumenthal D, 1996, NEW ENGL J MED, V335, P1734, DOI 10.1056/NEJM199612053352305; Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Eichenwald Kurt, 1999, N Y Times Web, pA16; Gillis J, 1999, WASHINGTON POST 0627, pA1; Krimsky S, 1996, Sci Eng Ethics, V2, P395, DOI 10.1007/BF02583927; OHARROW R, 2000, WASHINGTON POST  MAY, pA16; PRESS E, 2000, ATLANTIC MONTHLY, V285, P39; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P1238, DOI 10.1001/jama.277.15.1238; ROCHON PA, 1994, JAMA-J AM MED ASSOC, V272, P108, DOI 10.1001/jama.272.2.108; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; SHIPP A, 1992, BIOMEDICAL RES COLAB, P221; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812	17	138	139	2	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2203	2208		10.1001/jama.284.17.2203	http://dx.doi.org/10.1001/jama.284.17.2203			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056591	Bronze			2022-12-28	WOS:000090052600028
J	Henney, JE				Henney, JE			New treatment for leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Henney, JE (corresponding author), US FDA, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2178	2178		10.1001/jama.284.17.2178	http://dx.doi.org/10.1001/jama.284.17.2178			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056574				2022-12-28	WOS:000090052600007
J	Kassirer, JP				Kassirer, JP			Financial indigestion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Rothman DJ, 2000, NEW ENGL J MED, V342, P1284, DOI 10.1056/NEJM200004273421711	1	32	33	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2156	2157		10.1001/jama.284.17.2156	http://dx.doi.org/10.1001/jama.284.17.2156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056568				2022-12-28	WOS:000090052600001
J	Ji, Y; Heiblum, M; Sprinzak, D; Mahalu, D; Shtrikman, H				Ji, Y; Heiblum, M; Sprinzak, D; Mahalu, D; Shtrikman, H			Phase evolution in a Kondo-correlated system	SCIENCE			English	Article							QUANTUM-DOT; ANDERSON MODEL; EQUILIBRIUM; TRANSPORT	We measured the phase evolution of electrons as they traverse a quantum dot (QD) formed in a two-dimensional electron gas that serves as a Localized spin. The traversal phase, determined by embedding the QD in a double path electron interferometer and measuring the quantum interference of the electron wave functions manifested by conductance oscillation as a function of a weak magnetic field, evolved by pi radians, a range twice as Large as theoretically predicted. As the correlation weakened, a gradual transition to the familiar phase evolution of a QD was observed, The specific phase evolution observed is highly sensitive to the onset of Kondo correlation, possibly serving as an alternative fingerprint of the Kondo effect.	Weizmann Inst Sci, Braun Ctr Submicron Res, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Heiblum, M (corresponding author), Weizmann Inst Sci, Braun Ctr Submicron Res, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel.		Ji, Yang/H-7065-2012; heiblum, moty/Q-1193-2019	Ji, Yang/0000-0003-1671-9266; Sprinzak, David/0000-0001-6776-6957				ANDERSON PW, 1961, PHYS REV, V124, P41, DOI 10.1103/PhysRev.124.41; Gerland U, 2000, PHYS REV LETT, V84, P3710, DOI 10.1103/PhysRevLett.84.3710; GLAZMAN LI, 1988, JETP LETT+, V47, P452; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Kondo J, 1970, SOLID STATE PHYS, V23, P183; LANGRETH DC, 1966, PHYS REV, V150, P516, DOI 10.1103/PhysRev.150.516; MEIR Y, 1993, PHYS REV LETT, V70, P2601, DOI 10.1103/PhysRevLett.70.2601; MEIRAV U, 1995, SEMICONDUCTOR SCI TE, V10, P255; NG TK, 1988, PHYS REV LETT, V61, P1768, DOI 10.1103/PhysRevLett.61.1768; NOZIERES P, 1974, J LOW TEMP PHYS, V17, P31, DOI 10.1007/BF00654541; Schmid J, 2000, PHYS REV LETT, V84, P5824, DOI 10.1103/PhysRevLett.84.5824; Schuster R, 1997, NATURE, V385, P417, DOI 10.1038/385417a0; WINGREEN NS, 1994, PHYS REV B, V49, P11040, DOI 10.1103/PhysRevB.49.11040; YACOBY A, 1995, PHYS REV LETT, V74, P4047, DOI 10.1103/PhysRevLett.74.4047	14	227	229	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					779	783		10.1126/science.290.5492.779	http://dx.doi.org/10.1126/science.290.5492.779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052936	Green Submitted			2022-12-28	WOS:000090067600041
J	Alewell, C; Manderscheid, B; Meesenburg, H; Bittersohl, J				Alewell, C; Manderscheid, B; Meesenburg, H; Bittersohl, J			Environmental chemistry - Is acidification still an ecological threat?	NATURE			English	Article							FOREST ECOSYSTEM; RECOVERY; TRENDS		Univ Bayreuth, BITOK, D-95440 Bayreuth, Germany; Forest Res Stn Lower Saxony, D-37079 Gottingen, Germany; Bavarian State Off Water Management, D-80636 Munich, Germany	University of Bayreuth	Alewell, C (corresponding author), Univ Bayreuth, BITOK, POB 101251, D-95440 Bayreuth, Germany.		Meesenburg, Henning/H-5794-2019	Meesenburg, Henning/0000-0002-3035-4737				Alewell C, 1997, J ENVIRON QUAL, V26, P658, DOI 10.2134/jeq1997.00472425002600030010x; ARMBRUSTER M, 1998, BODENKUNDLICHE ABHAN, V38, P1; *BAYER LAND WASS, 1997, 197 BAYER LAND WASS; DISE N, 1994, ACIDIFICATION FRESHW; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; LISCHEID G, UNPUB J HYDROL; Reuss JO, 1986, ACIDIC DEPOSITION AC; Stoddard JL, 1999, NATURE, V401, P575, DOI 10.1038/44114; Vesely J, 1998, WATER AIR SOIL POLL, V108, P107, DOI 10.1023/A:1005064829981	9	72	76	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					856	857		10.1038/35038158	http://dx.doi.org/10.1038/35038158			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057655				2022-12-28	WOS:000089901900037
J	Tschop, M; Smiley, DL; Heiman, ML				Tschop, M; Smiley, DL; Heiman, ML			Ghrelin induces adiposity in rodents	NATURE			English	Article							HORMONE SECRETAGOGUE RECEPTOR; GROWTH-HORMONE; ARCUATE NUCLEUS; BODY-COMPOSITION; MESSENGER-RNA; RATS; PEPTIDE; EXPRESSION; METABOLISM; PITUITARY	The discovery of the peptide hormone ghrelin, an endogenous ligand for the growth hormone secretagogue (GHS) receptor(1,2), yielded the surprising result(3) that the principal site of ghrelin synthesis is the stomach and not the hypothalamus. Although ghrelin is likely to regulate pituitary growth hormone (GH) secretion(3,4) along with GH-releasing hormone and somatostatin, GHS receptors have also been identified on hypothalamic neurons(5) and in the brainstem(6). Apart from potential paracrine effects, ghrelin may thus offer an endocrine link between stomach, hypothalamus and pituitary, suggesting an involvement in regulation of energy balance. Here we show that peripheral daily administration of ghrelin caused weight gain by reducing fat utilization in mice and rats. Intracerebroventricular administration of ghrelin generated a dose-dependent increase in food intake and body weight. Rat serum ghrelin concentrations were increased by fasting and were reduced by re-feeding or oral glucose administration, but not by water ingestion. We propose that ghrelin, in addition to its role in regulating GH secretion, signals the hypothalamus when an increase in metabolic efficiency is necessary.	Lilly Res Labs, Endocrine Res & Biores Technol & Prot, Indianapolis, IN 46285 USA	Eli Lilly	Tschop, M (corresponding author), Lilly Res Labs, Endocrine Res & Biores Technol & Prot, Drop Code 0545, Indianapolis, IN 46285 USA.		Tschoep, Matthias H/I-5443-2014	Tschoep, Matthias/0000-0002-4744-371X				ATRENS DM, 1985, PHYSIOL BEHAV, V35, P15, DOI 10.1016/0031-9384(85)90165-9; Bailey ART, 1999, NEUROENDOCRINOLOGY, V70, P83, DOI 10.1159/000054462; Bailey ART, 2000, J NEUROENDOCRINOL, V12, P191; CHARLTON HM, 1988, J ENDOCRINOL, V119, P51, DOI 10.1677/joe.0.1190051; CHEN Y, IN PRESS REGUL PEPT; Elia M, 1992, World Rev Nutr Diet, V70, P68; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; FLATT JP, 1991, J NUTR BIOCHEM, V2, P193, DOI 10.1016/0955-2863(91)90016-X; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; HEIMAN ML, 1985, ENDOCRINOLOGY, V116, P410, DOI 10.1210/endo-116-1-410; Hosoda H, 2000, J BIOL CHEM, V275, P21995, DOI 10.1074/jbc.M002784200; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; HSIUNG HM, 1987, METHOD ENZYMOL, V153, P390; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kuriyama H, 2000, NEUROSCI LETT, V282, P109, DOI 10.1016/S0304-3940(00)00882-X; Luckman SM, 1999, NEUROENDOCRINOLOGY, V70, P93, DOI 10.1159/000054463; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; Okada K, 1996, ENDOCRINOLOGY, V137, P5155, DOI 10.1210/en.137.11.5155; Rose BS, 1998, J NUTR, V128, P246, DOI 10.1093/jn/128.2.246; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; SCHEURINK AJW, 1993, PHYSIOL BEHAV, V53, P879, DOI 10.1016/0031-9384(93)90264-G; Snitker S, 1998, J CLIN ENDOCR METAB, V83, P3977, DOI 10.1210/jc.83.11.3977; Vernon RG, 1996, J ENDOCRINOL, V150, P129, DOI 10.1677/joe.0.1500129; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491	24	3130	3246	1	146	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					908	913		10.1038/35038090	http://dx.doi.org/10.1038/35038090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057670				2022-12-28	WOS:000089901900053
J	Sonnenberg, A; Delco, F; Inadomi, JM				Sonnenberg, A; Delco, F; Inadomi, JM			Cost-effectiveness of colonoscopy in screening for colorectal cancer	ANNALS OF INTERNAL MEDICINE			English	Article							FECAL-OCCULT-BLOOD; FLEXIBLE SIGMOIDOSCOPY; CONTROLLED TRIAL; COMPLICATIONS; MORTALITY; TESTS; POLYPECTOMY; POPULATION; HEMOCCULT; ENDOSCOPY	Background: Fecal occult blood testing, flexible sigmoidoscopy, and colonoscopy are used to screen patients for colorectal cancer. Objective: To compare the cost-effectiveness of fecal occult blood testing, flexible sigmoidoscopy, and colonoscopy. Design: The cost-effectiveness of the three screening strategies was compared by using computer models of a Markov process. In the model, a hypothetical population of 100 000 persons 50 years of age undergoes annual fecal occult blood testing, sigmoidoscopy every 5 years, or colonoscopy every 10 years. Positive results on fecal occult blood testing or adenomatous polyps found during sigmoidoscopy are worked up by using colonoscopy. After polypectomy, colonoscopy is repeated every 3 years until no polyps are found. Data Sources: Transition rates were estimated from U.S. vital statistics and cancer statistics and from published data an the sensitivity, specificity, and efficacy of various screening techniques. Costs of screening and cancer care were estimated from Medicare reimbursement data. Target Population: Persons 50 years of age in the general population. Time Horizon: The study population was followed annually until death. Perspective: Third-party payer. Outcome Measure: Incremental cost-effectiveness ratio. Results of Base-Case Analysis: Compared with colonoscopy, annual screening with fecal occult blood testing costs less but saves fewer life-years. A screening strategy based on flexible sigmoidoscopy every 5 or 10 years is less cost-effective than the other two screening methods. Results of Sensitivity Analysis: Screening with fecal occult blood testing is more sensitive to changes in compliance rates, and it becomes easily dominated by colonoscopy under most conditions assuming less than perfect compliance. Other assumptions about the sensitivity and specificity of fecal occult blood testing, screening frequency, efficacy of colonoscopy in preventing cancer, and polyp incidence have a lesser influence on the differences in cost-effectiveness between colonoscopy and fecal occult blood testing. Conclusions: Colonoscopy represents a cost-effective means of screening for colorectal cancer because it reduces mortality at relatively low incremental costs. Low compliance rates render colonoscopy every 10 years the most cost-effective primary screening strategy for colorectal cancer.	Dept Vet Affairs Med Ctr, Albuquerque, NM 87108 USA; Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Sonnenberg, A (corresponding author), Dept Vet Affairs Med Ctr, 111F,1501 San Pedro Dr SE, Albuquerque, NM 87108 USA.		Arndt, Volker/AAI-7282-2020; Inadomi, John/A-6221-2014	Arndt, Volker/0000-0001-9320-8684; Inadomi, John/0000-0001-6776-8661				AHLQUIST DA, 1992, CANCER, V70, P1259, DOI 10.1002/1097-0142(19920901)70:3+<1259::AID-CNCR2820701511>3.0.CO;2-D; AHLQUIST DA, 1993, JAMA-J AM MED ASSOC, V269, P1262, DOI 10.1001/jama.269.10.1262; ALLISON JE, 1990, ANN INTERN MED, V112, P328, DOI 10.7326/0003-4819-112-5-328; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; American Cancer Society, 1998, CANC FACTS FIG 1998; BAT L, 1986, AM J GASTROENTEROL, V81, P647; Brevinge H, 1997, INT J COLORECTAL DIS, V12, P291, DOI 10.1007/s003840050108; DRUMMOND MF, 1997, METHODS EC EVALUATIO, P96; EDDY DM, 1990, ANN INTERN MED, V113, P373, DOI 10.7326/0003-4819-113-5-373; EDDY DM, 1987, GASTROENTEROLOGY, V92, P682, DOI 10.1016/0016-5085(87)90018-7; Garbay JR, 1996, BRIT J SURG, V83, P42, DOI 10.1002/bjs.1800830112; HART R, 1990, ENDOSCOPY, V22, P229, DOI 10.1055/s-2007-1010734; KEWENTER J, 1988, CANCER, V62, P645, DOI 10.1002/1097-0142(19880801)62:3<645::AID-CNCR2820620333>3.0.CO;2-#; Kirschner CG, 1999, CURRENT PROCEDURAL T; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; KRONBORG O, 1989, SCAND J GASTROENTERO, V24, P599, DOI 10.3109/00365528909093096; LEE JG, 1999, GASTROINTEST ENDOSC, V49; LIEBERMAN DA, 1995, GASTROENTEROLOGY, V109, P1781, DOI 10.1016/0016-5085(95)90744-0; LIEBERMAN DA, 1991, AM J GASTROENTEROL, V86, P946; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Provenzale D, 1998, AM J GASTROENTEROL, V93, P872; Puchner R, 1996, WIEN KLIN WOCHENSCHR, V108, P142; Ransohoff DF, 1997, ANN INTERN MED, V126, P811, DOI 10.7326/0003-4819-126-10-199705150-00014; REX DK, 1991, GASTROENTEROLOGY, V100, P64, DOI 10.1016/0016-5085(91)90583-7; RIES LAG, 1997, NIH PUBLICATION; RIFF ER, 1990, CLEV CLIN J MED, V57, P131, DOI 10.3949/ccjm.57.2.131; SEARE S, 1997, DRG GUIDE; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; SELBY JV, 1993, ANN INTERN MED, V118, P1, DOI 10.7326/0003-4819-118-1-199301010-00001; SHINYA H, 1979, ANN SURG, V190, P679, DOI 10.1097/00000658-197912000-00001; SINGARAM C, 1995, AM J GASTROENTEROL, V90, P146; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Torrance GW, 1996, COST EFFECTIVENESS H, P276; Towler B, 1998, BRIT MED J, V317, P559, DOI 10.1136/bmj.317.7158.559; *US DHHS, 1997, DHHS PUBL; VANGOSSUM A, 1992, GASTROINTEST ENDOSC, V38, P472, DOI 10.1016/S0016-5107(92)70479-9; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; VUKASIN AP, 1990, CANCER, V66, P2442, DOI 10.1002/1097-0142(19901201)66:11<2442::AID-CNCR2820661134>3.0.CO;2-5; WAGNER JL, 1991, ANN INTERN MED, V115, P807, DOI 10.7326/0003-4819-115-10-807; Wallace MB, 1998, ANN INTERN MED, V129, P273, DOI 10.7326/0003-4819-129-4-199808150-00002; WANGNER JL, 1996, PREVENTION EARLY DET, P321; Waye J D, 1996, Gastrointest Endosc Clin N Am, V6, P343; WAYE JD, 1992, J CLIN GASTROENTEROL, V15, P347, DOI 10.1097/00004836-199212000-00018; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; 1997, FED REG, V211	52	373	382	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					573	584		10.7326/0003-4819-133-8-200010170-00007	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00007			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033584				2022-12-28	WOS:000089906300001
J	Weiler, JM; Woodworth, G; Watson, G				Weiler, JM; Woodworth, G; Watson, G			Drug effects on driving performance - Response	ANNALS OF INTERNAL MEDICINE			English	Letter									Univ Iowa, Iowa City, IA 52242 USA	University of Iowa	Weiler, JM (corresponding author), Univ Iowa, Iowa City, IA 52242 USA.							BROOKHUIS K, 1994, ERGONOMICS, V37, P427, DOI 10.1080/00140139408963661; FRIEDEL B, 1991, USDOTHS807668 NAT HI; Hindmarch I, 1999, CLIN EXP ALLERGY, V29, P133, DOI 10.1046/j.1365-2222.1999.0290s3133.x; MOSKOWITZ H, 1974, ALCOHOL DRUGS TRAFFI, P295; 2000, BETTERS HOMES GA MAY, P57	5	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					657	658		10.7326/0003-4819-133-8-200010170-00024	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00024			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033602				2022-12-28	WOS:000089906300014
J	Ries, S; Biederer, C; Woods, D; Shifman, O; Shirasawa, S; Sasazuki, T; McMahon, M; Oren, M; McCormick, F				Ries, S; Biederer, C; Woods, D; Shifman, O; Shirasawa, S; Sasazuki, T; McMahon, M; Oren, M; McCormick, F			Opposing effects of Ras on p53: Transcriptional activation of mdm2 and induction of p19(ARF)	CELL			English	Article							AUTOREGULATORY FEEDBACK LOOP; TUMOR-SUPPRESSOR GENE; CANCER CELL-LINES; RETINOBLASTOMA PROTEIN; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; ONCOPROTEIN MDM2; MAMMALIAN-CELLS; NIH-3T3 CELLS; WILD-TYPE	Mdm2 acts as a major regulator of the tumor suppressor p53 by targeting its destruction. Here, we show that the mdm2 gene is also regulated by the Has-driven Raf/MEK/MAP kinase pathway, in a p53-independent manner. Mdma induced by activated Raf degrades p53 in the absence of the Mdm2 inhibitor p19(ARF). This regulatory pathway accounts for the observation that cells transformed by oncogenic Ras are more resistant to p53-dependent apoptosis following exposure to DNA damage. Activation of the Ras-induced Raf/MEK/MAP kinase may therefore play a key role in suppressing p53 during tumor development and treatment. In primary cells, Raf also activates the Mdm2 inhibitor p19(ARF). Levels of p53 are therefore determined by opposing effects of Raf-induced p19(ARF) and Mdm2.	Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94115 USA; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Kyushu Univ, Fukuoka 812, Japan	University of California System; University of California San Francisco; Weizmann Institute of Science; Kyushu University	McCormick, F (corresponding author), Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94115 USA.		McMahon, Martin/L-3303-2013	McMahon, Martin/0000-0003-2812-1042; Oren, Moshe/0000-0003-4311-7172				ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Biederer CH, 2000, J BIOL CHEM, V275, P26245, DOI 10.1074/jbc.M001430200; BOS JL, 1989, CANCER RES, V49, P4682; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cook SJ, 1999, MOL CELL BIOL, V19, P330; CORDONCARDO C, 1994, CANCER RES, V54, P794; CORDONCARDO C, 1995, AM J PATHOL, V147, P545; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Esteller M, 2000, CANCER RES, V60, P129; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; FITZGERALD TJ, 1985, AM J CLIN ONCOL-CANC, V8, P517, DOI 10.1097/00000421-198512000-00012; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Haber DA, 1997, CELL, V91, P555, DOI 10.1016/S0092-8674(00)80441-9; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heimbrook DC, 1998, CURR OPIN CELL BIOL, V10, P284, DOI 10.1016/S0955-0674(98)80152-X; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; JUVEN T, 1993, ONCOGENE, V8, P3411; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lane DP, 1997, TRENDS BIOCHEM SCI, V22, P372, DOI 10.1016/S0968-0004(97)01119-5; Lebowitz PF, 1997, CANCER RES, V57, P708; LENG P, 1995, ONCOGENE, V10, P1275; Leri A, 1999, AM J PATHOL, V154, P567, DOI 10.1016/S0002-9440(10)65302-3; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; LUNA RMD, 1995, NATURE, V378, P203; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; MITSUDOMI T, 1992, ONCOGENE, V7, P171; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; MOSER M, 1995, DEVELOPMENT, V121, P2779; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; PICKSLEY SM, 1993, BIOESSAYS, V15, P689, DOI 10.1002/bies.950151008; PIROLLO KF, 1993, RADIAT RES, V135, P234, DOI 10.2307/3578300; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; RIES SJ, 2000, IN PRESS NAT MED; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SHARMA S, 1993, CELL GROWTH DIFFER, V4, P861; Shaulian E, 1997, ONCOGENE, V15, P2717, DOI 10.1038/sj.onc.1201453; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; SKLAR MD, 1988, SCIENCE, V239, P645, DOI 10.1126/science.3277276; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	69	325	336	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 13	2000	103	2					321	330		10.1016/S0092-8674(00)00123-9	http://dx.doi.org/10.1016/S0092-8674(00)00123-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057904	Bronze			2022-12-28	WOS:000089864300015
J	Jeong, H; Tombor, B; Albert, R; Oltvai, ZN; Barabasi, AL				Jeong, H; Tombor, B; Albert, R; Oltvai, ZN; Barabasi, AL			The large-scale organization of metabolic networks	NATURE			English	Article							SMALL-WORLD NETWORKS	In a cell or microorganism, the processes that generate mass, energy, information transfer and cell-fate specification are seamlessly integrated through a complex network of cellular constituents and reactions(1). However, despite the key role of these networks in sustaining cellular functions, their large-scale structure is essentially unknown. Here we present a systematic comparative mathematical analysis of the metabolic networks of 43 organisms representing all three domains of life. We show that, despite significant variation in their individual constituents and pathways, these metabolic networks have the same topological scaling properties and show striking similarities to the inherent organization of complex non-biological systems(2). This may indicate that metabolic organization is not only identical for all living organisms, but also complies with the design principles of robust and error-tolerant scale-free networks(2-5), and may represent a common blueprint for the large-scale organization of interactions among all cellular constituents.	Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA	University of Notre Dame; Northwestern University	Oltvai, ZN (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	zno008@northwestern.edu; alb@nd.edu	Jeong, Hawoong/A-2469-2009; Albert, Reka/E-2195-2011; Jeong, Hawoong/AAR-2524-2021; Barabasi, Albert-Laszlo/S-6474-2017; Jeong, Hawoong/C-1587-2011	Jeong, Hawoong/0000-0002-2491-8620; Albert, Reka/0000-0002-9485-0828; Jeong, Hawoong/0000-0002-2491-8620; Barabasi, Albert/0000-0002-4028-3522				Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; AMARAL LAN, 2000, CLASSES BEHAV SMALL; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barthelemy M, 1999, PHYS REV LETT, V82, P3180, DOI 10.1103/PhysRevLett.82.3180; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bollobas B., 1985, RANDOM GRAPHS; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; DOROGOVTSEV SN, 2000, EVOLUTION REFERENCE; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; ERDOS P, 1960, B INT STATIST INST, V38, P343; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; INGBER DE, 1993, J CELL SCI, V104, P613; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp PP, 1999, TRENDS BIOTECHNOL, V17, P275, DOI 10.1016/S0167-7799(99)01316-5; KISCHNER M, 2000, CELL, V100, P79; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	28	3385	3556	9	457	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 5	2000	407	6804					651	654		10.1038/35036627	http://dx.doi.org/10.1038/35036627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034217	Green Submitted			2022-12-28	WOS:000089772800053
J	Campisi, J				Campisi, J			Aging, chromatin, and food restriction - Connecting the dots	SCIENCE			English	Article									Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Campisi, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.							Campisi J, 2000, IN VIVO, V14, P183; Han ES, 2000, MECH AGEING DEV, V115, P157, DOI 10.1016/S0047-6374(00)00119-6; Hodes RJ, 1999, J EXP MED, V190, P153, DOI 10.1084/jem.190.2.153; Jazwinski SM, 1996, SCIENCE, V273, P54, DOI 10.1126/science.273.5271.54; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Surralles J, 1999, AM J HUM GENET, V65, P1617, DOI 10.1086/302665; YU EE, 1996, SCIENCE, V272, P258	10	30	38	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2062	2063		10.1126/science.289.5487.2062	http://dx.doi.org/10.1126/science.289.5487.2062			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11032557				2022-12-28	WOS:000089430900029
J	Changnon, SA; Easterling, DR				Changnon, SA; Easterling, DR			Disaster management - US policies pertaining to weather and climate extremes	SCIENCE			English	Article							UNITED-STATES; IMPACTS		NOAA, Natl Climat Data Ctr, Asheville, NC 28801 USA; Univ Illinois, Dept Geog, Champaign, IL 61820 USA	National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Illinois System; University of Illinois Urbana-Champaign	Easterling, DR (corresponding author), NOAA, Natl Climat Data Ctr, Asheville, NC 28801 USA.	deasterl@ncdc.noaa.gov						BURBY RJ, 1998, CONFRONTING NATURAL; CHANGNON S, 1999, NAT HAZARDS, V8, P290; CHANGNON S, 2000, FLOODS; CHANGNON S, 1980, 94 ILL STAT WAT; Changnon SA, 1999, CLIMATIC CHANGE, V42, P51, DOI 10.1023/A:1005408131413; Changnon SA, 1998, WATER INT, V23, P263, DOI 10.1080/02508069808686781; Changnon SA, 1999, B AM METEOROL SOC, V80, P1819, DOI 10.1175/1520-0477(1999)080<1819:IOENOG>2.0.CO;2; Changnon SA., 2000, PREDICTION SCI DECIS; HOOKE W, 2000, NAT HAZARDS REV, P1; Hooke W.H., 2000, NAT HAZARDS REV, V1, P2, DOI 10.1061/(ASCE)1527-6988(2000)1:1(2); Kunkel KE, 1999, B AM METEOROL SOC, V80, P1077, DOI 10.1175/1520-0477(1999)080<1077:TFIWAC>2.0.CO;2; KUNREUTHER H, 1999, PAYING PRICE, P1; LAMBRIGHT WH, 1989, SCI TECHNOL HUM VAL, V14, P340, DOI 10.1177/016224398901400402; PIELKE RA, 1995, HURRICANE ANDREW S F; Riebsame W.E., 1991, DROUGHT NATURAL RESO; ROTH RJ, 1996, IMPACTS RESPONSES WE, P101; RYLAND H, 1998, STEPPING SAFER FUTUR; Ryland H. G., 2000, NAT HAZARDS REV, V1, P43; SYLVES R, 1998, DISASTERS COASTAL ZO; White G, 1958, 57 U CHIC DEP GEOGR; Wright J. M., 1996, GREAT FLOOD 1993 CAU, P245	21	17	18	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2000	289	5487					2053	2055		10.1126/science.289.5487.2053	http://dx.doi.org/10.1126/science.289.5487.2053			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11032554				2022-12-28	WOS:000089430900024
J	Strazisar, BR; Lin, C; Davis, HF				Strazisar, BR; Lin, C; Davis, HF			Mode-specific energy disposal in the four-atom reaction OH+D-2 -> HOD+D	SCIENCE			English	Article							DYNAMICS; PHOTODISSOCIATION; DISTRIBUTIONS; H+D-2->HD+D; CHEMISTRY; EXAMPLE; OH+H-2; BEAM	Experiments, employing crossed molecular beams, with vibrational state resolution have been performed on the simplest four-atom reaction, OH + D-2 --> HOD + D. In good agreement with the most recent quantum scattering predictions, mode-specific reaction dynamics is observed, with vibration in the newly formed oxygen-deuterium bond preferentially excited to v = 2. This demonstrates that quantum theoretical calculations, which in the past decade have achieved remarkable accuracy for three-atom reactions involving three dimensions, have progressed to the point where it is now possible to accurately predict energy disposal in four-atom reactions involving six dimensions.	Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14850 USA	Cornell University	Davis, HF (corresponding author), Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14850 USA.							Alagia M, 1996, CHEM PHYS, V207, P389, DOI 10.1016/0301-0104(95)00422-X; Alagia M, 1998, J CHEM PHYS, V108, P6698, DOI 10.1063/1.476085; Alagia M, 1996, SCIENCE, V273, P1519, DOI 10.1126/science.273.5281.1519; BRONIKOWSKI MJ, 1993, J PHYS CHEM-US, V97, P2204, DOI 10.1021/j100112a022; BRONIKOWSKI MJ, 1993, J PHYS CHEM-US, V97, P2194, DOI 10.1021/j100112a021; Casavecchia P, 2000, REP PROG PHYS, V63, P355, DOI 10.1088/0034-4885/63/3/203; de Aspuru GO, 1998, J PHYS CHEM A, V102, P9631, DOI 10.1021/jp982433i; DUNNING TH, 1990, ADV MOL ELECT STRUCT, V1; KUDLA K, 1995, CHEM DYNAMICS KINETI; Leu GH, 1996, CHEM PHYS LETT, V257, P481, DOI 10.1016/0009-2614(96)00567-2; LEVINE RD, 1987, MOL REACTION DYNAMIC; Liu XH, 2000, SCIENCE, V289, P1536, DOI 10.1126/science.289.5484.1536; MILLAR TJ, 1988, RATE COEFFICIENTS AT; NEUMARK DM, 1985, J CHEM PHYS, V82, P3045, DOI 10.1063/1.448254; Pogrebnya SK, 2000, PHYS CHEM CHEM PHYS, V2, P693, DOI 10.1039/a908080e; RINNEN KD, 1991, J CHEM PHYS, V95, P214, DOI 10.1063/1.461478; Schatz GC, 1996, J PHYS CHEM-US, V100, P12839, DOI 10.1021/jp953344y; SCHATZ GC, 1980, CHEM PHYS LETT, V73, P21, DOI 10.1016/0009-2614(80)85193-1; Schnieder L, 1997, J CHEM PHYS, V107, P6175, DOI 10.1063/1.474283; SCHNIEDER L, 1995, SCIENCE, V269, P207, DOI 10.1126/science.269.5221.207; SCHNIEDER L, 1990, J CHEM PHYS, V92, P7027, DOI 10.1063/1.458243; SINHA A, 1991, J CHEM PHYS, V94, P4928, DOI 10.1063/1.460578; WALCH SP, 1980, J CHEM PHYS, V72, P1303, DOI 10.1063/1.439193; WAMATZ J, 1984, COMBUSTION CHEM, pCH5	25	116	117	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2000	290	5493					958	961		10.1126/science.290.5493.958	http://dx.doi.org/10.1126/science.290.5493.958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062122				2022-12-28	WOS:000165103200041
J	Bergh, J; Wiklund, T; Erikstein, B; Lidbrink, E; Lindman, H; Malmstrom, P; Kellokumpu-Lehtinen, P; Bengtsson, NO; Soderlund, G; Anker, G; Wist, E; Ottosson, S; Salminen, E; Ljungman, P; Holte, H; Nilsson, J; Blomqvist, C; Wilking, N				Bergh, J; Wiklund, T; Erikstein, B; Lidbrink, E; Lindman, H; Malmstrom, P; Kellokumpu-Lehtinen, P; Bengtsson, NO; Soderlund, G; Anker, G; Wist, E; Ottosson, S; Salminen, E; Ljungman, P; Holte, H; Nilsson, J; Blomqvist, C; Wilking, N		Scandinavian Breast Grp 9401 Study	Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial	LANCET			English	Article							ANTICANCER DRUGS; CELL SUPPORT; TOXICITY; LEUKEMIA; THERAPY; CMF; PHARMACOKINETICS; METHOTREXATE; EFFICACY; REGIMEN	Background Chemotherapy drug distribution varies greatly among individual patients. Therefore, we developed an individualised fluorouracil. epirubicin, cyclophosphamide (FEC) regimen to improve outcomes in patients with high-risk early breast cancer. We then did a randomised trial to compare this individually tailored FEC regimen with conventional adjuvant chemotherapy followed by consolidation with high-dose chemotherapy with stem-cell support. Methods 525 women younger than 60 years of age with highrisk primary breast cancer were randomised after surgery to receive nine cycles of tailored FEC to haematological equitoxicity with granulocyte colony-stimulating factor (G-CSF) support (n=251), or three cycles of FEC at standard doses followed by high-dose chemotherapy with cyctophosphamide, thiotepa, and carboplatin (CTCb), and peripheral-blood stem-cell or bone-marrow support (n=274). Both groups received locoregional radiation therapy and tamoxifen for 5 years. The primary outcome measure was relapse-free survival, and analysis was by intention to treat. Findings At a median follow-up of 34.3 months, there were 81 breast-cancer relapses in the tailored FEC group versus 113 in the CTCb group (double triangular method p=0.04). 60 deaths occurred in the tailored FEC group and 82 in the CTCb group (log-rank p=0.12). Patients in the CTCb group experienced more grade 3 or 4 acute toxicity compared with the tailored FEC group (p<0.0001). Two treatment-related deaths (0.7%) occurred in the CTCb group. Six patients in the tailored FEC group developed acute myeloid leukaemia and three developed myelodysplastic syndrome. Interpretation Tailored FEC with G-CSF support resulted in a significantly improved relapse-free survival and fewer grade 3 and 4 toxicities compared with marrow-supported high-dose chemotherapy with CTCb as adjuvant therapy of women with high-risk primary breast cancer.	Karolinska Hosp, Radiumhemmet, S-10401 Stockholm, Sweden; Univ Helsinki Hosp, Helsinki, Finland; Norwegian Radium Hosp, Oslo, Norway; Soder Sjukhuset, S-10064 Stockholm, Sweden; Univ Uppsala, Akad Sjukhuset, Dept Oncol, Uppsala, Sweden; Univ Hosp, Lund, Sweden; Tampere Univ Hosp, Tampere, Finland; Univ Hosp, Umea, Sweden; Univ Hosp, Linkoping, Sweden; Haukeland Univ Hosp, N-5021 Bergen, Norway; Ulluval Univ Hosp, Gothenburg, Sweden; Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden; Turku Univ Hosp, FIN-20520 Turku, Finland; Huddinge Univ Hosp, Uppsala, Sweden; Reg Oncol Ctr, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oslo; Sodersjukhuset Hospital; Uppsala University; Uppsala University Hospital; Lund University; Skane University Hospital; Tampere University; Tampere University Hospital; Umea University; University of Bergen; Haukeland University Hospital; Sahlgrenska University Hospital; University of Turku; Karolinska Institutet	Bergh, J (corresponding author), Karolinska Hosp & Inst, Radiumhemmet, Dept Oncol, S-17176 Stockholm, Sweden.		Holte, Harald/AAO-5647-2020; Ljungman, Per/M-4946-2019	Blomqvist, Carl/0000-0003-3041-1938; Wiklund, Tom/0000-0002-9384-9614; Bergh, Jonas/0000-0001-5526-1847				AJANI JA, 1990, CANCER INVEST, V8, P147, DOI 10.3109/07357909009017560; [Anonymous], 1992, DESIGN ANAL SEQUENTI; ANTMAN K, 1988, ANN INTERN MED, V108, P570, DOI 10.7326/0003-4819-108-4-570; Antman KH, 1997, J CLIN ONCOL, V15, P1870, DOI 10.1200/JCO.1997.15.5.1870; Bastholt L, 1996, J CLIN ONCOL, V14, P1146, DOI 10.1200/JCO.1996.14.4.1146; Bergh J, 1998, RECENT RES CANCER, V152, P328; Bergh J, 2000, LANCET, V355, P944, DOI 10.1016/S0140-6736(00)90007-2; BONNETERRE J, 1998, P 34 ANN M AM SOC CL; Colleoni M, 1998, EUR J CANCER, V34, P1693, DOI 10.1016/S0959-8049(98)00209-3; DECILLIS A, 1997, P 33 ANN M AM SOC CL; Diamandidou E, 1996, J CLIN ONCOL, V14, P2722, DOI 10.1200/JCO.1996.14.10.2722; EVANS WE, 1989, CLIN PHARMACOKINET, V16, P327, DOI 10.2165/00003088-198916060-00001; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; Fisher B, 1997, J CLIN ONCOL, V15, P1858, DOI 10.1200/JCO.1997.15.5.1858; Fossati R, 1998, J CLIN ONCOL, V16, P3439, DOI 10.1200/JCO.1998.16.10.3439; Gurney H, 1996, J CLIN ONCOL, V14, P2590, DOI 10.1200/JCO.1996.14.9.2590; Gurney HP, 1998, J CLIN ONCOL, V16, P2299, DOI 10.1200/JCO.1998.16.7.2299; HENDERSON I, 1998, P 34 ANN M AM SOC CL; Hortobagyi GN, 2000, JNCI-J NATL CANCER I, V92, P225, DOI 10.1093/jnci/92.3.225; Levine MN, 1998, J CLIN ONCOL, V16, P2651, DOI 10.1200/JCO.1998.16.8.2651; Lindman H, 1999, ACTA ONCOL, V38, P239; PedersenBjergaard J, 1995, ANN ONCOL, V6, P751, DOI 10.1093/oxfordjournals.annonc.a059310; PETERS W, 1999, P 35 ANN M AM SOC CL; PETERS WP, 1988, J CLIN ONCOL, V6, P1368, DOI 10.1200/JCO.1988.6.9.1368; PETERS WP, 1993, J CLIN ONCOL, V11, P1132, DOI 10.1200/JCO.1993.11.6.1132; Poikonen P, 1999, BRIT J CANCER, V80, P1763, DOI 10.1038/sj.bjc.6690594; Rodenhuis S, 1998, LANCET, V352, P515, DOI 10.1016/S0140-6736(98)01350-6; RODENHUIS S, 2000, P 36 ANN M AM SOC CL; ROSTI G, 1997, SOLID TUMOURS WORKIN, P41; Saarto T, 1997, BRIT J CANCER, V75, P301, DOI 10.1038/bjc.1997.49; Sandstrom M, 1996, J CLIN ONCOL, V14, P1581, DOI 10.1200/JCO.1996.14.5.1581; Stadtmauer EA, 2000, NEW ENGL J MED, V342, P1069, DOI 10.1056/NEJM200004133421501; TRAVIS L, 1999, P 35 ANN M AM SOC CL; VALAGUSSA P, 1994, ANN ONCOL, V5, P803, DOI 10.1093/oxfordjournals.annonc.a059008; van Os R, 1998, BLOOD, V92, P1950, DOI 10.1182/blood.V92.6.1950.418k21_1950_1956	35	209	212	1	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1384	1391		10.1016/S0140-6736(00)02841-5	http://dx.doi.org/10.1016/S0140-6736(00)02841-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052580				2022-12-28	WOS:000089976100011
J	Pelton, S				Pelton, S			Prevention of acute and recurrent otitis media	LANCET			English	Editorial Material							XYLITOL		Boston Univ, Med Ctr, Div Pediat Infect Dis, Boston, MA 02118 USA	Boston University	Pelton, S (corresponding author), Boston Univ, Med Ctr, Div Pediat Infect Dis, Boston, MA 02118 USA.			Pelton, Stephen/0000-0003-4862-5344				ASMUSSEN L, 1999, AMBULATORY CHILD HLT, V5, P303; ESKOLA J, 1999, 39 INT C ANT AG CHEM; IdanpaanHeikkila I, 1997, J INFECT DIS, V176, P704; Kontiokari T, 1998, J ANTIMICROB CHEMOTH, V41, P563, DOI 10.1093/jac/41.5.563; Smith BL, 2000, J INFECT DIS, V182, P497, DOI 10.1086/315722; StGeme JW, 1997, PEDIATR INFECT DIS J, V16, P931, DOI 10.1097/00006454-199710000-00005; Tong HH, 1999, MICROB PATHOGENESIS, V26, P111, DOI 10.1006/mpat.1998.0257; Uhari M, 1996, BRIT MED J, V313, P1180, DOI 10.1136/bmj.313.7066.1180	8	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1370	1371		10.1016/S0140-6736(00)02835-X	http://dx.doi.org/10.1016/S0140-6736(00)02835-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052574				2022-12-28	WOS:000089976100004
J	Sharp, D				Sharp, D			Shuffles	LANCET			English	Editorial Material									The Lancet, London WC1X 8RR, England		Sharp, D (corresponding author), The Lancet, London WC1X 8RR, England.							ALDER P, 1997, BRIDGE PLAYERS BEDSI, P104; FORRESTER T, 2000, DAILY TELEGRAPH 1011, P46; Trefethen LN, 2000, P ROY SOC A-MATH PHY, V456, P2561, DOI 10.1098/rspa.2000.0625	3	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1374	1374		10.1016/S0140-6736(00)02838-5	http://dx.doi.org/10.1016/S0140-6736(00)02838-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052578				2022-12-28	WOS:000089976100008
J	Standen, N				Standen, N			Cardiovascular biology - Tuning channels for blood pressure	NATURE			English	Article									Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Standen, N (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, POB 138, Leicester LE1 9HN, Leics, England.							Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Jiang Z, 1999, GENOMICS, V55, P57, DOI 10.1006/geno.1998.5627; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nelson MT, 1990, AM J PHYSIOL, V259, P3; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075	7	4	4	1	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					845	848		10.1038/35038185	http://dx.doi.org/10.1038/35038185			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057648				2022-12-28	WOS:000089901900030
J	Wei, P; Zhang, J; Egan-Hafley, M; Liang, SG; Moore, DD				Wei, P; Zhang, J; Egan-Hafley, M; Liang, SG; Moore, DD			The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism	NATURE			English	Article							GENE; 1,4-BIS<2-(3,5-DICHLOROPYRIDYLOXY)>BENZENE; HEPATOTOXICITY; CARCINOGENS; EXPRESSION; LIVER; PXR	Organisms encounter a wide range of foreign compounds-or 'xenobiotics'-with potentially harmful consequences. The cytochrome P450 (CYP) enzymes metabolize xenobiotics and thus are a primary defence against these compounds. Increased expression of specific CYP genes in response to particular xenobiotics is a central component of this defence(1), although such induction can also increase production of toxic metabolites. Here we show that the nuclear receptor CAR mediates the response evoked by a class of xenobiotics known as the 'phenobarbital-like inducers'. The strong activation of Cyp2b10 gene expression by phenobarbital, or by the more potent TCPOBOP, is absent in mice lacking the CAR gene. These animals also show decreased metabolism of the classic CYP substrate zoxazolamine and a complete loss of the liver hypertrophic and hyperplastic responses to these inducers. Cocaine causes acute hepatotoxicity in wild-type mice previously exposed to phenobarbital-like inducers and this toxicity is also absent in the CAR-deficient animals. Thus, loss of CAR function alters sensitivity to toxins, increasing or decreasing it depending on the compound. Modulation of CAR activity in humans may significantly affect metabolism of drugs and other xenobiotics.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.							BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Bornheim LM, 1998, TOXICOL APPL PHARM, V150, P158, DOI 10.1006/taap.1998.8403; Carthew P, 1998, TOXICOL SCI, V44, P46, DOI 10.1093/toxsci/44.1.46; Choi HS, 1997, J BIOL CHEM, V272, P23565, DOI 10.1074/jbc.272.38.23565; Code EL, 1997, DRUG METAB DISPOS, V25, P985; Cunningham ML, 1996, MUTAT RES-REV GENET, V365, P59, DOI 10.1016/S0165-1110(96)90012-3; HEUBEL F, 1989, BIOCHEM PHARMACOL, V38, P1293, DOI 10.1016/0006-2952(89)90336-5; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Liang HCL, 1996, P NATL ACAD SCI USA, V93, P1671, DOI 10.1073/pnas.93.4.1671; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; POLAND A, 1980, MOL PHARMACOL, V18, P571; ROBINSON JR, 1974, MOL PHARMACOL, V10, P484; Selim K, 1999, HEPATOLOGY, V29, P1347, DOI 10.1002/hep.510290535; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116	22	551	576	3	41	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					920	923		10.1038/35038112	http://dx.doi.org/10.1038/35038112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057673				2022-12-28	WOS:000089901900056
J	Obmolova, G; Ban, C; Hsieh, P; Yang, W				Obmolova, G; Ban, C; Hsieh, P; Yang, W			Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA	NATURE			English	Article							ESCHERICHIA-COLI; REPLICATION FIDELITY; MUTATOR PHENOTYPES; THERMUS-AQUATICUS; ATP-BINDING; RECOGNITION; MUTATIONS; RECOMBINATION; HYDROLYSIS; SUBUNIT	DNA mismatch repair is critical for increasing replication fidelity in organisms ranging from bacteria to humans. MutS protein, a member of the ABC ATPase superfamily, recognizes mispaired and unpaired bases in duplex DNA and initiates mismatch repair. Mutations in human MutS genes cause a predisposition to hereditary nonpolyposis colorectal cancer as well as sporadic tumours. Here we report the crystal structures of a MutS protein and a complex of MutS with a heteroduplex DNA containing an unpaired base. The structures reveal the general architecture of members of the MutS family, an induced-fit mechanism of recognition between four domains of a MutS dimer and a heteroduplex kinked at the mismatch, a composite ATPase active site composed of residues from both MutS subunits, and a transmitter region connecting the mismatch-binding and ATPase domains. The crystal structures also provide a molecular framework for understanding hereditary nonpolyposis colorectal cancer mutations and for postulating testable roles of MutS.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NIDDKD, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	Wei.Yang@nih.gov	Ban, Changill/F-5426-2013; Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036119, Z01DK036119] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAJSKI SR, 2000, MUTAT RES, V447, P49; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Ban C, 1998, EMBO J, V17, P1526, DOI 10.1093/emboj/17.5.1526; Berger JM, 1996, CURR OPIN STRUC BIOL, V6, P84, DOI 10.1016/S0959-440X(96)80099-6; Biswas I, 1999, J BIOL CHEM, V274, P23673, DOI 10.1074/jbc.274.33.23673; Biswas I, 1996, J BIOL CHEM, V271, P5040; Bjornson KP, 2000, BIOCHEMISTRY-US, V39, P3176, DOI 10.1021/bi992286u; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; Dickerson RE, 1998, NUCLEIC ACIDS RES, V26, P1906, DOI 10.1093/nar/26.8.1906; Drotschmann K, 1999, P NATL ACAD SCI USA, V96, P2970, DOI 10.1073/pnas.96.6.2970; Drotschmann K, 1999, CURR BIOL, V9, P907, DOI 10.1016/S0960-9822(99)80396-0; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; GORBALENYA AE, 1990, J MOL BIOL, V213, P583, DOI 10.1016/S0022-2836(05)80243-8; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Jiricny J, 1998, MUTAT RES-DNA REPAIR, V409, P107, DOI 10.1016/S0921-8777(98)00056-1; JONES M, 1987, GENETICS, V115, P605; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Malkov VA, 1997, J BIOL CHEM, V272, P23811, DOI 10.1074/jbc.272.38.23811; Matic I, 1996, TRENDS MICROBIOL, V4, P69, DOI 10.1016/0966-842X(96)81514-9; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nakagawa T, 1999, P NATL ACAD SCI USA, V96, P14186, DOI 10.1073/pnas.96.25.14186; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Studamire B, 1999, MOL CELL BIOL, V19, P7558; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; TERWILLIGER TC, 1997, SOLVE AUTOMATED STRU; Umar A, 1996, EUR J BIOCHEM, V238, P297, DOI 10.1111/j.1432-1033.1996.0297z.x; WU TH, 1994, J BACTERIOL, V176, P5393, DOI 10.1128/JB.176.17.5393-5400.1994; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3; Zalevsky J, 1999, GENETICS, V153, P1271	47	521	528	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					703	710		10.1038/35037509	http://dx.doi.org/10.1038/35037509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048710				2022-12-28	WOS:000089773900032
J	Taskinen, M; Saarinen-Pihkala, UM; Hovi, L; Lipsanen-Nyman, M				Taskinen, M; Saarinen-Pihkala, UM; Hovi, L; Lipsanen-Nyman, M			Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood	LANCET			English	Article							CORONARY HEART-DISEASE; LONG-TERM SURVIVORS; INSULIN-RESISTANCE; RISK-FACTORS; CHILDREN; GROWTH; ADOLESCENTS; LEUKEMIA	Background This follow-up study aimed to assess the frequency of late effects on glucose and lipid metabolism after bone-marrow transplantation in childhood. Methods 23 long-term survivors (median age 20 years) were studied 3-18 years after bone-marrow transplantation and compared with 23 healthy controls matched for age and sex and with 13 patients in remission from leukaemia. Findings 12 (52%) of the 23 bone-marrow transplantation patients had insulin resistance, including impaired glucose tolerance in six and type 2 diabetes in four. The core signs of the metabolic syndrome (hyperinsulinaemia and hypertriglyceridaemia combined), were found in nine (39%) of the bone-marrow transplantation patients compared with one (8%) of the 13 leukaemia patients and none of the healthy controls (p=0.0015). The frequency of insulin resistance increased with the time since bone-marrow transplantation. Abdominal obesity, but not overweight, was common among the patients with insulin resistance. Interpretation Long-term survivors of bone-marrow transplantation are at substantial risk of insulin resistance, impaired glucose tolerance, and type 2 diabetes even at normal weight and young age. They also develop typical signs of the metabolic syndrome. We advocate measurement of serum lipids, fasting blood glucose, and serum insulin for the follow-up of all patients who undergo transplants in childhood, to be continued regularly and possibly lifelong.	Univ Helsinki, Hosp Children & Adolescents, FIN-00290 Helsinki, Finland; Univ Kuopio, Childrens Hosp, FIN-70211 Kuopio, Finland	University of Helsinki; University of Eastern Finland	Taskinen, M (corresponding author), Univ Helsinki, Hosp Children & Adolescents, Stenbackinkatu 11, FIN-00290 Helsinki, Finland.							Akasheh M, 1999, BONE MARROW TRANSPL, V23, P199, DOI 10.1038/sj.bmt.1701544; *AM DIAB ASS, 1996, DIABETES CARE S1, V19, pS4; Cutfield WS, 2000, LANCET, V355, P610, DOI 10.1016/S0140-6736(99)04055-6; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fruhbeck G, 1998, CLIN PHYSIOL, V18, P399, DOI 10.1046/j.1365-2281.1998.00129.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138; HOVI L, 1990, BONE MARROW TRANSPL, V5, P183; Kahn R, 1998, DIABETES CARE, V21, P310; KOSKELO EK, 1991, ACTA PAEDIATR SCAND, V80, P682, DOI 10.1111/j.1651-2227.1991.tb11929.x; KUUSISTO J, 1995, CIRCULATION, V91, P831, DOI 10.1161/01.CIR.91.3.831; LAWS A, 1993, BAILLIERE CLIN ENDOC, V7, P1063, DOI 10.1016/S0950-351X(05)80245-9; LEIPER AD, 1987, BRIT J HAEMATOL, V67, P419, DOI 10.1111/j.1365-2141.1987.tb06163.x; LORINI R, 1995, BONE MARROW TRANSPL, V15, P873; Prentice AM, 1998, BRIT MED J, V317, P1401, DOI 10.1136/bmj.317.7170.1401; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; RONNEMAA T, 1991, ANN MED, V23, P67, DOI 10.3109/07853899109147933; SANDERS JE, 1986, BLOOD, V68, P1129; SKLAR CA, 1982, AM J MED, V73, P688, DOI 10.1016/0002-9343(82)90411-9; SMEDMYR B, 1990, BONE MARROW TRANSPL, V6, P89; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103; Talvensaari KK, 1996, J CLIN ENDOCR METAB, V81, P3051, DOI 10.1210/jc.81.8.3051; Tritos NA, 1998, J CLIN ENDOCR METAB, V83, P3025, DOI 10.1210/jc.83.9.3025; Vanhala MJ, 1998, INT J OBESITY, V22, P369, DOI 10.1038/sj.ijo.0800597	24	208	212	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					993	997		10.1016/S0140-6736(00)02717-3	http://dx.doi.org/10.1016/S0140-6736(00)02717-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041401				2022-12-28	WOS:000089293600014
J	MITRANI, E; SHIMONI, Y				MITRANI, E; SHIMONI, Y			INDUCTION BY SOLUBLE FACTORS OF ORGANIZED AXIAL STRUCTURES IN CHICK EPIBLASTS	SCIENCE			English	Article											MITRANI, E (corresponding author), HEBREW UNIV JERUSALEM,INST LIFE SCI,DEPT ZOOL,IL-91904 JERUSALEM,ISRAEL.							ALTABA AR, 1989, NATURE, V341, P33; AZAR Y, 1979, J EMBRYOL EXP MORPH, V52, P79; AZAR Y, 1981, J EMBRYOL EXP MORPH, V61, P133; COOKE J, 1987, DEVELOPMENT, V101, P893; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; EYALGILADI H, 1984, CELL DIFFER DEV, V14, P245, DOI 10.1016/0045-6039(84)90013-7; GODSAVE SF, 1988, DEVELOPMENT, V102, P555; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; MITRANI E, 1989, DEVELOPMENT, V107, P275; MITRANI E, 1981, NATURE, V289, P800, DOI 10.1038/289800a0; MITRANI E, IN PRESS DEVELOPMENT; MITRANI E, 1982, DIFFERENTIATION, V21, P51; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P326; NICOLET G, 1970, Journal of Embryology and Experimental Morphology, V23, P79; PUTNEY M, 1973, EXPERIENTIA, V29, P466; ROSA F, 1988, SCIENCE, V239, P783, DOI 10.1126/science.3422517; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SMITH JC, 1988, DEVELOPMENT, V103, P591; SMITH JC, 1987, DEVELOPMENT, V99, P3; SMITH JC, 1989, DEVELOPMENT, V105, P665; VAKAET L, 1962, J EMBRYOL EXP MORPH, V10, P38; WADDINGTON CH, 1932, PHILOS T R SOC LON B, V211, P179; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7	23	59	63	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 2	1990	247	4946					1092	1094		10.1126/science.11032544	http://dx.doi.org/10.1126/science.11032544			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ973	11032544				2022-12-28	WOS:A1990CQ97300046
J	Welsh, J; Ulltveit-Moe, T				Welsh, J; Ulltveit-Moe, T			Guatemalan government acknowledges human-rights abuses	LANCET			English	Editorial Material									Amnesty Int, Program Med, London WC1X 0DW, England		Welsh, J (corresponding author), Amnesty Int, Program Med, London WC1X 0DW, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1436	1436		10.1016/S0140-6736(05)74071-X	http://dx.doi.org/10.1016/S0140-6736(05)74071-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052603				2022-12-28	WOS:000089976100048
J	Butler, D				Butler, D			French take physics archives into the future	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					825	825		10.1038/35038231	http://dx.doi.org/10.1038/35038231			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057634	Bronze			2022-12-28	WOS:000089901900011
J	Huntington, JA; Read, RJ; Carrell, RW				Huntington, JA; Read, RJ; Carrell, RW			Structure of a serpin-protease complex shows inhibition by deformation	NATURE			English	Article							CRYSTAL-STRUCTURE; ALPHA-1-PROTEINASE INHIBITOR; REACTIVE CENTER; ALPHA-1-ANTITRYPSIN; PROTEINASE; TRYPSIN; ANTITHROMBIN; MECHANISM; MOLSCRIPT; INSERTION	The serpins have evolved to be the predominant family of serine-protease inhibitors in man(1,2). Their unique mechanism of inhibition involves a profound change in conformation(3), although the nature and significance of this change has been controversial. Here we report the crystallographic structure of a typical serpin-protease complex and show the mechanism of inhibition. The conformational change is initiated by reaction of the active serine of the protease with the reactive centre of the serpin. This cleaves the reactive centre, which then moves 71 Angstrom to the opposite pole of the serpin, taking the tethered protease with it. The tight linkage of the two molecules and resulting overlap of their structures does not affect the hyperstable serpin, but causes a surprising 37% loss of structure in the protease. This is induced by the plucking of the serine from its active site, together with breakage of interactions formed during zymogen activation(4). The disruption of the catalytic site prevents the release of the protease from the complex, and the structural disorder allows its proteolytic destruction(5,6). It is this ability of the conformational mechanism to crush as well as inhibit proteases that provides the serpins with their selective advantage.	Univ Cambridge, Wellcome Trust Ctr Mol Mech Dis, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England	University of Cambridge	Huntington, JA (corresponding author), Univ Cambridge, Wellcome Trust Ctr Mol Mech Dis, Cambridge Inst Med Res, Dept Haematol, Hills Rd, Cambridge CB2 2XY, England.	jah52@cam.ac.uk; rwc1000@cam.ac.uk	Read, Randy J/L-1418-2013	Read, Randy J/0000-0001-8273-0047				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; COLMAN PM, 1976, CRYSTALLOGRAPHIC COM, P248; Elliott PR, 1998, J MOL BIOL, V275, P419, DOI 10.1006/jmbi.1997.1458; ENGH R, 1989, PROTEIN ENG, V2, P407, DOI 10.1093/protein/2.6.407; Engh RA, 1995, TRENDS BIOTECHNOL, V13, P503, DOI 10.1016/S0167-7799(00)89013-7; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Fa M, 2000, STRUCT FOLD DES, V8, P397, DOI 10.1016/S0969-2126(00)00121-0; Gils A, 1998, THROMB HAEMOSTASIS, V80, P531; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; Harrop SJ, 1999, STRUCTURE, V7, P43, DOI 10.1016/S0969-2126(99)80008-2; HERVE M, 1991, ARCH BIOCHEM BIOPHYS, V285, P142, DOI 10.1016/0003-9861(91)90341-F; HOLMES WE, 1987, SCIENCE, V238, P209, DOI 10.1126/science.2958938; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; KASLIK G, 1995, FEBS LETT, V370, P179, DOI 10.1016/0014-5793(95)00816-R; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lee SL, 1997, BIOCHEMISTRY-US, V36, P13180, DOI 10.1021/bi970912m; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OLSON ST, 1995, J BIOL CHEM, V270, P30007; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Picard V, 1999, J BIOL CHEM, V274, P4586, DOI 10.1074/jbc.274.8.4586; Plotnick MI, 1996, BIOCHEMISTRY-US, V35, P7586, DOI 10.1021/bi960233w; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Stavridi ES, 1996, BIOCHEMISTRY-US, V35, P10608, DOI 10.1021/bi9605806; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; WRIGHT HT, 1995, PROTEINS, V22, P210, DOI 10.1002/prot.340220303	36	885	923	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					923	926		10.1038/35038119	http://dx.doi.org/10.1038/35038119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057674				2022-12-28	WOS:000089901900057
J	McDonald, JJ; Teder-Salejarvi, WA; Hillyard, SA				McDonald, JJ; Teder-Salejarvi, WA; Hillyard, SA			Involuntary orienting to sound improves visual perception	NATURE			English	Article							AUDIOVISUAL LINKS; ATTENTION; MECHANISMS; IDENTIFICATION; MODALITY; CUES	To perceive real-world objects and events, we need to integrate several stimulus features belonging to different sensory modalities. Although the neural mechanisms and behavioural consequences of intersensory integration have been extensively studied(1-4), the processes that enable us to pay attention to multimodal objects are still poorly understood. An important question is whether a stimulus in one sensory modality automatically attracts attention to spatially coincident stimuli that appear subsequently in other modalities, thereby enhancing their perceptual salience. The occurrence of an irrelevant sound does facilitate motor responses to a subsequent light appearing nearby(5-7). However, because participants in previous studies made speeded responses rather than psychophysical judgements, it remains unclear whether involuntary auditory attention actually affects the perceptibility of visual stimuli as opposed to postperceptual decision and response processes. Here we provide psychophysical evidence that a sudden sound improves the detectability of a subsequent flash appearing at the same location. These data show that the involuntary orienting of attention to sound enhances early perceptual processing of visual stimuli.	Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	McDonald, JJ (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.		McDonald, John/P-6966-2015					Bertelson P, 1998, PSYCHON B REV, V5, P482, DOI 10.3758/BF03208826; Driver J, 1998, CURR OPIN NEUROBIOL, V8, P245, DOI 10.1016/S0959-4388(98)80147-5; Driver J, 1998, TRENDS COGN SCI, V2, P254, DOI 10.1016/S1364-6613(98)01188-7; Dufour A, 1999, EXP BRAIN RES, V126, P215, DOI 10.1007/s002210050731; GREEN DM, 1966, SIGNAL DETECTION THE; Luck SJ, 1999, PERCEPT PSYCHOPHYS, V61, P1424, DOI 10.3758/BF03206191; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; McDonald JJ, 2000, PSYCHOL SCI, V11, P167, DOI 10.1111/1467-9280.00233; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; Mondor TA, 1998, J EXP PSYCHOL HUMAN, V24, P745, DOI 10.1037/0096-1523.24.3.745; Pashler HE, 1998, PSYCHOL ATTENTION; SANTEE JL, 1982, J EXP PSYCHOL HUMAN, V8, P489, DOI 10.1037/0096-1523.8.4.489; Schmitt M, 2000, Q J EXP PSYCHOL-A, V53, P105, DOI 10.1080/027249800390691; SHIU LP, 1994, J EXP PSYCHOL HUMAN, V20, P1037, DOI 10.1037/0096-1523.20.5.1037; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; SPERLING G, 1986, HDB PERCEPTION HUMAN, V1, P2; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Stein BE., 1993, MERGING SENSES; Ward L. M., 1998, VISUAL ATTENTION, P232; Ward LM, 2000, PERCEPT PSYCHOPHYS, V62, P1258, DOI 10.3758/BF03212127; WARD LM, 1994, CAN J EXP PSYCHOL, V48, P242, DOI 10.1037/1196-1961.48.2.242; WELCH RB, 1986, HDB PERCEPTION HUMAN, V251, P25	23	339	343	1	34	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					906	908		10.1038/35038085	http://dx.doi.org/10.1038/35038085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	364PZ	11057669				2022-12-28	WOS:000089901900052
J	Felson, DT; Lawrence, RC; Dieppe, PA; Hirsch, R; Helmick, CG; Jordan, JM; Kington, RS; Lane, NE; Nevitt, MC; Zhang, YQ; Sowers, M; McAlindon, T; Spector, TD; Poole, AR; Yanovski, SZ; Ateshian, G; Sharma, L; Buckwalter, JA; Brandt, KD; Fries, JF				Felson, DT; Lawrence, RC; Dieppe, PA; Hirsch, R; Helmick, CG; Jordan, JM; Kington, RS; Lane, NE; Nevitt, MC; Zhang, YQ; Sowers, M; McAlindon, T; Spector, TD; Poole, AR; Yanovski, SZ; Ateshian, G; Sharma, L; Buckwalter, JA; Brandt, KD; Fries, JF			Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors	ANNALS OF INTERNAL MEDICINE			English	Article							ESTROGEN REPLACEMENT THERAPY; BONE-MINERAL DENSITY; INTERSTITIAL FLUID PRESSURIZATION; RADIOGRAPHIC KNEE OSTEOARTHRITIS; HUMAN ARTICULAR-CARTILAGE; 1ST NATIONAL-HEALTH; OSTEO-ARTHRITIS; FOLLOW-UP; GENERALIZED OSTEOARTHRITIS; QUADRICEPS WEAKNESS	Osteoarthritis is the most common form of arthritis, affecting millions of people in the United States. It is a complex disease whose etiology bridges biomechanics and biochemistry. Evidence is growing for the role of systemic factors (such as genetics, dietary intake, estrogen use, and bone density) and of local biomechanical factors (such as muscle weakness, obesity, and joint laxity). These risk factors are particularly important in weight-bearing joints, and modifying them may present opportunities for prevention of osteoarthritis-related pain and disability. Major advances in management to reduce pain and disability are yielding a panoply of available treatments ranging from nutriceuticals to chondrocyte transplantation, new oral anti-inflammatory medications, and health education. This article is part 1 of a two-part summary of a National Institutes of Health conference. The conference brought together experts on osteoarthritis from diverse backgrounds and provided a multidisciplinary and comprehensive summary of recent advances in the prevention of osteoarthritis onset, progression, and disability. Part 1 focuses on a new understanding of what osteoarthritis is and on risk factors that predispose to disease occurrence. It concludes with a discussion of the impact of osteoarthritis on disability.	Boston Univ Sch Med, Boston, MA 02118 USA; Natl Inst Arthrit & Musculoskeletal & Skin Dis, NIH, Bethesda, MD 20892 USA; Univ Bristol, MRC Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth Examinat Stat, Hyattsville, MD 20782 USA; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; Univ N Carolina, Thurston Arthrit Res Ctr, Chapel Hill, NC 27599 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth Examinat Stat, Hyattsville, MD 20782 USA; Univ Calif San Francisco, Div Rheumatol, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94105 USA; Boston Univ Sch Med, Arthrit Ctr, Boston, MA 02115 USA; Univ Michigan, Ann Arbor, MI 48109 USA; St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England; McGill Univ, Shriners Hosp Children, Joint Dis Lab, Quebec City, PQ H3G1A6, Canada; McGill Univ, Dept Surg, Quebec City, PQ H3G1A6, Canada; NIH, Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD 20892 USA; Columbia Univ, Orthoped Res Lab, New York, NY 10032 USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Iowa Hosp, Dept Orthopaed, Iowa City, IA 52242 USA; Indiana Univ Sch Med, Rheumatol Div, Indianapolis, IN 46202 USA; Stanford Univ Sch Med, Palo Alto, CA 94304 USA	Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Bristol; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Boston University; University of Michigan System; University of Michigan; Guy's & St Thomas' NHS Foundation Trust; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Columbia University; Northwestern University; University of Iowa; Indiana University System; Indiana University Bloomington; Stanford University	Lawrence, RC (corresponding author), Natl Inst Arthrit & Musculoskeletal & Skin Dis, NIH, Bldg 45,Room 5AS-37G, Bethesda, MD 20892 USA.		Spector, Tim D/F-6533-2012	Felson, David/0000-0002-2668-2447; Sharma, Leena/0000-0002-5571-1622; Zhang, Yuqing/0000-0001-7954-1149; Buckwalter, Joseph/0000-0003-4308-7583	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH); NIH Office of Disease Prevention; NIH National Center for Complementary and Alternative Medicine; NIH Office of Research on Women's Health; NIH Office of Behavioral and Social Sciences Research; NIH National Center for Medical Rehabilitation Research; National Institute of Child Health and Human Development; Centers for Disease Control and Prevention; Arthritis Foundation; American Academy of Orthopaedic Surgeons	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH Office of Disease Prevention; NIH National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIH Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); NIH Office of Behavioral and Social Sciences Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Medical Rehabilitation Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Arthritis Foundation; American Academy of Orthopaedic Surgeons	The conference was initiated, organized, and funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH), which also coordinated and funded the reporting of the proceedings. Cofunding for the conference was provided by the NIH Office of Disease Prevention, NIH National Center for Complementary and Alternative Medicine, NIH Office of Research on Women's Health, NIH Office of Behavioral and Social Sciences Research, NIH National Center for Medical Rehabilitation Research, National Institute of Child Health and Human Development, Centers for Disease Control and Prevention, Arthritis Foundation, and American Academy of Orthopaedic Surgeons.	AKIZUKI S, 1987, J ORTHOPAED RES, V5, P173, DOI 10.1002/jor.1100050204; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013; *ARTHR FDN ASS STA, 1999, NATL ARTHRIT ACTION; Ateshian GA, 1998, J TRIBOL-T ASME, V120, P241, DOI 10.1115/1.2834416; BHALLA AK, 1987, BIOCHIM BIOPHYS ACTA, V931, P26, DOI 10.1016/0167-4889(87)90046-2; BRAGE ME, 1994, CLIN ORTHOPAEDICS, V304, P184; BRANDT KD, INPRESS J RHEUMATOL; BROWN TD, 1988, J ORTHOPAED RES, V6, P851, DOI 10.1002/jor.1100060609; Buckwalter JA, 1997, AM J SPORT MED, V25, P873, DOI 10.1177/036354659702500624; Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022; CARMAN WJ, 1994, AM J EPIDEMIOL, V139, P119, DOI 10.1093/oxfordjournals.aje.a116974; Chapman K, 1999, AM J HUM GENET, V65, P167, DOI 10.1086/302465; Clark AG, 1999, ARTHRITIS RHEUM, V42, P2356, DOI 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R; Coggon D, 1998, AM J EPIDEMIOL, V147, P523; CUNNINGHAM LS, 1984, AM J PUBLIC HEALTH, V74, P574, DOI 10.2105/AJPH.74.6.574; DAVIS MA, 1991, J RHEUMATOL, V18, P591; Dieppe P, 1998, RHEUMATOLOGY EUROPE, V27, P55; DIEPPE PA, 1984, BRIT J RHEUMATOL, V23, P84; DOHERTY M, 1988, RHEUM DIS CLIN N AM, V14, P395; DOHERTY M, 1983, LANCET, V2, P8; DOUGADOS M, 1992, J RHEUMATOL, V19, P378; ETTINGER WH, 1994, J CLIN EPIDEMIOL, V47, P809, DOI 10.1016/0895-4356(94)90178-3; Felson DT, 1997, ARTHRITIS RHEUM, V40, P728, DOI 10.1002/art.1780400420; FELSON DT, 1992, ANN INTERN MED, V116, P535, DOI 10.7326/0003-4819-116-7-535; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; FELSON DT, 1991, J RHEUMATOL, V18, P1587; Felson DT, 1995, OSTEOARTHRITIC DISOR, P13; FISHER NM, 1985, ARCH PHYS MED REHAB, V72, P367; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; FRANK EH, 1987, J ORTHOPAED RES, V5, P497, DOI 10.1002/jor.1100050405; FREI B, 1994, AM J MED, V97, pS5, DOI 10.1016/0002-9343(94)90292-5; Fries James F., 1997, Am J Geriatr Cardiol, V6, P24; Fries JF, 1998, HEALTH AFFAIR, V17, P70, DOI 10.1377/hlthaff.17.2.70; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; GREENWALD RA, 1979, ARTHRITIS RHEUM, V22, P251, DOI 10.1002/art.1780220307; GUCCIONE AA, 1990, AM J PUBLIC HEALTH, V80, P945, DOI 10.2105/AJPH.80.8.945; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; HADLER NM, 1978, ARTHRITIS RHEUM, V21, P210, DOI 10.1002/art.1780210206; HADLEY NA, 1990, J ORTHOP RES, V8, P504, DOI 10.1002/jor.1100080406; HANNAN MT, 1993, ARTHRITIS RHEUM-US, V36, P1671, DOI 10.1002/art.1780361205; HENROTIN Y, 1993, BRIT J RHEUMATOL, V32, P562; HONKONEN SE, 1995, J ORTHOP TRAUMA, V9, P273, DOI 10.1097/00005131-199509040-00001; HUBERBETZER H, 1990, J BIOMECH, V23, P811, DOI 10.1016/0021-9290(90)90028-2; Jordan J, 1997, J RHEUMATOL, V24, P1344; Jordan J. M., 1997, Arthritis and Rheumatism, V40, pS236; Jordan JM, 1996, ARTHRIT CARE RES, V9, P483, DOI 10.1002/art.1790090610; Jordan JM, 1995, ARTHRIT CARE RES, V8, P242, DOI 10.1002/art.1790080407; KELLGREN JH, 1952, BRIT MED J, V1, P181, DOI 10.1136/bmj.1.4751.181; KIEL DP, 1995, NUTR ASSESSMENT ELDE, P277; KUJALA UM, 1995, ARTHRITIS RHEUM, V38, P539, DOI 10.1002/art.1780380413; KUJALA UM, 1994, BRIT MED J, V308, P231, DOI 10.1136/bmj.308.6923.231; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; Lane NE, 1999, ARTHRITIS RHEUM-US, V42, P854, DOI 10.1002/1529-0131(199905)42:5&lt;854::AID-ANR3&gt;3.0.CO;2-I; LANE NE, 1987, AM J MED, V82, P772, DOI 10.1016/0002-9343(87)90014-3; LANE NE, 1993, J RHEUMATOL, V20, P461; LANKHORST GJ, 1985, SCAND J REHABIL MED, V17, P167; LAWRENCE JS, 1966, ANN RHEUM DIS, V25, P1; Lawrence JS, 1980, AETIOPATHOGENESIS OS, P155; Lawrence JS, 1977, RHEUMATISM POPULATIO; LLINAS A, 1993, J BONE JOINT SURG AM, V75A, P1508, DOI 10.2106/00004623-199310000-00012; Lovasz G, 1998, CLIN ORTHOP RELAT R, P224; LUNGHI ME, 1978, J PSYCHOSOM RES, V22, P57, DOI 10.1016/0022-3999(78)90091-0; MACIROWSKI T, 1994, J BIOMECH ENG-T ASME, V116, P10, DOI 10.1115/1.2895693; Manninen P, 1996, INT J OBESITY, V20, P595; MAXIAN TA, 1995, J BIOMECH, V28, P159, DOI 10.1016/0021-9290(94)00054-8; McAlindon TE, 1996, ANN INTERN MED, V125, P353, DOI 10.7326/0003-4819-125-5-199609010-00001; MCALINDON TE, 1993, ANN RHEUM DIS, V52, P258, DOI 10.1136/ard.52.4.258; McAlindon TE, 1996, ARTHRITIS RHEUM-US, V39, P648, DOI 10.1002/art.1780390417; MCCORD JM, 1974, SCIENCE, V185, P529, DOI 10.1126/science.185.4150.529; MIKKELSEN WM, 1967, J CHRON DIS, V20, P351, DOI 10.1016/0021-9681(67)90009-4; MITCHELL NS, 1977, CAN MED ASSOC J, V117, P763; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; NEVITT MC, 1995, ARTHRITIS RHEUM-US, V38, P907, DOI 10.1002/art.1780380706; Nevitt MC, 1996, ARCH INTERN MED, V156, P2073, DOI 10.1001/archinte.156.18.2073; Newton PM, 1997, AM J SPORT MED, V25, P282, DOI 10.1177/036354659702500302; O'Reilly SC, 1998, ANN RHEUM DIS, V57, P588, DOI 10.1136/ard.57.10.588; Odding E, 1998, ANN RHEUM DIS, V57, P203, DOI 10.1136/ard.57.4.203; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Oliveria SA, 1996, EPIDEMIOLOGY, V7, P415, DOI 10.1097/00001648-199607000-00013; PARFITT AM, 1982, AM J CLIN NUTR, V36, P1014, DOI 10.1093/ajcn/36.5.1014; Petrella RJ, 1997, AM J PHYS MED REHAB, V76, P235, DOI 10.1097/00002060-199705000-00015; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; POOLE AR, 1997, OSTEOARTHRITIS PUBLI, P187; RATHAKRISHNAN C, 1992, J BONE MINER RES, V7, P1139; Rejeski WJ, 1996, J GERONTOL B-PSYCHOL, V51, pP24, DOI 10.1093/geronb/51B.1.P24; SALAFFI F, 1991, J RHEUMATOL, V18, P1581; Sandmark H, 1999, ANN RHEUM DIS, V58, P151, DOI 10.1136/ard.58.3.151; SCHOUTEN JSAG, 1992, ANN RHEUM DIS, V51, P932, DOI 10.1136/ard.51.8.932; SETTON LA, 1994, J ORTHOPAED RES, V12, P451, DOI 10.1002/jor.1100120402; Sharma L, 1998, ARTHRITIS RHEUM, V41, P1233, DOI 10.1002/1529-0131(199807)41:7<1233::AID-ART14>3.0.CO;2-L; Sharma L, 1999, RHEUM DIS CLIN N AM, V25, P299, DOI 10.1016/S0889-857X(05)70069-7; Sharma L, 1999, ARTHRITIS RHEUM, V42, P861, DOI 10.1002/1529-0131(199905)42:5<861::AID-ANR4>3.0.CO;2-N; Sharma L, 1999, ARTHRITIS RHEUM-US, V42, P25, DOI 10.1002/1529-0131(199901)42:1<25::AID-ANR3>3.0.CO;2-G; Sharma L, 1998, J RHEUMATOL, V25, P1; Sharma L, 1997, ARTHRITIS RHEUM, V40, P1518, DOI 10.1002/art.1780400821; Slemenda C, 1998, ARTHRITIS RHEUM, V41, P1951, DOI 10.1002/1529-0131(199811)41:11<1951::AID-ART9>3.0.CO;2-9; Slemenda C, 1997, ANN INTERN MED, V127, P97, DOI 10.7326/0003-4819-127-2-199707150-00001; SMYTHE H, 1998, RHEUMATOLOGY, P101; SOLOMON L, 1976, J BONE JOINT SURG BR, V58, P176, DOI 10.1302/0301-620X.58B2.932079; Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5; Sowers M, 1999, ARTHRITIS RHEUM, V42, P483, DOI 10.1002/1529-0131(199904)42:3<483::AID-ANR13>3.0.CO;2-O; Spector TD, 1996, BRIT MED J, V312, P940; SUMMERS MN, 1988, ARTHRITIS RHEUM, V31, P204, DOI 10.1002/art.1780310208; TEPPER S, 1993, AM J EPIDEMIOL, V137, P1081, DOI 10.1093/oxfordjournals.aje.a116611; *US DEP HLTH HUM S, 2000, OBJECTIVE 2 ARTHRIT; van Baar ME, 1998, J RHEUMATOL, V25, P125; VANSAASE JLCM, 1989, ANN RHEUM DIS, V48, P271, DOI 10.1136/ard.48.4.271; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506; Wada M, 1996, BRIT J RHEUMATOL, V35, P560; WANG H, 1998, T 44 ANN M ORTHOPAED, P488; WILLIAMS RA, 1981, PRACTITIONER, V225, P231; Wright GD, 1996, ANN RHEUM DIS, V55, P317, DOI 10.1136/ard.55.5.317; Xu LF, 1998, J HAND SURG-AM, V23A, P454, DOI 10.1016/S0363-5023(05)80463-0; YELIN E, 1998, OSTEOARTHRITIS, V23, P30; Zhang YQ, 1998, ARTHRITIS RHEUM, V41, P1867, DOI 10.1002/1529-0131(199810)41:10<1867::AID-ART20>3.0.CO;2-W; Zhang YQ, 2000, J RHEUMATOL, V27, P1032	118	1640	1713	11	422	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					635	646		10.7326/0003-4819-133-8-200010170-00016	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00016			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033593				2022-12-28	WOS:000089906300020
J	Glass, JI; Lefkowitz, EJ; Glass, JS; Heiner, CR; Chen, EY; Cassell, GH				Glass, JI; Lefkowitz, EJ; Glass, JS; Heiner, CR; Chen, EY; Cassell, GH			The complete sequence of the mucosal pathogen Ureaplasma urealyticum	NATURE			English	Article							MYCOPLASMA-GENITALIUM; ESCHERICHIA-COLI; PNEUMONIAE; MOLLICUTES; VIRULENCE; BACTERIA; UREASE; DNA	The comparison of the genomes of two very closely related human mucosal pathogens, Mycoplasma genitalium and Mycoplasma pneumoniae, has helped define the essential functions of a self-replicating minimal cell, as well as what constitutes a mycoplasma. Here we report the complete sequence of a more distant phylogenetic relative of those bacteria, Ureaplasma urealyticum (parvum biovar), which is also a mucosal pathogen of humans. It is the third mycoplasma to be sequenced, and has the smallest sequenced prokaryotic genome except for M. genitalium. Although the U. urealyticum genome is similar to the two sequenced mycoplasma genomes(1,2), features make this organism unique among mycoplasmas and all bacteria. Almost all ATP synthesis is the result of urea hydrolysis, which generates an energy-producing electrochemical gradient. Some highly conserved eubacterial enzymes appear not to be encoded by U. urealyticum, including the cell-division protein FtsZ, chaperonins GroES and GroEL, and ribonucleoside-diphosphate reductase. U. urealyticum has six closely related iron transporters, which apparently arose through gene duplication, suggesting that it has a kind of respiration system not present in other small genome bacteria The genome is only 25.5% G+C in nucleotide content, and the G+C content of individual genes may predict how essential those genes are to ureaplasma survival.	Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Eli Lilly & Co, Infect Dis Res & Clin Invest, Indianapolis, IN 46285 USA; Perkin Elmer Corp, Adv Ctr Genom Technol, Foster City, CA 94404 USA	University of Alabama System; University of Alabama Birmingham; Eli Lilly	Glass, JI (corresponding author), Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA.		Glass, John/A-6572-2015	Glass, John/0000-0002-3784-5301; Lefkowitz, Elliot/0000-0002-4748-4925				BAUMINGER ER, 1980, J BACTERIOL, V141, P378, DOI 10.1128/JB.141.1.378-381.1980; BRADBURY JM, 1997, INT J SYST BACTERIOL, V47, P911; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; CHEN EY, 1993, GENOMICS, V17, P651, DOI 10.1006/geno.1993.1385; DESILVA NS, 1991, J CLIN MICROBIOL, V29, P1498, DOI 10.1128/JCM.29.7.1498-1503.1991; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Heiner CR, 1998, GENOME RES, V8, P557, DOI 10.1101/gr.8.5.557; Himmelreich R, 1997, NUCLEIC ACIDS RES, V25, P701, DOI 10.1093/nar/25.4.701; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; JAYAKUMAR A, 1985, J BIOL CHEM, V260, P7528; KILIAN M, 1984, ACTA PATH MICRO IM B, V92, P61; LIGON JV, 1991, INFECT IMMUN, V59, P1170, DOI 10.1128/IAI.59.3.1170-1171.1991; MOBLEY HL, 1985, MICROBIOL REV, V59, P451; Neyrolles O, 1996, J BACTERIOL, V178, P647, DOI 10.1128/jb.178.3.647-655.1996; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; POLLACK JD, 1981, J BACTERIOL, V146, P907, DOI 10.1128/JB.146.3.907-913.1981; ROMANO N, 1986, PEDIATR INFECT DIS J, V5, P308; Shepard M.C., 1979, MYCOPLASMAS, P451; SHEPARD MC, 1966, HEALTH LAB SCI, V3, P163; Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398; SMITH DGE, 1993, J BACTERIOL, V175, P3253, DOI 10.1128/jb.175.11.3253-3258.1993; SMITH RL, 1995, J BACTERIOL, V177, P1233, DOI 10.1128/jb.177.5.1233-1238.1995; SOMERSON NL, 1965, SCIENCE, V150, P226, DOI 10.1126/science.150.3693.226; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; WILLIAMS MV, 1990, J BACTERIOL, V172, P2979, DOI 10.1128/jb.172.6.2979-2985.1990; WILLIAMS MV, 1988, DNA REPLICATION MUTA, P440; Wren BW, 1998, MICROBIOL-SGM, V144, P1205, DOI 10.1099/00221287-144-5-1205; ZHENG XT, 1995, INFECT IMMUN, V63, P891, DOI 10.1128/IAI.63.3.891-898.1995	30	271	563	0	28	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					757	762		10.1038/35037619	http://dx.doi.org/10.1038/35037619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048724				2022-12-28	WOS:000089773900046
J	Hart, DM; Branscomb, LM				Hart, DM; Branscomb, LM			Research, innovation and politics - What future for science and technology after this autumn's US elections?	NATURE			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University	Hart, DM (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.								0	2	2	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					561	562		10.1038/35036753	http://dx.doi.org/10.1038/35036753			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034186				2022-12-28	WOS:000089772800018
J	McCarthy, W				McCarthy, W			Programmable matter - How quantum wellstone ushered in our modern age.	NATURE			English	Editorial Material																			0	3	3	0	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					569	569		10.1038/35036656	http://dx.doi.org/10.1038/35036656			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034188	Bronze			2022-12-28	WOS:000089772800023
J	Smith, H				Smith, H			Phytochromes and light signal perception by plants - an emerging synthesis	NATURE			English	Review							NATURAL ALLELIC VARIATION; MOSS CERATODON-PURPUREUS; PHENOTYPIC PLASTICITY; ARABIDOPSIS-THALIANA; ADAPTIVE PLASTICITY; MOLECULAR-BASIS; PHOTORECEPTOR; PROTEIN; GENE; EXPRESSION	For plants, the sensing of light in the environment is as important as vision is for animals. Fluctuations in light can be crucial to competition and survival. One way plants sense light is through the phytochromes, a small family of diverse photochromic protein photoreceptors whose origins have been traced to the photosynthetic prokaryotes. During their evolution, the phytochromes have acquired sophisticated mechanisms to monitor light. Recent advances in understanding the molecular mechanisms of phytochromes and their significance to evolutionary biology make possible an interim synthesis of this rapidly advancing branch of photobiology.	Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester	Smith, H (corresponding author), Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England.	has@le.ac.uk						Ahmad M, 1996, PLANT MOL BIOL, V30, P851, DOI 10.1007/BF00020798; Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Alba R, 2000, MOL BIOL EVOL, V17, P362, DOI 10.1093/oxfordjournals.molbev.a026316; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Alonso-Blanco C, 1998, GENETICS, V149, P749; Ballare CL, 1997, FUNCT ECOL, V11, P441, DOI 10.1046/j.1365-2435.1997.00108.x; BALLARE CL, 1987, PLANT CELL ENVIRON, V10, P551, DOI 10.1111/1365-3040.ep11604091; Bognar LK, 1999, P NATL ACAD SCI USA, V96, P14652, DOI 10.1073/pnas.96.25.14652; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Callahan HS, 1997, BIOESSAYS, V19, P519, DOI 10.1002/bies.950190611; Cashmore AR, 1998, P NATL ACAD SCI USA, V95, P13358, DOI 10.1073/pnas.95.23.13358; Choi G, 1999, NATURE, V401, P610, DOI 10.1038/44176; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Donoghue MJ, 1998, MOL PHYLOGENET EVOL, V9, P489, DOI 10.1006/mpev.1998.0511; Esch H, 1999, PLANTA, V209, P290, DOI 10.1007/s004250050635; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; GILBERT IR, 1995, PLANT CELL ENVIRON, V18, P475, DOI 10.1111/j.1365-3040.1995.tb00549.x; Halliday KJ, 1999, P NATL ACAD SCI USA, V96, P5832, DOI 10.1073/pnas.96.10.5832; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Jiang ZY, 1999, SCIENCE, V285, P406, DOI 10.1126/science.285.5426.406; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kuno N, 2000, PLANT PHYSIOL, V122, P15, DOI 10.1104/pp.122.1.15; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; Mathews S, 1996, MOL BIOL EVOL, V13, P1141, DOI 10.1093/oxfordjournals.molbev.a025677; McSteen P, 1998, CURR OPIN BIOTECH, V9, P189, DOI 10.1016/S0958-1669(98)80114-6; Meyerowitz EM, 1999, TRENDS CELL BIOL, V9, pM65, DOI [10.1016/S0168-9525(99)01853-3, 10.1016/S0968-0004(99)01456-5]; MITCHELLOLDS T, 1995, TRENDS ECOL EVOL, V10, P324, DOI 10.1016/S0169-5347(00)89119-3; Nagy F, 2000, EMBO J, V19, P157, DOI 10.1093/emboj/19.2.157; Neff MM, 2000, GENE DEV, V14, P257; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Nozue K, 1998, P NATL ACAD SCI USA, V95, P15826, DOI 10.1073/pnas.95.26.15826; Olsen JE, 1997, PLANT J, V12, P1339, DOI 10.1046/j.1365-313x.1997.12061339.x; Parks BM, 1999, P NATL ACAD SCI USA, V96, P14142, DOI 10.1073/pnas.96.24.14142; Pigliucci M, 1999, J EVOLUTION BIOL, V12, P551, DOI 10.1046/j.1420-9101.1999.00057.x; Purugganan MD, 2000, MOL ECOL, V9, P1451, DOI 10.1046/j.1365-294x.2000.01016.x; PURUGGANAN MD, 1995, GENETICS, V140, P345; Quail PH, 1997, PLANT CELL ENVIRON, V20, P657, DOI 10.1046/j.1365-3040.1997.d01-108.x; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Robson PRH, 1996, NAT BIOTECHNOL, V14, P995, DOI 10.1038/nbt0896-995; Robson PRH, 1997, PLANT CELL ENVIRON, V20, P831, DOI 10.1046/j.1365-3040.1997.d01-106.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Schmitt J, 1999, AM NAT, V154, pS43, DOI 10.1086/303282; Schmitt J, 1995, AM NAT, V146, P937, DOI 10.1086/285832; SCHNEIDERPOETSCH HAW, 1992, PHOTOCHEM PHOTOBIOL, V56, P839, DOI 10.1111/j.1751-1097.1992.tb02241.x; SHACKLOCK PS, 1992, NATURE, V358, P753, DOI 10.1038/358753a0; SMITH H, 1987, PLANT PHYSIOL, V84, P1059, DOI 10.1104/pp.84.4.1059; SMITH H, 1990, PLANT CELL ENVIRON, V13, P585, DOI 10.1111/j.1365-3040.1990.tb01077.x; Smith H, 1997, PLANT PHYSIOL, V114, P637, DOI 10.1104/pp.114.2.637; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; SMITH H, 1995, ANNU REV PLANT PHYS, V46, P289, DOI 10.1146/annurev.pp.46.060195.001445; SULTAN SE, 1987, EVOL BIOL, V21, P127; Swarup K, 1999, PLANT J, V20, P67, DOI 10.1046/j.1365-313X.1999.00577.x; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; THUMMLER F, 1992, PLANT MOL BIOL, V20, P1003, DOI 10.1007/BF00028888; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Tobin Elaine M., 1994, Seminars in Cell Biology, V5, P335, DOI 10.1006/scel.1994.1040; VANTIENDEREN PH, 1994, GENET RES, V64, P115, DOI 10.1017/S0016672300032729; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; WADA M, 1993, J PHOTOCH PHOTOBIO B, V17, P3, DOI 10.1016/1011-1344(93)85002-P; Whitelam GC, 1997, PLANT CELL ENVIRON, V20, P752, DOI 10.1046/j.1365-3040.1997.d01-100.x; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	70	669	736	5	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2000	407	6804					585	591		10.1038/35036500	http://dx.doi.org/10.1038/35036500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034200				2022-12-28	WOS:000089772800036
J	Chow, WH; Gridley, G; Fraumeni, JF; Jarvholm, B				Chow, WH; Gridley, G; Fraumeni, JF; Jarvholm, B			Obesity, hypertension, and the risk of kidney cancer in men.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-CELL CANCER; GROWTH-FACTOR; PREDICTORS; CARCINOMA; HORMONE	Background: Obesity and hypertension have been implicated as risk factors for the development of renal-cell cancer. Methods: We examined the health records of 363,992 Swedish men who underwent at least one physical examination from 1971 to 1992 and were followed until death or the end of 1995. Men with cancer (renal-cell cancer in 759 and renal-pelvis cancer in 136) were identified by cross-linkage of data with the nationwide Swedish Cancer Registry. Poisson regression analysis was used to estimate relative risks, with adjustments for age, smoking status, body-mass index, and diastolic blood pressure. Results: As compared with men in the lowest three eighths of the cohort for body-mass index, men in the middle three eighths had a 30 to 60 percent greater risk of renal-cell cancer, and men in the highest two eighths had nearly double the risk (P for trend, <0.001). There was also a direct association between higher blood pressures and a higher risk of renal-cell cancer (P for trend, <0.001 for diastolic pressure; P for trend, 0.007 for systolic pressure). After the first five years of follow-up had been excluded to reduce possible effects of preclinical disease, the risk of renal-cell cancer was still consistently higher in men with a higher body-mass index or higher blood pressure. At the sixth-year follow-up, the risk rose further with increasing blood pressures and decreased with decreasing blood pressures, after adjustment for base-line measurements. Men who were current or former smokers had a greater risk of both renal-cell cancer and renal-pelvis cancer than men who were not smokers. There was no relation between body-mass index or blood pressure and the risk of renal-pelvis cancer. Conclusions: Higher body-mass index and elevated blood pressure independently increase the long-term risk of renal-cell cancer in men. A reduction in blood pressure lowers the risk. (N Engl J Med 2000;343:1305-11.) (C) 2000, Massachusetts Medical Society.	NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Umea University	Chow, WH (corresponding author), NCI, Div Canc Epidemiol & Genet, 6120 Execut Blvd,EPS 8100, Bethesda, MD 20892 USA.				NCI NIH HHS [N02-CP-71100] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chow WH, 1999, JAMA-J AM MED ASSOC, V281, P1628, DOI 10.1001/jama.281.17.1628; Chow WH, 2000, COMPREHENSIVE TXB GE, P101; Cohen PG, 1999, MED HYPOTHESES, V52, P49, DOI 10.1054/mehy.1997.0624; Coughlin SS, 1997, CANCER-AM CANCER SOC, V79, P2171, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2171::AID-CNCR15>3.3.CO;2-5; Cowley AW, 1996, JAMA-J AM MED ASSOC, V275, P1581, DOI 10.1001/jama.275.20.1581; ENGHOLM G, 1987, ANN OCCUP HYG, V31, P663, DOI 10.1093/annhyg/31.4B.663; Gago-Dominguez M, 1999, CANCER EPIDEM BIOMAR, V8, P999; Giovannucci E, 1999, HORM RES, V51, P34, DOI 10.1159/000053160; GROVE JS, 1991, AM J EPIDEMIOL, V134, P942, DOI 10.1093/oxfordjournals.aje.a116178; Hodgson AV, 1998, CARCINOGENESIS, V19, P2169, DOI 10.1093/carcin/19.12.2169; Hsieh CC, 1998, J CLIN EPIDEMIOL, V51, P837, DOI 10.1016/S0895-4356(98)00069-9; Klahr S, 1999, J NEPHROL, V12, pS53; Liaw KL, 1997, INT J CANCER, V70, P265, DOI 10.1002/(SICI)1097-0215(19970127)70:3<265::AID-IJC3>3.3.CO;2-H; LINDBLAD P, 1994, CANCER EPIDEM BIOMAR, V3, P631; LINDBLAD P, 1995, INT J CANCER, V61, P192, DOI 10.1002/ijc.2910610209; Matsumoto K, 1999, HYPERTENSION, V34, P279, DOI 10.1161/01.HYP.34.2.279; MATTSSON B, 1985, INT J EPIDEMIOL, V14, P64, DOI 10.1093/ije/14.1.64; MCCREDIE M, 1992, EUR J CANCER, V28A, P2050, DOI 10.1016/0959-8049(92)90254-Y; McLaughlin J. K., 1996, CANC EPIDEMIOLOGY PR, P1142; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; *NAT BOARD HLTH WE, 1995, SWED CANC REG CANC I; OSTLUND E, 1971, WORK ENV HLTH, V8, P27; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Schena FP, 1999, AM J NEPHROL, V19, P308, DOI 10.1159/000013466; Shapiro JA, 1999, AM J EPIDEMIOL, V149, P521; STEFFENS J, 1992, UROL RES, V20, P111, DOI 10.1007/BF00296521; WHITTEMORE AS, 1984, J UROLOGY, V132, P1256, DOI 10.1016/S0022-5347(17)50118-4	27	461	478	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2000	343	18					1305	1311		10.1056/NEJM200011023431804	http://dx.doi.org/10.1056/NEJM200011023431804			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368RP	11058675				2022-12-28	WOS:000090131600004
J	Cook, A; Sheikh, A				Cook, A; Sheikh, A			Trends in serious head injuries among cyclists in England: analysis of routinely collected data	BRITISH MEDICAL JOURNAL			English	Article							HELMETS		Imperial Coll Sch Med, Dept Primary Hlth Care & Gen Practice, London W2 1PG, England	Imperial College London	Cook, A (corresponding author), Imperial Coll Sch Med, Dept Primary Hlth Care & Gen Practice, London W2 1PG, England.		Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; MCCARTHY M, 1992, BRIT MED J, V305, P881, DOI 10.1136/bmj.305.6858.881; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Wardle S, 1998, J PUBLIC HEALTH MED, V20, P70, DOI 10.1093/oxfordjournals.pubmed.a024722	4	25	26	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 28	2000	321	7268					1055	1055		10.1136/bmj.321.7268.1055	http://dx.doi.org/10.1136/bmj.321.7268.1055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	369PU	11053177	Green Published, Bronze			2022-12-28	WOS:000165076800025
J	Kivotides, D; Barenghi, CF; Samuels, DC				Kivotides, D; Barenghi, CF; Samuels, DC			Triple vortex ring structure in superfluid helium II	SCIENCE			English	Article							QUANTIZED VORTICES; TURBULENCE; HE-4; TRANSITION; DYNAMICS; DECAY	Superfluids such as helium II consist of two interpenetrating fluids: the normal fluid and the superfluid. The helium II vortex ring has generally been considered merely as a superfluid object, neglecting any associated motion of the normal fluid. We report a three-dimensional calculation of the coupled motion of the normal-fluid and superfluid components, which shows that the helium II vortex ring consists of a superfluid vortex ring accompanied by two coaxial normal-fluid vortex rings of opposite polarity. The three vortex rings form a coherent, dissipative structure.	Newcastle Univ, Dept Math, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Barenghi, CF (corresponding author), Newcastle Univ, Dept Math, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	c.f.barenghi@ncl.ac.uk	Samuels, David/C-1365-2012; Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Kivotides, Demosthenes/0000-0001-5619-0534				BOWLEY RM, 1982, PHILOS T R SOC A, V307, P201, DOI 10.1098/rsta.1982.0109; Donnelly R. J., 1991, QUANTIZED VORTICES H, V2; Donnelly R. J, 1974, QUANTUM STAT MECH NA, P359; Feynman R. P., 1955, PROG LOW TEMP PHYS, V1, P17; FRISCH T, 1992, PHYS REV LETT, V69, P1644, DOI 10.1103/PhysRevLett.69.1644; Idowu OC, 2000, J LOW TEMP PHYS, V120, P269, DOI 10.1023/A:1004641912850; Idowu OC, 2000, PHYS REV B, V62, P3409, DOI 10.1103/PhysRevB.62.3409; Jackson B, 1998, PHYS REV LETT, V80, P3903, DOI 10.1103/PhysRevLett.80.3903; Jackson B, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.013604; JONES CA, 1982, J PHYS A-MATH GEN, V15, P2599, DOI 10.1088/0305-4470/15/8/036; Maurer J, 1998, EUROPHYS LETT, V43, P29, DOI 10.1209/epl/i1998-00314-9; Melotte DJ, 1998, PHYS REV LETT, V80, P4181, DOI 10.1103/PhysRevLett.80.4181; MUIRHEAD CM, 1984, PHILOS T R SOC A, V311, P433, DOI 10.1098/rsta.1984.0038; NEMIROVSKII SK, 1995, REV MOD PHYS, V67, P37, DOI 10.1103/RevModPhys.67.37; Raman C, 1999, PHYS REV LETT, V83, P2502, DOI 10.1103/PhysRevLett.83.2502; RAYFIELD GW, 1964, PHYS REV, V136, P1194, DOI 10.1103/PhysRev.136.A1194; Reatto L, 1999, INT J MOD PHYS B, V13, P607, DOI 10.1142/S0217979299000497; ROBERTS PH, 1971, J PHYS PT A GEN, V4, P55, DOI 10.1088/0305-4470/4/1/009; Saffman P., 1992, VORTEX DYNAMICS; SAMUELS DC, 1990, PHYS REV LETT, V65, P187, DOI 10.1103/PhysRevLett.65.187; Samuels DC, 1999, PHYS REV LETT, V83, P5306, DOI 10.1103/PhysRevLett.83.5306; SCHWARZ KW, 1988, PHYS REV B, V38, P2398, DOI 10.1103/PhysRevB.38.2398; SMITH MR, 1993, PHYS REV LETT, V71, P2583, DOI 10.1103/PhysRevLett.71.2583; Smith WD, 1999, J MOD HIST, V71, P751, DOI 10.1086/235337; Stalp SR, 1999, PHYS REV LETT, V82, P4831, DOI 10.1103/PhysRevLett.82.4831; SVISTUNOV BV, 1995, PHYS REV B, V52, P3647, DOI 10.1103/PhysRevB.52.3647; TILLEY DR, 1994, SUPERFLUIDITY SUPERC; TSUBOTA M, 1993, PHYS REV B, V47, P12040, DOI 10.1103/PhysRevB.47.12040; Vinen WF, 2000, PHYS REV B, V61, P1410, DOI 10.1103/PhysRevB.61.1410; WILLIAMS GA, 1995, J LOW TEMP PHYS, V101, P421, DOI 10.1007/BF00753331	30	52	52	4	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2000	290	5492					777	779		10.1126/science.290.5492.777	http://dx.doi.org/10.1126/science.290.5492.777			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052935				2022-12-28	WOS:000090067600040
J	Forrest, CB; Whelan, EM				Forrest, CB; Whelan, EM			Primary care safety-net delivery sites in the United States - A comparison of community health centers, hospital outpatient departments, and physicians' offices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the Pediatric-Academic-Societies	MAY 01-04, 1999	SAN FRANCISCO, CALIFORNIA	Pediat Acad Soc			PROVIDERS; SYSTEM	Context The US primary care safety net is composed of a loose network of community health centers, hospital outpatient departments, and physicians' offices. National data on how the mix of patients and services differ across sites are needed. Objective To develop and contrast national profiles of patient and service mix for primary care. Design, Setting, and Patients Comparative analyses of 3 national surveys of primary care visits occurring in 1994: for data on physician's office visits, the National Ambulatory Medical Care Survey (NAMCS); for hospital outpatient department data, the National Hospital Ambulatory Medical Care Survey (NHAMCS); and for data on community health centers, the Bureau of Primary Health Care's 1994 Survey of Visits to Community Health Centers. A time trend analysis also was conducted using the 1998 NAMCS and NHAMCS. Main Outcome Measures National estimates of primary care visit rates, types of patient presentation, patient case-mix, disposition of patients, and management interventions in 1994, and compared with 1998 data. Results The US population made 1.3 primary care visits per person in 1994, which accounted for 43.5% of all ambulatory visits to physicians' offices, community health centers, and hospital outpatient departments. Primary care visits per person were 20% lower for Hispanics and 33% lower for black, non-Hispanic persons compared with white, non-Hispanic persons. Visits to community health centers were more likely to be made by ethnic minorities, patients with Medicaid or no insurance, and rural dwellers than visits made to the other delivery sites. Visits at hospital outpatient departments were made by sicker populations and were characterized by less continuity than the other delivery sites. Controlling for patient mix, visits made to hospital outpatient departments were more commonly associated with imaging studies, minor surgery, and specialty referrals than those made to physicians' offices. In 1998, the US population made an estimated 3.4 visits per person, 45.6% of which were primary care visits. National estimates of primary care visit rates and patient mix and practice pattern comparisons between hospital outpatient departments and physicians' offices were similar in 1998 and 1994. Conclusions Expanding community health centers will likely improve access to primary care for vulnerable US populations. However, enhancing access to of physicians' offices is also needed to bolster the safety net. The greater service intensity and poorer continuity for primary care visits in hospital outpatient departments that we observed raises concern about the suitability of these clinics as primary care delivery sites.	Johns Hopkins Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Primary Care Policy Ctr Underserved, Baltimore, MD 21205 USA	Johns Hopkins University	Forrest, CB (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Primary Care Policy Ctr Underserved, 624 N Broadway,Room 689, Baltimore, MD 21205 USA.		Forrest, Christopher/CAF-1379-2022	Forrest, Christopher/0000-0003-1252-068X				*BUR PRIM HLTH CAR, 1996, 1994 1995 ANN REP; *BUR PRIM HLTH CAR, 1998, TECHN REP COMM HLTH; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P788, DOI 10.1001/jama.280.9.788; GRUMBACH K, 1995, AM J PUBLIC HEALTH, V85, P1402, DOI 10.2105/AJPH.85.10.1402; KELLERMANN AL, 1994, NEW ENGL J MED, V330, P1426; Lion J, 1985, Health Care Financ Rev, V6, P69; Lion J, 1982, Health Care Financ Rev, V4, P89; LIPKIND KL, 1996, ADV DATA VITAL HLTH; Lipson DJ, 1996, HEALTH AFFAIR, V15, P33, DOI 10.1377/hlthaff.15.2.33; Long SH, 1999, JAMA-J AM MED ASSOC, V281, P2035, DOI 10.1001/jama.281.21.2035; McDevitt R D, 1989, Health Care Financ Rev, V11, P43; *PHS US DEP HHS, 1988, INT CLASS DIS 9 REV; SCHAPPERT SM, 1996, ADV DATA VITAL HLTH; SLUSARACICK AL, 2000, ADV DATA VITAL HLTH; Starfield B, 1998, PRIMARY CARE BALANCI; STUART ME, 1993, MED CARE, V31, P1119, DOI 10.1097/00005650-199312000-00005; WEINER JP, 2000, J HOPKINS ACG CASE M; Wilson NJ, 1997, HEALTH AFFAIR, V16, P200, DOI 10.1377/hlthaff.16.4.200; WOODWELL DA, 2000, ADV DATA VITAL HLTH	19	169	170	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2077	2083		10.1001/jama.284.16.2077	http://dx.doi.org/10.1001/jama.284.16.2077			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364QA	11042756	Bronze			2022-12-28	WOS:000089902100028
J	Berger, A				Berger, A			Marijuana has potential for misuse	BRITISH MEDICAL JOURNAL			English	News Item																		Tanda G, 2000, NAT NEUROSCI, V3, P1073, DOI 10.1038/80577	1	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 21	2000	321	7267					979	979						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366ZF	11039950				2022-12-28	WOS:000090035600011
J	Scholefield, JH				Scholefield, JH			ABC of colorectal cancer - Screening	BRITISH MEDICAL JOURNAL			English	Review							FECAL-OCCULT-BLOOD		Univ Nottingham Hosp, Div Gastrointestinal Surg, Nottingham NG7 2UH, England	University of Nottingham	Scholefield, JH (corresponding author), Univ Nottingham Hosp, Div Gastrointestinal Surg, Nottingham NG7 2UH, England.							Kune G.A., 1996, CAUSES CONTROL COLOR; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; WINAWER SJ, 1991, JNCI-J NATL CANCER I, V83, P243, DOI 10.1093/jnci/83.4.243; YOUNG GP, 1996, PREVENTION EARLY DET	5	24	25	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 21	2000	321	7267					1004	1006		10.1136/bmj.321.7267.1004	http://dx.doi.org/10.1136/bmj.321.7267.1004			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366ZF	11039973	Green Published			2022-12-28	WOS:000090035600031
J	Wauters, H; Van Casteren, V; Buntinx, F				Wauters, H; Van Casteren, V; Buntinx, F			Rectal bleeding and colorectal cancer in general practice: diagnostic study	BRITISH MEDICAL JOURNAL			English	Article									Catholic Univ Louvain, Dept Gen Practice, B-3000 Louvain, Belgium; Sci Inst Publ Hlth, Dept Epidemiol, B-1050 Brussels, Belgium	Universite Catholique Louvain	Buntinx, F (corresponding author), Catholic Univ Louvain, Dept Gen Practice, B-3000 Louvain, Belgium.		Buntinx, Frank/E-4950-2011					BUNTINX F, 2000, INCIDENCE CANC BELGI; FIJTEN GH, 1993, THESIS U LIMBURG NET; GOULSTON KJ, 1986, LANCET, V2, P261; LOBET MP, 1987, INT J EPIDEMIOL, V16, P612, DOI 10.1093/ije/16.4.612; MANT A, 1989, DIS COLON RECTUM, V32, P191, DOI 10.1007/BF02554525	5	48	49	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 21	2000	321	7267					998	999		10.1136/bmj.321.7267.998	http://dx.doi.org/10.1136/bmj.321.7267.998			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366ZF	11039968	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000090035600028
J	Packard, CJ; O'Reilly, DSJ; Caslake, MJ; McMahon, AD; Ford, I; Cooney, J; Macphee, CH; Suckling, KE; Krishna, M; Wilkinson, FE; Rumley, A; Lowe, GDO				Packard, CJ; O'Reilly, DSJ; Caslake, MJ; McMahon, AD; Ford, I; Cooney, J; Macphee, CH; Suckling, KE; Krishna, M; Wilkinson, FE; Rumley, A; Lowe, GDO		W Scotland Coronary Prevention Stu	Lipoprotein-associated phospholipase A(2) as an independent predictor of coronary heart disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; ACTIVATING-FACTOR ACETYLHYDROLASE; LOW-DENSITY LIPOPROTEINS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; RISK-FACTORS; ATHEROSCLEROSIS; INFLAMMATION; ATHEROGENESIS	Background: Chronic inflammation is believed to increase the risk of coronary events by making atherosclerotic plaques in coronary vessels prone to rupture. We examined blood constituents potentially affected by inflammation as predictors of risk in men with hypercholesterolemia who were enrolled in the West of Scotland Coronary Prevention Study, a trial that evaluated the value of pravastatin in the prevention of coronary events. Methods: A total of 580 men who had had a coronary event (nonfatal myocardial infarction, death from coronary heart disease, or a revascularization procedure) were each matched for age and smoking status with 2 control subjects (total, 1160) from the same cohort who had not had a coronary event. Lipoprotein-associated phospholipase A(2), C-reactive protein, and fibrinogen levels and the white-cell count were measured at base line, along with other traditional risk factors. The association of these variables with the risk of coronary events was tested in regression models and by dividing the range of values according to quintiles. Results: Levels of C-reactive protein, the white-cell count, and fibrinogen levels were strong predictors of the risk of coronary events; the risk in the highest quintile of the study cohort for each variable was approximately twice that in the lowest quintile. However, the association of these variables with risk was markedly attenuated when age, systolic blood pressure, and lipoprotein levels were included in multivariate models. Levels of lipoprotein-associated phospholipase A(2) (platelet-activating factor acetylhydrolase), the expression of which is regulated by mediators of inflammation, had a strong, positive association with risk that was not confounded by other factors. It was associated with almost a doubling of the risk in the highest quintile as compared with the lowest quintile. Conclusions: Inflammatory markers are predictors of the risk of coronary events, but their predictive ability is attenuated by associations with other coronary risk factors. Elevated levels of lipoprotein-associated phospholipase A(2) appear to be a strong risk factor for coronary heart disease, a finding that has implications for atherogenesis and the assessment of risk. (N Engl J Med 2000;343:1148-55.) (C) 2000 Massachusetts Medical Society.	Glasgow Royal Infirm Univ NHS Trust, Glasgow Royal Infirm, Dept Pathol Biochem, Glasgow G31 2ER, Lanark, Scotland; Glasgow Royal Infirm, Dept Med, Glasgow G31 2ER, Lanark, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; SmithKline Beecham Pharmaceut, Harlow CM19 5AD, Essex, England; diaDexus, Santa Clara, CA USA	University of Glasgow; University of Glasgow; University of Glasgow; GlaxoSmithKline	Packard, CJ (corresponding author), Glasgow Royal Infirm Univ NHS Trust, Glasgow Royal Infirm, Dept Pathol Biochem, 4th Fl Queen Elizabeth Bldg,10 Alexandra Parade, Glasgow G31 2ER, Lanark, Scotland.		McMahon, Alex D/C-4304-2008; Ford, Ian/ABE-6145-2020					Berliner J, 1997, THROMB HAEMOSTASIS, V78, P195; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Cao Y, 1998, J BIOL CHEM, V273, P4012, DOI 10.1074/jbc.273.7.4012; Caslake MJ, 2000, ATHEROSCLEROSIS, V150, P413, DOI 10.1016/S0021-9150(99)00406-2; Danesh J, 1999, EUR HEART J, V20, P954, DOI 10.1053/euhj.1998.1309; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DAVIES MJ, 1993, BRIT HEART J, V69, P377; Elinder LS, 1997, ARTERIOSCL THROM VAS, V17, P2257, DOI 10.1161/01.ATV.17.10.2257; Hak AE, 1999, ARTERIOSCL THROM VAS, V19, P1986, DOI 10.1161/01.ATV.19.8.1986; Hakkinen T, 1999, ARTERIOSCL THROM VAS, V19, P2909, DOI 10.1161/01.ATV.19.12.2909; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Leitinger N, 1999, ARTERIOSCL THROM VAS, V19, P1291, DOI 10.1161/01.ATV.19.5.1291; LOWE GDO, IN PRESS THROMB HAEM; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sartipy P, 1999, J BIOL CHEM, V274, P25913, DOI 10.1074/jbc.274.36.25913; SHEPHERD J, 1995, AM J CARDIOL, V76, P485; Shepherd J, 1997, AM J CARDIOL, V79, P756; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SNYDER E, 1995, BIOCHIM BIOPHYS ACTA, V1254, P231; SNYDER F, 1995, BBA-LIPID LIPID MET, V1259, P121; SNYDER F, 1995, BIOCHIM BIOPHYS ACTA, V1257, P2977; Tew DG, 1996, ARTERIOSCL THROM VAS, V16, P591, DOI 10.1161/01.ATV.16.4.591; Tracy RP, 1999, CURR OPIN LIPIDOL, V10, P435, DOI 10.1097/00041433-199910000-00008; YARNELL JWG, 1991, CIRCULATION, V83, P836, DOI 10.1161/01.CIR.83.3.836; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	32	691	748	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2000	343	16					1148	1155		10.1056/NEJM200010193431603	http://dx.doi.org/10.1056/NEJM200010193431603			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364FY	11036120				2022-12-28	WOS:000089882800003
J	McCray, AT				McCray, AT			Better access to information about clinical trials	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED TRIALS; HEALTH-CARE; COCHRANE-COLLABORATION; SYSTEMATIC REVIEWS; UNPUBLISHED TRIALS; BARRIERS; PARTICIPANTS; REGISTRIES; MISCONDUCT; REGISTERS	Access to information about clinical trials is important to researchers, health care professionals, and patients. Many have argued for the establishment of clinical trials registries, citing their substantial benefits. Although some registries do exist, it has been difficult to create comprehensive, easily accessible systems. This paper briefly reviews existing registries, discusses the challenges in building registries, and reviews some of their benefits. The paper concludes with a description of a new, extensive Web-based registry called ClinicalTrials.gov (http://clinicaltrials.gov/), which was developed at the National Institutes of Health (NIH) by the National Library of Medicine as a result of recent legislation calling for a comprehensive, publicly accessible registry of clinical trials. The first version of the system became available in late February 2000 and contains information about approximately 5000 trials. The first release contains primarily NIH-sponsored trials, and new trials are regularly added to the system. Subsequent versions will contain information about trials sponsored by other federal agencies and by the private sector. The system was developed in accordance with basic informatics principles, including adherence to standards, usability considerations, and iterative testing and evaluation.	Natl Lib Med, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	McCray, AT (corresponding author), Natl Lib Med, 8600 Rockville Pike, Bethesda, MD 20894 USA.	mccray@nlm.nih.gov						[Anonymous], 1948, BMJ-BRIT MED J, V2, P769; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Boissel JP, 1997, FUNDAM CLIN PHARM, V11, P281, DOI 10.1111/j.1472-8206.1997.tb00197.x; CHALMERS I, 1993, ANN NY ACAD SCI, V703, P156, DOI 10.1111/j.1749-6632.1993.tb26345.x; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chalmers I, 1998, BMJ-BRIT MED J, V317, P1167, DOI 10.1136/bmj.317.7167.1167; Corbett F, 1996, J MED ETHICS, V22, P227, DOI 10.1136/jme.22.4.227; DICKERSIN K, 1988, CONTROL CLIN TRIALS, V9, P76; Dickersin K, 1998, CLIN OBSTET GYNECOL, V41, P315, DOI 10.1097/00003081-199806000-00012; EASTERBROOK PJ, 1992, STAT MED, V11, P345, DOI 10.1002/sim.4780110307; Fackler ML, 1996, ANN INTERN MED, V124, P741, DOI 10.7326/0003-4819-124-8-199604150-00007; Featherstone K, 1998, BRIT MED J, V317, P1177, DOI 10.1136/bmj.317.7167.1177; FLEMING ID, 1994, CANCER, V74, P2662, DOI 10.1002/1097-0142(19941101)74:9+<2662::AID-CNCR2820741813>3.0.CO;2-3; FRIEDMAN LM, 1998, FUNDAMENTALS CLIN TR, P333; FRIEDMAN MA, 1998, COMMUNICATION   0422; Haynes B, 1998, BMJ-BRIT MED J, V317, P273, DOI 10.1136/bmj.317.7153.273; Horton R, 1999, BRIT MED J, V319, P865, DOI 10.1136/bmj.319.7214.865; *INT COLL GROUP CL, 1903, CLIN TRIALS METAANAL, V28, P255; LILIENFELD AM, 1982, B HIST MED, V56, P1; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; MANSOUR EG, 1994, CANCER, V74, P2672, DOI 10.1002/1097-0142(19941101)74:9+<2672::AID-CNCR2820741815>3.0.CO;2-X; McCray AT, 2000, J AM MED INFORM ASSN, V7, P313, DOI 10.1136/jamia.2000.0070313; MCCRAY AT, 1999, NATL FORUM, V79, P19; MEINERT CL, 1988, CONTROL CLIN TRIALS, V9, P1, DOI 10.1016/0197-2456(88)90002-5; MOHER D, 1995, FUNDAM CLIN PHARM, V9, P381, DOI 10.1111/j.1472-8206.1995.tb00513.x; Morris RD, 1992, ONLINE J CURR CLIN T; *NIH LAUNCH, 2000, CLIN TRIALS; NOWAK R, 1994, SCIENCE, V264, P1538, DOI 10.1126/science.8202708; Rennie D, 1999, JAMA-J AM MED ASSOC, V282, P1766, DOI 10.1001/jama.282.18.1766; Roberts I, 1998, BRIT MED J, V317, P763, DOI 10.1136/bmj.317.7161.763; SCHAIN WS, 1994, CANCER, V74, P2666, DOI 10.1002/1097-0142(19941101)74:9+<2666::AID-CNCR2820741814>3.0.CO;2-P; Sim I, 1995, Proc Annu Symp Comput Appl Med Care, P863; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Smith R, 1997, BRIT MED J, V315, P622, DOI 10.1136/bmj.315.7109.622; SPILKER B, 1996, GUIDE CLIN TRIALS, P816; Tonks L, 1999, BMJ-BRIT MED J, V319, P1565, DOI 10.1136/bmj.319.7224.1565	36	61	61	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					609	614		10.7326/0003-4819-133-8-200010170-00013	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00013			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	364RH	11033590				2022-12-28	WOS:000089906300006
J	Foster, KR; Ratnieks, FLW				Foster, KR; Ratnieks, FLW			Social insects - Facultative worker policing in a wasp	NATURE			English	Article							HYMENOPTERA; BEES		Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Western Bank, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Foster, KR (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Western Bank, Sheffield S10 2TN, S Yorkshire, England.			Foster, Kevin/0000-0003-4687-6633				ESTOUP A, 1995, MOL ECOL, V4, P89, DOI 10.1111/j.1365-294X.1995.tb00195.x; Foster KR, 2000, MOL ECOL, V9, P735, DOI 10.1046/j.1365-294x.2000.00920.x; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Keller L, 1999, LEVELS SELECTION EVO; Peters JM, 1999, P ROY SOC B-BIOL SCI, V266, P379, DOI 10.1098/rspb.1999.0648; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Starr C.K., 1984, P427; THOREN PA, 1995, INSECT MOL BIOL, V4, P141, DOI 10.1111/j.1365-2583.1995.tb00019.x	9	115	119	0	56	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					692	693		10.1038/35037665	http://dx.doi.org/10.1038/35037665			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048706				2022-12-28	WOS:000089773900027
J	Farrison, PJH				Farrison, PJH			Dopamine and schizophrenia - proof at last?	LANCET			English	Editorial Material							RELEASE		Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England	University of Oxford	Farrison, PJH (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Neurosci Bldg, Oxford OX3 7JX, England.			Harrison, Paul/0000-0002-6719-1126				Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Bennett MR, 1998, J PSYCHOPHARMACOL, V12, P289, DOI 10.1177/026988119801200310; Bertolino A, 1999, BIOL PSYCHIAT, V45, P660, DOI 10.1016/S0006-3223(98)00380-1; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; DEUTCH AY, 1992, J NEURAL TRANSM-GEN, P61; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; HIETALA J, 1995, LANCET, V346, P1130, DOI 10.1016/S0140-6736(95)91801-9; Kapur S, 2000, AM J PSYCHIAT, V157, P514, DOI 10.1176/appi.ajp.157.4.514; Kerwin RW, 1996, PSYCHOL MED, V26, P221, DOI 10.1017/S0033291700034619; Laruelle M, 1999, J PSYCHOPHARMACOL, V13, P358, DOI 10.1177/026988119901300405; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Seeman P, 2000, P NATL ACAD SCI USA, V97, P7673, DOI 10.1073/pnas.97.14.7673; Seeman P, 1998, MOL PSYCHIATR, V3, P123, DOI 10.1038/sj.mp.4000336; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012	15	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					958	959		10.1016/S0140-6736(00)02710-0	http://dx.doi.org/10.1016/S0140-6736(00)02710-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041394				2022-12-28	WOS:000089293600007
J	Ghajar, J				Ghajar, J			Traumatic brain injury	LANCET			English	Article							SEVERE HEAD-INJURY; CARE MANAGEMENT; INTENSIVE-CARE; UNITED-STATES; MAJOR TRAUMA; MORTALITY; PRESSURE; EMERGENCY; COMATOSE; CENTERS	The decrease in mortality and improved outcome for patients with severe traumatic brain injury over the past 25 years can be attributed to the approach of "squeezing oxygenated blood through a swollen brain". Quantification of cerebral perfusion by monitoring of Intracranial pressure and treatment of cerebral hypoperfusion decrease secondary injury. Before the patient reaches hospital, an oganised trauma system that allows rapid resuscitation and transport directly to an experienced trauma centre significantly lowers mortality and morbidity. Only the education of medical personnel and the institution of trauma hospital systems can achieve further improvements in outcome for patients with traumatic brain injuries.	Cornell Univ, Brain Trauma Fdn, New York, NY 10021 USA	Cornell University	Ghajar, J (corresponding author), Cornell Univ, Brain Trauma Fdn, New York, NY 10021 USA.							American College of Surgeons, 1996, ADV TRAUM LIF SUPP I; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; *BRAIN TRAUM TASK, 2000, J NEUROTRAUM, V17, P557; Brain Trauma Foundation, 2000, GUID PREH MAN TRAUM; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; BULLOCK R, 2000, ABC MAJOR TRAUMA, P34; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; DeWitt D S, 1995, New Horiz, V3, P376; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Gruen P, 1998, EMERG MED CLIN N AM, V16, P63, DOI 10.1016/S0733-8627(05)70349-7; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hsiao A K, 1993, Prehosp Disaster Med, V8, P229; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARMAROU A, 1988, J NEUROSURG, V69, P15; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; MURRAY LS, 1999, BRIT J NEUROSURG, V13, P546; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; *NAT CTR INJ PREV, 1999, EP TRAUM BRAIN INJ U; Nicholl J, 1997, BRIT MED J, V315, P1349, DOI 10.1136/bmj.315.7119.1349; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROY PD, 1987, CAN J SURG, V30, P17; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; SAMPALIS JS, 1995, J TRAUMA, V39, P232, DOI 10.1097/00005373-199508000-00008; SCHIERHOUT G, 1999, COCHRANE LIB; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Silvestri S, 1997, MT SINAI J MED, V64, P329; Sosin DM, 1996, BRAIN INJURY, V10, P47; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Woodman R, 1999, BRIT MED J, V318, P1577, DOI 10.1136/bmj.318.7198.1577	51	590	630	1	49	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2000	356	9233					923	929		10.1016/S0140-6736(00)02689-1	http://dx.doi.org/10.1016/S0140-6736(00)02689-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036909				2022-12-28	WOS:000089259800038
J	Ayanian, JZ; Weissman, JS; Schneider, EC; Ginsburg, JA; Zaslavsky, AM				Ayanian, JZ; Weissman, JS; Schneider, EC; Ginsburg, JA; Zaslavsky, AM			Unmet health needs of uninsured adults in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE RISK-FACTORS; FECAL-OCCULT-BLOOD; COLORECTAL-CANCER; MULTIPLE IMPUTATION; INSURANCE STATUS; CARE; ACCESS; US; RELIABILITY; POPULATION	Context In 1998, 33 million US adults aged 18 to 64 years lacked health insurance. Determining the unmet health needs of this population may aid efforts to improve access to care. Objective To compare nationally representative estimates of the unmet health needs of uninsured and insured adults, particularly among persons with major health risks. Design and setting Random household telephone survey conducted in all 50 states and the District of Columbia through the Behavioral Risk Factor Surveillance System. Participants A total of 105 764 adults aged 18 to 64 years in 1997 and 117364 in 1998, classified as long-term (greater than or equal to 1 year) uninsured (9.7%), short-term (<1 year) uninsured (4.3 %), or insured (86.0%). Main Outcome Measures Adjusted proportions of participants who could not see a physician when needed due to cost in the past year, had not had a routine checkup within 2 years, and had not received clinically indicated preventive services, compared by insurance status. Results Long-term- and short-term-uninsured adults were more likely than insured adults to report that they could not see a physician when needed due to cost (26.8%, 21.7%, and 8.2%, respectively), especially among those in poor health (69.1 %, 51.9%, and 21.8%) or fair health (48.8%, 42.4%, and 15.7%) (P<.001). Long-term-uninsured adults in general were much more likely than short-term-uninsured and insured adults not to have had a routine checkup in the last 2 years (42.8%, 22.3%, and 17.8%, respectively) and among smokers, obese individuals, binge drinkers, and people with hypertension, elevated cholesterol, diabetes, or human immunodeficiency virus risk factors (P<.001), Deficits in cancer screening, cardiovascular risk reduction, and diabetes care were most pronounced among long-term-uninsured adults. Conclusions In our study, long-term-uninsured adults reported much greater unmet health needs than insured adults. Providing insurance to improve access to care for long-term-uninsured adults, particularly those with major health risks, could have substantial clinical benefits.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Gen Med & Primary Care, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Inst Hlth Policy, Boston, MA USA; Harvard Univ, Sch Med, Dept Hlth Policy & Management, Boston, MA USA; Amer Soc Internal Med, Amer Coll Phys, Washington, DC USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; American College of Physicians	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	ayanian@hcp.med.harvard.edu		Schneider, Eric/0000-0002-1132-5084				*AM DIAB ASS, 2000, DIABETES CARE, V21, P109; American College of Physicians-American Society of Internal Medicine, 2000, NO HLTH INS ITS EN M; American Diabetes Association, 1998, DIABETES CARE, V21, pS23, DOI [10.2337/diacare.21.1.S23, DOI 10.2337/DIACARE.21.1.S23]; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; Baker DW, 2000, ARCH INTERN MED, V160, P1269, DOI 10.1001/archinte.160.9.1269; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Blendon RJ, 1999, HEALTH AFFAIR, V18, P203, DOI 10.1377/hlthaff.18.6.203; Blumenthal D, 1999, NEW ENGL J MED, V340, P1916, DOI 10.1056/NEJM199906173402412; BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O; Bowlin SJ, 1996, J CLIN EPIDEMIOL, V49, P511, DOI 10.1016/0895-4356(96)00010-8; BRECHNER RJ, 1993, JAMA-J AM MED ASSOC, V270, P1714, DOI 10.1001/jama.270.14.1714; Burstin HR, 1998, INQUIRY-J HEALTH CAR, V35, P389; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P825; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P176; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P219; Cunningham PJ, 1999, HEALTH SERV RES, V34, P255; Cunningham PJ, 1999, JAMA-J AM MED ASSOC, V281, P1087, DOI 10.1001/jama.281.12.1087; DAVIS K, 1998, FUTURE US HLTH CARE, P247; DEGNAN D, 1992, AM J PUBLIC HEALTH, V82, P1386, DOI 10.2105/AJPH.82.10.1386; Donelan K, 1996, JAMA-J AM MED ASSOC, V276, P1346, DOI 10.1001/jama.276.16.1346; Fiore MC, 1996, JAMA-J AM MED ASSOC, V275, P1270, DOI 10.1001/jama.1996.03530400058039; Ford ES, 1998, J WOMENS HEALTH, V7, P997, DOI 10.1089/jwh.1998.7.997; FRANE J, 1989, SUDAAN PROFESSIONAL; FRANKS P, 1993, AM J PUBLIC HEALTH, V83, P1295, DOI 10.2105/AJPH.83.9.1295; FRANKS P, 1993, JAMA-J AM MED ASSOC, V270, P737, DOI 10.1001/jama.270.6.737; FRONSTIN P, 2000, SOURCES HLTH INSURAN, P1; GAGE LS, 1998, FUTURE US HEALTHCARE, P123; Garber AM, 1996, ANN INTERN MED, V124, P515, DOI 10.7326/0003-4819-124-5-199603010-00013; Garber AM, 1996, ANN INTERN MED, V124, P518, DOI 10.7326/0003-4819-124-5-199603010-00013; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HADLEY J, 1991, JAMA-J AM MED ASSOC, V265, P374, DOI 10.1001/jama.265.3.374; HAFNEREATON C, 1993, JAMA-J AM MED ASSOC, V269, P787, DOI 10.1001/jama.269.6.787; HAHN B, 1995, J HEALTH CARE POOR U, V6, P41; HAHN RA, 1990, JAMA-J AM MED ASSOC, V264, P2654, DOI 10.1001/jama.264.20.2654; Hawkins D. R., 1998, FUTURE US HEALTHCARE, P99; Heitjan DF, 1997, AM J PUBLIC HEALTH, V87, P548, DOI 10.2105/AJPH.87.4.548; HIMMELSTEIN DU, 1995, AM J PUBLIC HEALTH, V85, P341, DOI 10.2105/AJPH.85.3.341; JENSEN GA, 1992, MED CARE, V30, P598, DOI 10.1097/00005650-199207000-00003; KREBSCARTER M, 2000, STAT STRAT COV UN AD; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Ku LT, 1999, INQUIRY-J HEALTH CAR, V36, P471; LaVange L M, 1996, Stat Methods Med Res, V5, P311, DOI 10.1177/096228029600500306; Leape LL, 1999, ANN INTERN MED, V130, P183, DOI 10.7326/0003-4819-130-3-199902020-00003; LITTLE RJA, 1982, AM STAT, V36, P38, DOI 10.2307/2684091; LURIE N, 1986, NEW ENGL J MED, V314, P1266, DOI 10.1056/NEJM198605083141934; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; MARKS JS, 2000, MMWR-MORBID MORTAL W, V49, P35; McBride TD, 1997, HEALTH CARE FINANC R, V19, P145; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; MOY E, 1995, ARCH INTERN MED, V155, P1497, DOI 10.1001/archinte.155.14.1497; Powell-Griner Eve, 1997, Morbidity and Mortality Weekly Report, V46, P1; Prevention CfDCa, 2000, BEH RISK FACT SURV S; Roetzheim RG, 1999, J NATL CANCER I, V91, P1409, DOI 10.1093/jnci/91.16.1409; ROWLAND D, 1998, FUTURE US HEALTHCARE, P25; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schoen C, 1998, J URBAN HEALTH, V75, P30, DOI 10.1007/BF02344923; Schoen C, 2000, HEALTH SERV RES, V35, P187; Schoen C, 1997, HEALTH AFFAIR, V16, P163, DOI 10.1377/hlthaff.16.5.163; Schroeder SA, 1996, NEW ENGL J MED, V334, P1130, DOI 10.1056/NEJM199604253341713; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Selden TM, 1999, HEALTH AFFAIR, V18, P126, DOI 10.1377/hlthaff.18.2.126; SHEA S, 1991, AM J EPIDEMIOL, V133, P489, DOI 10.1093/oxfordjournals.aje.a115916; SHEA S, 1992, NEW ENGL J MED, V327, P776, DOI 10.1056/NEJM199209103271107; SHORT PF, 1998, TARGETING LONG SHORT; STEIN AD, 1995, AM J EPIDEMIOL, V141, P1097, DOI 10.1093/oxfordjournals.aje.a117375; STEIN AD, 1993, AM J PUBLIC HEALTH, V83, P1768, DOI 10.2105/AJPH.83.12.1768; SWARTZ K, 1993, INQUIRY-J HEALTH CAR, V30, P64; *US DEP HHS, 2000, HLTH PEOPL 2010 WEB; *US GAO, 2000, HLTH CAR ACC PROGR U; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889; WEISSMAN JS, 1991, ANN INTERN MED, V114, P325, DOI 10.7326/0003-4819-114-4-325; WEISSMAN JS, 1992, JAMA-J AM MED ASSOC, V268, P2388, DOI 10.1001/jama.268.17.2388; Weissman JS., 1994, FALLING SAFETY NET I; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WOOLHANDLER S, 1988, JAMA-J AM MED ASSOC, V259, P2872; 1998, MMWR MORB MORTAL WKL, V47, P73	83	541	544	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2061	2069		10.1001/jama.284.16.2061	http://dx.doi.org/10.1001/jama.284.16.2061			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	364QA	11042754	Bronze			2022-12-28	WOS:000089902100026
J	Boult, C; Kane, RL; Brown, R				Boult, C; Kane, RL; Brown, R			Managed care of chronically ill older people: the US experience	BRITISH MEDICAL JOURNAL			English	Article							HEALTH MAINTENANCE ORGANIZATIONS; RANDOMIZED CONTROLLED TRIAL; NURSING-HOME RESIDENTS; CLINICAL-TRIAL; HOSPITALIZATION; IMPROVE; PROGRAM; ELDERS; ADULTS		Univ Minnesota, Sch Med, Dept Family Practice & Community Med, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Publ Hlth, Div Hlth Serv Res & Policy, Minneapolis, MN 55455 USA; Math Policy Res, Princeton, NJ 08543 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mathematica	Boult, C (corresponding author), Univ Minnesota, Sch Med, Dept Family Practice & Community Med, Minneapolis, MN 55455 USA.							Beck A, 1997, J AM GERIATR SOC, V45, P543, DOI 10.1111/j.1532-5415.1997.tb03085.x; Boult C, 2000, J AM GERIATR SOC, V48, P996; Boult C, 1999, AM J MANAG CARE, V5, P1162; Boult C, 1998, J AM GERIATR SOC, V46, P499, DOI 10.1111/j.1532-5415.1998.tb02474.x; BOULT C, IN PRESS J AM GERIAT; Bowman C, 1999, BRIT MED J, V319, P1119, DOI 10.1136/bmj.319.7217.1119; Caplan GA, 1999, MED J AUSTRALIA, V170, P156, DOI 10.5694/j.1326-5377.1999.tb127711.x; CHATTERJI P, 1998, EVALUATION PROGRAM A; CHEN AR, 2000, BEST PRACTICE COORDI; Covinsky KE, 1997, J AM GERIATR SOC, V45, P729, DOI 10.1111/j.1532-5415.1997.tb01478.x; CUMMINGS JE, 1990, ARCH INTERN MED, V150, P1274, DOI 10.1001/archinte.150.6.1274; Gagnon AJ, 1999, J AM GERIATR SOC, V47, P1118; Iezzoni LI, 1998, NEW ENGL J MED, V339, P1933, DOI 10.1056/NEJM199812243392613; Joseph A, 1998, J AM GERIATR SOC, V46, P1152; Kane RL, 1997, J AM GERIATR SOC, V45, P101, DOI 10.1111/j.1532-5415.1997.tb00987.x; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; NEWCOMER R, 1995, J GERONTOL A-BIOL, V50, pM35, DOI 10.1093/gerona/50A.1.M35; PACALA JT, 1995, J AM GERIATR SOC, V43, P538, DOI 10.1111/j.1532-5415.1995.tb06102.x; Reuben DB, 1999, J AM GERIATR SOC, V47, P131, DOI 10.1111/j.1532-5415.1999.tb04569.x; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Stessman J, 1996, J AM GERIATR SOC, V44, P591; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V	24	15	15	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 21	2000	321	7267					1011	1014		10.1136/bmj.321.7267.1011	http://dx.doi.org/10.1136/bmj.321.7267.1011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	366ZF	11039975	Green Published			2022-12-28	WOS:000090035600033
J	Chen, Q; Ghilardi, N; Wang, H; Baker, T; Xie, MH; Gurney, A; Grewal, IS; de Sauvage, FJ				Chen, Q; Ghilardi, N; Wang, H; Baker, T; Xie, MH; Gurney, A; Grewal, IS; de Sauvage, FJ			Development of Th1-type immune responses requires the type I cytokine receptor TCCR	NATURE			English	Article							T-CELL SUBSETS; INTERFERON-GAMMA; DEFICIENT MICE; TH2 CELLS; IL-4; STAT6; GENERATION; MAP	On antigen challenge, T-helper cells differentiate into two functionally distinct subsets, Th1 and Th2, characterized by the different effector cytokines that they secrete(1). Th1 cells produce interleukin (IL)-2, interferon-gamma (IFN-gamma) and lymphotoxin-beta, which mediate pro-inflammatory functions critical for the development of cell-mediated immune responses, whereas Th2 cells secrete cytokines such as IL-4, IL-5 and IL-10 that enhance humoral immunity(1,2). This process of T-helper cell differentiation is tightly regulated by cytokines. Here we report a new member of the type I cytokine receptor family, designated T-cell cytokine receptor (TCCR). When challenged in vivo with protein antigen, TCCR-deficient mice had impaired Th1 response as measured by IFN-gamma production. TCCR-deficient mice also had increased susceptibility to infection with an intracellular pathogen, Listeria monocytogenes. In addition, levels of antigen-specific immunoglobulin-gamma 2a, which are dependent on Th1 cells, were markedly reduced in these mice. Our results demonstrate the existence of a new cytokine receptor involved in regulating the adaptive immune response and critical to the generation of a Th1 response.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	de Sauvage, FJ (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	sauvage@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Ghilardi, Nico/0000-0003-4945-3097; Grewal, Iqbal S/0000-0002-4775-055X				BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Heath VL, 2000, J IMMUNOL, V164, P2861, DOI 10.4049/jimmunol.164.6.2861; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Nishikomori R, 2000, J EXP MED, V191, P847, DOI 10.1084/jem.191.5.847; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Wu CY, 1997, J IMMUNOL, V159, P1658; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8	26	327	353	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					916	920		10.1038/35038103	http://dx.doi.org/10.1038/35038103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057672				2022-12-28	WOS:000089901900055
J	Limaye, AP; Connolly, PA; Sagar, M; Fritsche, TR; Cookson, BT; Wheat, LJ; Stamm, WE				Limaye, AP; Connolly, PA; Sagar, M; Fritsche, TR; Cookson, BT; Wheat, LJ; Stamm, WE			Transmission of Histoplasma capsulatum by organ transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-ALLOGRAFT; RECIPIENTS; INFECTION		Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Indiana University System; Indiana University-Purdue University Indianapolis	Limaye, AP (corresponding author), Univ Washington, Med Ctr, Dept Lab Med, Box 357110,1959 NE Pacific St, Seattle, WA 98195 USA.		Sagar, Manish/ABB-3816-2020	Sagar, Manish/0000-0001-9803-6594				Botterel F, 1999, EUR J CLIN MICROBIOL, V18, P662, DOI 10.1007/s100960050369; CONNOLLY P, 1999, 39 INT C ANT AG CHEM, P547; DAVIES SF, 1979, AM J SURG, V137, P686, DOI 10.1016/0002-9610(79)90050-3; GOODWIN RA, 1980, MEDICINE, V59, P1, DOI 10.1097/00005792-198001000-00001; GOTTESDIENER KM, 1989, ANN INTERN MED, V110, P1001, DOI 10.7326/0003-4819-110-12-1001; HOOD AB, 1965, CAN MED ASSOC J, V93, P587; KAUFFMAN CA, 1978, AM J MED, V64, P923, DOI 10.1016/0002-9343(78)90445-X; KEATH EJ, 1992, J CLIN MICROBIOL, V30, P2104, DOI 10.1128/JCM.30.8.2104-2107.1992; KERSULYTE D, 1992, J BACTERIOL, V174, P7075, DOI 10.1128/jb.174.22.7075-7079.1992; SUPERDOCK KR, 1994, AM J KIDNEY DIS, V23, P600, DOI 10.1016/S0272-6386(12)80386-6; VAIL GM, 1998, INF DIS SOC AM 36 AN, P141; WALKER JV, 1977, JAMA-J AM MED ASSOC, V237, P1350, DOI 10.1001/jama.237.13.1350; WATANABE M, 1988, ACTA PATHOL JAPON, V38, P769; Wheat J, 1997, ANTIMICROB AGENTS CH, V41, P410, DOI 10.1128/AAC.41.2.410; WHEAT LJ, 1989, EUR J CLIN MICROBIOL, V8, P480, DOI 10.1007/BF01964063; WHEAT LJ, 1983, ARCH INTERN MED, V143, P703, DOI 10.1001/archinte.143.4.703; WHEAT LJ, 1981, ANN INTERN MED, V94, P331, DOI 10.7326/0003-4819-94-3-331; Wheat LJ, 1982, ANN INTERN MED, V97, P680; WONG SY, 1992, CLIN INFECT DIS, V14, P232, DOI 10.1093/clinids/14.1.232	19	91	95	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2000	343	16					1163	1166		10.1056/NEJM200010193431605	http://dx.doi.org/10.1056/NEJM200010193431605			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364FY	11036122				2022-12-28	WOS:000089882800005
J	Bar-Sagi, D; Hall, A				Bar-Sagi, D; Hall, A			Ras and Rho GTPases: A family reunion	CELL			English	Review							ACTIVATED PROTEIN-KINASES; GROWTH-FACTOR ACTIVATION; CELL-CYCLE PROGRESSION; SERUM RESPONSE ELEMENT; FOCAL ADHESION KINASE; ACTIN STRESS FIBERS; KAPPA-B ACTIVATION; MAP KINASE; NADPH OXIDASE; NUCLEAR FACTOR		SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, CRC, Oncogene & Signal Transduct Lab, London WC1E 6BT, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of London; University College London; University of London; University College London; University of London; University College London	Bar-Sagi, D (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	barsagi@pharm.sunysb.edu		Bar-Sagi, Dafna/0000-0003-2597-8948				ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Baichwal VR, 1997, CURR BIOL, V7, pR94, DOI 10.1016/S0960-9822(06)00046-7; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOKOCH GM, 1991, SCIENCE, V254, P1794, DOI 10.1126/science.1763330; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; CARON E, 2000, IN PRESS CURR BIOL; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; DIKIC I, 1994, CURR BIOL, V4, P702, DOI 10.1016/S0960-9822(00)00155-X; Exton JH, 1999, BBA-MOL CELL BIOL L, V1439, P121, DOI 10.1016/S1388-1981(99)00089-X; Fan WT, 1998, CURR BIOL, V8, P935, DOI 10.1016/S0960-9822(07)00376-4; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; FOX PL, 1994, ONCOGENE, V9, P3519; Frankel P, 1999, BIOCHEM BIOPH RES CO, V255, P502, DOI 10.1006/bbrc.1999.0234; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; GABIG TG, 1995, BLOOD, V85, P804, DOI 10.1182/blood.V85.3.804.bloodjournal853804; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; HAN J, 1988, SCIENCE, V279, P558; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Henning SW, 1998, CURR OPIN IMMUNOL, V10, P322, DOI 10.1016/S0952-7915(98)80171-4; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Hu WM, 1999, J BIOL CHEM, V274, P3396, DOI 10.1074/jbc.274.6.3396; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Izawa I, 1998, ONCOGENE, V17, P2863, DOI 10.1038/sj.onc.1202213; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; JOSEPH G, 1995, J BIOL CHEM, V270, P29079, DOI 10.1074/jbc.270.49.29079; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kerkhoff E, 1998, ONCOGENE, V17, P1457, DOI 10.1038/sj.onc.1202185; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Leblanc V, 1998, MOL CELL BIOL, V18, P5567, DOI 10.1128/MCB.18.9.5567; Leng J, 1999, J BIOL CHEM, V274, P37855, DOI 10.1074/jbc.274.53.37855; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lin TH, 1997, J BIOL CHEM, V272, P8849; Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385; Luo JQ, 1997, BIOCHEM BIOPH RES CO, V235, P854, DOI 10.1006/bbrc.1997.6793; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Mittnacht S, 1997, CURR BIOL, V7, P219, DOI 10.1016/S0960-9822(97)70094-0; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, J CELL SCI, V108, P225; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Page K, 1999, J BIOL CHEM, V274, P22065, DOI 10.1074/jbc.274.31.22065; Park HO, 1997, P NATL ACAD SCI USA, V94, P4463, DOI 10.1073/pnas.94.9.4463; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Renshaw MW, 1999, J CELL BIOL, V147, P611, DOI 10.1083/jcb.147.3.611; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Sahai E, 1999, CURR BIOL, V9, P136, DOI 10.1016/S0960-9822(99)80067-0; Salojin KV, 2000, J BIOL CHEM, V275, P5966, DOI 10.1074/jbc.275.8.5966; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Schwartz MA, 1996, EMBO J, V15, P6525, DOI 10.1002/j.1460-2075.1996.tb01043.x; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Turner H, 1998, J EXP MED, V188, P527, DOI 10.1084/jem.188.3.527; VAN AL, 1997, GENE DEV, V11, P2295; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Weber JD, 1997, J BIOL CHEM, V272, P32966, DOI 10.1074/jbc.272.52.32966; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Wolthuis RMF, 1999, CURR OPIN GENET DEV, V9, P112, DOI 10.1016/S0959-437X(99)80016-1; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; ZHENG Y, 1995, J BIOL CHEM, V270, P626, DOI 10.1074/jbc.270.2.626; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; Zhong CL, 1997, MOL BIOL CELL, V8, P2329, DOI 10.1091/mbc.8.11.2329; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	120	680	702	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 13	2000	103	2					227	238		10.1016/S0092-8674(00)00115-X	http://dx.doi.org/10.1016/S0092-8674(00)00115-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057896	Bronze			2022-12-28	WOS:000089864300007
J	Ramirez-Weber, FA; Kornberg, TB				Ramirez-Weber, FA; Kornberg, TB			Signaling reaches to new dimensions in Drosophila imaginal discs	CELL			English	Review									Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kornberg, TB (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.							Beddington RSP, 1998, TRENDS GENET, V14, P277, DOI 10.1016/S0168-9525(98)01499-1; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gibson MC, 2000, CELL, V103, P343, DOI 10.1016/S0092-8674(00)00125-2; Goode S, 2000, TRENDS CELL BIOL, V10, P89, DOI 10.1016/S0962-8924(99)01723-7; GUSTAFSON T, 1967, BIOL REV, V42, P442, DOI 10.1111/j.1469-185X.1967.tb01482.x; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; McClay DR, 1999, EXP CELL RES, V253, P296, DOI 10.1006/excr.1999.4723; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; SABRY JH, 1991, J CELL BIOL, V115, P381, DOI 10.1083/jcb.115.2.381; Usui K, 2000, DEV BIOL, V225, P13, DOI 10.1006/dbio.2000.9766; WIGGLESWORTH VB, 1977, J CELL SCI, V26, P161	12	31	31	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 13	2000	103	2					189	192		10.1016/S0092-8674(00)00111-2	http://dx.doi.org/10.1016/S0092-8674(00)00111-2			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057892	Bronze			2022-12-28	WOS:000089864300003
J	Abraham, ER; Law, CS; Boyd, PW; Lavender, SJ; Maldonado, MT; Bowie, AR				Abraham, ER; Law, CS; Boyd, PW; Lavender, SJ; Maldonado, MT; Bowie, AR			Importance of stirring in the development of an iron-fertilized phytoplankton bloom	NATURE			English	Article							NORTH-ATLANTIC; SOUTHERN-OCEAN; TRACER; PATCHINESS; SEAWIFS; EVOLUTION	The growth of populations is known to be influenced by dispersal, which has often been described as purely diffusive(1,2). In the open ocean, however, the tendrils and filaments of phytoplankton populations provide evidence for dispersal by stirring(3,4). Despite the apparent importance of horizontal stirring for plankton ecology, this process remains poorly characterized. Here we investigate the development of a discrete phytoplankton bloom, which was initiated by the iron fertilization of a patch of water (7 km in diameter) in the Southern Ocean(5). Satellite images show a striking, 150-km-long bloom near the experimental site, six weeks after the initial fertilization. We argue that the ribbon-like bloom was produced from the fertilized patch through stirring, growth and diffusion, and we derive an estimate of the stirring rate. In this case, stirring acts as an important control on bloom development, mixing phytoplankton and iron out of the patch, but also entraining silicate. This may have prevented the onset of silicate limitation, and so allowed the bloom to continue for as long as there was sufficient iron. Stirring in the ocean is likely to be variable, so blooms that are initially similar may develop very differently.	Natl Inst Water & Atmospher Res, Wellington, New Zealand; Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; Univ Otago, NIWA, Ctr Chem & Phys Oceanog, Dept Chem, Dunedin, New Zealand; McGill Univ, Dept Biol, Montreal, PQ H2T 2V8, Canada; Univ Plymouth, Plymouth Environm Res Ctr, Dept Environm Sci, Plymouth PL4 8AA, Devon, England	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Plymouth Marine Laboratory; University of Otago; McGill University; University of Plymouth	Abraham, ER (corresponding author), Natl Inst Water & Atmospher Res, POb 14-901, Wellington, New Zealand.	e.abraham@niwa.cri.nz	Bowie, Andrew/C-8677-2013; Abraham, Edward R/D-7422-2011; Maldonado, Maria T/N-2877-2017; Boyd, Philip W/J-7624-2014	Bowie, Andrew/0000-0002-5144-7799; Abraham, Edward R/0000-0003-4490-6704; Maldonado, Maria T/0000-0001-8134-9375; Boyd, Philip W/0000-0001-7850-1911; Lavender, Samantha/0000-0002-5181-9425; Law, Cliff/0000-0002-7669-2475				ABBOTT MR, IN PRESS DEEP SEA RE; Abraham ER, 1998, NATURE, V391, P577, DOI 10.1038/35361; Bowie AR, 1998, ANAL CHIM ACTA, V361, P189, DOI 10.1016/S0003-2670(98)00015-4; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Charette MA, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000069; COMISO JC, 1993, J GEOPHYS RES-OCEANS, V98, P2419, DOI 10.1029/92JC02505; DEBAAR HJW, 1999, INT GEOSPHERE BIOSPH, P61; GARRETT C, 1983, DYNAM ATMOS OCEANS, V7, P265, DOI 10.1016/0377-0265(83)90008-8; GOWER JFR, 1980, NATURE, V288, P157, DOI 10.1038/288157a0; HAIDVOGEL DB, 1984, DYNAM ATMOS OCEANS, V8, P1, DOI 10.1016/0377-0265(84)90002-2; HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731; JACKSON GA, 1990, DEEP-SEA RES, V37, P1197, DOI 10.1016/0198-0149(90)90038-W; KIERSTEAD H, 1953, J MAR RES, V12, P141; Lavender SJ, 1999, INT J REMOTE SENS, V20, P1051, DOI 10.1080/014311699212830; Law CS, 1998, DEEP-SEA RES PT II, V45, P977, DOI 10.1016/S0967-0645(98)00022-8; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; Maldonado MT, 1999, DEEP-SEA RES PT II, V46, P2475, DOI 10.1016/S0967-0645(99)00072-7; Martin AP, 2000, J PLANKTON RES, V22, P597, DOI 10.1093/plankt/22.3.597; MARTIN AP, IN PRESS DEEP SEA RE; Moore JK, 1999, GEOPHYS RES LETT, V26, P1465, DOI 10.1029/1999GL900242; O'Reilly JE, 1998, J GEOPHYS RES-OCEANS, V103, P24937, DOI 10.1029/98JC02160; OKUBO A, 1971, DEEP-SEA RES, V18, P789, DOI 10.1016/0011-7471(71)90046-5; OKUBO A, 1966, J OCEANOGR SOC JAPAN, V22, P1; Okubo A., 1980, BIOMATHEMATICS, V10; OLSON RJ, IN PRESS DEEP SEA RE; Rintoul SR, 1997, DEEP-SEA RES PT I, V44, P1185, DOI 10.1016/S0967-0637(96)00125-2; Stanton TP, 1998, DEEP-SEA RES PT II, V45, P947, DOI 10.1016/S0967-0645(98)00018-6; SULLIVAN CW, 1993, SCIENCE, V262, P1832, DOI 10.1126/science.262.5141.1832; Sundermeyer MA, 1998, J GEOPHYS RES-OCEANS, V103, P21481, DOI 10.1029/98JC01999; Washburn L, 1998, DEEP-SEA RES PT I, V45, P1411, DOI 10.1016/S0967-0637(98)00023-5	30	211	216	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					727	730		10.1038/35037555	http://dx.doi.org/10.1038/35037555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048715				2022-12-28	WOS:000089773900037
J	Singh, PK; Schaefer, AL; Parsek, MR; Moninger, TO; Welsh, MJ; Greenberg, EP				Singh, PK; Schaefer, AL; Parsek, MR; Moninger, TO; Welsh, MJ; Greenberg, EP			Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA; PATHOGENESIS; EXPRESSION; GENES	The bacterium Pseudomonas aeruginosa permanently colonizes cystic fibrosis lungs despite aggressive antibiotic treatment(1-3). This suggests that P. aeruginosa might exist as biofilms-structured communities of bacteria encased in a self-produced polymeric matrix-in the cystic fibrosis lung(1,4). Consistent with this hypothesis, microscopy of cystic fibrosis sputum shows that P. aeruginosa are in biofilm-like structures. P. aeruginosa uses extracellular quorum-sensing signals (extracellular chemical signals that cue cell-density-dependent gene expression) to coordinate biofilm formation(5). Here we found that cystic fibrosis sputum produces the two principal P. aeruginosa quorum-sensing signals; however, the relative abundance of these signals was opposite to that of the standard P. aeruginosa strain PAO1 in laboratory broth culture. When P. aeruginosa sputum isolates were grown in broth, some showed quorum-sensing signal ratios like those of the laboratory strain. When we grew these isolates and PAO1 in a laboratory biofilm model, the signal ratios were like those in cystic fibrosis sputum. Our data support the hypothesis that P. aeruginosa are in a biofilm in cystic fibrosis sputum. Moreover, quorum-sensing signal profiling of specific P. aeruginosa strains may serve as a biomarker in screens to identify agents that interfere with biofilm development.	Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Northwestern Univ, Dept Civil Engn, Evanston, IL 60208 USA; Univ Iowa, Coll Med, Cent Microscopy Res Facil, Iowa City, IA 52242 USA	University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; Northwestern University; University of Iowa	Greenberg, EP (corresponding author), Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA.		Schaefer, Amy/AAU-8576-2020	Schaefer, Amy/0000-0003-0581-054X; Welsh, Michael/0000-0002-1646-6206; Greenberg, Everett/0000-0001-9474-8041	NHLBI NIH HHS [K24 HL102246] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL102246] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Burns J L, 1993, Adv Pediatr Infect Dis, V8, P53; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1983, REV INFECT DIS, V5, pS867; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COSTERTON JW, 1984, REV INFECT DIS S3, V6, P608; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DAVIES DG, 1993, APPL ENVIRON MICROB, V59, P1181, DOI 10.1128/AEM.59.4.1181-1186.1993; HOIBY N, 1993, ANNU REV MED, V44, P1, DOI 10.1146/annurev.me.44.020193.000245; JENSEN SE, 1980, J BACTERIOL, V144, P844, DOI 10.1128/JB.144.2.844-847.1980; MENDELMAN PM, 1985, AM REV RESPIR DIS, V132, P761; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Pesci EC, 1997, TRENDS MICROBIOL, V5, P132, DOI 10.1016/S0966-842X(97)01008-1; Rumbaugh KP, 1999, J BURN CARE REHABIL, V20, P42, DOI 10.1097/00004630-199901001-00008; Schaefer AL, 2000, METHOD ENZYMOL, V305, P288; SCHAEFER AL, IN PRESS METHODS ENZ; Tang HB, 1996, INFECT IMMUN, V64, P37, DOI 10.1128/IAI.64.1.37-43.1996; WELSH MJ, 1995, METABOLIC MOL BASES, V3, P3799; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904	18	1118	1194	10	305	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					762	764		10.1038/35037627	http://dx.doi.org/10.1038/35037627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048725				2022-12-28	WOS:000089773900047
J	Irwin, M; Marin, MC; Phillips, AC; Seelan, RS; Smith, DI; Liu, WG; Flores, ER; Tsai, KY; Jacks, T; Vousden, KH; Kaelin, WG				Irwin, M; Marin, MC; Phillips, AC; Seelan, RS; Smith, DI; Liu, WG; Flores, ER; Tsai, KY; Jacks, T; Vousden, KH; Kaelin, WG			Role for the p53 homologue p73 in E2F-1-induced apoptosis	NATURE			English	Article							P53-INDEPENDENT APOPTOSIS; LI-FRAUMENI; DNA-BINDING; IN-VIVO; E2F-1; FAMILY; OVEREXPRESSION; PROTEIN; DOMAIN; CELLS	The transcription factor E2F-1 induces both cell-cycle progression and, in certain settings, apoptosis. E2F-1 uses both p53-dependent and p53-independent pathways to kill cells(1-8). The p53-dependent pathway involves the induction by E2F-1 of the human tumour-suppressor protein p14ARF, which neutralizes HDM2 (human homologue of MDM2) and thereby stabilizes the p53 protein(9). Here we show that E2F-1 induces the transcription of the p53 homologue p73. Disruption of p73 function inhibited E2F-1-induced apoptosis in p53-defective tumour cells and in p53(-/-) mouse embryo fibroblasts. We conclude that activation of p73 provides a means for E2F-1 to induce death in the absence of p53.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; NCI, Regulat Cell Growth Lab, FCRDC, Frederick, MD 21702 USA; Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Lab Med & Pathol, Rochester, MN 55905 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Howard Hughes Med Inst, Chevy Chase, MD 20185 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.		Marin, Maria C/G-1040-2010; Marín Vieira, María del Carmen/B-8108-2015	Marin, Maria C/0000-0002-7149-287X; Marín Vieira, María del Carmen/0000-0002-7149-287X; Tsai, Kenneth/0000-0001-5325-212X; Seelan, Ratnam/0000-0002-8925-1070				Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Chen YNP, 1999, P NATL ACAD SCI USA, V96, P4325, DOI 10.1073/pnas.96.8.4325; Davison TS, 1999, J BIOL CHEM, V274, P18709, DOI 10.1074/jbc.274.26.18709; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fueyo J, 1998, NAT MED, V4, P685, DOI 10.1038/nm0698-685; Holme IB, 1998, PLANT CELL TISS ORG, V53, P143, DOI 10.1023/A:1006001419989; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Hunt KK, 1997, CANCER RES, V57, P4722; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaelin WG, 1999, J NATL CANCER I, V91, P594, DOI 10.1093/jnci/91.7.594; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Krek W, 1994, CELL, V78, P1; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Nip J, 1997, MOL CELL BIOL, V17, P1049, DOI 10.1128/MCB.17.3.1049; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Weber KL, 1998, BIOTECHNIQUES, V25, P415, DOI 10.2144/98253st02; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	29	515	526	0	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					645	648		10.1038/35036614	http://dx.doi.org/10.1038/35036614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034215				2022-12-28	WOS:000089772800051
J	Noda, S; Chutinan, A; Imada, M				Noda, S; Chutinan, A; Imada, M			Trapping and emission of photons by a single defect in a photonic bandgap structure	NATURE			English	Article								By introducing artificial defects and/or light-emitters into photonic bandgap structures(1,2), it should be possible to manipulate photons. For example, it has been predicted 2 that strong localization (or trapping) of photons should occur in structures with single defects, and that the propagation(3,4) of photons should be controllable using arrays of defects. But there has been little experimental progress in this regard, with the exception of a laser(5) based on a single-defect photonic crystal. Here we demonstrate photon trapping by a single defect that has been created artificially inside a two-dimensional photonic bandgap structure. Photons propagating through a linear waveguide are trapped by the defect, which then emits them to free space. We envisage that this phenomenon may be used in ultra-small optical devices whose function is to selectively drop (or add) photons with various energies from (or to) optical communication traffic. More generally, our work should facilitate the development of all-optical circuits incorporating photonic bandgap waveguides and resonators.	Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6068501, Japan	Kyoto University	Noda, S (corresponding author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6068501, Japan.							Chutinan A, 2000, PHYS REV B, V62, P4488, DOI 10.1103/PhysRevB.62.4488; Fan SH, 1998, PHYS REV LETT, V80, P960, DOI 10.1103/PhysRevLett.80.960; Joannoupoulos J.D., 1995, PHOTONIC CRYSTALS; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; MUR G, 1981, IEEE T ELECTROMAGN C, V23, P377, DOI 10.1109/TEMC.1981.303970; Painter O, 1999, J OPT SOC AM B, V16, P275, DOI 10.1364/JOSAB.16.000275; Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302	9	968	1014	2	217	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					608	610		10.1038/35036532	http://dx.doi.org/10.1038/35036532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034204				2022-12-28	WOS:000089772800040
J	Pai, LM; Barcelo, G; Schupbach, T				Pai, LM; Barcelo, G; Schupbach, T			D-cbl, a negative regulator of the Egfr pathway, is required for dorsoventral patterning in Drosophila oogenesis	CELL			English	Article							RECEPTOR TYROSINE KINASE; TRANSCRIPTION FACTOR CF2; GROWTH-FACTOR RECEPTOR; ALPHA-LIKE PROTEIN; FAINT-LITTLE-BALL; C-CBL; SIGNALING PATHWAYS; GENE GURKEN; GERM-LINE; EMBRYO	During Drosophila oogenesis, asymmetrically localized Gurken activates the EGF receptor (Egfr) and determines dorsal follicle cell fates. Using a mosaic follicle cell system we have identified a mutation in the D-cbl gene which causes hyperactivation of the Egfr pathway. Cbl proteins are known to downregulate activated receptors. We find that the abnormal Egfr activation is ligand dependent. Our results show that the precise regulation of Egfr activity necessary to establish different follicle cell fates requires two levels of control. The localized ligand Gurken activates Egfr to different levels in different follicle cells. In addition, Egfr activity has to be repressed through the activity of D-cbl to ensure the absence of signaling in the ventral most follicle cells.	Princeton Univ, Dept Mol Biol, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University	Schupbach, T (corresponding author), Princeton Univ, Dept Mol Biol, Howard Hughes Med Inst, Princeton, NJ 08544 USA.				NCI NIH HHS [P01 CA41086] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA041086] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chen B, 1998, GENETICS, V149, P157; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Chou TB, 1996, GENETICS, V144, P1673; Deng WM, 1997, DEVELOPMENT, V124, P4639; Duffy JB, 1998, DEVELOPMENT, V125, P2263; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hime GR, 1997, ONCOGENE, V14, P2709, DOI 10.1038/sj.onc.1201223; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hsu T, 1996, GENE DEV, V10, P1411, DOI 10.1101/gad.10.11.1411; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JONGEWARD GD, 1995, GENETICS, V139, P1553; Jordan KC, 2000, NAT GENET, V24, P429, DOI 10.1038/74294; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KLINGLER M, 1988, NATURE, V335, P275, DOI 10.1038/335275a0; Kramer S, 1999, DEVELOPMENT, V126, P2515; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LEWIS EB, 1968, GENE DEV, V6, P1740; Mantrova EY, 1998, GENE DEV, V12, P1166; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; MUSSACHIO M, 1996, DEV BIOL, V178, P63; NEUMANSILBERBERG FS, 1994, DEVELOPMENT, V120, P2457; NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; Nilson LA, 1998, CELL, V93, P253, DOI 10.1016/S0092-8674(00)81576-7; Perrimon N, 1997, CELL, V89, P13, DOI 10.1016/S0092-8674(00)80177-4; PRICE JV, 1989, CELL, V56, P1085, DOI 10.1016/0092-8674(89)90641-7; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Ray RP, 1996, GENE DEV, V10, P1711, DOI 10.1101/gad.10.14.1711; RAZ E, 1993, GENE DEV, V7, P1937, DOI 10.1101/gad.7.10.1937; Reich A, 1999, DEVELOPMENT, V126, P4139; RUOHOLABAKER H, 1993, CELL, V73, P953, DOI 10.1016/0092-8674(93)90273-S; SCHEJTER ED, 1989, CELL, V56, P1093, DOI 10.1016/0092-8674(89)90642-9; SCHUPBACH T, 1994, CURR OPIN GENET DEV, V4, P502, DOI 10.1016/0959-437X(94)90064-A; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Smit L, 1997, CRIT REV ONCOGENESIS, V8, P359, DOI 10.1615/CritRevOncog.v8.i4.50; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; STRECKER TR, 1989, SCIENCE, V243, P1062, DOI 10.1126/science.2922596; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Van Buskirk C, 1999, TRENDS CELL BIOL, V9, P1, DOI 10.1016/S0962-8924(98)01413-5; Wasserman JD, 1997, TRENDS CELL BIOL, V7, P431, DOI 10.1016/S0962-8924(97)01143-4; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; XU T, 1993, DEVELOPMENT, V117, P1223; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556	58	101	102	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					51	61		10.1016/S0092-8674(00)00104-5	http://dx.doi.org/10.1016/S0092-8674(00)00104-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051547	Bronze			2022-12-28	WOS:000089636400008
J	Hacke, W				Hacke, W			A late step in the right direction of stroke care	LANCET			English	Editorial Material									Klinikum Univ Heidelberg, Dept Neurol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Hacke, W (corresponding author), Klinikum Univ Heidelberg, Dept Neurol, D-69120 Heidelberg, Germany.		Hacke, Werner/ABE-8661-2020					Aboderin I, 1996, J INTERN MED, V240, P173, DOI 10.1046/j.1365-2796.1996.39861000.x; ADAMS HP, 1994, STROKE, V25, P1901, DOI 10.1161/01.STR.25.9.1901; Asplund K, 1997, BMJ-BRIT MED J, V314, P1151; Bogousslavsky J, 1996, CEREBROVASC DIS, V6, P315; European Stroke Council European Neurological Society and European Federation of Neurological Societies, 2000, CEREBROVASC DIS, V10, P335; KALRA L, 1995, STROKE, V26, P2031, DOI 10.1161/01.STR.26.11.2031; WADE DT, 1999, INTERCOLLEGIATE WORK	7	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2000	356	9233					869	870		10.1016/S0140-6736(00)02671-4	http://dx.doi.org/10.1016/S0140-6736(00)02671-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036886				2022-12-28	WOS:000089259800003
J	Westaby, S; Banning, AP; Jarvik, R; Frazier, OH; Pigott, DW; Jin, XY; Catarino, PA; Saito, S; Robson, D; Freeland, A; Myers, TJ; Poole-Wilson, PA				Westaby, S; Banning, AP; Jarvik, R; Frazier, OH; Pigott, DW; Jin, XY; Catarino, PA; Saito, S; Robson, D; Freeland, A; Myers, TJ; Poole-Wilson, PA			First permanent implant of the Jarvik 2000 Heart	LANCET			English	Article							DEVICE; CARDIOMYOPATHY; RECOVERY; SUPPORT; BRIDGE	Background Heart failure is a major public-health concern. Quality and duration of life on maximum medical therapy are poor. The availability of donor hearts is severely limited, therefore an alternative approach is necessary. We have explored the use of a new type of left-ventricular assist device intended as a long-term solution to end-stage heart failure. Methods As part of a prospective clinical trial, we implanted the first permanent Jarvik 2000 Heart-an intraventricular device with an innovative power delivery system-into a 61-year-old man (New York Heart Association functional class IV) with dilated cardiomyopathy. We assessed the effect of this left-ventricular assist device on both native heart function and the symptoms and systemic characteristics of heart failure. Findings The Jarvik 2000 Heart sustained the patient's circulation, and was practical and user-friendly. After 6 weeks, exercise tolerance, myocardial function, and endorgan function improved. Symptoms of heart failure have resolved, and continuous decreased pulse-pressure perfusion has had no adverse effects in the short term. There has been no significant haemolysis and no device-related complications. The skull-mounted pedestal is unobtrusive and has healed well. Conclusions The initial success of this procedure raises the possibility of a new treatment for end-stage heart failure. In the longer term, its role will be determined by mechanical reliability.	John Radcliffe Hosp, Oxford Heart Ctr, Oxford OX3 9DU, England; Texas Heart Inst, Houston, TX 77025 USA; Jarvik Heart Inc, New York, NY USA; Imperial Sch Med, Natl Heart & Lung Inst, London, England; Royal Brompton Hosp, London SW3 6LY, England	University of Oxford; Texas Heart Institute; Imperial College London; Royal Brompton Hospital	Westaby, S (corresponding author), John Radcliffe Hosp, Oxford Heart Ctr, Oxford OX3 9DU, England.		Jin, Xu Yu/AAX-5575-2020; banning, adrian p/AAF-7229-2021	Jin, Xu Yu/0000-0002-6078-7955; Banning, Adrian/0000-0002-2842-7861				DEVRIES WC, 1984, NEW ENGL J MED, V310, P273, DOI 10.1056/NEJM198402023100501; FARBER JF, 1988, J AM GERIATR SOC, V36, P509, DOI 10.1111/j.1532-5415.1988.tb04020.x; FRAZIER OH, 1995, ANN SURG, V222, P327, DOI 10.1097/00000658-199509000-00010; Frazier OH, 1996, ANN THORAC SURG, V62, P675, DOI 10.1016/S0003-4975(96)00437-7; GUYATT GH, 1993, J AM COLL CARDIOL  S, V22, P185; Jarvik R, 1998, ANN THORAC SURG, V65, P470, DOI 10.1016/S0003-4975(97)01343-X; KATSUMATA T, 1998, J CIRC SUPPORT, V1, P13; LEVIN HR, 1995, CIRCULATION, V91, P2717, DOI 10.1161/01.CIR.91.11.2717; Mann DL, 1998, CIRCULATION, V98, P2367, DOI 10.1161/01.CIR.98.22.2367; McCarthy PM, 1996, ANN THORAC SURG, V61, P359, DOI 10.1016/0003-4975(95)00990-6; Muller J, 1997, CIRCULATION, V96, P542; MYERS TJ, 2000, J CONGEST HEART FAIL, V1, P133; PARKIN JL, 1990, ANN OTO RHINOL LARYN, V99, P796, DOI 10.1177/000348949009901008; Schmid C, 1998, ANN THORAC SURG, V65, P1703, DOI 10.1016/S0003-4975(98)00299-9; Westaby S, 1998, CIRCULATION, V98, P1568, DOI 10.1161/01.CIR.98.15.1568	15	92	94	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					900	903		10.1016/S0140-6736(00)02680-5	http://dx.doi.org/10.1016/S0140-6736(00)02680-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036895				2022-12-28	WOS:000089259800012
J	Kaye, J; Martin, P				Kaye, J; Martin, P			Safeguards for research using large scale DNA collections	BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Millennium Festival of Medicine Conference	NOV 06-10, 2000	LONDON, ENGLAND						Univ Oxford St Catherines Coll, Oxford OX1 3UJ, England; Univ Nottingham, Sch Sociol & Social Policy, Genet & Soc Unit, Nottingham NG7 2RD, England	University of Oxford; University of Nottingham	Kaye, J (corresponding author), Univ Oxford St Catherines Coll, Oxford OX1 3UJ, England.			Kaye, Jane/0000-0002-7311-4725	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abbasi K, 2000, BRIT MED J, V320, P1295; BEECHAM L, 2000, BRIT MED J, V321, P72; Frewer L, 1999, AMBIO, V28, P569; *MIN HLTH SOC SEC, 2000, OP LIC ISS ISL ERF E; *MRC, 1999, PERS INF MED RES; *MRC, 1999, REP MRC WORK GROUP D; 1999, WELLCOME NEWS Q, V3, P18	7	35	35	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1146	1149		10.1136/bmj.321.7269.1146	http://dx.doi.org/10.1136/bmj.321.7269.1146			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061743	Green Published			2022-12-28	WOS:000165219600034
J	McArdle, C				McArdle, C			ABC of colorectal cancer - Primary treatment - does the surgeon matter?	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Royal Infirm, Univ Dept Surg, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh	McArdle, C (corresponding author), Royal Infirm, Univ Dept Surg, Edinburgh, Midlothian, Scotland.							Holm T, 1997, BRIT J SURG, V84, P657, DOI 10.1046/j.1365-2168.1997.02745.x; MCARDLE CS, 1991, BRIT MED J, V302, P1501, DOI 10.1136/bmj.302.6791.1501; Parry JM, 1999, BRIT J SURG, V86, P475, DOI 10.1046/j.1365-2168.1999.01064.x; Porter GA, 1998, ANN SURG, V227, P157, DOI 10.1097/00000658-199802000-00001	4	19	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2000	321	7269					1121	1123		10.1136/bmj.321.7269.1121	http://dx.doi.org/10.1136/bmj.321.7269.1121			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061734	Green Published			2022-12-28	WOS:000165219600026
J	Henney, JE				Henney, JE			Clarification on buprenorphine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Henney, JE (corresponding author), US FDA, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2178	2178		10.1001/jama.284.17.2178	http://dx.doi.org/10.1001/jama.284.17.2178			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056574				2022-12-28	WOS:000090052600005
J	Bosch, X				Bosch, X			Spain's science figures under fire	NATURE			English	News Item																		Bosch X, 2000, NATURE, V407, P664, DOI 10.1038/35037775	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					821	821		10.1038/35038212	http://dx.doi.org/10.1038/35038212			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057627	Bronze			2022-12-28	WOS:000089901900004
J	Ivany, LC; Patterson, WP; Lohmann, KC				Ivany, LC; Patterson, WP; Lohmann, KC			Cooler winters as a possible cause of mass extinctions at the eocene/oligocene boundary	NATURE			English	Article							ISOTOPIC COMPOSITION; FISH OTOLITHS; EOCENE; OXYGEN; TEMPERATURES; MISSISSIPPI; PALEOGENE; PATTERNS; ALABAMA; OCEAN	The Eocene/Oligocene boundary, at about 33.7 Myr ago, marks one of the largest extinctions of marine invertebrates in the Cenozoic period(1). For example, turnover of mollusc species in the US Gulf coastal plain was over 90% at this time(2,3). A temperature change across this boundary-from warm Eocene climates to cooler conditions in the Oligocene-has been suggested as a cause of this extinction event(4), but climate reconstructions have not provided support for this hypothesis. Here we report stable oxygen isotope measurements of aragonite in fish otoliths-ear stones-collected across the Eocene/Oligocene boundary. Palaeotemperatures reconstructed from mean otolith oxygen isotope values show little change through this interval, in agreement with previous studies(5,6). From incremental microsampling of otoliths, however, we can resolve the seasonal variation in temperature, recorded as the otoliths continue to accrete new material over the life of the fish. These seasonal data suggest that winters became about 4 degrees C colder across the Eocene/Oligocene boundary. We suggest that temperature variability, rather than change in mean annual temperature, helped to cause faunal turnover during this transition.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Syracuse Univ, Dept Earth Sci, Syracuse, NY 13244 USA	University of Michigan System; University of Michigan; Syracuse University	Ivany, LC (corresponding author), Univ Michigan, Dept Geol Sci, 1006 CC Little Bldg, Ann Arbor, MI 48109 USA.	lcivany@syr.edu	Patterson, William P/J-6473-2012; , Bill/GSD-6628-2022	Patterson, William/0000-0003-3387-708X; Lohmann, Kyger/0000-0002-0709-9192				BAUM JS, 1994, GEOL SOC AM BULL, V106, P824, DOI 10.1130/0016-7606(1994)106<0824:SIEFRA>2.3.CO;2; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; DETTMAN DL, 1993, GEOPH MONOG SERIES, V78, P153; Dockery D. T., 1982, MISSISSIPPI DEP NATU, V123, P1; Dockery D.T. III, 1986, Palaios, V1, P582; Frederiksen N.O., 1988, USGS PROFESSIONAL PA, V1448, P1; GROSSMAN EL, 1986, CHEM GEOL, V59, P59, DOI 10.1016/0168-9622(86)90057-6; Haasl DM, 1996, PALAIOS, V11, P487, DOI 10.2307/3515214; HANSEN T A, 1987, Palaios, V2, P69, DOI 10.2307/3514573; Hansen Thor, 1992, P341; IACUMIN P, 1992, MAR BIOL, V113, P537, DOI 10.1007/BF00349696; KALISH JM, 1991, MAR ECOL PROG SER, V75, P191, DOI 10.3354/meps075191; KALISH JM, 1991, MAR BIOL, V110, P37, DOI 10.1007/BF01313090; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; MACNEIL F. S., 1984, MISSISSIPPI DEP NATU, V124, P1; Miller K.G., 1992, EOCENE OLIGOCENE CLI, P160, DOI [10.1515/9781400862924.160, DOI 10.1515/9781400862924.160]; *NOAA PMEL, 1999, WORLD OC ATL; Oboh FE, 1996, REV PALAEOBOT PALYNO, V91, P23, DOI 10.1016/0034-6667(95)00075-5; PALMER KATHERINE V. W., 1965, BULL AMER PALEONTOL, V48, P1; PALMER KATHERINE V. W., 1966, BULL AMER PALEONTOL, V48, P471; PATTERSON WP, 1993, GEOPH MONOG SERIES, V78, P191; RAUP DM, 1986, SCIENCE, V231, P833, DOI 10.1126/science.11542060; SIESSER WG, 1984, PALAEOGEOGR PALAEOCL, V47, P261, DOI 10.1016/0031-0182(84)90098-1; Valentine J. W., 1973, EVOLUTIONARY PALAEOC; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT; WEIDMAN CR, 1994, J GEOPHYS RES-OCEANS, V99, P18305, DOI 10.1029/94JC01882; YANCEY TE, 1994, PALEOGENE SEQUENCE S; ZACHOS JC, 1992, GEOLOGY, V20, P569, DOI 10.1130/0091-7613(1992)020<0569:EOISEO>2.3.CO;2; ZACHOS JC, 1993, J GEOL, V101, P191, DOI 10.1086/648216; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	30	216	223	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					887	890		10.1038/35038044	http://dx.doi.org/10.1038/35038044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057663	Green Published			2022-12-28	WOS:000089901900046
J	Jayaraman, KS				Jayaraman, KS			India's finest, for hire	NATURE			English	Article																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					830	831		10.1038/35038246	http://dx.doi.org/10.1038/35038246			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057637	Bronze			2022-12-28	WOS:000089901900014
J	Wain-Hobson, S; Weiss, RA				Wain-Hobson, S; Weiss, RA			If free speech costs lives that's a high price to pay	NATURE			English	Letter									Inst Pasteur, Unite Retrovirol Mol, F-75724 Paris, France; UCL, Windeyer Inst Med Sci, London W1T 4JF, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London	Wain-Hobson, S (corresponding author), Inst Pasteur, Unite Retrovirol Mol, 28 Rue Dr Roux, F-75724 Paris, France.							2000, NATURE, V407, P286	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					834	834		10.1038/35038262	http://dx.doi.org/10.1038/35038262			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057643	Bronze			2022-12-28	WOS:000089901900020
J	Brodholt, JP				Brodholt, JP			Pressure-induced changes in the compression mechanism of aluminous perovskite in the Earth's mantle	NATURE			English	Article							SILICATE PEROVSKITE; FERRIC IRON; CRYSTAL-CHEMISTRY; TEMPERATURE	Although aluminium is the fifth most abundant element in the Earth's mantle, its effect on the physical properties of perovskite, the main mineral phase in the lower mantle, has largely been ignored. It is becoming clear, however, that many properties of MgSiO(3) perovskites are remarkably sensitive to small amounts of aluminium(1-4). In particular, perovskite with only 5 wt% Al(2)O(3) has a bulk modulus 10% lower than that of the pure magnesian end-member(12). The increased compressibility may be due to the high concentrations of oxygen vacancies required to balance the charge of the aluminium 5; if so, this would have important consequences for the mantle, as aluminous perovskites could be weaker, have lower seismic velocities and be hosts for water. To test whether oxygen vacancies exist in aluminous perovskites, I have calculated the compressibility of end-member defect-bearing perovskites using ab initio methods. The results show that perovskites with oxygen vacancies do have significantly greater compressibilities than those without such vacancies. But the results also suggest that oxygen vacancies become unfavourable at high pressures, in which case only the physical properties of the shallow lower mantle would be affected by aluminium-with the deeper mantle retaining properties similar to those of aluminium-free perovskite.	UCL, Dept Geol Sci, London WC1E 6BT, England	University of London; University College London	Brodholt, JP (corresponding author), UCL, Dept Geol Sci, Gower St, London WC1E 6BT, England.	j.brodholt@ucl.ac.uk	Brodholt, John P/B-7136-2011	Brodholt, John P/0000-0001-7395-5834				Andrault D, 1998, AM MINERAL, V83, P1045; Fei YW, 1999, AM MINERAL, V84, P272; Ito E, 1998, GEOPHYS RES LETT, V25, P821, DOI 10.1029/98GL00519; KESSON SE, 1995, EARTH PLANET SC LETT, V134, P187, DOI 10.1016/0012-821X(95)00112-P; McCammon C, 1997, NATURE, V387, P694, DOI 10.1038/42685; MCCAMMON C, 1999, EOS, V80, pF742; McCammon CA, 1998, PHYS CHEM MINER, V25, P292, DOI 10.1007/s002690050117; *MOL SIM INC, 1999, CASTEP VERS 3 9; Navrotsky A, 1999, SCIENCE, V284, P1788, DOI 10.1126/science.284.5421.1788; Richmond NC, 1998, AM MINERAL, V83, P947; Smyth DM, 1996, PHASE TRANSIT, V58, P57; Wood BJ, 1996, SCIENCE, V273, P1522, DOI 10.1126/science.273.5281.1522; Xu YS, 1998, SCIENCE, V282, P922, DOI 10.1126/science.282.5390.922; Zhang JZ, 1999, SCIENCE, V284, P782, DOI 10.1126/science.284.5415.782	14	124	126	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					620	622		10.1038/35036565	http://dx.doi.org/10.1038/35036565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034208				2022-12-28	WOS:000089772800044
J	Mizzen, CA; Allis, CD				Mizzen, CA; Allis, CD			Transcription - New insights into an old modification	SCIENCE			English	Editorial Material							CHROMATIN STRUCTURE; HISTONE; PHOSPHORYLATION		Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Mizzen, CA (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	cam8y@virginia.edu; allis@virginia.edu						DePinho RA, 1998, NATURE, V391, P533, DOI 10.1038/35257; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dikstein R, 1996, CELL, V84, P781, DOI 10.1016/S0092-8674(00)81055-7; Dou YL, 2000, MOL CELL, V6, P225, DOI 10.1016/S1097-2765(00)00024-1; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Dunphy EL, 2000, MOL CELL BIOL, V20, P1134, DOI 10.1128/MCB.20.4.1134-1139.2000; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Herrera RE, 1996, P NATL ACAD SCI USA, V93, P11510, DOI 10.1073/pnas.93.21.11510; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P958, DOI 10.1021/bi00429a006; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Paro R, 2000, NATURE, V406, P579, DOI 10.1038/35020675; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; SEKIGUCHI T, 1988, EMBO J, V7, P1683, DOI 10.1002/j.1460-2075.1988.tb02996.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5	19	25	27	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2000	289	5488					2290	2291		10.1126/science.289.5488.2290	http://dx.doi.org/10.1126/science.289.5488.2290			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11041795				2022-12-28	WOS:000089593500032
J	Hansen, D; Lou, HC; Olsen, J				Hansen, D; Lou, HC; Olsen, J			Serious life events and congenital malformations: a national study with complete follow-up	LANCET			English	Article							CARDIAC NEURAL CREST; DENMARK; CORTICOSTEROIDS; PREGNANCY; TWINS; RISK	Background Emotional stress during organogenesis could, in theory, cause congenital malformations. We undertook a follow-up study to test the hypothesis that psychosocial stress increases the prevalence of malformations, particularly of the cranial neural crest. Methods We defined severe life events as death or first hospital admission for cancer or acute myocardial infarction in partners or children. From 1980 to 1992 all women exposed to severe life events during pregnancy and up to 16 months previously were identified by means of five national registers. We included 3560 exposed pregnancies and 20 299 pregnancies without such exposures randomly selected as a control cohort. Findings The frequency of cranial-neural-crest malformations was higher in pregnancies with exposure to severe life events than in those without such exposure (42 [1.18%] vs 131[0.65%]; adjusted odds ratio 1.54 [95% CI 1.05-2.27]). For other malformations, the frequencies were 3.04% and 3.26% (1.14 [0.94-1.42]). Women exposed in two consecutive pregnancies had a higher risk of cranial-neural-crest malformations (2.99 [1.06-8.43]). Death of an older child during the first trimester was associated with an adjusted odds ratio of cranial-neural-crest malformations of 4.75 (1.63-13.8). Unexpected death of a child during the first trimester was associated with adjusted odds ratios of 8.36 (2.41-29.0) for cranial-neural-crest malformations and 3.64 (1.29-10.3) for other malformations. Interpretation These findings support the hypothesis that severe emotional stress during pregnancy, especially that related to death of a child, may cause congenital malformations, particularly those of the cranial neural crest.	John F Kennedy Inst, Neuropediat Dept, DK-2600 Glostrup, Denmark; Danish Epidemiol Sci Ctr, Copenhagen, Denmark; Danish Epidemiol Sci Ctr, Aarhus, Denmark	Aarhus University; Aarhus University	Hansen, D (corresponding author), John F Kennedy Inst, Neuropediat Dept, GI Landevej 7, DK-2600 Glostrup, Denmark.							ADAMS MM, 1989, J AM COLL CARDIOL, V14, P432, DOI 10.1016/0735-1097(89)90199-X; *AM PSYCH ASS, 1987, DIAGN CRIT DSMIIIR; Basso O, 1999, AM J EPIDEMIOL, V150, P598; BLOMBERG S, 1980, ACTA PSYCHIAT SCAND, V62, P315, DOI 10.1111/j.1600-0447.1980.tb00618.x; Bohman M, 1971, Acta Paediatr Scand Suppl, V221, P1; CARLSON BM, 1996, PATTENS FDN EMBRYOLO; Carmichael SL, 2000, EPIDEMIOLOGY, V11, P30, DOI 10.1097/00001648-200001000-00008; Christensen K, 1998, DAN MED BULL, V45, P91; Czeizel AE, 1997, TERATOLOGY, V56, P335, DOI 10.1002/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W; *DANM STAT, 1998, FERT DAT GUID EXTR D, P1; DOYLE PE, 1991, J EPIDEMIOL COMMUN H, V45, P43, DOI 10.1136/jech.45.1.43; FRASER FC, 1951, PEDIATRICS, V8, P527; Hansen D, 1999, BRIT MED J, V319, P548, DOI 10.1136/bmj.319.7209.548; HULTIN M, 1971, ACTA PSYCHIAT SCAND, V221, P59; JOHNSTON MC, 1995, CRIT REV ORAL BIOL M, V6, P368, DOI 10.1177/10454411950060040601; Kallen B, 1999, OBSTET GYNECOL, V93, P392, DOI 10.1016/S0029-7844(98)00454-2; KIRBY ML, 1985, ANAT RECORD, V213, P87, DOI 10.1002/ar.1092130112; KIRBY ML, 1987, PEDIATR RES, V21, P219, DOI 10.1203/00006450-198703000-00001; KNUDSEN LB, 1986, COMMUNITY MED, V8, P29; Knudsen LB, 1998, DAN MED BULL, V45, P221; LARSEN W, 1997, J HUMAN EMBRYOLOGY; LAYDE PM, 1980, AM J HUM GENET, V32, P69; LEDOUARIN NM, 1993, DEV BIOL, V159, P24, DOI 10.1006/dbio.1993.1219; LOU HC, 1994, DEV MED CHILD NEUROL, V36, P826; OLSEN J, 1993, SCAND J SOC MED, V21, P90, DOI 10.1177/140349489302100206; POLEDNAK AP, 1976, AM J OBSTET GYNECOL, V126, P734, DOI 10.1016/0002-9378(76)90534-2; Robert E, 1994, Int J Risk Saf Med, V6, P75, DOI 10.3233/JRS-1994-6201; Rodriguez-Pinilla E, 1998, TERATOLOGY, V58, P2, DOI 10.1002/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-4; Sadler TW, 1995, LANGMANS MED EMBRYOL; Sterling P., 1988, HDB LIFE STRESS COGN, P629, DOI DOI 10.1016/0005-7967(90)90076-U; SULIK KK, 1988, DEVELOPMENT, V103, P213; *SYG, 1981, SUNDH AKT I SYG; THOROGOOD P, 1997, EMBRYOS GENES BIRTH, P197; Torczynski E, 1989, EYE INFANCY, P9; Waldo K, 1998, DEV BIOL, V196, P129, DOI 10.1006/dbio.1998.8860	35	158	163	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					875	880		10.1016/S0140-6736(00)02676-3	http://dx.doi.org/10.1016/S0140-6736(00)02676-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036891				2022-12-28	WOS:000089259800008
J	Langley, P				Langley, P			Why a pomegranate?	BRITISH MEDICAL JOURNAL			English	Article									British Med Assoc, London WC1H 9JP, England		Langley, P (corresponding author), British Med Assoc, London WC1H 9JP, England.							[Anonymous], SONG SOLOMON, V4, P7; *CHELS PHYS GARD C, 1997, TREES CHELS PHYS GAR, P14; CHERRY J, 1995, MYTHICAL BEASTS, P47; CHEVALLIER A, 1996, ENCY MED PLANTS, P257; COOPER JC, 1995, ILLUSTRATED ENCY TRA, P134; CURTIS VS, 1996, PERSIAN MYTHS, P54; Freeman Margaret B., 1976, UNICORN TAPESTRIES; GARRISON W, 1980, STRANGE FACTS BIBLE, P184; GOOD A, 1968, FRUITS HOLY LAND; GUNTER RT, 1934, GREEK HERBAL DIOSCOR, P80; HALL J, 1995, HALLS ILLUSTRATED DI; HERODOTUS, 1996, HISTORIES, P389; MASON AS, 1992, J ROY COLL PHYS LOND, V26, P231; Modi Jivanji Jamshedji, 1922, RELIG CEREMONIES CUS; WIGODER DE, 1988, GARDEN EDEN COOKBOOK; 1983, NEW LAROUSSE ENCY MY	16	76	82	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1153	1154		10.1136/bmj.321.7269.1153	http://dx.doi.org/10.1136/bmj.321.7269.1153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061746	Green Published			2022-12-28	WOS:000165219600037
J	Iverson, RM; Reid, ME; Iverson, NR; LaHusen, RG; Logan, M; Mann, JE; Brien, DL				Iverson, RM; Reid, ME; Iverson, NR; LaHusen, RG; Logan, M; Mann, JE; Brien, DL			Acute sensitivity of landslide rates to initial soil porosity	SCIENCE			English	Article								Some landslides move imperceptibly downslope, whereas others accelerate catastrophically. Experimental Landslides triggered by rising pore water pressure moved at sharply contrasting rates due to small differences in initial porosity. Wet sandy soil with porosity of about 0.5 contracted during slope failure, partially liquefied, and accelerated within 1 second to speeds over 1 meter per second. The same soil with porosity of about 0.4 dilated during failure and slipped episodically at rates averaging 0.002 meter per second. Repeated slip episodes were induced by gradually rising pore water pressure and were arrested by pore dilation and attendant pore pressure decline.	US Geol Survey, Vancouver, WA 98661 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Iowa State Univ, Dept Geol & Atmospher Sci, Ames, IA 50011 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Iowa State University	Iverson, RM (corresponding author), US Geol Survey, 5400 MacArthur Blvd, Vancouver, WA 98661 USA.							ANDERSON SA, 1995, J GEOTECH ENG-ASCE, V121, P216, DOI 10.1061/(ASCE)0733-9410(1995)121:2(216); Blake GR., 1965, AGRONOMY, V9, P374, DOI [10.2134/agronmonogr9.1.c30, DOI 10.2134/AGRONMONOGR9.1.C30]; CASAGRANDE A, 1936, J BOSTON SOC CIV JAN, P13; Castro G, 1969, THESIS HARVARD U CAM; ECKERSLEY D, 1990, GEOTECHNIQUE, V40, P489, DOI 10.1680/geot.1990.40.3.489; FLEMING RW, 1989, ENG GEOL, V27, P201, DOI 10.1016/0013-7952(89)90034-3; Iverson NR, 1997, QUATERNARY SCI REV, V16, P1057, DOI 10.1016/S0277-3791(97)00036-X; Iverson RM, 2000, WATER RESOUR RES, V36, P1897, DOI 10.1029/2000WR900090; Iverson RM, 1997, ANNU REV EARTH PL SC, V25, P85, DOI 10.1146/annurev.earth.25.1.85; IVERSON RM, 1989, SCIENCE, V246, P796, DOI 10.1126/science.246.4931.796; LEROUEIL S, 1996, GEOTECHNICAL SPECIAL, V61, P1; MANN JE, 1999, EOS S, V80, pF443; Reid ME, 1997, DEBRIS-FLOW HAZARDS MITIGATION: MECHANICS, PREDICTION & ASSESSMENT, P1; Reynolds O., 1886, NATURE, V33, P429; Schofield A.N., 1968, CRITICAL STATE SOIL; Turner A.K., 1996, LANDSLIDES INVESTIGA; Wang GH, 1998, FOR SCI, V54, P591	17	243	261	8	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2000	290	5491					513	516		10.1126/science.290.5491.513	http://dx.doi.org/10.1126/science.290.5491.513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039931				2022-12-28	WOS:000089946000050
J	Peterson, BS; Vohr, B; Staib, LH; Cannistraci, CJ; Dolberg, A; Schneider, KC; Katz, KH; Westerveld, M; Sparrow, S; Anderson, AW; Duncan, CC; Makuch, RW; Gore, JC; Ment, LR				Peterson, BS; Vohr, B; Staib, LH; Cannistraci, CJ; Dolberg, A; Schneider, KC; Katz, KH; Westerveld, M; Sparrow, S; Anderson, AW; Duncan, CC; Makuch, RW; Gore, JC; Ment, LR			Regional brain volume abnormalities and long-term cognitive outcome in preterm infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT INFANTS; CEREBRAL BLOOD-FLOW; POSITRON EMISSION TOMOGRAPHY; SCHOOL-AGE-CHILDREN; INTRAVENTRICULAR HEMORRHAGE; PERIVENTRICULAR LEUKOMALACIA; CRANIAL ULTRASOUND; DISTINCT PATTERN; NEWBORN; RELIABILITY	Context Preterm infants have a high prevalence of long-term cognitive and behavioral disturbances. However, it is not known whether the stresses associated with premature birth disrupt regionally specific brain maturation or whether abnormalities in brain structure contribute to cognitive deficits. Objective To determine whether regional brain volumes differ between term and preterm children and to examine the association of regional brain volumes in prematurely born children with long-term cognitive outcomes. Design and Setting Case-control study conducted in 1998 and 1999 at 2 US university medical schools. Participants A consecutive sample of 25 eight-year-old preterm children recruited from a longitudinal follow-up study of preterm infants and 39 term control children who were recruited from the community and who were comparable with the preterm children in age, sex, maternal education, and minority status. Main Outcome Measures Volumes of cortical subdivisions, Ventricular system, cerebellum, basal ganglia, corpus callosum, amygdala, and hippocampus, derived from structural magnetic resonance imaging scans and compared between preterm and term children; correlations of regional brain volumes with cognitive measures (at age 8 years) and perinatal variables among preterm children. Results Regional cortical volumes were significantly smaller in the preterm children, most prominently in sensorimotor regions (difference: left, 14.6%; right, 14.3% [P<.001 for both]) but also in premotor (left, 11.2%; right, 12.6% [P<.001 for both]), midtemporal (left, 7.4% [P=.01]; right, 10.2% [P<.001]), parieto-occipital (left, 7.9% [P=.01]; right, 7.4% [P=.005]), and subgenual (left, 8.9% [P=.03]; right, 11.7% [P=.01])cortices. Preterm children's brain volumes were significantly larger (by 105.7%-271.6%) in the occipital and temporal horns of the ventricles (P<.001 for all) and smaller in the cerebellum (6.7%; P=.02), basal ganglia (11.4%-13.8%; P less than or equal to.005), amygdala (left, 20.2% [P=.001]; right, 30.0% [P<.001]), hippocampus (left, 16.0% [P=.001]; right, 12.0% [P=.007]), and corpus callosum (13.1%-35.2%; P less than or equal to.01 for all). Volumes of sensorimotor and midtemporal cortices were associated positively with full-scale, verbal, and performance IQ scores (P<.01 for all). Conclusions Our data indicate that preterm birth is associated with regionally specific, long-term reductions in brain volume and that morphological abnormalities are, in turn, associated with poorer cognitive outcome.	Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Diagnost Imaging, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; Brown Univ, Sch Med, Dept Pediat, Providence, RI 02912 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Brown University	Peterson, BS (corresponding author), Yale Univ, Ctr Child Study, 230 S Frontage Rd, New Haven, CT 06520 USA.			Staib, Lawrence/0000-0002-9516-5136	NCRR NIH HHS [RR 06022] Funding Source: Medline; NINDS NIH HHS [NS 27116, NS 35476] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035476, R01NS027116] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achenbach T M, 1991, Monogr Soc Res Child Dev, V56, P1; ALLAN WC, 1985, CLIN PERINATOL, V12, P195, DOI 10.1016/S0095-5108(18)30892-3; AZZARELLI B, 1980, CHILD BRAIN, V7, P132; Beery K. E., 2016, PEARSON; Borch K, 1998, PEDIATR RES, V43, P28, DOI 10.1203/00006450-199801000-00005; Caviness VS, 1996, J COGNITIVE NEUROSCI, V8, P566, DOI 10.1162/jocn.1996.8.6.566; CHUGANI HT, 1986, SCIENCE, V231, P840, DOI 10.1126/science.3945811; Cohen J., 1977, STAT ANAL BEHAV SCI; CONSTANTINE NA, 1987, J PEDIATR-US, V110, P921, DOI 10.1016/S0022-3476(87)80416-X; Cooke RWI, 1999, ARCH DIS CHILD-FETAL, V81, pF116, DOI 10.1136/fn.81.2.F116; DEVRIES LS, 1993, NEUROPEDIATRICS, V24, P263, DOI 10.1055/s-2008-1071554; Guo SS, 1997, EARLY HUM DEV, V47, P305, DOI 10.1016/S0378-3782(96)01793-8; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; Hack M, 1996, PEDIATRICS, V98, P931; Hegyi T, 1998, PEDIATRICS, V101, P77, DOI 10.1542/peds.101.1.77; Huppi PS, 1996, PEDIATR RES, V39, P895; Huppi PS, 1998, PEDIATR RES, V44, P584; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P27, DOI 10.1001/archneur.1990.00530010035015; Kates WR, 1997, PSYCHIAT RES-NEUROIM, V75, P31, DOI 10.1016/S0925-4927(97)00019-X; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; LOU HC, 1979, J PEDIATR-US, V95, P606, DOI 10.1016/S0022-3476(79)80779-9; LOW JA, 1993, ACTA PAEDIATR, V82, P433, DOI 10.1111/j.1651-2227.1993.tb12717.x; McCormick MC, 1996, PEDIATRICS, V97, P18; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; MENT LR, 1984, J PEDIATR-US, V104, P419, DOI 10.1016/S0022-3476(84)81109-9; Ment LR, 1999, PEDIATRICS, V104, P243, DOI 10.1542/peds.104.2.243; MENT LR, 1994, PEDIATRICS, V93, P543; MURPHY DJ, 1996, ARCH DIS CHILD, V75, P27; Olsen P, 1998, PEDIATRICS, V102, P329, DOI 10.1542/peds.102.2.329; Olsen P, 1997, ANN NEUROL, V41, P754, DOI 10.1002/ana.410410611; Pandya DN., 1986, 2 HEMISPHERES ONE BR, P47; Peterson BS, 2000, ARCH GEN PSYCHIAT, V57, P364, DOI 10.1001/archpsyc.57.4.364; PETERSON BS, IN PRESS ARCH GEN PS; PETERSON BS, IN PRESS HUM BRAIN M; PRYDS O, 1991, ANN NEUROL, V30, P321, DOI 10.1002/ana.410300302; RADEMAKERS RP, 1995, J COMPUT ASSIST TOMO, V19, P256, DOI 10.1097/00004728-199503000-00017; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAMAEKERS VT, 1990, EARLY HUM DEV, V24, P249, DOI 10.1016/0378-3782(90)90032-E; Rosenbaum JL, 1997, NEUROLOGY, V49, P1035, DOI 10.1212/WNL.49.4.1035; SCHLESSELMAN JJ, 1982, CASE CONTROL STUDIES, P105; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Sykes DH, 1997, J CHILD PSYCHOL PSYC, V38, P315, DOI 10.1111/j.1469-7610.1997.tb01516.x; VOLPE JJ, 1985, ANN NEUROL, V17, P287, DOI 10.1002/ana.410170312; VOLPE JJ, 1983, PEDIATRICS, V72, P589; Wechsler D., 1991, MANUAL WECHSLER INTE; Whitaker AH, 1997, ARCH GEN PSYCHIAT, V54, P847; WOLKE D, 1991, J CHILD PSYCHOL PSYC, V32, P723, DOI 10.1111/j.1469-7610.1991.tb01898.x	48	718	738	0	46	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1939	1947		10.1001/jama.284.15.1939	http://dx.doi.org/10.1001/jama.284.15.1939			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	362JC	11035890	Bronze			2022-12-28	WOS:000089774000026
J	Teruel, MN; Meyer, T				Teruel, MN; Meyer, T			Translocation and reversible localization of signaling proteins: A dynamic future for signal transduction	CELL			English	Review							LATERAL MOBILITY; RECEPTOR; MEMBRANE; CELLS; ACTIVATION; AKT/PKB; KINASE; CAMP		Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University	Teruel, MN (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, 269 Campus Dr, Stanford, CA 94305 USA.	mteruel@stanford.edu; tobiasmeyer@stanford.edu		Teruel, Mary/0000-0002-2854-3598; Meyer, Tobias/0000-0003-4339-3804				Arrio-Dupont M, 2000, BIOPHYS J, V78, P901, DOI 10.1016/S0006-3495(00)76647-1; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; GOUGH AH, 1993, J CELL BIOL, V121, P1095, DOI 10.1083/jcb.121.5.1095; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; JANS DA, 1990, EMBO J, V9, P2693, DOI 10.1002/j.1460-2075.1990.tb07455.x; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Niv H, 1999, J BIOL CHEM, V274, P1606, DOI 10.1074/jbc.274.3.1606; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Stauffer TP, 1997, J CELL BIOL, V139, P1447, DOI 10.1083/jcb.139.6.1447; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	19	184	190	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 13	2000	103	2					181	184		10.1016/S0092-8674(00)00109-4	http://dx.doi.org/10.1016/S0092-8674(00)00109-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057890	Bronze			2022-12-28	WOS:000089864300001
J	Lamers, MH; Perrakis, A; Enzlin, JH; Winterwerp, HHK; de Wind, N; Sixma, TK				Lamers, MH; Perrakis, A; Enzlin, JH; Winterwerp, HHK; de Wind, N; Sixma, TK			The crystal structure of DNA mismatch repair protein MutS binding to a G center dot T mismatch	NATURE			English	Article							ESCHERICHIA-COLI; HMUTS-ALPHA; TRANSLOCATION MECHANISM; HETERODUPLEX DNA; ATPASE ACTIVITY; RECOGNITION; COMPLEX; HYDROLYSIS; CANCER; ENDONUCLEASE	DNA mismatch repair ensures genomic integrity on DNA replication. Recognition of a DNA mismatch by a dimeric MutS protein initiates a cascade of reactions and results in repair of the newly synthesized strand; however, details of the molecular mechanism remain controversial. Here we present the crystal structure at 2.2 Angstrom of MutS from Escherichia coli bound to a G.T mismatch. The two MutS monomers have different conformations and form a heterodimer at the structural level. Only one monomer recognizes the mismatch specifically and has ADP bound. Mismatch recognition occurs by extensive minor groove interactions causing unusual base pairing and kinking of the DNA. Nonspecific major groove DNA-binding domains from both monomers embrace the DNA in a clamp-like structure. The interleaved nucleotide-binding sites are located far from the DNA. Mutations in human MutS alpha (MSH2/MSH6) that lead to hereditary predisposition for cancer, such as hereditary non-polyposis colorectal cancer, can be mapped to this crystal structure.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; European Mol Biol Lab, ILL, F-38043 Grenoble, France	Netherlands Cancer Institute; European Molecular Biology Laboratory (EMBL); Institut Laue-Langevin (ILL)	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	sixma@nki.nl	Lamers, Meindert/AGG-8911-2022; Perrakis, Anastassis/E-8704-2013	Lamers, Meindert/0000-0002-4205-1338; Sixma, Titia K/0000-0001-6180-0632; Perrakis, Anastassis/0000-0002-1151-6227				Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Biswas I, 1999, J BIOL CHEM, V274, P23673, DOI 10.1074/jbc.274.33.23673; Biswas I, 2000, BIOCHEM J, V347, P881, DOI 10.1042/0264-6021:3470881; Bjornson KP, 2000, BIOCHEMISTRY-US, V39, P3176, DOI 10.1021/bi992286u; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; Culligan KM, 2000, NUCLEIC ACIDS RES, V28, P463, DOI 10.1093/nar/28.2.463; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; FISHEL RA, 1986, J MOL BIOL, V188, P147, DOI 10.1016/0022-2836(86)90300-1; Galio L, 1999, NUCLEIC ACIDS RES, V27, P2325, DOI 10.1093/nar/27.11.2325; GERSTEIN M, 1993, J MOL BIOL, V229, P494, DOI 10.1006/jmbi.1993.1048; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; HUNTER WN, 1992, METHOD ENZYMOL, V211, P221; Iaccarino I, 2000, J BIOL CHEM, V275, P2080, DOI 10.1074/jbc.275.3.2080; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joshi A, 2000, NUCLEIC ACIDS RES, V28, P853, DOI 10.1093/nar/28.4.853; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; Lynch HT, 1999, J MED GENET, V36, P801; Malkov VA, 1997, J BIOL CHEM, V272, P23811, DOI 10.1074/jbc.272.38.23811; Marra G, 1999, BIOCHEM J, V338, P1, DOI 10.1042/0264-6021:3380001; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANUSKA JR, 1980, J BIOL CHEM, V255, P5208; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1988, J BIOL CHEM, V263, P6829; Takamatsu S, 1996, NUCLEIC ACIDS RES, V24, P640, DOI 10.1093/nar/24.4.640; Tsutakawa SE, 1999, CELL, V99, P615, DOI 10.1016/S0092-8674(00)81550-0; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wu TH, 1999, J BIOL CHEM, V274, P5948, DOI 10.1074/jbc.274.9.5948	50	528	537	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					711	717		10.1038/35037523	http://dx.doi.org/10.1038/35037523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048711				2022-12-28	WOS:000089773900033
J	Alley, PG				Alley, PG			Surgery for colorectal cancer in elderly patients	LANCET			English	Editorial Material									N Shore Hosp, Dept Surg, Auckland, New Zealand		Alley, PG (corresponding author), N Shore Hosp, Dept Surg, Auckland, New Zealand.							*GASTR TUM STUD GR, 1985, NEW ENGL J MED, V312, P1464; Heald RJ, 1997, RECTAL CANC SURG OPT, P203; *NHS HOSP ACT STAT, 1998, STAT B, P31; Slaney G, 1971, Mod Trends Surg, V3, P69; *WHO, 1997, WORLD HLTH STAT ANN	5	18	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					956	956		10.1016/S0140-6736(00)02707-0	http://dx.doi.org/10.1016/S0140-6736(00)02707-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041391				2022-12-28	WOS:000089293600004
J	Levin, M; Quint, PA; Goldstein, B; Barton, P; Bradley, JS; Shemie, SD; Yeh, T; Kim, SS; Cafaro, DP; Scannon, PJ; Giroir, BP				Levin, M; Quint, PA; Goldstein, B; Barton, P; Bradley, JS; Shemie, SD; Yeh, T; Kim, SS; Cafaro, DP; Scannon, PJ; Giroir, BP		rBPI21 Meningococcal Sepsis Study	Recombinant bactericidal/permeability-increasing protein (rBPI(21)) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial	LANCET			English	Article							AMINO-TERMINAL FRAGMENT; ENDOTOXIN; BINDING; PATHOPHYSIOLOGY; INFECTIONS; INHIBITION; ACTIVATION; RELEASE; SCORE	Background Endotoxin is a primary trigger of the inflammatory processes that lead to shock, multiorgan failure, and purpura fulminans in meningococcal sepsis. Bactericidal/permeability-increasing protein (BPI) is a natural protein, stored within the neutrophil granules, that binds to and neutralises the effects of endotoxin in vitro, in laboratory animals, and in humans. To establish whether a recombinant 21-kDa modified fragment of human BPI (rBPI(21)), containing the active antimicrobial and endotoxin-neutralising moiety, would decrease death and long-term disability from meningococcal sepsis, we did a randomised, double-blind, placebo-controlled trial of rBPI(21) in children with severe meningococcal sepsis. Methods We enrolled children (2 weeks to 18 years of age) presenting to 22 centres in the UK and the USA with a clinical picture suggestive of meningococcal sepsis, and with evidence of severe disease. Children were randomly assigned rBPI(21) (2 mg/kg over 30 min followed by 2 mg/kg over 24 h) or placebo (0.2 mg/mL human albumin solution) in addition to conventional medical therapy. Primary outcome variables were mortality, amputations, and change in paediatric overall performance category (POPC) from before illness to day 60. Analysis was by intention to treat. Findings Of 1287 patients screened, 892 were excluded, including 57 patients who died or who met criteria for imminent death before receiving the study drug. 190 patients received rBPI(21), and 203 placebo. 34 (8.7%) of 393 patients died during the study: 14 (7.4%) in the rBPI(21) group and 20 (9.9%) in the placebo group (odds ratio 1.31 [95% CI 0.62-2.74], p=0.48). Compared with patients randomised to placebo, fewer patients treated with rBPI(21) had multiple severe amputations (six of 190 [3.2%] vs 15 of 203 [7.4%], odds ratio 2.47 [0.94-6.51], p=0.067), and more had a functional outcome similar to that before illness (as measured by the POPC scale) at day 60 (136 of 176 [77.3%] vs 126 of 190 [66.3%], p=0.019). Interpretation Because most deaths occurred in the interval between identification of patients and study drug administration, the mortality rate in the placebo group was substantially lower than predicted. The trial was therefore underpowered to detect significant differences in mortality. However, patients receiving rBPI(21) had a trend towards improved outcome in all primary outcome variables. Given the excellent severity match between placebo and rBPI(21) groups at study entry, the results overall indicate that rBPI(21) is beneficial in decreasing complications of meningococcal disease.	Childrens Med Ctr, Dallas, TX 75235 USA; Imperial Coll Sch Med, London, England; Legacy Emanuel Hosp, Portland, OR USA; Oregon Hlth Sci Univ, Portland, OR 97201 USA; Childrens Hosp St Francis, Tulsa, OK USA; Childrens Hosp, San Diego, CA USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Childrens Hosp, Oakland, CA 94609 USA; XOMA US LLC, Berkeley, CA USA	Imperial College London; Oregon Health & Science University; Children's Hospital Los Angeles; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Giroir, BP (corresponding author), Childrens Med Ctr, Dallas, TX 75235 USA.		; Faust, Saul/J-9779-2014	Gedeit, Rainer/0000-0003-2420-9493; Faust, Saul/0000-0003-3410-7642; Levin, Michael/0000-0003-2767-6919				Ammons WS, 1996, J ENDOTOXIN RES, V3, P57; AMMONS WS, 1996, NOVEL THERAPEUTIC ST, P55; APPELMELK BJ, 1994, INFECT IMMUN, V62, P3564, DOI 10.1128/IAI.62.8.3564-3567.1994; BRANDTZAEG P, 1995, MENINGOCOCCAL DIS, P71; Cohen J, 1999, BRIT MED BULL, V55, P212, DOI 10.1258/0007142991902222; de Kleijn ED, 1998, EUR J PEDIATR, V157, P869, DOI 10.1007/s004310050958; Derkx B, 1999, CLIN INFECT DIS, V28, P770, DOI 10.1086/515184; ELSBACH P, 1995, INFECT AGENT DIS, V4, P102; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; GAZZANOSANTORO H, 1995, INFECT IMMUN, V63, P2201, DOI 10.1128/IAI.63.6.2201-2205.1995; Giroir BP, 1997, LANCET, V350, P1439, DOI 10.1016/S0140-6736(97)06468-4; HEYDERMAN RS, 1993, RECENT ADV PAEDIAT, V2, P1; Horwitz AH, 1996, PROTEIN EXPRES PURIF, V8, P28, DOI 10.1006/prep.1996.0071; JONES D, 1995, MENINGOCOCCAL DIS, P147; KAHN A, 1978, CLIN PEDIATR, V17, P680, DOI 10.1177/000992287801700902; Kirsch EA, 1996, PEDIATR INFECT DIS J, V15, P967, DOI 10.1097/00006454-199611000-00009; MCMANUS ML, 1993, CRIT CARE MED, V21, P706, DOI 10.1097/00003246-199305000-00014; NADEL S, 1995, MENINGOCOCCAL DIS, P207; OOI CE, 1991, J EXP MED, V174, P649, DOI 10.1084/jem.174.3.649; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Schildkamp RL, 1996, SCAND J INFECT DIS, V28, P47, DOI 10.3109/00365549609027149; TESORO LJ, 1991, AM J DIS CHILD, V145, P218, DOI 10.1001/archpedi.1991.02160020112029; THOMSON APJ, 1991, CRIT CARE MED, V19, P26, DOI 10.1097/00003246-199101000-00010; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; VONDERMOHLEN MAM, 1995, BLOOD, V85, P3437, DOI 10.1182/blood.V85.12.3437.bloodjournal85123437; VONDERMOHLEN MAM, 1995, J INFECT DIS, V172, P144, DOI 10.1093/infdis/172.1.144; WEISS J, 1992, J CLIN INVEST, V90, P1122, DOI 10.1172/JCI115930; YAO YM, 1995, ANN SURG, V221, P398, DOI 10.1097/00000658-199504000-00011	30	267	289	1	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					961	967		10.1016/S0140-6736(00)02712-4	http://dx.doi.org/10.1016/S0140-6736(00)02712-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041396				2022-12-28	WOS:000089293600009
J	McCarthy, M				McCarthy, M			Fighting for public health along the USA-Mexico border	LANCET			English	Article									Lancet, London WC1X 8RR, England		McCarthy, M (corresponding author), Lancet, 84 Theobalds Rd, London WC1X 8RR, England.		Potter, Joseph E/A-3122-2008						0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					1020	1022		10.1016/S0140-6736(00)02700-8	http://dx.doi.org/10.1016/S0140-6736(00)02700-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041415				2022-12-28	WOS:000089293600040
J	Gemperli, MP				Gemperli, MP			Rethinking the role of the learned intermediary: The effect of direct-to-consumer advertising on litigation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Gemperli, MP (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.							HUTTON MB, 1996, TRIAL, V32, P74; Terzian TV, 1999, AM J LAW MED, V25, P149	2	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2241	2241		10.1001/jama.284.17.2241	http://dx.doi.org/10.1001/jama.284.17.2241			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056600	hybrid			2022-12-28	WOS:000090052600036
J	Goddard, J; Jarratt, J; de Castro, FR				Goddard, J; Jarratt, J; de Castro, FR			Evolution of the fire ant lesion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDOORS		Mississippi State Dept Hlth, Jackson, MS 39215 USA; Mississippi State Univ, Starkville, MS USA; Dermatopathol Reference Lab, Lexington, KY USA	Mississippi State University	Goddard, J (corresponding author), Mississippi State Dept Hlth, 2423 N State St,POB 1700, Jackson, MS 39215 USA.							BAER H, 1979, TOXICON, V17, P397, DOI 10.1016/0041-0101(79)90267-8; BUREN W F, 1972, Journal of the Georgia Entomological Society, V7, P1; DESHAZO RD, 1994, J ALLERGY CLIN IMMUN, V93, P847, DOI 10.1016/0091-6749(94)90376-X; DESHAZO RD, 1995, SOUTHERN MED J, V88, P712, DOI 10.1097/00007611-199507000-00003; deShazo RD, 1999, ANN INTERN MED, V131, P424, DOI 10.7326/0003-4819-131-6-199909210-00005; FOX RW, 1982, J ALLERGY CLIN IMMUN, V70, P120, DOI 10.1016/0091-6749(82)90239-1; GODDARD J, 2000, PHYSICIANS GUIDE ART; Levy A. L., 1998, Journal of Agromedicine, V5, P49, DOI 10.1300/J096v05n04_05; LOFGREN CS, 1975, ANNU REV ENTOMOL, V20, P1, DOI 10.1146/annurev.en.20.010175.000245; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141	10	10	12	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2162	2163		10.1001/jama.284.17.2162	http://dx.doi.org/10.1001/jama.284.17.2162			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056570				2022-12-28	WOS:000090052600002
J	Callaway, RM; Aschehoug, ET				Callaway, RM; Aschehoug, ET			Invasive plants versus their new and old neighbors: A mechanism for exotic invasion	SCIENCE			English	Article							ROOT COMMUNICATION; DESERT SHRUBS; COMMUNITIES; COMPETITORS; GROWTH; FIELD	Invading exotic plants are thought to succeed primarily because they have escaped their natural enemies, not because of novel interactions with their new neighbors. However, we find that Centaurea diffuse, a noxious weed in North America, has much stronger negative effects on grass species from North America than on closely related grass species from communities to which Centaurea is native. Centaurea's advantage against North American species appears to be due to differences in the effects of its root exudates and how these root exudates affect competition for resources. Our results may help to explain why some exotic species so successfully invade natural plant communities.	Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Callaway, RM (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.							AARSSEN LW, 1979, CAN J BOT, V57, P2695, DOI 10.1139/b79-319; CALDWELL MM, 1985, SCIENCE, V229, P384, DOI 10.1126/science.229.4711.384; Callaway RM, 1997, OECOLOGIA, V112, P143, DOI 10.1007/s004420050293; CHAPIN FS, 1985, ECOLOGY, V66, P564, DOI 10.2307/1940405; Cheremisinoff PN, 1978, CARBON ADSORPTION HD; FISCHER NH, 1985, CHEM ALLELOPATHY BIO; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; GOLDBERG DE, 1983, AM J BOT, V70, P1098, DOI 10.2307/2442821; GOODNIGHT CJ, 1990, EVOLUTION, V44, P1625, DOI 10.1111/j.1558-5646.1990.tb03851.x; MAHALL BE, 1991, P NATL ACAD SCI USA, V88, P874, DOI 10.1073/pnas.88.3.874; MAHALL BE, 1992, ECOLOGY, V73, P2145, DOI 10.2307/1941462; MENCHACA L, 1990, J ECOL, V78, P223, DOI 10.2307/2261047; RIDENOUR WL, THESIS U MONTANA MIS; Schreiner O, 1908, BOT GAZ, V45, P73, DOI 10.1086/329469; STEENHAGEN DA, 1979, WEED SCI, V27, P1; TANG CS, 1995, ALLELOPATHY ORGANISM; TURKINGTON R, 1989, J ECOL, V77, P717, DOI 10.2307/2260981; TURKINGTON R, 1990, PERSPECTIVES PLANT C, pCH15; VANDRIESCHE RG, 1996, BIOL CONTROL, pCH1; Wilson DS, 1997, ECOLOGY, V78, P2018, DOI 10.2307/2265941	20	1013	1204	21	750	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					521	523		10.1126/science.290.5491.521	http://dx.doi.org/10.1126/science.290.5491.521			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039934				2022-12-28	WOS:000089946000053
J	Didenko, YT; McNamara, WB; Suslick, KS				Didenko, YT; McNamara, WB; Suslick, KS			Molecular emission from single-bubble sonoluminescence	NATURE			English	Article							NONAQUEOUS LIQUIDS; SPECTRA; CAVITATION; WATER	Ultrasound can drive a single gas bubble in water into violent oscillation; as the bubble is compressed periodically, extremely short flashes of light (about 100 ps) are generated with clock-like regularity(1-4). This process, known as single-bubble sonoluminescence, gives rise to featureless continuum emission(4,5) in water (from 200 to 800 nm, with increasing intensity into the ultraviolet). In contrast, the emission of light from clouds of cavitating bubbles at higher acoustic pressures (multi-bubble sonoluminescence(1)) is dominated by atomic and molecular excited-state emission(6-11) at much lower temperatures(6). These observations have spurred intense effort to uncover the origin of sonoluminescence and to generalize the conditions necessary for its creation. Here we report a series of polar aprotic liquids that generate very strong single-bubble sonoluminescence, during which emission from molecular excited states is observed. Previously, single-bubble sonoluminescence from liquids other than water has proved extremely elusive(12,13). Our results give direct proof of the existence of chemical reactions and the formation of molecular excited states during single-bubble cavitation, and provide a spectroscopic link between single- and multi-bubble sonoluminescence.	Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Suslick, KS (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.		Suslick, Kenneth S/A-1841-2010	Suslick, Kenneth S/0000-0001-5422-0701				Bernstein LS, 1996, J PHYS CHEM-US, V100, P6612, DOI 10.1021/jp953643n; BERNSTEIN LS, 1995, J PHYS CHEM-US, V99, P14619, DOI 10.1021/j100040a008; DIDENKO YT, 1994, J PHYS CHEM-US, V98, P9742, DOI 10.1021/j100090a006; FLINT EB, 1991, J PHYS CHEM-US, V95, P1484, DOI 10.1021/j100156a084; FLINT EB, 1989, J AM CHEM SOC, V111, P6987, DOI 10.1021/ja00200a014; GAITAN DF, 1992, J ACOUST SOC AM, V91, P3166, DOI 10.1121/1.402855; Gaitan DF, 1996, PHYS REV E, V54, P525, DOI 10.1103/PhysRevE.54.525; Gaydon A.G., 1974, SPECTROSCOPY FLAMES; Gompf B, 1997, PHYS REV LETT, V79, P1405, DOI 10.1103/PhysRevLett.79.1405; Hertzberg G., 1966, MOL SPECTRA MOL STRU; Hilgenfeldt S, 1999, NATURE, V398, P402, DOI 10.1038/18842; HILLER R, 1992, PHYS REV LETT, V69, P1182, DOI 10.1103/PhysRevLett.69.1182; Hiller RA, 1998, PHYS REV LETT, V80, P1090, DOI 10.1103/PhysRevLett.80.1090; Ketterling JA, 1998, PHYS REV LETT, V81, P4991, DOI 10.1103/PhysRevLett.81.4991; LIDE DR, 1993, CRC HDB CHEM PHYSICS; Lohse D, 1997, J CHEM PHYS, V107, P6986, DOI 10.1063/1.474939; Lohse D, 1997, PHYS REV LETT, V78, P1359, DOI 10.1103/PhysRevLett.78.1359; Matula TJ, 1998, PHYS REV LETT, V80, P865, DOI 10.1103/PhysRevLett.80.865; McNamara WB, 1999, NATURE, V401, P772, DOI 10.1038/44536; Moran MJ, 1998, PHYS REV LETT, V80, P4987, DOI 10.1103/PhysRevLett.80.4987; Moss WC, 1997, SCIENCE, V276, P1398, DOI 10.1126/science.276.5317.1398; SUSLICK KS, 1987, NATURE, V330, P553, DOI 10.1038/330553a0; SUSLICK KS, 1993, J PHYS CHEM-US, V97, P3098, DOI 10.1021/j100115a007; Suslick KS., 1997, ENCYCL ACOUST, V1, P271, DOI DOI 10.1002/9780470172513.CH26; WENINGER K, 1995, J PHYS CHEM-US, V99, P14195, DOI 10.1021/j100039a001; Weninger KR, 1997, PHYS REV E, V56, P6745, DOI 10.1103/PhysRevE.56.6745; Zeldovich Y.B., 1967, PHYS SHOCK WAVES HIG, V2, DOI 10.1063/1.3021982	27	142	150	3	60	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					877	879		10.1038/35038020	http://dx.doi.org/10.1038/35038020			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057659				2022-12-28	WOS:000089901900042
J	Petty, TL				Petty, TL			Screening strategies for early detection of lung cancer - The time is now	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SPUTUM; OBSTRUCTION; POPULATION; TOMOGRAPHY; CARCINOMA; CELLS; RISK		Natl Lund Hlth Educ Program, Denver, CO 80218 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Rush University	Petty, TL (corresponding author), Natl Lund Hlth Educ Program, 1850 High St, Denver, CO 80218 USA.	tlpdoc@aol.com						ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; BECHTEL JJ, 1994, ARCH INTERN MED, V154, P975, DOI 10.1001/archinte.154.9.975; BECHTEL JJ, IN PRESS LUNG CANC; BURNS DM, 1998, P INT C PREV EARL DI, P164; EDDY DM, 1989, ANN INTERN MED, V111, P232, DOI 10.7326/0003-4819-111-3-232; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; FONTANA RS, 1984, AM REV RESPIR DIS, V130, P561; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Hillner BE, 1998, J CLIN ONCOL, V16, P1420, DOI 10.1200/JCO.1998.16.4.1420; Kennedy TC, 1996, CANCER RES, V56, P4673; Koike T, 1999, LUNG CANCER-J IASLC, V24, P75, DOI 10.1016/S0169-5002(99)00031-8; KUBIK A, 1990, INT J CANCER, V45, P26, DOI 10.1002/ijc.2910450107; Lam S, 1998, CHEST, V113, P696, DOI 10.1378/chest.113.3.696; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; MELAMED MR, 1984, CHEST, V86, P44, DOI 10.1378/chest.86.1.44; MOON MA, 2000, INTERNAL MED NEWS, V33, P5; MOON MA, 2000, INTERNAL MED NEWS, V33, P1; Mulshine JL, 1997, ENVIRON HEALTH PERSP, V105, P935, DOI 10.2307/3433307; Petty TL, 2000, CHEST, V117, P1, DOI 10.1378/chest.117.1.1; Petty TL, 1997, JAMA-J AM MED ASSOC, V277, P246, DOI 10.1001/jama.277.3.246; PETTY TL, 1991, J RESP DIS, V12, P403; SACCOMANNO G, 1974, CANCER-AM CANCER SOC, V33, P256, DOI 10.1002/1097-0142(197401)33:1<256::AID-CNCR2820330139>3.0.CO;2-G; SAITO Y, 1992, J THORAC CARDIOV SUR, V104, P401; Salomaa ER, 1998, CHEST, V114, P1514, DOI 10.1378/chest.114.6.1514; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; Sazon DAD, 1996, AM J RESP CRIT CARE, V153, P417, DOI 10.1164/ajrccm.153.1.8542152; SHAW GL, 1998, P INT C PREV EARL DI, P221; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Smith IE, 1999, LANCET, V354, P86, DOI 10.1016/S0140-6736(99)00228-7; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Strauss GM, 1998, CHEST, V114, P1502, DOI 10.1378/chest.114.6.1502; Strauss GM, 1997, CHEST, V111, P754, DOI 10.1378/chest.111.3.754; STRAUSS GM, 1998, LUNG CANC SCREENING, P57; TOCKMAN MS, 1988, J CLIN ONCOL, V6, P1685, DOI 10.1200/JCO.1988.6.11.1685; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512; TOCKMAN MS, 1986, CHEST, V89, pS324, DOI 10.1378/chest.89.4_Supplement.324S-a; *US DEP HHS, 1990, PUBL CDC	37	33	33	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1977	1980		10.1001/jama.284.15.1977	http://dx.doi.org/10.1001/jama.284.15.1977			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362JC	11035898				2022-12-28	WOS:000089774000034
J	Schaff, EA; Fielding, SL; Westhoff, C; Ellertson, C; Eisinger, SH; Stadalius, LS; Fuller, L				Schaff, EA; Fielding, SL; Westhoff, C; Ellertson, C; Eisinger, SH; Stadalius, LS; Fuller, L			Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Meeting of the Association-of-Reproductive-Health-Professionals	SEP   16, 2000	CHICAGO, ILLINOIS	Assoc Reprod Hlth Profess			PREGNANCY; RU-486; TERMINATION	Context The conventional timing of misoprostol administration after mifepristone for medical abortion is 2 days, but more flexible intervals, which may make the regimen more convenient, have not been studied. Objective To determine whether vaginal misoprostol administered 1,2, or 3 days after mifepristone influences safety or effectiveness for abortion at Lip to 56 days' gestation. Design Prospective, randomized, open-label trial conducted from March 1998 to June 1999. Setting Sixteen US primary care and referral abortion facilities. Patients A total of 2295 healthy patients aged 18 years or older who were 56 or fewer days pregnant. Forty (1.7%) were lost to follow-up. Interventions Patients received 200 mg of oral mifepristone and were randomly assigned to self-administer 800 mu g of vaginal misoprostol at home 1 (n =745), 2 (n = 778), or 3 (n = 772) days later, Women returned to the clinic up to 8 days after mifepristone for ultrasonographic evaluation. A second dose of misoprostol was administered if the abortion was not complete. Patients with continuing pregnancy, excessive bleeding, or retained pregnancy tissue 5 weeks later received an aspiration curettage. Main Outcome Measures Effectiveness of the procedure (ie, a complete medical abortion without surgical intervention), adverse effects, acceptability of the procedure based on patient questionnaires, reasons for surgical intervention, and adverse outcomes, compared among the study groups. Results Of the 2255 women completing follow-up, complete medical abortion rates were 98% (95% confidence interval [CI], 97%-99%) among those using misoprostol after 1 day, 98% (95% CI, 97%-99%) for those using misoprostol after 2 days, and 96% (95% CI, 95%-97%) among those using misoprostol after 3 days. Fifty-five subjects aborted before taking misoprostol, 9 had early surgery, and 103 did not take misoprostol on their assigned day, No blood transfusions were required. Cramping and nausea were the most common adverse effects reported, with similar percentages of patients in all 3 groups reporting such effects. Thirteen unexpected or serious adverse events occurred: 6 in those using misoprostol after 1 day; 4 in those using it after 2 days; and 3 in those using it after 3 days. Nearly all women (>90%) found the procedure to be acceptable. Conclusions Our results suggest that vaginal misoprostol, 800 mu g, can be used from 1 to 3 days after mifepristone, 200 mg, for early medical abortion, and need not be administered strictly 48 hours after mifepristone.	Univ Rochester, Sch Med, Dept Family Med, Reprod Hlth Program, Rochester, NY 14620 USA; Columbia Univ, Sch Publ Hlth, New York, NY USA; Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; Populat Council, New York, NY 10021 USA	University of Rochester; Columbia University; Columbia University; Population Council	Schaff, EA (corresponding author), Univ Rochester, Sch Med, Dept Family Med, Reprod Hlth Program, 1000 South Ave,Box 101, Rochester, NY 14620 USA.							Creinin MD, 1996, CONTRACEPTION, V53, P321, DOI 10.1016/0010-7824(96)00080-7; ELREFAEY H, 1995, NEW ENGL J MED, V332, P983, DOI 10.1056/NEJM199504133321502; PEYRON R, 1993, NEW ENGL J MED, V328, P1509, DOI 10.1056/NEJM199305273282101; Schaff E A, 1995, Arch Fam Med, V4, P774, DOI 10.1001/archfami.4.9.774; Schaff EA, 1999, CONTRACEPTION, V59, P1, DOI 10.1016/S0010-7824(98)00150-4; Schaff EA, 1997, J FAM PRACTICE, V44, P353; Schaff EA, 2000, CONTRACEPTION, V61, P41, DOI 10.1016/S0010-7824(99)00119-5; SILVESTRE L, 1990, NEW ENGL J MED, V322, P645, DOI 10.1056/NEJM199003083221001; Spitz IM, 1998, NEW ENGL J MED, V338, P1241, DOI 10.1056/NEJM199804303381801; Zieman M, 1997, OBSTET GYNECOL, V90, P88, DOI 10.1016/S0029-7844(97)00111-7	10	146	151	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1948	1953		10.1001/jama.284.15.1948	http://dx.doi.org/10.1001/jama.284.15.1948			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362JC	11035891	Bronze			2022-12-28	WOS:000089774000027
J	Shah, S				Shah, S			Five miles from tomorrow	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1897	1898		10.1001/jama.284.15.1897	http://dx.doi.org/10.1001/jama.284.15.1897			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362JC	11035868				2022-12-28	WOS:000089774000001
J	Schuchter, LM; Haller, DG				Schuchter, LM; Haller, DG			Update in oncology	ANNALS OF INTERNAL MEDICINE			English	Review							PROSTATE-CANCER		Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA	University of Pennsylvania	Schuchter, LM (corresponding author), Univ Penn, Ctr Canc, 16 Penn Tower,3400 Spruce St, Philadelphia, PA 19104 USA.	schuchte@mail.med.upenn.edu						Eisen A, 1999, NEW ENGL J MED, V340, P137, DOI 10.1056/NEJM199901143400209; Gray R, 1997, JNCI-J NATL CANCER I, V89, P497; MYERS RP, 1992, J UROLOGY, V147, P910, DOI 10.1016/S0022-5347(17)37420-7; SLAMON D, 1998, P AN M AM SOC CLIN, V17, P98; Tannock IF, 1996, J CLIN ONCOL, V14, P1756, DOI 10.1200/JCO.1996.14.6.1756	5	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					615	621		10.7326/0003-4819-133-8-200010170-00014	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00014			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033591				2022-12-28	WOS:000089906300007
J	Bienz, M; Clevers, H				Bienz, M; Clevers, H			Linking colorectal cancer to Wnt signaling	CELL			English	Review							TUMOR-SUPPRESSOR PROTEIN; POLYPOSIS-COLI PROTEIN; BETA-CATENIN; AXIS FORMATION; DROSOPHILA HOMOLOG; APC GENE; METALLOPROTEINASE MATRILYSIN; TRANSCRIPTIONAL ACTIVATION; INTESTINAL TUMORIGENESIS; FUNCTIONAL INTERACTION		MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Med Ctr, Dept Immunol, NL-3508 GA Utrecht, Netherlands; Univ Med Ctr, Ctr Biomed Genet, NL-3508 GA Utrecht, Netherlands	MRC Laboratory Molecular Biology; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Bienz, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ahmed Y, 1998, CELL, V93, P1171, DOI 10.1016/S0092-8674(00)81461-0; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bienz M, 1999, CURR OPIN GENET DEV, V9, P595, DOI 10.1016/S0959-437X(99)00016-7; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Boutros M, 2000, SCIENCE, V288, P1825, DOI 10.1126/science.288.5472.1825; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Brannon M, 1999, DEVELOPMENT, V126, P3159; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CARLSSON P, 1993, GENE DEV, V7, P2418, DOI 10.1101/gad.7.12a.2418; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Furuuchi K, 2000, AM J PATHOL, V156, P1997, DOI 10.1016/S0002-9440(10)65072-9; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; GIESE K, 1993, EMBO J, V12, P4667, DOI 10.1002/j.1460-2075.1993.tb06155.x; Grady WM, 1998, CANCER RES, V58, P3101; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; Hamada F, 1999, GENES CELLS, V4, P465, DOI 10.1046/j.1365-2443.1999.00272.x; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hayashi S, 1997, P NATL ACAD SCI USA, V94, P242, DOI 10.1073/pnas.94.1.242; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; HULSKEN J, 1994, CURR OPIN CELL BIOL, V6, P711, DOI 10.1016/0955-0674(94)90098-1; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Kolligs FT, 2000, GENE DEV, V14, P1319; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Lal G, 2000, SEMIN SURG ONCOL, V18, P314; Lamlum H, 2000, P NATL ACAD SCI USA, V97, P2225, DOI 10.1073/pnas.040564697; LIU W, 2000, IN PRESS NAT GENET; Marikawa Y, 1998, MECH DEVELOP, V77, P75, DOI 10.1016/S0925-4773(98)00134-8; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Merritt AJ, 1997, P NATL ACAD SCI USA, V94, P13927, DOI 10.1073/pnas.94.25.13927; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Moskaluk CA, 1996, BBA-REV CANCER, V1288, pM31, DOI 10.1016/S0304-419X(96)00033-9; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; Nakagawa H, 1998, CANCER RES, V58, P5176; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; Oshima H, 1997, CANCER RES, V57, P1644; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; PEIFER M, 1994, DEVELOPMENT, V120, P369; PERRIMON N, 1994, CELL, V76, P781, DOI 10.1016/0092-8674(94)90351-4; Polakis P, 2000, GENE DEV, V14, P1837; Polyak K, 1996, BBA-REV CANCER, V1242, P185, DOI 10.1016/0304-419X(95)00009-5; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Riggins GJ, 1996, NAT GENET, V13, P347, DOI 10.1038/ng0796-347; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Samowitz WS, 1999, CANCER RES, V59, P1442; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Smits R, 1997, CARCINOGENESIS, V18, P321, DOI 10.1093/carcin/18.2.321; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; SU LK, 1993, CANCER RES, V53, P2728; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; TOWNSLEY FM, 2000, IN PRESS CURR BIOL; van Es JH, 1999, CURR BIOL, V9, P105, DOI 10.1016/S0960-9822(99)80024-4; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Yu X, 1999, MECH DEVELOP, V84, P69, DOI 10.1016/S0925-4773(99)00072-6; Yu X, 1999, NAT CELL BIOL, V1, P144, DOI 10.1038/11064; Yu X, 1996, DEVELOPMENT, V122, P849; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	109	1248	1355	3	99	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 13	2000	103	2					311	320		10.1016/S0092-8674(00)00122-7	http://dx.doi.org/10.1016/S0092-8674(00)00122-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057903	Green Published, Bronze			2022-12-28	WOS:000089864300014
J	Boyd, PW; Watson, AJ; Law, CS; Abraham, ER; Trull, T; Murdoch, R; Bakker, DCE; Bowie, AR; Buesseler, KO; Chang, H; Charette, M; Croot, P; Downing, K; Frew, R; Gall, M; Hadfield, M; Hall, J; Harvey, M; Jameson, G; LaRoche, J; Liddicoat, M; Ling, R; Maldonado, MT; McKay, RM; Nodder, S; Pickmere, S; Pridmore, R; Rintoul, S; Safi, K; Sutton, P; Strzepek, R; Tanneberger, K; Turner, S; Waite, A; Zeldis, J				Boyd, PW; Watson, AJ; Law, CS; Abraham, ER; Trull, T; Murdoch, R; Bakker, DCE; Bowie, AR; Buesseler, KO; Chang, H; Charette, M; Croot, P; Downing, K; Frew, R; Gall, M; Hadfield, M; Hall, J; Harvey, M; Jameson, G; LaRoche, J; Liddicoat, M; Ling, R; Maldonado, MT; McKay, RM; Nodder, S; Pickmere, S; Pridmore, R; Rintoul, S; Safi, K; Sutton, P; Strzepek, R; Tanneberger, K; Turner, S; Waite, A; Zeldis, J			A mesoscale phytoplankton bloom in the polar Southern Ocean stimulated by iron fertilization	NATURE			English	Article							EQUATORIAL PACIFIC-OCEAN; SUB-ARCTIC PACIFIC; ANTARCTIC CIRCUMPOLAR CURRENT; MARINE-PHYTOPLANKTON; SULFUR-HEXAFLUORIDE; ATMOSPHERIC CO2; NEW-ZEALAND; CARBON; LIGHT; LIMITATION	Changes in iron supply to oceanic plankton are thought to have a significant effect on concentrations of atmospheric carbon dioxide by altering rates of carbon sequestration, a theory known as the `iron hypothesis'. For this reason, it is important to understand the response of pelagic biota to increased iron supply. Here we report the results of a mesoscale iron fertilization experiment in the polar Southern Ocean, where the potential to sequester iron-elevated algal carbon is probably greatest. Increased iron supply led to elevated phytoplankton biomass and rates of photosynthesis in surface waters, causing a large drawdown of carbon dioxide and macronutrients, and elevated dimethyl sulphide levels after 13 days. This drawdown was mostly due to the proliferation of diatom stocks. But downward export of biogenic carbon was not increased. Moreover, satellite observations of this massive bloom 30 days later, suggest that a sufficient proportion of the added iron was retained in surface waters. Our findings demonstrate that iron supply controls phytoplankton growth and community composition during summer in these polar Southern Ocean waters, but the fate of algal carbon remains unknown and depends on the interplay between the processes controlling export, remineralisation and timescales of water mass subduction.	Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; Natl Inst Water & Atmosphere, Wellington, New Zealand; Univ Tasmania, Antarctic Cooperat Res Ctr, Hobart, Tas 7001, Australia; Univ Plymouth, Dept Environm Sci, Drake Circus, Plymouth PL4 8AA, Devon, England; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem MS25, Woods Hole, MA 02543 USA; Netherlands Inst Sea Res, Dept Marine Chem & Geol, NL-1790 AB Den Burg, Netherlands; Univ Otago, Dept Chem, Dunedin, New Zealand; Natl Inst Water & Atmosphere, Christchurch, New Zealand; Natl Inst Water & Atmosphere, Hamilton, New Zealand; Univ Kiel, Inst Meereskunde, D-24105 Kiel, Germany; McGill Univ, Dept Biol, Montreal, PQ H2T 2V8, Canada; Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; CSIRO, Div Marine Res, Hobart, Tas 7001, Australia; Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Oceanog, Vancouver, BC V6T 1Z4, Canada; Univ Western Australia, Dept Environm Engn, Ctr Water Res, Nedlands, WA 6907, Australia	University of East Anglia; Plymouth Marine Laboratory; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Tasmania; University of Plymouth; Woods Hole Oceanographic Institution; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Otago; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Kiel; McGill University; University System of Ohio; Bowling Green State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of British Columbia; University of British Columbia; University of Western Australia	Boyd, PW (corresponding author), Univ Otago, Dept Chem, Natl Inst Water & Atmosphere, Ctr Chem & Phys Oceanog, POB 56, Dunedin, New Zealand.		Rintoul, Stephen R/A-1471-2012; Maldonado, Maria T/N-2877-2017; Strzepek, Robert/GQH-8703-2022; Waite, Anya M/A-5492-2015; Frew, Russell/HDN-6138-2022; Strzepek, Robert Francis/A-1216-2011; Frew, Russell/I-5591-2012; Abraham, Edward R/D-7422-2011; Croot, Peter L/C-8460-2009; Bowie, Andrew/C-8677-2013; Croot, Peter/U-5296-2019; Harvey, Mike/A-5354-2010; LaRoche, Julie/A-1109-2010; Trull, Tom W/B-7028-2014; Bakker, Dorothee C E/E-4951-2015; Charette, Matthew/I-9495-2012; McKay, Robert Michael/P-3759-2017; Boyd, Philip W/J-7624-2014	Rintoul, Stephen R/0000-0002-7055-9876; Maldonado, Maria T/0000-0001-8134-9375; Waite, Anya M/0000-0003-2965-0296; Strzepek, Robert Francis/0000-0002-6442-7121; Frew, Russell/0000-0002-6138-2116; Abraham, Edward R/0000-0003-4490-6704; Croot, Peter L/0000-0003-1396-0601; Bowie, Andrew/0000-0002-5144-7799; Harvey, Mike/0000-0002-0979-0227; Bakker, Dorothee C E/0000-0001-9234-5337; McKay, Robert Michael/0000-0003-2723-5371; Boyd, Philip W/0000-0001-7850-1911; Law, Cliff/0000-0002-7669-2475; Sutton, Phil/0000-0003-2936-0918; Watson, Andrew/0000-0002-9654-8147; LaRoche, Julie/0000-0003-4809-6411; Safi, Karl/0000-0002-7785-1909				Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; BANSE K, 1991, J GEOPHYS RES-OCEANS, V96, P741, DOI 10.1029/90JC02371; Behrenfeld MJ, 1998, PHOTOSYNTH RES, V58, P259, DOI 10.1023/A:1006138630573; Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; BISHOP JKB, 1991, J GEOPHYS RES-OCEANS, V96, P16839, DOI 10.1029/91JC01754; Boyd P, 1999, J GEOPHYS RES-OCEANS, V104, P13395, DOI 10.1029/1999JC900009; Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; Bradford-Grieve JM, 1999, J PLANKTON RES, V21, P405, DOI 10.1093/plankt/21.3.405; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; BUESSELER KO, 1991, NATURE, V353, P420, DOI 10.1038/353420a0; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Cooper DJ, 1996, NATURE, V383, P511, DOI 10.1038/383511a0; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; DEBAAR HJW, 1999, DYNAMIC OCEAN CARBON, P61; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FITZWATER SE, 1982, LIMNOL OCEANOGR, V27, P544, DOI 10.4319/lo.1982.27.3.0544; Geider RJ, 1999, NATURE, V400, P815, DOI 10.1038/23582; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; JACKSON GA, 1990, DEEP-SEA RES, V37, P1197, DOI 10.1016/0198-0149(90)90038-W; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; LaRoche J, 1996, NATURE, V382, P802; LAUBSCHER RK, 1993, POLAR BIOL, V13, P471; LAW CS, 1994, MAR CHEM, V48, P57, DOI 10.1016/0304-4203(94)90062-0; Law CS, 1998, DEEP-SEA RES PT II, V45, P977, DOI 10.1016/S0967-0645(98)00022-8; Maldonado MT, 1999, DEEP-SEA RES PT II, V46, P2447, DOI 10.1016/S0967-0645(99)00071-5; Maldonado MT, 1999, DEEP-SEA RES PT II, V46, P2475, DOI 10.1016/S0967-0645(99)00072-7; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; McKay RML, 1997, PLANT PHYSIOL, V114, P615, DOI 10.1104/pp.114.2.615; MILLERO FJ, 1987, GEOCHIM COSMOCHIM AC, V51, P793, DOI 10.1016/0016-7037(87)90093-7; MITCHELL BG, 1991, LIMNOL OCEANOGR, V36, P1662, DOI 10.4319/lo.1991.36.8.1662; MONTAGNES DJS, 1994, LIMNOL OCEANOGR, V39, P1044, DOI 10.4319/lo.1994.39.5.1044; Moore JK, 1999, GEOPHYS RES LETT, V26, P1465, DOI 10.1029/1999GL900242; Morel F.M.M., 1991, OCEANOGRAPHY, V4, P56, DOI [10.5670/oceanog.1991.03, DOI 10.5670/0CEAN0G.1991.03]; Muggli DL, 1996, MAR ECOL PROG SER, V132, P215, DOI 10.3354/meps132215; Neale PJ, 1998, NATURE, V392, P585, DOI 10.1038/33374; NELSON DM, 1991, LIMNOL OCEANOGR, V36, P1650, DOI 10.4319/lo.1991.36.8.1650; NOWLIN WD, 1986, REV GEOPHYS, V24, P469, DOI 10.1029/RG024i003p00469; Obata A, 1996, J GEOPHYS RES-OCEANS, V101, P20657, DOI 10.1029/96JC01734; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; PENG TH, 1991, LIMNOL OCEANOGR, V36, P1919, DOI 10.4319/lo.1991.36.8.1919; Popp BN, 1997, PALAEOGEOGR PALAEOCL, V132, P119, DOI 10.1016/S0031-0182(97)00061-8; Rintoul SR, 1997, DEEP-SEA RES PT I, V44, P1185, DOI 10.1016/S0967-0637(96)00125-2; Rintoul SR, 1999, DEEP-SEA RES PT I, V46, P1417, DOI 10.1016/S0967-0637(99)00013-8; SARMIENTO JL, 1991, LIMNOL OCEANOGR, V36, P1928, DOI 10.4319/lo.1991.36.8.1928; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; TRENBERTH KE, 1990, J PHYS OCEANOGR, V20, P1742, DOI 10.1175/1520-0485(1990)020<1742:TMACIG>2.0.CO;2; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; WATSON A, 1991, LIMNOL OCEANOGR, V36, P1960, DOI 10.4319/lo.1991.36.8.1960; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168; ZENTARA SJ, 1981, DEEP-SEA RES, V28, P455, DOI 10.1016/0198-0149(81)90137-0	54	1177	1240	10	677	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					695	702		10.1038/35037500	http://dx.doi.org/10.1038/35037500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048709				2022-12-28	WOS:000089773900031
J	Cooper, VS; Lenski, RE				Cooper, VS; Lenski, RE			The population genetics of ecological specialization in evolving Escherichia coli populations	NATURE			English	Article							GENOMIC MUTATION-RATE; DELETERIOUS MUTATIONS; EVOLUTIONARY-THEORIES; ADAPTATION; FITNESS; SENESCENCE	When organisms adapt genetically to one environment, they may lose fitness in other environments(1-4). Two distinct population genetic processes can produce ecological specialization-mutation accumulation and antagonistic pleiotropy(5-8). In mutation accumulation, mutations become fixed by genetic drift in genes that are not maintained by selection; adaptation to one environment and loss of adaptation to another are caused by different mutations. Antagonistic pleiotropy arises from trade-offs, such that the same mutations that are beneficial in one environment are detrimental in another. In general, it is difficult to distinguish between these processes(5-8). We analysed the decay of unused catabolic functions in 12 lines of Escherichia coli propagated on glucose for 20,000 generations(9,10). During that time, several lines evolved high mutation rates(11). If mutation accumulation is important, their unused functions should decay more than the other lines, but no significant difference was observed. Moreover, most catabolic losses occurred early in the experiment when beneficial mutations were being rapidly fixed, a pattern predicted by antagonistic pleiotropy. Thus, antagonistic pleiotropy appears more important than mutation accumulation for the decay of unused catabolic functions in these populations.	Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Michigan State University	Cooper, VS (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.	cooperva@msu.edu		Lenski, Richard/0000-0002-1064-8375; Cooper, Vaughn/0000-0001-7726-0765				BENNETT AF, 1993, EVOLUTION, V47, P1, DOI 10.1111/j.1558-5646.1993.tb01194.x; *BIOL, 1993, BIOL ES MICR INSTR U; COOPER VS, 2000, THESIS MICHIGAN STAT; COOPER VS, UNPUB J BACTERIOL; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; FRY JD, 1990, AM NAT, V136, P569, DOI 10.1086/285116; Funchain P, 2000, GENETICS, V154, P959; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Guckert JB, 1996, J MICROBIOL METH, V27, P183, DOI 10.1016/S0167-7012(96)00948-7; Holt RD, 1996, EVOL ECOL, V10, P1, DOI 10.1007/BF01239342; HOULE D, 1992, NATURE, V359, P58, DOI 10.1038/359058a0; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; Kimura M., 1983, NEUTRAL THEORY MOL E; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; ROSE M. R., 1991, EVOLUTIONARY BIOL AG; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; SZATHMARY E, 1993, GENETICS, V133, P127	24	365	372	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					736	739		10.1038/35037572	http://dx.doi.org/10.1038/35037572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048718				2022-12-28	WOS:000089773900040
J	Venema, L				Venema, L			Fathers of electronic revolution are rewarded	NATURE			English	News Item																			0	2	2	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					662	662		10.1038/35037763	http://dx.doi.org/10.1038/35037763			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048686	Bronze			2022-12-28	WOS:000089773900004
J	Gill, P				Gill, P			Precision measurements - Optical clocks coming of age	NATURE			English	Editorial Material							SINGLE-ION; LASER; TRANSITION		Natl Phys Lab, Teddington TW11 0LW, Middx, England	National Physical Laboratory - UK	Gill, P (corresponding author), Natl Phys Lab, Teddington TW11 0LW, Middx, England.							Barwood GP, 1999, PHYS REV A, V59, pR3178, DOI 10.1103/PhysRevA.59.R3178; BERGQUIST JC, 1994, P INT SCH PHYS, V120, P359; Bernard JE, 1999, PHYS REV LETT, V82, P3228, DOI 10.1103/PhysRevLett.82.3228; DEHMELT HG, 1982, IEEE T INSTRUM MEAS, V31, P83, DOI 10.1109/TIM.1982.6312526; Diddams SA, 2000, PHYS REV LETT, V84, P5102, DOI 10.1103/PhysRevLett.84.5102; Fertig C, 2000, PHYS REV LETT, V85, P1622, DOI 10.1103/PhysRevLett.85.1622; Rafac RJ, 2000, PHYS REV LETT, V85, P2462, DOI 10.1103/PhysRevLett.85.2462; Reichert J, 2000, PHYS REV LETT, V84, P3232, DOI 10.1103/PhysRevLett.84.3232; Roberts M, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.020501; SORTAIS Y, IN PRESS PHYS REV LE; Tamm C, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.053405; Urabe S, 1998, APPL PHYS B-LASERS O, V67, P223, DOI 10.1007/s003400050497; WINELAND DJ, 1984, SCIENCE, V226, P395, DOI 10.1126/science.226.4673.395; Young BC, 1999, PHYS REV LETT, V82, P3799, DOI 10.1103/PhysRevLett.82.3799; YU N, 1994, PHYS REV A, V50, P2738, DOI 10.1103/PhysRevA.50.2738; ZANIER JV, 1999, OPT COMMUN, V166, P57	16	4	4	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					579	580		10.1038/35036680	http://dx.doi.org/10.1038/35036680			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034194				2022-12-28	WOS:000089772800030
J	Li, M; Indra, AK; Warot, X; Brocard, J; Messaddeq, N; Kato, S; Metzger, D; Chambon, P				Li, M; Indra, AK; Warot, X; Brocard, J; Messaddeq, N; Kato, S; Metzger, D; Chambon, P			Skin abnormalities generated by temporally controlled RXR alpha mutations in mouse epidermis	NATURE			English	Article							VITAMIN-D-RECEPTOR; TRANSGENIC MICE; ACID RECEPTOR; MUTANT MICE; PPAR-ALPHA; EXPRESSION; GENE; DIFFERENTIATION; MORPHOGENESIS; MUTAGENESIS	Nuclear receptors for retinoids (RARs) and vitamin D (VDR), and for some other ligands (TRs, PPARs and LXRs), may be critical in the development and homeostasis of mammalian epidermis(1-8). It is believed that these receptors form heterodimers with retinoid X receptors (RXRs) to act as transcriptional regulators(9,10). However, most genetic approaches aimed at establishing their physiological functions in the skin have been inconclusive owing either to pleiotropic effects and redundancies between receptor isotypes in gene knockouts, or to equivocal interpretation of dominant-negative mutant studies in transgenic mice(1,13-15). Moreover, knockout of RXR alpha, the main skin RXR isotype, is lethal in utero before skin formation(11,12,16,17). Here we have resolved these problems by developing an efficient technique to create spatiotemporally controlled somatic mutations in the mouse. We used tamoxifen-inducible Cre-ER(T) recombinases(18,19) to ablate RXR alpha selectively in adult mouse keratinocytes. We show that RXR alpha has key roles in hair cycling, probably through RXR/VDR heterodimers, and in epidermal keratinocyte proliferation and differentiation.	Coll France, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 113, Japan; Japan Sci & Technol, CREST, Kawaguchi, Saitama 332, Japan	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Tokyo; Japan Science & Technology Agency (JST)	Chambon, P (corresponding author), Coll France, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, France.	chambon@igbmc.u-strasbg.fr	Indra, Arup/AAG-2376-2019; Brocard, Jacques/I-3135-2017	Indra, Arup/0000-0001-6137-7555; Metzger, Daniel/0000-0002-5555-046X; Li, Mei/0000-0003-4225-6699; Brocard, Jacques/0000-0002-0752-5737				Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Feng X, 1997, GENE DEV, V11, P59, DOI 10.1101/gad.11.1.59; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Hanley K, 2000, J INVEST DERMATOL, V114, P545, DOI 10.1046/j.1523-1747.2000.00895.x; Hanley K, 2000, J BIOL CHEM, V275, P11484, DOI 10.1074/jbc.275.15.11484; Hanley K, 1997, J CLIN INVEST, V100, P705, DOI 10.1172/JCI119583; IMAKADO S, 1995, GENE DEV, V9, P317, DOI 10.1101/gad.9.3.317; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Komuves LG, 1998, J INVEST DERMATOL, V111, P429, DOI 10.1046/j.1523-1747.1998.00296.x; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mascrez B, 1998, DEVELOPMENT, V125, P4691; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; METZGER D, IN PRESS METHODS; Panteleyev AA, 1998, EXP DERMATOL, V7, P249, DOI 10.1111/j.1600-0625.1998.tb00295.x-i1; Porter RM, 1998, J INVEST DERMATOL, V110, P951, DOI 10.1046/j.1523-1747.1998.00218.x; REICHRATH J, 1994, BRIT J DERMATOL, V131, P477; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Sundberg JP, 1996, DERMATOL CLIN, V14, P619, DOI 10.1016/S0733-8635(05)70389-2; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Wendling O, 1999, P NATL ACAD SCI USA, V96, P547, DOI 10.1073/pnas.96.2.547; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	30	248	261	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					633	636		10.1038/35036595	http://dx.doi.org/10.1038/35036595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034212				2022-12-28	WOS:000089772800048
J	Loudet, JC; Barois, P; Poulin, P				Loudet, JC; Barois, P; Poulin, P			Colloidal ordering from phase separation in a liquid-crystalline continuous phase	NATURE			English	Article							ELECTRORHEOLOGICAL FLUIDS; TOPOLOGICAL DEFECTS; NEMATIC EMULSIONS; PARTICLE; AGGREGATION; FORCES; CHAINS	Some binary mixtures exist as a single phase at high temperatures and as two phases at lower temperatures; rapid cooling therefore induces phase separation that proceeds through the initial formation of small particles and subsequent growth and coarsening(1). In solid and liquid media, this process leads to growing particles with a range of sizes, which eventually separate to form a macroscopically distinct phase. Such behaviour is of particular interest in systems composed of an isotropic fluid and a liquid crystal(2), where the random distribution of liquid-crystal droplets in an isotropic polymer matrix may give rise to interesting electro-optical properties. Here we report that a binary mixture consisting of an isotropic fluid and a liquid crystal forming the continuous phase does not fully separate into two phases, but self-organizes into highly ordered arrays of monodisperse colloidal droplet chains. We rnd that the size and spatial organization of the droplets are controlled by the orientational elasticity of the liquid-crystal phase and the defects caused by droplets exceeding a critical size. We expect that our approach to forming monodisperse, spatially ordered droplets in liquid crystals will allow the controlled design of ordered composites that may have useful rheological and optical properties.	CNRS, Ctr Rech Paul Pascal, F-33600 Pessac, France	Centre de Recherche Paul Pascal; Centre National de la Recherche Scientifique (CNRS)	Poulin, P (corresponding author), CNRS, Ctr Rech Paul Pascal, Ave Schweitzer, F-33600 Pessac, France.			Poulin, Philippe/0000-0001-7748-8671				Benmouna F, 1998, MACROMOL THEOR SIMUL, V7, P599, DOI 10.1002/(SICI)1521-3919(19981101)7:6<599::AID-MATS599>3.3.CO;2-V; CALDERON FL, 1994, PHYS REV LETT, V72, P2959, DOI 10.1103/PhysRevLett.72.2959; DEGENNES PG, 1993, PHYSICS LIQUID CRYST; Drzaic P. S, 1995, SERIES LIQUID CRYSTA, V1; Gunton JD, 1983, PHASE TRANSITIONS CR, P267; HALSEY TC, 1990, J STAT PHYS, V61, P1257, DOI 10.1007/BF01014374; HALSEY TC, 1990, PHYS REV LETT, V65, P2820, DOI 10.1103/PhysRevLett.65.2820; LAVRENTOVICH OD, 1992, PHYS REV A, V45, pR6969, DOI 10.1103/PhysRevA.45.R6969; Lubensky TC, 1998, PHYS REV E, V57, P610, DOI 10.1103/PhysRevE.57.610; Meeker SP, 2000, PHYS REV E, V61, pR6083, DOI 10.1103/PhysRevE.61.R6083; Miguel MC, 1999, PHYS REV E, V59, P826, DOI 10.1103/PhysRevE.59.826; MIYAZIMA S, 1987, PHYS REV A, V36, P1421, DOI 10.1103/PhysRevA.36.1421; Mondain-Monval O, 1999, EUR PHYS J B, V12, P167, DOI 10.1007/s100510050992; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Poulin P, 1997, PHYS REV LETT, V79, P4862, DOI 10.1103/PhysRevLett.79.4862; Poulin P, 1998, PHYS REV E, V57, P626, DOI 10.1103/PhysRevE.57.626; Ruhwandl RW, 1997, PHYS REV E, V56, P5561, DOI 10.1103/PhysRevE.56.5561; SEE H, 1991, J PHYS SOC JPN, V60, P2778, DOI 10.1143/JPSJ.60.2778; SHEN CS, 1995, J CHEM PHYS, V102, P556, DOI 10.1063/1.469435; Stark H, 1999, EUR PHYS J B, V10, P311, DOI 10.1007/s100510050860; YURKE B, 1992, PHYSICA B, V178, P56, DOI 10.1016/0921-4526(92)90179-V	21	422	427	3	129	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					611	613		10.1038/35036539	http://dx.doi.org/10.1038/35036539			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034205				2022-12-28	WOS:000089772800041
J	Berk, AJ				Berk, AJ			TBP-like factors come into focus	CELL			English	Review							TATA-BINDING PROTEIN; TRANSCRIPTION; DROSOPHILA		Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Berk, AJ (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Paul D Boyer Hall, Los Angeles, CA 90095 USA.		BERK, ARNOLD/AAF-7052-2020					Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; CROWLEY TE, 1993, NATURE, V361, P557, DOI 10.1038/361557a0; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; Dantonel JC, 1999, TRENDS BIOCHEM SCI, V24, P335, DOI 10.1016/S0968-0004(99)01436-X; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Holmes MC, 2000, SCIENCE, V288, P867, DOI 10.1126/science.288.5467.867; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; Maldonado E, 1999, J BIOL CHEM, V274, P12963, DOI 10.1074/jbc.274.19.12963; Moore PA, 1999, MOL CELL BIOL, V19, P7610; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Shen YH, 1998, MOL CELL BIOL, V18, P1692, DOI 10.1128/MCB.18.3.1692; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; Teichmann M, 1999, P NATL ACAD SCI USA, V96, P13720, DOI 10.1073/pnas.96.24.13720; WHITE RJ, 1998, RNA POLYM 3 TRANSCRI; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000	19	62	64	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					5	8		10.1016/S0092-8674(00)00098-2	http://dx.doi.org/10.1016/S0092-8674(00)00098-2			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051541	Bronze			2022-12-28	WOS:000089636400002
J	Schwartz, MW				Schwartz, MW			Staying slim with insulin in mind	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; BODY-WEIGHT; LEPTIN		Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Schwartz, MW (corresponding author), Univ Washington, Div Metab Endocrinol & Nutr, Seattle, WA 98105 USA.		Schwartz, Michael W/H-9950-2012					Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; BASKIN DG, 1988, TRENDS NEUROSCI, V11, P107, DOI 10.1016/0166-2236(88)90155-5; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Havel PJ, 2000, DIABETES, V49, P244, DOI 10.2337/diabetes.49.2.244; Kaiyala KJ, 2000, DIABETES, V49, P1525, DOI 10.2337/diabetes.49.9.1525; KENNEDY GC, 1953, P ROY SOC LOND B BIO, V140, P579; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; Porte D, 1998, DIABETOLOGIA, V41, P863, DOI 10.1007/s001250051002; SCHWARTZ MW, 1995, J CLIN ENDOCR METAB, V80, P1571, DOI 10.1210/jc.80.5.1571; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	13	30	32	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2066	2067		10.1126/science.289.5487.2066	http://dx.doi.org/10.1126/science.289.5487.2066			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11032558				2022-12-28	WOS:000089430900032
J	Tolley, D				Tolley, D			Ureteric stents, far from ideal	LANCET			English	Editorial Material							EXPERIENCE; OBSTRUCTION		Western Gen Hosp, Dept Urol, Scottish Lithotriptor Ctr, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Tolley, D (corresponding author), Western Gen Hosp, Dept Urol, Scottish Lithotriptor Ctr, Edinburgh EH4 2XU, Midlothian, Scotland.							*ASTM SUBC, 1995, F047001 ASTM SUBC; Basu S, 2000, BJU INT S, V85, P22; DOCIMO SG, 1989, J UROLOGY, V142, P277, DOI 10.1016/S0022-5347(17)38729-3; FINNEY RP, 1978, J UROLOGY, V120, P678, DOI 10.1016/S0022-5347(17)57326-7; GIBBONS RP, 1974, J UROLOGY, V111, P594, DOI 10.1016/S0022-5347(17)60023-5; LIBBY JM, 1988, J UROLOGY, V139, P15, DOI 10.1016/S0022-5347(17)42274-9; MARDIS HK, 1988, UROL CLIN N AM, V15, P471; MCFARLANE JP, 2000, BJU INT S5, V85, P21; PAUER W, 1992, J UROLOGY, V148, P281, DOI 10.1016/S0022-5347(17)36573-4; RAMSAY JWA, 1985, BRIT J UROL, V57, P630, DOI 10.1111/j.1464-410X.1985.tb07021.x; REINBERG Y, 1994, J UROLOGY, V151, P1619, DOI 10.1016/S0022-5347(17)35319-3; Richter S, 2000, BJU INT, V85, P408, DOI 10.1046/j.1464-410x.2000.00478.x; RYAN PC, 1994, BRIT J UROL, V74, P434, DOI 10.1111/j.1464-410X.1994.tb00418.x; SALTZMAN B, 1988, UROL CLIN N AM, V15, P481; Slepian MJ, 1997, ADV DRUG DELIVER REV, V24, P11, DOI 10.1016/S0169-409X(96)00479-6; TULLOCH W S, 1952, Br J Urol, V24, P42; VALIMAA T, 1998, STENTING URINARY SYS, pCH6	17	36	37	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					872	873		10.1016/S0140-6736(00)02674-X	http://dx.doi.org/10.1016/S0140-6736(00)02674-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036889				2022-12-28	WOS:000089259800006
J	Piro, L; Garmire, G; Garcia, M; Stratta, G; Costa, E; Feroci, M; Meszaros, P; Vietri, M; Bradt, H; Frail, D; Frontera, F; Halpern, J; Heise, J; Hurley, K; Kawai, N; Kippen, RM; Marshall, F; Murakami, T; Sokolov, VV; Takeshima, T; Yoshida, A				Piro, L; Garmire, G; Garcia, M; Stratta, G; Costa, E; Feroci, M; Meszaros, P; Vietri, M; Bradt, H; Frail, D; Frontera, F; Halpern, J; Heise, J; Hurley, K; Kawai, N; Kippen, RM; Marshall, F; Murakami, T; Sokolov, VV; Takeshima, T; Yoshida, A			Observation of X-ray lines from a gamma-ray burst (GRB991216): Evidence of moving ejecta from the progenitor	SCIENCE			English	Article							IRON LINE; AFTERGLOW; SPECTRA; EDGE	We report on the discovery of two emission features observed in the x-ray spectrum of the afterglow of the gamma-ray burst (GRB) of 16 December 1999 by the Chandra X-ray Observatory. These features are identified with the Ly(alpha), Line and the narrow recombination continuum by hydrogenic ions of iron at a redshift z = 1.00 +/- 0.02, providing an unambiguous measurement of the distance of a GRB. Line width and intensity imply that the progenitor of the GRB was a massive star system that ejected, before the GRB event, a quantity of iron similar to0.01 of the mass of the sun at a velocity similar to0.1 of the speed of light, probably by a supernova explosion.	CNR, Ist Astrofis Spaziale, I-00133 Rome, Italy; Penn State Univ, Dept Astron & Astrophys, Davey Lab 525, University Pk, PA 16802 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Roma Tre, Dept Phys, I-00146 Rome, Italy; MIT, Cambridge, MA 02139 USA; Natl Radio Astron Observ, Socorro, NM 87801 USA; CNR, Ist Tecnol & Studio Radiaz Extraterr, I-40129 Bologna, Italy; Columbia Univ, Dept Astrophys, New York, NY 10027 USA; SRON, NL-3584 CA Utrecht, Netherlands; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; Univ Alabama, NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35899 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Inst Space & Astronaut Sci, Kanagawa 2298510, Japan; Russian Acad Sci, Special Astrophys Observ, Nizhnii Arkhyz 369167, Karachaevo Cher, Russia; NASDA, Natl Space Dev Agcy Japan, Minato Ku, Tokyo 10560, Japan	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Roma Tre University; Massachusetts Institute of Technology (MIT); National Radio Astronomy Observatory (NRAO); Consiglio Nazionale delle Ricerche (CNR); Columbia University; University of California System; University of California Berkeley; RIKEN; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of Alabama System; University of Alabama Huntsville; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Russian Academy of Sciences; Special Astrophysics Observatory of the Russian Academy of Sciences; Japan Aerospace Exploration Agency (JAXA)	Piro, L (corresponding author), CNR, Ist Astrofis Spaziale, Via Fosso del Cavaliere, I-00133 Rome, Italy.	piro@ias.rm.cnr.it	Stratta, Maria Giuliana/L-3045-2016; PIRO, LUIGI/E-4954-2013; Sokolov, Vladimir/AAM-5469-2021	Stratta, Maria Giuliana/0000-0003-1055-7980; PIRO, LUIGI/0000-0003-4159-3984; Costa, Enrico/0000-0003-4925-8523; Feroci, Marco/0000-0002-7617-3421; Sokolov, Vladimir/0000-0003-2983-2874				Amati L, 2000, SCIENCE, V290, P953, DOI 10.1126/science.290.5493.953; BOETTCHER M, UNPUB; Bottcher M, 1999, ASTRON ASTROPHYS, V343, P111; BOUCHET P, 1991, ASTRON ASTROPHYS, V245, P490; DAISUKE Y, 2000, PUBL ASTRON SOC JAPA, V52, P509; DJORGOVSKI SG, 2000, 510 GCN; FRAIL DA, IN PRESS ASTROPHYS J; Fryer CL, 1999, ASTROPHYS J, V526, P152, DOI 10.1086/307992; HALPERN JP, IN PRESS ASTROPHYS J; HURLEY K, 2000, 484 GCN; HURLEY K, 2000, 505 GCN; KALLMAN TR, 1982, ASTROPHYS J SUPPL S, V50, P263, DOI 10.1086/190828; KIPPEN RM, 2000, 504 GCN; KULKARNI SR, IN PRESS P 5 HUNTSV; Lazzati D, 1999, MON NOT R ASTRON SOC, V304, pL31, DOI 10.1046/j.1365-8711.1999.02517.x; Meszaros P, 1998, MON NOT R ASTRON SOC, V299, pL10, DOI 10.1046/j.1365-8711.1998.01992.x; Paczynski B, 1998, ASTROPHYS J, V494, pL45, DOI 10.1086/311148; Paerels F, 2000, ASTROPHYS J, V535, pL25, DOI 10.1086/312699; Perna R, 1998, ASTROPHYS J, V501, P467, DOI 10.1086/305865; Piro L, 1999, ASTROPHYS J, V514, pL73, DOI 10.1086/311946; PIRO L, 1993, P UV XRAY SPECTR LAB, P448; PIRO L, 2000, 500 GCN; Sandquist EL, 1998, ASTROPHYS J, V500, P909, DOI 10.1086/305778; Sari R, 1998, ASTROPHYS J, V497, pL17, DOI 10.1086/311269; TAKESHIMA T, 2000, 478 GCN; Vietri M, 1999, MON NOT R ASTRON SOC, V308, pL29, DOI 10.1046/j.1365-8711.1999.02918.x; VLETRI M, 1998, ASTROPHYS J, V507, pL45; VREESWIJK PM, 2000, 496 GCN; Weisskopf MC, 1996, PROC SPIE, V2805, P2, DOI 10.1117/12.245079; Wijers RAMJ, 1999, ASTROPHYS J, V523, P177, DOI 10.1086/307705; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359; Yoshida A, 1999, ASTRON ASTROPHYS SUP, V138, P433, DOI 10.1051/aas:1999297	33	248	251	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2000	290	5493					955	958		10.1126/science.290.5493.955	http://dx.doi.org/10.1126/science.290.5493.955			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062121				2022-12-28	WOS:000165103200040
J	Kennedy, MB				Kennedy, MB			Signal-processing machines at the postsynaptic density	SCIENCE			English	Review							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; NITRIC-OXIDE SYNTHASE; NMDA RECEPTOR; GLUTAMATE-RECEPTOR; DENDRITIC SPINES; PHOSPHORYLATION SITE; ION CHANNELS; NR2B SUBUNIT	Dendrites of individual neurons in the vertebrate central nervous system are contacted by thousands of synaptic terminals relaying information about the environment. The postsynaptic membrane at each synaptic terminal is the first place where information is processed as it converges on the dendrite. At the postsynaptic membrane of excitatory synapses, neurotransmitter receptors are attached to large protein "signaling machines" that delicately regulate the strength of synaptic transmission. These machines are visible in the electron microscope and are called the postsynaptic density. By changing synaptic strength in response to neural activity, the postsynaptic density contributes to information processing and the formation of memories.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Kennedy, MB (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	kennedym@its.caltech.edu		Kennedy, Mary/0000-0003-1369-0525	NINDS NIH HHS [R01 NS028710, NS17660, NS28710] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028710, R01NS017660] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bray D, 1997, TRENDS BIOCHEM SCI, V22, P325, DOI 10.1016/S0968-0004(97)01083-9; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CARR DW, 1992, J BIOL CHEM, V267, P16816; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GLANTZ SB, 1992, MOL BIOL CELL, V3, P1215, DOI 10.1091/mbc.3.11.1215; GRAY EG, 1959, J ANAT, V93, P420; Greengard P, 1998, BRAIN RES REV, V26, P274, DOI 10.1016/S0165-0173(97)00057-X; Halpain S, 1998, J NEUROSCI, V18, P9835; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Korte M, 1996, J PHYSIOLOGY-PARIS, V90, P157, DOI 10.1016/S0928-4257(97)81415-5; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lin JW, 1998, J NEUROSCI, V18, P2017; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Nakamura T, 1998, J BIOL CHEM, V273, P6960, DOI 10.1074/jbc.273.12.6960; Niethammer M, 1996, J NEUROSCI, V16, P2157; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; PALAY SL, 1958, EXP CELL RES       S, V5, P275; Price NE, 1999, CURR OPIN NEUROBIOL, V9, P336, DOI 10.1016/S0959-4388(99)80049-X; Quinlan EM, 1996, NEURON, V16, P357, DOI 10.1016/S0896-6273(00)80053-7; Racca C, 2000, J NEUROSCI, V20, P2512; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 1996, CURR OPIN NEUROBIOL, V6, P602, DOI 10.1016/S0959-4388(96)80091-2; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; STEVENS CF, 1994, CURR BIOL, V4, P687, DOI 10.1016/S0960-9822(00)00153-6; STILES JR, IN PRESS SYNAPSES; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Walikonis R. S., 1999, Society for Neuroscience Abstracts, V25, P2005; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999	78	596	637	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2000	290	5492					750	754		10.1126/science.290.5492.750	http://dx.doi.org/10.1126/science.290.5492.750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052931				2022-12-28	WOS:000090067600036
J	Weiss, BP; Kirschvink, JL; Baudenbacher, FJ; Vali, H; Peters, NT; Macdonald, FA; Wikswo, JP				Weiss, BP; Kirschvink, JL; Baudenbacher, FJ; Vali, H; Peters, NT; Macdonald, FA; Wikswo, JP			A low temperature transfer of ALH84001 from Mars to Earth	SCIENCE			English	Article							MARTIAN METEORITE ALH84001; MONOCLINIC PYRRHOTITE FE7S8; NOBLE-GASES; ALLAN-HILLS-84001; MAGNETIZATION; PLANETS; SEARCH; EJECTA; ORIGIN; LIFE	The ejection of material from Mars is thought to be caused by Large impacts that would heat much of the ejecta to high temperatures. Images of the magnetic field of martian meteorite ALH84001 reveal a spatially heterogeneous pattern of magnetization associated with fractures and rock fragments. Heating the meteorite to 40 degreesC reduces the intensity of some magnetic features, indicating that the interior of the rock has not been above this temperature since before its ejection from the surface of Mars. Because this temperature cannot sterilize most bacteria or eukarya, these data support the hypothesis that meteorites could transfer Life between planets in the solar system.	CALTECH, Div Geol & Planetary Sci 17025, Pasadena, CA 91125 USA; Vanderbilt Univ, Dept Phys & Astron, Stevenson Ctr 6301, Nashville, TN 37235 USA; McGill Univ, Ctr Electron Microscopy, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ H3A 2B2, Canada	California Institute of Technology; Vanderbilt University; McGill University; McGill University	Weiss, BP (corresponding author), CALTECH, Div Geol & Planetary Sci 17025, Pasadena, CA 91125 USA.	bweiss@gps.caltech.edu	Vali, Hojatollah/F-3511-2012	Vali, Hojatollah/0000-0003-3464-9943				Bada JL, 1998, SCIENCE, V279, P362, DOI 10.1126/science.279.5349.362; BAUDENBACHER FJ, 1999, B AM PHYS SOC, V44, P702; BAUDENBACHER FJ, 2000, B AM PHYS SOC, V45, P651; BINA M, 1994, PHYS EARTH PLANET IN, V85, P83, DOI 10.1016/0031-9201(94)90009-4; Bogard DD, 1999, METEORIT PLANET SCI, V34, P451, DOI 10.1111/j.1945-5100.1999.tb01353.x; Borg LE, 1999, SCIENCE, V286, P90, DOI 10.1126/science.286.5437.90; BREARLEY AJ, 2000, LUNAR PLANET SCI, V31; BRONSHTEN VA, 1983, PHYSICS METEORIC PHE; Collinson DW, 1997, METEORIT PLANET SCI, V32, P803, DOI 10.1111/j.1945-5100.1997.tb01571.x; DiGregorio B.E, 1997, MARS LIVING PLANET; Dunlop D. J., 1997, ROCK MAGNETISM FUNDA; Fuller M., 1987, GEOMAGN AERON, V2, P307; Gilmour JD, 1998, GEOCHIM COSMOCHIM AC, V62, P2555, DOI 10.1016/S0016-7037(98)00165-3; Gladman B, 1997, ICARUS, V130, P228, DOI 10.1006/icar.1997.5828; Gladman BJ, 1996, SCIENCE, V271, P1387, DOI 10.1126/science.271.5254.1387; Gladman BJ, 1996, SCIENCE, V274, P161; Goswami JN, 1997, METEORIT PLANET SCI, V32, P91, DOI 10.1111/j.1945-5100.1997.tb01244.x; GRATZ AJ, 1993, NATURE, V363, P522, DOI 10.1038/363522a0; HORNECK G, 1994, ADV SPACE RES, V14, P41, DOI 10.1016/0273-1177(94)90448-0; Kirschvink JL, 1997, SCIENCE, V275, P1629, DOI 10.1126/science.275.5306.1629; Kirtley JR, 1999, ANNU REV MATER SCI, V29, P117, DOI 10.1146/annurev.matsci.29.1.117; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; MELOSH HJ, 1988, NATURE, V332, P687, DOI 10.1038/332687a0; MELOSH HJ, 1993, NATURE, V363, P498, DOI 10.1038/363498a0; MELOSH HJ, 1986, IMPACT CRATERING GEO; MENYEH A, 1995, PHYS EARTH PLANET IN, V89, P51, DOI 10.1016/0031-9201(94)02999-R; Menyeh A, 1996, J GEOPHYS RES-SOL EA, V101, P25045, DOI 10.1029/96JB01188; NYQUIST LE, 1995, LUNAR PLANET SCI, V26; PULLAIAH G, 1975, EARTH PLANET SC LETT, V28, P133, DOI 10.1016/0012-821X(75)90221-6; Shearer CK, 1999, METEORIT PLANET SCI, V34, P331, DOI 10.1111/j.1945-5100.1999.tb01343.x; Sugiura N, 2000, METEORIT PLANET SCI, V35, P373, DOI 10.1111/j.1945-5100.2000.tb01783.x; SWINDLE TD, 1995, GEOCHIM COSMOCHIM AC, V59, P793, DOI 10.1016/0016-7037(94)00359-T; THOMAS IM, 1992, GEOPHYS RES LETT, V19, P2139, DOI 10.1029/92GL02322; THOMASKEPRTA KL, IN PRESS GEOCHIM COS; Treiman AH, 1998, METEORIT PLANET SCI, V33, P753, DOI 10.1111/j.1945-5100.1998.tb01681.x; TREIMAN AH, 2000, LUNAR PLANET SCI, V31; Wikswo JP, 1996, NATO ADV SCI I E-APP, V329, P307; ZAPLETAL K, 1992, PHYS EARTH PLANET IN, V70, P302, DOI 10.1016/0031-9201(92)90196-3	38	168	173	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					791	795		10.1126/science.290.5492.791	http://dx.doi.org/10.1126/science.290.5492.791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052940				2022-12-28	WOS:000090067600045
J	Fiscella, K; Franks, P; Gold, MR; Clancy, CM				Fiscella, K; Franks, P; Gold, MR; Clancy, CM			Inequalities in racial access to health care - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA; CUNY, Sch Med, New York, NY 10031 USA; Agcy Healthcare Res & Qual, Rockville, MD USA	University of Rochester; City University of New York (CUNY) System; Agency for Healthcare Research & Quality	Fiscella, K (corresponding author), Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA.							Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; Owen WF, 1996, BLOOD PURIFICAT, V14, P278; Schappert SM, 1999, VITAL HLTH STAT 13, V13, P1; Tao GY, 1999, J ACQ IMMUN DEF SYND, V22, P395	4	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2053	2053						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364QA	11042742				2022-12-28	WOS:000089902100013
J	Rosenthal, TC; Fox, C				Rosenthal, TC; Fox, C			Access to health care for the rural elderly	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SERVICE UTILIZATION; HOME; RESIDENCE; NEEDS		SUNY Buffalo, Dept Family Med, Buffalo, NY 14215 USA; SUNY Buffalo, Lake Plains Rural Hlth Network, Buffalo, NY 14215 USA; Journal Rural Hlth, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Rosenthal, TC (corresponding author), SUNY Buffalo, Dept Family Med, 462 Grider St, Buffalo, NY 14215 USA.							BUEHLER JA, 1998, CONCEPTUAL BASIS RUR; Congdon JG, 1998, GERIATR NURS, V19, P157, DOI 10.1016/S0197-4572(98)90062-3; Coward R., 1998, AGING RURAL SETTINGS; Culler SD, 1998, MED CARE, V36, P804, DOI 10.1097/00005650-199806000-00004; Evans JG, 1997, BMJ-BRIT MED J, V315, P1075, DOI 10.1136/bmj.315.7115.1075; Goodman DC, 1997, AM J PUBLIC HEALTH, V87, P1144, DOI 10.2105/AJPH.87.7.1144; Horwitz M E, 1994, J Rural Health, V10, P266, DOI 10.1111/j.1748-0361.1994.tb00240.x; KENNEY GM, 1992, MED CARE, V30, P43, DOI 10.1097/00005650-199201000-00004; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Lindberg CCS, 1997, J AM MED INFORM ASSN, V4, P14, DOI 10.1136/jamia.1997.0040014; Ludmerer KM, 1999, TIME HEAL; Miller E A, 1998, Am J Med Qual, V13, P127, DOI 10.1177/106286069801300304; Nesbitt TS, 1997, AM J PUBLIC HEALTH, V87, P85, DOI 10.2105/AJPH.87.1.85; Ricketts III TC, 1999, RURAL HLTH US; Rosenthal T C, 1992, J Am Board Fam Pract, V5, P265; Rosenthal TC, 1998, J RURAL HEALTH, V14, P44, DOI 10.1111/j.1748-0361.1998.tb00861.x; Rosenthal TC, 2000, FAM MED, V32, P174; ROSENTHAL TC, 2000, TXB RURAL HLTH CARE; Rost K, 1998, J RURAL HEALTH, V14, P36, DOI 10.1111/j.1748-0361.1998.tb00860.x; Saag KG, 1998, ARTHRIT CARE RES, V11, P177, DOI 10.1002/art.1790110305; Saag KG, 1998, MED CARE, V36, P965, DOI 10.1097/00005650-199807000-00004; Schultz AA, 1997, PUBLIC HEALTH NURS, V14, P28, DOI 10.1111/j.1525-1446.1997.tb00407.x; SHORTELL SM, 1995, MILBANK Q, V73, P131, DOI 10.2307/3350254; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; WEINER J, 1995, ANN INTERN MED, V122, P380	26	73	73	5	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2034	2036		10.1001/jama.284.16.2034	http://dx.doi.org/10.1001/jama.284.16.2034			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	364QA	11042733				2022-12-28	WOS:000089902100002
J	Falk, D				Falk, D			Careers in science offer women an unusual bonus: immortality	NATURE			English	Letter									SUNY Albany, Dept Anthropol, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany	Falk, D (corresponding author), SUNY Albany, Dept Anthropol, Albany, NY 12222 USA.		Falk, Dean/C-6400-2019	Falk, Dean/0000-0003-1654-0469				Wadman M, 2000, NATURE, V404, P800, DOI 10.1038/35009224; 2000, NATURE, V404, P795	2	4	4	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					833	833		10.1038/35038251	http://dx.doi.org/10.1038/35038251			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057638				2022-12-28	WOS:000089901900015
J	Piperno, DR; Ranere, AJ; Holst, I; Hansell, P				Piperno, DR; Ranere, AJ; Holst, I; Hansell, P			Starch grains reveal early root crop horticulture in the Panamanian tropical forest	NATURE			English	Article							MANIHOT	Native American populations are known to have cultivated a large number of plants and domesticated them for their starch-rich underground organs(1). Suggestions(2,3) that the likely source of many of these crops, the tropical forest, was an early and influential centre of plant husbandry have long been controversial(4-6) because the organic remains of roots and tubers are poorly preserved in archaeological sediments from the humid tropics. Here we report the occurrence of starch grains identifiable as manioc (Manihot esculenta Crantz), yams (Dioscorea sp.) and arrowroot (Maranta arundinacea L.) on assemblages of plant milling stones from preceramic horizons at the Aguadulce Shelter, Panama, dated between 7,000 and 5,000 years before present (BP). The artefacts also contain maize starch (Zea mays L.), indicating that early horticultural systems in this region were mixtures of root and seed crops. The data provide the earliest direct evidence for root crop cultivation in the Americas, and support an ancient and independent emergence of plant domestication in the lowland Neotropical forest.	Smithsonian Trop Res Inst, Balboa, Panama; Temple Univ, Dept Anthropol, Philadelphia, PA 19122 USA	Smithsonian Institution; Smithsonian Tropical Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Piperno, DR (corresponding author), Smithsonian Trop Res Inst, Box 2072, Balboa, Panama.							Barton H, 1998, J ARCHAEOL SCI, V25, P1231, DOI 10.1006/jasc.1998.0300; CORTELLA AR, 1994, ECON BOT, V48, P171, DOI 10.1007/BF02908212; Harlan JR, 1992, CROPS MAN, V2nd; HARRIS DR, 1972, AM SCI, V60, P180; KELLY EF, 1991, QUATERNARY RES, V35, P222, DOI 10.1016/0033-5894(91)90069-H; Lathrap DW, 1970, UPPER AMAZON; MANGELSDORF PC, 1953, REV AGR ORIGINS DISP, V19, P87; Meggers BJ, 1954, AM ANTHROPOL, V56, P801, DOI 10.1525/aa.1954.56.5.02a00060; Olsen KM, 1999, P NATL ACAD SCI USA, V96, P5586, DOI 10.1073/pnas.96.10.5586; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno D.R., 1991, GEOARCHAEOLOGY, P227; Piperno DR, 1998, J ARCHAEOL SCI, V25, P765, DOI 10.1006/jasc.1997.0258; Pohl M.D., 1996, LATIN AM ANTIQ, V7, P355, DOI [DOI 10.2307/972264, 10.2307/972264]; Ranere A. J, 1980, PEABODY MUSEUM MONOG, V5, P118; Ranere A.J., 1975, LITHIC TECHNOLOGY MA, P173; Ranere A.J., 1996, PATHS CENTRAL AM PRE, P49; Ranere A.J., 1978, PREHISTORIC COASTAL, P43; Reichert E.T, 1913, DIFFERENTIATION SPEC; Sauer Carl O., 1952, AGR ORIGINS DISPERSA; SEIDERMANN J, 1966, STARKE ATLAS; Smith B. D., 1998, EMERGENCE AGR; SNYDER EM, 1984, STARCH CHEM TECHNOLO, P661; THERIN R, 1999, PREHISTORY FOOD, P438; UGENT D, 1986, ECON BOT, V40, P78, DOI 10.1007/BF02858949; UGENT D, 1982, ECON BOT, V41, P17; WILDING LP, 1967, SCIENCE, V156, P66, DOI 10.1126/science.156.3771.66; [No title captured]	27	235	257	1	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					894	897		10.1038/35038055	http://dx.doi.org/10.1038/35038055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057665				2022-12-28	WOS:000089901900048
J	Smaglik, P; Abbott, A				Smaglik, P; Abbott, A			Project offers free mouse sequence	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					663	664		10.1038/35037772	http://dx.doi.org/10.1038/35037772			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048689	Bronze			2022-12-28	WOS:000089773900007
J	[Anonymous]				[Anonymous]			In defence of animal research	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					659	659						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048683				2022-12-28	WOS:000089773900001
J	Butler, D				Butler, D			French lab seeks recipe for success	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					551	551		10.1038/35036733	http://dx.doi.org/10.1038/35036733			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034180	Bronze			2022-12-28	WOS:000089772800012
J	Feldman, J				Feldman, J			Minimization of Boolean complexity in human concept learning	NATURE			English	Article							CLASSIFICATION	One of the unsolved problems in the field of human concept learning concerns the factors that determine the subjective difficulty of concepts: why are some concepts psychologically simple and easy to learn, while others seem difficult, complex or incoherent? This question was much studied in the 1960s(1) but was never answered, and more recent characterizations of concepts as prototypes rather than logical rules(2,3) leave it unsolved(4-6). Here I investigate this question in the domain of Boolean concepts (categories defined by logical rules). A series of experiments measured the subjective difficulty of a wide range of logical varieties of concepts (41 mathematically distinct types in six families-a for wider range than has been tested previously). The data reveal a surprisingly simple empirical 'law': the subjective difficulty of a concept is directly proportional to its Boolean complexity (the length of the shortest logically equivalent propositional formula)-that is, to its logical incompressibility.	Rutgers State Univ, Ctr Cognit Sci, Dept Psychol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Feldman, J (corresponding author), Rutgers State Univ, Ctr Cognit Sci, Dept Psychol, New Brunswick, NJ 08903 USA.							BOURNE LE, 1970, PSYCHOL REV, V77, P546, DOI 10.1037/h0030000; BOURNE LE, 1969, J EXP PSYCHOL, V82, P538, DOI 10.1037/h0028358; CHAITIN GJ, 1966, J ACM, V13, P547, DOI 10.1145/321356.321363; Chater N, 1996, PSYCHOL REV, V103, P566, DOI 10.1037/0033-295X.103.3.566; Garey M.R., 1979, COMPUTERS INTRACTABI; Givone D.D., 1970, INTRO SWITCHING CIRC; HAYGOOD RC, 1967, J EXP PSYCHOL, V74, P230, DOI 10.1037/h0024596; HOVLAND CI, 1953, J EXP PSYCHOL, V45, P175, DOI 10.1037/h0062351; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; KOMATSU LK, 1992, PSYCHOL BULL, V112, P500, DOI 10.1037/0033-2909.112.3.500; LI M, 1997, INTRO KOLMOGOROV COM; MEDIN DL, 1987, COGNITIVE PSYCHOL, V19, P242, DOI 10.1016/0010-0285(87)90012-0; MEDIN DL, 1987, COGNITIVE SCI, V11, P299, DOI 10.1207/s15516709cog1103_3; MEDIN DL, 1984, ANNU REV PSYCHOL, V35, P113, DOI 10.1146/annurev.ps.35.020184.000553; NAHINSKY ID, 1970, J EXP PSYCHOL, V84, P64, DOI 10.1037/h0028951; NEISSER U, 1962, J EXP PSYCHOL, V64, P640, DOI 10.1037/h0042549; NOSOFSKY RM, 1994, MEM COGNITION, V22, P352, DOI 10.3758/BF03200862; NOSOFSKY RM, 1994, PSYCHOL REV, V101, P53, DOI 10.1037/0033-295X.101.1.53; OSHERSON DN, 1981, COGNITION, V9, P35, DOI 10.1016/0010-0277(81)90013-5; PINKER S, 1991, SCIENCE, V253, P530, DOI 10.1126/science.1857983; POSNER MI, 1968, J EXP PSYCHOL, V77, P353, DOI 10.1037/h0025953; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; ROSCH EH, 1973, COGNITIVE PSYCHOL, V4, P328, DOI 10.1016/0010-0285(73)90017-0; SHEPARD RN, 1961, PSYCHOL MONOGR, V75, P1, DOI 10.1037/h0093825; Smith EE, 1998, COGNITION, V65, P167, DOI 10.1016/S0010-0277(97)00043-7; SOLOMONOFF RJ, 1964, INFORM CONTROL, V7, P1, DOI 10.1016/S0019-9958(64)90223-2	27	279	280	4	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					630	633		10.1038/35036586	http://dx.doi.org/10.1038/35036586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	362HP	11034211				2022-12-28	WOS:000089772800047
J	Fata, JE; Kong, YY; Li, J; Sasaki, T; Irie-Sasaki, J; Moorehead, RA; Elliott, R; Scully, S; Voura, EB; Lacey, DL; Boyle, WJ; Khokha, R; Penninger, JM				Fata, JE; Kong, YY; Li, J; Sasaki, T; Irie-Sasaki, J; Moorehead, RA; Elliott, R; Scully, S; Voura, EB; Lacey, DL; Boyle, WJ; Khokha, R; Penninger, JM			The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development	CELL			English	Article							T-CELLS; RECEPTOR; MICE; PROLACTIN; PREGNANCY; LACTATION; PROTEIN; MOUSE	Osteoprotegerin-ligand (OPGL) is a key osteoclast differentiation/activation factor essential for bone remodeling. We report that mice lacking OPGL or its receptor RANK fail to form lobulo-alveolar mammary structures during pregnancy, resulting in death of newborns. Transplantation and OPGL-rescue experiments in opgl(-/-) and rank(-/-) pregnant females showed that OPGL acts directly on RANK-expressing mammary epithelial cells. The effects of OPGL are autonomous to epithelial cells. The mammary gland defect in female opgl(-/-) mice is characterized by enhanced apoptosis and failures in proliferation and PKB activation in lobulo-alveolar buds that can be reversed by recombinant OPGL treatment. These data provide a novel paradigm in mammary gland development and an evolutionary rationale for hormonal regulation and gender bias of osteoporosis in females.	Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Ontario Canc Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Amgen Inc, Dept Cell Biol, Thousand Oaks, CA 91320 USA; Amgen Inc, Dept Pathol, Thousand Oaks, CA 91320 USA	Pohang University of Science & Technology (POSTECH); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Amgen; Amgen	Kong, YY (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea.		Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Sasaki, Takehiko/0000-0003-1837-3748; , Roger/0000-0001-9539-6295				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Brisken C, 2000, GENE DEV, V14, P650; Couse JF, 1998, J MOL MED-JMM, V76, P497, DOI 10.1007/s001090050244; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Dunbar ME, 1999, J MAMMARY GLAND BIOL, V4, P21, DOI 10.1023/A:1018700502518; Fata JE, 1999, DEV BIOL, V211, P238, DOI 10.1006/dbio.1999.9313; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; Honore P, 2000, NAT MED, V6, P521, DOI 10.1038/74999; Horseman ND, 1999, J MAMMARY GLAND BIOL, V4, P79, DOI 10.1023/A:1018708704335; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Kurihara N, 2000, J CLIN INVEST, V105, P607, DOI 10.1172/JCI8489; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Neville MC, 1999, CLIN PERINATOL, V26, P251, DOI 10.1016/S0095-5108(18)30053-8; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; POLLARD JW, 1994, P NATL ACAD SCI USA, V91, P9312, DOI 10.1073/pnas.91.20.9312; Robinson GW, 1999, J MAMMARY GLAND BIOL, V4, P9, DOI 10.1023/A:1018748418447; Robinson GW, 2000, GENE DEV, V14, P889; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Ross FP, 2000, J CLIN INVEST, V105, P555, DOI 10.1172/JCI9557; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	32	565	595	0	24	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					41	50		10.1016/S0092-8674(00)00103-3	http://dx.doi.org/10.1016/S0092-8674(00)00103-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051546	Bronze			2022-12-28	WOS:000089636400007
J	Bergman, L; Beelen, MLR; Gallee, MPW; Hollema, H; Benraadt, J; van Leeuwen, FE				Bergman, L; Beelen, MLR; Gallee, MPW; Hollema, H; Benraadt, J; van Leeuwen, FE		Comprehensive Canc Ctr ALERT Grp	Risk and prognosis of endometrial cancer after tamoxifen for breast cancer	LANCET			English	Article							ADJUVANT TAMOXIFEN; RECEPTOR STATUS; THERAPY; CARCINOMA; P53; OVEREXPRESSION; RADIOTHERAPY; PROJECT; TRIAL	Background Tamoxifen increases the risk of endometrial cancer. However, few studies have produced reliable risk estimates by duration, dose, and recency of use, or addressed the prognosis of endometrial cancers in tamoxifen-treated women. Methods We did a nationwide case-control study on the risk and prognosis of endometrial cancer after tamoxifen use for breast cancer. Information on tamoxifen use and other risk factors for endometrial cancer was obtained from 309 women with endometrial cancer after breast cancer (cases), and 860 matched controls with breast cancer but without endometrial cancer. For 276 cases, we obtained tissue blocks of endometrial cancer to review the diagnosis, and used immunohistochemistry to examine hormone-receptor status and overexpression of p53, Findings Tamoxifen had been used by 108 (36.1%) of 299 cases and 245 (28.5%) controls (relative risk 1.5 [95% CI 1.1-2.0]). Risk of endometrial cancer increased with longer duration of tamoxifen use (p<0.001), with relative risks of 2.0 (1.2-3.2) for 2-5 years and 6.9 (2.4-19.4) for at least 5 years compared with non-users. Endometrial cancers of stage III and IV occurred more frequently in long-term tamoxifen users (greater than or equal to 2 years) than in non-users (17.4% vs 5.4%, p=0.006). long-term users were more likely than non-users to have had malignant mixed mesodermal tumours or sarcomas of the endometrium (15.4% vs 2.9%, p less than or equal to 0.02), p53-positive tumours (31.4% vs 18.2%, p=0.05), and negative oestrogen-receptor concentrations (60.8% vs 26.2%, p less than or equal to 0.001). 3-year endometrial-cancer-specific survival was significantly worse for long-term tamoxifen users than for non-users (76% for greater than or equal to 5 years, 85% for 2-5 years vs 94% for non-users, p=0.02). Interpretation Long-term tamoxifen users have a worse prognosis of endometrial cancers, which seems to be due to less favourable histology and higher stage. However, the benefit of tamoxifen on breast-cancer survival far outweighs the increased mortality from endometrial cancer. Nevertheless, we seriously question widespread use of tamoxifen as a preventive agent against breast cancer in healthy women.	Netherlands Canc Inst, Dept Epidemiol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; Acad Hosp Groningen, Dept Pathol, Groningen, Netherlands; Ctr Comprehens Canc, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Groningen	van Leeuwen, FE (corresponding author), Netherlands Canc Inst, Dept Epidemiol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.		Schouten, Leo J/AAB-2275-2019	Schouten, Leo J/0000-0003-3361-7560				ALTARAS MM, 1993, GYNECOL ONCOL, V49, P255, DOI 10.1006/gyno.1993.1118; ANDERSSON M, 1991, J NATL CANCER I, V83, P1013, DOI 10.1093/jnci/83.14.1013; Ansink AC, 1997, J CLIN PATHOL, V50, P328, DOI 10.1136/jcp.50.4.328; Barakat R, 1998, EUR J CANCER, V34, pS49, DOI 10.1016/S0959-8049(98)00112-9; BARAKAT RR, 1994, GYNECOL ONCOL, V55, P164, DOI 10.1006/gyno.1994.1271; Bernstein L, 1999, J NATL CANCER I, V91, P1654, DOI 10.1093/jnci/91.19.1654; BOCKLAGE T, 1992, GYNECOL ONCOL, V44, P104, DOI 10.1016/0090-8258(92)90021-A; Carmichael PL, 1996, CANCER RES, V56, P1475; Clarke M, 1998, LANCET, V351, P1451; COLLETTE HJA, 1984, LANCET, V1, P1224; COOK LS, 1995, J NATL CANCER I, V87, P1359, DOI 10.1093/jnci/87.18.1359; Curtis RE, 1996, J NATL CANCER I, V88, P832, DOI 10.1093/jnci/88.12.832; DALLENBACHHELLWEG G, 1995, INT J GYNECOL PATHOL, V14, P7, DOI 10.1097/00004347-199501000-00003; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; FORNANDER T, 1989, LANCET, V1, P117; ISMAIL SM, 1994, J CLIN PATHOL, V47, P827, DOI 10.1136/jcp.47.9.827; JORDAN VC, 1994, EUR J CANCER, V30A, P1714, DOI 10.1016/0959-8049(94)00349-A; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; KOSHIYAMA M, 1993, VIRCHOWS ARCH A, V423, P265, DOI 10.1007/BF01606889; Kuwashima Y, 1998, INT J GYNECOL PATHOL, V17, P135, DOI 10.1097/00004347-199804000-00007; MAGRIPLES U, 1993, J CLIN ONCOL, V11, P485, DOI 10.1200/JCO.1993.11.3.485; Mignotte H, 1998, INT J CANCER, V76, P325, DOI 10.1002/(SICI)1097-0215(19980504)76:3<325::AID-IJC7>3.0.CO;2-X; MUIR C, 1987, CANC INCIDENCE 5 CON, V5; Olson SH, 1997, CANCER EPIDEM BIOMAR, V6, P815; Powles T, 1998, LANCET, V352, P98; RUTQVIST LE, 1995, J NATL CANCER I, V87, P645, DOI 10.1093/jnci/87.9.645; Sasco AJ, 1996, EPIDEMIOLOGY, V7, P9, DOI 10.1097/00001648-199601000-00003; SASCO AJ, 1995, INT J GYNECOL OBSTET, V48, P307, DOI 10.1016/0020-7292(94)02285-7; Schwartz L, 1998, EUR J CANCER, V34, pS23, DOI 10.1016/S0959-8049(98)00095-1; Scully RE, 1994, HISTOLOGICAL TYPING; TOSI P, 1989, OBSTET GYNECOL, V73, P75; van Leeuwen F, 1998, EUR J CANCER, V34, pS44, DOI 10.1016/S0959-8049(98)00108-7; VANLEEUWEN FE, 1994, LANCET, V343, P448, DOI 10.1016/S0140-6736(94)92692-1; Veronesi U, 1998, LANCET, V352, P93	35	392	398	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					881	887		10.1016/S0140-6736(00)02677-5	http://dx.doi.org/10.1016/S0140-6736(00)02677-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036892				2022-12-28	WOS:000089259800009
J	Johnson, RE; Chutuape, MA; Strain, EC; Walsh, SL; Stitzer, ML; Bigelow, GE				Johnson, RE; Chutuape, MA; Strain, EC; Walsh, SL; Stitzer, ML; Bigelow, GE			A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CLINICAL-TRIAL; MAINTENANCE TREATMENT; ADDICTION; EFFICACY; USERS; ABUSE	Background: Opioid dependence is a chronic, relapsing disorder with important public health implications. Methods: In a 17-week randomized study of 220 patients, we compared levomethadyl acetate (75 to 115 mg), buprenorphine (16 to 32 mg), and high-dose (60 to 100 mg) and low-dose (20 mg) methadone as treatments for opioid dependence. Levomethadyl acetate and buprenorphine were administered three times a week. Methadone was administered daily. Doses were individualized except in the group assigned to low-dose methadone. Patients with poor responses to treatment were switched to methadone. Results: There were 55 patients in each group; 51 percent completed the trial. The mean (+/-SE) number of days that a patient remained in the study was significantly higher for those receiving levomethadyl acetate (89+/-6), buprenorphine (96+/-4), and high-dose methadone (105+/-4) than for those receiving low-dose methadone (70+/-4, P<0.001). Continued participation in the study was also significantly more frequent among patients receiving high-dose methadone than among those receiving levomethadyl acetate (P=0.02). The percentage of patients with 12 or more consecutive opioid-negative urine specimens was 36 percent in the levomethadyl acetate group, 26 percent in the buprenorphine group, 28 percent in the high-dose methadone group, and 8 percent in the low-dose methadone group (P=0.005). At the time of their last report, patients reported on a scale of 0 to 100 that their drug problem had a mean severity of 35 with levomethadyl acetate, 34 with buprenorphine, 38 with high-dose methadone, and 53 with low-dose methadone (P=0.002). Conclusions: As compared with low-dose methadone, levomethadyl acetate, buprenorphine, and high-dose methadone substantially reduce the use of illicit opioids. (N Engl J Med 2000;343:1290-7.) (C) 2000, Massachusetts Medical Society.	Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21224 USA	Johns Hopkins University	Johnson, RE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, 5510 Nathan Shock Dr, Baltimore, MD 21224 USA.			Walsh, Sharon/0000-0002-9722-5681	NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005273, K02DA000332, K05DA000050] Funding Source: NIH RePORTER; NIDA NIH HHS [P50 DA05273, K02 DA00332, K05 DA00050] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		AMASS L, 1994, J ADDICT DIS, V13, P33; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Bickel WK, 1999, PSYCHOPHARMACOLOGY, V146, P111, DOI 10.1007/s002130051096; CAPLEHORN JRM, 1993, MED J AUSTRALIA, V159, P640, DOI 10.5694/j.1326-5377.1993.tb138072.x; CAPLEHORN JRM, 1991, MED J AUSTRALIA, V154, P195, DOI 10.5694/j.1326-5377.1991.tb121030.x; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; de los Cobos JP, 2000, DRUG ALCOHOL DEPEN, V59, P223, DOI 10.1016/S0376-8716(99)00122-2; Diggle PJ, 1995, J AM STAT ASSOC; DOLE VP, 1965, J AMER MED ASSOC, V193, P646, DOI 10.1001/jama.1965.03090080008002; Eissenberg T, 1997, JAMA-J AM MED ASSOC, V277, P1945, DOI 10.1001/jama.277.24.1945; FOLLMANN D, 1995, BIOMETRICS, V51, P151, DOI 10.2307/2533322; *FOOD DRUG ADM, 1985, COSTART; FUDALA PJ, 1990, CLIN PHARMACOL THER, V47, P525, DOI 10.1038/clpt.1990.67; GERSTEIN DR, 1990, TREATING DRUG PROBLE, V1; Gunne L. M., 1984, SOCIAL MED ASPECTS D, P205; HENDERSON GL, 1977, J ANAL TOXICOL, V1, P1; HENDERSON GL, 1977, CLIN PHARMACOL THER, V21, P16; IMBER SD, 1992, METHODOLOGICAL ISSUE, P665; JAFFE JH, 1971, J AMER MED ASSOC, V216, P1303, DOI 10.1001/jama.216.8.1303; JAFFE JH, 1972, J AMER MED ASSOC, V222, P437, DOI 10.1001/jama.222.4.437; JASINSKI DR, 1978, ARCH GEN PSYCHIAT, V35, P501; JOHNSON RE, 1992, JAMA-J AM MED ASSOC, V267, P2750, DOI 10.1001/jama.267.20.2750; JOHNSON RE, 1995, DRUG ALCOHOL DEPEN, V40, P27, DOI 10.1016/0376-8716(95)01189-7; Jones HE, 1998, ARCH GEN PSYCHIAT, V55, P729, DOI 10.1001/archpsyc.55.8.729; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KARPGELERNTER E, 1982, INT J ADDICT, V17, P805, DOI 10.3109/10826088209056328; KOSTEN TR, 1993, J NERV MENT DIS, V181, P358, DOI 10.1097/00005053-199306000-00004; Lewis J W, 1973, Adv Biochem Psychopharmacol, V8, P123; Ling W, 1996, ARCH GEN PSYCHIAT, V53, P401; Ling W, 1998, ADDICTION, V93, P475, DOI 10.1046/j.1360-0443.1998.9344753.x; LING W, 1978, ARCH GEN PSYCHIAT, V35, P345; LING W, 1976, ARCH GEN PSYCHIAT, V33, P709; *MED EC, 2000, PHYS DESK REF; NEWMAN RG, 1979, LANCET, V2, P485; Office of National Drug Control Policy, 2000, NAT DRUG CONTR STRAT; Oliveto AH, 1998, AM J ADDICTION, V7, P272; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; PIANTADOSI S, 1997, CLIN TRIALS METHODOL; Preston K L, 1997, NIDA Res Monogr, V167, P130; SAVAGE C, 1976, COMPR PSYCHIAT, V17, P415, DOI 10.1016/0010-440X(76)90044-4; Schottenfeld RS, 1997, ARCH GEN PSYCHIAT, V54, P713; SENAY EC, 1977, JAMA-J AM MED ASSOC, V237, P138, DOI 10.1001/jama.237.2.138; SIEGEL S, 1956, NONPARAMETRIC STAT, P107; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; STRAIN EC, 1993, ANN INTERN MED, V119, P23, DOI 10.7326/0003-4819-119-1-199307010-00004; Strain EC, 1999, JAMA-J AM MED ASSOC, V281, P1000, DOI 10.1001/jama.281.11.1000; STRAIN EC, 1994, PSYCHOPHARMACOLOGY, V116, P401, DOI 10.1007/BF02247469; WALSH SL, 1995, PSYCHOPHARMACOLOGY, V119, P268, DOI 10.1007/BF02246290; WALSH SL, 1995, J PHARMACOL EXP THER, V274, P361	49	459	469	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2000	343	18					1290	1297		10.1056/NEJM200011023431802	http://dx.doi.org/10.1056/NEJM200011023431802			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	368RP	11058673				2022-12-28	WOS:000090131600002
J	Hausser, M; Spruston, N; Stuart, GJ				Hausser, M; Spruston, N; Stuart, GJ			Diversity and dynamics of dendritic signaling	SCIENCE			English	Review							CA1 PYRAMIDAL NEURONS; PROPAGATING ACTION-POTENTIALS; EXCITATORY POSTSYNAPTIC POTENTIALS; CEREBELLAR PURKINJE NEURONS; SODIUM-CHANNEL INACTIVATION; LONG-LASTING POTENTIATION; DISTAL APICAL DENDRITES; RAT BARREL CORTEX; HIPPOCAMPAL-NEURONS; IN-VIVO	Communication between neurons in the brain occurs primarily through synapses made onto elaborate treelike structures called dendrites. New electrical and optical recording techniques have Led to tremendous advances in our understanding of how dendrites contribute to neuronal computation in the mammalian brain. The varied morphology and electrical and chemical properties of dendrites enable a spectrum of local and Long-range signaling, defining the input-output relationship of neurons and the rules for induction of synaptic plasticity. In this way, diversity in dendritic signaling allows individual neurons to carry out specialized functions within their respective networks.	UCL, Dept Physiol, London WC1E 6BT, England; Northwestern Univ, Inst Neurosci, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia	University of London; University College London; Northwestern University; Australian National University; John Curtin School of Medical Research	Hausser, M (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	m.hausser@ucl.ac.uk	Hausser, Michael/AAW-6827-2020; stuart, greg j/F-7328-2011	Hausser, Michael/0000-0002-2673-8957; stuart, greg/0000-0001-9395-2219				Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; AGMONSNIR H, 1993, J NEUROPHYSIOL, V70, P2066, DOI 10.1152/jn.1993.70.5.2066; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; Andreasen M, 1998, J PHYSIOL-LONDON, V507, P441, DOI 10.1111/j.1469-7793.1998.441bt.x; ANDREASEN M, 1995, J PHYSIOL-LONDON, V483, P421, DOI 10.1113/jphysiol.1995.sp020595; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BORST A, 1994, TRENDS NEUROSCI, V17, P257, DOI 10.1016/0166-2236(94)90009-4; Bower J.M., 1998, BOOK GENESIS; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; Cash S, 1998, J NEUROSCI, V18, P10; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; Colbert CM, 1997, J NEUROSCI, V17, P6512; De Schutter E, 1998, J NEUROPHYSIOL, V80, P504; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Eilers J, 1997, CURR OPIN NEUROBIOL, V7, P385, DOI 10.1016/S0959-4388(97)80067-0; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; FUJITA Y, 1968, J NEUROPHYSIOL, V31, P131, DOI 10.1152/jn.1968.31.2.131; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Helmchen F., 1999, Society for Neuroscience Abstracts, V25, P800; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; HELMCHEN F, 1999, DENDRITES, P161; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; IANSEK R, 1973, J PHYSIOL-LONDON, V234, P613, DOI 10.1113/jphysiol.1973.sp010364; Ito M, 1984, CEREBELLUM NEURAL CO; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Jung HY, 1997, J NEUROSCI, V17, P6639; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kamondi A, 1998, J NEUROSCI, V18, P3919; kandel, 1977, NERVOUS SYSTEM, V1; KOCH C, 1993, J NEUROSCI, V13, P413; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 1996, J NEUROPHYSIOL, V75, P154, DOI 10.1152/jn.1996.75.1.154; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; LASSERROSS N, 1991, J NEUROSCI METH, V36, P253, DOI 10.1016/0165-0270(91)90051-Z; Laurent G, 1999, DENDRITES, P290; LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167, DOI 10.1152/jn.1992.68.4.1167; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; LLINAS R, 1976, P NATL ACAD SCI USA, V73, P2520, DOI 10.1073/pnas.73.7.2520; LLINAS R, 1968, SCIENCE, V160, P1132, DOI 10.1126/science.160.3832.1132; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Magee J. C., 1999, DENDRITES, P139; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1998, J NEUROSCI, V18, P7613; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; MILLS LR, 1994, J NEUROSCI, V14, P6815; Miyashita T, 1997, BRAIN RES, V750, P251, DOI 10.1016/S0006-8993(96)01365-0; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Nusser Z., 1999, DENDRITES, P85; Pare D, 1998, NEUROSCIENCE, V84, P377, DOI 10.1016/S0306-4522(97)00530-7; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; Sandler VM, 1999, J NEUROSCI, V19, P4325; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Segev I, 1998, NATURE, V393, P207, DOI 10.1038/30340; Segev I, 1998, TRENDS NEUROSCI, V21, P453, DOI 10.1016/S0166-2236(98)01327-7; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Spruston N., 1999, DENDRITES, P231; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Stricker C, 1996, J PHYSIOL-LONDON, V490, P419, DOI 10.1113/jphysiol.1996.sp021155; Stuart G., 1998, Society for Neuroscience Abstracts, V24, P1810; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Stuart G. J., 1999, Society for Neuroscience Abstracts, V25, P1739; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; Tsubokawa H, 2000, J NEUROSCI, V20, P4878; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; TURNER RW, 1991, J NEUROSCI, V11, P2270; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Urban NN, 1998, P NATL ACAD SCI USA, V95, P11450, DOI 10.1073/pnas.95.19.11450; URBAN NN, 2000, SOC NEUR ABSTR, V26, P1585; Velte TJ, 1999, J NEUROPHYSIOL, V81, P1412, DOI 10.1152/jn.1999.81.3.1412; VETTER P, IN PRESS J NEUROPHYS; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; WANG SSH, IN PRESS NATURE NEUR; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Williams SR, 2000, J NEUROSCI, V20, P1307; WILLIAMS SR, IN PRESS J NEUROSCI; WONG RKS, 1978, BRAIN RES, V159, P385, DOI 10.1016/0006-8993(78)90544-9; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	129	571	583	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					739	744		10.1126/science.290.5492.739	http://dx.doi.org/10.1126/science.290.5492.739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052929				2022-12-28	WOS:000090067600034
J	Fu, DX; Libson, A; Miercke, LJW; Weitzman, C; Nollert, P; Krucinski, J; Stroud, RM				Fu, DX; Libson, A; Miercke, LJW; Weitzman, C; Nollert, P; Krucinski, J; Stroud, RM			Structure of a glycerol-conducting channel and the basis for its selectivity	SCIENCE			English	Article							WATER CHANNELS; ESCHERICHIA-COLI; XENOPUS-OOCYTES; FUNCTIONAL RECONSTITUTION; ELECTRON CRYSTALLOGRAPHY; MEMBRANE-PROTEINS; HELIX PACKING; MIP FAMILY; AQUAPORIN-1; PERMEABILITY	Membrane channel proteins of the aquaporin family are highly selective for permeation of specific small molecules, with absolute exclusion of ions and charged solutes and without dissipation of the electrochemical potential across the cell membrane. We report the crystal structure of the Escherichia coli glycerol facilitator (GlpF) with its primary permeant substrate glycerol at 2.2 angstrom resolution. Glycerol molecules line up in an amphipathic channel in single file. In the narrow selectivity filter of the channel the glycerol alkyl backbone is wedged against a hydrophobic corner, and successive hydroxyl groups form hydrogen bonds with a pair of acceptor, and donor atoms. Two conserved aspartic acid-proline-alanine motifs form a key interface between two gene-duplicated segments that each encode three-and-one-half membrane-spanning helices around the channel. This structure elucidates the mechanism of selective permeability for linear carbohydrates and suggests how ions and water are excluded.	Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA.		Stroud, Rhonda/GQZ-0151-2022; Stroud, Rhonda M./C-5503-2008	Stroud, Rhonda/0000-0001-5242-8015; Stroud, Rhonda M./0000-0001-5242-8015; Fu, Dax/0000-0002-2663-1316	NIGMS NIH HHS [GM24485] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024485, R37GM024485] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agre P, 1999, Methods Enzymol, V294, P550; ANDERSEN OS, 1992, PHYSIOL REV, V72, pS89, DOI 10.1152/physrev.1992.72.suppl_4.S89; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Anthony TL, 2000, MOL PHARMACOL, V57, P576, DOI 10.1124/mol.57.3.576; Bernal JD, 1933, J CHEM PHYS, V1, P515, DOI 10.1063/1.1749327; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; BRUNGER AT, 1996, XPLOR VERSION 3 843; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; DEEN PMT, 1995, J CLIN INVEST, V95, P2291, DOI 10.1172/JCI117920; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Doyle DA, 1997, J MOL BIOL, V266, P963, DOI 10.1006/jmbi.1996.0837; Eisenberg D. S., 2005, STRUCTURE PROPERTIES; Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800; Finkelstein A., 1987, WATER MOVEMENT LIPID; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; LAFORTELLE ED, 1997, CRYSTALLOGRAPHIC COM, V7; Lagree V, 1998, J BIOL CHEM, V273, P12422, DOI 10.1074/jbc.273.20.12422; LAUGER P, 1982, BIOPHYS CHEM, V16, P209, DOI 10.1016/0301-4622(82)87004-X; Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263; MALONEY PC, 1989, ARCH BIOCHEM BIOPHYS, V269, P1, DOI 10.1016/0003-9861(89)90080-5; MAUREL C, 1993, EMBO J, V12, P2241, DOI 10.1002/j.1460-2075.1993.tb05877.x; MAUREL C, 1994, J BIOL CHEM, V269, P11869; Mitsuoka K, 1999, J STRUCT BIOL, V128, P34, DOI 10.1006/jsbi.1999.4177; MULLINS LJ, 1959, J GEN PHYSIOL, V42, P817, DOI 10.1085/jgp.42.4.817; PAO GM, 1991, MOL MICROBIOL, V5, P33, DOI 10.1111/j.1365-2958.1991.tb01823.x; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; Prasad GVR, 1998, J BIOL CHEM, V273, P33123, DOI 10.1074/jbc.273.50.33123; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540; Ringler P, 1999, J MOL BIOL, V291, P1181, DOI 10.1006/jmbi.1999.3031; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SMITH BL, 1991, J BIOL CHEM, V266, P6407; SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343; Walther D, 1996, J MOL BIOL, V255, P536, DOI 10.1006/jmbi.1996.0044; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; WISTOW GJ, 1991, TRENDS BIOCHEM SCI, V16, P170, DOI 10.1016/0968-0004(91)90065-4; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; Yool AJ, 1996, SCIENCE, V273, P1216, DOI 10.1126/science.273.5279.1216	43	816	851	1	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					481	486		10.1126/science.290.5491.481	http://dx.doi.org/10.1126/science.290.5491.481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039922				2022-12-28	WOS:000089946000041
J	Higgie, M; Chenoweth, S; Blows, MW				Higgie, M; Chenoweth, S; Blows, MW			Natural selection and the reinforcement of mate recognition	SCIENCE			English	Article							DROSOPHILA; SPECIATION	Natural selection on mate recognition may often contribute to speciation, resulting in reproductive character displacement. Field populations of Drosophila serrata display reproductive character displacement in cuticular hydrocarbons when sympatric with Drosophila birchii. We exposed field sympatric and allopatric populations of D. serrata to experimental sympatry with D. birchii for nine generations. Cuticular hydrocarbons of field allopatric D. serrata populations evolved to resemble the field sympatric populations, whereas field sympatric D. serrata populations remained unchanged. Our experiment indicates that natural selection on mate recognition resulted in the field pattern of reproductive character displacement.	Univ Queensland, Dept Zool & Entomol, St Lucia, Qld 4072, Australia; Griffith Univ, Fac Environm Sci, Nathan, Qld 4111, Australia	University of Queensland; Griffith University	Higgie, M (corresponding author), Univ Queensland, Dept Zool & Entomol, St Lucia, Qld 4072, Australia.	MHiggie@zoology.uq.edu.au	Chenoweth, Stephen F/A-7211-2012; Chenoweth, Steve/AAV-9916-2020; Blows, Mark W/B-6195-2008; Higgie, Megan/A-6131-2008	Chenoweth, Stephen F/0000-0002-8303-9159; Chenoweth, Steve/0000-0002-8303-9159; Blows, Mark W/0000-0002-1065-5524; Higgie, Megan/0000-0002-2397-0240				AYALA FJ, 1965, GENETICS, V51, P527; AYALA FJ, 1965, EVOLUTION, V19, P538, DOI 10.1111/j.1558-5646.1965.tb03329.x; BIRCH LC, 1963, EVOLUTION, V17, P72, DOI 10.1111/j.1558-5646.1963.tb03255.x; BLAIR WF, 1964, Q REV BIOL, V39, P333, DOI 10.1086/404323; Blows MW, 1998, AM NAT, V152, P826, DOI 10.1086/286211; Blows MW, 1998, AM NAT, V151, P538, DOI 10.1086/286139; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; BUTLIN RK, 1995, TRENDS ECOL EVOL, V10, P432, DOI 10.1016/S0169-5347(00)89173-9; Butlin Roger, 1995, P327; DOBZHANSKY T, 1951, GENETICS ORIGIN SPEC, P206; HICKS CR, 1993, FUNDAMENTAL CONCEPTS, P268; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Kim YK, 1996, BEHAV GENET, V26, P27, DOI 10.1007/BF02361156; KOOPMAN KF, 1950, EVOLUTION, V4, P135, DOI 10.1111/j.1558-5646.1950.tb00048.x; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; Noor MAF, 1997, AM NAT, V149, P1156, DOI 10.1086/286044; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; Saetre GP, 1997, NATURE, V387, P589	21	243	246	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2000	290	5491					519	521		10.1126/science.290.5491.519	http://dx.doi.org/10.1126/science.290.5491.519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039933				2022-12-28	WOS:000089946000052
J	Abbott, A; Schiermeier, Q				Abbott, A; Schiermeier, Q			Deep roots of Nazi science revealed	NATURE			English	News Item																		Abbott A, 2000, NATURE, V403, P474, DOI 10.1038/35000735	1	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					823	824		10.1038/35038223	http://dx.doi.org/10.1038/35038223			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057631	Bronze			2022-12-28	WOS:000089901900008
J	Dalton, R				Dalton, R			Anger as Princeton closes 'inspirational' museum	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					825	825		10.1038/35038234	http://dx.doi.org/10.1038/35038234			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057635	Bronze			2022-12-28	WOS:000089901900012
J	Hedstrom, L; Frey, PA				Hedstrom, L; Frey, PA			Robert H. Abeles (1926-2000) - Obituary	NATURE			English	Biographical-Item									Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	Brandeis University; University of Wisconsin System; University of Wisconsin Madison	Hedstrom, L (corresponding author), Brandeis Univ, Dept Biochem, MS 009,415 South St, Waltham, MA 02454 USA.								0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					854	854		10.1038/35038202	http://dx.doi.org/10.1038/35038202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057653				2022-12-28	WOS:000089901900035
J	Frame, PS				Frame, PS			Routine screening for lung cancer? Maybe someday, but not yet	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSTITUTE; MORTALITY; PROGRAM		Tri County Family Med, Cohocton, NY 14826 USA; Univ Rochester, Sch Med & Dent, Rochester, NY USA	University of Rochester	Frame, PS (corresponding author), Tri County Family Med, 25 Park Ave, Cohocton, NY 14826 USA.	psframe@frontiernet.net						BERLIN NI, 1984, AM REV RESPIR DIS, V130, P545; BOUCOT KR, 1959, NEW ENGL J MED, V260, P742, DOI 10.1056/NEJM195904092601503; BOUCOT KR, 1973, JAMA-J AM MED ASSOC, V224, P1361, DOI 10.1001/jama.224.10.1361; BRETT GZ, 1969, BRIT MED J, V4, P260, DOI 10.1136/bmj.4.5678.260; Brownson RC, 1998, EPIDEMIOL REV, V20, P218, DOI 10.1093/oxfordjournals.epirev.a017982; *CONS STAT PREV EA, 1999, ONCOLOGY, V13, P298; Eddy D, 1980, CA Cancer J Clin, V30, P193; FONTANA RS, 1986, J OCCUP ENVIRON MED, V28, P746, DOI 10.1097/00043764-198608000-00038; FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0; Frame P S, 1998, J Am Board Fam Pract, V11, P87; GOHAGAN JK, 1995, CANCER, V75, P1869, DOI 10.1002/1097-0142(19950401)75:7+<1869::AID-CNCR2820751617>3.0.CO;2-7; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; KUBIK A, 1986, CANCER-AM CANCER SOC, V57, P2427, DOI 10.1002/1097-0142(19860615)57:12<2427::AID-CNCR2820571230>3.0.CO;2-M; LILIENFE.A, 1966, CANCER RES, V26, P2083; MELAMED MR, 1984, CHEST, V86, P44, DOI 10.1378/chest.86.1.44; NASH FA, 1968, BRIT MED J, V2, P715, DOI 10.1136/bmj.2.5607.715; *NCI, 1979, NIH CONS DEV C SUMM, V1, P4; Payne PW, 1997, MAYO CLIN PROC, V72, P697; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; TOCKMAN MS, 1986, CHEST, V89, pS324, DOI 10.1378/chest.89.4_Supplement.324S-a; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P135; Wingo PA, 1998, CANCER-AM CANCER SOC, V82, P1197, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1197::AID-CNCR26>3.0.CO;2-0	22	26	26	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1980	1983		10.1001/jama.284.15.1980	http://dx.doi.org/10.1001/jama.284.15.1980			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362JC	11035899				2022-12-28	WOS:000089774000035
J	Yuan, JY; Yankner, BA				Yuan, JY; Yankner, BA			Apoptosis in the nervous system	NATURE			English	Review							PROGRAMMED CELL-DEATH; AMYLOID-BETA-PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; FAMILIAL ALZHEIMERS-DISEASE; NEURONAL INTRANUCLEAR INCLUSIONS; TROPHIC-FACTOR DEPRIVATION; TRANSGENIC MICE; GROWTH-FACTOR; CYTOCHROME-C; SUPEROXIDE-DISMUTASE	Neuronal apoptosis sculpts the developing brain and has a potentially important role in neurodegenerative diseases. The principal molecular components of the apoptosis programme in neurons include Apaf-1 (apoptotic protease-activating factor 1) and proteins of the Bcl-2 and caspase families. Neurotrophins regulate neuronal apoptosis through the action of critical protein kinase cascades, such as the phosphoinositide 3-kinase/Akt and mitogen-activated protein kinase pathways. Similar cell-death-signalling pathways might be activated in neurodegenerative diseases by abnormal protein structures, such as amyloid fibrils in Alzheimer's disease. Elucidation of the cell death machinery in neurons promises to provide multiple points of therapeutic intervention in neurodegenerative diseases.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	junying_yuan@hms.harvard.edu; yankner@al.tch.harvard.edu						[Anonymous], [No title captured]; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barbacid M, 1995, ANN NY ACAD SCI, V766, P442, DOI 10.1111/j.1749-6632.1995.tb26693.x; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davey F, 1998, CURR BIOL, V8, P915, DOI 10.1016/S0960-9822(07)00371-5; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Estus S, 1997, J NEUROSCI, V17, P7736; Frade JM, 1996, NATURE, V383, P166; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Giulian D, 1996, J NEUROSCI, V16, P6021; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Imaizumi K, 1999, J BIOL CHEM, V274, P7975, DOI 10.1074/jbc.274.12.7975; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lee VMY, 1999, NEURON, V24, P507, DOI 10.1016/S0896-6273(00)81106-X; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LI Y, 1995, STROKE, V26, P1252, DOI 10.1161/01.STR.26.7.1252; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Liu XH, 1999, J CEREBR BLOOD F MET, V19, P1099, DOI 10.1097/00004647-199910000-00006; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Lunkes A, 1997, NAT MED, V3, P1201, DOI 10.1038/nm1197-1201; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X; Mattson MP, 1998, J NEUROCHEM, V70, P1; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Namura S, 1998, J NEUROSCI, V18, P3659; Ohagen A, 1999, J VIROL, V73, P897, DOI 10.1128/JVI.73.2.897-906.1999; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Orr HT, 2000, CELL, V101, P1, DOI 10.1016/S0092-8674(00)80617-0; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Philpott KL, 1997, J CELL BIOL, V139, P809, DOI 10.1083/jcb.139.3.809; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Troncoso JC, 1996, J NEUROPATH EXP NEUR, V55, P1134, DOI 10.1097/00005072-199611000-00004; Troy CM, 2000, J NEUROSCI, V20, P1386; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; YAO R, 1995, ONCOGENE, V11, P1607; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	100	1449	1593	1	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					802	809		10.1038/35037739	http://dx.doi.org/10.1038/35037739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048732				2022-12-28	WOS:000089773900056
J	Kovalchuk, O; Dubrova, YE; Arkhipov, A; Hohn, B; Kovalchuk, I				Kovalchuk, O; Dubrova, YE; Arkhipov, A; Hohn, B; Kovalchuk, I			Germline DNA - Wheat mutation rate after Chernobyl	NATURE			English	Article							INDUCTION		Novartis Res Fdn, Friedrich Miescher Inst, CH-4002 Basel, Switzerland; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Chernobyl Sci & Tech Ctr Int Res, UA-255620 Chernobyl, Ukraine	Friedrich Miescher Institute for Biomedical Research; Novartis; University of Leicester	Kovalchuk, O (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst, POB 2543, CH-4002 Basel, Switzerland.	Olga.Kovalchuk@fmi.ch	Dubrova, Yuri/ABA-7148-2020	Dubrova, Yuri/0000-0001-5281-7539				CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dubrova YE, 1998, INT J RADIAT BIOL, V74, P689, DOI 10.1080/095530098140952; FRANKENBERGSCHWAGER M, 1990, RADIAT ENVIRON BIOPH, V29, P273, DOI 10.1007/BF01210408; Kovalchuk I, 1998, NAT BIOTECHNOL, V16, P1054, DOI 10.1038/3505; Kovalchuk O, 2000, MUTAT RES-FUND MOL M, V449, P47, DOI 10.1016/S0027-5107(00)00029-4; MOISEEV A, 1991, DIRECTORY DOSIMETRY; Roder MS, 1998, GENETICS, V149, P2007; SADAMOTO S, 1994, INT J RADIAT BIOL, V65, P549, DOI 10.1080/09553009414550641; SHIELDS R, 1993, NATURE, V365, P297, DOI 10.1038/365297a0	9	108	112	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2000	407	6804					583	584		10.1038/35036692	http://dx.doi.org/10.1038/35036692			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034198				2022-12-28	WOS:000089772800034
J	Chawla, A; Saez, E; Evans, RM				Chawla, A; Saez, E; Evans, RM			"Don't know much bile-ology"	CELL			English	Review							ACID BIOSYNTHESIS; NUCLEAR RECEPTOR; CHOLESTEROL; IDENTIFICATION; MICE; GENE		Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965				Bahar RJ, 1999, GASTROENTEROL CLIN N, V28, P27, DOI 10.1016/S0889-8553(05)70042-X; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Parker KL, 1999, ANNU REV PHYSIOL, V61, P417, DOI 10.1146/annurev.physiol.61.1.417; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; Schwarz M, 1998, CURR OPIN LIPIDOL, V9, P113, DOI 10.1097/00041433-199804000-00006; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Wan YJY, 2000, MOL CELL BIOL, V20, P4436, DOI 10.1128/MCB.20.12.4436-4444.2000; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g	19	104	106	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					1	4		10.1016/S0092-8674(00)00097-0	http://dx.doi.org/10.1016/S0092-8674(00)00097-0			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051540	Bronze			2022-12-28	WOS:000089636400001
J	Tisdale, MJ				Tisdale, MJ			Biomedicine - Protein loss in cancer cachexia	SCIENCE			English	Editorial Material							SKELETAL-MUSCLE; PROTEASOME		Aston Univ, Pharmaceut Sci Res Inst, Birmingham B4 7ET, W Midlands, England	Aston University	Tisdale, MJ (corresponding author), Aston Univ, Pharmaceut Sci Res Inst, Birmingham B4 7ET, W Midlands, England.							Barber MD, 1999, BRIT J CANCER, V81, P80, DOI 10.1038/sj.bjc.6690654; Du J, 2000, J BIOL CHEM, V275, P19661, DOI 10.1074/jbc.M907258199; Grune T, 1998, J BIOL CHEM, V273, P10857, DOI 10.1074/jbc.273.18.10857; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Kawamura I, 1999, GENE THER, V6, P91, DOI 10.1038/sj.gt.3300819; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Llovera M, 1997, BIOCHEM BIOPH RES CO, V230, P238, DOI 10.1006/bbrc.1996.5827; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; MOLDAWER LL, 1987, AM J PHYSIOL, V253, pC766, DOI 10.1152/ajpcell.1987.253.6.C766; Moldawer LL, 1997, CANCER-AM CANCER SOC, V79, P1828; Smith HJ, 1999, CANCER RES, V59, P5507; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398	12	56	67	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2293	2294		10.1126/science.289.5488.2293	http://dx.doi.org/10.1126/science.289.5488.2293			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11041796				2022-12-28	WOS:000089593500034
J	Xu, CY; Kauffmann, RC; Zhang, JJ; Kladny, S; Carthew, RW				Xu, CY; Kauffmann, RC; Zhang, JJ; Kladny, S; Carthew, RW			Overlapping activators and repressors delimit transcriptional response to receptor tyrosine kinase signals in the Drosophila eye	CELL			English	Article							EGF RECEPTOR; MAP KINASE; CELL FATE; R7 CELL; PATHWAY; DIFFERENTIATION; LOZENGE; EXPRESSION; PHYLLOPOD; EMBRYO	Regulated transcription of the prospero gene in the Drosophila eye provides a model for how gene expression is specifically controlled by signals from receptor tyrosine kinases. We show that prospero is controlled by signals from the EGF receptor DER and the Sevenless receptor. A direct link is established between DER activation of a transcription enhancer in prospero and binding of two transcription factors that are targets of DER signaling. Binding of the cell-specific Lozenge protein is also required for activation, and overlapping Lozenge protein distribution and DER signaling establishes expression in a subset of equivalent cells competent to respond to Sevenless. We show that Sevenless activates prospero independent of the enhancer and involves targeted degradation of Tramtrack, a transcription repressor.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carthew, RW (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.				NATIONAL EYE INSTITUTE [R01EY010111] Funding Source: NIH RePORTER; NEI NIH HHS [EY10111] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; CHANG HC, 1995, CELL, V80, P463, DOI 10.1016/0092-8674(95)90497-2; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; Crew JR, 1997, DEV GENES EVOL, V206, P481, DOI 10.1007/s004270050079; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; DICKSON BJ, 1995, CELL, V80, P453, DOI 10.1016/0092-8674(95)90496-4; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Flores GV, 1998, DEVELOPMENT, V125, P3681; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Golembo M, 1999, GENE DEV, V13, P158, DOI 10.1101/gad.13.2.158; Greenwood S, 1997, DEVELOPMENT, V124, P4879; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Li LH, 1999, DEVELOPMENT, V126, P3313; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; PERRIMON N, 1994, CURR OPIN CELL BIOL, V6, P260, DOI 10.1016/0955-0674(94)90145-7; Queenan AM, 1997, DEVELOPMENT, V124, P3871; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Rodan GA, 1997, CELL, V89, P677, DOI 10.1016/S0092-8674(00)80249-4; Rogge R, 1995, DEVELOPMENT, V121, P3947; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	32	123	125	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					87	97		10.1016/S0092-8674(00)00107-0	http://dx.doi.org/10.1016/S0092-8674(00)00107-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051550	Bronze			2022-12-28	WOS:000089636400011
J	Horton, R				Horton, R			The less acceptable face of bias	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Horton, R (corresponding author), Lancet, London WC1X 8RR, England.							Bassand JP, 2000, EUR HEART J, V21, P1289, DOI 10.1053/euhj.2000.2256; BERO LA, 1992, NEW ENGL J MED, V327, P1135, DOI 10.1056/NEJM199210153271606; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Hall A, 2000, LANCET, V356, P851, DOI 10.1016/S0140-6736(00)02667-2; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; KNIGHT M, 2000, J BR CARDIAC PAT AUG, P3; Kubler W, 2000, HEART, V84, P134, DOI 10.1136/heart.84.2.134; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Tallon D, 2000, LANCET, V355, P2037, DOI 10.1016/S0140-6736(00)02351-5	11	19	19	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					959	960						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041395				2022-12-28	WOS:000089293600008
J	Vandermeer, J; de la Cerda, IG; Boucher, D; Perfecto, I; Ruiz, J				Vandermeer, J; de la Cerda, IG; Boucher, D; Perfecto, I; Ruiz, J			Hurricane disturbance and tropical tree species diversity	SCIENCE			English	Article							FOREST; NICARAGUA	The debate over the maintenance of high diversity of tree species in tropical forests centers on the role of tree-fall gaps as a primary source of disturbance. Using a 10-year data series accumulated since Hurricane loan struck the Caribbean coast of Nicaragua in 1988, we examined the pattern of species accumulation over time and with increased sampling of individuals. Our analysis shows that the pattern after a hurricane differs from the pattern after a simple tree-fall disturbance, and we conclude that pioneers are limited in Large disturbances and thus do not suppress other species the way they do in smaller disturbances.	Univ Michigan, Dept Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Univ Herbarium, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; Hood Coll, Dept Biol, Frederick, MD 21701 USA; Univ Reg Autonomas Costa Caribe Nicaraguense, Bluefields, Nicaragua	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Vandermeer, J (corresponding author), Univ Michigan, Dept Biol, Nat Sci Bldg, Ann Arbor, MI 48109 USA.	jvander@umich.edu						ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P247, DOI 10.1016/0378-1127(94)90114-7; Begon M., 1996, ECOLOGY; BELLINGHAM PJ, 1994, J ECOL, V82, P747, DOI 10.2307/2261440; Bove MC, 1998, B AM METEOROL SOC, V79, P2477, DOI 10.1175/1520-0477(1998)079<2477:EOENOO>2.0.CO;2; Brokaw N. V. L., 1985, The ecology of natural disturbance and patch dynamics, P53; BROKAW NVL, 1991, BIOTROPICA, V23, P442, DOI 10.2307/2388264; Chazdon R.L., 1999, SCIENCE, V285, P1459, DOI DOI 10.1126/science.285.5433.1459a; Chazdon RL, 1998, MAN BIOSPH, V20, P285; CHAZDON RL, 1999, SCIENCE, V285, P1459; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; GARWOOD NC, 1979, SCIENCE, V205, P997, DOI 10.1126/science.205.4410.997; Guariguata MR, 1997, PLANT ECOL, V132, P107, DOI 10.1023/A:1009726421352; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; MILLER TE, 1982, AM NAT, V120, P533, DOI 10.1086/284009; TRENBERTH KE, 1998, CURRENT, V15, P12; VANDERMEER J, 1995, J TROP ECOL, V11, P465, DOI 10.1017/S0266467400008956; Whitmore T. C., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P549; YIH K, 1991, BIOTROPICA, V23, P106, DOI 10.2307/2388295	20	103	107	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2000	290	5492					788	791		10.1126/science.290.5492.788	http://dx.doi.org/10.1126/science.290.5492.788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052939				2022-12-28	WOS:000090067600044
J	Seidl, R; Tiefenthaler, M; Hauser, E; Lubec, G				Seidl, R; Tiefenthaler, M; Hauser, E; Lubec, G			Effects of transdermal nicotine on cognitive performance in Down's syndrome	LANCET			English	Article							ALZHEIMERS	Down's syndrome involves age-dependent neuropathological and neurochemical changes similar to Alzheimer's disease, with cholinergic deficits being the most consistent. There is currently no proven treatment for Down's syndrome. We investigated the effect of nicotine-agonistic stimulation with 5 mg transdermal patches, compared with placebo, on cognitive performance in five adults with the disorder. Improvements possibly related to attention and information processing were seen for Down's syndrome patients compared with healthy controls. Our preliminary findings are encouraging, although not generalisable because of small numbers.	Univ Vienna, Dept Pediat, Vienna, Austria	University of Vienna	Lubec, G (corresponding author), Waehringerguertel 18-20, A-1090 Vienna, Austria.			Lubec, Gert/0000-0002-6333-9461; Tiefenthaler, Martin/0000-0002-5905-7955				Frodl-Bauch T, 1999, NEUROPSYCHOBIOLOGY, V40, P86, DOI 10.1159/000026603; Kishnani PS, 1999, LANCET, V353, P1064, DOI 10.1016/S0140-6736(98)05285-4; Newhouse PA, 1997, DRUG AGING, V11, P206, DOI 10.2165/00002512-199711030-00005; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; YATES CM, 1980, LANCET, V2, P979	5	16	16	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1409	1410		10.1016/S0140-6736(00)02848-8	http://dx.doi.org/10.1016/S0140-6736(00)02848-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052587				2022-12-28	WOS:000089976100018
J	Vane, JR; Warner, TD				Vane, JR; Warner, TD			Nomenclature for COX-2 inhibitors	LANCET			English	Editorial Material									Univ London St Bartholomews Hosp Med Coll, Coll Med, William Harvey Res Inst, London EC1M 6BQ, England	University of London; Queen Mary University London	Vane, JR (corresponding author), Univ London St Bartholomews Hosp Med Coll, Coll Med, William Harvey Res Inst, London EC1M 6BQ, England.		Warner, Timothy D/A-1980-2009	Warner, Timothy D/0000-0003-3988-4408				BOMBADIER C, 2000, EULAR M NIC JUN 22; Dequeker J, 1998, BRIT J RHEUMATOL, V37, P946; Hawkey C, 1998, BRIT J RHEUMATOL, V37, P937; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; Schoenfeld Philip, 1999, American Journal of Medicine, V107, p48S; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563	8	38	39	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1373	1374		10.1016/S0140-6736(00)02837-3	http://dx.doi.org/10.1016/S0140-6736(00)02837-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052577				2022-12-28	WOS:000089976100007
J	Acremann, Y; Back, CH; Buess, M; Portmann, O; Vaterlaus, A; Pescia, D; Melchior, H				Acremann, Y; Back, CH; Buess, M; Portmann, O; Vaterlaus, A; Pescia, D; Melchior, H			Imaging precessional motion of the magnetization vector	SCIENCE			English	Article							DYNAMICS	We report on imaging of three-dimensional precessional orbits of the magnetization vector in a magnetic field by means of a time-resolved vectorial Kerr experiment that measures all three components of the magnetization vector with picosecond resolution. Images of the precessional mode taken with submicrometer spatial resolution reveal that the dynamical excitation in this time regime roughly mirrors the symmetry of the underlying equilibrium spin configuration and that its propagation has a non-wavelike character. These results should form the basis for realistic models of the magnetization dynamics in a largely unexplored but technologically increasingly relevant time scale.	ETH Zurich, Festkorperphys Lab, CH-8093 Zurich, Switzerland; ETH Zurich, Inst Quantenelekt, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Back, CH (corresponding author), ETH Zurich, Festkorperphys Lab, CH-8093 Zurich, Switzerland.		Back, Christian/A-8969-2012; Back, Christian/AAD-7824-2021	Back, Christian/0000-0003-3840-0993; Back, Christian/0000-0003-3840-0993				Back CH, 1999, SCIENCE, V285, P864, DOI 10.1126/science.285.5429.864; BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; CHEN DX, 1991, IEEE T MAGN, V27, P3601, DOI 10.1109/20.102932; CRAIK D, 1995, MAGNETISM PRINCIPLES, P289; Crawford TM, 1999, APPL PHYS LETT, V74, P3386, DOI 10.1063/1.123353; DIETRICH W, 1960, IBM J RES DEV, V4, P189, DOI 10.1147/rd.42.0189; Elezzabi AY, 1996, APPL PHYS LETT, V68, P3546, DOI 10.1063/1.116632; FISHBANE PM, 1996, PHYSICS SCI ENG, P419; Freeman MR, 1996, J APPL PHYS, V79, P5898, DOI 10.1063/1.361896; Hicken RJ, 1999, J APPL PHYS, V85, P4580, DOI 10.1063/1.370414; Hiebert WK, 1997, PHYS REV LETT, V79, P1134, DOI 10.1103/PhysRevLett.79.1134; JACKSON JD, 1962, CLASSICAL ELECTRODYN, P225; Jorzick J, 1999, PHYS REV B, V60, P15194, DOI 10.1103/PhysRevB.60.15194; Kikkawa JM, 1997, SCIENCE, V277, P1284, DOI 10.1126/science.277.5330.1284; KITTEL C, 1948, PHYS REV, V73, P155, DOI 10.1103/PhysRev.73.155; KITTEL C, 1946, PHYS REV, V70, P965, DOI 10.1103/PhysRev.70.965; LANDAU LD, 1972, MECH ELECTRODYNAMICS, P211; LEISI HJ, 1996, KLASSISCHE PHYSIK, P274; MERCEREAU JE, 1956, PHYS REV, V104, P63, DOI 10.1103/PhysRev.104.63; Stamm C, 1998, SCIENCE, V282, P449, DOI 10.1126/science.282.5388.449	20	206	208	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					492	495		10.1126/science.290.5491.492	http://dx.doi.org/10.1126/science.290.5491.492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039924				2022-12-28	WOS:000089946000043
J	Buehler, EJ; Boland, JJ				Buehler, EJ; Boland, JJ			Dimer preparation that mimics the transition state for the adsorption of H-2 on the Si(100)-2 x 1 surface	SCIENCE			English	Article							HYDROGEN ADSORPTION; REACTION DYNAMICS; SILICON SURFACES; DETAILED BALANCE; D-2 ADSORPTION; DESORPTION; TEMPERATURE; STICKING; KINETICS; SI(001)	A chemically induced dimer configuration was prepared on the silicon (Si) (100) surface and was characterized by scanning tunneling microscopy (STM) and spectroscopy (STS). These prepared dimers, which are essentially untilted and differ both electronically and structurally from the dynamically tilting dimers normally found on this surface, are more reactive than normal dimers. For molecular hydrogen (H-2) adsorption, the enhancement is about 10(9) at room temperature. There is no appreciable barrier for the H-2 reaction at prepared sites, indicating the prepared configuration closely approximates the actual dimer structure in the transition state. This previously unknown ability to prepare specific surface configurations has important implications for understanding and controlling reaction dynamics on semiconductor surfaces.	Univ N Carolina, Dept Chem, Venable & Kenan Labs, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Boland, JJ (corresponding author), Univ N Carolina, Dept Chem, Venable & Kenan Labs, CB 3290, Chapel Hill, NC 27599 USA.		Boland, John/AAB-8498-2022; Boland, John J/P-9740-2016	Boland, John/0000-0002-3229-8038; Boland, John J/0000-0002-3229-8038				Biedermann A, 1999, PHYS REV LETT, V83, P1810, DOI 10.1103/PhysRevLett.83.1810; BOLAND JJ, 1991, PHYS REV LETT, V67, P1539, DOI 10.1103/PhysRevLett.67.1539; Bratu P, 1996, CHEM PHYS LETT, V251, P1, DOI 10.1016/0009-2614(96)00085-1; Bratu P, 1996, PHYS REV B, V54, P5978, DOI 10.1103/PhysRevB.54.5978; BRENIG W, 1994, Z PHYS B CON MAT, V96, P231, DOI 10.1007/BF01313289; Doren DJ, 1996, ADV CHEM PHYS, V95, P1, DOI 10.1002/9780470141540.ch1; JING Z, 1993, J CHEM PHYS, V98, P7466, DOI 10.1063/1.464685; Kolasinski K.W., 1992, J CHEM PHYS, V96, P3995, DOI [10.1063/1.461849, DOI 10.1063/1.461849]; KOLASINSKI KW, 1994, PHYS REV LETT, V72, P1356, DOI 10.1103/PhysRevLett.72.1356; KOLASINSKI KW, 1994, J CHEM PHYS, V101, P7082, DOI 10.1063/1.468419; KRATZER P, 1994, CHEM PHYS LETT, V229, P645, DOI 10.1016/0009-2614(94)01100-1; Kratzer P, 1998, PHYS REV LETT, V81, P5596, DOI 10.1103/PhysRevLett.81.5596; Lauridsen EM, 2000, SURF SCI, V453, P18, DOI 10.1016/S0039-6028(00)00314-9; NORTHRUP JE, 1993, PHYS REV B, V47, P10032, DOI 10.1103/PhysRevB.47.10032; PEHLKE E, 1995, PHYS REV LETT, V74, P952, DOI 10.1103/PhysRevLett.74.952; Radeke MR, 1996, PHYS REV B, V54, P11803, DOI 10.1103/PhysRevB.54.11803; Shen TC, 1997, SURF SCI, V390, P35, DOI 10.1016/S0039-6028(97)00506-2; WEAKLIEM PC, 1990, SURF SCI, V232, pL219, DOI 10.1016/0039-6028(90)90112-L; WISE ML, 1991, SURF SCI, V258, P166, DOI 10.1016/0039-6028(91)90911-B; WOLKOW RA, 1992, PHYS REV LETT, V68, P2636, DOI 10.1103/PhysRevLett.68.2636; Zimmermann FM, 2000, PHYS REV LETT, V85, P618, DOI 10.1103/PhysRevLett.85.618	21	41	41	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					506	509		10.1126/science.290.5491.506	http://dx.doi.org/10.1126/science.290.5491.506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039929				2022-12-28	WOS:000089946000048
J	Hotzel, MJ				Hotzel, MJ			Achievers should stay to aid Brazilian science ...	NATURE			English	Letter									Univ Fed Santa Catarina, CCA Dept Zootecn & Desenvolvimento Rural, BR-88034001 Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Hotzel, MJ (corresponding author), Univ Fed Santa Catarina, CCA Dept Zootecn & Desenvolvimento Rural, Rodovia Admar Gonzaga,1346 Itacorubi, BR-88034001 Florianopolis, SC, Brazil.		Hötzel, Maria José/H-6975-2014	Hötzel, Maria José/0000-0003-1034-3202				[Anonymous], 2000, Nature, V406, P109; Macilwain C, 2000, NATURE, V407, P440, DOI 10.1038/35035207	2	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					834	834		10.1038/35038258	http://dx.doi.org/10.1038/35038258			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057641	Bronze			2022-12-28	WOS:000089901900018
J	Parkes, RJ				Parkes, RJ			Microbiology - A case of bacterial immortality?	NATURE			English	Article							HALOBACTERIA		Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	University of Bristol	Parkes, RJ (corresponding author), Univ Bristol, Dept Earth Sci, Wills Mem Bldg, Bristol BS8 1RJ, Avon, England.		Parkes, Ronald/B-1731-2010	Parkes, Ronald/0000-0001-9402-5943				Arahal DR, 1999, INT J SYST BACTERIOL, V49, P521, DOI 10.1099/00207713-49-2-521; CANO RJ, 1995, SCIENCE, V268, P1060, DOI 10.1126/science.7538699; DAVIS P, 1998, 5 MIRACLE SEARCH ORI; DOMBROWSKI HJ, 1960, PARASIT INFEK HYG AB, V178, P89; Grant WD, 1998, EXTREMOPHILES, V2, P279, DOI 10.1007/s007920050070; KENNEDY MJ, 1994, MICROBIOL-SGM, V140, P2513, DOI 10.1099/00221287-140-10-2513; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Madigan MT, 1997, BROCK BIOL MICROORGA; McGenity TJ, 2000, ENVIRON MICROBIOL, V2, P243, DOI 10.1046/j.1462-2920.2000.00105.x; NORTON CF, 1993, J GEN MICROBIOL, V139, P1077, DOI 10.1099/00221287-139-5-1077; NORTON CF, 1988, J GEN MICROBIOL, V134, P1365; POSTGATE J, 1990, NEW SCI, V21, P46; SNEATH PHA, 1962, NATURE, V195, P643, DOI 10.1038/195643a0; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; Wellsbury P, 1997, NATURE, V388, P573, DOI 10.1038/41544	15	15	16	0	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					844	845		10.1038/35038181	http://dx.doi.org/10.1038/35038181			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057647				2022-12-28	WOS:000089901900029
J	Steen, VD; Medsger, TA				Steen, VD; Medsger, TA			Long-term outcomes of scleroderma renal crisis	ANNALS OF INTERNAL MEDICINE			English	Article							SYSTEMIC-SCLEROSIS	Background: Although scleroderma renal crisis, a complication of systemic sclerosis, can be treated with angiotensin-converting enzyme (ACE) inhibitors, its long-term outcomes are not known. Objective: To determine outcomes, natural history, and risk factors in patients with systemic sclerosis and scleroderma renal crisis. Design: Prospective observational cohort study. Setting: University program specializing in scleroderma. Patients: 145 patients with scleroderma renal crisis who received ACE inhibitors and 662 patients with scleroderma who did not have renal crisis. Measurements: Among patients with renal crisis, the four outcomes studied were no dialysis, temporary dialysis, permanent dialysis, and early death. Demographic, clinical, and laboratory data were compared to identify risk factors for specific outcomes. Follow-up was 5 to 10 years. Results: 61% of patients with renal crisis had good outcomes (55 received no dialysis, and 34 received temporary dialysis); only 4 of these (4%) progressed to chronic renal failure and permanent dialysis. More than half of the patients who Initially required dialysis could discontinue it 3 to 18 months later. Survival of patients in the good outcome group was similar to that of patients with diffuse scleroderma who did not have renal crisis. Some patients (39%) had bad outcomes (permanent dialysis or early death). Conclusions: Renal crisis can be effectively managed when hypertension is aggressively controlled with ACE inhibitors. Patients should continue taking ACE inhibitors even after beginning dialysis in hopes of discontinuing dialysis.	Georgetown Univ, Washington, DC 20007 USA; Univ Pittsburgh, Pittsburgh, PA USA	Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Steen, VD (corresponding author), Georgetown Univ, 3800 Reservoir Rd NW,LL Gorman, Washington, DC 20007 USA.	steenv@gunet.georgetown.edu						Bunn CC, 1998, BRIT J RHEUMATOL, V37, P15; DONOHOE JF, 1992, KIDNEY INT, V41, P462, DOI 10.1038/ki.1992.65; LEROY EC, 1988, J RHEUMATOL, V15, P202; OKANO Y, 1993, ANN INTERN MED, V119, P1005, DOI 10.7326/0003-4819-119-10-199311150-00007; Rocco MV, 1996, AM J KIDNEY DIS, V28, P250, DOI 10.1016/S0272-6386(96)90308-X; STEEN VD, 1993, ARTHRITIS RHEUM, V36, pS131; Steen VD, 1999, OBSTET GYNECOL, V94, P15, DOI 10.1016/S0029-7844(99)00233-1; Steen VD, 1997, ARTHRITIS RHEUM, V40, P1146, DOI 10.1002/art.1780400620; Steen VD, 1996, RHEUM DIS CLIN N AM, V22, P861, DOI 10.1016/S0889-857X(05)70305-7; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207; STEEN VD, 1990, ANN INTERN MED, V113, P352, DOI 10.7326/0003-4819-113-5-352; STEEN VD, 1984, AM J MED, V76, P779, DOI 10.1016/0002-9343(84)90986-0; WEBER J, 1993, PERITON DIALYSIS INT, V13, P224	13	208	223	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					600	603		10.7326/0003-4819-133-8-200010170-00010	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033587				2022-12-28	WOS:000089906300004
J	Dustin, ML; Chan, AC				Dustin, ML; Chan, AC			Signaling takes shape in the immune system	CELL			English	Review							T-CELL RECEPTOR; FREE FATTY-ACIDS; ADAPTER PROTEIN; TYROSINE-PHOSPHATASE; CUTTING EDGE; SH2 DOMAINS; RHO-FAMILY; ACTIVATION; ADHESION; COMPLEX		Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Dustin, ML (corresponding author), Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA.	dustin@pathbox.wustl.edu; achan@im.wustl.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389				Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; BRAUN J, 1978, J CELL BIOL, V79, P409, DOI 10.1083/jcb.79.2.409; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Cheng AM, 1997, CURR OPIN IMMUNOL, V9, P528, DOI 10.1016/S0952-7915(97)80106-9; CLOUTIER JF, 1995, MOL CELL BIOL, V15, P5937; Costello PS, 2000, J EXP MED, V192, P77, DOI 10.1084/jem.192.1.77; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; D'Oro U, 1999, J IMMUNOL, V162, P1879; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Ebnet K, 1996, ANNU REV IMMUNOL, V14, P155, DOI 10.1146/annurev.immunol.14.1.155; ELSON EL, 1990, BIORHEOLOGY, V27, P849; FELDER S, 1993, MOL CELL BIOL, V13, P1449, DOI 10.1128/MCB.13.3.1449; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Harden N, 1996, MOL CELL BIOL, V16, P1896; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KLAUSNER RD, 1980, J BIOL CHEM, V255, P1286; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Linder S, 2000, J IMMUNOL, V165, P221, DOI 10.4049/jimmunol.165.1.221; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Lub M, 1997, MOL BIOL CELL, V8, P341, DOI 10.1091/mbc.8.2.341; Machesky LM, 2000, CELL, V101, P685, DOI 10.1016/S0092-8674(00)80879-X; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; NORCROSS MA, 1984, ANN INST PASTEUR IMM, VD135, P113, DOI 10.1016/S0769-2625(84)81105-8; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; RICHIERI GV, 1990, J IMMUNOL, V144, P671; Roach TIA, 1998, CURR BIOL, V8, P1035, DOI 10.1016/S0960-9822(07)00426-5; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Sperling AI, 1998, J IMMUNOL, V161, P6459; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stewart DM, 1999, J IMMUNOL, V162, P5019; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Szollosi J, 1996, J IMMUNOL, V157, P2939; Tuosto L, 1998, EUR J IMMUNOL, V28, P2131, DOI 10.1002/(SICI)1521-4141(199807)28:07<2131::AID-IMMU2131>3.0.CO;2-Q; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; UNANUE ER, 1972, J EXP MED, V136, P885, DOI 10.1084/jem.136.4.885; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wei XB, 1999, P NATL ACAD SCI USA, V96, P8471, DOI 10.1073/pnas.96.15.8471; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yang WC, 2000, IMMUNITY, V12, P373, DOI 10.1016/S1074-7613(00)80189-2; Yashiro-Ohtani Y, 2000, J IMMUNOL, V164, P1251, DOI 10.4049/jimmunol.164.3.1251; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	98	193	198	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 13	2000	103	2					283	294		10.1016/S0092-8674(00)00120-3	http://dx.doi.org/10.1016/S0092-8674(00)00120-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057901	Bronze			2022-12-28	WOS:000089864300012
J	Kolodner, RD				Kolodner, RD			DNA repair - Guarding against mutation	NATURE			English	Editorial Material							MISMATCH-REPAIR; RECOMBINATION; CANCER		Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.							Gong JG, 1999, NATURE, V399, P806; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Li GM, 1999, ONCOL RES, V11, P393; Lynch HT, 1999, J MED GENET, V36, P801; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0	10	12	12	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					687	689		10.1038/35037701	http://dx.doi.org/10.1038/35037701			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048703				2022-12-28	WOS:000089773900024
J	Rich, T; Allen, RL; Wyllie, AH				Rich, T; Allen, RL; Wyllie, AH			Defying death after DNA damage	NATURE			English	Review							RADIATION-INDUCED APOPTOSIS; STRAND BREAKS; CELL-DEATH; C-ABL; P53; PROTEIN; ARREST; REPAIR; SENSITIVITY; INDUCTION	DNA damage frequently triggers death by apoptosis. The irreversible decision to die can be facilitated or forestalled through integration of a wide variety of stimuli from within and around the cell. Here we address some fundamental questions that arise from this model. Why should DNA damage initiate apoptosis in the first place? In damaged cells, what are the alternatives to death and why should they be selected in some circumstances but not others? What signals register DNA damage and how do they impinge on the effector pathways of apoptosis? Is there a suborganellar apoptosome complex effecting the integration of death signals within the nucleus, just as there is in the cytoplasm? And what are the consequences of failure to initiate apoptosis in response to DNA damage?.	Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Rich, T (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	ahw21@cam.ac.uk		Allen, Rachel/0000-0001-9834-8475				Aguda BD, 1999, ONCOGENE, V18, P2846, DOI 10.1038/sj.onc.1202462; Anderson WF, 2000, NAT MED, V6, P862, DOI 10.1038/78610; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Attardi LD, 2000, GENE DEV, V14, P704; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Blattner C, 1999, MOL CELL BIOL, V19, P3704; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; CLARKE AR, 1994, ONCOGENE, V9, P1767; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P108; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Gasser SM, 2000, SCIENCE, V288, P1377, DOI 10.1126/science.288.5470.1377; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gray JW, 2000, CARCINOGENESIS, V21, P443, DOI 10.1093/carcin/21.3.443; Griffiths SD, 1997, ONCOGENE, V14, P523, DOI 10.1038/sj.onc.1200871; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hodges M, 1998, AM J HUM GENET, V63, P297, DOI 10.1086/301991; Hoekstra MF, 1997, CURR OPIN GENET DEV, V7, P170, DOI 10.1016/S0959-437X(97)80125-6; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Kannan K, 2000, FEBS LETT, V470, P77, DOI 10.1016/S0014-5793(00)01291-6; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Kharbanda S, 1998, ONCOGENE, V17, P3309, DOI 10.1038/sj.onc.1202571; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lieber MR, 1998, AM J PATHOL, V153, P1323, DOI 10.1016/S0002-9440(10)65716-1; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Linares-Cruz G, 1998, P NATL ACAD SCI USA, V95, P1131, DOI 10.1073/pnas.95.3.1131; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Lohrum MAE, 2000, TRENDS CELL BIOL, V10, P197, DOI 10.1016/S0962-8924(00)01736-0; Lombard DB, 2000, CANCER RES, V60, P2331; Loughran O, 2000, MOL CELL BIOL, V20, P2186, DOI 10.1128/MCB.20.6.2186-2197.2000; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; MacCallum DE, 1996, ONCOGENE, V13, P2575; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Matsuyama S, 1999, CURR OPIN MICROBIOL, V2, P618, DOI 10.1016/S1369-5274(99)00031-4; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Meek DW, 1999, ONCOGENE, V18, P7666, DOI 10.1038/sj.onc.1202951; MERRITT AJ, 1994, CANCER RES, V54, P614; Morris VB, 2000, EXP CELL RES, V256, P122, DOI 10.1006/excr.2000.4800; Munsch D, 2000, J BIOL CHEM, V275, P3867, DOI 10.1074/jbc.275.6.3867; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nickerson JA, 1998, J CELL BIOCHEM, V70, P172, DOI 10.1002/(SICI)1097-4644(19980801)70:2<172::AID-JCB3>3.0.CO;2-L; O'Connor L, 2000, CANCER RES, V60, P1217; Oshima H, 1997, CANCER RES, V57, P1644; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Shaul Y, 2000, CELL DEATH DIFFER, V7, P10, DOI 10.1038/sj.cdd.4400626; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Toft NJ, 1999, P NATL ACAD SCI USA, V96, P3911, DOI 10.1073/pnas.96.7.3911; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; Van Sloun PPH, 1999, NUCLEIC ACIDS RES, V27, P3276, DOI 10.1093/nar/27.16.3276; Wang Y, 2000, GENE DEV, V14, P927; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wu GS, 1999, ONCOGENE, V18, P6411, DOI 10.1038/sj.onc.1203025; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Zhao RB, 2000, GENE DEV, V14, P981; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	78	536	557	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					777	783		10.1038/35037717	http://dx.doi.org/10.1038/35037717			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048728				2022-12-28	WOS:000089773900052
J	Socie, G				Socie, G			Is syndrome "X" another late complication of bone-marrow transplantation?	LANCET			English	Editorial Material							STEM-CELL TRANSPLANTATION		Hop St Louis, Serv Hematol Greffe de Moelle, F-75475 Paris 10, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Socie, G (corresponding author), Hop St Louis, Serv Hematol Greffe de Moelle, F-75475 Paris 10, France.							BENYUNES MC, 1995, INT J RADIAT ONCOL, V32, P661, DOI 10.1016/0360-3016(94)00392-X; Deeg HJ, 1998, BLOOD, V91, P1833, DOI 10.1182/blood.V91.6.1833.1833_1833_1844; Leiper AD, 1999, LANCET, V353, P1544, DOI 10.1016/S0140-6736(99)90033-8; McCann S, 1999, LANCET, V354, P778, DOI 10.1016/S0140-6736(05)76021-9; NEGLIA JP, 1991, NEW ENGL J MED, V325, P1330, DOI 10.1056/NEJM199111073251902; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103	6	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					957	958		10.1016/S0140-6736(00)02709-4	http://dx.doi.org/10.1016/S0140-6736(00)02709-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041393				2022-12-28	WOS:000089293600006
J	Weatherall, DJ				Weatherall, DJ			Science, medicine, and the future - Single gene disorders or complex traits: lessons from the thalassaemias and other monogenic diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Millennium Festival of Medicine Conference	NOV 06-10, 2000	LONDON, ENGLAND						John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Weatherall, DJ (corresponding author), John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England.							Summers KM, 1996, HUM MUTAT, V7, P283; Todd JA, 1999, BIOESSAYS, V21, P164, DOI 10.1002/(SICI)1521-1878(199902)21:2<164::AID-BIES10>3.3.CO;2-W; Weatherall D, 1999, PHILOS T R SOC B, V354, P1995, DOI 10.1098/rstb.1999.0539; Weatherall DJ, 2000, HARVEY LECT, V94, P1; WEATHERALL DJ, IN PRESS THALASSAEMI; Wolf U, 1997, HUM GENET, V100, P305, DOI 10.1007/s004390050509	6	63	67	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2000	321	7269					1117	1120		10.1136/bmj.321.7269.1117	http://dx.doi.org/10.1136/bmj.321.7269.1117			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	372DT	11061733	Bronze, Green Published			2022-12-28	WOS:000165219600025
J	Buckley, RH				Buckley, RH			Primary immunodeficiency diseases due to defects in lymphocytes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							WISKOTT-ALDRICH-SYNDROME; HYPER-IGM SYNDROME; RECEPTOR-GAMMA-CHAIN; CLASS-II DEFICIENCY; LINKED LYMPHOPROLIFERATIVE-DISEASE; B-CELL DEVELOPMENT; ADENOSINE-DEAMINASE DEFICIENCY; ATAXIA-TELANGIECTASIA GENE; COMBINED IMMUNE-DEFICIENCY; CD40 LIGAND		Duke Univ, Sch Med, Dept Pediat, Durham, NC 27710 USA; Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA	Duke University; Duke University	Buckley, RH (corresponding author), Duke Univ, Sch Med, Dept Pediat, Box 2818, Durham, NC 27710 USA.	buckl003@mc.duke.edu	Buckley, Rebecca/AAB-1578-2019					ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; Altman PL, 1961, BLOOD OTHER BODY FLU, P125; [Anonymous], 1999, PRIMARY IMMUNODEFICI; ARNAIZVILLENA A, 1992, NEW ENGL J MED, V327, P529, DOI 10.1056/NEJM199208203270805; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; Beamish H, 1996, J BIOL CHEM, V271, P20486, DOI 10.1074/jbc.271.34.20486; Brooks EG, 1999, BLOOD, V93, P242, DOI 10.1182/blood.V93.1.242.401k27_242_250; BRUTON OC, 1952, PEDIATRICS, V9, P722; BUCKLEY RH, 1973, J ALLERGY CLIN IMMUN, V51, P308, DOI 10.1016/0091-6749(73)90133-4; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Buckley RH, 1997, J PEDIATR-US, V130, P378, DOI 10.1016/S0022-3476(97)70199-9; BUCKLEY RH, 1972, PEDIATRICS, V49, P59; BUCKLEY RH, 1996, CLIN IMMUNOLOGY, P1813; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; CONLEY ME, 1994, J CLIN INVEST, V94, P1404, DOI 10.1172/JCI117476; de la Salle H, 1999, J CLIN INVEST, V103, pR9, DOI 10.1172/JCI5687; DELASALLE H, 1994, SCIENCE, V266, P1464; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; Derry JM, 1994, CELL, V79, P922; DEWEERS M, 1993, EUR J IMMUNOL, V23, P3109, DOI 10.1002/eji.1830231210; DISANTO JP, 1994, NEW ENGL J MED, V330, P969, DOI 10.1056/NEJM199404073301404; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; DONATO L, 1995, J PEDIATR-US, V127, P895, DOI 10.1016/S0022-3476(95)70024-2; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; FACCHETTI F, 1995, J IMMUNOL, V154, P6624; Farr N., 1996, Equine Veterinary Education, V8, P6, DOI 10.1111/j.2042-3292.1996.tb01642.x; Filipovich A. H., 1997, Journal of Allergy and Clinical Immunology, V99, pS102; Furukawa H, 1999, J CLIN INVEST, V103, P755, DOI 10.1172/JCI5335; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; GLANZMANN E, 1950, Ann Paediatr, V175, P1; Goldman FD, 1998, J CLIN INVEST, V102, P421, DOI 10.1172/JCI3205; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; GRIERSON HL, 1991, AM J MED GENET, V40, P294, DOI 10.1002/ajmg.1320400309; Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Henwood J, 1996, J IMMUNOL, V156, P895; HERSHFIELD MS, 1995, CLIN IMMUNOL IMMUNOP, V76, pS228, DOI 10.1016/S0090-1229(95)90306-2; HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005; INOUE R, 1995, SCAND J IMMUNOL, V41, P188, DOI 10.1111/j.1365-3083.1995.tb03552.x; Jirapongsananuruk O, 1999, CLIN EXP IMMUNOL, V118, P1; Katz F, 1996, HUM MUTAT, V8, P223, DOI 10.1002/(SICI)1098-1004(1996)8:3<223::AID-HUMU5>3.0.CO;2-A; KLEIN C, 1993, J PEDIATR-US, V123, P921, DOI 10.1016/S0022-3476(05)80388-9; KONDOH T, 1995, AM J MED GENET, V60, P364, DOI 10.1002/ajmg.1320600504; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; Kung C, 2000, NAT MED, V6, P343; KWAN SP, 1995, P NATL ACAD SCI USA, V92, P4706, DOI 10.1073/pnas.92.10.4706; LEDERMAN HM, 1985, MEDICINE, V64, P145, DOI 10.1097/00005792-198505000-00001; LEFRANC M-P, 1991, Immunodeficiency Reviews, V2, P265; Levy J, 1997, J PEDIATR-US, V131, P47, DOI 10.1016/S0022-3476(97)70123-9; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; MARTIN JV, 1995, AM J SURG PATHOL, V19, P1082, DOI 10.1097/00000478-199509000-00013; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; Meffre E, 1996, J CLIN INVEST, V98, P1519, DOI 10.1172/JCI118943; Minegishi Y, 1999, J CLIN INVEST, V104, P1115, DOI 10.1172/JCI7696; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; MOHIUDDIN AA, 1991, J ALLERGY CLIN IMMUN, V87, P104, DOI 10.1016/0091-6749(91)90219-E; MULLEN CA, 1993, BLOOD, V82, P2961; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101; Notarangelo LD, 1996, IMMUNOL TODAY, V17, P511, DOI 10.1016/0167-5699(96)30059-5; OLIVA A, 1995, J ALLERGY CLIN IMMUN, V96, P403, DOI 10.1016/S0091-6749(95)70060-9; PADAYACHEE M, 1992, GENOMICS, V14, P551, DOI 10.1016/S0888-7543(05)80270-8; Parolini O, 1998, NEW ENGL J MED, V338, P291, DOI 10.1056/NEJM199801293380504; Puck JM, 1997, BLOOD, V89, P1968; PUCK JM, 1993, HUM MOL GENET, V2, P1099, DOI 10.1093/hmg/2.8.1099; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rieux-Laucat F, 1998, J CLIN INVEST, V102, P312, DOI 10.1172/JCI332; Rocca B, 1996, BLOOD, V87, P4538, DOI 10.1182/blood.V87.11.4538.bloodjournal87114538; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; SCHAFFER FM, 1989, P NATL ACAD SCI USA, V86, P8015, DOI 10.1073/pnas.86.20.8015; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Schwarz K, 1996, IMMUNOL TODAY, V17, P496, DOI 10.1016/0167-5699(96)30061-3; SHARFE N, 1995, BLOOD, V86, P2077, DOI 10.1182/blood.V86.6.2077.bloodjournal8662077; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; SHOVLIN CL, 1994, J IMMUNOL, V153, P2331; SOUDAIS C, 1993, NAT GENET, V3, P77, DOI 10.1038/ng0193-77; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Sullivan J L, 1989, Immunodefic Rev, V1, P325; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Teisserenc H, 1997, IMMUNOL LETT, V57, P183, DOI 10.1016/S0165-2478(97)00072-2; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VETRIE D, 1993, NATURE, V364, P362, DOI 10.1038/364362a0; Vihinen M, 1998, NUCLEIC ACIDS RES, V26, P242, DOI 10.1093/nar/26.1.242; VILLA A, 1995, NAT GENET, V9, P414, DOI 10.1038/ng0495-414; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Watson HG, 1997, LANCET, V349, P179, DOI 10.1016/S0140-6736(05)60980-4; WILFERT CM, 1977, NEW ENGL J MED, V296, P1485, DOI 10.1056/NEJM197706302962601; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yang YP, 1996, SCIENCE, V273, P1862, DOI 10.1126/science.273.5283.1862; Yel L, 1996, NEW ENGL J MED, V335, P1486, DOI 10.1056/NEJM199611143352003; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9	106	136	143	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2000	343	18					1313	1324		10.1056/NEJM200011023431806	http://dx.doi.org/10.1056/NEJM200011023431806			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368RP	11058677				2022-12-28	WOS:000090131600006
J	Gottlieb, S				Gottlieb, S			No advantage in screening for endometrial cancer	BRITISH MEDICAL JOURNAL			English	News Item																		Barakat RR, 2000, J CLIN ONCOL, V18, P3459, DOI 10.1200/JCO.2000.18.20.3459; 2000, J CLIN ONCOLOGY, V63, P3464	2	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 28	2000	321	7268					1039	1039						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PU	11053162				2022-12-28	WOS:000165076800011
J	Hill, AA; Hunter, CP; Tsung, BT; Tucker-Kellogg, G; Brown, EL				Hill, AA; Hunter, CP; Tsung, BT; Tucker-Kellogg, G; Brown, EL			Genomic analysis of gene expression in C-elegans	SCIENCE			English	Article								Until now, genome-wide transcriptional profiling has been Limited to single-cell organisms. The nematode Caenorhabditis elegans is a well-characterized metazoan in which the expression of all genes can be monitored by oligonucleotide arrays. We used such arrays to quantitate the expression of C. elegans genes throughout the development of this organism. The results provide an estimate of the number of expressed genes in the nematode, reveal relations between gene function and gene expression that can guide analysis of uncharacterized worm genes, and demonstrate a shift in expression from evolutionarily conserved genes to worm-specific genes over the course of development.	Genet Inst Inc, Dept Genom, Cambridge, MA 02140 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Hill, AA (corresponding author), Genet Inst Inc, Dept Genom, Cambridge, MA 02140 USA.	ahill@genetics.com; hunter@mcb.harvard.edu	Tucker-Kellogg, Greg/G-3344-2012	Tucker-Kellogg, Greg/0000-0001-8407-9251				C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CARTER PW, 1990, MOL GEN GENET, V221, P72, DOI 10.1007/BF00280370; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; HILL AF, UNPUB; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020; Priess J. R., 1997, C ELEGANS 2; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wood WB, 1988, NEMATODE CAENORHABDI; XIN JH, 1982, DEV BIOL, V89, P527, DOI 10.1016/0012-1606(82)90342-6	15	244	255	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2000	290	5492					809	812		10.1126/science.290.5492.809	http://dx.doi.org/10.1126/science.290.5492.809			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052945				2022-12-28	WOS:000090067600050
J	Broyles, RS; Tyson, JE; Heyne, ET; Heyne, RJ; Hickman, JF; Swint, M; Adams, SS; West, LA; Pomeroy, N; Hicks, PJ; Ahn, C				Broyles, RS; Tyson, JE; Heyne, ET; Heyne, RJ; Hickman, JF; Swint, M; Adams, SS; West, LA; Pomeroy, N; Hicks, PJ; Ahn, C			Comprehensive follow-up cave and life-threatening illnesses among high-risk infants - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BIRTH-WEIGHT; COST-EFFECTIVENESS; PRIMARY-CARE; HEALTH; CHILDREN; MORTALITY; OUTCOMES; NEWBORNS; MEDICINE; AGE	Context Inner-city high-risk infants often receive limited and fragmented care, a problem that may increase serious illness. Objective To assess whether access to comprehensive care in a follow-up clinic is cost-effective in reducing life-threatening illnesses among high-risk, inner-city infants. Design Randomized controlled trial. Setting and Participants A total of 887 very-low-birth-weight infants born in a Texas county hospital between January 1988 and March 1996 and followed up in a children's hospital clinic. One hundred four infants who became ineligible or died after randomization but before nursery discharge were excluded from the analysis. Interventions Infants were randomly assigned to receive routine follow-up care (well-baby care and care for chronic illnesses; n=441) or comprehensive care (which included the components of routine care plus care for acute illnesses, with 24-hour access to a primary caregiver; n=446). Main Outcome Measures Life-threatening illnesses (ie, causing death or hospital admission for pediatric intensive care) occurring between nursery discharge and age 1 year, assessed by blinded evaluators from inpatient charts and state Medicaid and vital statistics records; and hospital costs (estimated from department-specific cost-to-charge ratios). Results Comprehensive care resulted in a mean of 3.1 more clinic visits and 6.7 more telephone conversations with clinic staff (P<.001 for both). One-year outcomes were unknown for fewer comprehensive-care infants than routine-care infants (9 vs 28; P=.001). Identified deaths were similar (11 in comprehensive care vs 13 in routine care; P=.68). The comprehensive-care group had 48% fewer life-threatening illnesses (33 vs 63; P<.001), 57% fewer intensive care admissions (23 vs 53; P=.003), and 42% fewer intensive care days (254 vs 440; P=.003). Comprehensive care did not increase the mean estimated cost per infant for all care ($6265 with comprehensive care and $9913 with routine care). Conclusion Comprehensive follow-up care by experienced caregivers can be highly effective in reducing life-threatening illness without increasing costs among high-risk inner-city infants.	Univ Texas, Sch Med, Dept Internal Med, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX USA; Univ Texas, Houston Sch Publ Hlth, Houston, TX USA; Childrens Med Ctr Dallas, Dallas, TX USA	University of Texas System; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System	Tyson, JE (corresponding author), Univ Texas, Sch Med, Dept Internal Med, 6431 Fannin St,MSB 3-228, Houston, TX 77030 USA.			Hicks, Patricia/0000-0003-3781-780X	AHRQ HHS [HS06837] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006837] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; AYLWARD GP, 1985, J DEV BEHAV PEDIATR, V6, P3; BOYLE MH, 1983, NEW ENGL J MED, V308, P1330, DOI 10.1056/NEJM198306023082206; Broyles RS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.3.e8; CROWLEY PA, 1995, AM J OBSTET GYNECOL, V173, P322, DOI 10.1016/0002-9378(95)90222-8; GROSS RT, 1990, JAMA-J AM MED ASSOC, V263, P3035; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Hannan EL, 1999, NEW ENGL J MED, V340, P1677, DOI 10.1056/NEJM199905273402112; Hoffmann C, 1997, AM J MED SCI, V313, P99, DOI 10.1097/00000441-199702000-00005; LASKY RE, 1987, AM J DIS CHILD, V141, P100, DOI 10.1001/archpedi.1987.04460010100037; LAVE JR, 1994, MED CARE, V32, pJS77; LEUTWYLER K, 1995, SCI AM, V272, P124, DOI 10.1038/scientificamerican0495-124; LEWIT EM, 1995, FUTURE CHILD, V5, P35, DOI 10.2307/1602506; LITTLE BB, 1988, AM J PERINAT, V5, P206, DOI 10.1055/s-2007-999686; Lorenz JM, 1998, ARCH PEDIAT ADOL MED, V152, P425, DOI 10.1001/archpedi.152.5.425; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; ORNSTEIN M, 1991, ACTA PAEDIATR SCAND, V80, P741, DOI 10.1111/j.1651-2227.1991.tb11943.x; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Rogowski J, 1998, PEDIATRICS, V102, P35, DOI 10.1542/peds.102.1.35; SACKETT DL, 2000, EVIDENCE BASED MED, V5, P112; Scholer SJ, 1999, PEDIATRICS, V103, P1183, DOI 10.1542/peds.103.6.1183; SCOTT DT, 1999, OSKIS PEDIAT PRINCIP, P209; SHWARTZ M, 1995, INQUIRY, V32, P4765; SMITH DR, 1991, AM J MED SCI, V302, P313, DOI 10.1097/00000441-199111000-00010; SOLL RF, 1992, EFFECTIVE CARE NEWBO, P329; Stevenson DK, 1998, AM J OBSTET GYNECOL, V179, P1632, DOI 10.1016/S0002-9378(98)70037-7; Tin W, 1998, ARCH DIS CHILD-FETAL, V79, pF83, DOI 10.1136/fn.79.2.F83; TYSON JE, 1988, EARLY HUM DEV, V16, P13, DOI 10.1016/0378-3782(88)90083-7; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WOLKE D, 1995, LANCET, V345, P447, DOI 10.1016/S0140-6736(95)90425-5	34	55	55	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2070	2076		10.1001/jama.284.16.2070	http://dx.doi.org/10.1001/jama.284.16.2070			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364QA	11042755	Bronze			2022-12-28	WOS:000089902100027
J	Stapleton, FB				Stapleton, FB			My name is jack	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2027	2027		10.1001/jama.284.16.2027	http://dx.doi.org/10.1001/jama.284.16.2027			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364QA	11042731				2022-12-28	WOS:000089902100001
J	Brunner, G; Zweiker, R; Krejs, GJ				Brunner, G; Zweiker, R; Krejs, GJ			A toxicological surprise	LANCET			English	Article									Karl Franzens Univ Graz, Dept Internal Med, A-8036 Graz, Austria	University of Graz	Brunner, G (corresponding author), Karl Franzens Univ Graz, Dept Internal Med, Auenbruggerpl 15, A-8036 Graz, Austria.							Braunwald E., 1997, HEART DIS TXB CARDIO, P640; ELENHORN MJ, 1997, ELLENHORNS MED TOXIC, P541; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; TROSTER S, 1992, DEUT MED WOCHENSCHR, V117, P1149, DOI 10.1055/s-2008-1062424; Yeghiazarians Y, 2000, NEW ENGL J MED, V342, P101, DOI 10.1056/NEJM200001133420207	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1406	1406		10.1016/S0140-6736(00)02845-2	http://dx.doi.org/10.1016/S0140-6736(00)02845-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052584				2022-12-28	WOS:000089976100015
J	Pier, H; Kapon, E; Moser, M				Pier, H; Kapon, E; Moser, M			Strain effects and phase transitions in photonic resonator crystals	NATURE			English	Article							SURFACE-EMITTING LASERS; ARRAYS; LOCALIZATION; LATTICES	Optical structures with periodic variations of the dielectric constant in one or more directions (photonic crystals(1)) have been employed extensively for studying optical diffraction phenomena. Practical interest in such structures arises from the possibilities(2-4) they offer for tailoring photon modes, and thereby the characteristics of light propagation and light-matter interactions. Photonic resonator crystals comprising two-dimensional arrays of coupled optical microcavities have been fabricated using vertical-cavity surface-emitting laser wafers(5). In such structures, the light propagates mostly normal to the periodic plane. Therefore, the corresponding lateral Bragg-periodicities are larger, a feature that is advantageous for device manufacture as it allows for larger lattice constants in the lateral direction. Here we investigate strain effects in a photonic resonator crystal by shifting neighbouring lattice rows of microcavities in opposite directions, thereby introducing an alternating square or quasi-hexagonal pattern of shear strain. We rnd that, for strain values below a critical threshold, the lasing photon mode is virtually locked to the corresponding mode supported by the unstrained photonic crystal. At the critical strain value, we observe a phase-transition-like switching between the square and quasi-hexagonal lattice modes. The tolerance of subcritical strains suggests that the resonator crystal may be useful for applications requiring high spatial coherence across the lattice, while the mode switching could potentially be exploited in free-space optical communications.	Swiss Fed Inst Technol EPFL, Dept Phys, CH-1015 Lausanne, Switzerland; Avalon Photon, CH-8048 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Pier, H (corresponding author), Swiss Fed Inst Technol EPFL, Dept Phys, CH-1015 Lausanne, Switzerland.							Bayer M, 1998, PHYS REV LETT, V81, P2582, DOI 10.1103/PhysRevLett.81.2582; Bir GL., 1974, SYMMETRY STRAIN INDU; Fishman T, 1999, APPL PHYS LETT, V74, P3595, DOI 10.1063/1.123192; Fishman T, 2000, APPL PHYS LETT, V76, P816, DOI 10.1063/1.125594; Golshani A, 1999, J APPL PHYS, V85, P2454, DOI 10.1063/1.369567; Hardy A, 1996, IEEE J QUANTUM ELECT, V32, P966, DOI 10.1109/3.502373; Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0; JOHN S, 1991, PHYS TODAY, V44, P32, DOI 10.1063/1.881300; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Knight JC, 1998, SCIENCE, V282, P1476, DOI 10.1126/science.282.5393.1476; Lin SY, 1998, SCIENCE, V282, P274, DOI 10.1126/science.282.5387.274; Mekis A, 1996, PHYS REV LETT, V77, P3787, DOI 10.1103/PhysRevLett.77.3787; ORENSTEIN M, 1991, APPL PHYS LETT, V58, P804, DOI 10.1063/1.105218; ORENSTEIN M, 1992, APPL PHYS LETT, V60, P1535, DOI 10.1063/1.107243; Pier H, 1997, OPT LETT, V22, P546, DOI 10.1364/OL.22.000546; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059	16	33	33	1	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					880	883		10.1038/35038026	http://dx.doi.org/10.1038/35038026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057660				2022-12-28	WOS:000089901900043
J	Chua, JD; Wilkoff, BL; Lee, I; Juratli, N; Longworth, DL; Gordon, SM				Chua, JD; Wilkoff, BL; Lee, I; Juratli, N; Longworth, DL; Gordon, SM			Diagnosis and management of infections involving implantable electrophysiologic cardiac devices	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	North-American-Society-of-Pacing-and-Electrophysiology Meeting	MAY 12-15, 1999	TORONTO, CANADA	N Amer Soc Pacing & Electrophysiol			CARDIOVERTER-DEFIBRILLATORS; PACEMAKER LEADS; REMOVAL; ENDOCARDITIS	Background: Optimal treatment of infections related to implantable electrophysiologic cardiac devices is poorly defined. Objective: To describe the clinical presentation, treatment, and outcome of patients with such infections. Design: Retrospective we series. Setting: The Cleveland Clinic Foundation, Cleveland, Ohio. Patients: 123 patients with infections involving implantable cardiac electrophysiologic devices. Measurements: Demographic characteristics, clinical manifestations, time to diagnosis, management, and outcome. Results: 87 patients with permanent pacemakers and 36 patients with implantable cardioverter defibrillators had infections. The most common signs and symptoms were pocket erythema and local pain. The most common pathogens were coagulase-negative staphylococci (68%) and Staphylococcus aureus (23%). In 117 patients (95%), all equipment was extracted and antibiotic therapy lasted a median of 28 days. Operative mortality was zero. Follow-up showed crude mortality and relapse rates of 8% and 3%, respectively. Conclusion: For infections related to implantable electrophysiologic devices, complete device removal and antimicrobial therapy allow timely, successful reimplantation at a remote anatomic site without substantial risk for operative mortality or recurrent infection.	Cleveland Clin Fdn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Wilkoff, BL (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave,F-15, Cleveland, OH 44195 USA.							ARBER N, 1994, MEDICINE, V73, P299, DOI 10.1097/00005792-199411000-00003; BYRD CL, 2000, CLIN CARDIAC PACING, P669; Cacoub P, 1998, AM J CARDIOL, V82, P480, DOI 10.1016/S0002-9149(98)00365-8; CAMUS C, 1993, CLIN INFECT DIS, V17, P46, DOI 10.1093/clinids/17.1.46; FRAME R, 1993, PACE, V16, P2343, DOI 10.1111/j.1540-8159.1993.tb02348.x; KEARNEY RA, 1994, ANN INTERN MED, V121, P219, DOI 10.7326/0003-4819-121-3-199408010-00010; Klug D, 1997, CIRCULATION, V95, P2098, DOI 10.1161/01.CIR.95.8.2098; Lai KK, 1998, CLIN INFECT DIS, V27, P265, DOI 10.1086/514673; Lee JH, 1996, PACE, V19, P437, DOI 10.1111/j.1540-8159.1996.tb06514.x; Molina JE, 1997, ANN THORAC SURG, V63, P504; ONunain S, 1997, J THORAC CARDIOV SUR, V113, P121, DOI 10.1016/S0022-5223(97)70407-0; POHLMAN JK, 1995, J CLIN MICROBIOL, V33, P2856, DOI 10.1128/JCM.33.11.2856-2858.1995; Samuels LE, 1997, ANN THORAC SURG, V64, P1702, DOI 10.1016/S0003-4975(97)00920-X; Smith PN, 1998, PACE, V21, P42, DOI 10.1111/j.1540-8159.1998.tb01060.x; SPRATT KA, 1993, CLIN INFECT DIS, V17, P679; TRAPPE HJ, 1995, BRIT HEART J, V73, P20; Turkisher V, 1997, PACE, V20, P2268, DOI 10.1111/j.1540-8159.1997.tb04247.x; Victor F, 1999, HEART, V81, P82, DOI 10.1136/hrt.81.1.82; Wilkoff BL, 1999, J AM COLL CARDIOL, V33, P1671, DOI 10.1016/S0735-1097(99)00074-1	19	333	346	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					604	608		10.7326/0003-4819-133-8-200010170-00011	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	364RH	11033588				2022-12-28	WOS:000089906300005
J	Gibson, MC; Schubiger, G				Gibson, MC; Schubiger, G			Peripodial cells regulate proliferation and patterning of Drosophila imaginal discs	CELL			English	Article							WING DISKS; GENE; EYE; MELANOGASTER; EXPRESSION; DIFFERENTIATION; MORPHOGENESIS; COMPARTMENTS; POLYPEPTIDE; EVAGINATION	Cells employ a diverse array of signaling mechanisms to establish spatial patterns during development. Nowhere is this better understood than in Drosophila, where the limbs and eyes arise from discrete epithelial sacs called imaginal discs. Molecular-genetic analyses of pattern formation have generally treated discs as single epithelial sheets. Anatomically, however, discs comprise a columnar cell monolayer covered by a squamous epithelium known as the peripodial membrane. Here we demonstrate that during development, peripodial cells signal to disc columnar cells via microtubule-based apical extensions. Ablation and targeted gene misexpression experiments demonstrate that peripodial cell signaling contributes to growth control and pattern formation in the eye and wing primordia. These findings challenge the traditional view of discs as monolayers and provide foundational evidence for peripodial cell function in Drosophila appendage development.	Univ Washington, Dept Zool, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Schubiger, G (corresponding author), Univ Washington, Dept Zool, Seattle, WA 98195 USA.	gerold@u.washington.edu			NIGMS NIH HHS [GM58282, T32 GM07270] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058282, T32GM007270] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agnes F, 1999, DEVELOPMENT, V126, P5453; Allen MJ, 1999, J NEUROSCI, V19, P9374; AUERBACH C, 1936, T R SOC ED 3, V58; Basler K, 2000, EMBO J, V19, P1169, DOI 10.1093/emboj/19.6.1169; BLAIR SS, 1995, BIOESSAYS, V17, P299, DOI 10.1002/bies.950170406; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bryant PJ, 1999, CURR BIOL, V9, pR655, DOI 10.1016/S0960-9822(99)80416-3; BRYANT PJ, 1971, DEV BIOL, V26, P606, DOI 10.1016/0012-1606(71)90146-1; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; Cohen S. M., 1993, DEV DROSOPHILA MELAN, P747; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Fan SS, 1997, DEVELOPMENT, V124, P1497; Fawcett DW, 1981, CELL, P410; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; Fristrom D, 1993, DEV DROSOPHILA MELAN, P843; Gibson MC, 1999, DEVELOPMENT, V126, P1591; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; GUSTAFSON T, 1961, EXP CELL RES, V24, P64, DOI 10.1016/0014-4827(61)90248-8; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; Ju BG, 2000, NATURE, V405, P191, DOI 10.1038/35012090; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; KOOH PJ, 1993, DEVELOPMENT, V117, P493; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; MADHAVAN MM, 1977, ROUX ARCH DEV BIOL, V183, P269, DOI 10.1007/BF00848459; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; MILLER J, 1995, DEVELOPMENT, V121, P2501; MILNER MJ, 1984, ROUX ARCH DEV BIOL, V193, P180, DOI 10.1007/BF00848893; Montell DJ, 1999, DEVELOPMENT, V126, P3035; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; NARDI JB, 1987, DEV BIOL, V119, P20, DOI 10.1016/0012-1606(87)90202-8; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Plough HH, 1935, GENETICS, V20, P0042; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Schubiger G., 1968, Wilhelm Roux Archiv fur Entwicklungsmechanik der Organismen, V160, P9, DOI 10.1007/BF00573645; SCHUBIGER G, 1971, DEV BIOL, V26, P277, DOI 10.1016/0012-1606(71)90127-8; SPEICHER SA, 1994, DEVELOPMENT, V120, P535; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Sun X, 1997, DEVELOPMENT, V124, P3439; SWAROOP A, 1987, P NATL ACAD SCI USA, V84, P6501, DOI 10.1073/pnas.84.18.6501; THOMAS U, 1991, DEVELOPMENT, V111, P749; Tomlinson A, 1999, DEVELOPMENT, V126, P5725; Vincent S, 1997, DEVELOPMENT, V124, P2741; WatermanStorer CM, 1996, J BIOL CHEM, V271, P1153, DOI 10.1074/jbc.271.2.1153; Wolff Tanya, 1993, P1277; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947	51	80	81	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 13	2000	103	2					343	350		10.1016/S0092-8674(00)00125-2	http://dx.doi.org/10.1016/S0092-8674(00)00125-2			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057906	Bronze			2022-12-28	WOS:000089864300017
J	Hengartner, MO				Hengartner, MO			The biochemistry of apoptosis	NATURE			English	Review							PROGRAMMED CELL-DEATH; BCL-X-L; INDUCED-PROXIMITY MODEL; CYTOCHROME-C; CASPASE ACTIVATION; NMR STRUCTURE; COMPLEX; FAMILY; MITOCHONDRIA; PROTEINS	Apoptosis - the regulated destruction of a cell - is a complicated process. The decision to die cannot be taken lightly, and the activity of many genes influence a cell's likelihood of activating its self-destruction programme. Once the decision is taken, proper execution of the apoptotic programme requires the coordinated activation and execution of multiple subprogrammes. Here I review the basic components of the death machinery, describe how they interact to regulate apoptosis in a coordinated manner, and discuss the main pathways that are used to activate cell death.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Hengartner, MO (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Jansen, Heiko T./A-5770-2008; Petit, Patrice X./A-3692-2009; Hengartner, Michael O/A-7058-2008; Hengartner, Michael O/E-6235-2011	Jansen, Heiko T./0000-0003-0178-396X; Petit, Patrice X./0000-0002-5038-9101; Hengartner, Michael/0000-0002-7584-596X				Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Borner C, 1999, CELL DEATH DIFFER, V6, P497, DOI 10.1038/sj.cdd.4400525; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Buendia B, 1999, J CELL SCI, V112, P1743; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Chau BN, 2000, MOL CELL, V6, P31, DOI 10.1016/S1097-2765(00)00005-8; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cikala M, 1999, CURR BIOL, V9, P959, DOI 10.1016/S0960-9822(99)80423-0; Depraetere V, 1998, SCAND J IMMUNOL, V47, P523; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hausmann G, 2000, J CELL BIOL, V149, P623, DOI 10.1083/jcb.149.3.623; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Loeffler M, 2000, EXP CELL RES, V256, P19, DOI 10.1006/excr.2000.4833; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Nicholson DW, 1996, NAT BIOTECHNOL, V14, P297, DOI 10.1038/nbt0396-297; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Robertson GS, 2000, BRAIN PATHOL, V10, P283, DOI 10.1111/j.1750-3639.2000.tb00262.x; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang J, 2000, J CELL SCI, V113, P753; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xanthoudakis S, 2000, NAT CELL BIOL, V2, pE163, DOI 10.1038/35023643; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	75	5829	6194	23	1227	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					770	776		10.1038/35037710	http://dx.doi.org/10.1038/35037710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048727				2022-12-28	WOS:000089773900051
J	Gatzoulis, MA; Balaji, S; Webber, SA; Siu, SC; Hokanson, JS; Poile, C; Rosenthal, M; Nakazawa, M; Moller, JH; Gillette, PC; Webb, GD; Redington, AN				Gatzoulis, MA; Balaji, S; Webber, SA; Siu, SC; Hokanson, JS; Poile, C; Rosenthal, M; Nakazawa, M; Moller, JH; Gillette, PC; Webb, GD; Redington, AN			Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study	LANCET			English	Article							PULMONARY VALVE-REPLACEMENT; VENTRICULAR-TACHYCARDIA; SURGICAL REPAIR; FOLLOW-UP; INSUFFICIENCY; REGURGITATION; STENOSIS; EXERCISE; ADULTS	Background Ventricular arrhythmia and sudden cardiac death tate after repair of tetralogy of Fallot are devastating complications in adult survivors of early surgery, but their prediction remains difficult. Methods We examined surgical, electrocardiographic, and late haemodynamic data, and their relation to clinical arrhythmia and sudden death occurring over 10 years, in a multicentre cohort of patients with repaired tetralogy, who were alive in 1985. Results Of 793 patients (mean age at repair 8.2 years [SD 8], mean time from repair 21.1 years [8.7]) who entered the study, 33 patients developed sustained monomorphic Ventricular tachycardia, 16 died suddenly, and 29 had new-onset sustained atrial flutter or fibrillation. Electrocardiographic markers (QRS duration, QRS rate of change between 1985 and 1995) were significantly greater in the Ventricular tachycardia and sudden-death groups. Older age at repair was associated with a higher risk of sudden death and atrial tachyarrhythmia. Pulmonary regurgitation was the main underlying haemodynamic lesion for patients with ventricular tachycardia and sudden death, whereas tricuspid regurgitation was for those with atrial flutter/fibrillation. Despite adverse haemodynamics, no patient who died suddenly had undergone late reoperation. Conclusion Arrhythmia and sudden death are important late sequelae for: patients after repair of tetralogy of Fallot. The electrophysiological and haemodynamic substrate of sudden death resembled that of sustained ventricular tachycardia, with pulmonary regurgitation being the predominant haemodynamic lesion. Preservation or restoration of pulmonary Valve function may thus reduce the risk of sudden death. Furthermore, electrocardiographic markers can help to identify patients at risk.	Royal Brompton Hosp, Dept Paediat, London SW3 6NP, England; Royal Brompton Hosp, Adult Congenital Heart Unit, London SW3 6NP, England; Natl Heart & Lung Inst, London SW3 6NP, England; Med Univ S Carolina, S Carolina Childrens Heart Ctr, Charleston, SC 29425 USA; Childrens Hosp Pittsburgh, Dept Cardiol, Pittsburgh, PA 15213 USA; Univ Minnesota Hosp & Clin, Variety Club Childrens Hosp, Dept Cardiol, Minneapolis, MN 55455 USA; Heart Inst Japan, Tokyo, Japan; Tokyo Womens Med Coll, Tokyo 162, Japan; Univ Toronto, Toronto Hosp, Congenital Cardiac Ctr Adults, Toronto, ON, Canada	Royal Brompton Hospital; Royal Brompton Hospital; Imperial College London; Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota Hospital; Tokyo Women's Medical University; University of Toronto; Toronto Congenital Cardiac Centre for Adults; University Toronto Affiliates; University Health Network Toronto	Gatzoulis, MA (corresponding author), Royal Brompton Hosp, Dept Paediat, London SW3 6NP, England.	m.gatzoulis@rbh.nthames.nhs.uk	Siu, Sam C/G-3346-2011	Siu, Sam C/0000-0002-1104-3669				[Anonymous], 1989, NEW ENGL J MED, V321, P406; AtallahYunes NH, 1996, CIRCULATION, V94, P22; BOVE EL, 1985, J THORAC CARDIOV SUR, V90, P50; BRICKER JT, 1995, CIRCULATION, V92, P158, DOI 10.1161/01.CIR.92.2.158; CASTANEDA AR, 1977, J THORAC CARDIOV SUR, V74, P372; Chaturvedi RR, 1997, CIRCULATION, V95, P643, DOI 10.1161/01.CIR.95.3.643; CULLEN S, 1994, J AM COLL CARDIOL, V23, P1151, DOI 10.1016/0735-1097(94)90604-1; DEAN JW, 1989, LANCET, V1, P1309; DEANFIELD JE, 1984, BRIT HEART J, V52, P77; DOWNAR E, 1992, J AM COLL CARDIOL, V20, P648, DOI 10.1016/0735-1097(92)90020-N; GARSON A, 1985, J AM COLL CARDIOL, V5, pB134, DOI 10.1016/S0735-1097(85)80543-X; GARSON A, 1979, CIRCULATION, V59, P1232, DOI 10.1161/01.CIR.59.6.1232; GARSON A, 1985, J AM COLL CARDIOL, V6, P221, DOI 10.1016/S0735-1097(85)80279-5; GATZOULIS MA, 1995, CIRCULATION, V92, P231, DOI 10.1161/01.CIR.92.2.231; GILLETTE PC, 1977, CIRCULATION, V56, P566, DOI 10.1161/01.CIR.56.4.566; GOLDBERG SJ, 1985, AM J CARDIOL, V56, P131, DOI 10.1016/0002-9149(85)90581-8; ILBAWI MN, 1987, J THORAC CARDIOV SUR, V93, P36; JARMAKANI JM, 1976, CIRCULATION, V53, P555, DOI 10.1161/01.CIR.53.3.555; KATZ NM, 1982, CIRCULATION, V65, P403, DOI 10.1161/01.CIR.65.2.403; LILLEHEI CW, 1986, ANN SURG, V204, P490, DOI 10.1097/00000658-198610000-00017; MARIE PY, 1992, AM J CARDIOL, V69, P785, DOI 10.1016/0002-9149(92)90506-T; MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901; Norgard G, 1996, CIRCULATION, V94, P3276, DOI 10.1161/01.CIR.94.12.3276; ROOSHESSELINK J, 1995, CIRCULATION, V91, P2214, DOI 10.1161/01.CIR.91.8.2214; ROSENTHAL A, 1993, NEW ENGL J MED, V329, P655, DOI 10.1056/NEJM199308263290911; RYAN M, 1975, NEW ENGL J MED, V292, P224, DOI 10.1056/NEJM197501302920502; Satoh T, 1996, J CARDIOVASC ELECTR, V7, P833, DOI 10.1111/j.1540-8167.1996.tb00596.x; Till JA, 1995, CIRCULATION S, V92, pI707; Yemets IM, 1997, ANN THORAC SURG, V64, P526, DOI 10.1016/S0003-4975(97)00577-8; ZAHKA KG, 1988, CIRCULATION, V78, P14	30	1087	1139	0	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2000	356	9234					975	981		10.1016/S0140-6736(00)02714-8	http://dx.doi.org/10.1016/S0140-6736(00)02714-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041398				2022-12-28	WOS:000089293600011
J	Jordhoy, MS; Fayers, P; Saltnes, T; Ahlner-Elmqvist, M; Jannert, M; Kaasa, S				Jordhoy, MS; Fayers, P; Saltnes, T; Ahlner-Elmqvist, M; Jannert, M; Kaasa, S			A palliative-care intervention and death at home: a cluster randomised trial	LANCET			English	Article							CANCER-PATIENTS; COST-EFFECTIVENESS; TERMINALLY ILL; PLACE; CHALLENGES; PROGRAMS; HOSPICE; ISSUES	Background The Palliative Medicine Unit at University Hospital of Trondheim, Norway, started an intervention programme that aims to enable patients to spend more time at home and die there if they prefer. Close cooperation was needed with the community health-care professionals, who acted as the principal formal caregivers, and a multidisciplinary consultant team coordinated the care. We did a cluster randomised trial to assess the intervention's effectiveness compared with conventional care Methods Community health-care districts in and around Trondheim, Norway, were defined as the clusters to be randomised. We enrolled 434 patients (235 assigned intervention and 199 conventional care [controls]) in these districts who had incurable malignant disease and an expected survival of 2-9 months. Main outcomes were place of death and time spent in institutions in the last month of life. Findings 395 patients died. Of these, more intervention patients than controls died at home (54 [25%] vs 26 [15%], p<0.05). The time spent at home was not significantly increased, although intervention patients spent a smaller proportion of time in nursing homes in the last month of life than did controls (7.2 vs 14.6%, p<0.05). Hospital use was similar in the two groups. Interpretation The palliative-care intervention enabled more patients to die at home. More resources for care in the home (palliative care training and staff) and an increased focus on use of nursing homes would be necessary, however, to increase time at home and reduce hospital admissions.	Univ Trondheim Hosp, Kreftbygget Univ Hosp Trondheim, Norwegian Univ Sci & Technol, Unit Appl Clin Res, N-7006 Trondheim, Norway; Malmo Univ Hosp, Dept Otorhinolaryngol, Malmo, Sweden; Univ Trondheim Hosp, Dept Radiotherapy & Oncol, Palliat Med Unit, N-7006 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Lund University; Skane University Hospital; Norwegian University of Science & Technology (NTNU)	Jordhoy, MS (corresponding author), Univ Trondheim Hosp, Kreftbygget Univ Hosp Trondheim, Norwegian Univ Sci & Technol, Unit Appl Clin Res, N-7006 Trondheim, Norway.		Fayers, Peter M/A-5999-2010	Slaaen, Marit/0000-0002-1038-8032; Fayers, Peter/0000-0003-4778-1513				Ashby M, 1993, Palliat Med, V7, P273, DOI 10.1177/026921639300700403; DeConno F, 1996, EUR J CANCER, V32A, P1142, DOI 10.1016/0959-8049(96)00036-6; DUNLOP RJ, 1989, PALLIAT MED, V0003, P00197, DOI DOI 10.1177/026921638900300305; EFFRAN B, 1993, INTRO BOOTSTRAP, P88; Grande GE, 1998, SOC SCI MED, V47, P565, DOI 10.1016/S0277-9536(98)00115-4; Grande GE, 1999, BRIT MED J, V319, P1472, DOI 10.1136/bmj.319.7223.1472; GREER DS, 1986, J CHRON DIS, V39, P9, DOI 10.1016/0021-9681(86)90103-7; Hearn J, 1998, PALLIATIVE MED, V12, P317, DOI 10.1191/026921698676226729; Higginson IJ, 1999, BRIT MED J, V319, P462, DOI 10.1136/bmj.319.7208.462; Higginson IJ, 1998, PALLIATIVE MED, V12, P353, DOI 10.1191/026921698672530176; Hinton John, 1994, Palliative Medicine, V8, P197, DOI 10.1177/026921639400800303; Hughes SL, 1997, HEALTH SERV RES, V32, P415; HUGHES SL, 1992, HEALTH SERV RES, V26, P801; Jordhoy MS, 1999, PALLIATIVE MED, V13, P299, DOI 10.1191/026921699668963873; KANE RL, 1984, LANCET, V1, P890; KOEPSELL TD, 1992, ANNU REV PUBL HEALTH, V13, P31, DOI 10.1146/annurev.pu.13.050192.000335; MCCORKLE R, 1989, CANCER, V64, P1375, DOI 10.1002/1097-0142(19890915)64:6<1375::AID-CNCR2820640634>3.0.CO;2-6; *NORG OFF UTR, 1997, OMS KUNNSK NORSK KRE; Porta M, 1997, PALLIATIVE MED, V11, P116, DOI 10.1177/026921639701100205; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; Raftery JP, 1996, PALLIATIVE MED, V10, P151, DOI 10.1177/026921639601000210; Rinck GC, 1997, J CLIN ONCOL, V15, P1697, DOI 10.1200/JCO.1997.15.4.1697; Smeenk FWJM, 1998, BRIT MED J, V316, P1939, DOI 10.1136/bmj.316.7149.1939; *SOS HELS I SAM ME, 1998, STYR INF HELS SOS I; Stajduhar KI, 1998, J PALLIAT CARE, V14, P8, DOI 10.1177/082585979801400304; TOWNSEND J, 1990, BRIT MED J, V301, P415, DOI 10.1136/bmj.301.6749.415; VINCIGUERRA V, 1986, J CLIN ONCOL, V4, P1521, DOI 10.1200/JCO.1986.4.10.1521; ZIMMER JG, 1985, AM J PUBLIC HEALTH, V75, P134, DOI 10.2105/AJPH.75.2.134	28	221	225	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					888	893		10.1016/S0140-6736(00)02678-7	http://dx.doi.org/10.1016/S0140-6736(00)02678-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	353DP	11036893				2022-12-28	WOS:000089259800010
J	Messori, A; Trippoli, S; Vaiani, M; Gorini, M; Corrado, A				Messori, A; Trippoli, S; Vaiani, M; Gorini, M; Corrado, A			Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CRITICALLY ILL PATIENTS; VENTILATED TRAUMA PATIENTS; SEVERE HEAD-INJURY; NOSOCOMIAL PNEUMONIA; UNIT PATIENTS; CIMETIDINE PROPHYLAXIS; SECONDARY PNEUMONIA; DOUBLE-BLIND; COMPLICATIONS; METAANALYSES	Objectives To determine the effectiveness of ranitidine and sucralfate in the prevention of stress ulcer in critical patients and to assess if these treatments affect the risk of nosocomial pneumonia. Design Published studies retrieved through Medline and other databases. Five meta-analyses evaluated effectiveness in terms of bleeding rates (A: ranitidine v placebo; B: sucralfate v placebo) and infectious complications in terms of incidence of nosocomial pneumonia (C: ranitidine v placebo; D: sucralfate v placebo; E: ranitidine v sucralfate). Trial quality was determined with an empirical ad hoc procedure. Main outcome measures Rates of clinically important gastrointestinal bleeding and nosocomial pneumonia (compared between the two study arms and expressed with odds ratios specific for individual studies and meta-analytic summary odds ratios); Results Meta-analysis A (five studies) comprised 398 patients; meta-analysis C (three studies) comprised 311 patients; meta-analysis D (two studies) comprised 226 patients: and meta-analysis E (eight studies) comprised 1825 patients. Meta-analysis B was not carried out as the literature search selected only one clinical trial. In meta-analysis A ranitidine was found to have the same effectiveness as placebo (odds ratio of bleeding 0.72, 95% confidence interval 0.30 to 1.70, P = 0.46). In placebo controlled studies (meta-analyses C and D) ranitidine and sucralfate had no influence on the incidence of nosocomial pneumonia. In comparison with sucralfate, ranitidine significantly increased the incidence of nosocomial pneumonia (meta-analysis E: 1.35, 1.07 to 1.70, P = 0.012). The mean quality score in the four analyses (on a 0 to 10 scale) ranged from 5.6 in meta-analysis E to 6.6 in meta-analysis A. Conclusions Ranitidine is ineffective in the prevention of gastrointestinal bleeding in patients in intensive care and might increase the risk of pneumonia. Studies on sucralfate do not provide conclusive results. These findings are based on small numbers of patients, and firm conclusions cannot presently be proposed.	Azienda Osped Careggi, Serv Farmaceut, Ctr Informaz Farm, Lab SIFO Farmacoecon, I-50134 Florence, Italy; Azienda Osped Careggi, Unita Terapia Intens Resp, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi	Messori, A (corresponding author), Azienda Osped Careggi, Serv Farmaceut, Ctr Informaz Farm, Lab SIFO Farmacoecon, I-50134 Florence, Italy.	md3439@mclink.it	Messori, Andrea/U-6903-2019		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		APTE NM, 1992, CRIT CARE MED, V20, P590, DOI 10.1097/00003246-199205000-00008; BENMENACHEM T, 1994, ANN INTERN MED, V121, P568, DOI 10.7326/0003-4819-121-8-199410150-00003; BRANDAO A, 1991, GASTROINTEST ESOPHAG, V10, P105; BURGESS P, 1995, DIGEST DIS SCI, V40, P645, DOI 10.1007/BF02064385; COLLINS R, 1985, BMJ-BRIT MED J, V290, P17, DOI 10.1136/bmj.290.6461.17; Cook D, 1998, NEW ENGL J MED, V338, P791, DOI 10.1056/NEJM199803193381203; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EDDLESTON JM, 1991, CRIT CARE MED, V19, P1491, DOI 10.1097/00003246-199112000-00009; EDDLESTON JM, 1994, CRIT CARE MED, V22, P1949; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; GROLL A, 1986, GUT, V27, P135, DOI 10.1136/gut.27.2.135; HALLORAN LG, 1980, AM J SURG, V139, P44, DOI 10.1016/0002-9610(80)90228-7; Hanisch EW, 1998, AM J SURG, V176, P453, DOI 10.1016/S0002-9610(98)00239-6; KARLSTADT RG, 1990, J INTENSIVE CARE MED, V5, P26, DOI DOI 10.1177/088506669000500106; LABATTUT AG, 1992, CLIN INTENSIVE CARE, V3, P519; LAGGNER AN, 1989, AM J MED, V86, P81, DOI 10.1016/0002-9343(89)90164-2; Lam NP, 1999, CRIT CARE MED, V27, P98, DOI 10.1097/00003246-199901000-00034; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Levy MJ, 1997, DIGEST DIS SCI, V42, P1255, DOI 10.1023/A:1018810325370; MAIER RV, 1994, ANN SURG, V220, P353; MANNUCCI PM, 1985, LANCET, V1, P1505; MCKIBBON KA, 1996, EVIDENCE BASED MED, V1, P70; METZ CA, 1993, CRIT CARE MED, V21, P1844, DOI 10.1097/00003246-199312000-00010; MUSTAFA NA, 1995, INTENS CARE MED, V21, P287, DOI 10.1007/BF01701491; O'Keefe GE, 1998, ANN SURG, V227, P120, DOI 10.1097/00000658-199801000-00017; Petitti DB, 1999, METAANALYSIS DECISIO; PEURA DA, 1985, ANN INTERN MED, V103, P173, DOI 10.7326/0003-4819-103-2-173; PICKWORTH KK, 1993, CRIT CARE MED, V21, P1856, DOI 10.1097/00003246-199312000-00012; PRODHOM G, 1994, ANN INTERN MED, V120, P653, DOI 10.7326/0003-4819-120-8-199404150-00005; REUSSER P, 1990, CRIT CARE MED, V18, P270, DOI 10.1097/00003246-199003000-00004; RUIZSANTANA S, 1991, CRIT CARE MED, V19, P887, DOI 10.1097/00003246-199107000-00011; SALATA RA, 1987, AM REV RESPIR DIS, V135, P426; Thomason MH, 1996, J TRAUMA, V41, P503, DOI 10.1097/00005373-199609000-00020; Tryba M, 1997, DRUGS, V54, P581, DOI 10.2165/00003495-199754040-00005; TRYHA M, 1997, DRUGS, V54, P581; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; ZINNER MJ, 1981, SURG GYNECOL OBSTET, V153, P214	39	131	144	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2000	321	7269					1103	A7		10.1136/bmj.321.7269.1103	http://dx.doi.org/10.1136/bmj.321.7269.1103			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061729	Green Published, Bronze			2022-12-28	WOS:000165219600021
J	Kwiatkowski, D				Kwiatkowski, D			Science, medicine, and the future - Susceptibility to infection	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HUMAN-LEUKOCYTE ANTIGEN; MYCOBACTERIAL INFECTION; SEVERE MALARIA; ENVIRONMENTAL-INFLUENCES; NATURAL-SELECTION; TUBERCULOSIS; GENE; POLYMORPHISM; ASSOCIATION; LEPROSY		Wellcome Trust Ctr Human Genet, MRC, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Kwiatkowski, D (corresponding author), Wellcome Trust Ctr Human Genet, MRC, Roosevelt Dr, Oxford OX3 7BN, England.	dominic.kwiatkowski@paediatrics.ox.ac.uk		Kwiatkowski, Dominic/0000-0002-5023-0176				Altare F, 1998, CURR OPIN IMMUNOL, V10, P413, DOI 10.1016/S0952-7915(98)80114-3; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; FINE PEM, 1981, INT J LEPROSY, V49, P437; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; JEPSON AP, 1995, J INFECT DIS, V172, P316, DOI 10.1093/infdis/172.1.316; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; MALATY HM, 1994, ANN INTERN MED, V120, P982, DOI 10.7326/0003-4819-120-12-199406150-00002; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; Marsh DG, 1997, NAT GENET, V15, P389; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roy S, 1997, J INFECT DIS, V176, P530, DOI 10.1086/517282; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; SINGH SPN, 1983, J INFECT DIS, V148, P676, DOI 10.1093/infdis/148.4.676; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; TODD JR, 1990, REV INFECT DIS, V12, P63; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224	29	48	50	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2000	321	7268					1061	1065		10.1136/bmj.321.7268.1061	http://dx.doi.org/10.1136/bmj.321.7268.1061			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PU	11053181	Green Published			2022-12-28	WOS:000165076800028
J	Currie, Z; Bhan, A; Pepper, I				Currie, Z; Bhan, A; Pepper, I			Reliability of Snellen charts for testing visual acuity for driving: prospective study and postal questionnaire	BRITISH MEDICAL JOURNAL			English	Article								Objectives To assess the ability of patients with binocular 6/9 or 6/12 vision on the Snellen chart (Snellen acuity) to read a number plate at 20.5 m (the required standard for driving) and to determine how health professionals advise such patients about driving. Design Prospective study of patients and postal questionnaire to healthcare professionals. Subjects 50 patients with 6/9 vision and 50 with 6/12 vision and 100 general practitioners, 100 optometrists or opticians, and 100 ophthalmologists. Setting Ophthalmology outpatient clinics in Sheffield. Main outcome measures Ability to read a number plate at 20.5 m and health professionals' advice about driving on the basis of visual acuity. Results 26% of patients with 6/9 vision failed the number plate test, and 34% with 6/12 vision passed it Of the general practitioners advising patients with 6/9 vision, 76% said the patients could drive, 13% said they should not drive, and 11% were unsure. Of the general practitioners advising patients with 6/12 vision, 21% said the patients could drive, 54% said they should not drive, and 25% were unsure. The level of acuity at which optometrists, opticians, and ophthalmologists would advise drivers against driving ranged from 6/9(-2) (ability to read all except two letters on the 6/9 line of the Snellen chart) to less than 6/18. Conclusions Snellen acuity is a poor predictor of an individual's ability to meet the required visual standard for driving. Patients with 6/9 vision or less should be warned that they may fail to meet this standard, but those with 6/12 vision should not be assumed to be below the standard.	Royal Hallamshire Hosp, Dept Ophthalmol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Currie, Z (corresponding author), Royal Hallamshire Hosp, Dept Ophthalmol, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.							CHARMAN WN, 1985, OPHTHAL PHYSL OPT, V5, P211, DOI 10.1111/j.1475-1313.1985.tb00658.x; *DEP TRANSP, 1998, CONS TRENDS SURV; DRASDO N, 1981, OPHTHAL PHYSL OPT, V1, P39, DOI 10.1016/0275-5408(81)90060-0; *DRIV VEH LIC AUTH, 1998, GLANC GUID CURR MED, P25; MARSDEN AM, 1966, T ILLUMINATING ENG S, V31, P2; MCCAGHREY GE, 1987, OPTOMETRY TODAY, V27, P178; Shipp M D, 1995, J Am Optom Assoc, V66, P343; Taylor SP, 1997, OPHTHAL PHYSL OPT, V17, P473, DOI 10.1111/j.1475-1313.1997.tb00085.x	8	32	34	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 21	2000	321	7267					990	992		10.1136/bmj.321.7267.990	http://dx.doi.org/10.1136/bmj.321.7267.990			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366ZF	11039964	Bronze, Green Published			2022-12-28	WOS:000090035600025
J	Elderfield, H				Elderfield, H			Global change - A world in transition.	NATURE			English	Article									Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Elderfield, H (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.							Ivany LC, 2000, NATURE, V407, P887, DOI 10.1038/35038044; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Prothero D.R., 1994, EOCENE OLIGOCENE TRA; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	6	5	6	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					851	852		10.1038/35038196	http://dx.doi.org/10.1038/35038196			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057651				2022-12-28	WOS:000089901900033
J	Izban, KF; Gooneratne, S				Izban, KF; Gooneratne, S			Mullerian adenosarcoma and early pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Loyola Univ, Med Ctr, Maywood, IL 60153 USA	Loyola University Chicago	Izban, KF (corresponding author), Loyola Univ, Med Ctr, 2160 S 1st Ave, Maywood, IL 60153 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2000	343	16					1167	1167		10.1056/NEJM200010193431606	http://dx.doi.org/10.1056/NEJM200010193431606			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364FY	11036123				2022-12-28	WOS:000089882800006
J	Macilwain, C				Macilwain, C			NSF puts big money into complex ecology	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					823	823		10.1038/35038220	http://dx.doi.org/10.1038/35038220			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057630	Bronze			2022-12-28	WOS:000089901900007
J	Narymbetov, B; Omerzu, A; Kabanov, VV; Tokumoto, M; Kobayashi, H; Mihailovic, D				Narymbetov, B; Omerzu, A; Kabanov, VV; Tokumoto, M; Kobayashi, H; Mihailovic, D			Origin of ferromagnetic exchange interactions in a fullerene-organic compound	NATURE			English	Article							MAGNETIC-PROPERTIES; TDAE-C-60; TETRAKIS(DIMETHYLAMINO)ETHYLENE; TRANSITION; NITROXIDE; TDAE	Organic ferromagnets, which exhibit exchange interactions between unpaired electrons in pi-orbitals, are rare(1-6), and the origin of ferromagnetism in these compounds has so far remained unexplained. Tetrakis(dimethylamino)ethylene-fullerene[60] (TDAE-C-60) shows a transition to a ferromagnetic state with fully saturated s = 1/2 molecular spins at the relatively high Curie temperature (for organic materials) of 16 K (ref. 4). It has been suggested(7-9) that the orientations of the C-60 molecules may be important for ferromagnetism in this material, but in the absence of structural data at low temperatures there has been little progress towards understanding these microscopic interactions. Here we report the results of a comparative structural study of two different magnetic forms of TDAE-C-60 crystals at low temperatures, correlating the structural properties-in particular, the intermolecular orientations-with the magnetic properties. We rnd that both ferromagnetism and spin-glasslike ordering are possible in this material, and depend on the orientational state of C-60 molecules. This resolves the apparent contradictions posed by different macroscopic measurements(4,10-14), and opens the way to a microscopic understanding of pi-electron ferromagnetic exchange interactions in organic materials.	Inst Josef Stefan, Ljubljana 1000, Slovenia; Inst Mol Sci, Okazaki, Aichi 4448585, Japan; Electrotech Lab, Tsukuba, Ibaraki 3058568, Japan	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); National Institute of Advanced Industrial Science & Technology (AIST)	Mihailovic, D (corresponding author), Inst Josef Stefan, Jamova 39, Ljubljana 1000, Slovenia.		Mihailovic, Dragan/H-6753-2014; /AAD-1694-2020; Omerzu, Ales/H-7915-2017	Mihailovic, Dragan/0000-0003-2074-2899; /0000-0002-3663-5855; Omerzu, Ales/0000-0003-3292-5457				ALLEMAND PM, 1991, SCIENCE, V253, P301, DOI 10.1126/science.253.5017.301; Arcon D, 1996, PHYS REV B, V53, P9137, DOI 10.1103/PhysRevB.53.9137; Arcon D, 1998, PHYS REV LETT, V80, P1529, DOI 10.1103/PhysRevLett.80.1529; BLINC R, 1994, PHYS REV B, V50, P1; CHIARELLI R, 1993, NATURE, V363, P147, DOI 10.1038/363147a0; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; GOLIC L, 1996, FULLERENES FULLERENE, P531; Kahn O., 1993, MOL MAGNETISM; MIHAILOVIC D, 1995, SCIENCE, V268, P400, DOI 10.1126/science.268.5209.400; Mrzel A, 1996, PHYS REV B, V53, pR2922, DOI 10.1103/PhysRevB.53.R2922; Mrzel A, 1998, CHEM PHYS LETT, V298, P329, DOI 10.1016/S0009-2614(98)01184-1; NAKAZAWA Y, 1992, PHYS REV B, V46, P8906, DOI 10.1103/PhysRevB.46.8906; Omerzu A, 2000, PHYS REV B, V61, P11883, DOI 10.1103/PhysRevB.61.R11883; Sato T, 1997, PHYS REV B, V55, P11052, DOI 10.1103/PhysRevB.55.11052; TANAKA K, 1995, CHEM PHYS LETT, V237, P123, DOI 10.1016/0009-2614(95)00296-G; Tanaka K, 1996, CHEM PHYS LETT, V259, P574, DOI 10.1016/0009-2614(96)00831-7; TANAKA K, 1993, PHYS REV B, V47, P7554, DOI 10.1103/PhysRevB.47.7554; Umek P, 2000, CHEM PHYS, V253, P361, DOI 10.1016/S0301-0104(99)00404-8; VENTURINI P, 1992, INT J MOD PHYS B, V6, P3947, DOI 10.1142/S021797929200205X	19	157	159	3	41	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					883	885		10.1038/35038032	http://dx.doi.org/10.1038/35038032			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057661				2022-12-28	WOS:000089901900044
J	Levin, A				Levin, A			Vaccines today	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		1997, PEDIATRICS, V100, P1015; 2000, ANN INTERN MED, V133, P489	2	5	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					661	664		10.7326/0003-4819-133-8-200010170-00102	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00102			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033609				2022-12-28	WOS:000089906300019
J	Massague, J; Blain, SW; Lo, RS				Massague, J; Blain, SW; Lo, RS			TGF beta signaling in growth control, cancer, and heritable disorders	CELL			English	Review							CELL-CYCLE ARREST; HEREDITARY HEMORRHAGIC TELANGIECTASIA; II RECEPTOR GENE; MICROSATELLITE INSTABILITY; CLEIDOCRANIAL DYSPLASIA; TUMOR-SUPPRESSOR; COLORECTAL-CANCER; BREAST-CANCER; MUTATIONAL INACTIVATION; CRYSTAL-STRUCTURE		Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Cell Biol Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Cell Biol Program, New York, NY 10021 USA.	j-massague@ski.mskcc.org		Massague, Joan/0000-0001-9324-8408				Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; Akiyama Y, 1997, GASTROENTEROLOGY, V112, P33, DOI 10.1016/S0016-5085(97)70216-6; ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Allard S, 2000, DEVELOPMENT, V127, P3349; Anbazhagan R, 1999, CANCER RES, V59, P3363; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Barcellos-Hoff MH, 2000, BREAST CANCER RES, V2, P92, DOI 10.1186/bcr40; Belville C, 1999, AM J MED GENET, V89, P218, DOI 10.1002/(SICI)1096-8628(19991229)89:4<218::AID-AJMG6>3.0.CO;2-E; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; BLAIN SW, 2000, IN PRESS J BIOL CHEM; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bottinger EP, 1997, CANCER RES, V57, P5564; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Chang J, 1997, CANCER RES, V57, P2856; Chen RH, 1997, CELL GROWTH DIFFER, V8, P821; Chen TP, 1998, CANCER RES, V58, P4805; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Dai JL, 1999, MOL CARCINOGEN, V26, P37, DOI 10.1002/(SICI)1098-2744(199909)26:1<37::AID-MC5>3.0.CO;2-6; Dang CV, 1999, MOL CELL BIOL, V19, P1; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; EWEN ME, 1995, GENE DEV, V9, P204, DOI 10.1101/gad.9.2.204; Facchini LM, 1998, FASEB J, V12, P633, DOI 10.1096/fasebj.12.9.633; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; GENG Y, 1993, P NATL ACAD SCI USA, V90, P10315, DOI 10.1073/pnas.90.21.10315; Germain S, 2000, GENE DEV, V14, P435; Go C, 2000, ONCOGENE, V19, P3623, DOI 10.1038/sj.onc.1203701; Goggins M, 1998, CANCER RES, V58, P5329; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Gouedard L, 2000, J BIOL CHEM, V275, P27973; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Grady WM, 1999, CANCER RES, V59, P320; Graham A, 1996, MOL CELL NEUROSCI, V8, P76, DOI 10.1006/mcne.1996.0046; Greenwald J, 1999, NAT STRUCT BIOL, V6, P18; Gripp KW, 2000, NAT GENET, V25, P205, DOI 10.1038/76074; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howell M, 1999, DEV BIOL, V214, P354, DOI 10.1006/dbio.1999.9430; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Iavarone A, 1997, NATURE, V387, P417; Izumoto S, 1997, CANCER LETT, V112, P251, DOI 10.1016/S0304-3835(96)04583-1; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; LANE K, IN PRESS NAT GENET; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Lu SL, 1996, CANCER RES, V56, P4595; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Lux A, 2000, HUM MOL GENET, V9, P745, DOI 10.1093/hmg/9.5.745; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Marshall C, 1999, CURR OPIN CELL BIOL, V11, P732, DOI 10.1016/S0955-0674(99)00044-7; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Masuyama N, 1999, J BIOL CHEM, V274, P12163, DOI 10.1074/jbc.274.17.12163; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Mishina Y, 1999, ENDOCRINOLOGY, V140, P2084, DOI 10.1210/en.140.5.2084; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Mundlos S, 1999, J MED GENET, V36, P177; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; MYEROFF LL, 1995, CANCER RES, V55, P5545; Nagahara H, 1999, P NATL ACAD SCI USA, V96, P14961, DOI 10.1073/pnas.96.26.14961; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nguyen AV, 2000, DEVELOPMENT, V127, P3107; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Padgett RW, 1998, BIOESSAYS, V20, P382, DOI 10.1002/(SICI)1521-1878(199805)20:5&lt;382::AID-BIES5&gt;3.0.CO;2-Q; Pardali E, 2000, J BIOL CHEM, V275, P3552, DOI 10.1074/jbc.275.5.3552; PARSONS R, 1995, CANCER RES, V55, P5548; Pasche B, 1999, CANCER RES, V59, P5678; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Peacock AJ, 1999, THORAX, V54, P1107, DOI 10.1136/thx.54.12.1107; Pece-Barbara N, 1999, HUM MOL GENET, V8, P2171, DOI 10.1093/hmg/8.12.2171; Piantanida M, 1996, J MED GENET, V33, P441, DOI 10.1136/jmg.33.6.441; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Reiss M, 1997, ONCOL RES, V9, P447; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Reynisdottir I, 1997, GENE DEV, V11, P492, DOI 10.1101/gad.11.4.492; Saltzman A, 1998, EXP CELL RES, V242, P244, DOI 10.1006/excr.1998.4096; Sandhu C, 1997, MOL CELL BIOL, V17, P2458, DOI 10.1128/MCB.17.5.2458; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Schiemann WP, 1999, BLOOD, V94, P2854, DOI 10.1182/blood.V94.8.2854.420k07_2854_2861; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Takatsu Y, 2000, MOL CELL BIOL, V20, P3015, DOI 10.1128/MCB.20.9.3015-3026.2000; Takenoshita S, 1997, ONCOGENE, V14, P1255, DOI 10.1038/sj.onc.1200938; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Uchida K, 1996, CANCER RES, V56, P5583; Villanueva A, 1998, ONCOGENE, V17, P1969, DOI 10.1038/sj.onc.1202118; Wang D, 2000, CANCER RES, V60, P4507; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Watanabe M, 2000, EMBO REP, V1, P176, DOI 10.1093/embo-reports/kvd029; Westendorf JJ, 1999, J CELL BIOCHEM, P51; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wong C, 1999, MOL CELL BIOL, V19, P1821; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Xu J, 2000, P NATL ACAD SCI USA, V97, P4820, DOI 10.1073/pnas.97.9.4820; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Xu XL, 2000, ONCOGENE, V19, P1868, DOI 10.1038/sj.onc.1203504; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang ZJ, 1998, RNA, V4, P394; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; Zou H, 1997, COLD SPRING HARB SYM, V62, P269	148	1955	2116	3	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 13	2000	103	2					295	309		10.1016/S0092-8674(00)00121-5	http://dx.doi.org/10.1016/S0092-8674(00)00121-5			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057902	Bronze			2022-12-28	WOS:000089864300013
J	Lee, JT				Lee, JT			Disruption of imprinted X inactivation by parent-of-origin effects at Tsix	CELL			English	Article							BECKWITH-WIEDEMANN-SYNDROME; METHYLATED CPG ISLAND; CHROMOSOME INACTIVATION; DNA METHYLATION; MOUSE EMBRYOS; EXPRESSED TRANSCRIPT; DOSAGE COMPENSATION; XIST EXPRESSION; CONTROL REGION; SNRPN GENE	In marsupials and in extraembryonic tissues of placental mammals, X inactivation is imprinted to occur on the paternal chromosome. Here, we find that imprinting is controlled by the antisense Xist gene, Tsix. Tsix is maternally expressed and mice carrying a Tsix deletion show normal paternal but impaired maternal transmission. Maternal inheritance occurs infrequently, with surviving progeny showing intrauterine growth retardation and reduced fertility. Transmission ratio distortion results from disrupted imprinting and postimplantation loss of mutant embryos. In contrast to effects in embryonic stem cells, deleting Tsix causes ectopic X inactivation in early male embryos and inactivation of both X chromosomes in female embryos, indicating that X chromosome counting cannot override Tsix imprinting. These results highlight differences between imprinted and random X inactivation but show that Tsix regulates both. We propose that an imprinting center lies within Tsix.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM58839] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bielinska B, 2000, NAT GENET, V25, P74, DOI 10.1038/75629; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Debrand E, 1999, MOL CELL BIOL, V19, P8513; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; Goto Y, 2000, CHROMOSOME RES, V8, P101, DOI 10.1023/A:1009234217981; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HUNT PA, 1991, DEVELOPMENT, V111, P1137; Jamieson RV, 1998, DEV BIOL, V201, P13, DOI 10.1006/dbio.1998.8972; Jones BK, 1998, GENE DEV, V12, P2200, DOI 10.1101/gad.12.14.2200; KASLOW DC, 1987, P NATL ACAD SCI USA, V84, P6210, DOI 10.1073/pnas.84.17.6210; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Latham KE, 1996, TRENDS GENET, V12, P134, DOI 10.1016/0168-9525(96)10017-2; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; LYON MF, 1971, NATURE-NEW BIOL, V232, P229, DOI 10.1038/newbio232229a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MCMAHON A, 1983, J EMBRYOL EXP MORPH, V74, P207; MIGEON BR, 1989, EXP CELL RES, V182, P597, DOI 10.1016/0014-4827(89)90262-0; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; OHNO S, 1969, ANNU REV GENET, V3, P495, DOI 10.1146/annurev.ge.03.120169.002431; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Schmidt JV, 1999, P NATL ACAD SCI USA, V96, P9733, DOI 10.1073/pnas.96.17.9733; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Solter D, 1997, GENE DEV, V11, P153, DOI 10.1101/gad.11.2.153; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tada T, 2000, DEVELOPMENT, V127, P3101; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; THORNHILL AR, 1993, DEVELOPMENT, V118, P171; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; Willard HF, 1996, CELL, V86, P5, DOI 10.1016/S0092-8674(00)80071-9; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	56	232	246	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 29	2000	103	1					17	27		10.1016/S0092-8674(00)00101-X	http://dx.doi.org/10.1016/S0092-8674(00)00101-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051544	Bronze			2022-12-28	WOS:000089636400005
J	Brown, P				Brown, P			BSE and transmission through blood	LANCET			English	Editorial Material							CREUTZFELDT-JAKOB-DISEASE		NIH, Lab Cent Nervous Syst Studies, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Brown, P (corresponding author), NIH, Lab Cent Nervous Syst Studies, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002957] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1995, Curr Opin Hematol, V2, P472; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; ROHWER RG, 2000, CAMBR HEALTHT I 6 AN	5	30	32	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 16	2000	356	9234					955	956		10.1016/S0140-6736(00)02706-9	http://dx.doi.org/10.1016/S0140-6736(00)02706-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041390				2022-12-28	WOS:000089293600003
J	Pathman, DE; Taylor, DH; Konrad, TR; King, TS; Harris, T; Henderson, TM; Bernstein, JD; Tucker, T; Crook, KD; Spaulding, C; Koch, GG				Pathman, DE; Taylor, DH; Konrad, TR; King, TS; Harris, T; Henderson, TM; Bernstein, JD; Tucker, T; Crook, KD; Spaulding, C; Koch, GG			State scholarship, loan forgiveness, and related programs - The unheralded safety net	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL-HEALTH-SERVICE; EDUCATION; POLICY	Context In the mid-1980s, states expanded their initiatives of scholarships, loan repayment programs, and similar incentives to recruit primary care practitioners into underserved areas. With no national coordination or mandate to publicize these efforts, little is known about these state programs and their recent growth. Objectives To identify and describe state programs that provide financial support to physicians and midlevel practitioners in exchange for a period of service in underserved area;, and to begin to assess the magnitude of the contributions of these programs to the US health care safety net. Design Cross-sectional, descriptive study of data collected by telephone, mail questionnaires, and through other available documents, (eg, program brochures, Web sites). Setting and Participants All state programs operating in 1996 that provided financial support in exchange for service in defined underserved areas to student, resident, and practicing physicians; nurse practitioners; physician assistants; and nurse midwives. We excluded local community initiatives and programs that received federal support, including that from the National Health Service Corps. Main Outcome Measures Number and types of state support-for-service programs in 1996; trends in program types and numbers since 1990; distribution of programs across states; numbers of participating physicians and other practitioners in 1996; numbers in state programs relative to federal programs; and basic features of state programs. Results In 1996, there were 82 eligible programs operating in 41 states, including 29 loan repayment programs, 29 scholarship programs, 11 loan programs, 8 direct financial incentive programs, and Ei resident support programs. Programs more than doubled in number between 1990 (n=39) and 1996 (n=82). In 1996, an estimated 1306 physicians and 370 midlevel practitioners were serving obligations to these state pro-grams, a number comparable with those in federal programs. Common features of state programs were a mission to influence the distribution of the health care workforce within their states' borders, an emphasis on primary care, and reliance on annual state appropriations and other public funding mechanisms. Conclusions In 1996, states fielded an obligated primary care workforce comparable in size to the better-known federal programs. These state programs constitute a major portion of the US health care safety net, and their activities should be monitored, coordinated, and evaluated. State programs should not be omitted from listings of safety-net initiatives or overlooked in future plans to further improve health care access.	Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Family Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; Duke Univ, Terry Sanford Inst Publ Policy Studies, Durham, NC USA; Penn State Univ, Dept Hlth Evaluat Sci, Hershey, PA USA; Natl Conference State Legislatures, Washington, DC USA; N Carolina Off Rural Hlth & Resource Dev, Raleigh, NC USA; Piedmont Hlth Serv Inc, Carrboro, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Pathman, DE (corresponding author), Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, CB7590, Chapel Hill, NC 27599 USA.		Konrad, Thomas R./AAT-9276-2020	Konrad, Thomas R/0000-0002-5269-0440; Pathman, Donald/0000-0002-6708-3707	AHRQ HHS [R01-HS09165] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS009165] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*ADV COUNC NAT HLT, 1989, PROP STRAT FULF PRIM; *ASS AM MED COLL, 1995, STAT OTH LOAN REP FO; AVERY CH, 1971, J AMER MED ASSOC, V218, P1194; Beran RL, 1998, JAMA-J AM MED ASSOC, V280, P819, DOI 10.1001/jama.280.9.819; CARPENTER ES, 1981, NATL COMPENDIUM NONF; *COUNC GRAD MED ED, 1999, 14 COUNC GRAD MED ED; DONOHOE E, 1990, ACAD MED, V65, pS92, DOI 10.1097/00001888-199012000-00038; *G WASH U, 1993, REV STAT LEG REL INC; GIBBENS B, 1994, PLACEMENT RETENTION; HELMS LB, 1991, ACAD MED, V66, P71, DOI 10.1097/00001888-199102000-00003; HENDERSO TM, 1994, STATE EFFORTS INCREA; HENDERSON TM, 1997, EVALUATIO STATE EFFO; HENDERSON TM, 1996, STATE INCENTIVES IMP; HUGHES RG, 1991, NEW ENGL J MED, V325, P404, DOI 10.1056/NEJM199108083250606; JOHNS MME, 1993, JAMA-J AM MED ASSOC, V269, P3156, DOI 10.1001/jama.269.24.3156; LEICHTER H, 1992, HLTH POLICY REFORM A; Marwick C, 2000, JAMA-J AM MED ASSOC, V283, P2641, DOI 10.1001/jama.283.20.2641; MCCLOSKEY AH, 1989, STATE INITIATIVES IM; Mullan F, 1999, HEALTH AFFAIR, V18, P168, DOI 10.1377/hlthaff.18.2.168; *NAT GOV ASS, 1989, RUR HLTH CAR POL STA; *NAT HLTH SERV COR, REP C YEARS 1990 199; *OFF DAT AN MAN, 1986, 287 BUR HLTH PROF; Pew Health Professions Commission, 1994, PRIM CAR WORKF 2000; REYNOLDS R, 1993, NY TIMES        0601, pA17; RIVO ML, 1995, AM J PUBLIC HEALTH, V85, P405, DOI 10.2105/AJPH.85.3.405; SIEGEL S, 1998, ACCESS PRIMARY CARE; Sparer MS, 1997, J HEALTH POLIT POLIC, V22, P789, DOI 10.1215/03616878-22-3-789; *SPEC COMM AG US S, 1988, RUR HLTH CAR CHALL, V100; STROSBERG MA, 1982, J MED EDUC, V57, P586; SWANSON AG, 1975, J MED EDUC, V50, P406; U.S.) C on GME, DHHSPUBL 1998 HRSA, V97, P53; *US C OFF TECHN AS, 1990, PUBL US C; *US C OFF TECHN AS, 1991, RUR AM CROSSR NETW F; *US GAO, 2000, PUBL US GAO; *US GAO IND HLTH S, 1994, PUBL US GAO; WEISSERT CS, 1994, J HEALTH POLIT POLIC, V19, P361, DOI 10.1215/03616878-19-2-361; WEISSERT CS, 1992, STATES ROLE REFORM H; WILLIAMS JL, 1980, SHORTTERM EVALUATION	38	60	61	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2084	2092		10.1001/jama.284.16.2084	http://dx.doi.org/10.1001/jama.284.16.2084			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	364QA	11042757				2022-12-28	WOS:000089902100029
J	Carr, A; Cooper, DA				Carr, A; Cooper, DA			Adverse effects of antiretroviral therapy	LANCET			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; HIV PROTEASE INHIBITORS; CHRONIC HEPATITIS-B; MITOCHONDRIAL TOXICITY; RISK-FACTORS; METABOLIC ABNORMALITIES; VIROLOGICAL FAILURE; INSULIN-RESISTANCE; NUCLEOSIDE-ANALOG; LACTIC-ACIDOSIS	Antiretroviral toxicity is an increasingly important issue in the management of HIV infected patients. With the sustained major declines in opportunistic complications, HIV infection is a more chronic disease, and so more drugs are being used in more patients for longer periods. This review focuses on the pathogenesis, clinical features, and management of the principal toxicities of the 15 licensed antiretroviral drugs, including mitochondrial toxicity, hypersensitivity, and lipodystrophy, as well as more drug-specific adverse effects and special clinical settings.	St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia; Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney; Kirby Institute	Carr, A (corresponding author), St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia.	acarr@stvincents.com.au						Altice FL, 1999, AIDS, V13, P957, DOI 10.1097/00002030-199905280-00012; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0; Boubaker K, 1998, AIDS, V12, pF249, DOI 10.1097/00002030-199818000-00003; Bouscarat F, 1998, NEW ENGL J MED, V338, P1776, DOI 10.1056/NEJM199806113382417; Bouscarat F, 1999, NEW ENGL J MED, V341, P618, DOI 10.1056/NEJM199908193410818; Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Brodie SB, 1998, AIDS, V12, P2433, DOI 10.1097/00002030-199818000-00012; CARR A, 1994, CLIN EXP IMMUNOL, V97, P260, DOI 10.1111/j.1365-2249.1994.tb06078.x; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1997, LANCET, V349, P995, DOI 10.1016/S0140-6736(05)62892-9; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; CARR A, 1996, AIDS CLIN REV 1995 1; CHEN CH, 1989, J BIOL CHEM, V264, P11934; Cihlar T, 1999, MOL PHARMACOL, V56, P570, DOI 10.1124/mol.56.3.570; COOPMAN SA, 1993, NEW ENGL J MED, V328, P1670, DOI 10.1056/NEJM199306103282304; DALAKAS MC, 1994, ANN NEUROL, V35, P482, DOI 10.1002/ana.410350418; DANNER SA, 1995, NEW ENGL J MED, V333, P1528, DOI 10.1056/NEJM199512073332303; Dube MP, 1997, LANCET, V350, P713, DOI 10.1016/S0140-6736(05)63513-1; DUBE MP, IN PRESS CLIN INFECT; FICHTENBAUM C, 2000, P 7 C RETR OPP INF S; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Flynn TE, 1999, ANN INTERN MED, V131, P548, DOI 10.7326/0003-4819-131-7-199910050-00032; Gervasoni C, 1999, AIDS, V13, P465, DOI 10.1097/00002030-199903110-00004; GRUNFELD C, 1999, P 6 C RETR OPP INF C; Henry K, 1998, LANCET, V351, P1328, DOI 10.1016/S0140-6736(05)79053-X; Henry K, 1998, LANCET, V352, P1031, DOI 10.1016/S0140-6736(98)00022-1; Ippolito Giuseppe, 1997, American Journal of Medicine, V102, P58, DOI 10.1016/S0002-9343(97)00064-8; LAI KK, 1991, ANN INTERN MED, V115, P283, DOI 10.7326/0003-4819-115-4-283; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Lenhard JM, 2000, BIOCHEM PHARMACOL, V59, P1063, DOI 10.1016/S0006-2952(00)00246-X; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; LORI F, 1999, AIDS, V13, P1443; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Markowitz M, 1998, J INFECT DIS, V177, P1533, DOI 10.1086/515312; MARKOWITZ M, 1995, NEW ENGL J MED, V333, P1534, DOI 10.1056/NEJM199512073332304; Martinez E, 1999, CLIN INFECT DIS, V29, P422, DOI 10.1086/520226; Martinez E, 1999, AIDS, V13, P805, DOI 10.1097/00002030-199905070-00009; Mauss S, 1999, ANN INTERN MED, V131, P313, DOI 10.7326/0003-4819-131-4-199908170-00024; MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702; MILLER J, IN PRESS AIDS; MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020; MONTANER J, 2000, P 13 WORLDS AIDS C J; Moyle GJ, 1998, DRUG SAFETY, V19, P481, DOI 10.2165/00002018-199819060-00005; PETERSON PL, 1995, BBA-MOL BASIS DIS, V1271, P275, DOI 10.1016/0925-4439(95)00039-7; Pollmann H, 1998, THROMB HAEMOSTASIS, V79, P1213; Ponce-de-Leon S, 1999, LANCET, V353, P1244, DOI 10.1016/S0140-6736(99)01172-1; Race EM, 1998, LANCET, V351, P252, DOI 10.1016/S0140-6736(97)04352-3; ROCHSTER H, 1990, ANN INTERN MED, V113, P111; Roubenoff R, 1999, AIDS, V13, P1373, DOI 10.1097/00002030-199907300-00015; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; Rutschmann OT, 1998, AIDS, V12, pF71, DOI 10.1097/00002030-199808000-00003; Saint-Marc T, 1999, AIDS, V13, P1659, DOI 10.1097/00002030-199909100-00009; Saint-Marc T, 1999, AIDS, V13, P2188, DOI 10.1097/00002030-199910220-00035; SCHINDZIELORZ A, 1994, CLIN INFECT DIS, V19, P1076, DOI 10.1093/clinids/19.6.1076; Sperling RS, 1998, AIDS, V12, P1805, DOI 10.1097/00002030-199814000-00012; Stanworth SJ, 1998, HAEMOPHILIA, V4, P109; van Heeswijk RPG, 1999, AIDS, V13, pF95, DOI 10.1097/00002030-199910010-00001; Vandercam B, 1998, INFECTION, V26, P313, DOI 10.1007/BF02962257; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Zhang B, 1999, J CLIN ENDOCR METAB, V84, P4274, DOI 10.1210/jc.84.11.4274	66	762	790	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2000	356	9239					1423	1430		10.1016/S0140-6736(00)02854-3	http://dx.doi.org/10.1016/S0140-6736(00)02854-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052597				2022-12-28	WOS:000089976100042
J	van Haastregt, JCM; Diederiks, JPM; van Rossum, E; de Witte, LP; Voorhoeve, PM; Crebolder, HFJM				van Haastregt, JCM; Diederiks, JPM; van Rossum, E; de Witte, LP; Voorhoeve, PM; Crebolder, HFJM			Effects of a programme of multifactorial home visits on falls and mobility impairments in elderly people at risk: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SICKNESS IMPACT PROFILE; SHORT GENERIC VERSION; ACTIVITIES INDEX; STROKE PATIENTS; OLDER ADULTS; COMMUNITY; POPULATION	Objective To evaluate whether a programme of multifactorial home visits reduces falls and impairments in mobility in elderly people living in the community. Design Randomised controlled trial with 18 months of follow up. Setting Six general practices in Hoensbroek, the Netherlands. Participants 316 people aged 70 and over living in the community, with moderate impairments in mobility or a history of recent falls. Intervention Five home visits by a community nurse over a period of one year. Visits consisted of screening for medical, environmental, and behavioural factors causing falls and impairments in mobility, followed by specific advice, referrals, and other actions aimed at dealing with the observed hazards. Main outcome measures Falls and impairments in mobility. Results No differences were found in falls and mobility outcomes between the intervention and usual care groups. Conclusion Multifactorial home visits had no effects on falls and impairments in mobility in elderly people at risk who were living in the community. Because falls and impairments in mobility remain a serious problem among elderly people, alternative strategies should be developed and evaluated.	Inst Rehabil Res, Div Res, NL-6430 AD Hoensbroek, Netherlands; Maastricht Univ, Dept Med Sociol, NL-6200 MD Maastricht, Netherlands; Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands; Maastricht Univ, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; Primary Care Hlth Ctr, NL-6431 HN Hoensbroek, Netherlands	Maastricht University; Maastricht University; Maastricht University	van Haastregt, JCM (corresponding author), Inst Rehabil Res, Div Res, POB 192, NL-6430 AD Hoensbroek, Netherlands.	jolanda.vanhaastregt@irv.nl	De+Witte, Luc/AAI-3518-2020	De+Witte, Luc/0000-0002-3013-2640				BUCHNER DM, 1993, J AM GERIATR SOC, V41, P297, DOI 10.1111/j.1532-5415.1993.tb06708.x; CUNHA UV, 1988, GERIATRICS, V43, P33; DEBRUIN AF, 1994, J CLIN EPIDEMIOL, V47, P863, DOI 10.1016/0895-4356(94)90189-9; DEBRUIN AF, 1994, J CLIN EPIDEMIOL, V47, P407, DOI 10.1016/0895-4356(94)90162-7; Donald CA, 1978, CONCEPTUALIZATION ME, VIV; FABACHER D, 1994, J AM GERIATR SOC, V42, P630, DOI 10.1111/j.1532-5415.1994.tb06862.x; GILLESPIE LD, 1997, COCHRANE LIB, V4, P1; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; Lundgren-Lindquist B, 1990, Int Disabil Stud, V12, P1; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; Pocock SJ., 1983, CLIN TRIALS PRACTICA; RUBENSTEIN LZ, 1990, ANN INTERN MED, V113, P308, DOI 10.7326/0003-4819-113-4-308; SATTIN RW, 1992, ANNU REV PUBL HEALTH, V13, P489, DOI 10.1146/annurev.pu.13.050192.002421; SCHIRICKE K, 1993, THESIS I REHABILITAT; SCHULING J, 1993, STROKE, V24, P1173, DOI 10.1161/01.STR.24.8.1173; *Stalenhoef P., 1998, EUR J GEN PRACT, V4, P114, DOI [10. 3109/13814789809160362, DOI 10.3109/13814789809160362]; Stalenhoef PA, 1997, EUR J PUBLIC HEALTH, V7, P328, DOI 10.1093/eurpub/7.3.328; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; van Haastregt JCM, 2000, BMJ-BRIT MED J, V320, P754, DOI 10.1136/bmj.320.7237.754; VANDERZEE I, 1993, METEN ALGEMENE GEZON; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800; WICKHAM C, 1989, AGE AGEING, V18, P47, DOI 10.1093/ageing/18.1.47; 1992, RAND HLTH SCI PROGRA	24	111	112	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2000	321	7267					994	998		10.1136/bmj.321.7267.994	http://dx.doi.org/10.1136/bmj.321.7267.994			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	366ZF	11039967	Green Published, Bronze			2022-12-28	WOS:000090035600027
J	Cheung, P; Allis, CD; Sassone-Corsi, P				Cheung, P; Allis, CD; Sassone-Corsi, P			Signaling to chromatin through histone modifications	CELL			English	Review							MITOTIC CHROMOSOME CONDENSATION; EARLY GENE INDUCTION; SILENT MATING LOCI; PROTEIN-KINASE; N-TERMINUS; TRANSCRIPTION FACTOR; PHOSPHORYLATION; H3; NUCLEOSOME; YEAST		Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Biol, Charlottesville, VA 22908 USA; ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France	University of Virginia; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Allis, CD (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Biol, Box 800733, Charlottesville, VA 22908 USA.	allis@virginia.edu; paolosc@igbmc.u-strasbg.fr	Sassone-Corsi, Paolo/H-6182-2011; Tatchell, Kelly/A-9643-2009					Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439; Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Arenhovel H., 1991, Few-Body Systems Supplementum, P1, DOI 10.1007/978-3-7091-6701-4_1; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; BARRATT MJ, 1994, P NATL ACAD SCI USA, V91, P4781, DOI 10.1073/pnas.91.11.4781; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; De Cesare D, 1999, TRENDS BIOCHEM SCI, V24, P281, DOI 10.1016/S0968-0004(99)01414-0; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; De Souza CPC, 2000, CELL, V102, P293, DOI 10.1016/S0092-8674(00)00035-0; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dou YL, 2000, MOL CELL, V6, P225, DOI 10.1016/S1097-2765(00)00024-1; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Georgel PT, 1997, EMBO J, V16, P4717, DOI 10.1093/emboj/16.15.4717; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Helps NR, 2000, BIOCHEM J, V349, P509, DOI 10.1042/0264-6021:3490509; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Lee JH, 2000, BIOCHEM BIOPH RES CO, V274, P105, DOI 10.1006/bbrc.2000.3049; Lee KM, 1999, BIOCHEMISTRY-US, V38, P8423, DOI 10.1021/bi990090o; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Ma XJ, 1996, GENE DEV, V10, P1327, DOI 10.1101/gad.10.11.1327; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; Ornaghi P, 1999, J MOL BIOL, V287, P1, DOI 10.1006/jmbi.1999.2577; OSMANI SA, 1988, CELL, V53, P237, DOI 10.1016/0092-8674(88)90385-6; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; PANTAZIS P, 1984, MOL CELL BIOL, V4, P1186, DOI 10.1128/MCB.4.6.1186; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reed JC, 2000, CELL, V102, P545, DOI 10.1016/S0092-8674(00)00076-3; RICHMOND TJ, 1993, COLD SPRING HARB SYM, V58, P265, DOI 10.1101/SQB.1993.058.01.031; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossignol M, 1999, J BIOL CHEM, V274, P22387, DOI 10.1074/jbc.274.32.22387; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Smith MM, 1991, CURR OPIN CELL BIOL, V3, P429, DOI 10.1016/0955-0674(91)90070-F; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Van Holde KE., 1988, SPRINGER SERIES MOL, P111; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; WHITLOCK JP, 1977, J BIOL CHEM, V252, P6516; Winston F, 1999, NAT STRUCT BIOL, V6, P601, DOI 10.1038/10640; WOLFFE AP, 1998, CHROAMTIN STRUCTURE; YE XS, 1995, EMBO J, V14, P986, DOI 10.1002/j.1460-2075.1995.tb07079.x	76	788	819	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 13	2000	103	2					263	271		10.1016/S0092-8674(00)00118-5	http://dx.doi.org/10.1016/S0092-8674(00)00118-5			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057899	Bronze			2022-12-28	WOS:000089864300010
J	Vinge, V				Vinge, V			Win a Nobel prize!	NATURE			English	Editorial Material									San Diego State Univ, San Diego, CA 92182 USA	California State University System; San Diego State University	Vinge, V (corresponding author), San Diego State Univ, San Diego, CA 92182 USA.								0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					679	679		10.1038/35037684	http://dx.doi.org/10.1038/35037684			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048698	Bronze			2022-12-28	WOS:000089773900019
J	Laval, B; Cady, SL; Pollack, JC; McKay, CP; Bird, JS; Grotzinger, JP; Ford, DC; Bohm, HR				Laval, B; Cady, SL; Pollack, JC; McKay, CP; Bird, JS; Grotzinger, JP; Ford, DC; Bohm, HR			Modern freshwater microbialite analogues for ancient dendritic reef structures	NATURE			English	Article							LAKE WATER; PRECIPITATION; ALGAE	Microbialites are organosedimentary structures that can be constructed by a variety of metabolically distinct taxa(1). Consequently, microbialite structures abound in the fossil record, although the exact nature of the biogeochemical processes that produced them is often unknown(2). One such class of ancient calcareous structures(3-5), Epiphyton and Girvanella, appear in great abundance during the Early Cambrian. Together with Archeocyathids, stromatolites and thrombolites, they formed major Cambrian reef belts. To a large extent, Middle to Late Cambrian reefs are similar to Precambrian reefs(6), with the exception that the latter, including terminal Proterozoic reefs(7), do not contain Epiphyton or Girvanella. Here we report the discovery in Pavilion Lake, British Columbia, Canada, of a distinctive assemblage of freshwater calcite microbialites, some of which display microstructures similar to the fabrics displayed by Epiphyton and Girvanella. The morphologies of the modern microbialites vary with depth, and dendritic microstructures of the deep water (>30 m) mounds indicate that they may be modern analogues for the ancient calcareous structures. These microbialites thus provide an opportunity to study the biogeochemical interactions that produce fabrics similar to those of some enigmatic Early Cambrian reef structures.	Simon Fraser Univ, Sch Engn Sci, Burnaby, BC V5A 1S6, Canada; Portland State Univ, Dept Geol, Portland, OR 97201 USA; Forest Sci, Nelson Forest Reg, Nelson, BC V1L 4C6, Canada; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; MIT, Cambridge, MA 02139 USA; McMaster Univ, Hamilton, ON L8S 4KL, Canada	Simon Fraser University; Portland State University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Massachusetts Institute of Technology (MIT); McMaster University	Cady, SL (corresponding author), Simon Fraser Univ, Sch Engn Sci, Burnaby, BC V5A 1S6, Canada.		Laval, Bernard E/J-9861-2012	Laval, Bernard/0000-0002-4810-9246				AHR WM, 1971, J SEDIMENT PETROL, V41, P205; BERTRANDSARFATI J, 1985, PRECAMBRIAN RES, V29, P207, DOI 10.1016/0301-9268(85)90069-5; BISCHOFF JL, 1993, GEOCHIM COSMOCHIM AC, V57, P3855, DOI 10.1016/0016-7037(93)90339-X; BURNE R V, 1987, Palaios, V2, P241, DOI 10.2307/3514674; CHAFETZ H S, 1992, Palaios, V7, P277, DOI 10.2307/3514973; EDWARDS RL, 1986, EARTH PLANET SC LETT, V81, P175; Eggleston JR, 1976, STROMATOLITES, P479; Ferris FG, 1997, PALAIOS, V12, P213, DOI 10.2307/3515423; FISCHL P, 1992, 1992 18 BRIT COL MIN; Grotzinger J.P., 1989, SOC EC PALEONTOLOGIS, V44, P79, DOI DOI 10.2110/PEC; GROTZINGER JP, 1995, C P, V27; HALLEY RB, 1976, STROMATOLITES, P435; JAMES NP, 1981, GEOL SOC AM BULL, V92, P799, DOI 10.1130/0016-7606(1981)92<799:MOCAIT>2.0.CO;2; Lauritzen SE, 1999, HOLOCENE, V9, P659, DOI 10.1191/095968399667823929; PRATT BR, 1984, J SEDIMENT PETROL, V54, P948; READ JF, 1983, J SEDIMENT PETROL, V53, P761; Riding R, 1991, CALCAREOUS ALGAE STR, P55, DOI [DOI 10.1007/978-3-642-52335-9_3, 10.1007/978-3-642-52335-9_3, DOI 10.1007/978-3-642-52335-9]; THOMPSON J B, 1990, Palaios, V5, P52, DOI 10.2307/3514996; THOMPSON JB, 1990, GEOLOGY, V18, P995, DOI 10.1130/0091-7613(1990)018<0995:CPOGCA>2.3.CO;2; Thompson JB, 1997, LIMNOL OCEANOGR, V42, P133; WALTER MR, 1972, SPEC PAP PALAEONTOL, V11, P103; Wray J. L., 1977, CALCAREOUS ALGAE, V4	22	108	121	1	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					626	629		10.1038/35036579	http://dx.doi.org/10.1038/35036579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034210				2022-12-28	WOS:000089772800046
J	Rauchhaus, M; Coats, AJS; Anker, SD				Rauchhaus, M; Coats, AJS; Anker, SD			The endotoxin-lipoprotein hypothesis	LANCET			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; HIGH-DENSITY-LIPOPROTEIN; SERUM-CHOLESTEROL LEVELS; CORONARY HEART-DISEASE; NECROSIS-FACTOR-ALPHA; FAILURE; MORTALITY; PROTECTION; PREVENTION; EXPRESSION	The advent of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) has revolutionised the treatment of hypercholesterolaemia. Statin treatment, by lowering the atherogenic lipoprotein profile, reduces morbidity and mortality in patients with cardiovascular disease. Treatment with simvastatin causes a reduction of events of new-onset heart failure, but this may be attributable to properties other than its lipid-lowering effects. There is some evidence that lower serum cholesterol concentrations las a surrogate for the totality of lipoproteins) relate to impaired survival in patients with chronic heart failure (CHF). Inflammation is a feature in patients with Ci IF and increased lipopolysaccharide may contribute substantially. We postulate that higher concentrations of total cholesterol are beneficial in these patients. This is potentially attributable to the property of lipoproteins to bind lipopolysaccharide, thereby preventing its detrimental effects. We hypothesise there is an optimum lipoprotein concentration below which lipid reduction would, on balance, be detrimental. We also propose that, in patients with CHF, a non-lipid-lowering statin (with ancillary properties such as immune modulatory and anti-inflammatory actions) could be as effective or even more beneficial than a lipid-lowering statin.	Natl Heart & Lung Inst, Dept Clin Cardiol, London SW3 6LY, England; Univ Halle Wittenberg, Klin Innere Med Kardiol 3, Halle, Germany; Max Delbruck Ctr Mol Med, Charite, Franz Volhard Klin, Berlin, Germany	Imperial College London; Martin Luther University Halle Wittenberg; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rauchhaus, M (corresponding author), Natl Heart & Lung Inst, Dept Clin Cardiol, Dovehouse St, London SW3 6LY, England.	m.rauchhaus@ic.ac.uk	Coats, Andrew J Stewart/E-4451-2012	Coats, Andrew J Stewart/0000-0002-2771-4260				Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Boren J, 1998, J CLIN INVEST, V101, P1197, DOI 10.1172/JCI1785; FEINGOLD KR, 1995, INFECT IMMUN, V63, P2041, DOI 10.1128/IAI.63.5.2041-2046.1995; FLEGEL WA, 1993, INFECT IMMUN, V61, P5140, DOI 10.1128/IAI.61.12.5140-5146.1993; FORETTE B, 1989, LANCET, V1, P868; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Gordon BR, 1996, CRIT CARE MED, V24, P584, DOI 10.1097/00003246-199604000-00006; HARRIS HW, 1990, J CLIN INVEST, V86, P696, DOI 10.1172/JCI114765; HUBSCH AP, 1995, J LAB CLIN MED, V126, P548; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; Kjekshus J, 1997, J Card Fail, V3, P249, DOI 10.1016/S1071-9164(97)90022-1; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; Lequier LL, 2000, CHEST, V117, P1706, DOI 10.1378/chest.117.6.1706; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; MATSUMORI A, 1994, CIRCULATION, V89, P955, DOI 10.1161/01.CIR.89.3.955; Netea MG, 1998, INFECT IMMUN, V66, P2365, DOI 10.1128/IAI.66.5.2365-2367.1998; Netea MG, 1996, J CLIN INVEST, V97, P1366, DOI 10.1172/JCI118556; Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; READ TE, 1995, J EXP MED, V182, P267, DOI 10.1084/jem.182.1.267; Richartz BM, 1998, CARDIOLOGY, V89, P184, DOI 10.1159/000006785; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; SEGAL R, 2000, EUR J HEART FAIL S2, V2, P96; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shimokawa H, 1998, AM HEART J, V136, P991, DOI 10.1016/S0002-8703(98)70155-3; Vaughan CJ, 1996, LANCET, V348, P1079, DOI 10.1016/S0140-6736(96)05190-2; Vonhof S, 1998, INT J CARDIOL, V63, P237, DOI 10.1016/S0167-5273(97)00332-X; Vredevoe DL, 1998, AM J CARDIOL, V82, P323, DOI 10.1016/S0002-9149(98)00334-8; Wagner DR, 1998, CIRC RES, V82, P47; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025	31	418	434	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2000	356	9233					930	933		10.1016/S0140-6736(00)02690-8	http://dx.doi.org/10.1016/S0140-6736(00)02690-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036910				2022-12-28	WOS:000089259800039
J	Hobbs, FDR				Hobbs, FDR			ABC of colorectal cancer - The role of primary care	BRITISH MEDICAL JOURNAL			English	Review							CARCINOMA; SYMPTOMS		Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Hobbs, FDR (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.			hobbs, richard/0000-0001-7976-7172				Carter S, 1998, INT J COLORECTAL DIS, V13, P27, DOI 10.1007/s003840050127; CROSLAND A, 1995, BRIT MED J, V311, P486, DOI 10.1136/bmj.311.7003.486; CURLESS R, 1994, GUT, V35, P1267, DOI 10.1136/gut.35.9.1267; FIJTEN GH, 1995, FAM PRACT, V12, P279, DOI 10.1093/fampra/12.3.279; HOBBS FDR, 1992, BRIT MED J, V304, P483, DOI 10.1136/bmj.304.6825.483; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Spurgeon P, 2000, BRIT MED J, V320, P838, DOI 10.1136/bmj.320.7238.838; STJOHN DJB, 1993, ANN INTERN MED, V118, P785, DOI 10.7326/0003-4819-118-10-199305150-00005	9	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 28	2000	321	7268					1068	1070		10.1136/bmj.321.7268.1068	http://dx.doi.org/10.1136/bmj.321.7268.1068			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PU	11053184	Green Published			2022-12-28	WOS:000165076800030
J	Small, R; Lumly, J; Donohue, L; Potter, A; Waldenstrom, U				Small, R; Lumly, J; Donohue, L; Potter, A; Waldenstrom, U			Randomised controlled trial of midwife led debriefing to reduce maternal depression after operative childbirth	BRITISH MEDICAL JOURNAL			English	Article							POSTNATAL DEPRESSION; CESAREAN DELIVERY; VICTIMS; HEALTH; MORBIDITY; TRAUMA	Objective To assess die effectiveness of a midwife led debriefing session during the postpartum hospital stay in reducing the prevalence of maternal depression at six months postpartum among women giving birth by caesarean section, forceps, or vacuum extraction. Design Randomised controlled trial. Setting Large maternity teaching hospital in Melbourne, Australia. Participants 1041 women who had given birth by caesarean section (n=624) or with the use of forceps (n=353) or vacuum extraction (n=64). Main outcome measures Maternal depression (score greater than or equal to 13 on the Edinburgh postnatal depression scale) and overall health status (comparison of mean scores on SF-36 subscales) measured by postal questionnaire at six months postpartum. Results 917 (88%) of the women recruited responded to the outcome questionnaire. More women allocated to debriefing scored as depressed six months after birth than women allocated to usual postpartum care (81 (17%) v 65 (14%)), although this difference was not significant (odds ratio = 1.24, 95% confidence interval 0.87 to 1.77). They were also more likely to report that depression had been a problem for them since the birth, but the difference was not significant (123 (28%) v 94 (22%); odds ratio = 1.37, 1.00 to 1.86). Women allocated to debriefing had poorer health status on seven of the eight SF-36 subscales, although the difference was significant only for role functioning (emotional): mean scores 73.32 v 78.98, t= - 2.31, 95% confidence interval - 10.48 to - 0.84). Conclusions Midwife led debriefing after operative birth is ineffective in reducing maternal morbidity at six months postpartum. The possibility that debriefing contributed to emotional health problems for some women cannot be excluded.	La Trobe Univ, Sch Publ Hlth, Ctr Study Mothers & Childrens Hlth, Carlton, Vic 3053, Australia; La Trobe Univ, Sch Nursing, Grad Clin Sch Midwifery & Womens Hlth, Carlton, Vic 3053, Australia; Karolinska Inst, Dept Nursing, S-17177 Stockholm, Sweden	La Trobe University; La Trobe University; Karolinska Institutet	Small, R (corresponding author), La Trobe Univ, Sch Publ Hlth, Ctr Study Mothers & Childrens Hlth, Carlton, Vic 3053, Australia.		Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X; Small, Rhonda/0000-0003-0345-4676				ASTBURY J, 1994, AUST J PUBLIC HEALTH, V18, P176; BISSON JI, 1994, BRIT J PSYCHIAT, V165, P717, DOI 10.1192/bjp.165.6.717; Bisson JI, 1997, BRIT J PSYCHIAT, V171, P78, DOI 10.1192/bjp.171.1.78; Brown S, 1998, BRIT J OBSTET GYNAEC, V105, P156, DOI 10.1111/j.1471-0528.1998.tb10045.x; BROWN S, 1994, MISSING VOICES EXPER, P101; Conlon L, 1999, J PSYCHOSOM RES, V46, P37, DOI 10.1016/S0022-3999(98)00068-3; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; ELLIOT S, 1984, J REPROD INFANT PSYC, V2, P18; FISHER JRW, 1990, J PSYCHOSOM OBST GYN, V11, P91, DOI 10.3109/01674829009084406; HAGAN R, 1999, P 3 ANN C PER SOC AU, P95; HILLAN EM, 1992, BIRTH-ISS PERINAT C, V19, P190, DOI 10.1111/j.1523-536X.1992.tb00401.x; Hobbs M, 1996, BRIT MED J, V313, P1438, DOI 10.1136/bmj.313.7070.1438; Lavender T, 1998, BIRTH-ISS PERINAT C, V25, P215, DOI 10.1046/j.1523-536X.1998.00215.x; Lee C, 1996, BRIT J MED PSYCHOL, V69, P47, DOI 10.1111/j.2044-8341.1996.tb01849.x; MACARTHUR C, 1991, BRIT J OBSTET GYNAEC, V98, P1193, DOI 10.1111/j.1471-0528.1991.tb15386.x; NOTT PN, 1987, BRIT J PSYCHIAT, V151, P523, DOI 10.1192/bjp.151.4.523; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Ralph K, 1994, Nurs Times, V90, P28; RAPHAEL B, 1995, BRIT MED J, V310, P1479, DOI 10.1136/bmj.310.6993.1479; *SPSS, 1998, SPSS WIND VERS 9 0; *STAT CORP, 1999, STAT STAT SOFTW; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wessely S, 1998, BIRTH-ISS PERINAT C, V25, P220, DOI 10.1046/j.1523-536X.1998.00220.x; WESSELY S, 1999, COCHRANE COLLABORATI	24	119	121	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 28	2000	321	7268					1043	1047		10.1136/bmj.321.7268.1043	http://dx.doi.org/10.1136/bmj.321.7268.1043			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	369PU	11053173	Green Published, Bronze			2022-12-28	WOS:000165076800022
J	Andrew, P; Barnes, WL				Andrew, P; Barnes, WL			Forster energy transfer in an optical microcavity	SCIENCE			English	Article							DIPOLE-DIPOLE INTERACTION; SPONTANEOUS EMISSION; LIGHT	By studying the transfer of excitation energy between dye molecules confined within an optical microcavity, we demonstrate experimentally that Forster energy transfer is influenced by the Local photonic mode density. Locating donor and acceptor molecules at well-defined positions allows the transfer rate to be determined as a function of both mutual separation and cavity Length. The results show that the Forster transfer rate depends Linearly on the donor emission rate and hence photonic mode density, providing the potential to control energy transfer by modification of the optical environment.	Univ Exeter, Sch Phys, Thin Film Photon Grp, Exeter EX4 4QL, Devon, England	University of Exeter	Andrew, P (corresponding author), Univ Exeter, Sch Phys, Thin Film Photon Grp, Exeter EX4 4QL, Devon, England.		Barnes, William L/J-7111-2013; Andrew, Piers/F-8188-2013	Barnes, William L/0000-0002-9474-5534; Andrew, Piers/0000-0001-5601-5322				Agarwal GS, 1998, PHYS REV A, V57, P667, DOI 10.1103/PhysRevA.57.667; ANDREWS DL, 1989, CHEM PHYS, V135, P195, DOI 10.1016/0301-0104(89)87019-3; Baldo MA, 2000, NATURE, V403, P750, DOI 10.1038/35001541; Berggren M, 1997, APPL PHYS LETT, V71, P2230, DOI 10.1063/1.120065; BERMAN PR, 1994, ADV ATOMIC MOL OPT S, V2; Dodabalapur A, 1996, J APPL PHYS, V80, P6954, DOI 10.1063/1.363768; Drexhage K. H., 1974, PROGR OPTICS, V12, P163, DOI DOI 10.1016/S0079-6638(08)70266-X; Fermi E, 1932, REV MOD PHYS, V4, P0087, DOI 10.1103/RevModPhys.4.87; FOLAN LM, 1985, CHEM PHYS LETT, V118, P322, DOI 10.1016/0009-2614(85)85324-0; FORSTER T, 1959, DISCUSS FARADAY SOC, P7; Gerard JM, 1998, PHYS REV LETT, V81, P1110, DOI 10.1103/PhysRevLett.81.1110; Herek JL, 2000, BIOPHYS J, V78, P2590, DOI 10.1016/S0006-3495(00)76803-2; Hopmeier M, 1999, PHYS REV LETT, V82, P4118, DOI 10.1103/PhysRevLett.82.4118; JOHN S, 1991, PHYS REV B, V43, P12772, DOI 10.1103/PhysRevB.43.12772; KOBAYASHI T, 1995, PHYS REV A, V52, P2835, DOI 10.1103/PhysRevA.52.2835; Kuhn H., 1972, PHYSICAL TECHNIQU 3B, V1, P577; KURIZKI G, 1988, PHYS REV LETT, V61, P2269, DOI 10.1103/PhysRevLett.61.2269; Kurizki G, 1996, PHYS REV A, V53, pR35, DOI 10.1103/PhysRevA.53.R35; Lidzey DG, 2000, SCIENCE, V288, P1620, DOI 10.1126/science.288.5471.1620; Oppenheimer J. R., 1941, PHYS REV, V60, P158; Salt MG, 1999, OPT COMMUN, V166, P151, DOI 10.1016/S0030-4018(99)00248-5; Scherer A, 1999, J LIGHTWAVE TECHNOL, V17, P1928, DOI 10.1109/JLT.1999.1673018; VANGRONDELLE R, 1994, BBA-BIOENERGETICS, V1187, P1, DOI 10.1016/0005-2728(94)90166-X; Worthing PT, 1999, PHYS REV A, V59, P865, DOI 10.1103/PhysRevA.59.865	24	261	263	5	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					785	788		10.1126/science.290.5492.785	http://dx.doi.org/10.1126/science.290.5492.785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052938				2022-12-28	WOS:000090067600043
J	Borde, V; Goldman, ASH; Lichten, M				Borde, V; Goldman, ASH; Lichten, M			Direct coupling between meiotic DNA replication and recombination initiation	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; YEAST CHROMOSOME-III; SACCHAROMYCES-CEREVISIAE; MEIOSIS; MRE11; TIME; ACTIVATION; MUTATIONS; CHROMATIN; ORIGINS	During meiosis in Saccharomyces cerevisiae, DNA replication occurs 1.5 to 2 hours before recombination initiates by DNA double-strand break formation. We show that replication and recombination initiation are directly linked. Blocking meiotic replication prevented double-strand break formation in a replication-checkpoint-independent manner, and delaying replication of a chromosome segment specifically delayed break formation in that segment. Consequently, the time between replication and break formation was held constant in all regions. We suggest that double-strand break formation occurs as part of a process initiated by DNA replication, which thus determines when meiotic recombination initiates on a regional rather than a cell-wide basis.	NCI, Div Basic Sci, Biochem Lab, Bethesda, MD 20892 USA; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Sheffield	Lichten, M (corresponding author), NCI, Div Basic Sci, Biochem Lab, Bethesda, MD 20892 USA.		Lichten, Michael/C-5795-2013; Borde, Valerie/G-5228-2012	Lichten, Michael/0000-0001-9707-2956; Goldman, Alastair/0000-0002-0516-3197	NATIONAL CANCER INSTITUTE [ZIABC005268, Z01BC005268] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; BORDE V, UNPUB; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BUDD ME, 1989, MOL CELL BIOL, V9, P365, DOI 10.1128/MCB.9.2.365; Cha RS, 2000, GENE DEV, V14, P493; COLLINS I, 1994, MOL CELL BIOL, V14, P3524, DOI 10.1128/MCB.14.5.3524; COLLINS I, 1994, CELL, V76, P65, DOI 10.1016/0092-8674(94)90173-2; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; JOHNSTON LH, 1982, EXP CELL RES, V141, P53, DOI 10.1016/0014-4827(82)90067-2; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Ohta K, 1998, P NATL ACAD SCI USA, V95, P646, DOI 10.1073/pnas.95.2.646; REYNOLDS AE, 1989, MOL CELL BIOL, V9, P4488, DOI 10.1128/MCB.9.10.4488; Rocco V, 1996, GENES CELLS, V1, P645, DOI 10.1046/j.1365-2443.1996.00256.x; Rothstein R, 2000, GENE DEV, V14, P1; SCHILD D, 1978, CHROMOSOMA, V70, P109, DOI 10.1007/BF00292220; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SIMCHEN G, 1976, MOL GEN GENET, V144, P21, DOI 10.1007/BF00277299; SMITH K, COMMUNICATION; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x	25	192	199	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					806	809		10.1126/science.290.5492.806	http://dx.doi.org/10.1126/science.290.5492.806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052944				2022-12-28	WOS:000090067600049
J	Finney, BP; Gregory-Eaves, I; Sweetman, J; Dougas, MSV; Smol, JP				Finney, BP; Gregory-Eaves, I; Sweetman, J; Dougas, MSV; Smol, JP			Impacts of climatic change and fishing on Pacific salmon abundance over the past 300 years	SCIENCE			English	Article							BRITISH-COLUMBIA; LAKES; SEA	The effects of climate variability on Pacific salmon abundance are uncertain because historical records are short and are complicated by commercial harvesting and habitat alteration. We use Lake sediment records of delta N-15 and biological indicators to reconstruct sockeye salmon abundance in the Bristol Bay and Kodiak Island regions of Alaska over the past 300 years. Marked shifts in populations occurred over decades during this period, and some pronounced changes appear to be related to climatic change. Variations in salmon returns due to climate or harvesting can have strong impacts on sockeye nursery Lake productivity in systems where adult salmon carcasses are important nutrient sources.	Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK 99775 USA; Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; Univ Toronto, Dept Geol, Toronto, ON M5S 3B1, Canada	University of Alaska System; University of Alaska Fairbanks; Queens University - Canada; University of Toronto	Finney, BP (corresponding author), Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK 99775 USA.		Smol, John P/A-8838-2015; Sweetman, Jon/A-6457-2011; Gregory-Eaves, Irene/U-9325-2019	Gregory-Eaves, Irene/0000-0002-0380-5061; Sweetman, Jon/0000-0002-9849-7355; Smol, John/0000-0002-2499-6696				ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; Anderson NJ, 1997, EUR J PHYCOL, V32, P35; [Anonymous], 1986, HDB HOLOCENE PALAEOE; BEAMISH RJ, 1993, CAN J FISH AQUAT SCI, V50, P1002, DOI 10.1139/f93-116; BELCHER JH, 1966, J ECOL, V54, P335, DOI 10.2307/2257952; Ben-David M, 1998, OIKOS, V83, P47, DOI 10.2307/3546545; BILBY RE, 1996, CAN J FISH AQUAT SCI, V53, P163; BRADBURY J P, 1988, Journal of Paleolimnology, V1, P115; Burgner R.L., 1991, P1; D'Arrigo R, 1999, GEOPHYS RES LETT, V26, P2757, DOI 10.1029/1999GL900504; ENNIS GL, 1983, CAN J BOT, V61, P1983, DOI 10.1139/b83-214; FINNEY BP, 1998, PAC ANADROMOUS FISH, V1, P388; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; Gregory-Eaves I, 1999, ARCT ANTARCT ALP RES, V31, P353, DOI 10.2307/1552584; Hall Roland I., 1999, P128; Haworth E.Y., 1986, P 8 INT DIAT S, P43; KLINE TC, 1993, CAN J FISH AQUAT SCI, V50, P2350, DOI 10.1139/f93-259; Koenings J.P., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P419; Kyle GB, 1997, FRESHWATERS ALASKA E, P205; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; PENNINGTON WINIFRED, 1961, HYDROBIOLOGIA, V17, P183, DOI 10.1007/BF00040420; REAVIE ED, 1995, J PALEOLIMNOL, V14, P49, DOI 10.1007/BF00682593; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Roppel P, 1986, SALMON KODIAK HIST S; Schmidt D.C., 1997, DEV SUSTAINING WORLD, P687; TALBOT MR, 1992, EARTH PLANET SC LETT, V110, P23, DOI 10.1016/0012-821X(92)90036-U; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; VENIAMINOV I, 1984, NOTES ISLANDS UNALAS, P39; Welch DW, 1998, CAN J FISH AQUAT SCI, V55, P937, DOI 10.1139/cjfas-55-4-937; WILES GC, 1996, CAN J FOREST RES, V26, P31; Wunsam S., 1995, MEMORIE I ITALIANO I, V53, P85	32	261	274	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					795	799		10.1126/science.290.5492.795	http://dx.doi.org/10.1126/science.290.5492.795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052941				2022-12-28	WOS:000090067600046
J	Prehoda, KE; Scott, JA; Mullins, RD; Lim, WA				Prehoda, KE; Scott, JA; Mullins, RD; Lim, WA			Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex	SCIENCE			English	Article							ACTIN-DEPOLYMERIZING PROTEIN; ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; N-WASP; PHOSPHOINOSITIDE BINDING; CYTOSKELETON; NUCLEATION; MOTILITY; DOMAINS; CDC42	The protein N-WASP [a homolog to the Wiskott-Aldrich syndrome protein (WASP)I regulates actin polymerization by stimulating the actin-nucleating activity of the actin-related protein 2/3 (Arp2/3) complex. N-WASP is tightly regulated by multiple signals: Only costimulation by Cdc42 and phosphatidylinositol (4,5)-bisphosphate (PIP2) yields potent polymerization. We found that regulation requires N-WASP's constitutively active output domain (VCA) and two regulatory domains: a Cdc42-binding domain and a previously undescribed PIP2-binding domain. In the absence of stimuli, the regulatory modules together hold the VCA-Arp2/3 complex in an inactive "closed" conformation. In this state, both the Cdc42- and PIP2-binding sites are masked. Binding of either input destabilizes the closed state and enhances binding of the other input. This cooperative activation mechanism shows how combinations of simple binding domains can be used to integrate and amplify coincident signals.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prehoda, KE (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.			Prehoda, Ken/0000-0003-4214-6158				BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Carlier MF, 1999, CHEM BIOL, V6, pR235, DOI 10.1016/S1074-5521(99)80107-0; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Perutz M, 1990, COOPERATIVITY ALLOST; PERUTZ MF, 1978, SCI AM, V239, P92, DOI 10.1038/scientificamerican1278-92; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; PREHODA KE, UNPUB; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Stenmark H, 1999, J CELL SCI, V112, P4175; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169	29	405	413	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					801	806		10.1126/science.290.5492.801	http://dx.doi.org/10.1126/science.290.5492.801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052943				2022-12-28	WOS:000090067600048
J	Lau, S; Illi, S; Sommerfeld, C; Niggemann, B; Bergmann, R; von Mutius, E; Wahn, U				Lau, S; Illi, S; Sommerfeld, C; Niggemann, B; Bergmann, R; von Mutius, E; Wahn, U		Multicentre Allergy Study Grp	Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study	LANCET			English	Article							SKIN-TEST REACTIVITY; RISK FACTOR; SENSITIZATION; CHILDREN; ASSOCIATION; ALTITUDE; FEL-D-1	Background In a prospective birth-cohort study, we assessed the relevance of mite and cat allergen exposure for the development of childhood asthma up to age 7 years. Methods Of 1314 newborn infants enrolled in five German cities in 1990, follow-up data at age 7 years were available far 939 children. Assessments included repeated measurement of specific IgE to food and inhalant allergens, measurement of indoor allergen exposure at 6 months, 18 months, and 3 years of age, and yearly interviews by a paediatrician. At age 7 years, pulmonary function was tested and bronchial hyper-responsiveness was measured in 645 children. Findings At age 7, the prevalence of wheezing in the past 12 months was 10.0% (94 of 938), and 6.1% (57 of 939) parents reported a doctor's diagnosis of asthma in their children. Sensitisation to indoor allergens was associated with asthma, wheeze, and increased bronchial responsiveness. However, no relation between early indoor allergen exposure and the prevalence of asthma, wheeze, and bronchial hyper-responsiveness was seen. Interpretation Our data do not support the hypothesis that exposure to environmental allergens causes asthma in childhood, but rather that the induction of specific IgE responses and the development of childhood asthma are determined by independent factors.	Humboldt Univ, Dept Paediat Pneumol & Immunol, Berlin, Germany; Univ Munich, Childrens Hosp, D-8000 Munich, Germany	Humboldt University of Berlin; University of Munich	Lau, S (corresponding author), Charite Virchow Klinikum, Klin Padiat Pneumol & Immunol, Augustenburger Pl 1, D-13353 Berlin, Germany.							ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bergmann R L, 1994, Pediatr Allergy Immunol, V5, P19, DOI 10.1111/j.1399-3038.1994.tb00343.x; BURR M L, 1989, Archives of Disease in Childhood, V64, P1452, DOI 10.1136/adc.64.10.1452; CHARPIN D, 1991, AM REV RESPIR DIS, V143, P983, DOI 10.1164/ajrccm/143.5_Pt_1.983; Custovic A, 1998, J ALLERGY CLIN IMMUN, V101, pS81; Custovic A, 1996, J ALLERGY CLIN IMMUN, V98, P64, DOI 10.1016/S0091-6749(96)70227-0; Demissie K, 1996, THORAX, V51, P59, DOI 10.1136/thx.51.1.59; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; Hide DW, 1996, ALLERGY, V51, P89, DOI 10.1111/j.1398-9995.1996.tb04563.x; Hodge L, 1998, EUR RESPIR J, V11, P361, DOI 10.1183/09031936.98.11020361; INGRAM JM, 1995, J ALLERGY CLIN IMMUN, V96, P449, DOI 10.1016/S0091-6749(95)70286-5; KUHR J, 1995, J ALLERGY CLIN IMMUN, V95, P655; KUHR J, 1994, J ALLERGY CLIN IMMUN, V94, P44; LAU S, 1989, J ALLERGY CLIN IMMUN, V84, P718, DOI 10.1016/0091-6749(89)90300-X; LAUSCHADENDORF S, 1991, J ALLERGY CLIN IMMUN, V87, P41, DOI 10.1016/0091-6749(91)90211-6; MARKS GB, 1995, J ALLERGY CLIN IMMUN, V96, P441, DOI 10.1016/S0091-6749(95)70285-7; MATTHYS H, 1993, RESPIRATION, V60, P343; Nishioka K, 1998, J ALLERGY CLIN IMMUN, V101, P28, DOI 10.1016/S0091-6749(98)70189-7; Pearce N, 2000, THORAX, V55, P424, DOI 10.1136/thorax.55.5.424; Peat JK, 1996, AM J RESP CRIT CARE, V153, P141, DOI 10.1164/ajrccm.153.1.8542107; Peterson EL, 1999, J ALLERGY CLIN IMMUN, V104, P348, DOI 10.1016/S0091-6749(99)70378-7; PLATTSMILLS TAE, 1995, J ALLERGY CLIN IMMUN, V96, P435, DOI 10.1016/S0091-6749(95)70284-9; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2; SCHWARTZ J, 1990, AM REV RESPIR DIS, V142, P555, DOI 10.1164/ajrccm/142.3.555; SEARS MR, 1989, CLIN EXP ALLERGY, V19, P419, DOI 10.1111/j.1365-2222.1989.tb02408.x; Shaheen SO, 1996, LANCET, V347, P1792, DOI 10.1016/S0140-6736(96)91617-7; Shaheen SO, 1999, CLIN EXP ALLERGY, V29, P291; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Sporik R, 1999, THORAX, V54, P675, DOI 10.1136/thx.54.8.675; SPORIK R, 1995, AM J RESP CRIT CARE, V151, P1388, DOI 10.1164/ajrccm.151.5.7735590; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; VONMUTIUS E, 1994, BRIT MED J, V308, P692, DOI 10.1136/bmj.308.6930.692; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7; Weiland SK, 1999, EUR RESPIR J, V14, P862, DOI 10.1034/j.1399-3003.1999.14d23.x; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	35	517	539	2	46	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1392	1397		10.1016/S0140-6736(00)02842-7	http://dx.doi.org/10.1016/S0140-6736(00)02842-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052581				2022-12-28	WOS:000089976100012
J	Ukkonen, P; Varis, K; Jernfors, M; Herva, E; Jokinen, J; Ruokokoski, E; Zopf, D; Kilpi, T				Ukkonen, P; Varis, K; Jernfors, M; Herva, E; Jokinen, J; Ruokokoski, E; Zopf, D; Kilpi, T			Treatment of acute otitis media with an antiadhesive oligosaccharide: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							ESCHERICHIA-COLI; EPITHELIAL-CELLS; BACTERIA; XYLITOL; ATTACHMENT; INFECTION; RECEPTORS; ADHERENCE; ADHESION; CHILDREN	Background Antiadhesive compounds are promising candidates for prevention or treatment of infections. We have investigated the efficacy of such an agent, 3'-sialyllacto-N-neotetraose (NE-1530), given intranasally far prophylaxis of acute otitis media and for effect on nasopharyngeal carriage of bacteria. Methods We did a randomised, double-blind placebo-controlled study at one study site. 507 healthy children were randomly assigned either NE-1530 (n=254) or placebo (253) as intranasal sprays twice daily during 3 months. The children were examined by the study physicians once a month and during illness. Treatment efficacy was estimated from Cox proportional hazards model. A sample of nasopharyngeal secretion was taken at every visit for culture of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Adverse events were recorded in study diaries. Findings At least one event of acute otitis media was diagnosed in 108 (43%) of 254 children in the NE-1530 group and in 86 (34%) of 253 children in the placebo group. The efficacy of treatment was negative, -27% (95% CI -68 to 5; p=0.10). The nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and M catarrhalis was not affected by treatment, and the adverse event profiles were almost identical for NE-1530 and placebo. Interpretation NE-1530 did not have a beneficial effect on the occurrence of acute otitis media or on the nasopharyngeal carriage of bacteria in children.	Natl Publ Hlth Inst, SF-00300 Helsinki, Finland; Neose Technol, Horsham, PA USA	Finland National Institute for Health & Welfare	Ukkonen, P (corresponding author), Natl Publ Hlth Inst, Mannerheimintie 166, SF-00300 Helsinki, Finland.	pentti.ukkonen@hus.fi						ALHO OP, 1991, INT J PEDIATR OTORHI, V21, P7, DOI 10.1016/0165-5876(91)90054-F; ALHO OP, 1990, INT J PEDIATR OTORHI, V19, P151, DOI 10.1016/0165-5876(90)90221-C; ANIANSSON G, 1994, PEDIATR INFECT DIS J, V13, P183, DOI 10.1097/00006454-199403000-00003; Balows A, 1991, MANUAL CLIN MICROBIO; BARSHAVIT Z, 1977, BIOCHEM BIOPH RES CO, V78, P455, DOI 10.1016/0006-291X(77)91276-1; Barthelson R, 1998, INFECT IMMUN, V66, P1439, DOI 10.1128/IAI.66.4.1439-1444.1998; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; CARLSON SE, 1985, AM J CLIN NUTR, V41, P720, DOI 10.1093/ajcn/41.4.720; Chien Y.W., 1989, NASAL SYSTEMIC DRUG, P1; DUNCAN B, 1993, PEDIATRICS, V91, P867; ESKOLA J, 1999, 39 M ICAAC SAN FRANC; GHERNA RL, 1981, MANUAL METHODS GEN B, P208; GIBSON LF, 1986, LETT APPL MICROBIOL, V3, P127, DOI 10.1111/j.1472-765X.1986.tb01565.x; Gratten Mike, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P123; IdanpaanHeikkila I, 1997, J INFECT DIS, V176, P704; KARMA P, 1987, ANN OTO RHINOL LARYN, V96, P1; KLEIN JO, 1994, CLIN INFECT DIS, V19, P823, DOI 10.1093/clinids/19.5.823; Kontiokari T, 1998, J ANTIMICROB CHEMOTH, V41, P563, DOI 10.1093/jac/41.5.563; KONTIOKARI T, 1995, ANTIMICROB AGENTS CH, V39, P1820, DOI 10.1128/AAC.39.8.1820; Lingwood CA, 1998, CURR OPIN CHEM BIOL, V2, P695, DOI 10.1016/S1367-5931(98)80105-1; MOURICOUT M, 1990, INFECT IMMUN, V58, P98, DOI 10.1128/IAI.58.1.98-106.1990; Mysore JV, 1999, GASTROENTEROLOGY, V117, P1316, DOI 10.1016/S0016-5085(99)70282-9; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; SAARINEN UM, 1982, ACTA PAEDIATR SCAND, V71, P567, DOI 10.1111/j.1651-2227.1982.tb09476.x; Simon PM, 1997, INFECT IMMUN, V65, P750, DOI 10.1128/IAI.65.2.750-757.1997; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Uhari M, 1996, BRIT MED J, V313, P1180, DOI 10.1136/bmj.313.7066.1180; UKKONEN P, 1999, 17 ANN M EUR SOC PAE; vandenBerg T, 1996, J IMMUNOL, V157, P3130; Zopf D, 1996, LANCET, V347, P1017, DOI 10.1016/S0140-6736(96)90150-6; [No title captured]	31	42	44	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2000	356	9239					1398	1402		10.1016/S0140-6736(00)02843-9	http://dx.doi.org/10.1016/S0140-6736(00)02843-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052582				2022-12-28	WOS:000089976100013
J	Deng, L; Wang, C; Spencer, E; Yang, LY; Braun, A; You, JX; Slaughter, C; Pickart, C; Chen, ZJ				Deng, L; Wang, C; Spencer, E; Yang, LY; Braun, A; You, JX; Slaughter, C; Pickart, C; Chen, ZJ			Activation of the I kappa B kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain	CELL			English	Article							SITE-SPECIFIC PHOSPHORYLATION; DEFECTIVE INTERLEUKIN-1; PROTEASOME PATHWAY; ALPHA; PROTEIN; OSTEOPETROSIS; PRECURSOR; INDUCTION; DOMAIN; MUTANT	TRAF6 is a signal transducer in the NF-kappa B pathway that activates I kappa B kinase (IKK) in response to proinflammatory cytokines. We have purified a heterodimeric protein complex that links TRAF6 to IKK activation. Peptide mass fingerprinting analysis reveals that this complex is composed of the ubiquitin conjugating enzyme Ubc13 and the Ubc-like protein Uev1A. We find that TRAF6, a RING domain protein, functions together with Ubc13/Uev1A to catalyze the synthesis of unique polyubiquitin chains linked through lysine-63 (K63) of ubiquitin. Blockade of this polyubiquitin chain synthesis, but not inhibition of the proteasome, prevents the activation of IKK by TRAF6. These results unveil a new regulatory function for ubiquitin, in which IKK is activated through the assembly of K63-linked polyubiquitin chains.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	Chen, ZJ (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.		Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	NIGMS NIH HHS [GM 59203, GM 60372] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059203, R01GM060372] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHEN ZJ, 1998, UBIQUITIN BIOL CELL, P303; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothofsky ML, 1997, GENE, V195, P141, DOI 10.1016/S0378-1119(97)00097-8; Rudolph D, 2000, GENE DEV, V14, P854; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; You JX, 1999, BIOTECHNIQUES, V27, P950, DOI 10.2144/99275st01; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	39	1443	1509	4	85	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 13	2000	103	2					351	361		10.1016/S0092-8674(00)00126-4	http://dx.doi.org/10.1016/S0092-8674(00)00126-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057907	Bronze			2022-12-28	WOS:000089864300018
J	Blomgren, GE				Blomgren, GE			Making a potential difference	NATURE			English	Editorial Material									Blomgren Consulting Serv Ltd, Lakewood, OH 44107 USA		Blomgren, GE (corresponding author), Blomgren Consulting Serv Ltd, 1554 Clarence Ave, Lakewood, OH 44107 USA.							Aurbach D, 2000, NATURE, V407, P724, DOI 10.1038/35037553; CONNOR JH, 1957, J ELECTROCHEM SOC, V104, P38, DOI 10.1149/1.2428492	2	10	15	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					681	682		10.1038/35037687	http://dx.doi.org/10.1038/35037687			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048699				2022-12-28	WOS:000089773900020
J	Lissy, NA; Davis, PK; Irwin, M; Kaelin, WG; Dowdy, SF				Lissy, NA; Davis, PK; Irwin, M; Kaelin, WG; Dowdy, SF			A common E2F-1 and p73 pathway mediates cell death induced by TCR activation	NATURE			English	Article							PERIPHERAL T-LYMPHOCYTES; LI-FRAUMENI; APOPTOSIS; P53; EXPRESSION; PROTEINS; GENE; MICE; COMPLEXITY; INDUCTION	Strong stimulation of the T-cell receptor (TCR) on cycling peripheral T cells causes their apoptosis by a process called TCR-activation-induced cell death (TCR-AICD)(1-3). TCR-AICD occurs from a late G1 phase cell-cycle check point(4) independently of the 'tumour suppressor' protein p53 (refs 5, 6). Disruption of the gene for the E2F-1 transcription factor(7,8), an inducer of apoptosis(9-11), causes significant increases in T-cell number and splenomegaly(12-15). Here we show that T cells undergoing TCR-AICD induce the p53-related gene p73, another mediator of apoptosis(16), which is hypermethylated in lymphomas(17,18). Introducing a dominant-negative E2F-1 protein or a dominant-negative p73 protein into T cells protects them from TCR-mediated apoptosis, whereas dominant-negative E2F-2, E2F-4 or p53 does not. Furthermore, E2F-1-null or p73-null primary T cells do not undergo TCR-mediated apoptosis either. We conclude that TCR-AICD occurs from a late G1 cell-cycle checkpoint that is dependent on both E2F-1 and p73 activities. These observations indicate that, unlike p53, p73 serves to integrate receptor-mediated apoptotic stimuli.	Washington Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Dowdy, SF (corresponding author), Washington Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, St Louis, MO 63110 USA.							ABRAMS SI, 1991, J IMMUNOL, V146, P405; Boehme SA, 1996, J IMMUNOL, V156, P4075; Corn PG, 1999, CANCER RES, V59, P3352; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Garcia I, 2000, CELL GROWTH DIFFER, V11, P91; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; JONES LA, 1990, SCIENCE, V250, P1726, DOI 10.1126/science.2125368; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; KABELITZ D, 1993, IMMUNOL TODAY, V14, P338, DOI 10.1016/0167-5699(93)90231-9; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Kawano S, 1999, BLOOD, V94, P1113; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Lissy NA, 1998, IMMUNITY, V8, P57, DOI 10.1016/S1074-7613(00)80458-6; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; Malcomson RDG, 1997, J PATHOL, V181, P166; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Zhu JW, 1999, CELL GROWTH DIFFER, V10, P829	30	283	288	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					642	645		10.1038/35036608	http://dx.doi.org/10.1038/35036608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034214				2022-12-28	WOS:000089772800050
J	Luu, DT; Qin, XK; Morse, D; Cappadocia, M				Luu, DT; Qin, XK; Morse, D; Cappadocia, M			S-RNase uptake by compatible pollen tubes in gametophytic self-incompatibility	NATURE			English	Article							SOLANUM-CHACOENSE BITT; NICOTIANA-ALATA; FLOWERING PLANTS; GENETIC-ANALYSIS; GROWTH; ALLELES; POLLINATION; HYPOTHESIS; CLONING; CULTURE	Many flowering plants avoid inbreeding through a genetic mechanism termed self-incompatibility. An extremely polymorphic S-locus(1) controls the gametophytic self-incompatibility system that causes pollen rejection (that is, active arrest of pollen tube growth inside the style) when an S-allele carried by haploid pollen matches one of the S-alleles present in the diploid style. The only known product of the S-locus is an S-RNase expressed in the mature style(2). The pollen component to this cell-cell recognition system is unknown and current models(3,4) propose that it either acts as a gatekeeper allowing only its cognate S-RNase to enter the pollen tube, or as an inhibitor of non-cognate S-RNases. In the latter case, all S-RNases are presumed to enter pollen tubes; thus, the two models make diametrically opposed predictions concerning the entry of S-RNases into compatible pollen. Here we use immunocytochemical labelling of pollen tubes growing in styles to show accumulation of an S-RNase in the cytoplasm of all pollen-tube haplotypes, thus providing experimental support for the inhibitor model.	Univ Montreal, Dept Biol, Montreal, PQ H1X 2B2, Canada	Universite de Montreal	Cappadocia, M (corresponding author), Univ Montreal, Dept Biol, Montreal, PQ H1X 2B2, Canada.			Morse, David/0000-0003-4131-4367; Luu, Doan Trung/0000-0001-9765-2125				ANDERSON MA, 1986, NATURE, V321, P38, DOI 10.1038/321038a0; Certal AC, 1999, SEX PLANT REPROD, V12, P94, DOI 10.1007/s004970050177; Cheung AY, 1996, SEX PLANT REPROD, V9, P330, DOI 10.1007/BF02441951; De Nettancourt D, 1973, J Cell Sci, V12, P403; de Nettancourt D., 1977, INCOMPATIBILITY ANGI; DESPRES C, 1994, SEX PLANT REPROD, V7, P169, DOI 10.1007/BF00228490; Dodds PN, 1996, CELL, V85, P141, DOI 10.1016/S0092-8674(00)81090-9; Golz JF, 2000, ANN BOT-LONDON, V85, P95, DOI 10.1006/anbo.1999.1060; GRAY JE, 1991, PLANT CELL, V3, P271, DOI 10.1105/tpc.3.3.271; HESS D, 1974, Z PFLANZENPHYSIOL, V74, P371; HUANG S, 1994, PLANT CELL, V6, P1021, DOI 10.1105/tpc.6.7.1021; JAHNEN W, 1989, PLANT CELL, V1, P501, DOI 10.1105/tpc.1.5.501; Kao TH, 1996, P NATL ACAD SCI USA, V93, P12059, DOI 10.1073/pnas.93.22.12059; LEWIS D, 1961, NATURE, V190, P990, DOI 10.1038/190990a0; MARTIN FW, 1959, STAIN TECHNOL, V34, P125, DOI 10.3109/10520295909114663; Matton DP, 1997, PLANT CELL, V9, P1757, DOI 10.1105/tpc.9.10.1757; Matton DP, 1999, PLANT CELL, V11, P2087, DOI 10.1105/tpc.11.11.2087; MCCLURE B, 1989, NATURE, V32, P955; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; MCFADDEN G, 1991, ELECT MICROSCOPY PLA, P220; PANDEY KK, 1967, HEREDITY, V22, P255, DOI 10.1038/hdy.1967.31; RIVARD SR, 1994, GENOME, V37, P775, DOI 10.1139/g94-111; SABAELLEIL MK, 1994, PLANT MOL BIOL, V24, P571, DOI 10.1007/BF00023555; STEER MW, 1989, NEW PHYTOL, V111, P323, DOI 10.1111/j.1469-8137.1989.tb00697.x; Van Sint Jan V, 1996, PLANT CELL TISS ORG, V47, P9; Vandenbosch K A, 1991, ELECT MICROSCOPY PLA, P181; VERONNEAU H, 1992, PLANT CELL TISS ORG, V30, P199, DOI 10.1007/BF00040022	27	191	212	0	34	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					649	651		10.1038/35036623	http://dx.doi.org/10.1038/35036623			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034216				2022-12-28	WOS:000089772800052
J	Halfon, MS; Carmena, A; Gisselbrecht, S; Sackerson, CM; Jimenez, F; Baylies, MK; Michelson, AM				Halfon, MS; Carmena, A; Gisselbrecht, S; Sackerson, CM; Jimenez, F; Baylies, MK; Michelson, AM			Ras pathway specificity is determined by the integration of multiple signal-activated and tissue-restricted transcription factors	CELL			English	Article							GROWTH-FACTOR RECEPTOR; DROSOPHILA EMBRYONIC MESODERM; ELEGANS VULVAL INDUCTION; GENE-EXPRESSION; CELL FATES; C-ELEGANS; MUSCLE PROGENITORS; PROTEINS ACT; BOX GENES; DIFFERENTIATION	Ras signaling elicits diverse outputs, yet how Ras specificity is generated remains incompletely understood. We demonstrate that Wingless (Wg) and Decapentaplegic (Dpp) confer competence for receptor tyrosine kinase-mediated induction of a subset of Drosophila muscle and cardiac progenitors by acting both upstream of and in parallel to Pas. In addition to regulating the expression of proximal Ras pathway components, Wg and Dpp coordinate the direct effects of three signal-activated (dTCF, Mad, and Pointed-functioning in the Wg, Dpp, and Ras/MAPK pathways, respectively) and two tissue-restricted (Twist and Tinman) transcription factors on a progenitor identity gene enhancer. The integration of Pointed with the combinatorial effects of dTCF, Mad, Twist, and Tinman determines inductive Ras signaling specificity in muscle and heart development.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Dept Mol Biol, New York, NY 10021 USA; Iona Coll, Dept Biol, New Rochelle, NY 10801 USA; Univ Miguel Hernandez, Inst Neurociencias, Alicante, Spain	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Iona College; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Michelson, AM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, Boston, MA 02115 USA.		Carmena, Ana/H-3506-2015; Halfon, Marc S./H-3447-2019	Carmena, Ana/0000-0003-1855-7934; Halfon, Marc S./0000-0002-4149-2705; Gisselbrecht, Stephen/0000-0001-8723-902X	NIGMS NIH HHS [GM 56989, R01 GM056989] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056989] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Bang AG, 2000, GENE DEV, V14, P177; Bate Michael, 1993, Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie, V316, P1047; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; BODMER R, 1993, DEVELOPMENT, V118, P719; BOPP D, 1989, EMBO J, V8, P3447, DOI 10.1002/j.1460-2075.1989.tb08509.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Buff E, 1998, DEVELOPMENT, V125, P2075; Carmena A, 1998, GENE DEV, V12, P3910, DOI 10.1101/gad.12.24.3910; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; CHEN T, 1992, DEV BIOL, V151, P176, DOI 10.1016/0012-1606(92)90225-6; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Ericson J, 1998, DEVELOPMENT, V125, P1005; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; FRASCH M, 1995, NATURE, V374, P646; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Gomez MR, 1997, DEVELOPMENT, V124, P4857; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; Hepker J, 1999, DEVELOPMENT, V126, P3669; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Imam F, 1999, GENETICS, V152, P307; Jiang LI, 1998, DEVELOPMENT, V125, P2337; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; KLAMBT C, 1993, DEVELOPMENT, V117, P163; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lawrence PA, 1995, DEVELOPMENT, V121, P4303; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Maloof JN, 1998, DEVELOPMENT, V125, P181; Michelson AM, 1998, DEVELOPMENT, V125, P4379; Michelson AM, 1998, DEV GENET, V22, P212, DOI 10.1002/(SICI)1520-6408(1998)22:3<212::AID-DVG4>3.0.CO;2-9; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pai LM, 1997, DEVELOPMENT, V124, P2255; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Reifers F, 2000, DEVELOPMENT, V127, P225; Rommel C, 1998, CURR OPIN GENET DEV, V8, P412, DOI 10.1016/S0959-437X(98)80111-1; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Sackerson C, 1999, DEV BIOL, V211, P39, DOI 10.1006/dbio.1999.9301; SEKELSKY JJ, 1995, GENETICS, V139, P1347; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; STERN CURT, 1954, AMER SCI, V42, P213; Stern HM, 1997, DEVELOPMENT, V124, P3511; Su MT, 1999, DEVELOPMENT, V126, P3241; Szuts D, 1998, GENE DEV, V12, P2022, DOI 10.1101/gad.12.13.2022; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Tan PBO, 1999, TRENDS GENET, V15, P145, DOI 10.1016/S0168-9525(99)01694-7; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354	58	258	262	2	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					63	74		10.1016/S0092-8674(00)00105-7	http://dx.doi.org/10.1016/S0092-8674(00)00105-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051548	Bronze			2022-12-28	WOS:000089636400009
J	Amati, L; Frontera, F; Vietri, M; in't Zand, JJM; Soffitta, P; Costa, E; Del Sordo, S; Pian, E; Piro, L; Antonelli, LA; Dal Fiume, D; Feroci, M; Gandolfi, G; Guidorzi, C; Heise, J; Kuulkers, E; Masetti, N; Montanari, E; Nicastro, L; Orlandini, M; Palazzi, E				Amati, L; Frontera, F; Vietri, M; in't Zand, JJM; Soffitta, P; Costa, E; Del Sordo, S; Pian, E; Piro, L; Antonelli, LA; Dal Fiume, D; Feroci, M; Gandolfi, G; Guidorzi, C; Heise, J; Kuulkers, E; Masetti, N; Montanari, E; Nicastro, L; Orlandini, M; Palazzi, E			Discovery of a transient absorption edge in the X-ray spectrum of GRB 990705	SCIENCE			English	Article							PHOTOELECTRIC ABSORPTION; ASTRONOMY SATELLITE; ON-BOARD; BEPPOSAX; ONBOARD; BURSTS	We report the discovery of a transient equivalent hydrogen column density with an absorption edge at similar to3.8 kiloelectron volts in the spectrum of the prompt x-ray emission of gamma-ray burst (GRB) 990705. This feature can be satisfactorily modeled with a photoelectric absorption by a medium Located at a redshift of similar to0.86 and with an iron abundance of similar to 75 times the solar one. The transient behavior is attributed to the strong ionization produced in the circumburst medium by the GRB photons. The high iron abundance points to the existence of a burst environment enriched by a supernova along the Line of sight. The supernova explosion is estimated to have occurred about 10 years before the burst. Our results agree with models in which GRBs originate from the collapse of very massive stars and are preceded by a supernova event.	CNR, Ist Tecnol & Studio Radiaz Extraterr, I-40129 Bologna, Italy; Univ Ferrara, Dipartmento Fis, I-44100 Ferrara, Italy; Terza Univ Roma, Dipartimento Fis, I-00146 Rome, Italy; Space Res Org Netherlands, NL-3584 CA Utrecht, Netherlands; Ist Fis Cosm Applicaz Informat, I-00133 Rome, Italy; Osserv Astron Roma, I-00040 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Ferrara; Roma Tre University; Istituto Nazionale Astrofisica (INAF)	Amati, L (corresponding author), CNR, Ist Tecnol & Studio Radiaz Extraterr, Via Gobetti 101, I-40129 Bologna, Italy.	amati@tesre.bo.cnr.it	Nicastro, Luciano/F-5866-2015; Soffitta, Paolo/AAA-7514-2021; PIRO, LUIGI/E-4954-2013; Orlandini, Mauro/H-3114-2014; sui, laizhi/G-5629-2010; Nicastro, Luciano/AAU-5914-2021; Palazzi, Eliana/N-4746-2015; Frontera, Filippo/B-4410-2014; Amati, Lorenzo/N-5586-2015	Nicastro, Luciano/0000-0001-8534-6788; Soffitta, Paolo/0000-0002-7781-4104; PIRO, LUIGI/0000-0003-4159-3984; Orlandini, Mauro/0000-0003-0946-3151; Nicastro, Luciano/0000-0001-8534-6788; Antonelli, Lucio Angelo/0000-0002-5037-9034; Frontera, Filippo/0000-0003-2284-571X; Palazzi, Eliana/0000-0002-8691-7666; Masetti, Nicola/0000-0001-9487-7740; Costa, Enrico/0000-0003-4925-8523; DEL SORDO, Stefano/0000-0002-3340-1404; Feroci, Marco/0000-0002-7617-3421; Guidorzi, Cristiano/0000-0001-6869-0835; Amati, Lorenzo/0000-0001-5355-7388; Gandolfi, Giangiacomo/0000-0002-6768-0675; Pian, Elena/0000-0001-8646-4858				Amati L, 1999, ASTRON ASTROPHYS SUP, V138, P403, DOI 10.1051/aas:1999285; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ANTONELLI LA, IN PRESS ASTROPHYS J; BAND D, 1993, ASTROPHYS J, V413, P281, DOI 10.1086/172995; Boella G, 1997, ASTRON ASTROPHYS SUP, V122, P299, DOI 10.1051/aas:1997136; Bottcher M, 1999, ASTRON ASTROPHYS, V343, P111; Cohen JG, 2000, ASTROPHYS J, V538, P29, DOI 10.1086/309096; Costa E, 1998, ADV SPACE RES, V22, P1129, DOI 10.1016/S0273-1177(98)00208-7; Frontera F, 2000, ASTROPHYS J SUPPL S, V127, P59, DOI 10.1086/313316; Frontera F, 1997, ASTRON ASTROPHYS SUP, V122, P357, DOI 10.1051/aas:1997140; HOLLAND S, 2000, 753 GCN; Jager R, 1997, ASTRON ASTROPHYS SUP, V125, P557, DOI 10.1051/aas:1997243; Masetti N, 2000, ASTRON ASTROPHYS, V354, P473; MORRISON R, 1983, ASTROPHYS J, V270, P119, DOI 10.1086/161102; Paczynski B, 1998, ASTROPHYS J, V494, pL45, DOI 10.1086/311148; Piro L, 1999, ASTROPHYS J, V514, pL73, DOI 10.1086/311946; Piro L, 2000, SCIENCE, V290, P955, DOI 10.1126/science.290.5493.955; TSUNEMI H, IN PRESS PUBL ASTRON; Vietri M, 1998, ASTROPHYS J, V507, pL45, DOI 10.1086/311674; Weth C, 2000, ASTROPHYS J, V534, P581, DOI 10.1086/308792; WOOSLEY SE, 1986, ANNU REV ASTRON ASTR, V24, P205, DOI 10.1146/annurev.aa.24.090186.001225; Yoshida A, 1999, ASTRON ASTROPHYS SUP, V138, P433, DOI 10.1051/aas:1999297	22	171	174	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2000	290	5493					953	955		10.1126/science.290.5493.953	http://dx.doi.org/10.1126/science.290.5493.953			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11062120	Green Submitted			2022-12-28	WOS:000165103200039
J	Lipscomb, GH; Stovall, TG; Ling, FW				Lipscomb, GH; Stovall, TG; Ling, FW			Nonsurgical treatment of ectopic pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SINGLE-DOSE METHOTREXATE; HUMAN CHORIONIC-GONADOTROPIN; TUBAL PREGNANCY; MEDICAL-TREATMENT; SYSTEMIC METHOTREXATE; RANDOMIZED TRIAL; INJECTION; IDENTIFICATION; SALPINGOSTOMY; SONOGRAPHY		Univ Tennessee, Dept Obstet & Gynecol, Div Gynecol, Memphis, TN 38103 USA	University of Tennessee System; University of Tennessee Health Science Center	Lipscomb, GH (corresponding author), Univ Tennessee, Dept Obstet & Gynecol, Div Gynecol, Memphis, TN 38103 USA.		Martin, Daniel/Q-1759-2018	Martin, Daniel/0000-0002-1904-1449				ABOULGHAR MA, 1990, HUM REPROD, V5, P887, DOI 10.1093/oxfordjournals.humrep.a137204; Alexander JM, 1996, OBSTET GYNECOL, V88, P123, DOI 10.1016/0029-7844(96)00086-5; ALTARAS M, 1988, BRIT J OBSTET GYNAEC, V95, P1321, DOI 10.1111/j.1471-0528.1988.tb06826.x; BERNASCHEK G, 1988, AM J OBSTET GYNECOL, V158, P608, DOI 10.1016/0002-9378(88)90039-7; BROWN DL, 1991, OBSTET GYNECOL, V77, P406; CORSAN GH, 1995, HUM REPROD, V10, P2719, DOI 10.1093/oxfordjournals.humrep.a135774; CREININ MD, 1993, FERTIL STERIL, V60, P963; DAYA S, 1987, AM J OBSTET GYNECOL, V156, P286, DOI 10.1016/0002-9378(87)90269-9; DEVOE RW, 1948, AM J OBSTET GYNECOL, V56, P1119, DOI 10.1016/S0002-9378(48)90357-3; Gazvani MR, 1999, AM J OBSTET GYNECOL, V180, P1599, DOI 10.1016/S0002-9378(99)70067-0; GLOCK JL, 1994, FERTIL STERIL, V62, P716; Hajenius PJ, 1997, LANCET, V350, P774, DOI 10.1016/S0140-6736(97)05487-1; HENRY MA, 1994, AM J OBSTET GYNECOL, V171, P1584, DOI 10.1016/0002-9378(94)90406-5; KADAR N, 1982, FERTIL STERIL, V37, P542; KADAR N, 1990, FERTIL STERIL, V54, P783; KADAR N, 1981, OBSTET GYNECOL, V58, P162; KADAR N, 1981, OBSTET GYNECOL, V58, P156; KENIGSBERG D, 1987, FERTIL STERIL, V47, P702; LANG PF, 1990, LANCET, V336, P78, DOI 10.1016/0140-6736(90)91593-Y; Lecuru F, 1998, INT J GYNECOL OBSTET, V61, P253, DOI 10.1016/S0020-7292(98)00038-1; LINDAHL B, 1986, OBSTET GYNECOL, V67, P79; LINDBLOM B, 1990, FERTIL STERIL, V54, P404; Lipscomb GH, 1999, OBSTET GYNECOL, V93, P590, DOI 10.1016/S0029-7844(98)00523-7; Lipscomb GH, 1999, NEW ENGL J MED, V341, P1974, DOI 10.1056/NEJM199912233412604; Lipscomb GH, 1998, AM J OBSTET GYNECOL, V178, P1354, DOI 10.1016/S0002-9378(98)70343-6; McCord ML, 1996, FERTIL STERIL, V66, P513, DOI 10.1016/S0015-0282(16)58560-4; PITTAWAY DE, 1985, AM J OBSTET GYNECOL, V152, P299, DOI 10.1016/S0002-9378(85)80215-5; Saraj AJ, 1998, OBSTET GYNECOL, V92, P989, DOI 10.1016/S0029-7844(98)00324-X; SCHAFER D, 1994, J AM ASSOC GYN LAP, V1, P213, DOI 10.1016/S1074-3804(05)81012-6; Stika CS, 1996, AM J OBSTET GYNECOL, V174, P1840, DOI 10.1016/S0002-9378(96)70219-3; STOVALL TG, 1991, OBSTET GYNECOL, V77, P749; STOVALL TG, 1993, AM J OBSTET GYNECOL, V168, P1759, DOI 10.1016/0002-9378(93)90687-E; STOVALL TG, 1991, OBSTET GYNECOL, V77, P754; STOVALL TG, 1990, FERTIL STERIL, V54, P537; Thoen LD, 1997, FERTIL STERIL, V68, P727, DOI 10.1016/S0015-0282(97)00284-7; 1995, MMWR MORB MORTAL WKL, V44, P46	36	105	117	2	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2000	343	18					1325	1329		10.1056/NEJM200011023431807	http://dx.doi.org/10.1056/NEJM200011023431807			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368RP	11058678				2022-12-28	WOS:000090131600007
J	Bonhoeffer, P; Boudjemline, Y; Saliba, Z; Merckx, J; Aggoun, Y; Bonnet, D; Acar, P; Le Bidois, J; Sidi, D; Kachaner, J				Bonhoeffer, P; Boudjemline, Y; Saliba, Z; Merckx, J; Aggoun, Y; Bonnet, D; Acar, P; Le Bidois, J; Sidi, D; Kachaner, J			Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction	LANCET			English	Article							TERM FOLLOW-UP; IMPLANTATION; HOMOGRAFT; FAILURE; STENTS; FATE	Background Valved conduits from the right ventricle to the pulmonary artery are frequently used in paediatric cardiac surgery. However, stenosis and insufficiency of the conduit usually occur in the follow-up and lead to reoperations. Conduit stenting can delay surgical replacement, but it aggravates pulmonary insufficiency. We developed an innovative system for percutaneous stent implantation combined with valve replacement. Methods A 12-year-old boy with stenosis and insufficiency of a prosthetic conduit from the right ventricle to the pulmonary artery underwent percutaneous implantation of a bovine jugular valve in the conduit. Findings Angiography, haemodynamic assessment, and echocardiography after the procedure showed no insufficiency of the implanted valve, and partial relief of the conduit stenosis. There were no complications after 1 month of follow-up, and the patient is presently in good physical condition. Interpretation We have shown that percutaneous valve replacement in the pulmonary position is possible. With further technical improvements, this new technique might also be used for valve replacement in other cardiac and non-cardiac positions.	Hop Necker Enfants Malad, Serv Cardiol Pediat, F-75743 Paris 15, France; Hop Necker Enfants Malad, Dept Anesthesie, F-75743 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Bonhoeffer, P (corresponding author), Hop Necker Enfants Malad, Serv Cardiol Pediat, F-75743 Paris 15, France.		AGGOUN, Yacine/ABC-7903-2020					BANDO K, 1995, J THORAC CARDIOV SUR, V109, P509, DOI 10.1016/S0022-5223(95)70282-2; Bonhoeffer P, 2000, CIRCULATION, V102, P813, DOI 10.1161/01.CIR.102.7.813; BOVE EL, 1983, J THORAC CARDIOV SUR, V85, P691; BULL C, 1987, J THORAC CARDIOV SUR, V94, P12; Champsaur G, 1998, J THORAC CARDIOV SUR, V116, P793, DOI 10.1016/S0022-5223(98)00443-7; CLEVELAND DC, 1992, CIRCULATION, V86, P150; DOWNING TP, 1985, CIRCULATION, V72, P84; HOSKING MCK, 1992, J AM COLL CARDIOL, V20, P373, DOI 10.1016/0735-1097(92)90105-V; JONAS RA, 1985, CIRCULATION, V72, P77; KIRKLIN JW, 1987, ANN THORAC SURG, V44, P598, DOI 10.1016/S0003-4975(10)62142-X; MCGOON DC, 1982, AM J CARDIOL, V49, P1741, DOI 10.1016/0002-9149(82)90254-5; Oesterle SN, 1998, AM HEART J, V136, P578, DOI 10.1016/S0002-8703(98)70004-3; OLAUGHLIN MP, 1993, CIRCULATION, V88, P605, DOI 10.1161/01.CIR.88.2.605; Ovaert C, 1999, J THORAC CARDIOV SUR, V118, P886, DOI 10.1016/S0022-5223(99)70058-9; POWELL AJ, 1995, CIRCULATION, V92, P3282, DOI 10.1161/01.CIR.92.11.3282; RAZZOUK AJ, 1992, CIRCULATION, V86, P154; Saliba Z, 1999, ARCH MAL COEUR VAISS, V92, P591; Schlichter AJ, 1996, ANN THORAC SURG, V62, P155, DOI 10.1016/0003-4975(96)00263-9; Schlichter AJ, 2000, J THORAC CARDIOV SUR, V119, P869, DOI 10.1016/S0022-5223(00)70081-X; Stark J, 1998, J THORAC CARDIOV SUR, V115, P506, DOI 10.1016/S0022-5223(98)70312-5	20	669	833	0	26	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1403	1405		10.1016/S0140-6736(00)02844-0	http://dx.doi.org/10.1016/S0140-6736(00)02844-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052583				2022-12-28	WOS:000089976100014
J	Vasquez, KM; Narayanan, L; Glazer, PM				Vasquez, KM; Narayanan, L; Glazer, PM			Specific mutations induced by triplex-forming oligonucleotides in mice	SCIENCE			English	Article							TRANSCRIPTION-COUPLED REPAIR; MAMMALIAN-CELLS; GENE-EXPRESSION; HELIX FORMATION; INSTABILITY; MUTAGENESIS; STABILITY; INVIVO	Tripler-forming oligonucleotides (TFOs) recognize and bind to specific duplex DNA sequences and have been used extensively to modify gene function in cells. Although germ line mutations can be incorporated by means of embryonic stem cell technology, little progress has been made toward introducing mutations in somatic cells of living organisms. Here we demonstrate that TFOs can induce mutations at specific genomic sites in somatic cells of adult mice. Mutation detection was facilitated by the use of transgenic mice bearing chromosomal copies of the supF and cll reporter genes. Mice treated with a supF-targeted TFO displayed about fivefold greater mutation frequencies in the supF gene compared with mice treated with a scrambled sequence control oligomer, No mutagenesis was detected in the control gene (cll) with either oligonucleotide. These results demonstrate that site-specific, TFO-directed genome modification can be accomplished in intact animals.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Therapeut Radiol, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Genet, New Haven, CT 06536 USA	Yale University; Yale University	Glazer, PM (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Therapeut Radiol, 295 Congress Ave, New Haven, CT 06536 USA.	peter.glazer@yale.edu	Glazer, Peter/S-7651-2019	Glazer, Peter/0000-0003-4525-5560	NCI NIH HHS [CA64186, F32 CA075723, CA75723] Funding Source: Medline; NIGMS NIH HHS [GM54731] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA064186, F32CA075723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054731] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGRAWAL S, 1991, P NATL ACAD SCI USA, V88, P7595, DOI 10.1073/pnas.88.17.7595; Barre FX, 2000, P NATL ACAD SCI USA, V97, P3084, DOI 10.1073/pnas.050368997; Bramlage B, 1998, TRENDS BIOTECHNOL, V16, P434, DOI 10.1016/S0167-7799(98)01236-0; CHEN TS, 1990, DRUG METAB DISPOS, V18, P882; ColeStrauss A, 1996, SCIENCE, V273, P1386, DOI 10.1126/science.273.5280.1386; Famulok M, 1999, CURR OPIN STRUC BIOL, V9, P324, DOI 10.1016/S0959-440X(99)80043-8; Faruqi AF, 2000, MOL CELL BIOL, V20, P990, DOI 10.1128/MCB.20.3.990-1000.2000; Galderisi U, 1999, J CELL PHYSIOL, V181, P251, DOI 10.1002/(SICI)1097-4652(199911)181:2<251::AID-JCP7>3.0.CO;2-D; Good L, 1997, ANTISENSE NUCLEIC A, V7, P431, DOI 10.1089/oli.1.1997.7.431; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; Jakubczak JL, 1996, P NATL ACAD SCI USA, V93, P9073, DOI 10.1073/pnas.93.17.9073; Majumdar A, 1998, NAT GENET, V20, P212, DOI 10.1038/2530; MYHR BC, 1991, ENVIRON MOL MUTAGEN, V18, P308, DOI 10.1002/em.2850180420; Narayanan L, 1997, P NATL ACAD SCI USA, V94, P3122, DOI 10.1073/pnas.94.7.3122; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Vasquez KM, 1999, NUCLEIC ACIDS RES, V27, P1176, DOI 10.1093/nar/27.4.1176; Vasquez KM, 1998, TRENDS BIOCHEM SCI, V23, P4, DOI 10.1016/S0968-0004(97)01158-4; WANG G, 1995, MOL CELL BIOL, V15, P1759; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; Yao X, 1999, P NATL ACAD SCI USA, V96, P6850, DOI 10.1073/pnas.96.12.6850; ZENDEGUI JG, 1992, NUCLEIC ACIDS RES, V20, P307, DOI 10.1093/nar/20.2.307	23	242	249	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2000	290	5491					530	533		10.1126/science.290.5491.530	http://dx.doi.org/10.1126/science.290.5491.530			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039937				2022-12-28	WOS:000089946000056
J	Simmons, RM				Simmons, RM			Prophets without honour? Or honour without profits?	NATURE			English	Editorial Material									Kings Coll London, Randall Ctr, London SE1 1UL, England	University of London; King's College London	Simmons, RM (corresponding author), Kings Coll London, Randall Ctr, Guys Campus, London SE1 1UL, England.							MAYNARD J, 2000, NATURE, V403, P594	1	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					839	839		10.1038/35038172	http://dx.doi.org/10.1038/35038172			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057644	Bronze			2022-12-28	WOS:000089901900026
J	Frazier, AL; Colditz, GA; Fuchs, CS; Kuntz, KM				Frazier, AL; Colditz, GA; Fuchs, CS; Kuntz, KM			Cost-effectiveness of screening for colorectal cancer in the general population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL OCCULT-BLOOD; LARGE BOWEL; UNRESECTED POLYPS; LARGE-INTESTINE; COLON; RISK; COLONOSCOPY; SIGMOIDOSCOPY; PREVALENCE; RECURRENCE	Context A recent expert panel recommended that persons at average risk of colorectal cancer (CRC) begin screening for CRC at age 50 years using 1 of several strategies. However, many aspects of different CRC screening strategies remain uncertain. Objective To assess the consequences, costs, and cost-effectiveness of CRC screening in average-risk individuals. Design Cost-effectiveness analysis from a societal perspective using a Markov model. Subjects Hypothetical subjects representative of the 50-year-old US population at average risk for CRC. Setting Simulated clinical practice in the United States. Main Outcome Measures Discounted lifetime costs, life expectancy, and incremental cost-effectiveness (CE) ratio, compared used 22 different CRC screening strategies, including those recommended by the expert panel. Results In 1 base-case analysis, compliance was assumed to be 60% with the initial screen and 80% with follow-up or surveillance colonoscopy. The most effective strategy for white men was annual rehydrated fecal occult blood testing (FOBT) plus sigmoidoscopy (followed by colonoscopy if either a low- or high-risk polyp was found) every 5 years from age 50 to 85 years, which resulted in a 60% reduction in cancer incidence and an 80% reduction in CRC mortality compared with no screening, and an incremental CE ratio of $92 900 per year of life gained compared with annual unrehydrated FOBT plus sigmoidoscopy every 5 years. In a base-case analysis in which compliance with screening and follow-up is assumed to be 100%, screening more often than every 10 years was prohibitively expensive; annual rehydrated FOBT plus sigmoidoscopy every 5 years had an incremental CE ratio of $489 900 per life-year gained compared with the same strategy every 10 years. Other strategies recommended by the expert panel were either less effective or cost more per year of life gained than the alternatives. Colonoscopy every 10 years was less effective than the combination of annual FOBI plus sigmoidoscopy every 5 years. However, a single colonoscopy at age 55 years achieves nearly half of the reduction in CRC mortality obtainable with clolonoscopy every 10 years. Because of increased life expectancy among white women and increased cancer mortality among blacks, CRC screening was even more cost-effective in these groups than in white men. Conclusions Screening for CRC, even in the setting of imperfect compliance, significantly reduces CRC mortality at rests comparable to other cancer screening procedures. However, compliance rates significantly affect the incremental CE ratios. In this model of CRC, 60% compliance with an every 5-year schedule of screening was roughly equivalent to 100% compliance with an every 10-year schedule. Mathematical modeling used to inform clinical guidelines needs to take into account expected compliance rates.	Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Frazier, AL (corresponding author), Brigham & Womens Hosp, Channing Lab, Dept Med, 181 Longwood Ave, Boston, MA 02115 USA.		Launoy, Guy/K-7372-2015; Colditz, Graham/A-3963-2009; wang, edwin/G-5372-2010; BERCHI, Célia/L-7238-2015	Colditz, Graham/0000-0002-7307-0291; 	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS007038] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K07CA062252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703] Funding Source: NIH RePORTER; AHRQ HHS [HS07038] Funding Source: Medline; NCI NIH HHS [5 K07 CA62252-03] Funding Source: Medline; NIDDK NIH HHS [T32DK07703] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLISON JE, 1990, ANN INTERN MED, V112, P328, DOI 10.7326/0003-4819-112-5-328; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; *AM CANC SOC, 1998, WHAT ARE KEY STAT CO; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BROWN ML, 1999, PRIM CARE CANC, V19, P15; Cockburn J, 1995, J Med Screen, V2, P79; COOPER GS, 1995, CANCER, V75, P775, DOI 10.1002/1097-0142(19950201)75:3<775::AID-CNCR2820750305>3.0.CO;2-D; DINNING JP, 1994, ARCH INTERN MED, V154, P853, DOI 10.1001/archinte.154.8.853; DISARIO JA, 1991, AM J GASTROENTEROL, V86, P941; EDDY DM, 1990, ANN INTERN MED, V113, P373, DOI 10.7326/0003-4819-113-5-373; EIDE TJ, 1978, CANCER, V42, P2839, DOI 10.1002/1097-0142(197812)42:6<2839::AID-CNCR2820420645>3.0.CO;2-Y; Geul KW, 1997, SCAND J GASTROENTERO, V32, P79; Glick S, 1998, AM J ROENTGENOL, V170, P629, DOI 10.2214/ajr.170.3.9490943; Gold MR, 1996, COST EFFECTIVENESS H; GREENBERG ER, 1994, NEW ENGL J MED, V331, P141, DOI 10.1056/NEJM199407213310301; GROSSMAN S, 1989, GASTROENTEROLOGY, V96, P299, DOI 10.1016/0016-5085(89)91551-5; HENRY LG, 1975, ANN SURG, V182, P511, DOI 10.1097/00000658-197510000-00017; HIXSON LJ, 1991, GASTROINTEST ENDOSC, V37, P125, DOI 10.1016/S0016-5107(91)70668-8; HOFF G, 1986, SCAND J GASTROENTERO, V21, P853, DOI 10.3109/00365528609011130; HOFSTAD B, 1994, SCAND J GASTROENTERO, V29, P640, DOI 10.3109/00365529409092485; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; JENTSCHURA D, 1994, SURG ENDOSC-ULTRAS, V8, P672, DOI 10.1007/BF00678564; KNOERNSCHILD H E, 1963, Surg Forum, V14, P137; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; LIEBERMAN DA, 1991, AM J GASTROENTEROL, V86, P946; LO AY, 1994, J AM COLL SURGEONS, V179, P333; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MORSON B, 1974, P ROY SOC MED, V67, P451, DOI 10.1177/00359157740676P115; MORSON BC, 1985, BRIT J SURG, V72, P23; NEUGUT AI, 1985, CANCER, V55, P1586, DOI 10.1002/1097-0142(19850401)55:7<1586::AID-CNCR2820550729>3.0.CO;2-I; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; RANSOHOFF DF, 1994, AM J GASTROENTEROL, V89, P1765; RANSOHOFF DF, 1994, GASTROENTEROLOGY, V106, pA24; REX DK, 1991, GASTROENTEROLOGY, V100, P64, DOI 10.1016/0016-5085(91)90583-7; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; RIES LAG, 1994, SEER CANC STAT REV 1; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; TAPLIN SH, 1995, J NATL CANCER I, V87, P417, DOI 10.1093/jnci/87.6.417; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Towler B, 1998, BRIT MED J, V317, P559, DOI 10.1136/bmj.317.7158.559; Trnka Y M, 1997, HMO Pract, V11, P130; US Bureau of the Census, 1998, STAT ABSTR US 1998; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Wagner JL, 1996, PREVENTION EARLY DET, P321; WEGENER M, 1986, DIS COLON RECTUM, V29, P383, DOI 10.1007/BF02555053; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Winawer SJ, 2000, NEW ENGL J MED, V342, P1766, DOI 10.1056/NEJM200006153422401; ZARCHY TM, 1994, GASTROENTEROLOGY, V106, P1501, DOI 10.1016/0016-5085(94)90403-0; 1999, MMWR MORB MORTAL WKL, V48, P116	54	470	482	0	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1954	1961		10.1001/jama.284.15.1954	http://dx.doi.org/10.1001/jama.284.15.1954			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362JC	11035892	Bronze			2022-12-28	WOS:000089774000028
J	O'Connor, JB; Johanson, JF				O'Connor, JB; Johanson, JF			Use of the Web for medical information by a gastroenterology clinic population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WORLD-WIDE-WEB	Context Surveys have shown that 60 million persons in the United States searched for health information online in 1998. However, lack of sampling-from a clinic population limits the generalizability of these surveys to clinical practice, Objectives To determine gastroenterology patients' access to and use of the Web as a medical information resource, to identify for what information patients search, and to determine how often physicians recommend that patients search the Web. Design, Setting, and Participants Cross-sectional survey of 1006 gastroenterology outpatients in Durharn, NC, and Rockford, ill, conducted in August 1999. Main Outcome Measures Patient characteristics and education level, access to the Web, use of the Web as a medical information resource, search methods, and plans for future Web use. Results A total of 924 patients (92%) completed the questionnaire. Median age was 53 years, 41% were men, and the median education level was having completed some college. Fifty percent (462/924) reported having access to the Web. Of the 462 with access, 235 (51%) had searched the Web for medical information within the previous 12 months. Therefore, 25.5% of all patients surveyed had searched the Web for medical information within the previous year. Sixty percent of patients intended to use the Web as a medical information resource in the future, Only 35 (4%) of 825 had ever been referred to the Web by a physician, Conclusions In this clinic setting, more than one quarter of gastroenterology outpatients reported having obtained medical information from the Web within the previous year. More than two thirds of patients stated they would use the Web as a medical information resource in the future.	Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; Rockford Gastroenterol Associates, Rockford, IL USA	Duke University	O'Connor, JB (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Box 3662, Durham, NC 27710 USA.							Eysenbach G, 2000, BMJ-BRIT MED J, V320, P1713, DOI 10.1136/bmj.320.7251.1713; Impicciatore P, 1997, BMJ-BRIT MED J, V314, P1875, DOI 10.1136/bmj.314.7098.1875; Jadad AR, 1999, BMJ-BRIT MED J, V319, P761, DOI 10.1136/bmj.319.7212.761; OCONNOR JFB, 1997, AM J GASTROENTEROL, V92, P1721; Podolsky DK, 1998, GASTROENTEROLOGY, V114, P5, DOI 10.1016/S0016-5085(98)70623-7	5	86	86	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1962	1964		10.1001/jama.284.15.1962	http://dx.doi.org/10.1001/jama.284.15.1962			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362JC	11035893	Bronze			2022-12-28	WOS:000089774000029
J	Schmelzle, T; Hall, MN				Schmelzle, T; Hall, MN			TOR, a central controller of cell growth	CELL			English	Review							PROTEIN PHOSPHATASE 2A; PHOSPHATIDYLINOSITOL KINASE HOMOLOG; P70 S6 KINASE; SIGNALING PATHWAY; MAMMALIAN TARGET; MESSENGER-RNA; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; PHOSPHOINOSITIDE 3-KINASE; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION	Cell growth (increase in cell mass) and cell proliferation (increase in cell number) are distinct yet coupled processes that go hand-in-hand to give rise to an organ, organism, or tumor. Cyclin-dependent kinase(s) is the central regulator of cell proliferation. Is there an equivalent regulator for cell growth? Recent findings reveal that the target of rapamycin TOR controls an unusually abundant and diverse set of readouts all of which are important for cell growth, suggesting that this conserved kinase is such a central regulator.	Univ Basel, Bioctr, Dept Biochem, CH-4056 Basel, Switzerland	University of Basel	Hall, MN (corresponding author), Univ Basel, Bioctr, Dept Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.	m.hall@unibas.ch		Hall, Michael N/0000-0002-2998-0757				Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1999, CELL, V99; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burns DM, 1998, SENSOR ACTUAT A-PHYS, V70, P6, DOI 10.1016/S0924-4247(98)00106-X; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Edgar BA, 1999, NAT CELL BIOL, V1, pE191, DOI 10.1038/70217; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Grewe M, 1999, CANCER RES, V59, P3581; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 1998, J BIOL CHEM, V273, P22160; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; HARTWELL LH, 1967, J BACTERIOL, V93, P1662, DOI 10.1128/JB.93.5.1662-1670.1967; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Helliwell SB, 1998, GENETICS, V148, P99; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kumar V, 2000, EMBO J, V19, P1087, DOI 10.1093/emboj/19.5.1087; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Leevers SJ, 1999, SCIENCE, V285, P2082, DOI 10.1126/science.285.5436.2082; Leicht M, 1996, CELL GROWTH DIFFER, V7, P1199; Luo Y, 1996, MOL CELL BIOL, V16, P6744; MAHAJAN PB, 1994, INT J IMMUNOPHARMACO, V16, P711, DOI 10.1016/0192-0561(94)90091-4; MEYUHAS O, 1996, TRANSLATIONAL CONTRO, P363; MITCHISON JM, 1971, BIOL CELL CYCLE; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Neufeld TP, 1998, CURR OPIN CELL BIOL, V10, P784, DOI 10.1016/S0955-0674(98)80122-1; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Parekh D, 1999, J BIOL CHEM, V274, P34758, DOI 10.1074/jbc.274.49.34758; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Penuel E, 1999, MOL BIOL CELL, V10, P1693, DOI 10.1091/mbc.10.6.1693; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; STAN R, 1994, J BIOL CHEM, V269, P32027; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weinkove D, 2000, CURR OPIN GENET DEV, V10, P75, DOI 10.1016/S0959-437X(99)00042-8; Weinkove D, 1999, CURR BIOL, V9, pR867; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; White RJ, 1997, TRENDS BIOCHEM SCI, V22, P77, DOI 10.1016/S0968-0004(96)10067-0; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Zaffran S, 1998, DEVELOPMENT, V125, P3571; Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6; Ziegler WH, 1999, CURR BIOL, V9, P522, DOI 10.1016/S0960-9822(99)80236-X	100	1640	1753	3	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 13	2000	103	2					253	262		10.1016/S0092-8674(00)00117-3	http://dx.doi.org/10.1016/S0092-8674(00)00117-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057898	Bronze			2022-12-28	WOS:000089864300009
J	Tran, J; Brenner, TJ; DiNardo, S				Tran, J; Brenner, TJ; DiNardo, S			Somatic control over the germline stem cell lineage during Drosophila spermatogenesis	NATURE			English	Article							BAG-OF-MARBLES; CONTRACTILE RING; PROLIFERATION; PROTEIN; MAINTENANCE; DIVISION; FUSOME; SIGNAL	Stem cells divide both to produce new stem cells and to generate daughter cells that can differentiate(1). The underlying mechanisms are not well understood, but conceptually are of two kinds(2). Intrinsic mechanisms may control the unequal partitioning of determinants leading to asymmetric cell divisions that yield one stem cell and one differentiated daughter cell. Alternatively, extrinsic mechanisms, involving stromal cell signals, could cause daughter cells that remain in their proper niche to stay stem cells, whereas daughter cells that leave this niche differentiate. Here we use Drosophila spermatogenesis as a model stem cell system(3) to show that there are excess stem cells and gonialblasts in testes that are deficient for Raf activity. In addition, the germline stem cell population remains active for a longer fraction of lifespan than in wild type. Finally, raf is required in somatic cells that surround germ cells. We conclude that a cell-extrinsic mechanism regulates germline stem cell behaviour.	Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	DiNardo, S (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 1215 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.			DiNardo, Stephen/0000-0003-4131-5511	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060804] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060804] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROSIO L, 1989, NATURE, V342, P288, DOI 10.1038/342288a0; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Fuller Margaret T., 1993, P71; GONCZY P, 1992, DEVELOPMENT, V114, P89; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Gonczy P, 1997, DEVELOPMENT, V124, P4361; HALL PA, 1989, DEVELOPMENT, V106, P619; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hime GR, 1996, J CELL SCI, V109, P2779; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Lee T, 1996, DEVELOPMENT, V122, P409; LIN HF, 1994, DEVELOPMENT, V120, P947; Matunis E, 1997, DEVELOPMENT, V124, P4383; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; TRAN T, 1998, GENETIC ANAL GERM LI, P122; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	21	191	203	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					754	757		10.1038/35037613	http://dx.doi.org/10.1038/35037613			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048723				2022-12-28	WOS:000089773900045
J	Watson, AJ; Bakker, DCE; Ridgwell, AJ; Boyd, PW; Law, CS				Watson, AJ; Bakker, DCE; Ridgwell, AJ; Boyd, PW; Law, CS			Effect of iron supply on Southern Ocean CO2 uptake and implications for glacial atmospheric CO2	NATURE			English	Article							EQUATORIAL PACIFIC-OCEAN; FERTILIZATION EXPERIMENT; MODEL; PHYTOPLANKTON; PRODUCTIVITY; DEPOSITION; SEDIMENTS; MAXIMUM; CLIMATE; GROWTH	Photosynthesis by marine phytoplankton in the Southern Ocean, and the associated uptake of carbon, is thought to be currently limited by the availability of iron(1,2). One implication of this limitation is that a larger iron supply to the region in glacial times(3) could have stimulated algal photosynthesis, leading to lower concentrations of atmospheric CO2. Similarly, it has been proposed that artificial iron fertilization of the oceans might increase future carbon sequestration. Here we report data from a whole-ecosystem test of the iron-limitation hypothesis in the Southern Ocean(4), which show that surface uptake of atmospheric CO2 and uptake ratios of silica to carbon by phytoplankton were strongly influenced by nanomolar increases of iron concentration. We use these results to inform a model of global carbon and ocean nutrients, forced with atmospheric iron fluxes to the region derived from the Vostok(3) ice-core dust record. During glacial periods, predicted magnitudes and timings of atmospheric CO2 changes match ice-core records well. At glacial terminations, the model suggests that forcing of Southern Ocean biota by iron caused the initial similar to 40 p. p. m. of glacial-interglacial CO2 change, but other mechanisms must have accounted for the remaining 40 p. p. m. increase. The experiment also confirms that modest sequestration of atmospheric CO2 by artificial additions of iron to the Southern Ocean is in principle possible, although the period and geographical extent over which sequestration would be effective remain poorly known.	Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Univ Otago, NIWA, Ctr Chem & Phys Oceanog, Dept Chem, Dunedin, New Zealand; Plymouth Marine Lab, Ctr Coastal & Marine Studies, Plymouth PL1 3DH, Devon, England	University of East Anglia; University of Otago; Plymouth Marine Laboratory	Watson, AJ (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.		Bakker, Dorothee C E/E-4951-2015; Ridgwell, Andy/AAD-9487-2021; Boyd, Philip W/J-7624-2014	Bakker, Dorothee C E/0000-0001-9234-5337; Ridgwell, Andy/0000-0003-2333-0128; Boyd, Philip W/0000-0001-7850-1911; Watson, Andrew/0000-0002-9654-8147; Law, Cliff/0000-0002-7669-2475				Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; ARCHER D, 1991, J GEOPHYS RES-OCEANS, V96, P17037, DOI 10.1029/91JC01812; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Broecker WS, 1987, GLOBAL BIOGEOCHEM CY, V1, P15, DOI 10.1029/GB001i001p00015; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Cooper DJ, 1998, MAR CHEM, V60, P147, DOI 10.1016/S0304-4203(97)00082-0; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; JICKELLS TD, IN PRESS BIOGEOCHEMI; Keir RS, 1988, PALEOCEANOGRAPHY, V3, P413, DOI 10.1029/PA003i004p00413; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; Levitus S., 1994, WORLD OCEAN ATLAS 19, V3; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MORTLOCK RA, 1991, NATURE, V351, P220, DOI 10.1038/351220a0; PENG TH, 1991, NATURE, V349, P227, DOI 10.1038/349227a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Rickaby REM, 1999, PALEOCEANOGRAPHY, V14, P293, DOI 10.1029/1999PA900007; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; Sigman DM, 1999, PALEOCEANOGRAPHY, V14, P118, DOI 10.1029/1998PA900018; Smith HJ, 1999, NATURE, V400, P248, DOI 10.1038/22291; Sohrin Y, 2000, DEEP-SEA RES PT I, V47, P55, DOI 10.1016/S0967-0637(99)00049-7; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Stevens DP, 1997, Q J ROY METEOR SOC, V123, P929, DOI 10.1002/qj.49712354008; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; WATSON A, 1991, LIMNOL OCEANOGR, V36, P1960, DOI 10.4319/lo.1991.36.8.1960	32	352	375	2	197	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					730	733		10.1038/35037561	http://dx.doi.org/10.1038/35037561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048716				2022-12-28	WOS:000089773900038
J	Murata, K; Mitsuoka, K; Hirai, T; Walz, T; Agre, P; Heymann, JB; Engel, A; Fujiyoshi, Y				Murata, K; Mitsuoka, K; Hirai, T; Walz, T; Agre, P; Heymann, JB; Engel, A; Fujiyoshi, Y			Structural determinants of water permeation through aquaporin-1	NATURE			English	Article							INTEGRAL MEMBRANE-PROTEIN; CELL CHIP28 PROTEIN; ELECTRON CRYSTALLOGRAPHY; CHANNEL PROTEINS; 3-DIMENSIONAL STRUCTURE; RESOLUTION; PERMEABILITY; SELECTIVITY; MICROSCOPY; INHIBITION	Human red cell AQP1 is the first functionally defined member of the aquaporin family of membrane water channels. Here we describe an atomic model of AQP1 at 3.8 Angstrom resolution from electron crystallographic data. Multiple highly conserved amino-acid residues stabilize the novel fold of AQP1. The aqueous pathway is lined with conserved hydrophobic residues that permit rapid water transport, whereas the water selectivity is due to a constriction of the pore diameter to about 3 Angstrom over a span of one residue. The atomic model provides a possible molecular explanation to a longstanding puzzle in physiology-how membranes can be freely permeable to water but impermeable to protons.	Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Univ Basel, Bioctr, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins University; University of Basel	Fujiyoshi, Y (corresponding author), Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	yoshi@em.biophys.kyoto-u.ac.jp	Heymann, Bernard/F-6825-2011; Heymann, Bernard/H-8265-2019; Fujiyoshi, Yoshinori/E-5989-2012; Hirai, Teruhisa/G-2105-2015	Heymann, Bernard/0000-0002-8872-5326; Fujiyoshi, Yoshinori/0000-0002-8070-1493; Hirai, Teruhisa/0000-0002-2114-8149; Walz, Thomas/0000-0003-2606-2835				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FUJIYOSHI Y, 1991, ULTRAMICROSCOPY, V38, P241, DOI 10.1016/0304-3991(91)90159-4; Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1; GUTIERREZ AM, 1995, J MEMBRANE BIOL, V143, P189; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Hirai T, 1999, J ELECTRON MICROSC, V48, P653, DOI 10.1093/oxfordjournals.jmicro.a023731; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JUNG JS, 1994, J BIOL CHEM, V269, P14648; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRIVANEK OL, 1993, ULTRAMICROSCOPY, V49, P95, DOI 10.1016/0304-3991(93)90216-K; Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263; MACEY RI, 1970, BIOCHIM BIOPHYS ACTA, V211, P104, DOI 10.1016/0005-2736(70)90130-6; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mitsuoka K, 1999, J STRUCT BIOL, V128, P34, DOI 10.1006/jsbi.1999.4177; Mitsuoka K, 1997, ULTRAMICROSCOPY, V68, P109, DOI 10.1016/S0304-3991(97)00020-X; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; Pomes R, 1996, BIOPHYS J, V71, P19, DOI 10.1016/S0006-3495(96)79211-1; PRESTIDGE BR, 1994, INT J RADIAT ONCOL, V28, P17, DOI 10.1016/0360-3016(94)90136-8; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1994, J BIOL CHEM, V269, P1668; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; REIZER J, 1993, CRIT REV BIOCHEM MOL, V28, P235, DOI 10.3109/10409239309086796; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Scheuring S, 2000, J MOL BIOL, V299, P1271, DOI 10.1006/jmbi.2000.3811; Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981; SCHULZ GE, 1979, PRINCIPLES PROTEIN S, P17; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; VANHOEK AN, 1991, J BIOL CHEM, V266, P16633; WALZ T, 1994, J BIOL CHEM, V269, P1583; WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; WISTOW GJ, 1991, TRENDS BIOCHEM SCI, V16, P170, DOI 10.1016/0968-0004(91)90065-4; Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; ZHANG RB, 1993, BIOCHEMISTRY-US, V32, P2938, DOI 10.1021/bi00063a002; [No title captured]; [No title captured]; [No title captured]; [No title captured]	47	1315	1386	12	409	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2000	407	6804					599	605		10.1038/35036519	http://dx.doi.org/10.1038/35036519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034202				2022-12-28	WOS:000089772800038
J	Humke, EW; Shriver, SK; Starovasnik, MA; Fairbrother, WJ; Dixit, VM				Humke, EW; Shriver, SK; Starovasnik, MA; Fairbrother, WJ; Dixit, VM			ICEBERG: A novel inhibitor of interleukin-1 beta generation	CELL			English	Article							CASPASE RECRUITMENT DOMAIN; INDUCED-PROXIMITY MODEL; DEATH-EFFECTOR DOMAIN; CONVERTING-ENZYME; NMR STRUCTURE; CYSTEINE PROTEASE; CRYSTAL-STRUCTURE; BINDING DOMAIN; MICE DEFICIENT; GRANZYME-B	ProIL-1 beta is a proinflammatory cytokine that is proteolytically processed to its active form by caspase-1. Upon receipt of a proinflammatory stimulus, an upstream adaptor, RIP2, binds and oligomerizes caspase-1 zymogen, promoting its autoactivation. ICEBERG is a novel protein that inhibits generation of IL-1 beta by interacting with caspase-1 and preventing its association with RIP2. ICEBERG is induced by proinflammatory stimuli, suggesting that it may be part of a negative feedback loop. Consistent with this, enforced retroviral expression of ICEBERG inhibits lipopolysaccharide-induced IL-1 beta generation. The structure of ICEBERG reveals it to be a member of the death-domain-fold superfamily. The distribution of surface charge is complementary to the homologous prodomain of caspase-1, suggesting that charge-charge interactions mediate binding of ICEBERG to the prodomain of caspase-1.	Genentech Inc, Dept Prot Engn, S San Francisco, CA 94080 USA; Univ Michigan, Sch Med, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA; Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA	Roche Holding; Genentech; University of Michigan System; University of Michigan; Roche Holding; Genentech	Fairbrother, WJ (corresponding author), Genentech Inc, Dept Prot Engn, 460 Point San Bruno Blvd, S San Francisco, CA 94080 USA.		dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326	NIGMS NIH HHS [T32 GM07863] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; Cavanagh J., 1995, PROTEIN NMR SPECTROS; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Day CL, 1999, CELL DEATH DIFFER, V6, P1125, DOI 10.1038/sj.cdd.4400584; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Duan HJ, 1996, J BIOL CHEM, V271, P1621, DOI 10.1074/jbc.271.3.1621; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; FAIRBROTHER WJ, 1994, J MOL BIOL, V242, P252, DOI 10.1006/jmbi.1994.1577; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; GARCIA GM, 1986, CELL, V45, P453, DOI 10.1016/0092-8674(86)90331-4; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; GU Y, 1995, EMBO J, V14, P1923, DOI 10.1002/j.1460-2075.1995.tb07184.x; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hawley RG, 1996, P NATL ACAD SCI USA, V93, P10297, DOI 10.1073/pnas.93.19.10297; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Hu SM, 1997, J BIOL CHEM, V272, P9621; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Koradi R, 1996, J MOL GRAPHICS, V14, P29; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; MacCorkle RA, 1998, P NATL ACAD SCI USA, V95, P3655, DOI 10.1073/pnas.95.7.3655; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MILLER DK, 1993, J BIOL CHEM, V268, P18062; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Nicholls A., 1992, GRASP GRAPHICAL REPR; O'Reilly M, 1999, SHOCK, V12, P411, DOI 10.1097/00024382-199912000-00001; OROURKE KM, 1992, J BIOL CHEM, V267, P24921; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X; VanCriekinge W, 1996, J BIOL CHEM, V271, P27245, DOI 10.1074/jbc.271.44.27245; Vaughn DE, 1999, J MOL BIOL, V293, P439, DOI 10.1006/jmbi.1999.3177; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Yang RB, 1999, J IMMUNOL, V163, P639; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Yoza B, 1998, PROG CLIN BIOL RES, V397, P209; Zeisberger E, 1998, ANN NY ACAD SCI, V856, P116, DOI 10.1111/j.1749-6632.1998.tb08320.x; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	66	235	248	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					99	111		10.1016/S0092-8674(00)00108-2	http://dx.doi.org/10.1016/S0092-8674(00)00108-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051551	Bronze			2022-12-28	WOS:000089636400012
J	Kelley, RL; Kuroda, MI				Kelley, RL; Kuroda, MI			Noncoding RNA genes in dosage compensation and imprinting	CELL			English	Review							DROSOPHILA		Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute	Kelley, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.							Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; AKHTAR A, 2000, MOL CELL, V407, P405; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Meller VH, 2000, TRENDS CELL BIOL, V10, P54, DOI 10.1016/S0962-8924(99)01693-1; Meller VH, 2000, CURR BIOL, V10, P136, DOI 10.1016/S0960-9822(00)00311-0; Schmidt JV, 2000, GENE DEV, V14, P1997; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Solter D, 1997, GENE DEV, V11, P153, DOI 10.1101/gad.11.2.153; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	16	97	105	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					9	12		10.1016/S0092-8674(00)00099-4	http://dx.doi.org/10.1016/S0092-8674(00)00099-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051542	Bronze			2022-12-28	WOS:000089636400003
J	Baker, CD; Lorimer, AR				Baker, CD; Lorimer, AR			Cardiology: the development of a managed clinical network	BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Millennium Festival of Medicine Conference	NOV 06-10, 2000	LONDON, ENGLAND						Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow	Lorimer, AR (corresponding author), Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland.							*NHSIS MAN EX, 1999, INTR MAN CLIN NETW S; *SCOTT OF DEP HLTH, 1998, AC SERV REV REP 1998	2	25	25	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1152	1153		10.1136/bmj.321.7269.1152	http://dx.doi.org/10.1136/bmj.321.7269.1152			2	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061745	Green Published			2022-12-28	WOS:000165219600036
J	Lemoine, R; Dusmet, M				Lemoine, R; Dusmet, M			Pulmonary granulomas in an intravenous drug user.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Lausanne Hosp, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Lemoine, R (corresponding author), Univ Lausanne Hosp, CH-1011 Lausanne, Switzerland.								0	2	2	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2000	343	18					1312	1312		10.1056/NEJM200011023431805	http://dx.doi.org/10.1056/NEJM200011023431805			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368RP	11058676	Green Published			2022-12-28	WOS:000090131600005
J	O'Malley, PG; Jones, DL; Feuerstein, IM; Taylor, AJ				O'Malley, PG; Jones, DL; Feuerstein, IM; Taylor, AJ			Lack of correlation between psychological factors and subclinical coronary artery disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BEAM COMPUTED-TOMOGRAPHY; HEART-DISEASE; MYOCARDIAL-INFARCTION; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; PSYCHIATRIC-DISORDERS; LUMEN STENOSIS; DEPRESSION; HOSTILITY; CALCIFICATION	Background: The relation between psychological variables and clinically evident coronary artery disease has been studied extensively, although the potential mechanisms of such a relation remain speculative. We studied the relation between multiple psychological variables and subclinical coronary artery disease to assess the possible role of such variables in atherogenesis. Methods: We conducted a prospective study of 630 consecutive consenting, active-duty U.S. Army personnel, 39 to 45 years of age, without known coronary artery disease. Each participant was assessed for depression, anxiety, somatization, hostility, and stress. Subclinical coronary artery disease was identified by electron-beam computed tomography. Results: The mean (+/-SD) age of the subjects was 42+/-2 years; 82 percent were male, and 72 percent were white. The prevalence of coronary-artery calcification was 17.6 percent (mean calcification score, 10+/-49). The prevalence of prior or current psychiatric disorders was 12.7 percent. There was no correlation between the coronary-calcification score and the scores measuring depression (r=-0.07, P=0.08), anxiety (r=-0.07, P=0.10), hostility (r=-0.07, P=0.10), or stress (r=-0.002, P=0.96). Somatization (the number and severity of durable physical symptoms) was inversely correlated with calcification scores (r=-0.12, P=0.003), even after we controlled for age and sex. In multivariate logistic-regression models, a somatization score greater than 4 (out of a possible 26) was independently associated with the absence of any coronary-artery calcification (odds ratio, 0.49; 95 percent confidence interval, 0.25 to 0.96). Conclusions: Our data suggest that depression, anxiety, hostility, and stress are not related to coronary-artery calcification and that somatization is associated with the absence of calcification. (N Engl J Med 2000;343:1298-304.) (C) 2000, Massachusetts Medical Society.	Uniformed Serv Univ Hlth Sci, Dept Med EDP, Gen Internal Med Serv, Bethesda, MD 20814 USA; Walter Reed Army Med Ctr, Dept Med, Washington, DC 20307 USA; Walter Reed Army Med Ctr, Dept Radiol, Washington, DC 20307 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	O'Malley, PG (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med EDP, Gen Internal Med Serv, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	patrick.omalley@na.amedd.army.mil						AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; ALMADA SJ, 1991, PSYCHOSOM MED, V53, P165, DOI 10.1097/00006842-199103000-00006; *AM PSYCH ASS, DSM4 AM PSYCH ASS; Appels A, 1997, J PSYCHOSOM RES, V43, P443, DOI 10.1016/S0022-3999(97)00158-X; BAREFOOT JC, 1989, PSYCHOSOM MED, V51, P46, DOI 10.1097/00006842-198901000-00005; Barefoot JC, 1996, CIRCULATION, V93, P1976, DOI 10.1161/01.CIR.93.11.1976; BECKER MH, 1985, MED CARE, V23, P539, DOI 10.1097/00005650-198505000-00014; BOOTHKEWLEY S, 1987, PSYCHOL BULL, V101, P343, DOI 10.1037/0033-2909.101.3.343; Cook WW, 1954, J APPL PSYCHOL, V38, P414, DOI 10.1037/h0060667; COSTA PT, 1993, DIAGNOSIS TREATMENT, P155; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; de Leon CFM, 1998, ARCH INTERN MED, V158, P2341; FALLAVOLLITA JA, 1994, CIRCULATION, V89, P285, DOI 10.1161/01.CIR.89.1.285; Ford DE, 1998, ARCH INTERN MED, V158, P1422, DOI 10.1001/archinte.158.13.1422; FRASURESMITH N, 1994, JAMA-J AM MED ASSOC, V271, P1082; FRIEDMAN GD, 1974, PSYCHOSOM MED, V36, P327, DOI 10.1097/00006842-197407000-00007; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; HORWITZ RI, 1993, ARCH INTERN MED, V153, P1863, DOI 10.1001/archinte.153.16.1863; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2546, DOI 10.1001/jama.283.19.2546; JENKINS CD, 1971, NEW ENGL J MED, V284, P244, DOI 10.1056/NEJM197102042840506; JENKINS CD, 1976, NEW ENGL J MED, V294, P987, DOI 10.1056/NEJM197604292941806; JULKUNEN J, 1994, PSYCHOSOM MED, V56, P519, DOI 10.1097/00006842-199411000-00007; Kajinami K, 1997, J AM COLL CARDIOL, V29, P1549, DOI 10.1016/S0735-1097(97)00090-9; Kaufmann MW, 1999, AM HEART J, V138, P549, DOI 10.1016/S0002-8703(99)70159-6; Kawachi I, 1998, CIRCULATION, V98, P405, DOI 10.1161/01.CIR.98.5.405; KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225; Knox SS, 1998, AM J CARDIOL, V82, P1192, DOI 10.1016/S0002-9149(98)00599-2; Kop WJ, 1996, J PSYCHOSOM RES, V40, P397, DOI 10.1016/0022-3999(95)00613-3; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Kroenke K, 1994, Arch Fam Med, V3, P774; LOUIS TA, 1986, J CHRON DIS, V39, P831, DOI 10.1016/0021-9681(86)90085-8; LOUIS TA, 1987, J CHRON DIS, V40, P369; Low KG, 1998, ANN BEHAV MED, V20, P221, DOI 10.1007/BF02884964; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; Matthews KA, 1998, PSYCHOSOM MED, V60, P633, DOI 10.1097/00006842-199809000-00021; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Miller TQ, 1996, PSYCHOL BULL, V119, P322, DOI 10.1037/0033-2909.119.2.322; O'Malley PG, 1998, J PSYCHOSOM RES, V44, P279, DOI 10.1016/S0022-3999(97)00250-X; O'Malley PG, 1998, ARCH INTERN MED, V158, P2357, DOI 10.1001/archinte.158.21.2357; O'Malley PG, 2000, AM J CARDIOL, V85, P945, DOI 10.1016/S0002-9149(99)00906-6; O'Malley PG, 1999, AM HEART J, V137, P932, DOI 10.1016/S0002-8703(99)70419-9; PICKERING TG, 1985, J BEHAV MED, V8, P203, DOI 10.1007/BF00870308; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; Rumberger JA, 1997, J AM COLL CARDIOL, V29, P1542, DOI 10.1016/S0735-1097(97)00093-4; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Sesso HD, 1998, AM J CARDIOL, V82, P851, DOI 10.1016/S0002-9149(98)00491-3; SIMON A, 1995, CIRCULATION, V92, P1414, DOI 10.1161/01.CIR.92.6.1414; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sullivan MD, 1997, AM J MED, V103, P348, DOI 10.1016/S0002-9343(97)00167-8; Taylor AJ, 1998, NEW ENGL J MED, V339, P2018, DOI 10.1056/NEJM199812313392711; TENNANT CC, 1987, PSYCHOL MED, V17, P425, DOI 10.1017/S0033291700024983; VOLLMER WM, 1986, CHEST, V90, P416, DOI 10.1378/chest.90.3.416; WARDWELL WI, 1973, J CHRON DIS, V26, P447, DOI 10.1016/0021-9681(73)90096-9; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; ZYZANSKI SJ, 1976, ARCH INTERN MED, V136, P1234, DOI 10.1001/archinte.136.11.1234	55	93	93	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2000	343	18					1298	1304		10.1056/NEJM200011023431803	http://dx.doi.org/10.1056/NEJM200011023431803			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	368RP	11058674	Bronze			2022-12-28	WOS:000090131600003
J	Majeed, A; Bardsley, M; Morgan, D; O'Sullivan, C; Bindman, AB				Majeed, A; Bardsley, M; Morgan, D; O'Sullivan, C; Bindman, AB			Cross sectional study of primary care groups in London: association of measures of socioeconomic and health status with hospital admission rates	BRITISH MEDICAL JOURNAL			English	Article							SMALL-AREA ANALYSIS; ALLOCATING RESOURCES; CLINICAL GOVERNANCE; INPATIENT SERVICES; GENERAL PRACTICES; NEW-ZEALAND; AUTHORITIES; MODEL	Objectives To calculate socioeconomic and health status measures for the primary care groups in London and to examine the association between these measures and hospital admission rates. Design Cross sectional study. Setting 66 primary care groups in London, total list size 8.0 million people. Main outcome measures Elective and emergency standardised hospital admission ratios; standardised admission rates for diabetes and asthma. Results Standardised hospital admission ratios varied from 74 to 116 for total admissions and from 50 to 124 for emergency admissions. Directly standardised admission rates for asthma varied from 152 to 801 per 100 000 (mean 364) and for diabetes from 235 to 1034 per 100 000 (mean 538). There were large differences in the mortality, socioeconomic, and general practice characteristics of the primary care groups. Hospital admission rates were significantly correlated with many of the measures of chronic illness and deprivation. The strongest correlations were with disability living allowance (R = 0.64 for total admissions and R = 0.62 for emergency admissions, P <0.0001). Practice characteristics were less strongly associated with hospital admission rates. Conclusions It is feasible to produce a range of socioeconomic, health status, and practice measures for primary care groups for use in needs assessment and in planning and monitoring health services. These measures show that primary care groups have highly variable patient and practice characteristics and that hospital admission rates are associated with chronic illness and deprivation. These variations will need to be taken into account when assessing performance.	UCL, Sch Publ Policy, London WC1H 9EZ, England; E & City London Hlth Author, Hlth Londoners Project, London E1 1RD, England; UCL Hosp NHS Trust, Res & Dev Directorate, London NW1 2LT, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Majeed, A (corresponding author), UCL, Sch Publ Policy, London WC1H 9EZ, England.	a.majeed@ucl.ac.uk	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Bardsley, Martin/0000-0002-9853-6019; Majeed, Azeem/0000-0002-2357-9858	FIC NIH HHS [F06 TW002336] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F06TW002336] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Aveyard P, 1997, J Eval Clin Pract, V3, P275, DOI 10.1046/j.1365-2753.1997.t01-1-00004.x; Baker R, 1999, BRIT MED J, V318, P779, DOI 10.1136/bmj.318.7186.779; BARDSLEY M, 2000, MAPING HLTH PRIMARY; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; CARRHILL RA, 1994, BRIT MED J, V309, P1046, DOI 10.1136/bmj.309.6961.1046; Dixon J, 1998, BRIT MED J, V317, P125, DOI 10.1136/bmj.317.7151.125; Griffiths C, 1997, BRIT MED J, V314, P482, DOI 10.1136/bmj.314.7079.482; Majeed A, 1999, BRIT MED J, V318, P772, DOI 10.1136/bmj.318.7186.772; MAJEED A, 1999, PUBLIC HLTH MED, V1, P4; MAJEED FA, 1994, BRIT MED J, V308, P1272, DOI 10.1136/bmj.308.6939.1272; MAJEED FA, 1995, BRIT MED J, V310, P1511, DOI 10.1136/bmj.310.6993.1511; Malcolm L, 1997, BRIT MED J, V314, P1890, DOI 10.1136/bmj.314.7098.1890; Malcolm L, 1999, BRIT MED J, V319, P1340, DOI 10.1136/bmj.319.7221.1340; *NHS EX, 1999, QUAL PERF NHS HIGH L; *NHS EX, 1988, EX ATTR DAT SET; Reid FDA, 1999, BRIT MED J, V319, P98, DOI 10.1136/bmj.319.7202.98; SCALLY G, 1998, BRIT MED J, V316, P39; *SECR STAT HLTH, 1997, NEW NHS; SMITH P, 1994, BRIT MED J, V309, P1050, DOI 10.1136/bmj.309.6961.1050	19	63	63	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 28	2000	321	7268					1057	1060		10.1136/bmj.321.7268.1057	http://dx.doi.org/10.1136/bmj.321.7268.1057			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PU	11053180	Bronze, Green Published			2022-12-28	WOS:000165076800027
J	Grassme, H; Kirschnek, S; Riethmueller, J; Riehle, A; von Kurthy, G; Lang, F; Weller, M; Gulbins, E				Grassme, H; Kirschnek, S; Riethmueller, J; Riehle, A; von Kurthy, G; Lang, F; Weller, M; Gulbins, E			CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa	SCIENCE			English	Article							T-CELLS; FAS LIGAND; APOPTOSIS; MACROPHAGES; ACTIVATION; PATHWAYS; RECEPTOR; SIGNAL	Pseudomonas aeruginosa causes severe infections, particularly of the lung, that are life threatening. Here, we show that P. aeruginosa infection induces apoptosis of lung epithelial cells by activation of the endogenous CD95/CD95 ligand system. Deficiency of CD95 or CD95 ligand on epithelial cells prevented apoptosis of lung epithelial cells in vivo as well as in vitro. The importance of CD95/CD95 ligand-mediated lung epithelial cell apoptosis was demonstrated by the rapid development of sepsis in CD95- or CD95 ligand-deficient mice, but not in normal mice, after P. aeruginosa infection.	Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany; Univ Tubingen, Dept Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Gulbins, E (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Gulbins, Erich/L-6989-2014	Gulbins, Erich/0000-0002-3117-1342; Weller, Michael/0000-0002-1748-174X				Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; CIFONE MG, 1995, EMBO J, V14, P5859, DOI 10.1002/j.1460-2075.1995.tb00274.x; Fernandez-Prada C, 1998, INFECT IMMUN, V66, P3918, DOI 10.1128/IAI.66.8.3918-3924.1998; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P579, DOI 10.1128/IAI.65.2.579-586.1997; Halaas O, 1998, J IMMUNOL, V160, P4330; Kang PJ, 1997, MOL MICROBIOL, V24, P1249; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Latinis KM, 1996, BLOOD, V87, P871, DOI 10.1182/blood.V87.3.871.bloodjournal873871; Merrick JC, 1997, AM J PATHOL, V151, P785; MULLER KP, 1995, EUR J IMMUNOL, V25, P2996, DOI 10.1002/eji.1830251043; Nagata S, 1998, J HUM GENET, V43, P2, DOI 10.1007/s100380050029; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; PAYNE CM, 1995, LEUKEMIA LYMPHOMA, V19, P43, DOI 10.3109/10428199509059662; RENSINGEHL A, 1995, J INFLAMM, V45, P161; WANG ZQ, 1994, EUR J IMMUNOL, V24, P1549, DOI 10.1002/eji.1830240714; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	21	210	226	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					527	530		10.1126/science.290.5491.527	http://dx.doi.org/10.1126/science.290.5491.527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039936				2022-12-28	WOS:000089946000055
J	Vreeland, RH; Rosenzweig, WD; Powers, DW				Vreeland, RH; Rosenzweig, WD; Powers, DW			Isolation of a 250 million-year-old halotolerant bacterium from a primary salt crystal	NATURE			English	Article							SP. NOV.; DOMINICAN AMBER; NEW-MEXICO; EVAPORITES; HALOBACTERIA; DIVERSITY; ORIGIN; GENUS	Bacteria have been found associated with a variety of ancient samples(1), however few studies are generally accepted due to questions about sample quality and contamination. When Cano and Borucki(2) isolated a strain of Bacillus sphaericus from an extinct bee trapped in 25-30 million-year-old amber, careful sample selection and stringent sterilization techniques were the keys to acceptance. Here we report the isolation and growth of a previously unrecognized spore-forming bacterium (Bacillus species, designated 2-9-3) from a brine inclusion within a 250 million-year-old salt crystal from the Permian Salado Formation. Complete gene sequences of the 16S ribosomal DNA show that the organism is part of the lineage of Bacillus marismortui and Virgibacillus pantothenticus. Delicate crystal structures and sedimentary features indicate the salt has not recrystallized since formation. Samples were rejected if brine inclusions showed physical signs of possible contamination. Surfaces of salt crystal samples were sterilized with strong alkali and acid before extracting brines from inclusions. Sterilization procedures reduce the probability of contamination to less than 1 in 10(9).	W Chester Univ, Dept Biol, W Chester, PA 19383 USA	Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania	Vreeland, RH (corresponding author), W Chester Univ, Dept Biol, W Chester, PA 19383 USA.	rvreeland@wcupa.edu						Arahal DR, 1999, INT J SYST BACTERIOL, V49, P521, DOI 10.1099/00207713-49-2-521; CANO RJ, 1995, SCIENCE, V268, P1060, DOI 10.1126/science.7538699; Cournoyer B, 1999, FEMS MICROBIOL LETT, V177, P29, DOI 10.1111/j.1574-6968.1999.tb13709.x; CROFT J. S., 1978, THESIS OHIO STATE U; DENNER EBM, 1994, INT J SYST BACTERIOL, V44, P774, DOI 10.1099/00207713-44-4-774; Garabito MJ, 1997, INT J SYST BACTERIOL, V47, P735, DOI 10.1099/00207713-47-3-735; Grant WD, 1998, EXTREMOPHILES, V2, P279, DOI 10.1007/s007920050070; Greenblatt CL, 1999, MICROBIAL ECOL, V38, P58, DOI 10.1007/s002489900153; Hardie L.A., 1983, 6 INT S SALT I ALEX, V1, P11; Heyndrickx M, 1998, INT J SYST BACTERIOL, V48, P99, DOI 10.1099/00207713-48-1-99; HOLT RM, 1990, 90051 DOEWIPP US DEP, P1; HOLT RM, 1990, GEOLOGICAL HYDROLOGI, V14, P45; HUVAL JH, 1991, GEN APPL ASPECTS HAL, V201, P53; Lambert LH, 1998, INT J SYST BACTERIOL, V48, P511, DOI 10.1099/00207713-48-2-511; LOWENSTEIN TK, 1990, AM J SCI, V290, P1, DOI 10.2475/ajs.290.1.1; LOWENSTEIN TK, 1985, SEDIMENTOLOGY, V32, P627, DOI 10.1111/j.1365-3091.1985.tb00478.x; LOWENSTEIN TK, 1988, GEOL SOC AM BULL, V100, P592, DOI 10.1130/0016-7606(1988)100<0592:OODCIA>2.3.CO;2; NORTON CF, 1993, J GEN MICROBIOL, V139, P1077, DOI 10.1099/00221287-139-5-1077; ONSTOTT TC, 1995, EOS, V76, pS285; POWERS DW, 1985, J SEDIMENT PETROL, V55, P769; RENNE PR, 1998, MINERAL MAG A, V62, P1253, DOI DOI 10.1180/MINMAG.1998.62A.2.320; RENNE PR, 1996, EOS T AM GEOPHYS UN, V77, P794; ROEDDER E, 1984, AM MINERAL, V69, P413; ROSENZWEIG WD, IN PRESS GEOMICROBIO; VREELAND RH, 1984, J BACTERIOL, V160, P879, DOI 10.1128/JB.160.3.879-883.1984; Vreeland RH, 1998, EXTREMOPHILES, V2, P321, DOI 10.1007/s007920050075; Vreeland RH, 1998, MICR EXTREM UNUSUAL, P53; VREELAND RH, 1998, ENIGMATIC EXTREME MI, P387; Waino M, 1999, INT J SYST BACTERIOL, V49, P821, DOI 10.1099/00207713-49-2-821; Walter J. C. Jr., 1953, Journal of Paleontology, V27, P679	30	458	490	3	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					897	900		10.1038/35038060	http://dx.doi.org/10.1038/35038060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057666				2022-12-28	WOS:000089901900049
J	Kotler, DP				Kotler, DP			Cachexia	ANNALS OF INTERNAL MEDICINE			English	Review							TUMOR-NECROSIS-FACTOR; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; CHRONIC HEART-FAILURE; OBSTRUCTIVE PULMONARY-DISEASE; PLACEBO-CONTROLLED TRIAL; RESTING ENERGY-EXPENDITURE; PHASE PROTEIN RESPONSE; LEAN BODY-MASS; GASTROINTESTINAL CANCER-PATIENTS; RANDOMIZED CONTROLLED TRIAL	Cachexia represents the clinical consequence of a chronic, systemic inflammatory response, and its manifestations differ considerably from those of starvation. Although cachexia is classically associated with chronic infections and malignant conditions, some of its elements have been identified in a wide variety of chronic diseases and in aging persons. Cachexia has repeatedly been associated with adverse clinical outcomes. The changes seen in cachexia are multidimensional and highly coordinated. Most obvious is a redistribution of the body's protein content, with preferential depletion of skeletal muscle and an increase in the synthesis of proteins involved in the response to tissue injury-the so-called acute-phase response. The physiologic, metabolic, and behavioral changes of cachexia are tightly regulated by cytokines, which signal the synthesis of acute-phase proteins as well as changes in intermediary metabolism that provide substrate and energy. The metabolic adaptations, notably the increase in the rate of protein degradation, limit the ability of hypercaloric feeding to reverse the depletion of lean mass. Recent studies have demonstrated the ability of anabolic and anticatabolic agents to mitigate the loss of skeletal muscle and to improve clinical outcomes in selected circumstances. Preclinical initiatives target the cytokine regulation of protein metabolism. It should be stressed that metabolic manipulation in cachexia could have positive or negative clinical effects, which must be distinguished through appropriate clinical trials.	Columbia Univ, New York, NY USA	Columbia University	Kotler, DP (corresponding author), St Lukes Roosevelt Hosp, Gastrointestinal Div S&R 301, 421 W 113st St, New York, NY 10025 USA.	dpkotler@aol.com						Anker SD, 1999, AM J CARDIOL, V83, P612, DOI 10.1016/S0002-9149(98)00927-8; Anker SD, 1999, CURR OPIN CARDIOL, V14, P211, DOI 10.1097/00001573-199905000-00004; Anker SD, 1998, QJM-MON J ASSOC PHYS, V91, P199, DOI 10.1093/qjmed/91.3.199; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Baarends EM, 1997, THORAX, V52, P780, DOI 10.1136/thx.52.9.780; BARACOS V, 1983, NEW ENGL J MED, V308, P553, DOI 10.1056/NEJM198303103081002; Barber MD, 1999, CLIN SCI, V96, P83, DOI 10.1042/CS19980185; BARTLETT DL, 1995, SURGERY, V117, P260, DOI 10.1016/S0039-6060(05)80199-0; Belardinelli R, 1999, CIRCULATION, V99, P1173, DOI 10.1161/01.CIR.99.9.1173; Berkowitz DE, 1998, AM J PHYSIOL-ENDOC M, V274, pE992, DOI 10.1152/ajpendo.1998.274.6.E992; BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0; Bhasin S, 1998, J CLIN ENDOCR METAB, V83, P3155, DOI 10.1210/jc.83.9.3155; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; Burdet L, 1997, AM J RESP CRIT CARE, V156, P1800, DOI 10.1164/ajrccm.156.6.9704142; COSTELLI P, 1995, J CLIN INVEST, V95, P2367, DOI 10.1172/JCI117929; Daneryd P, 1998, CANCER RES, V58, P5374; Demling RH, 1997, J TRAUMA, V43, P47, DOI 10.1097/00005373-199707000-00012; DIFRANCIA M, 1994, AM J RESP CRIT CARE, V150, P1453, DOI 10.1164/ajrccm.150.5.7952575; Edelman MJ, 1999, CANCER-AM CANCER SOC, V86, P684; Eliaz R, 1996, CYTOKINE, V8, P482, DOI 10.1006/cyto.1996.0065; FALCONER JS, 1995, CANCER, V75, P2077, DOI 10.1002/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9; Fazio S, 1996, NEW ENGL J MED, V334, P809, DOI 10.1056/NEJM199603283341301; Fearon KCH, 1998, ANN SURG, V227, P249, DOI 10.1097/00000658-199802000-00015; FEINGOLD KR, 1989, ENDOCRINOLOGY, V125, P267, DOI 10.1210/endo-125-1-267; FELIG P, 1970, NEW ENGL J MED, V282, P166; FERRARI R, 1995, CIRCULATION, V92, P1479, DOI 10.1161/01.CIR.92.6.1479; Ferreira IM, 1998, CHEST, V114, P19, DOI 10.1378/chest.114.1.19; FONG Y, 1989, AM J PHYSIOL, V256, pR659, DOI 10.1152/ajpregu.1989.256.3.R659; FORBES GB, 1987, NUTR REV, V45, P225; Fujita J, 1996, INT J CANCER, V68, P637, DOI 10.1002/(SICI)1097-0215(19961127)68:5<637::AID-IJC14>3.0.CO;2-Z; Gaughan WJ, 1997, AM J KIDNEY DIS, V30, P495, DOI 10.1016/S0272-6386(97)90307-3; Gold J, 1996, AIDS, V10, P745, DOI 10.1097/00002030-199606001-00008; GOTSCHLICH EC, 1989, ANN NY ACAD SCI, V557, P9; Grinspoon S, 1999, CLIN INFECT DIS, V28, P634, DOI 10.1086/515162; Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P4051, DOI 10.1210/jc.81.11.4051; Grinspoon S, 1997, J CLIN ENDOCR METAB, V82, P1332, DOI 10.1210/jc.82.5.1332; Grinspoon S, 1998, ANN INTERN MED, V129, P18, DOI 10.7326/0003-4819-129-1-199807010-00005; Grunfeld C, 1996, J CLIN INVEST, V97, P2152, DOI 10.1172/JCI118653; Grunfeld C, 1996, J CLIN ENDOCR METAB, V81, P4342, DOI 10.1210/jc.81.12.4342; GRUNFELD C, 1992, AM J CLIN NUTR, V55, P455, DOI 10.1093/ajcn/55.2.455; HARRIS HW, 1993, J CLIN INVEST, V91, P1028, DOI 10.1172/JCI116259; HARRIS HW, 1990, J CLIN INVEST, V86, P696, DOI 10.1172/JCI114765; Isgaard J, 1998, EUR HEART J, V19, P1704, DOI 10.1053/euhj.1998.1123; Johansen KL, 1999, JAMA-J AM MED ASSOC, V281, P1275, DOI 10.1001/jama.281.14.1275; Kaibara A, 1998, AM J PHYSIOL-REG I, V274, pR1518, DOI 10.1152/ajpregu.1998.274.6.R1518; Kawamura I, 1999, GENE THER, V6, P91, DOI 10.1038/sj.gt.3300819; KAYSEN GA, 1995, KIDNEY INT, V48, P510, DOI 10.1038/ki.1995.321; Keith M, 1998, J AM COLL CARDIOL, V31, P1352, DOI 10.1016/S0735-1097(98)00101-6; Khan S, 1999, INT J CANCER, V80, P444, DOI 10.1002/(SICI)1097-0215(19990129)80:3<444::AID-IJC18>3.3.CO;2-L; Klausner JD, 1996, J ACQ IMMUN DEF SYND, V11, P247, DOI 10.1097/00042560-199603010-00005; Kotler Donald P., 1996, P229; Kotler DP, 1999, AM J CLIN NUTR, V69, P432; KOTLER DP, 1985, AM J CLIN NUTR, V42, P1255, DOI 10.1093/ajcn/42.6.1255; KOTLER DP, 1990, JPEN-PARENTER ENTER, V14, P454, DOI 10.1177/0148607190014005454; KOTLER DP, 1989, AM J CLIN NUTR, V50, P444, DOI 10.1093/ajcn/50.3.444; KUSHNER I, 1993, PERSPECT BIOL MED, V36, P611; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Llovera M, 1996, BIOCHEM BIOPH RES CO, V221, P653, DOI 10.1006/bbrc.1996.0651; Lorite MJ, 1998, BRIT J CANCER, V78, P850, DOI 10.1038/bjc.1998.592; LUNDHOLM K, 1994, CANCER RES, V54, P5602; MACALLAN DC, 1995, AM J CLIN NUTR, V61, P818, DOI 10.1093/ajcn/61.4.818; MACALLAN DC, 1995, NEW ENGL J MED, V333, P83, DOI 10.1056/NEJM199507133330202; Mannix ET, 1999, CHEST, V115, P708, DOI 10.1378/chest.115.3.708; MANTOVANI G, 1995, INT J CLIN LAB RES, V25, P135, DOI 10.1007/BF02592554; Martin F, 1999, CYTOKINE, V11, P80, DOI 10.1006/cyto.1998.0398; McMillan DC, 1997, BRIT J CANCER, V76, P788, DOI 10.1038/bjc.1997.463; MENDENHALL CL, 1993, HEPATOLOGY, V17, P564, DOI 10.1002/hep.1840170407; Miller K, 1998, J CLIN ENDOCR METAB, V83, P2717, DOI 10.1210/jc.83.8.2717; Mitch WE, 1998, AM J CLIN NUTR, V67, P359, DOI 10.1093/ajcn/67.3.359; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Moore FD, 1963, BODY CELL MASS ITS S; Nakashima J, 1998, CLIN CANCER RES, V4, P1743; Nomura K, 1996, SURG TODAY, V26, P89, DOI 10.1007/BF00311770; NORTON JA, 1985, CANCER RES, V45, P5547; Ohara M, 1998, METABOLISM, V47, P101, DOI 10.1016/S0026-0495(98)90201-3; Oka M, 1996, CANCER RES, V56, P2776; Okada S, 1998, JPN J CLIN ONCOL, V28, P12, DOI 10.1093/jjco/28.1.12; Osterziel KJ, 1998, LANCET, V351, P1233, DOI 10.1016/S0140-6736(97)11329-0; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Papadakis MA, 1996, ANN INTERN MED, V124, P708, DOI 10.7326/0003-4819-124-8-199604150-00002; Paton NI, 1999, AIDS, V13, P1195, DOI 10.1097/00002030-199907090-00007; Plank LD, 1998, ANN SURG, V228, P146, DOI 10.1097/00000658-199808000-00002; POEHLMAN ET, 1994, ANN INTERN MED, V121, P860, DOI 10.7326/0003-4819-121-11-199412010-00006; POPP MB, 1981, SURGERY, V90, P195; POWANDA MC, 1982, AM J CLIN NUTR, V35, P762, DOI 10.1093/ajcn/35.4.762; Preston T, 1998, J NUTR, V128, P1355, DOI 10.1093/jn/128.8.1355; ReyesTeran G, 1996, AIDS, V10, P1501, DOI 10.1097/00002030-199611000-00007; RIGAUD D, 1994, AM J CLIN NUTR, V60, P775, DOI 10.1093/ajcn/60.5.775; Riquelme R, 1996, AM J RESP CRIT CARE, V154, P1450, DOI 10.1164/ajrccm.154.5.8912763; Rosenbaum K, 2000, JPEN-PARENTER ENTER, V24, P52, DOI 10.1177/014860710002400252; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Roubenoff R, 1999, AIDS, V13, P231, DOI 10.1097/00002030-199902040-00011; Roubenoff R, 1997, ARTHRITIS RHEUM, V40, P534, DOI 10.1002/art.1780400320; Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20; ROUBENOFF R, 1994, J CLIN INVEST, V93, P2379, DOI 10.1172/JCI117244; Sarraf P, 1997, J EXP MED, V185, P171, DOI 10.1084/jem.185.1.171; Sauerwein RW, 1997, AM J CLIN NUTR, V65, P1534, DOI 10.1093/ajcn/65.5.1534; Schambelan M, 1996, ANN INTERN MED, V125, P873, DOI 10.7326/0003-4819-125-11-199612010-00002; Schols AMWJ, 1999, AM J RESP CRIT CARE, V160, P1220, DOI 10.1164/ajrccm.160.4.9811033; Shibata M, 1996, ANN NY ACAD SCI, V795, P410, DOI 10.1111/j.1749-6632.1996.tb52707.x; Shibata M, 1998, SURG TODAY, V28, P884, DOI 10.1007/s005950050247; SHIKE M, 1984, ANN INTERN MED, V101, P303, DOI 10.7326/0003-4819-101-3-303; Simons JPFHA, 1998, CANCER, V82, P553, DOI 10.1002/(SICI)1097-0142(19980201)82:3<553::AID-CNCR18>3.3.CO;2-Z; Simons JPFHA, 1997, CLIN SCI, V93, P273, DOI 10.1042/cs0930273; Srivastava MD, 1998, IMMUNOPHARMACOLOGY, V40, P179, DOI 10.1016/S0162-3109(98)00041-1; Strawford A, 1999, J ACQ IMMUN DEF SYND, V20, P137, DOI 10.1097/00042560-199902010-00005; Strawford A, 1999, JAMA-J AM MED ASSOC, V281, P1282, DOI 10.1001/jama.281.14.1282; SZALKOWSKI D, 1995, ENDOCRINOLOGY, V136, P1474, DOI 10.1210/en.136.4.1474; Takabatake N, 1999, AM J RESP CRIT CARE, V159, P1215, DOI 10.1164/ajrccm.159.4.9806134; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Thea DM, 1996, ANN INTERN MED, V124, P757, DOI 10.7326/0003-4819-124-8-199604150-00009; Timpone JG, 1997, AIDS RES HUM RETROV, V13, P305, DOI 10.1089/aid.1997.13.305; Toth MJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE469, DOI 10.1152/ajpendo.1997.272.3.E469; TRACEY KJ, 1990, J CLIN INVEST, V86, P2014, DOI 10.1172/JCI114937; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; Wallace AM, 1998, CLIN CANCER RES, V4, P2977; Warren S, 1932, AM J MED SCI, V184, P610, DOI 10.1097/00000441-193211000-00002; Wigmore SJ, 1996, NUTRITION, V12, pS27; WINTER BK, 1995, BRIT J CANCER, V72, P1173, DOI 10.1038/bjc.1995.482; Yarasheski KE, 1998, AM J PHYSIOL-ENDOC M, V275, pE577, DOI 10.1152/ajpendo.1998.275.4.E577; Zachwieja JJ, 1999, PHYS THER, V79, P76, DOI 10.1093/ptj/79.1.76	121	350	363	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2000	133	8					622	634		10.7326/0003-4819-133-8-200010170-00015	http://dx.doi.org/10.7326/0003-4819-133-8-200010170-00015			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364RH	11033592				2022-12-28	WOS:000089906300008
J	Lundberg, P; Ranta, E; Kaitala, V; Jonzen, N				Lundberg, P; Ranta, E; Kaitala, V; Jonzen, N			Biodiversity - Coexistence and resource competition	NATURE			English	Article							EXCLUSION		Univ Lund, Dept Theoret Ecol, S-22362 Lund, Sweden; Univ Helsinki, Dept Ecol & Systemat, Div Populat Biol, Integrat Ecol Unit, FIN-00014 Helsinki, Finland; Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40351, Finland	Lund University; University of Helsinki; University of Jyvaskyla	Lundberg, P (corresponding author), Univ Lund, Dept Theoret Ecol, Ecol Bldg, S-22362 Lund, Sweden.		Lundberg, Per/A-2479-2010					ARMSTRONG RA, 1976, J THEOR BIOL, V56, P499, DOI 10.1016/S0022-5193(76)80089-6; ARMSTRONG RA, 1976, THEOR POPUL BIOL, V9, P317, DOI 10.1016/0040-5809(76)90051-4; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; EBENHOH W, 1994, ECOL MODEL, V75, P83, DOI 10.1016/0304-3800(94)90009-4; Fryxell J.M., 1997, INDIVIDUAL BEHAV COM; Gause G. F., 1934, STRUGGLE EXISTENCE; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; KALAN JL, 1977, AM NAT, V111, P1032; KOCH AL, 1974, J THEOR BIOL, V44, P387, DOI 10.1016/0022-5193(74)90169-6; MCGEHEE R, 1977, J DIFFER EQUATIONS, V23, P30, DOI 10.1016/0022-0396(77)90135-8; Sommer U, 1999, NATURE, V402, P366, DOI 10.1038/46453; Yodzis P., 1989, INTRO THEORETICAL EC	13	9	10	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					694	694		10.1038/35037672	http://dx.doi.org/10.1038/35037672			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048708	Bronze			2022-12-28	WOS:000089773900029
J	Nicholson, DW				Nicholson, DW			From bench to clinic with apoptosis-based therapeutic agents	NATURE			English	Review							CELL-DEATH; ISCHEMIA-REPERFUSION; ICE/CED-3 PROTEASE; CASPASE INHIBITOR; CYSTEINE PROTEASE; MICE; SURVIVAL; FAMILY; ACTIVATION; RECEPTORS	A retrospective look at the basis of human disease pathogenesis almost always reveals an apoptotic component that either contributes to disease progression or accounts for it. What makes this field particularly exciting is the breadth of therapeutic opportunities that are on offer. The pace of apoptosis research has raised expectations that therapeutics will follow soon. But many of the organizations that are best placed to take advantage of these discoveries consider the ability to modulate the life or death of a cell for the purpose of disease treatment as perhaps being 'too good to be true'. Nevertheless, practical therapeutics that modulate apoptosis will no doubt appear in the clinic or on the shelf in the next few years.	Merck Frosst Ctr Therapeut Res, Merck Res Labs, Pointe Claire, PQ H9R 4P8, Canada	Merck & Company	Nicholson, DW (corresponding author), Merck Frosst Ctr Therapeut Res, Merck Res Labs, POB 1005, Pointe Claire, PQ H9R 4P8, Canada.	donald_nicholson@merck.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; ASHKENAZI A, 2000, P AM ASS CANC RES C; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; CORY S, 1995, ANNU REV IMMUNOL, V13, P513, DOI 10.1146/annurev.iy.13.040195.002501; Cursio R, 1999, FASEB J, V13, P253, DOI 10.1096/fasebj.13.2.253; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; Farber A, 1999, J VASC SURG, V30, P752, DOI 10.1016/S0741-5214(99)70115-1; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Grobmyer SR, 1999, MOL MED, V5, P585, DOI 10.1007/BF03402071; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Jansen B, 1998, NAT MED, V4, P232, DOI 10.1038/nm0298-232; JANSEN B, 2000, P AM ASS CANC RES C, pA59; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Kim KH, 2000, CLIN CANCER RES, V6, P335; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kondratyev A, 2000, MOL BRAIN RES, V75, P216, DOI 10.1016/S0169-328X(99)00292-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lee D, 2000, J BIOL CHEM, V275, P16007, DOI 10.1074/jbc.275.21.16007; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Marsters SA, 1999, RECENT PROG HORM RES, V54, P225; Mocanu MM, 2000, BRIT J PHARMACOL, V130, P197, DOI 10.1038/sj.bjp.0703336; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 2000, NAT MED, V6, P502, DOI 10.1038/74972; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Que FG, 1999, HEPATOLOGY, V30, P1398, DOI 10.1002/hep.510300618; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Reed JC, 1999, NAT BIOTECHNOL, V17, P1064, DOI 10.1038/15048; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Schierle GS, 1999, NAT MED, V5, P97, DOI 10.1038/4785; Schlagbauer-Wadl H, 2000, J INVEST DERMATOL, V114, P725, DOI 10.1046/j.1523-1747.2000.00937.x; Schneider P, 2000, Pharm Acta Helv, V74, P281, DOI 10.1016/S0031-6865(99)00038-2; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Vocero-Akbani AM, 1999, NAT MED, V5, P29, DOI 10.1038/4710; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Waters JS, 2000, J CLIN ONCOL, V18, P1812, DOI 10.1200/JCO.2000.18.9.1812; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zangemeister-Wittke U, 2000, CLIN CANCER RES, V6, P2547; Zhang XD, 2000, J IMMUNOL, V164, P3961, DOI 10.4049/jimmunol.164.8.3961	63	572	622	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					810	816		10.1038/35037747	http://dx.doi.org/10.1038/35037747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048733				2022-12-28	WOS:000089773900057
J	Maruyama, M; Lam, KP; Rajewsky, K				Maruyama, M; Lam, KP; Rajewsky, K			Memory B-cell persistence is independent of persisting immunizing antigen	NATURE			English	Article							IN-VIVO; T-CELLS; MICE; IMMUNOGLOBULIN; GENERATION	Immunological memory in the antibody system is generated in T-cell-dependent responses and carried by long-lived memory B cells that recognize antigen by high-affinity antibodies(1,2). But it remains controversial(1) whether these B cells represent true 'memory' cells (that is, their maintenance is independent of the immunizing antigen), or whether they are a product of a chronic immune response driven by the immunizing antigen, which can be retained in the organism for extended time periods on the surface of specialized antigen-presenting cells (follicular dendritic cells)(3). Cell transfer experiments provided evidence in favour of a role of the immunizing antigen(4,5); however, analysis of memory cells in intact animals, which showed that these cells are mostly resting(6) and can persist in the absence of detectable T-cell help(7) or follicular dendritic cells(8), argued against it. Here we show, by using a genetic switch mediated by Cre recombinase, that memory B cells switching their antibody specificity away from the immunizing antigen are indeed maintained in the animal over long periods of time, similar to cells retaining their original antigen-binding specificity.	Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117609, Singapore	University of Cologne; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Rajewsky, K (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-50931 Cologne, Germany.		Lam, Kong-Peng/G-5374-2012; MARUYAMA, MITSUO/A-7083-2016	Lam, Kong-Peng/0000-0002-1316-4333; Rajewsky, Klaus/0000-0002-6633-6370				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; ASKONAS BA, 1972, EUR J IMMUNOL, V2, P494, DOI 10.1002/eji.1830020604; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; ESSER C, 1990, ANNU REV IMMUNOL, V8, P717, DOI 10.1146/annurev.iy.08.040190.003441; GRAY D, 1988, NATURE, V336, P70, DOI 10.1038/336070a0; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Karrer U, 2000, J IMMUNOL, V164, P768, DOI 10.4049/jimmunol.164.2.768; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lam KP, 1998, P NATL ACAD SCI USA, V95, P13171, DOI 10.1073/pnas.95.22.13171; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nemazee D, 1996, IMMUNOL TODAY, V17, P25, DOI 10.1016/0167-5699(96)80565-2; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; OKUMURA K, 1976, EUR J IMMUNOL, V6, P467, DOI 10.1002/eji.1830060704; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SPRENT J, 1994, CELL, V76, P315, DOI 10.1016/0092-8674(94)90338-7; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Torres RM, 1997, LAB PROTOCOLS CONDIT; VIEIRA P, 1990, INT IMMUNOL, V2, P487, DOI 10.1093/intimm/2.6.487; ZOU YR, 1993, EMBO J, V12, P811, DOI 10.1002/j.1460-2075.1993.tb05721.x	30	241	249	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					636	642		10.1038/35036600	http://dx.doi.org/10.1038/35036600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034213				2022-12-28	WOS:000089772800049
J	McNab, BK				McNab, BK			Metabolic scaling - Energy constraints on carnivore diet	NATURE			English	Article							MAMMALS		Univ Florida, Dept Zool, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	McNab, BK (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.							Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; LAURIE A, 1977, J ZOOL, V182, P187; MCNAB BK, 1980, J MAMMAL, V61, P606, DOI 10.2307/1380307; MCNAB BK, 1992, FUNCT ECOL, V6, P672, DOI 10.2307/2389963; MCNAB BK, 1984, J ZOOL, V203, P485, DOI 10.1111/j.1469-7998.1984.tb02345.x; MCNAB BK, 1988, Q REV BIOL, V63, P25, DOI 10.1086/415715; MCNAB BK, 1992, J MAMMAL, V73, P168, DOI 10.2307/1381879; WESTOBY M, 1995, J ECOL, V83, P531, DOI 10.2307/2261605	8	31	33	4	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					584	584		10.1038/35036695	http://dx.doi.org/10.1038/35036695			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034199	Bronze			2022-12-28	WOS:000089772800035
J	Schilling, G				Schilling, G			A hundred million points of light	NATURE			English	News Item																		Fan XH, 2000, ASTRON J, V120, P1167, DOI 10.1086/301534; Strauss MA, 1999, ASTROPHYS J, V522, pL61, DOI 10.1086/312218; Tsvetanov ZI, 2000, ASTROPHYS J, V531, pL61, DOI 10.1086/312515	3	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					557	557		10.1038/35036744	http://dx.doi.org/10.1038/35036744			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034182	Bronze			2022-12-28	WOS:000089772800014
J	Terada, S; Kinjo, M; Hirokawa, N				Terada, S; Kinjo, M; Hirokawa, N			Oligomeric tubulin in large transporting complex is transported via kinesin in squid giant axone	CELL			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; CYTOPLASMIC DYNEIN; MONOCLONAL-ANTIBODY; GROWING AXONS; LOLIGO-PEALEI; MICROTUBULES; NEURONS; AXOPLASM; MOLECULES; MYOSIN	Slow axonal transport depends on an active mechanism that conveys cytosolic proteins. To investigate its molecular mechanism, we now constructed an in vitro experimental system for observation of tubulin transport, using squid giant axons. After injecting fluorescence-labeled tubulin into the axons, we monitored the movement of fluorescence by confocal laser scanning microscopy and fluorescence correlation spectroscopy. Here, from the pharmacological experiments and the functional blocking of kinesin motor protein by anti-kinesin antibody, we show that the directional movement of fluorescent profile was dependent on kinesin motor function. The fluorescent correlation function and estimated translational diffusion time revealed that tubulin molecule was transported in a unique form of large transporting complex distinct from those of stable polymers or other cytosolic protein.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; Hokkaido Univ, Res Inst Elect Sci, Lab Supramol Biophys, Kita Ku, Sapporo, Hokkaido 0600812, Japan	University of Tokyo; Hokkaido University	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Kinjo, Masataka/F-5267-2011	Kinjo, Masataka/0000-0001-8889-8369				Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Baas PW, 1997, TRENDS CELL BIOL, V7, P380, DOI 10.1016/S0962-8924(97)01148-3; BEARER EL, 1993, P NATL ACAD SCI USA, V90, P11252, DOI 10.1073/pnas.90.23.11252; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; Campenot RB, 1996, J CELL BIOL, V135, P701, DOI 10.1083/jcb.135.3.701; Chang SH, 1999, NAT CELL BIOL, V1, P399, DOI 10.1038/15629; Dillman JF, 1996, P NATL ACAD SCI USA, V93, P141, DOI 10.1073/pnas.93.1.141; Dillman JF, 1996, J NEUROSCI, V16, P6742; EHRENBER.M, 1974, CHEM PHYS, V4, P390, DOI 10.1016/0301-0104(74)85005-6; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Funakoshi T, 1996, J CELL BIOL, V133, P1347, DOI 10.1083/jcb.133.6.1347; GALLANT PE, 1988, J NEUROSCI, V8, P1479; GILBERT SP, 1984, J CELL BIOL, V99, P445, DOI 10.1083/jcb.99.2.445; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; Hackney DD, 1996, ANNU REV PHYSIOL, V58, P731; HIGUCHI H, 1989, J BIOCHEM-TOKYO, V105, P638, DOI 10.1093/oxfordjournals.jbchem.a122717; HIRAMOTO Y, 1974, EXP CELL RES, V87, P403, DOI 10.1016/0014-4827(74)90503-5; HIRAMOTO Y, 1962, EXP CELL RES, V27, P416, DOI 10.1016/0014-4827(62)90006-X; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; Hirokawa N, 1997, TRENDS CELL BIOL, V7, P384, DOI 10.1016/S0962-8924(97)01133-1; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; KIEHART DP, 1982, METHOD CELL BIOL, V25, P13, DOI 10.1016/S0091-679X(08)61418-1; Kinjo M, 1998, ANAL CHIM ACTA, V365, P43, DOI 10.1016/S0003-2670(97)00706-X; Kinjo M, 1998, BIOTECHNIQUES, V25, P706, DOI 10.2144/98254rr01; Kinjo M, 1997, BIOIMAGING, V5, P134; KOPPEL DE, 1974, PHYS REV A, V10, P1938, DOI 10.1103/PhysRevA.10.1938; KUZNETSOV SA, 1992, NATURE, V356, P722, DOI 10.1038/356722a0; Lasek RJ, 1984, J CELL BIOL 2, V99, p212s; LIM SS, 1989, J CELL BIOL, V109, P253, DOI 10.1083/jcb.109.1.253; LIM SS, 1990, J CELL BIOL, V111, P123, DOI 10.1083/jcb.111.1.123; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Maiti S, 1997, P NATL ACAD SCI USA, V94, P11753, DOI 10.1073/pnas.94.22.11753; METUZALS J, 1978, J CELL BIOL, V78, P597, DOI 10.1083/jcb.78.2.597; Miller KE, 1996, J CELL BIOL, V133, P1355, DOI 10.1083/jcb.133.6.1355; Nixon RA, 1998, CURR OPIN CELL BIOL, V10, P87, DOI 10.1016/S0955-0674(98)80090-2; OKABE S, 1992, J CELL BIOL, V117, P105, DOI 10.1083/jcb.117.1.105; OKABE S, 1993, J CELL BIOL, V120, P1177, DOI 10.1083/jcb.120.5.1177; OKABE S, 1990, NATURE, V343, P479, DOI 10.1038/343479a0; OKABE S, 1988, J CELL BIOL, V107, P651, DOI 10.1083/jcb.107.2.651; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; RIGLER R, 1992, FLUORESCENCE SPECTRO, P13; RIGLER R, 1990, BIOSCIENCE, P180; SABRY J, 1995, NEURON, V14, P1247, DOI 10.1016/0896-6273(95)90271-6; SCHNAPP BJ, 1992, J CELL BIOL, V119, P389, DOI 10.1083/jcb.119.2.389; TAKEDA S, 1995, NEURON, V14, P1257, DOI 10.1016/0896-6273(95)90272-4; Terada S, 1996, SCIENCE, V273, P784, DOI 10.1126/science.273.5276.784; TERASAKI M, 1995, P NATL ACAD SCI USA, V92, P11500, DOI 10.1073/pnas.92.25.11500; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4	53	108	112	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					141	155		10.1016/S0092-8674(00)00094-5	http://dx.doi.org/10.1016/S0092-8674(00)00094-5			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051554	Bronze			2022-12-28	WOS:000089636400015
J	Gibb, DM; Goodall, RL; Dunn, DT; Healy, M; Neave, P; Cafferkey, M; Butler, K				Gibb, DM; Goodall, RL; Dunn, DT; Healy, M; Neave, P; Cafferkey, M; Butler, K			Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission	LANCET			English	Article							POLYMERASE CHAIN-REACTION; VERTICAL TRANSMISSION; PERINATAL TRANSMISSION; RISK-FACTORS; INFECTION; INFANTS; BORN; HIV	Background Little information is available about the timing of mother-to-child transmission of hepatitis C virus (HCV), and no interventions to decrease transmission rates have been identified. We examined the effect of risk factors, including mode of delivery, on the vertical transmission rate. Methods Data from HCV-infected women and their infants from three hospitals in Ireland and from a British Paediatric Surveillance Unit study of infants born to HCV-infected mothers were used to estimate the vertical transmission rate and risk factors for transmission. We used a probabilistic model using methods that simultaneously estimated the time to HCV-antibody loss in uninfected infants and the diagnostic accuracy of PCR tests for HCV RNA. Findings 441 mother-child pairs from the UK (227) and Ireland (214) were included. 50% of uninfected children became HCV-antibody negative by 8 months and 95% by 13 months. The estimated specificity of PCR for HCV RNA was 97% (95% CI 96-99) and was unrelated to age; sensitivity was only 22% (7-46) in the first month but rose sharply to 97% (85-100) thereafter. The vertical transmission rate was 6.7% (4.1-10.2) overall, and 3.8 times higher in HIV coinfected (n=22) than in HIV-negative women after adjustment for other factors (p=0.06). No effect of breastfeeding on transmission was observed, although only 59 women breastfed. However, delivery by elective caesarean section before membrane rupture was associated with a lower transmission risk than vaginal or emergency caesarean-section delivery (odds ratio 0 [0-0.87], p=0.04, after adjustment for other factors). Interpretation The low sensitivity of HCV RNA soon after birth and the finding of a lower transmission rate after delivery by elective caesarean section suggest that HCV transmission occurs predominantly around the time of delivery. If the findings on elective caesarean section are confirmed in other studies, the case for antenatal HCV testing should be reconsidered.	MRC, Clin Trials Unit, London NW1 2DA, England; Rotunda Hosp, Dublin, Ireland; Inst Child Hlth, London, England; Our Ladys Hosp Sick Children, Dublin, Ireland; Childrens Hosp, Dublin, Ireland	Medical Research Council Clinical Trials Unit; University of London; University College London; Our Ladys Children Hospital Crumlin; Trinity College Dublin	Gibb, DM (corresponding author), MRC, Clin Trials Unit, 222 Euston Rd, London NW1 2DA, England.			Goodall, Ruth/0000-0003-0622-5035; Gibb, Diana/0000-0002-9738-5490; Dunn, David/0000-0003-1836-4446				ADES AE, IN PRESS EPIDEMIOL I; Andiman W, 1999, NEW ENGL J MED, V340, P977, DOI 10.1056/NEJM199904013401301; *BRIT PAED SURV UN, 1999, ANN REP 1998 99; Dore GJ, 1997, BRIT MED J, V315, P333; Dunn DT, 1996, J AM STAT ASSOC, V91, P935, DOI 10.2307/2291712; DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V; DUNN DT, 1995, AIDS, V9, P7; Duong T, 1999, BRIT MED J, V319, P1227, DOI 10.1136/bmj.319.7219.1227; Dusheiko GM, 1995, HEPATOLOGY, V22, P1863, DOI 10.1016/0270-9139(95)90216-3; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Halsey NA, 1998, PEDIATRICS, V101, P481, DOI 10.1542/peds.101.3.481; HEALY M, 1999, 3 SPRING M ROYAL COL; PACCAGNINI S, 1995, PEDIATR INFECT DIS J, V14, P195, DOI 10.1097/00006454-199503000-00005; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2; Resti M, 1998, BMJ-BRIT MED J, V317, P437, DOI 10.1136/bmj.317.7156.437; Spencer JD, 1997, J VIRAL HEPATITIS, V4, P395, DOI 10.1046/j.1365-2893.1997.00073.x; Thomas DL, 1998, J INFECT DIS, V177, P1480, DOI 10.1086/515315; Thomas SL, 1998, INT J EPIDEMIOL, V27, P108, DOI 10.1093/ije/27.1.108; Thomas SL, 1997, EUR J CLIN MICROBIOL, V16, P711, DOI 10.1007/BF01709250; Tovo PA, 1997, CLIN INFECT DIS, V25, P1121, DOI 10.1086/516102	20	249	262	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					904	907		10.1016/S0140-6736(00)02681-7	http://dx.doi.org/10.1016/S0140-6736(00)02681-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036896				2022-12-28	WOS:000089259800013
J	Bayer, A; Tadd, W				Bayer, A; Tadd, W			Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study	BRITISH MEDICAL JOURNAL			English	Article									Univ Wales, Coll Med, Llandough Hosp, Dept Geriatr Med, Penarth CF64 2XX, S Glam, Wales		Bayer, A (corresponding author), Univ Wales, Coll Med, Llandough Hosp, Dept Geriatr Med, Penarth CF64 2XX, S Glam, Wales.		Bayer, Antony/H-4434-2019; Bayer, Antony/H-4376-2019	Bayer, Antony/0000-0002-7514-248X; 				*AG CONC, 1999, TURN YOUR BACK US; Bowling A, 1999, BRIT MED J, V319, P1353, DOI 10.1136/bmj.319.7221.1353; Bugeja G, 1997, BRIT MED J, V315, P1059, DOI 10.1136/bmj.315.7115.1059; *EUR COMM COMM PRO, 1998, GUID CLIN INV MED PR	4	100	102	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 21	2000	321	7267					992	993		10.1136/bmj.321.7267.992	http://dx.doi.org/10.1136/bmj.321.7267.992			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366ZF	11039965	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000090035600026
J	Kwiat, PG; Berglund, AJ; Altepeter, JB; White, AG				Kwiat, PG; Berglund, AJ; Altepeter, JB; White, AG			Experimental verification of decoherence-free subspaces	SCIENCE			English	Article							QUANTUM COMPUTATION; ENTANGLED STATES; DISSIPATION; COMPUTERS; SEARCH; CODES	Using spontaneous parametric down-conversion, we produce polarization-entangled states of two photons and characterize them using two-photon tomography to measure the density matrix. A controllable decoherence is imposed on the states by passing the photons through thick, adjustable birefringent elements. When the system is subject to collective decoherence, one particular entangled state is seen to be decoherence-free, as predicted by theory. Such decoherence-free systems may have an important role for the future of quantum computation and information processing.	Los Alamos Natl Lab, Div Phys, Los Alamos, NM 87545 USA; Univ Queensland, Dept Phys, Brisbane, Qld 4072, Australia	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Queensland	Kwiat, PG (corresponding author), Los Alamos Natl Lab, Div Phys, P-23, Los Alamos, NM 87545 USA.		White, Andrew G./AAI-1062-2020; White, Andrew G/A-1088-2009; Altepeter, Joseph/F-7878-2010	White, Andrew G/0000-0001-9639-5200; 				Bacon D, 1999, PHYS REV A, V60, P1944, DOI 10.1103/PhysRevA.60.1944; Beige A, 2000, PHYS REV LETT, V85, P1762, DOI 10.1103/PhysRevLett.85.1762; Bennett CH, 1998, IEEE T INFORM THEORY, V44, P2724, DOI 10.1109/18.720553; BERGLUND AJ, 2000, THESIS DARTMOUTH COL; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Cerf NJ, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.032303; Duan LM, 1997, PHYS REV LETT, V79, P1953, DOI 10.1103/PhysRevLett.79.1953; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Gottesman D, 1996, PHYS REV A, V54, P1862, DOI 10.1103/PhysRevA.54.1862; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; JOZSA R, 1994, J MOD OPTIC, V41, P2315, DOI 10.1080/09500349414552171; Kwiat PG, 1999, PHYS REV A, V60, pR773, DOI 10.1103/PhysRevA.60.R773; Kwiat PG, 2000, J MOD OPTIC, V47, P257, DOI 10.1080/095003400148187; Kwiat PG, 1997, J MOD OPTIC, V44, P2173, DOI 10.1080/095003497152438; Lidar DA, 1998, PHYS REV LETT, V81, P2594, DOI 10.1103/PhysRevLett.81.2594; Palma GM, 1996, P ROY SOC A-MATH PHY, V452, P567, DOI 10.1098/rspa.1996.0029; SHOR PW, 1994, P 35 ANN S FDN COMP, P116; Somaroo S, 1999, PHYS REV LETT, V82, P5381, DOI 10.1103/PhysRevLett.82.5381; Viola L, 1999, PHYS REV LETT, V82, P2417, DOI 10.1103/PhysRevLett.82.2417; White AG, 1999, PHYS REV LETT, V83, P3103, DOI 10.1103/PhysRevLett.83.3103; Zanardi P, 1999, PHYS REV A, V60, pR729, DOI 10.1103/PhysRevA.60.R729; Zanardi P, 1997, PHYS REV LETT, V79, P3306, DOI 10.1103/PhysRevLett.79.3306	23	429	438	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					498	501		10.1126/science.290.5491.498	http://dx.doi.org/10.1126/science.290.5491.498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039926				2022-12-28	WOS:000089946000045
J	Rioult-Pedotti, MS; Friedman, D; Donoghue, JP				Rioult-Pedotti, MS; Friedman, D; Donoghue, JP			Learning-induced LTP in neocortex	SCIENCE			English	Article							LONG-TERM POTENTIATION; RAT MOTOR CORTEX; HORIZONTAL CONNECTIONS; SYNAPTIC ENHANCEMENT; CORTICAL CONNECTIONS; WATER MAZE; IN-VITRO; ACQUISITION; SATURATION; PLASTICITY	The hypothesis that learning occurs through long-term potentiation (LTP)- and long-term depression (LTD)-like mechanisms is widely held but unproven. This hypothesis makes three assumptions: Synapses are modifiable, they modify with learning, and they strengthen through an LTP-like mechanism. We previously established the ability for synaptic modification and a synaptic strengthening with motor skill learning in horizontal connections of the rat motor cortex (MI), Here we investigated whether learning strengthened these connections through LTP. We demonstrated that synapses in the trained MI were near the ceiling of their modification range, compared with the untrained MI, but the range of synaptic modification was not affected by learning. In the trained MI, LTP was markedly reduced and LTD was enhanced. These results are consistent with the use of LTP to strengthen synapses during learning.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Rioult-Pedotti, MS (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.		Rioult-Pedotti, Mengia-Seraina/AAF-1377-2021		NINDS NIH HHS [NS27164] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AOU SJ, 1992, J NEUROSCI, V12, P560; ARONIADOU VA, 1995, CEREB CORTEX, V5, P353, DOI 10.1093/cercor/5.4.353; BARNES CA, 1994, J NEUROSCI, V14, P5793; CAIN DP, 1993, HIPPOCAMPUS, V3, P153, DOI 10.1002/hipo.450030208; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; DARIAN SC, 1994, NATURE, V368, P737; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Hess G, 1996, EUR J NEUROSCI, V8, P658, DOI 10.1111/j.1460-9568.1996.tb01251.x; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; JEFFERY KJ, 1993, HIPPOCAMPUS, V3, P133, DOI 10.1002/hipo.450030205; Jeffery KJ, 1997, HIPPOCAMPUS, V7, P95; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KLEIM JA, 1996, J NEUROSCI, V212, P76; KOROL DL, 1993, HIPPOCAMPUS, V3, P127, DOI 10.1002/hipo.450030204; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MCNAUGHTON BL, 1986, J NEUROSCI, V6, P563; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Moyer JR, 1996, J NEUROSCI, V16, P5536; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; ROBINSON GB, 1992, HIPPOCAMPUS, V2, P389, DOI 10.1002/hipo.450020406; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shors TJ, 1997, BEHAV BRAIN SCI, V20, P597, DOI 10.1017/S0140525X97001593; Sorra KE, 1998, J NEUROSCI, V18, P658; SUTHERLAND RJ, 1993, HIPPOCAMPUS, V3, P141, DOI 10.1002/hipo.450030206; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574	34	709	715	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					533	536		10.1126/science.290.5491.533	http://dx.doi.org/10.1126/science.290.5491.533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039938				2022-12-28	WOS:000089946000057
J	Brenner, R; Perez, GJ; Bonev, AD; Eckman, DM; Kosek, JC; Wiler, SW; Patterson, AJ; Nelson, MT; Aldrich, RW				Brenner, R; Perez, GJ; Bonev, AD; Eckman, DM; Kosek, JC; Wiler, SW; Patterson, AJ; Nelson, MT; Aldrich, RW			Vasoregulation by the beta 1 subunit of the calcium-activated potassium channel	NATURE			English	Article							CA2+-ACTIVATED K+ CHANNEL; CEREBRAL-ARTERIES; SMOOTH-MUSCLE; RYANODINE RECEPTORS; MOLECULAR-BASIS; PROTEIN-KINASE; BLOOD-PRESSURE; CA CHANNELS; BK CHANNELS; WALL CA2+	Small arteries exhibit tone, a partially contracted state that is an important determinant of blood pressure. In arterial smooth muscle cells, intracellular calcium paradoxically controls both contraction and relaxation. The mechanisms by which calcium can differentially regulate diverse physiological responses within a single cell remain unresolved. Calcium-dependent relaxation is mediated by local calcium release from the sarcoplasmic reticulum. These 'calcium sparks' activate calcium-dependent potassium (BK) channels comprised of alpha and beta 1 subunits. Here we show that targeted deletion of the gene for the beta 1 subunit leads to a decrease in the calcium sensitivity of BK channels, a reduction in functional coupling of calcium sparks to BK channel activation, and increases in arterial tone and blood pressure. The beta 1 subunit of the BK channel, by tuning the channel's calcium sensitivity, is a key molecular component in translating calcium signals to the central physiological function of vasoregulation.	Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; Palo Alto Vet Adm Healthcare Syst, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Vermont; Stanford University	Aldrich, RW (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	raldrich@leland.stanford.edu	Perez, Guillermo J/D-5932-2013	Perez, Guillermo J/0000-0003-0237-2150; Brenner, Robert/0000-0002-1036-8031; Nelson, Mark/0000-0002-6608-8784				Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Berkowitz RD, 1998, J VIROL, V72, P10108, DOI 10.1128/JVI.72.12.10108-10117.1998; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Desai KH, 1997, AM J PHYSIOL-HEART C, V272, pH1053, DOI 10.1152/ajpheart.1997.272.2.H1053; Dong H, 1998, BRIT J PHARMACOL, V123, P821, DOI 10.1038/sj.bjp.0701680; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Han JX, 1998, LAB ANIM SCI, V48, P256; Hogan B, 1994, MANIPULATING MOUSE E; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Jiang Z, 1999, GENOMICS, V55, P57, DOI 10.1006/geno.1998.5627; JOYNER AL, 1993, GENE TARGETING PRACT, V18, P234; Kaczorowski GJ, 1996, J BIOENERG BIOMEMBR, V28, P255, DOI 10.1007/BF02110699; Khan SA, 1998, J PHARMACOL EXP THER, V284, P838; KNAUS HG, 1994, J BIOL CHEM, V269, P23336; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Knot HJ, 1996, J PHYSIOL-LONDON, V492, P419, DOI 10.1113/jphysiol.1996.sp021318; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P211, DOI 10.1111/j.1469-7793.1998.211br.x; LATORRE R, 1994, MEMBRANE CHANNELS MO, P79; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meera P, 1996, FEBS LETT, V382, P84, DOI 10.1016/0014-5793(96)00151-2; MEININGER GA, 1992, AM J PHYSIOL, V263, pH647, DOI 10.1152/ajpheart.1992.263.3.H647; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Perez GJ, 1999, J GEN PHYSIOL, V113, P229, DOI 10.1085/jgp.113.2.229; Poolos NP, 1999, J NEUROSCI, V19, P5205; Riazi MA, 1999, GENOMICS, V62, P90, DOI 10.1006/geno.1999.5975; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; SIMPSON LO, 1980, PATHOLOGY, V12, P347, DOI 10.3109/00313028009077096; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Wilson PWF, 1999, CLIN CARDIOL, V22, pV1; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Xia XM, 2000, J NEUROSCI, V20, P4890; Zhou XB, 1998, PFLUG ARCH EUR J PHY, V436, P725, DOI 10.1007/s004240050695	47	653	674	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2000	407	6806					870	876		10.1038/35038011	http://dx.doi.org/10.1038/35038011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057658				2022-12-28	WOS:000089901900041
J	Burstein, GT; Hutchings, IM; Sasaki, K				Burstein, GT; Hutchings, IM; Sasaki, K			Electrochemically induced annealing of stainless-steel surfaces	NATURE			English	Article							DEFORMATION; MARTENSITE	Modification of the surface properties of metals without affecting their bulk properties is of technological interest in demanding applications where surface stability and hardness are important. When austenitic stainless steel is heavily plastically deformed by grinding or rolling, a martensitic phase transformation occurs that causes significant changes in the bulk and surface mechanical properties(1-9) of the alloy. This martensitic phase can also be generated in stainless-steel surfaces by cathodic charging, as a consequence of lattice strain generated by absorbed hydrogen(10-16). Heat treatment of the steel to temperatures of several hundred degrees can result in loss of the martensitic structure(1), but this alters the bulk properties of the alloy. Here we show that martensitic structures in stainless steel can be removed by appropriate electrochemical treatment in aqueous solutions at much lower temperature than conventional annealing treatments. This electrochemically induced annealing process allows the hardness of cold-worked stainless steels to be maintained, while eliminating the brittle martensitic phase from the surface. Using this approach, we are able to anneal the surface and near-surface regions of specimens that contain rolling-induced martensite throughout their bulk, as well as those containing surface martensite induced by grinding. Although the origin of the electrochemical annealing process still needs further clarification, we expect that this treatment will lead to further development in enhancing the surface properties of metals.	Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	University of Cambridge	Burstein, GT (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.							ANGEL T, 1954, J IRON STEEL I, V177, P165; BENTLEY AP, 1986, METALL TRANS A, V17, P1593, DOI 10.1007/BF02650096; HUANG GL, 1989, METALL TRANS A, V20, P1239, DOI 10.1007/BF02647406; LUDWIGSON DC, 1969, J IRON STEEL I, V207, P63; NARITA N, 1982, METALL TRANS A, V13, P1355, DOI 10.1007/BF02642872; NEWMAN RC, 1980, J ELECTROCHEM SOC, V127, P2527, DOI 10.1149/1.2129510; Ohtani N., 1973, Journal of the Japan Institute of Metals, V37, P746; OKADA H, 1970, CORROSION, V26, P183; OLSON GB, 1982, METALL TRANS A, V13, P1907, DOI 10.1007/BF02645934; OLSON GB, 1975, METALL TRANS, VA  6, P791, DOI 10.1007/BF02672301; PERNG TP, 1986, ACTA METALL MATER, V34, P1771, DOI 10.1016/0001-6160(86)90123-9; Peterson SF, 1997, JOM-J MIN MET MAT S, V49, P54, DOI 10.1007/BF02914352; SUMITOMO H, 1991, J IRON STEEL I JPN, V77, P558; SZUMMER A, 1979, CORROSION, V35, P461, DOI 10.5006/0010-9312-35.10.461; SZUMMER A, 1985, HYDROGEN DEGRADATION, P512; TAHTINEN S, 1985, SCRIPTA METALL MATER, V19, P967, DOI 10.1016/0036-9748(85)90293-5; TAKAKI S, 1994, ISIJ INT, V34, P522, DOI 10.2355/isijinternational.34.522; TOMIMURA K, 1991, ISIJ INT, V31, P1431, DOI 10.2355/isijinternational.31.1431	18	39	45	5	76	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					885	887		10.1038/35038040	http://dx.doi.org/10.1038/35038040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057662				2022-12-28	WOS:000089901900045
J	Crudgington, HS; Siva-Jothy, MT				Crudgington, HS; Siva-Jothy, MT			Genital damage, kicking and early death - The battle of the sexes takes a sinister turn in the bean weevil.	NATURE			English	Article							ADAPTATION		Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Crudgington, HS (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.							ARNQVIST G, 1995, P ROY SOC B-BIOL SCI, V261, P123, DOI 10.1098/rspb.1995.0126; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BAUMANN H, 1974, J INSECT PHYSIOL, V20, P2347, DOI 10.1016/0022-1910(74)90022-5; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; EADY P, 1994, ECOL ENTOMOL, V19, P11, DOI 10.1111/j.1365-2311.1994.tb00384.x; MERRITT DJ, 1989, ZOOMORPHOLOGY, V108, P359, DOI 10.1007/BF00312276; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Simmons L.W., 1998, P341, DOI 10.1016/B978-012100543-6/50035-0; WAAGE JK, 1979, SCIENCE, V203, P916, DOI 10.1126/science.203.4383.916	10	444	457	3	197	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					855	856		10.1038/35038154	http://dx.doi.org/10.1038/35038154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057654				2022-12-28	WOS:000089901900036
J	Dalton, R				Dalton, R			US court slashes damages in polymerase-beta theft case	NATURE			English	News Item																		1998, NATURE, V393, P504	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					824	824		10.1038/35038228	http://dx.doi.org/10.1038/35038228			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057632	Bronze			2022-12-28	WOS:000089901900009
J	Langer, O; Conway, DL; Berkus, MD; Xenakis, EMJ; Gonzales, O				Langer, O; Conway, DL; Berkus, MD; Xenakis, EMJ; Gonzales, O			A comparison of glyburide and insulin in women with gestational diabetes mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATIC GLUCOSE-PRODUCTION; ORAL HYPOGLYCEMIC AGENTS; GLYCEMIC CONTROL; PREGNANCY; MANAGEMENT; GLIBENCLAMIDE; PERFORMANCE; METFORMIN; TRANSPORT; SECRETION	Background Women with gestational diabetes mellitus are rarely treated with a sulfonylurea drug, because of concern about teratogenicity and neonatal hypoglycemia. There is little information about the efficacy of these drugs in this group of women. Methods We studied 404 women with singleton pregnancies and gestational diabetes that required treatment. The women were randomly assigned tween 11 and 33 weeks of gestation to receive glyburide or insulin according to an intensified treatment protocol. The primary end point was achievement of desired level of glycemic control. Secondary end points included maternal and neonatal complications. Results The mean (+/-SD) pretreatment blood glucose concentration as measured at home for one week was 114 +/- 19 mg per deciliter (6.4 +/- 1. 1 mmol per liter) in the glyburide group and 116 +/- 22 mg per deciliter (6.5 +/- 1. 2 mmol per liter) in the insulin group (P = 0.33). The mean concentrations during treatment were 105 +/- 16 mg per deciliter (5.9 +/- 0.9 mmol per liter) in the glyburide group and 105 +/- 18 mg per deciliter (5.9 +/- 1. 0 per liter) in the insulin group (P = 0.99). Eight women in the glyburide group (4 percent) required insulin therapy. There were no significant differences between the glyburide and insulin groups in the percentage of infants who were large for gestational age (12 percent and 13 percent, respectively); who had macrosomia, defined as a birth weight of 4000 g or more (7 percent and 4 percent); who had lung complications (8 percent and 6 percent); who had hypoglycemia (9 percent and 6 percent); who were admitted to a neonatal intensive care unit (6 percent and 7 cent); or who had fetal anomalies (2 percent and 2 percent). The cord-serum insulin concentrations were similar in the two groups, and glyburide was not detected in the cord serum of any infant in the glyburide group. Conclusions In women with gestational diabetes, glyburide is a clinically effective alternative to insulin therapy. (N Engl J Med 2000; 343:1134-8.) (C) 2000, Massachusetts Medical Society.	Columbia Univ, St Lukes Roosevelt Hosp Ctr, Dept Obstet & Gynecol, New York, NY 10019 USA; Univ Texas, Hlth Sci Ctr, Dept Obstet & Gynecol, San Antonio, TX 78284 USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; University of Texas System; University of Texas Health San Antonio	Langer, O (corresponding author), Columbia Univ, St Lukes Roosevelt Hosp Ctr, Dept Obstet & Gynecol, 1000 10th Ave, New York, NY 10019 USA.		/AAO-2076-2020					*ACOG, 1994, ACOG TECHN B, V200, P359; American Diabetes Association, 1998, DIABETES CARE S1, V21, pS60; Berkus MD, 1999, CLIN OBSTET GYNECOL, V42, P766, DOI 10.1097/00003081-199912000-00006; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; COETZEE EJ, 1979, DIABETOLOGIA, V16, P241, DOI 10.1007/BF01221950; COETZEE EJ, 1980, S AFR MED J, V58, P795; COETZEE EJ, 1984, S AFR MED J, V65, P635; CORBET A, 1991, J PEDIATR-US, V118, P277, DOI 10.1016/S0022-3476(05)80502-5; DEFRONZO RA, 1984, DIABETES CARE, V7, P72; DENNO KM, 1994, TERATOLOGY, V49, P260, DOI 10.1002/tera.1420490405; DOLGER H, 1962, DIABETES, V11, P97; DOUGLAS CP, 1967, DIABETES, V16, P60, DOI 10.2337/diab.16.1.60; ELLIOTT BD, 1991, AM J OBSTET GYNECOL, V165, P807, DOI 10.1016/0002-9378(91)90421-M; ELLIOTT BD, 1994, AM J OBSTET GYNECOL, V171, P653, DOI 10.1016/0002-9378(94)90078-7; Elliott BD, 1997, AM J OBSTET GYNECOL, V176, P527, DOI 10.1016/S0002-9378(97)70541-6; EMILSSON H, 1986, J CHROMATOGR, V383, P93, DOI 10.1016/S0378-4347(00)83445-3; Farquhar J W, 1968, S Afr Med J, V42, P237; GERICH JE, 1990, NEW ENGL J MED, V322, P71; GROOP L, 1987, DIABETES, V36, P1320, DOI 10.2337/diabetes.36.11.1320; GROOP LC, 1991, DIABETES CARE, V14, P724, DOI 10.2337/diacare.14.8.724; JACKSON WPU, 1963, BMJ-BRIT MED J, P1652, DOI 10.1136/bmj.2.5373.1652-c; JACKSON WPU, 1962, DIABETES, V11, P98; KANG IS, 1993, PLACENTA, V14, P341, DOI 10.1016/S0143-4004(05)80432-1; KEMBALL ML, 1970, ARCH DIS CHILD, V45, P696, DOI 10.1136/adc.45.243.696; LANGER O, 1991, DIABETES, V40, P186, DOI 10.2337/diab.40.2.S186; LANGER O, 1989, AM J OBSTET GYNECOL, V161, P646, DOI 10.1016/0002-9378(89)90371-2; LANGER O, 1994, AM J OBSTET GYNECOL, V170, P1036, DOI 10.1016/S0002-9378(94)70097-4; Langer O, 1998, DIABETES CARE, V21, pB91; LANGER O, 1986, AM J OBSTET GYNECOL, V155, P635, DOI 10.1016/0002-9378(86)90293-0; LANGER O, 1987, AM J OBSTET GYNECOL, V157, P669, DOI 10.1016/S0002-9378(87)80026-1; Lebovitz HE, 1999, DIABETES REV, V7, P139; MALINS JM, 1964, BRIT MED J, V2, P187, DOI 10.1136/bmj.2.5402.187; Metzger BE, 1998, DIABETES CARE, V21, pB161; NOTELOVITZ M, 1971, South African Medical Journal, V45, P226; NOTELOVITZ M, 1974, LANCET, V2, P902; PIACQUADIO K, 1991, LANCET, V338, P866, DOI 10.1016/0140-6736(91)91512-S; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Rouse DJ, 1996, JAMA-J AM MED ASSOC, V276, P1480, DOI 10.1001/jama.276.18.1480; RYDBERG T, 1991, J CHROMATOGR-BIOMED, V564, P223, DOI 10.1016/0378-4347(91)80084-P; SIMONSON DC, 1984, DIABETES, V33, P838, DOI 10.2337/diabetes.33.9.838; SIVAN E, 1995, DIABETOLOGIA, V38, P753, DOI 10.1007/s001250050348; SMOAK IW, 1990, AM J OBSTET GYNECOL, V163, P619, DOI 10.1016/0002-9378(90)91213-V; Smoak IW, 1992, TERATOLOGY, V45, P474; STEEL JM, 1991, LANCET, V338, P1222, DOI 10.1016/0140-6736(91)92096-K; SUTHERLAND HW, 1973, BMJ-BRIT MED J, V3, P9, DOI 10.1136/bmj.3.5870.9; SUTHERLAND HW, 1974, ARCH DIS CHILD, V49, P283, DOI 10.1136/adc.49.4.283; ZUCKER P, 1968, PEDIATRICS, V42, P824; 1974, LANCET, V2, P32	48	506	542	1	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2000	343	16					1134	1138		10.1056/NEJM200010193431601	http://dx.doi.org/10.1056/NEJM200010193431601			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364FY	11036118				2022-12-28	WOS:000089882800001
J	Lazar, MA				Lazar, MA			Gene regulation - One man's food	NATURE			English	Article							ALPHA		Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Penn Diabet Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.		Lazar, Mitchell A/AAF-3738-2019					BARTLETT J, 2001, BARTLETTS FAMILIAR Q; BOELSTERLI UA, 1991, ARCH TOXICOL, V65, P351, DOI 10.1007/BF02284256; Holden PR, 1999, J MOL ENDOCRINOL, V22, P1, DOI 10.1677/jme.0.0220001; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Okino S T, 2000, Vitam Horm, V59, P241, DOI 10.1016/S0083-6729(00)59009-8; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116	12	3	4	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					852	853		10.1038/35038199	http://dx.doi.org/10.1038/35038199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057652				2022-12-28	WOS:000089901900034
J	Williams, EJB; Hurst, LD				Williams, EJB; Hurst, LD			The proteins of linked genes evolve at similar rates	NATURE			English	Article							NONSYNONYMOUS SUBSTITUTION; POSITIVE SELECTION; EVOLUTION; GENOME; RECOMBINATION; REGIONS; MOUSE; MAMMALS	Much more variation in the rate of protein evolution occurs than is expected by chance(1). But why some proteins evolve rapidly but others slowly is poorly resolved. It was proposed, for example, that essential genes might evolve slower than dispensable ones(2), but this is not the case(3); and despite earlier claims(4), rates of evolution do not correlate with amino-acid composition(5). A few patterns have been found: proteins involved in antagonistic coevolution (for example, immune genes(3,6), parasite antigens(7) and reproductive conflict genes(8-10)) tend to be rapidly evolving, and there is a correlation between the rate of protein evolution and the mutation rate of the gene(1,11,12). Here we report a new highly statistically significant predictor of a protein's rate of evolution, and show that linked genes have similar rates of protein evolution. There is also a weaker similarity of rates of silent site evolution (see ref. 13), which appears to be, in part, a consequence of the similarity in rates of protein evolution. The similarity in rates of protein evolution is not a consequence of underlying mutational patterns. A pronounced negative correlation between the rate of protein evolution and a covariant of the recombination rate indicates that rates of protein evolution possibly reflect, in part, the local strength of stabilizing selection.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.		Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054				Averof M, 2000, SCIENCE, V287, P1283, DOI 10.1126/science.287.5456.1283; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; Caccio S, 1997, GENE, V205, P119, DOI 10.1016/S0378-1119(97)00560-X; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Casane D, 1997, J MOL EVOL, V45, P216, DOI 10.1007/PL00006223; DROUIN R, 1994, ADV HUM GENET, V22, P47; DURET L, 1994, NUCLEIC ACIDS RES, V22, P2360, DOI 10.1093/nar/22.12.2360; EYREWALKER A, 1993, P ROY SOC B-BIOL SCI, V252, P237, DOI 10.1098/rspb.1993.0071; Galtier N, 1998, GENETICS, V150, P1577; GRAUR D, 1985, J MOL EVOL, V22, P53, DOI 10.1007/BF02105805; HUGHES AL, 1991, GENETICS, V127, P345; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Hurst LD, 1998, CURR OPIN GENET DEV, V8, P701, DOI 10.1016/S0959-437X(98)80040-3; KUMA K, 1995, MOL BIOL EVOL, V12, P123, DOI 10.1093/oxfordjournals.molbev.a040181; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Makalowski W, 1998, J MOL EVOL, V47, P119, DOI 10.1007/PL00006367; Matassi G, 1999, CURR BIOL, V9, P786, DOI 10.1016/S0960-9822(99)80361-3; Nachman MW, 1996, GENETICS, V142, P537; Nordborg M, 1996, GENET RES, V67, P159, DOI 10.1017/S0016672300033619; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Silver L. M., 1995, MOUSE GENETICS; Smith NGC, 1999, GENETICS, V152, P661; Smith NGC, 1999, GENETICS, V153, P1395; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; Tsaur SC, 1997, MOL BIOL EVOL, V14, P544, DOI 10.1093/oxfordjournals.molbev.a025791; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; WOLFE KH, 1993, J MOL EVOL, V37, P441, DOI 10.1007/BF00178874; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070	29	93	93	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					900	903		10.1038/35038066	http://dx.doi.org/10.1038/35038066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057667				2022-12-28	WOS:000089901900050
J	Boudaoud, A; Patricio, P; Couder, Y; Ben Amar, M				Boudaoud, A; Patricio, P; Couder, Y; Ben Amar, M			Dynamics of singularities in a constrained elastic plate	NATURE			English	Article							SHEET; BALL	Large deformations of thin elastic plates usually lead to the formation of singular structures which are either linear(1-4) (ridges) or pointlike(5-8) (developable cones). These structures are thought to be generic for crumpled plates(3,5), although they have been investigated quantitatively only in simplified geometries(1-4,6-8). Previous studies(9-11) have also shown that a large number of singularities are generated by successive instabilities. Here we study, experimentally and numerically, a generic situation in which a plate is initially bent in one direction into a cylindrical arch, then deformed in the other direction by a load applied at its centre. This induces the generation of pairs of singularities; we study their position, their dynamics and the corresponding resistance of the plate to deformation. We solve numerically the equations describing large deformations of plates; developable cones are predicted, in quantitative agreement with the experiments. We use geometrical arguments to predict the observed patterns, assuming that the energy of the plate is given by the energy of the singularities.	Univ Paris 06, ENS, Phys Stat Lab, F-75231 Paris 05, France; Univ Paris 07, CNRS, F-75231 Paris 05, France; Univ Lisbon, Ctr Fis Mat Condensada, P-1649003 Lisbon, Portugal	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universidade de Lisboa	Boudaoud, A (corresponding author), Univ Paris 06, ENS, Phys Stat Lab, 24 Rue Lhomond, F-75231 Paris 05, France.	arezki.boudaoud@lps.ens.fr	Patrício, Pedro/AAN-5993-2020; Boudaoud, Arezki/Q-7436-2016; Patricio, Pedro/A-2750-2009	Boudaoud, Arezki/0000-0002-2780-4717; Ben Amar, Martine/0000-0001-9132-2053; Patricio, Pedro/0000-0002-9050-9956				BenAmar M, 1997, P ROY SOC A-MATH PHY, V453, P729, DOI 10.1098/rspa.1997.0041; Cerda E, 1999, NATURE, V401, P46, DOI 10.1038/43395; Cerda E, 1998, PHYS REV LETT, V80, P2358, DOI 10.1103/PhysRevLett.80.2358; Chaieb S, 1997, PHYS REV E, V56, P4736, DOI 10.1103/PhysRevE.56.4736; Chaieb S, 1998, PHYS REV LETT, V80, P2354, DOI 10.1103/PhysRevLett.80.2354; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; LOBKOVSKY A, 1995, SCIENCE, V270, P1482, DOI 10.1126/science.270.5241.1482; Lobkovsky AE, 1996, PHYS REV E, V53, P3750, DOI 10.1103/PhysRevE.53.3750; Patricio P, 1998, PHYSICA D, V124, P285, DOI 10.1016/S0167-2789(98)00203-6; Pauchard L, 1998, PHILOS MAG B, V78, P225, DOI 10.1080/13642819808202945; Pippard A. B., 1990, European Journal of Physics, V11, P359, DOI 10.1088/0143-0807/11/6/008; Pogorelov A., 1988, TRANSLATIONS MATH MO, V72; Pomeau Y, 1997, CR ACAD SCI II B, V325, P181, DOI 10.1016/S1251-8069(97)88276-0; WITTEN TA, 1993, EUROPHYS LETT, V23, P51, DOI 10.1209/0295-5075/23/1/009; [No title captured]	15	83	83	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					718	720		10.1038/35037535	http://dx.doi.org/10.1038/35037535			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048712				2022-12-28	WOS:000089773900034
J	Chisholm, SW				Chisholm, SW			Oceanography - Stirring times in the Southern Ocean	NATURE			English	Editorial Material							EQUATORIAL PACIFIC-OCEAN; FERTILIZATION; CO2		MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chisholm, SW (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chisholm@mit.edu		Chisholm, Sallie/0000-0003-1480-2445				Abraham ER, 2000, NATURE, V407, P727, DOI 10.1038/35037555; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; CARPENTER SR, 1995, SCIENCE, V269, P324, DOI 10.1126/science.269.5222.324; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; FUHRMAN JA, 1991, LIMNOL OCEANOGR, V36, P1951, DOI 10.4319/lo.1991.36.8.1951; Goldenfeld N, 1999, SCIENCE, V284, P87, DOI 10.1126/science.284.5411.87; Jones ISF, 1997, ENERG CONVERS MANAGE, V38, pS367, DOI 10.1016/S0196-8904(96)00296-8; MARKELS M, 1998, REGULATION, V21, P9; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MARTIN JH, 1992, ENVIR SCI R, V43, P123; Ney RA, 2000, ENVIRON SCI TECHNOL, V34, p176A, DOI 10.1021/es003230m; RAWLS R, 2000, CHEM ENG NEWS   0918, P66; SARMIENTO JL, 1991, LIMNOL OCEANOGR, V36, P1928, DOI 10.4319/lo.1991.36.8.1928; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; 5965117; 5992089; 6056919	18	93	111	16	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					685	687		10.1038/35037696	http://dx.doi.org/10.1038/35037696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048702				2022-12-28	WOS:000089773900023
J	Moore, PD				Moore, PD			Conservation biology - Seeds of doubt	NATURE			English	Editorial Material									Kings Coll London, Div Life Sci, London SE1 8WA, England	University of London; King's College London	Moore, PD (corresponding author), Kings Coll London, Div Life Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 8WA, England.	peter.moore@kcl.ac.uk						Chuine I, 2000, J ECOL, V88, P561, DOI 10.1046/j.1365-2745.2000.00468.x; EVANS EI, 1997, BR BIRDS, V90, P123; Keller M, 2000, J APPL ECOL, V37, P647, DOI 10.1046/j.1365-2664.2000.00517.x; MacDonald Ian A. W., 1994, P199; Montalvo AM, 2000, CONSERV BIOL, V14, P1034, DOI 10.1046/j.1523-1739.2000.99250.x	5	7	7	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2000	407	6805					683	685		10.1038/35037693	http://dx.doi.org/10.1038/35037693			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048701				2022-12-28	WOS:000089773900022
J	Ostrov, DA; Shi, WX; Schwartz, JCD; Almo, SC; Nathenson, SG				Ostrov, DA; Shi, WX; Schwartz, JCD; Almo, SC; Nathenson, SG			Structure of murine CTLA-4 and its role in modulating T cell responsiveness	SCIENCE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; IMMUNOLOGICAL SYNAPSE; FC FRAGMENT; PROTEIN; RESOLUTION; COMPLEX; COSTIMULATION; RECEPTOR; CD28	The effective regulation of T cell responses is dependent on opposing signals transmitted through two related cell-surface receptors, CD28 and cytotoxic T Lymphocyte-associated antigen 4 (CTLA-4). Dimerization of CTLA-4 is required for the formation of high-avidity complexes with B7 ligands and for transmission of signals that attenuate T cell activation. We determined the crystal structure of the extracellular portion of CTLA-4 to 2.0 angstrom resolution. CTLA-4 belongs to the immunoglobulin superfamily and displays a strand topology similar to Vor domains, with an unusual mode of dimerization that places the B7 binding sites distal to the dimerization interface. This organization allows each CTLA-4 dimer to bind two bivalent B7 molecules and suggests that a periodic arrangement of these components within the immunological synapse may contribute to the regulation of T cell responsiveness.	Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Nathenson, SG (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA.	nathenso@aecom.yu.edu			NATIONAL CANCER INSTITUTE [T32CA009173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI007289, R37AI007289, R01AI042970, R01AI007289] Funding Source: NIH RePORTER; NCI NIH HHS [CA09173] Funding Source: Medline; NIAID NIH HHS [AI07289, AI42970] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Bluestone JA, 1997, J IMMUNOL, V158, P1989; BODIAN DL, 1994, STRUCTURE, V2, P755, DOI 10.1016/S0969-2126(94)00076-X; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; Ikemizu S, 1999, P NATL ACAD SCI USA, V96, P4289, DOI 10.1073/pnas.96.8.4289; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Janeway C A Jr, 1996, Semin Immunol, V8, P108; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kwon ED, 1997, P NATL ACAD SCI USA, V94, P8099, DOI 10.1073/pnas.94.15.8099; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Linsley PS, 1996, CURR BIOL, V6, P398, DOI 10.1016/S0960-9822(02)00506-7; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Olsson C, 1999, J BIOL CHEM, V274, P14400, DOI 10.1074/jbc.274.20.14400; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEACH RJ, 1994, J EXP MED, V180, P20498; Sayegh MH, 1999, J CLIN INVEST, V103, P1223, DOI 10.1172/JCI6952; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; [No title captured]	44	116	140	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2000	290	5492					816	819		10.1126/science.290.5492.816	http://dx.doi.org/10.1126/science.290.5492.816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052947				2022-12-28	WOS:000090067600052
J	Pignone, M; Phillips, C; Mulrow, C				Pignone, M; Phillips, C; Mulrow, C			Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials	BRITISH MEDICAL JOURNAL			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; HYPERCHOLESTEROLEMIC PATIENTS; CAROTID ATHEROSCLEROSIS; RISK-FACTORS; CHOLESTEROL; EFFICACY; PRAVASTATIN; LOVASTATIN; POPULATION; MORTALITY	Objective To summarise the effect of primary prevention with lipid lowering drugs on coronary heart disease events, coronary heart disease mortality and all cause mortality. Design Meta-analysis. Identification Systematic search of the Medline database from January 1994 to June 1999 for English language studies examining drug treatment for lipid disorders (use of the MeSH terms "hyperlipidemia" and "anticholesteremic agents," keyword searches for individual drug names, and a search strategy for identifying randomised trials to capture relevant articles); identification of older studies through systematic reviews and hand search of bibliographies. Inclusion criteria All randomised trials of at least one year's duration that examined drug treatment for patients with no known coronary heart disease, cerebrovascular disease, or peripheral vascular disease and that measured clinical end points, including all cause mortality, coronary heart disease mortality and non-fatal myocardial infarctions. Data extraction Review of the articles and extracted relevant data by two authors separately, with disagreements resolved by consensus. Results Four studies met eligibility criteria. Drug treatment reduced the odds of a coronary heart disease event by 30% (summary odds ratio 0.70, 95% confidence interval 0.62 to 0.79) but not the odds of all cause mortality (0.94, 0.81 to 1.09). When statin drugs were considered alone, no substantial differences in results were found. Conclusions Treatment with lipid lowering drugs lasting five to seven years reduces coronary heart disease events but not all cause mortality in people with no known cardiovascular disease.	Univ N Carolina, Div Gen Internal Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Prevent Med Residency Program, Chapel Hill, NC USA; Audie L Murphy VA Hosp, Div Gen Internal Med, San Antonio, TX 78284 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Pignone, M (corresponding author), Univ N Carolina, Div Gen Internal Med, 5039 Old Clin Bldg, Chapel Hill, NC 27599 USA.			Pignone, Michael/0000-0002-6657-7342				Athyros VG, 1997, AM J CARDIOL, V80, P608, DOI 10.1016/S0002-9149(97)00430-X; BEHOUNEK BD, 1993, AM J CARDIOL, V72, P1031; BRADFORD RH, 1991, ARCH INTERN MED, V151, P43, DOI 10.1001/archinte.151.1.43; Bredie SJH, 1996, NETH J MED, V49, P59, DOI 10.1016/0300-2977(96)00015-0; Caro J, 1997, BRIT MED J, V315, P1577, DOI 10.1136/bmj.315.7122.1577; Committee of Principal Investigators, 1978, BRIT HEART J, V40, P1069; DORR AE, 1978, J CHRON DIS, V31, P5, DOI 10.1016/0021-9681(78)90076-0; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Elkeles RS, 1998, DIABETES CARE, V21, P641, DOI 10.2337/diacare.21.4.641; Eriksson M, 1998, J INTERN MED, V243, P373; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; HOWES LG, 1994, AUST NZ J MED, V24, P107, DOI 10.1111/j.1445-5994.1994.tb04445.x; IVES DG, 1993, AM J PREV MED, V9, P274, DOI 10.1016/S0749-3797(18)30703-7; LANSBERG PJ, 1995, ATHEROSCLEROSIS, V116, P153, DOI 10.1016/0021-9150(95)05523-Y; MCCAUGHAN D, 1981, ARCH INTERN MED, V141, P1428, DOI 10.1001/archinte.141.11.1428; Mercuri M, 1996, AM J MED, V101, P627, DOI 10.1016/S0002-9343(96)00333-6; Pharoah PDP, 1996, BMJ-BRIT MED J, V312, P1443, DOI 10.1136/bmj.312.7044.1443; Ramsay LE, 1996, LANCET, V348, P387, DOI 10.1016/S0140-6736(96)05516-X; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; SALONEN R, 1995, CIRCULATION, V92, P1758, DOI 10.1161/01.CIR.92.7.1758; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SMITH GD, 1993, BMJ-BRIT MED J, V306, P1367, DOI 10.1136/bmj.306.6889.1367; SMITH R, 1993, BRIT MED J, V306, P3, DOI 10.1136/bmj.306.6869.3; The Kyushu Lipid Intervention Study Group, 1996, J ATHEROSCLER THROMB, V3, P95	27	162	169	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 21	2000	321	7267					983	986		10.1136/bmj.321.7267.983	http://dx.doi.org/10.1136/bmj.321.7267.983			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366ZF	11039962	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000090035600023
J	Spittle, N; McCluskey, A				Spittle, N; McCluskey, A			Lesson of the week - Tracheal stenosis after intubation	BRITISH MEDICAL JOURNAL			English	Review									Stepping Hill Hosp, Dept Anaesthesia, Stockport SK2 7JE, Lancs, England; Hope Hosp, Dept Anaesthesia, Salford M6 8HD, Lancs, England		McCluskey, A (corresponding author), Stepping Hill Hosp, Dept Anaesthesia, Stockport SK2 7JE, Lancs, England.							ANDREWS MJ, 1973, BRIT J SURG, V60, P208, DOI 10.1002/bjs.1800600311; BRAIDY J, 1989, THORAX, V44, P753, DOI 10.1136/thx.44.9.753; Brichet A, 1999, EUR RESPIR J, V13, P888, DOI 10.1034/j.1399-3003.1999.13d32.x; COOPER JD, 1969, SURG GYNECOL OBSTETR, V129, P1235; CROFT CB, 1979, LARYNGOSCOPE, V89, P482; Grillo H C, 1996, Semin Thorac Cardiovasc Surg, V8, P370; KNOWLSON GT, 1970, BRIT J ANAESTH, V42, P834, DOI 10.1093/bja/42.10.834; MATHIAS DB, 1974, BRIT J ANAESTH, V46, P849, DOI 10.1093/bja/46.11.849; Partridge MR, 1997, RESP MED, V91, P503, DOI 10.1016/S0954-6111(97)90118-9; STAUFFER JL, 1981, AM J MED, V70, P65, DOI 10.1016/0002-9343(81)90413-7; 1973, LANCET, V135, P1161	11	44	46	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 21	2000	321	7267					1000	1002		10.1136/bmj.321.7267.1000	http://dx.doi.org/10.1136/bmj.321.7267.1000			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	366ZF	11039970	Green Published			2022-12-28	WOS:000090035600029
J	Voit, J; Perfetti, L; Zwick, F; Berger, H; Margaritondo, G; Gruner, G; Hochst, H; Grioni, M				Voit, J; Perfetti, L; Zwick, F; Berger, H; Margaritondo, G; Gruner, G; Hochst, H; Grioni, M			Electronic structure of solids with competing periodic potentials	SCIENCE			English	Article							ONE-DIMENSIONAL CONDUCTORS; PHOTOEMISSION; FLUCTUATIONS; (TASE4)(2)I; STATES; ENERGY; CHAIN	When electrons are subject to a potential with two incommensurate periods, translational invariance is lost, and no periodic band structure is expected. However, model calculations based on nearly free one-dimensional electrons and experimental results from high-resolution photoemission spectroscopy on a quasi-one-dimensional material do show dispersing band states with signatures of both periodicities. Apparent band structures are generated by the nonuniform distribution of electronic spectral weight over the complex eigenvalue spectrum.	Univ Bayreuth, D-95440 Bayreuth, Germany; Ecole Polytech Fed Lausanne, Inst Phys Appl, CH-1015 Lausanne, Switzerland; Univ Calif Los Angeles, Dept Phys, Los Angeles, CA 90095 USA; Univ Wisconsin, Ctr Synchrotron Radiat, Stoughton, WI 53589 USA	University of Bayreuth; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of California System; University of California Los Angeles; University of Wisconsin System	Voit, J (corresponding author), Univ Bayreuth, POB 101251, D-95440 Bayreuth, Germany.		Margaritondo, Giorgio/B-1367-2008					Ashcroft N.W, 1976, SOLID STATE PHYS; Claessen R, 1997, PHYS REV B, V56, P12643, DOI 10.1103/PhysRevB.56.12643; DARDEL B, 1991, PHYS REV LETT, V67, P3144, DOI 10.1103/PhysRevLett.67.3144; DEGIORGI L, 1995, PHYS REV B, V52, P5603, DOI 10.1103/PhysRevB.52.5603; FUJISHITA H, 1984, SOLID STATE COMMUN, V49, P313, DOI 10.1016/0038-1098(84)90576-3; GESERICH HP, 1986, PHYSICA B & C, V143, P198, DOI 10.1016/0378-4363(86)90093-8; GRESSIER P, 1984, INORG CHEM, V23, P1221, DOI 10.1021/ic00177a011; Gruner G., 1994, DENSITY WAVES SOLIDS; HIRAMOTO H, 1992, INT J MOD PHYS B, V6, P81; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; HWU Y, 1992, PHYS REV B, V46, P13624, DOI 10.1103/PhysRevB.46.13624; Monceau P., 1985, ELECT PROPERTIES INO; NAKANO M, 1986, PHYS REV B, V33, P6718, DOI 10.1103/PhysRevB.33.6718; PIECHON F, 1995, PHYS REV LETT, V74, P5248, DOI 10.1103/PhysRevLett.74.5248; Shannon N, 1996, J PHYS-CONDENS MAT, V8, P10493, DOI 10.1088/0953-8984/8/49/037; Vescoli V, 2000, PHYS REV LETT, V84, P1272, DOI 10.1103/PhysRevLett.84.1272	16	155	155	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					501	503		10.1126/science.290.5491.501	http://dx.doi.org/10.1126/science.290.5491.501			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039927				2022-12-28	WOS:000089946000046
J	Gore, A				Gore, A			The Republican and Democratic candidates speak on health care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Drazen, Jeffrey M/E-5841-2012						0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2000	343	16					1184	1189		10.1056/NEJM200010193431611	http://dx.doi.org/10.1056/NEJM200010193431611			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364FY	11036128				2022-12-28	WOS:000089882800011
J	Rehkamper, M				Rehkamper, M			Geochemistry - Tracing the Earth's evolution	NATURE			English	Article							UPPER MANTLE; CONSTRAINTS		ETH Zurich, Inst Isotope Geol & Mineral Resources, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Rehkamper, M (corresponding author), ETH Zurich, Inst Isotope Geol & Mineral Resources, CH-8092 Zurich, Switzerland.							Alard O, 2000, NATURE, V407, P891, DOI 10.1038/35038049; Chou CL, 1978, P LUNAR PLANET SCI, V9, P219; Holzheid A, 2000, NATURE, V406, P396, DOI 10.1038/35019050; JONES JH, 1986, NATURE, V322, P221, DOI 10.1038/322221a0; MITCHELL RH, 1981, GEOCHIM COSMOCHIM AC, V45, P2425, DOI 10.1016/0016-7037(81)90096-X; MORGAN JW, 1981, TECTONOPHYSICS, V75, P47, DOI 10.1016/0040-1951(81)90209-2; Pattou L, 1996, NATURE, V379, P712, DOI 10.1038/379712a0; Rehkamper M, 1999, EARTH PLANET SC LETT, V172, P65, DOI 10.1016/S0012-821X(99)00193-4; Snow JE, 1998, NATURE, V391, P166, DOI 10.1038/34396	9	2	3	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					848	849		10.1038/35038190	http://dx.doi.org/10.1038/35038190			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057649				2022-12-28	WOS:000089901900031
J	Berl, V; Huc, I; Khoury, RG; Krische, MJ; Lehn, JM				Berl, V; Huc, I; Khoury, RG; Krische, MJ; Lehn, JM			Interconversion of single and double helices formed from synthetic molecular strands	NATURE			English	Article							GRAMICIDIN-A; OLIGOMERS; OLIGOANTHRANILAMIDES; COMPLEXES; FAMILY; MOTIFS	Synthetic single-helical conformations are quite common, but the formation of double helices based on recognition between the two constituent strands is relatively rare. Known examples include duplex formation through base-pair-specific hydrogen bonding and stacking, as found in nucleic acids and their analogues, and polypeptides composed of amino acids with alternating L and D configurations(1,2). Some synthetic polymers(3) and self-assembled fibres(4) have double-helical winding induced by van der Waals interactions. A third mode of non-covalent interaction, coordination of organic ligands to metal ions(5-7), can give rise to double, triple and quadruple helices, although in this case the assembly is driven by the coordination geometry of the metal and the structure of the ligands, rather than by direct inter-strand complementarity. Here we describe a family of oligomeric molecules with bent conformations, which exhibit dynamic exchange between single and double molecular helices in solution, through spiral sliding of the synthetic oligomer strands. The bent conformations leading to the helical shape of the molecules result from intramolecular hydrogen bonding within 2'-pyridyl-2-pyridinecarboxamide units(8-12), with extensive intermolecular aromatic stacking stabilizing the double-stranded helices that form through dimerization.	Univ Strasbourg 1, ISIS, Lab Chim Supramol, F-67000 Strasbourg, France; Forschungszentrum Karlsruhe GmbH, Inst Nanotechnol, D-76021 Karlsruhe, Germany; ENSCPB, Inst Europeen Chim & Biol, F-33402 Talence, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Karlsruhe Institute of Technology	Huc, I (corresponding author), Univ Strasbourg 1, ISIS, Lab Chim Supramol, 4 Rue Blaise Pascal, F-67000 Strasbourg, France.			Berl, Volker/0000-0002-0665-2718				BARSUKOV IL, 1987, BIOORG KHIM+, V13, P1501; Bassani DM, 1997, ANGEW CHEM INT EDIT, V36, P1845, DOI 10.1002/anie.199718451; BELL TW, 1994, NATURE, V367, P441, DOI 10.1038/367441a0; Berl V, 2000, CHEM-EUR J, V6, P1938; Cuccia LA, 2000, ANGEW CHEM INT EDIT, V39, P233, DOI 10.1002/(SICI)1521-3773(20000103)39:1<233::AID-ANIE233>3.0.CO;2-R; DIBLASIO B, 1989, BIOPOLYMERS, V28, P203, DOI 10.1002/bip.360280122; Engelkamp H, 1999, SCIENCE, V284, P785, DOI 10.1126/science.284.5415.785; Hamuro Y, 1997, J AM CHEM SOC, V119, P10587, DOI 10.1021/ja963449u; HAMURO Y, 1994, ANGEW CHEM INT EDIT, V33, P446, DOI 10.1002/anie.199404461; Hasenknopf B, 1996, ANGEW CHEM INT EDIT, V35, P1838, DOI 10.1002/anie.199618381; KOERT U, 1990, NATURE, V346, P339, DOI 10.1038/346339a0; Kusanagi H, 1996, POLYM J, V28, P708, DOI 10.1295/polymj.28.708; LANGS DA, 1988, SCIENCE, V241, P188, DOI 10.1126/science.2455345; Mazik M, 1999, TETRAHEDRON, V55, P12771, DOI 10.1016/S0040-4020(99)00789-9; Nelson JC, 1997, SCIENCE, V277, P1793, DOI 10.1126/science.277.5333.1793; Ohkita M, 1999, CHEM-EUR J, V5, P3471, DOI 10.1002/(SICI)1521-3765(19991203)5:12<3471::AID-CHEM3471>3.0.CO;2-5; Redmore SM, 1997, INORG CHEM, V36, P4743, DOI 10.1021/ic961534x; SYCHEV SV, 1993, EUR BIOPHYS J BIOPHY, V22, P279, DOI 10.1007/BF00180262; VEATCH WR, 1974, BIOCHEMISTRY-US, V13, P5257, DOI 10.1021/bi00723a002; Yu Q, 1999, CHEM COMMUN, P1467, DOI 10.1039/a900541b	20	596	597	1	202	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					720	723		10.1038/35037545	http://dx.doi.org/10.1038/35037545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048713				2022-12-28	WOS:000089773900035
J	Weaver, AJ; Zwiers, FW				Weaver, AJ; Zwiers, FW			Uncertainty in climate change	NATURE			English	Editorial Material							GREENHOUSE-GAS		Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada; Univ Victoria, Canadian Ctr Modelling & Anal, Meteorol Serv Canada, Victoria, BC V8W 2Y2, Canada	University of Victoria; Environment & Climate Change Canada; Meteorological Service of Canada; University of Victoria	Weaver, AJ (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, POB 3055, Victoria, BC V8W 3P6, Canada.		Weaver, Andrew J/E-7590-2011	Weaver, Andrew J/0000-0001-8919-3598				Allen MR, 2000, NATURE, V407, P617, DOI 10.1038/35036559; [Anonymous], 1996, SCI CLIM CHANG; Hansen J, 1997, PHILOS T R SOC B, V352, P231, DOI 10.1098/rstb.1997.0018; HASSELMANN K, 1995, P MOD DYN MET S HON, P201; Haywood JM, 1997, GEOPHYS RES LETT, V24, P1335, DOI 10.1029/97GL01163; Hegerl GC, 1997, CLIM DYNAM, V13, P613, DOI 10.1007/s003820050186; *INT PAN CLIM CHAN, 1992, SUPPL REP IPCC SCI A; MITCHELL JFB, 1995, NATURE, V376, P501, DOI 10.1038/376501a0; Nakicenovic N., 2000, EMISSION SCENARIOS I; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164	10	20	20	1	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					571	572		10.1038/35036659	http://dx.doi.org/10.1038/35036659			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034189				2022-12-28	WOS:000089772800024
J	Sisodia, SS				Sisodia, SS			Neuroscience - An accomplice for gamma-secretase brought into focus	SCIENCE			English	Editorial Material							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; PRESENILIN		Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Sisodia, SS (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.							Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; De Strooper B, 2000, NATURE, V405, P627, DOI 10.1038/35015193; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	10	13	13	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 29	2000	289	5488					2296	2297		10.1126/science.289.5488.2296	http://dx.doi.org/10.1126/science.289.5488.2296			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	359CG	11041797				2022-12-28	WOS:000089593500036
J	Howard, SC; Gajjar, A; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sandlund, JT; Harrison, PL; de Armendi, A; Dahl, GV; Pui, CH				Howard, SC; Gajjar, A; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sandlund, JT; Harrison, PL; de Armendi, A; Dahl, GV; Pui, CH			Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPINAL SUBARACHNOID HEMATOMA; REVERSIBLE PARAPLEGIA; PLATELET TRANSFUSIONS; THERAPY; ANTICOAGULATION; COMPLICATIONS; THRESHOLD	Context Patients with thrombocytopenia are at risk for spontaneous or procedure-related hemorrhage. Whether such patients can safely undergo lumbar puncture (LP) without prophylactic platelet transfusion is unknown. Objective To determine whether an association exists between thrombocytopenia and LP complications among children with acute lymphoblastic leukemia. Design, Setting, and Patients Retrospective review of the records of 958 consecutive children (median age, 5.5 years) with newly diagnosed acute lymphoblastic leukemia who were treated at a pediatric cancer center between February 1984 and July 1998. Interventions All patients underwent a diagnostic LP followed by a median of 4 LPs to instill intrathecal chemotherapy. Main Outcome Measure Serious complications of LP occurring during the remission induction and consolidation treatment periods (when thrombocytopenia is likely to occur), defined as any neurologic, infectious, or hemorrhagic problems related to the procedure, reported by platelet count at the time of the procedure. Results Of the 5223 LPs evaluated, 29 were performed at platelet counts of 10 x 10(9)/L or less, 170 at platelet counts of 11 to 20 x 10(9)/L, and 742 at platelet counts of 21 to 50 x 10(9)/L. No serious complications were encountered, regardless of the platelet count. The 95% confidence interval for the proportion of serious complications in the 199 patients with platelet counts of 20 x 10(9)/L or less was 0% to 1.75% and that for the 941 patients with platelet counts of 50 x 10(9)/L or less was 0% to 0.37%. Conclusions In our study of children undergoing remission induction or consolidation therapy for acute lymphoblastic leukemia, serious complications of LP were not observed, regardless of platelet count. Prophylactic platelet transfusion is not necessary in children with platelet counts higher than 10 x 10(9)/L. Due to the small number of patients in our study with platelet counts of 10 x 10(9)/L or less, conclusions cannot yet be drawn for such patients.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biostat & Epidemiol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Anesthesiol, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Stanford University	Howard, SC (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, ALSAC Bldg,Room C6005,332 N Lauderdale St, Memphis, TN 38105 USA.		Howard, Scott C/K-3401-2013; Gajjar, Amar/N-8059-2018; Pui, Ching-Hon/N-8076-2018; Rubnitz, Jeffrey E/N-2619-2018	Howard, Scott C/0000-0003-2244-1686; Pui, Ching-Hon/0000-0003-0303-5658; Rubnitz, Jeffrey E/0000-0001-9885-3527	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [CA-21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS RD, 1999, PRINCIPLES NEUROLOGY; BLADE J, 1983, J NEUROSURG, V58, P438, DOI 10.3171/jns.1983.58.3.0438; BREM SS, 1981, NEW ENGL J MED, V304, P1020, DOI 10.1056/NEJM198104233041705; CASELLA G, 1986, CAN J STAT, V14, P113, DOI 10.2307/3314658; DZIK S, 1999, TRANSFUSION THERAPY, P151; Evans RW, 1998, NEUROL CLIN, V16, P83, DOI 10.1016/S0733-8619(05)70368-6; FISHMAN RA, 1995, MERRITS TXB NEUROLOG, P93; HART IK, 1988, BRIT MED J, V296, P51, DOI 10.1136/bmj.296.6614.51; Heckman KD, 1997, J CLIN ONCOL, V15, P1143, DOI 10.1200/JCO.1997.15.3.1143; Kruskall MS, 1997, NEW ENGL J MED, V337, P1914, DOI 10.1056/NEJM199712253372609; Lederle FA, 1996, AM J MED, V100, P237, DOI 10.1016/S0002-9343(97)89465-X; MALNWARING C, 1998, BR J HAEMATOL S1, V101, P73; MAYUMI T, 1983, ANESTH ANALG, V62, P777; OWENS EL, 1986, ANESTH ANALG, V65, P1201; Peltola J, 1996, LANCET, V347, P131, DOI 10.1016/S0140-6736(96)90262-7; PUI CH, 1983, J CLIN ONCOL, V1, P380, DOI 10.1200/JCO.1983.1.6.380; PUI CH, IN PRESS LEUKEMIA; RASMUS KT, 1989, OBSTET GYNECOL, V73, P943; Rebulla P, 1997, NEW ENGL J MED, V337, P1870, DOI 10.1056/NEJM199712253372602; RIBEIRO RC, 1986, J CLIN ONCOL, V4, P1212, DOI 10.1200/JCO.1986.4.8.1212; RUFF RL, 1981, STROKE, V12, P879, DOI 10.1161/01.STR.12.6.879; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; SCOTT EW, 1989, NEUROSURGERY, V25, P287, DOI 10.1227/00006123-198908000-00022; Van Schaeybroeck P, 1998, CLIN NEUROL NEUROSUR, V100, P283, DOI 10.1016/S0303-8467(98)00044-4; WULF H, 1988, Regional-Anaesthesie, V11, P26	25	111	115	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2222	2224		10.1001/jama.284.17.2222	http://dx.doi.org/10.1001/jama.284.17.2222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056594	Bronze			2022-12-28	WOS:000090052600031
J	Kahn, JO; Cherng, DW; Mayer, K; Murray, H; Lagakos, S				Kahn, JO; Cherng, DW; Mayer, K; Murray, H; Lagakos, S		806 Investigator Team	Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; POTENT ANTIRETROVIRAL THERAPY; DELAYED-TYPE HYPERSENSITIVITY; VIRAL LOAD; ENVELOPE GLYCOPROTEIN; IMMUNIZATION; DISEASE; VACCINE; AIDS; INDIVIDUALS	Context Despite enormous improvements achieved through the use of antiretroviral therapies (ARTs), the risk for eventual human immunodeficiency virus (HIV) disease progression remains high. Agents that enhance the immunologic mechanism for viral recognition might reduce disease progression. Objective To determine whether the addition of HIV-1 Immunogen would confer added clinical efficacy to that achievable by ARTs. Design and Setting Multicenter, double-blind, placebo-controlled, randomized trial beginning March 1996 and ending May 1999 conducted at 77 centers in the United States providing primary care or referral care for persons infected with HIV. Patients Adults infected with HIV who have baseline CD4 cell counts between 300 x 10(6)/L and 549 x 10(6)/L without prior acquired immunodeficiency syndrome-defining conditions receiving stable ART (or no therapy) were screened and 2527 were randomized. Interventions Ten units of HIV-1 Immunogen, derived from a Zairian HIV isolate, inactivated and formulated with incomplete Freund adjuvant, was administered intramuscularly every 12 weeks. The placebo was incomplete Freund adjuvant. Changes in ARTs were allowed. Main Outcome Measures HIV progression-free survival; secondary end points included overall survival, changes in HIV RNA, CD4 cell counts, CD4 percentage, body weight, and immunogenicity. Results The overall event rate was 1.8 per 100 person-years of follow-up. Fifty-three subjects developed clinical progression in each treatment group (relative risk [RR], 0.97; 95% confidence interval [CI], 0.66-1.42; P=.89). There were 19 and 23 deaths in the placebo and HIV-1 Immunogen groups, respectively (RR, 0.81; 95% CI, 0.44-1.48; P=.49). There were no statistically significant differences between the groups with respect to changes in HIV RNA (P=.59), CD4 percentage (P=.63), or body weight (P=.89), Subjects in the HIV-1 Immunogen group had an increase in average CD4 cell count of approximately 10 x 10(6)/L greater than the placebo group (P=.02). Conclusion HIV-1 Immunogen with unrestricted ART failed to demonstrate an increase in HIV progression-free survival.	San Francisco Gen Hosp, San Francisco, CA 94110 USA; Univ Calif San Francisco, Posit Hlth Program, San Francisco, CA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Brown Univ, Mem Hosp Rhode Isl, Pawtucket, RI 02860 USA; Brown Univ, Providence, RI 02912 USA; Cornell Univ, Henry Weill Med Coll, New York, NY USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Brown University; Brown University; Cornell University	Kahn, JO (corresponding author), San Francisco Gen Hosp, 995 Potrero Ave, San Francisco, CA 94110 USA.		Murray, Heather/GQY-8016-2022		NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037] Funding Source: NIH RePORTER; NIMH NIH HHS [P30 MH59037] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Birx DL, 2000, J INFECT DIS, V181, P881, DOI 10.1086/315308; Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Bradley JV., 1968, DISTRIBUTION FREE ST; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Choi DJ, 1997, AIDS RES HUM RETROV, V13, P357, DOI 10.1089/aid.1997.13.357; Davey RT, 2000, JAMA-J AM MED ASSOC, V284, P183, DOI 10.1001/jama.284.2.183; DAWSON JD, 1993, BIOMETRICS, V49, P1022, DOI 10.2307/2532244; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Eron JJ, 1996, LANCET, V348, P1547; Goebel FD, 1999, AIDS, V13, P1461, DOI 10.1097/00002030-199908200-00004; Gulick RM, 2000, ANN INTERN MED, V133, P35, DOI 10.7326/0003-4819-133-1-200007040-00007; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Kalish LA, 1999, J INFECT DIS, V180, P1514, DOI 10.1086/315064; LAN KKG, 1989, BIOMETRICS, V45, P1017, DOI 10.2307/2531701; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Levine AM, 1996, J ACQ IMMUN DEF SYND, V11, P351, DOI 10.1097/00042560-199604010-00005; Lutz H, 1996, AIDS RES HUM RETROV, V12, P431, DOI 10.1089/aid.1996.12.431; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Moss RB, 1996, J CLIN IMMUNOL, V16, P266, DOI 10.1007/BF01541391; Moss RB, 1999, J INFECT DIS, V180, P641, DOI 10.1086/314924; Mossman SP, 1996, J VIROL, V70, P1953, DOI 10.1128/JVI.70.3.1953-1960.1996; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Richardson J, 1997, J VIROL, V71, P9640, DOI 10.1128/JVI.71.12.9640-9649.1997; SALK J, 1987, NATURE, V327, P473, DOI 10.1038/327473a0; SIEBELINK KHJ, 1995, J VIROL, V69, P3704, DOI 10.1128/JVI.69.6.3704-3711.1995; TRAUGER RJ, 1994, J INFECT DIS, V169, P1256, DOI 10.1093/infdis/169.6.1256; TURNER JL, 1994, AIDS, V8, P1429, DOI 10.1097/00002030-199410000-00009	31	140	143	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2193	2202		10.1001/jama.284.17.2193	http://dx.doi.org/10.1001/jama.284.17.2193			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056590				2022-12-28	WOS:000090052600027
J	Josefson, D				Josefson, D			Statins may reduce risk of Alzheimer's disease	BRITISH MEDICAL JOURNAL			English	News Item																		Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439	1	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 28	2000	321	7268					1040	1040		10.1136/bmj.321.7268.1040	http://dx.doi.org/10.1136/bmj.321.7268.1040			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PU	11053163	Green Published			2022-12-28	WOS:000165076800012
J	Maclean, N; Pound, P; Wolfe, C; Rudd, A				Maclean, N; Pound, P; Wolfe, C; Rudd, A			Qualitative analysis of stroke patients' motivation for rehabilitation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ILLNESS	Objective To explore the attitudes and beliefs of stroke patients identified by professionals as having either "high" or "low" motivation for rehabilitation. Design Qualitative study with semistructured interviews. Setting The stroke unit of an inner city teaching hospital. Participants 22 patients with stroke who were undergoing rehabilitation; 14 with high motivation for rehabilitation and eight with low motivation. Results All patients thought rehabilitation was important for recovery. High motivation patients were more likely to view rehabilitation as the most important means of recovery and to accord themselves an active role in rehabilitation. These patients were also more likely to understand rehabilitation and in particular to understand the specialist role of the nursing staff, Many patients reported independence at home as a personal goal, though few low motivation patients related this goal to success in rehabilitation. Information from professionals about rehabilitation, favourable comparisons with Other stroke patients, and the desire to leave hospital had a positive effect on motivation. Conversely overprotection from family members and professionals, lack of information or the receipt of "mixed messages" from professionals, and unfavourable comparisons with other patients had a negative effect. Conclusions There are some differences in beliefs between stroke patients identified as having low or high motivation for rehabilitation. These beliefs seem to be influenced by the environment in which the patient is rehabilitated. Professionals and carers should be made a aware of the ways in which their behaviour can positively and negatively affect motivation.	Kings Coll London, Guys Sch Med & Dent, Dept Publ Hlth Sci, London SE1 3QD, England; Kings Coll London, St Thomass Hosp Sch Med & Dent, Dept Publ Hlth Sci, London SE1 3QD, England; Kings Coll London, Kins Coll Sch Med & Dent, Dept Publ Hlth Sci, London SE1 3QD, England; St Thomas Hosp, Elderly Care Unit, London SE1 7EH, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Maclean, N (corresponding author), Kings Coll London, Guys Sch Med & Dent, Dept Publ Hlth Sci, London SE1 3QD, England.	macleanniall@hotmail.com						ANDERSON R, 1992, AFTERMATH STROKE; BECKER G, 1995, MED ANTHROPOL Q, V9, P165, DOI 10.1525/maq.1995.9.2.02a00040; Clark MS, 1997, CLIN REHABIL, V11, P162, DOI 10.1177/026921559701100210; Fitzpatrick R, 1994, Qual Health Care, V3, P107; Gold S, 1983, QUAL SOCIOL, V6, P238, DOI [10.1007/BF00987448, DOI 10.1007/BF00987448]; GRIFFITHS L, 1993, SOCIOL REV, V41, P415, DOI 10.1111/j.1467-954X.1993.tb00072.x; GUBRIUM J, 1982, DESCRIBING CARE IMAG; HOFFMAN JE, 1981, HLTH CANADIAN SOC; IBBOTSON J, 1978, PHYSIOTHERAPY, V61, P189; KAUFMAN S, 1986, SOC SCI MED, V22, P983, DOI 10.1016/0277-9536(86)90171-1; KAUFMAN S, 1988, J AGING STUD, V2, P217, DOI 10.1016/0890-4065(88)90002-3; KAUFMAN S R, 1988, Medical Anthropology Quarterly, V2, P338, DOI 10.1525/maq.1988.2.4.02a00040; KING P, 1939, CLIN REHABIL, V3, P289; Maclean N, 2000, SOC SCI MED, V50, P495; NIGEL G, 1993, RES SOCIAL LIFE; O'Gorman G, 1975, Physiotherapy, V61, P176; Patton M.Q., 1987, USE QUALITATIVE METH; Strauss A., 1990, BASICS QUALITATIVE R; TUPPER A, 1987, International Journal of Rehabilitation Research, V10, P119, DOI 10.1097/00004356-198700105-00024; WADE DT, 1987, BRIT J HOSP MED, V37, P200; Weber R. P., 1990, BASIC CONTENT ANAL, V2nd; WOLFE B B, 1969, Pennsylvania Medicine, V72, P68	22	253	254	1	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2000	321	7268					1051	1054		10.1136/bmj.321.7268.1051	http://dx.doi.org/10.1136/bmj.321.7268.1051			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	369PU	11053175	Bronze, Green Published			2022-12-28	WOS:000165076800024
J	Xu, JA; Mao, HK				Xu, JA; Mao, HK			Moissanite: A window for high-pressure experiments	SCIENCE			English	Article							DIAMOND-ANVIL CELLS; RAMAN-SPECTROSCOPY; ICE-VII; HYDROGEN; GIGAPASCALS; FLUORESCENCE; TEMPERATURE; PHASE; RUBY; GPA	We achieved a pressure of 52.1 gigapascals with moissanite anvils, which have optical, thermal, electric, magnetic, and x-ray properties that rival those of diamond. The mode-softening of D2O toward the pressure-induced hydrogen bond symmetrization and the Raman shifts of diamond under hydrostatic and nonhydrostatic compressions were studied with moissanite anvils in the spectral regions normally obscured by diamond anvils. Moissanite anvil cells allow maximum sample volumes 1000 times Larger than those allowed by diamond anvil cells and may enable the next level of advancement in high-pressure experiments.	Carnegie Inst Washington, Ctr High Pressure Res, Washington, DC 20015 USA; Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA	Carnegie Institution for Science; Carnegie Institution for Science	Xu, JA (corresponding author), Carnegie Inst Washington, Ctr High Pressure Res, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.							ALEKSANDROV IV, 1987, ZH EKSP TEOR FIZ, V66, P384; Bassett W A, 1998, REV HIGH PRESSURE SC, V7, P142; BELL PM, 1984, SCIENCE, V226, P542, DOI 10.1126/science.226.4674.542; DUFFY TS, 1994, SCIENCE, V263, P1590, DOI 10.1126/science.263.5153.1590; Eremets MI, 1998, SCIENCE, V281, P1333, DOI 10.1126/science.281.5381.1333; FEI YW, 1994, SCIENCE, V266, P1678, DOI 10.1126/science.266.5191.1678; Goncharov AF, 1996, SCIENCE, V273, P218, DOI 10.1126/science.273.5272.218; Goncharov AF, 1999, PHYS REV LETT, V83, P1998, DOI 10.1103/PhysRevLett.83.1998; HANFLAND M, 1985, PHYS REV B, V31, P6896, DOI 10.1103/PhysRevB.31.6896; Hemley RJ, 1999, SCIENCE, V285, P1026, DOI 10.1126/science.285.5430.1026; HEMLEY RJ, 1987, SCIENCE, V237, P605, DOI 10.1126/science.237.4815.605; Hemley RJ, 1998, PHYS TODAY, V51, P26, DOI 10.1063/1.882374; Hemley RJ, 1997, SCIENCE, V276, P1242, DOI 10.1126/science.276.5316.1242; Iota V, 1999, SCIENCE, V283, P1510, DOI 10.1126/science.283.5407.1510; LEE SH, 1992, REV SCI INSTRUM, V63, P3674, DOI 10.1063/1.1143597; Li BS, 1998, SCIENCE, V281, P675, DOI 10.1126/science.281.5377.675; Link P, 1998, PHYS REV LETT, V80, P173, DOI 10.1103/PhysRevLett.80.173; MAO HK, 1979, SCIENCE, V203, P1004, DOI 10.1126/science.203.4384.1004; MAO HK, 1976, SCIENCE, V191, P851, DOI 10.1126/science.191.4229.851; MAO HK, 1978, SCIENCE, V200, P1145, DOI 10.1126/science.200.4346.1145; MAO HK, 1975, CARNEGIE I WASHINGTO, V74, P402; McMillan PF, 1998, NATURE, V391, P539, DOI 10.1038/35267; Merkel S, 1999, APPL PHYS LETT, V74, P656, DOI 10.1063/1.123031; Nassau K., 1997, GEMS GEMOL, V33, P260; Nelmes RJ, 1998, PHYS REV LETT, V81, P2719, DOI 10.1103/PhysRevLett.81.2719; PRUZAN P, 1990, EUROPHYS LETT, V13, P81, DOI 10.1209/0295-5075/13/1/014; Schiferl D, 1997, J APPL PHYS, V82, P3256, DOI 10.1063/1.366268; Struzhkin VV, 1997, NATURE, V390, P382, DOI 10.1038/37074; TAKAHASHI T, 1964, SCIENCE, V145, P483, DOI 10.1126/science.145.3631.483; Xu JA, 1996, J RAMAN SPECTROSC, V27, P823, DOI 10.1002/(SICI)1097-4555(199611)27:11<823::AID-JRS23>3.0.CO;2-0; Xu JA, 1996, HIGH PRESSURE RES, V15, P127, DOI 10.1080/08957959608240466; XU JA, 1986, SCIENCE, V232, P1404, DOI 10.1126/science.232.4756.1404	32	86	103	5	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					783	785		10.1126/science.290.5492.783	http://dx.doi.org/10.1126/science.290.5492.783			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052937				2022-12-28	WOS:000090067600042
J	Hendry, AP; Wenburg, JK; Bentzen, P; Volk, EC; Quinn, TP				Hendry, AP; Wenburg, JK; Bentzen, P; Volk, EC; Quinn, TP			Rapid evolution of reproductive isolation in the wild: Evidence from introduced salmon	SCIENCE			English	Article							ONCORHYNCHUS-NERKA; SOCKEYE-SALMON; LAKE-WASHINGTON; BODY-SIZE; ECOLOGICAL SPECIATION; NATURAL-SELECTION; SYMPATRIC RACES; LIFE-HISTORY; GENE FLOW; REINFORCEMENT	Colonization of new environments should promote rapid speciation as a byproduct of adaptation to divergent selective regimes. Although this process of ecological speciation is known to have occurred over millennia or centuries, nothing is known about how quickly reproductive isolation actually evolves when new environments are first colonized. Using DNA microsatellites, population-specific natural tags, and phenotypic variation, we tested for reproductive isolation between two adjacent salmon populations of a common ancestry that colonized divergent reproductive environments (a river and a lake beach). We found evidence for the evolution of reproductive isolation after fewer than 13 generations.	Univ Massachusetts, Organism & Evolutionary Biol Program, Amherst, MA 01003 USA; Univ Washington, Marine Mol Biotechnol Lab, Seattle, WA 98105 USA; Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; Washington Dept Fish & Wildlife, Olympia, WA 98501 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington Department of Fish & Wildlife (WDFW)	Hendry, AP (corresponding author), Univ Massachusetts, Organism & Evolutionary Biol Program, Amherst, MA 01003 USA.	ahendry@bio.umass.edu	Hendry, Andrew/C-5765-2008; Ebersole, Joseph L/A-8371-2009; Langerhans, R. Brian/A-7205-2009; Wenburg, John/Y-4373-2019	Hendry, Andrew/0000-0002-4807-6667; Wenburg, John/0000-0001-9831-1672; Bentzen, Paul/0000-0003-4288-7730				[Anonymous], 1997, TFPGA TOOLS POPULATI; BLAIR GR, 1993, T AM FISH SOC, V122, P550, DOI 10.1577/1548-8659(1993)122&lt;0550:VILHCA&gt;2.3.CO;2; BUTLIN RK, 1995, TRENDS ECOL EVOL, V10, P432, DOI 10.1016/S0169-5347(00)89173-9; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; Hendry AP, 1997, CAN J FISH AQUAT SCI, V54, P75, DOI 10.1139/f96-257; Hendry AP, 1996, CAN J FISH AQUAT SCI, V53, P823, DOI 10.1139/cjfas-53-4-823; Hendry AP, 1998, CAN J FISH AQUAT SCI, V55, P1387, DOI 10.1139/cjfas-55-6-1387; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; LANDE R, 1988, J THEOR BIOL, V133, P85, DOI 10.1016/S0022-5193(88)80026-2; LIOU LW, 1994, EVOLUTION, V48, P1451, DOI 10.1111/j.1558-5646.1994.tb02187.x; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Olsen JB, 1996, MOL MAR BIOL BIOTECH, V5, P259; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; *PERK CORP, 1993, GEN 67I SOFTW US MAN; *PERK CORP, 1996, GEN 2 0 US MAN; QUINN TP, 1994, ANIM BEHAV, V48, P751, DOI 10.1006/anbe.1994.1300; Quinn TP, 1999, CAN J ZOOL, V77, P766, DOI 10.1139/cjz-77-5-766; Quinn TP, 2000, EVOLUTION, V54, P1372, DOI 10.1111/j.0014-3820.2000.tb00569.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Schluter D, 1998, ENDLESS FORMS, P114; SCHLUTER D, 1996, AM NAT, V148, P540; Steen RP, 1999, CAN J ZOOL, V77, P836, DOI 10.1139/cjz-77-5-836; Taylor EB, 1997, MOL ECOL, V6, P503, DOI 10.1046/j.1365-294X.1997.00213.x; Taylor EB, 1999, REV FISH BIOL FISHER, V9, P299, DOI 10.1023/A:1008955229420; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Volk EC, 1999, FISH RES, V43, P205, DOI 10.1016/S0165-7836(99)00073-9; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wood CC, 1995, AM FISH S S, V17, P195	32	414	428	1	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					516	518		10.1126/science.290.5491.516	http://dx.doi.org/10.1126/science.290.5491.516			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11039932				2022-12-28	WOS:000089946000051
J	McCarty, DR; Chory, J				McCarty, DR; Chory, J			Conservation and innovation in plant signaling pathways	CELL			English	Review							ARABIDOPSIS-THALIANA; PROTEIN-KINASES; AUXIN-RESPONSE; SELF-INCOMPATIBILITY; GENE-EXPRESSION; MESSENGER-RNA; CELL-WALL; RECEPTOR; MAIZE; ETHYLENE		Univ Florida, Dept Hort Sci, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	State University System of Florida; University of Florida; Howard Hughes Medical Institute; Salk Institute	McCarty, DR (corresponding author), Univ Florida, Dept Hort Sci, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA.	drm@ufl.edu						AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Becraft PW, 1996, SCIENCE, V273, P1406, DOI 10.1126/science.273.5280.1406; Bergey DR, 1996, P NATL ACAD SCI USA, V93, P12053, DOI 10.1073/pnas.93.22.12053; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; BRAAM J, 1990, CELL, V60, P357, DOI 10.1016/0092-8674(90)90587-5; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; Carson CB, 1997, PLANT J, V12, P1231, DOI 10.1046/j.1365-313x.1997.12061231.x; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Charlesworth D, 1998, HEREDITY, V81, P1, DOI 10.1038/sj.hdy.6884000; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Constabel CP, 1998, PLANT MOL BIOL, V36, P55, DOI 10.1023/A:1005986004615; Cosgrove DJ, 1997, ANNU REV CELL DEV BI, V13, P171, DOI 10.1146/annurev.cellbio.13.1.171; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; Durner J, 1999, P NATL ACAD SCI USA, V96, P14206, DOI 10.1073/pnas.96.25.14206; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Fowler JE, 1997, ANNU REV CELL DEV BI, V13, P697, DOI 10.1146/annurev.cellbio.13.1.697; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Green PB, 1996, ANN BOT-LONDON, V77, P515, DOI 10.1006/anbo.1996.0062; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; HARRIS RA, 1995, ADV ENZYME REGUL, V35, P147, DOI 10.1016/0065-2571(94)00020-4; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; He ZH, 1999, PLANT MOL BIOL, V39, P1189, DOI 10.1023/A:1006197318246; Herve C, 1996, J MOL BIOL, V258, P778, DOI 10.1006/jmbi.1996.0286; Hobo T, 1999, P NATL ACAD SCI USA, V96, P15348, DOI 10.1073/pnas.96.26.15348; HOECKER U, 1995, GENE DEV, V9, P2459, DOI 10.1101/gad.9.20.2459; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; Jonak C, 1996, P NATL ACAD SCI USA, V93, P11274, DOI 10.1073/pnas.93.20.11274; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Kost B, 1999, J CELL BIOL, V145, P317, DOI 10.1083/jcb.145.2.317; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Kutz D., 1998, J EXP BIOL, V201, P3015; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 1997, P NATL ACAD SCI USA, V94, P3554, DOI 10.1073/pnas.94.8.3554; Ligterink W, 2000, RES PRO CEL, V27, P11; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Ma H, 2000, CELL, V101, P5, DOI 10.1016/S0092-8674(00)80618-2; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; Mizoguchi T, 1997, TRENDS BIOTECHNOL, V15, P15, DOI 10.1016/S0167-7799(96)10074-3; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Neff MM, 2000, GENE DEV, V14, P257; OpsahlFerstad HG, 1997, PLANT J, V12, P235, DOI 10.1046/j.1365-313X.1997.12010235.x; Plakidou-Dymock S, 1998, CURR BIOL, V8, P315, DOI 10.1016/S0960-9822(98)70131-9; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Schumaker KS, 1998, ANNU REV PLANT PHYS, V49, P501, DOI 10.1146/annurev.arplant.49.1.501; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Scott MP, 2000, CELL, V100, P27, DOI 10.1016/S0092-8674(00)81681-5; Smalle J, 1998, P NATL ACAD SCI USA, V95, P3318, DOI 10.1073/pnas.95.6.3318; Smith H, 1999, NATURE, V400, P710, DOI 10.1038/23354; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Summers JE, 1996, PLANT PHYSIOL, V111, P901, DOI 10.1104/pp.111.3.901; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; TREWAVAS A, 1994, PLANT MOL BIOL, V26, P1329, DOI 10.1007/BF00016478; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Veit B, 1998, PLANT CELL, V10, P1407; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; WEIGEL D, 1995, PLANT CELL, V7, P388, DOI 10.1105/tpc.7.4.388; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	83	99	104	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 13	2000	103	2					201	209		10.1016/S0092-8674(00)00113-6	http://dx.doi.org/10.1016/S0092-8674(00)00113-6			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057894	Bronze			2022-12-28	WOS:000089864300005
J	Bosch, X				Bosch, X			Anger as Spain boosts R&D figures with defence money	NATURE			English	News Item																			0	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					664	664		10.1038/35037775	http://dx.doi.org/10.1038/35037775			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048690	Bronze			2022-12-28	WOS:000089773900008
J	Rummel, JD				Rummel, JD			Survival on the edge: the tube worm's strategy	NATURE			English	Letter									NASA, Washington, DC 20546 USA	National Aeronautics & Space Administration (NASA)	Rummel, JD (corresponding author), NASA, Washington, DC 20546 USA.							Snieder R, 2000, NATURE, V406, P939, DOI 10.1038/35023062; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD	2	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					671	671		10.1038/35037802	http://dx.doi.org/10.1038/35037802			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048696	Bronze			2022-12-28	WOS:000089773900014
J	Smil, V				Smil, V			Magic beans - The Japanese invader that's good for you.	NATURE			English	Editorial Material									Univ Manitoba, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Smil, V (corresponding author), Univ Manitoba, Winnipeg, MB R3T 2N2, Canada.								0	15	15	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					567	567		10.1038/35036653	http://dx.doi.org/10.1038/35036653			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034187	Bronze			2022-12-28	WOS:000089772800022
J	van Deuren, L; Brandtzaeg, P				van Deuren, L; Brandtzaeg, P			Parents' and GPs' key role in diagnosis of meningococcal septicaemia	LANCET			English	Editorial Material							DISEASE; ENDOTOXIN; CHILDREN		Univ Med Ctr Nijmegen, Dept Gen Internal Med, NL-6500 HB Nijmegen, Netherlands; Univ Oslo, Ulleval Univ Hosp, Dept Paediat, N-0316 Oslo, Norway	Radboud University Nijmegen; University of Oslo	van Deuren, L (corresponding author), Univ Med Ctr Nijmegen, Dept Gen Internal Med, NL-6500 HB Nijmegen, Netherlands.			Brandtzaeg, Petter/0000-0002-0667-1097				BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; BRANDTZAEG P, 1995, LIPOPOLYSACCHARIDES, P219; BRANDTZAEG P, 1995, MENINGOCOCCAL DIS, P71; CARTWRIGHT K, 1992, BMJ-BRIT MED J, V305, P143, DOI 10.1136/bmj.305.6846.143; Derkx B, 1999, CLIN INFECT DIS, V28, P770, DOI 10.1086/515184; GEDDEDAHL TW, 1990, REV INFECT DIS, V12, P359; GIRARDIN E, 1992, J INFECT DIS, V165, P695, DOI 10.1093/infdis/165.4.695; Giroir BP, 1997, LANCET, V350, P1439, DOI 10.1016/S0140-6736(97)06468-4; HAZELZET JA, 2000, SHOCK, V13, P28; Herrick WW, 1919, ARCH INTERN MED, V23, P409, DOI 10.1001/archinte.1919.00090210003001; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Wang VJ, 2000, ARCH PEDIAT ADOL MED, V154, P556, DOI 10.1001/archpedi.154.6.556	12	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2000	356	9234					954	955		10.1016/S0140-6736(00)02705-7	http://dx.doi.org/10.1016/S0140-6736(00)02705-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041389				2022-12-28	WOS:000089293600002
J	Huusko, TM; Karppi, P; Avikainen, V; Kautiainen, H; Sulkava, R				Huusko, TM; Karppi, P; Avikainen, V; Kautiainen, H; Sulkava, R			Randomised, clinically controlled trial of intensive geriatric rehabilitation in patients with hip fracture: subgroup analysis of patients with dementia	BRITISH MEDICAL JOURNAL			English	Article							ACUTE CONFUSIONAL STATES; MINI-MENTAL-STATE; ELDERLY PATIENTS; FEMORAL-NECK; PREDICTION; MORTALITY; OUTCOMES; FINLAND; FOLLOW; STROKE	Objective To evaluate the effect of intensive geriatric rehabilitation on demented patients with hip fracture. Design Preplanned subanalysis of randomised intervention study. Setting-Jyvaskyla Central Hospital, Finland, Participants 243 independently living patients aged 65 years or older admitted to hospital with hip fracture. Intervention After surgery patients in the intervention group (n = 120) were referred to the geriatric ward whereas those in the control group were discharged to local hospitals. Main outcome measures Length of hospital stay, mortality, and place of residence three months and one year after surgery for hip fracture. Results The median length of hospital stay of hip fracture patients with moderate dementia (mini mental state examination score 12-17) was 47 days in the intervention group (n = 24) and 147 days in the control group (n = 12, P = 0.04). The corresponding figures for patients with mild dementia (score 18-23) were 29 days in the intervention group (n = 35) and 46.5 days in the control group (n = 42, P = 0.002). Three months after the operation, in the intervention group 91% (32) of the patients with mild dementia and 63% (15) of the patients with moderate dementia were living independently. Ln the control group, the corresponding figures were 67% (28) and 17% (2). There were no significant differences in mortality or in the lengths of hospital stay of severely demented patients and patients with normal mini mental state examination scores. Conclusions Hip fracture patients with mild or moderate dementia can often return to the community if they are provided with active geriatric rehabilitation.	Univ Kuopio, Dept Publ Hlth & Gen Practice, Div Geriatr, FIN-70211 Kuopio, Finland; Cent Hosp Cent Finland, Dept Rehabil, Div Geriatr, Kinkomaa 40930, Finland; Cent Hosp Cent Finland, Dept Orthopaed & Trauma Surg, Jyvaskyla 40620, Finland; Rheumatism Fdn Hosp, SF-18120 Heinola, Finland	University of Eastern Finland; Central Finland Central Hospital; Central Finland Central Hospital; Rheumatism Foundation Hospital	Huusko, TM (corresponding author), Univ Kuopio, Dept Publ Hlth & Gen Practice, Div Geriatr, POB 1627, FIN-70211 Kuopio, Finland.							Aguero-Torres H, 1998, AM J PUBLIC HEALTH, V88, P1452, DOI 10.2105/AJPH.88.10.1452; BUCHNER DM, 1987, JAMA-J AM MED ASSOC, V257, P1492, DOI 10.1001/jama.257.11.1492; Cameron I D, 1993, Disabil Rehabil, V15, P29; CAMERON ID, 1994, J CLIN EPIDEMIOL, V47, P1307, DOI 10.1016/0895-4356(94)90136-8; CLAYER MT, 1989, J TRAUMA, V29, P1673, DOI 10.1097/00005373-198912000-00016; FITZGERALD JF, 1988, NEW ENGL J MED, V319, P1395; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORSELL Y, 1992, ACTA PSYCHIAT SCAND, V86, P49, DOI 10.1111/j.1600-0447.1992.tb03225.x; GALVARD H, 1995, AGING-CLIN EXP RES, V7, P11, DOI 10.1007/BF03324284; GILCHRIST WJ, 1988, BRIT MED J, V297, P1116, DOI 10.1136/bmj.297.6656.1116; Goldstein FC, 1997, J AM GERIATR SOC, V45, P35, DOI 10.1111/j.1532-5415.1997.tb00975.x; GRACE J, 1995, ARCH NEUROL-CHICAGO, V52, P477, DOI 10.1001/archneur.1995.00540290067019; GUSTAFSON Y, 1991, J AM GERIATR SOC, V39, P655, DOI 10.1111/j.1532-5415.1991.tb03618.x; Heruti RJ, 1999, ARCH PHYS MED REHAB, V80, P432, DOI 10.1016/S0003-9993(99)90281-2; Huusko T, 1999, ANN CHIR GYNAECOL FE, V88, P55; Hux MJ, 1998, CAN MED ASSOC J, V159, P457; JETTE AM, 1987, ARCH PHYS MED REHAB, V68, P735; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1984, DOI 10.1001/jama.264.15.1984; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; KENNIE DC, 1988, BRIT MED J, V297, P1083, DOI 10.1136/bmj.297.6656.1083; Kramer AM, 1997, JAMA-J AM MED ASSOC, V277, P396, DOI 10.1001/jama.277.5.396; KYO T, 1993, CLIN ORTHOP RELAT R, P215; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lieberman D, 1996, DISABIL REHABIL, V18, P224, DOI 10.3109/09638289609166305; Lyons AR, 1997, AM J MED, V103, P51; PARKER MJ, 1995, AGE AGEING, V24, P96, DOI 10.1093/ageing/24.2.96; PITTO RP, 1994, INT ORTHOP, V18, P109, DOI 10.1007/BF02484420; REID J, 1989, BRIT MED J, V299, P25, DOI 10.1136/bmj.299.6690.25-a; Steiner JF, 1997, J AM GERIATR SOC, V45, P1510, DOI 10.1111/j.1532-5415.1997.tb03204.x; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; SULKAVA R, 1985, NEUROLOGY, V35, P1025, DOI 10.1212/WNL.35.7.1025; VANDERSLUIJS JA, 1991, ACTA ORTHOP SCAND, V62, P567, DOI 10.3109/17453679108994498; WILLIAMS MA, 1985, RES NURS HEALTH, V8, P329, DOI 10.1002/nur.4770080405	34	192	195	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1107	1111		10.1136/bmj.321.7269.1107	http://dx.doi.org/10.1136/bmj.321.7269.1107			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	372DT	11061730	Green Published, Bronze			2022-12-28	WOS:000165219600022
J	McMurdo, MET				McMurdo, MET			A healthy old age: realistic or futile goal?	BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	Millennium Festival of Medicine Conference	NOV 06-10, 2000	LONDON, ENGLAND				PHYSICAL-ACTIVITY; CONTROLLED TRIAL; RANDOMIZED TRIAL; LIFE-STYLE; EXERCISE; DISABILITY; WOMEN; CARE		Univ Dundee, Ninewells Hosp & Med Sch, Dept Med, Dundee DD1 9SY, Scotland	University of Dundee	McMurdo, MET (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Med, Dundee DD1 9SY, Scotland.							Allaire SH, 1999, AM J PUBLIC HEALTH, V89, P1678, DOI 10.2105/AJPH.89.11.1678; Andersen RE, 1999, JAMA-J AM MED ASSOC, V281, P335, DOI 10.1001/jama.281.4.335; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; CAMPBELL AJ, 1997, BRIT MED J, V315, P1095; Dunn AL, 1999, JAMA-J AM MED ASSOC, V281, P327, DOI 10.1001/jama.281.4.327; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gordon M, 1997, LANCET, V350, P1166, DOI 10.1016/S0140-6736(97)05069-1; GRAY JAM, 1985, PREVENTION DIS ELDER, P78; Harland J, 1999, BRIT MED J, V319, P828, DOI 10.1136/bmj.319.7213.828; Malbut-Shennan K, 1999, CORONARY ARTERY DIS, V10, P37; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; MCMURDO MET, 1993, AGE AGEING, V22, P11, DOI 10.1093/ageing/22.1.11; McMurdo MET, 1997, BRIT MED J, V314, P569, DOI 10.1136/bmj.314.7080.569; McMurdo MET, 1999, BRIT J SPORT MED, V33, P295, DOI 10.1136/bjsm.33.5.295; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; POLLOCK M. L., 1988, EXERCISE ADHERENCE I, P259; Shaw AB, 1996, DRUG AGING, V9, P403, DOI 10.2165/00002512-199609060-00003; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506	19	47	48	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1149	1151		10.1136/bmj.321.7269.1149	http://dx.doi.org/10.1136/bmj.321.7269.1149			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11061744	Green Published			2022-12-28	WOS:000165219600035
J	Henney, JE				Henney, JE			New drug for HIV infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Henney, JE (corresponding author), US FDA, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2178	2178		10.1001/jama.284.17.2178	http://dx.doi.org/10.1001/jama.284.17.2178			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056574				2022-12-28	WOS:000090052600006
J	Steinman, MA				Steinman, MA			Gifts to physicians in the consumer marketing era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PHARMACEUTICAL SALES REPRESENTATIVES; ATTITUDES; RESIDENTS; BEHAVIOR; INDUSTRY; FACULTY		San Francisco Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Steinman, MA (corresponding author), San Francisco Vet Affairs Med Ctr, San Francisco, CA 94121 USA.							AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; Blake R L Jr, 1995, J Am Board Fam Pract, V8, P457; BROTZMAN GL, 1993, J GEN INTERN MED, V8, P130, DOI 10.1007/BF02599757; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Gibbons RV, 1998, J GEN INTERN MED, V13, P151, DOI 10.1046/j.1525-1497.1998.00048.x; Hopper JA, 1997, J GEN INTERN MED, V12, P639, DOI 10.1046/j.1525-1497.1997.07126.x; LICHSTEIN PR, 1992, ARCH INTERN MED, V152, P1009, DOI 10.1001/archinte.152.5.1009; LURIE N, 1990, J GEN INTERN MED, V5, P240, DOI 10.1007/BF02600542; MCKINNEY WP, 1990, JAMA-J AM MED ASSOC, V264, P1693, DOI 10.1001/jama.264.13.1693; Perri M, 1999, CLIN THER, V21, P1798, DOI 10.1016/S0149-2918(99)80058-7; Sergeant MD, 1996, CAN MED ASSOC J, V155, P1243; Steinman MA, 2000, J GEN INTERN MED, V15, P45; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296; ZUGER A, 1999, NY TIMES        0111, P13; Zuger Abigail, 1999, NY TIMES, pA1	15	11	12	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2243	2243		10.1001/jama.284.17.2243	http://dx.doi.org/10.1001/jama.284.17.2243			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056602	hybrid			2022-12-28	WOS:000090052600038
J	Bush, GW				Bush, GW			Ensuring access to health care - The Bush plan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2108	2109		10.1001/jama.284.16.2108	http://dx.doi.org/10.1001/jama.284.16.2108			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364QA	11042760				2022-12-28	WOS:000089902100032
J	Cusack, DA				Cusack, DA			Ireland: breakdown of trust between doctor and patient	LANCET			English	Article								By European standards ireland experiences a very high level of medical litigation. The possible reasons for this are numerous but not yet determined with any certainty. The consequences are quite clear with negative effects on medical practice, on the psychological health of doctors and patients alike, and on finances of the state. There are different patterns of medical litigation throughout Europe. Ireland may be merely anticipating the emerging increase in such actions elsewhere in the region. The present adversarial basis for medical litigation is not wholly without merit and has contributed to professional accountability. Nevertheless, a change in the present system ensuring accountability and fair compensation is required, together with a striving to ensure that trust is rebuilt between doctors and patients.	Natl Univ Ireland Univ Coll Dublin, Dept Forens Med, Div Legal Med, Dublin 2, Ireland	University College Dublin	Cusack, DA (corresponding author), Natl Univ Ireland Univ Coll Dublin, Dept Forens Med, Div Legal Med, Dublin 2, Ireland.		Cusack, Denis/AAG-9530-2020	Cusack, Denis/0000-0002-6677-9059					0	14	14	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2000	356	9239					1431	1432		10.1016/S0140-6736(00)02855-5	http://dx.doi.org/10.1016/S0140-6736(00)02855-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XQ	11052598				2022-12-28	WOS:000089976100043
J	Kopp, C; Tarr, A				Kopp, C; Tarr, A			WHO and industry partnership - All commercial enterprises should be excluded from the development process	BRITISH MEDICAL JOURNAL			English	Letter									Int Soc Drug Bulletins, F-75527 Paris, France; Drug & Therapeut Bulletin, Int Soc Drug Bulletins, London NW1 4DF, England		Kopp, C (corresponding author), Int Soc Drug Bulletins, Revue Prescrire, F-75527 Paris, France.							*ASS MED CAN, 1999, CAN MED ASSOC J, V161, pSF1; Chalmers J, 1999, J HYPERTENS, V17, P151; Ferriman A, 2000, BRIT MED J, V320, P1362, DOI 10.1136/bmj.320.7246.1362; *NIH, 1997, 6 NIH JOINT NAT COMM, P1; *PRESCR ED STAFF, 1999, PRESCR INT, V8, P121; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917	6	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 14	2000	321	7266					958	958						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	365XE	11030703				2022-12-28	WOS:000089975100044
J	Jordan, JD; Landau, EM; Iyengar, R				Jordan, JD; Landau, EM; Iyengar, R			Signaling networks: The origins of cellular multitasking	CELL			English	Review							LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY; MAP KINASE; PATHWAY; PHOSPHORYLATION; RECEPTORS; PROTEINS; BINDING		CUNY Mt Sinai Sch Med, Dept Pharmacol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Iyengar, R (corresponding author), CUNY Mt Sinai Sch Med, Dept Pharmacol, Box 1215, New York, NY 10029 USA.			Jordan, Dedrick/0000-0002-0706-9583	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA005798] Funding Source: NIH RePORTER; NIDA NIH HHS [F30 DA005798, DA-05798] Funding Source: Medline; NIGMS NIH HHS [R01 GM054508, GM-54508] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; CHEN JH, 1994, SCIENCE, V263, P1278, DOI 10.1126/science.8122111; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Pieroni J P, 1993, Curr Opin Neurobiol, V3, P345, DOI 10.1016/0959-4388(93)90127-K; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Rossi EA, 1999, J BIOL CHEM, V274, P27201, DOI 10.1074/jbc.274.38.27201; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Siegelbaum S A, 1991, Curr Opin Neurobiol, V1, P113, DOI 10.1016/0959-4388(91)90018-3; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	31	310	315	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 13	2000	103	2					193	200		10.1016/S0092-8674(00)00112-4	http://dx.doi.org/10.1016/S0092-8674(00)00112-4			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057893	Bronze, Green Accepted			2022-12-28	WOS:000089864300004
J	Flores, GV; Duan, H; Yan, HJ; Nagaraj, R; Fu, WM; Zou, Y; Noll, M; Banerjee, U				Flores, GV; Duan, H; Yan, HJ; Nagaraj, R; Fu, WM; Zou, Y; Noll, M; Banerjee, U			Combinatorial signaling in the specification of unique cell fates	CELL			English	Article							DEVELOPING DROSOPHILA RETINA; EYE DEVELOPMENT; EGF RECEPTOR; TRANSCRIPTION FACTORS; PAX2 HOMOLOG; PATTERN-FORMATION; PIGMENT-CELLS; COMPOUND EYE; ETS DOMAIN; MAP KINASE	How multifunctional signals combine to specify unique cell fates during pattern formation is not well understood. Here, we demonstrate that together with the transcription factor Lozenge, the nuclear effecters of the EGFR and Notch signaling pathways directly regulate D-Pax2 transcription in cone cells of the Drosophila eye disc. Moreover, the specificity of D-Pax2 expression can be altered upon genetic manipulation of these inputs. Thus, a relatively small number of temporally and spatially controlled signals received by a set of pluripotent cells can create the unique combinations of activated transcription factors required to regulate target genes and ultimately specify distinct cell fates within this group. We expect that similar mechanisms may specify pattern formation in vertebrate developmental systems that involve intercellular communication.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Zurich; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.				NATIONAL EYE INSTITUTE [R01EY008152] Funding Source: NIH RePORTER; NEI NIH HHS [2R01EY08152] Funding Source: Medline; NIGMS NIH HHS [GM07195] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnone MI, 1997, DEVELOPMENT, V124, P1851; Arnosti DN, 1996, DEVELOPMENT, V122, P205; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ausubel FM., 2006, ENZYMATIC MANIPULATI; Bae SC, 1999, HISTOL HISTOPATHOL, V14, P1213, DOI 10.14670/HH-14.1213; BAKER NE, 1992, DEV BIOL, V150, P381, DOI 10.1016/0012-1606(92)90250-K; BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; BASLER K, 1990, GENE DEV, V4, P728, DOI 10.1101/gad.4.5.728; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Crew JR, 1997, DEV GENES EVOL, V206, P481, DOI 10.1007/s004270050079; Czerny T, 1997, MECH DEVELOP, V67, P179, DOI 10.1016/S0925-4773(97)00119-6; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; DICKSON B, 1992, GENE DEV, V6, P2327, DOI 10.1101/gad.6.12a.2327; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; Flores GV, 1998, DEVELOPMENT, V125, P3681; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066; Fu WM, 1998, DEVELOPMENT, V125, P2943; Go MJ, 1998, DEVELOPMENT, V125, P2031; Gupta BP, 1995, J NEUROGENET, V10, P137, DOI 10.3109/01677069509083460; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; HUANG JD, 1993, GENE DEV, V7, P694, DOI 10.1101/gad.7.4.694; Ito K, 1997, DEVELOPMENT, V124, P761; KAMACHI Y, 1990, J VIROL, V64, P4808, DOI 10.1128/JVI.64.10.4808-4819.1990; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; Kavaler J, 1999, DEVELOPMENT, V126, P2261; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; Kumar J, 1997, GENE DEV, V11, P2023, DOI 10.1101/gad.11.16.2023; Kumar JP, 1998, DEVELOPMENT, V125, P3875; LAWRENCE PA, 1979, DEV BIOL, V71, P142, DOI 10.1016/0012-1606(79)90088-5; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Matsuno K, 1997, DEVELOPMENT, V124, P4265; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Tio M, 1997, DEVELOPMENT, V124, P343; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; WOLFF T, 1991, DEVELOPMENT, V113, P841; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; XU T, 1993, DEVELOPMENT, V117, P1223; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	54	201	205	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					75	85		10.1016/S0092-8674(00)00106-9	http://dx.doi.org/10.1016/S0092-8674(00)00106-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051549	Green Published, Bronze			2022-12-28	WOS:000089636400010
J	Franceschi, S; Munoz, N; Snijders, PJF				Franceschi, S; Munoz, N; Snijders, PJF			How strong and how wide is the link between HPV and oropharyngeal cancer?	LANCET			English	Editorial Material							UPPER AERODIGESTIVE TRACT; HUMAN-PAPILLOMAVIRUS; TONSILLAR; WORLDWIDE; RISK		Int Agcy Res Canc, Unit Field & Intervent Studies, F-69372 Lyon 08, France; Free Univ Amsterdam Hosp, Dept Pathol, Amsterdam, Netherlands	World Health Organization; International Agency for Research on Cancer (IARC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Franceschi, S (corresponding author), Int Agcy Res Canc, Unit Field & Intervent Studies, 150 Cours Albert Thomas, F-69372 Lyon 08, France.		franceschi, silvia/M-2452-2014	franceschi, silvia/0000-0003-4181-8071				BARON AE, 1993, CANCER EPIDEM BIOMAR, V2, P519; Franceschi S, 2000, ORAL ONCOL, V36, P106, DOI 10.1016/S1368-8375(99)00070-6; Franceschi S, 1996, CANCER EPIDEM BIOMAR, V5, P567; Frisch M, 1999, LANCET, V354, P1442, DOI 10.1016/S0140-6736(99)92824-6; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; HERRERO R, 2000, P 18 INT PAP C BARC, P184; *IARC, 1995, MON EV CARC RISKS HU, V64; McNeil C, 2000, J NATL CANCER I, V92, P680, DOI 10.1093/jnci/92.9.680; MUIR C, 1995, CANCER, V75, P147, DOI 10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0.CO;2-U; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Snijders PJF, 1997, CLIN DERMATOL, V15, P415, DOI 10.1016/S0738-081X(96)00156-3; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; *WHO, 1999, WHOVB9904; Wilczynski SP, 1998, AM J PATHOL, V152, P145	15	37	37	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2000	356	9233					871	872		10.1016/S0140-6736(00)02673-8	http://dx.doi.org/10.1016/S0140-6736(00)02673-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036888				2022-12-28	WOS:000089259800005
J	Golbe, LI				Golbe, LI			Progressive supranuclear palsy in the molecular age	LANCET			English	Editorial Material							TAU-GENE; NATURAL-HISTORY; SYSTEM; ASSOCIATION; PREVALENCE; DEMENTIA		Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Golbe, LI (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08901 USA.							Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Caparros-Lefebvre D, 1999, LANCET, V354, P281, DOI 10.1016/S0140-6736(98)10166-6; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; Dickson DW, 1997, ANN NEUROL, V42, P541, DOI 10.1002/ana.410420403; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; FLAMENT S, 1991, ACTA NEUROPATHOL, V81, P591, DOI 10.1007/BF00296367; Golbe LI, 1996, NEUROLOGY, V47, P148, DOI 10.1212/WNL.47.1.148; GOLBE LI, 1988, NEUROLOGY, V38, P1031, DOI 10.1212/WNL.38.7.1031; Higgins JJ, 1999, NEUROLOGY, V53, P1421, DOI 10.1212/WNL.53.7.1421; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; LANNUZEL A, 2000, MOV DISORD S3, V15, P28; LITVAN I, 1994, ANN NEUROL, V36, P55, DOI 10.1002/ana.410360112; MAHER ER, 1986, NEUROLOGY, V36, P1005, DOI 10.1212/WNL.36.7.1005; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stanford PM, 2000, BRAIN, V123, P880, DOI 10.1093/brain/123.5.880; SWERDLOW RH, IN PRESS J NEUROCHEM	17	8	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					870	871		10.1016/S0140-6736(00)02672-6	http://dx.doi.org/10.1016/S0140-6736(00)02672-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036887				2022-12-28	WOS:000089259800004
J	Hayden, FG; Gubareva, LV; Monto, AS; Klein, TC; Elliott, MJ; Hammond, JM; Sharp, SJ; Ossi, MJ				Hayden, FG; Gubareva, LV; Monto, AS; Klein, TC; Elliott, MJ; Hammond, JM; Sharp, SJ; Ossi, MJ		Zanamivir Family Study Grp	Inhaled zanamivir for the prevention of influenza in families.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							A VIRUS; RIMANTADINE; NEURAMINIDASE; RESISTANT; TRANSMISSION; 4-GUANIDINO-NEU5AC2EN; HYDROCHLORIDE; EMERGENCE	Background: As prophylaxis against influenza in families, amantadine and rimantadine have had inconsistent effectiveness, partly because of the transmission of drug-resistant variants from treated index patients. We performed a double-blind, placebo-controlled study of inhaled zanamivir for the treatment and prevention of influenza in families. Methods: We enrolled families (with two to five members and at least one child who was five years of age or older) before the 1998-1999 influenza season. If an influenza-like illness developed in one member, the family was randomly assigned to receive either inhaled zanamivir or placebo. The family member with the index illness was treated with either 10 mg of inhaled zanamivir (163 subjects) or placebo (158) twice a day for 5 days, and the other family members received either 10 mg of zanamivir (414 subjects) or placebo (423) once a day as prophylaxis for 10 days. The primary end point was the proportion of families in which at least one household contact had symptomatic, laboratory-confirmed influenza. Results: The proportion of families with at least one initially healthy household contact in whom influenza developed was smaller in the zanamivir group than in the placebo group (4 percent vs. 19 percent, P<0.001); the difference represented a 79 percent reduction in the proportion of families with at least one affected contact. Zanamivir provided protection against both influenza A and influenza B. A neuraminidase-inhibition assay and sequencing of the neuraminidase and hemagglutinin genes revealed no zanamivir-resistant variants. Among the subjects with index cases of laboratory-confirmed influenza, the median duration of symptoms was 2.5 days shorter in the zanamivir group than in the placebo group (5.0 vs. 7.5 days, P=0.01). Zanamivir was well tolerated. Conclusions: When combined with the treatment of index cases, prophylactic treatment of family members with once-daily inhaled zanamivir is well tolerated and prevents the development of influenza. In this study there was no evidence of the emergence of resistant influenza variants. (N Engl J Med 2000;343:1282-9.) (C) 2000, Massachusetts Medical Society.	Univ Virginia, Hlth Sci Ctr, Charlottesville, VA 22908 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Heartland Res, Wichita, KS USA; Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA; Glaxo Wellcome Res & Dev Ltd, Greenford, Middx, England	University of Virginia; University of Michigan System; University of Michigan; GlaxoSmithKline; GlaxoSmithKline	Hayden, FG (corresponding author), Univ Virginia, Hlth Sci Ctr, Box 800473, Charlottesville, VA 22908 USA.							Barnett JM, 2000, ANTIMICROB AGENTS CH, V44, P78, DOI 10.1128/AAC.44.1.78-87.2000; Boivin G, 2000, J INFECT DIS, V181, P1471, DOI 10.1086/315392; BRICAIRE F, 1990, PRESSE MED, V19, P69; Capasso L, 1999, LANCET, V353, P504, DOI 10.1016/S0140-6736(05)75184-9; COX DR, 1966, BIOMETRIKA, V53, P215, DOI 10.2307/2334067; Ellis JS, 1997, J CLIN MICROBIOL, V35, P2076, DOI 10.1128/JCM.35.8.2076-2082.1997; GALBRAIT.AW, 1969, B WORLD HEALTH ORGAN, V41, P677; GALBRAITH AW, 1969, LANCET, V2, P1026; GART JJ, 1970, BIOMETRIKA, V57, P471, DOI 10.1093/biomet/57.3.471; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Gubareva LV, 1997, J VIROL, V71, P3385, DOI 10.1128/JVI.71.5.3385-3390.1997; Gubareva LV, 1996, J VIROL, V70, P1818, DOI 10.1128/JVI.70.3.1818-1827.1996; HALL CB, 1987, PEDIATRICS, V80, P275; Hayden FG, 1999, ANTIMICROBIAL, P1344; HAYDEN FG, 1991, ANTIMICROB AGENTS CH, V35, P1741, DOI 10.1128/AAC.35.9.1741; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; HAYDEN FG, 1989, NEW ENGL J MED, V321, P1696, DOI 10.1056/NEJM198912213212502; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Hedrick JA, 2000, PEDIATR INFECT DIS J, V19, P410, DOI 10.1097/00006454-200005000-00005; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; Koch GG, 1988, BIOPHARMACEUTICAL ST, P403; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Makela MJ, 2000, J INFECTION, V40, P42, DOI 10.1053/jinf.1999.0602; MIST Study Grp, 1999, LANCET, V353, P1104; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; NICHOLSON K, 1999, MANAGING INFLUENZA P, P24; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; SHUSTER JJ, 1993, CONTROL CLIN TRIALS, V14, P198, DOI 10.1016/0197-2456(93)90003-V; Silagy C, 1998, LANCET, V352, P1877, DOI 10.1016/S0140-6736(98)10190-3; Webster A, 1999, CLIN PHARMACOKINET, V36, P51, DOI 10.2165/00003088-199936001-00006	30	251	266	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2000	343	18					1282	1289		10.1056/NEJM200011023431801	http://dx.doi.org/10.1056/NEJM200011023431801			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368RP	11058672				2022-12-28	WOS:000090131600001
J	Boyd, EA; Bero, LA				Boyd, EA; Bero, LA			Assessing faculty financial relationships with industry - A case study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONFLICT-OF-INTEREST; LIFE SCIENCES; TRIALS; DRUGS	Context A growing number of academic researchers receive industry funding for clinical and basic research, but little is known about the personal financial relationships of researchers with their industry sponsors. Objectives To assess the extent to which faculty researchers have personal financial relationships with the sponsors of their research, the nature of those financial relationships, and efforts made at the institutional level to address disclosed financial relationships and perceived conflicts of interest. Design and Setting Case study of the University of California, San Francisco (UCSF). Data sources included disclosure forms and official documents maintained by the UCSF Office of Research Administration from December 1980 to October 1999, including decisions made by the UCSF Chancellor's Advisory Panel on Relations with Industry. Main Outcome Measures Number and types of personal financial relationships with external sponsors (positive financial disclosures from all clinical, basic, or social science faculty who were principal investigators), amount of annual income received from sponsors, and decisions and management strategies used by the advisory panel. Results By 1999, almost 7.6% of faculty investigators reported personal financial ties with sponsors of their research. Throughout the study period, 34% of disclosed relationships involved paid speaking engagements (range, $250-$20000 per year), 33% involved consulting agreements between researcher and sponsor (range, <$1000-$120 000 per year), and 32% involved the investigator holding a position on a scientific advisory board or board of directors. Fourteen percent involved equity ownership, and 12% involved multiple relationships. The advisory panel recommended managing perceived conflicts of interest in 26% of the cases, including recommending the sale of stock, ref using additional payment for talks, resigning from a management position, or naming a new principal investigator for a project. Conclusions Faculty researchers are increasingly involved in financial relationships with their research sponsors. Guidelines for what constitutes a conflict and how the conflict should be managed are needed if researchers are to have consistent standards of behavior among institutions.	Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA; Dept Vet Affairs, Ctr Hlth Care Evaluat, Hlth Serv Res & Dev Program, Palo Alto, CA USA; Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; Univ Calif San Francisco, Chancellors Advisory Panel Relat Ind, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bero, LA (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, 3333 Calif St,Suite 265, San Francisco, CA 94143 USA.	bero@medicine.ucsf.edu						Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; Angell M, 2000, NEW ENGL J MED, V342, P586, DOI 10.1056/NEJM200002243420812; Blumenthal D, 1996, NEW ENGL J MED, V334, P368, DOI 10.1056/NEJM199602083340606; Blumenthal D, 1996, NEW ENGL J MED, V335, P1734, DOI 10.1056/NEJM199612053352305; Blumenthal D, 1996, ACAD MED, V71, P1291, DOI 10.1097/00001888-199612000-00010; Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Campbell EG, 1998, JAMA-J AM MED ASSOC, V279, P995, DOI 10.1001/jama.279.13.995; CARLSON S, 2000, CHRON HIGHER ED 0414, pA49; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; DAVIDSON RA, 1986, J GEN INTERN MED, V1, P155, DOI 10.1007/BF02602327; Frankel MS, 1996, ACAD MED, V71, P1297, DOI 10.1097/00001888-199612000-00011; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Krimsky S, 1996, Sci Eng Ethics, V2, P395, DOI 10.1007/BF02583927; PRESS E, 2000, ATLANTIC MONTHLY, V285, P39; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; Stolberg S G, 2000, N Y Times Web, pA15; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812	18	121	121	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2209	2214		10.1001/jama.284.17.2209	http://dx.doi.org/10.1001/jama.284.17.2209			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056592	Bronze			2022-12-28	WOS:000090052600029
J	Ismail, W; Taylor, SJC; Beddow, E				Ismail, W; Taylor, SJC; Beddow, E			Advice on driving after groin hernia surgery in the United Kingdom: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article									Harold Wood Hosp, Havering Hosp NHS Trust, Romford RM3 0BE, Essex, England; Univ London Queen Mary & Westfield Coll, Dept Gen Practice & Primary Care, London E1 4NS, England; St Bartholomews Hosp, Dept Cardiothorac Surg, London EC1A 7BE, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Ismail, W (corresponding author), Harold Wood Hosp, Havering Hosp NHS Trust, Romford RM3 0BE, Essex, England.		TAYLOR, STEPHANIE/GYV-4768-2022					AMID PK, 1993, AM J SURG, V165, P369, DOI 10.1016/S0002-9610(05)80847-5; Giddins GEB, 1996, INJURY, V27, P495, DOI 10.1016/0020-1383(96)00054-X; ROBERTSON GSM, 1993, ANN ROY COLL SURG, V75, P30; The Royal College of Surgeons of England, 1993, CLIN GUID MAN GROIN; Wright DM, 1999, SURG ENDOSC-ULTRAS, V13, P332, DOI 10.1007/s004649900983	5	15	15	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 28	2000	321	7268					1056	1056		10.1136/bmj.321.7268.1056	http://dx.doi.org/10.1136/bmj.321.7268.1056			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PU	11053178	Green Published, Bronze			2022-12-28	WOS:000165076800026
J	King, J				King, J			For and against - Why journals should not publish articles funded by the tobacco industry	BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERVENTION; CANCER		Canc Res Campaign, London NW1 4JL, England		King, J (corresponding author), Canc Res Campaign, London NW1 4JL, England.							*ASH, 1998, TOB EXPL; *CANC RES CAMP, 1997, BREAK ADD TOB FUND; Cohen JE, 1999, TOB CONTROL, V8, P70, DOI 10.1136/tc.8.1.70; Department of Health, 1998, SMOK KILLS; DOLL R, 1996, BR MED B, V52, P3; Dyer C, 1998, BRIT MED J, V316, P1555; HEDLEY AJ, 2000, TOBACCO GROWING EPID; HEDLEY AJ, 2000, EUR J PUBLIC HLT MAR; McVie JG, 1999, EUR J CANCER PREV, V8, P377, DOI 10.1097/00008469-199910000-00002; Ong EK, 2000, LANCET, V355, P1253, DOI 10.1016/S0140-6736(00)02098-5; PETO R, 1994, MORTALITY SMOKING; *ROYAL COLL PHYS L, 2000, NIC ADD BRIT; *ROYAL COLL PHYS L, 1992, SMOK YOUNG; Rylander R, 1999, EUR J PUBLIC HEALTH, V9, P142, DOI 10.1093/eurpub/9.2.142; SIMPSON D, 1996, TOB CONTROL, V5, P262; Smith GD, 1996, BRIT MED J, V313, P929; *WORLD BANK, 1999, CURB EP; Young KJ, 1999, EUR J CANCER PREV, V8, P91, DOI 10.1097/00008469-199904000-00003	18	11	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	OCT 28	2000	321	7268					1074	1075		10.1136/bmj.321.7268.1074	http://dx.doi.org/10.1136/bmj.321.7268.1074			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	369PU	11053186	Green Published			2022-12-28	WOS:000165076800032
J	Matus, A				Matus, A			Actin-based plasticity in dendritic spines	SCIENCE			English	Review							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; SYNAPTIC PLASTICITY; CEREBRAL-CORTEX; SILENT SYNAPSES; AMPA RECEPTORS; POSTSYNAPTIC DENSITIES; SOMATOSENSORY CORTEX; HIPPOCAMPAL-NEURONS; CORTICAL PLASTICITY	The central nervous system functions primarily to convert patterns of activity in sensory receptors into patterns of muscle activity that constitute appropriate behavior. At the anatomical Level this requires two complementary processes: a set of genetically encoded rules for building the basic network of connections, and a mechanism for subsequently fine tuning these connections on the basis of experience. Identifying the Locus and mechanism of these structural changes has long been among neurobiology's major objectives. Evidence has accumulated implicating a particular class of contacts, excitatory synapses made onto dendritic spines, as the sites where connective plasticity occurs. New developments in Light microscopy allow changes in spine morphology to be directly visualized in living neurons and suggest that a common mechanism, based on dynamic actin filaments, is involved in both the formation of dendritic spines during development and their structural plasticity at mature synapses.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Matus, A (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	matus@fmi.ch						Allison DW, 1998, J NEUROSCI, V18, P2423; BLISS TVP, 1990, SCIENCE, V249, P973, DOI 10.1126/science.2396098; Bray D., 1992, CELL MOVEMENTS; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; Carlier MF, 1997, J MOL BIOL, V269, P459, DOI 10.1006/jmbi.1997.1062; CARLIN RK, 1983, P NATL ACAD SCI-BIOL, V80, P3517, DOI 10.1073/pnas.80.11.3517; CHOI DW, 1994, PROG BRAIN RES, V100, P47; COHEN RS, 1985, CELL MOL NEUROBIOL, V5, P271, DOI 10.1007/BF00711012; COOPER JA, 1991, ANNU REV PHYSIOL, V53, P585, DOI 10.1146/annurev.ph.53.030191.003101; COSS RG, 1985, BEHAV NEURAL BIOL, V44, P151, DOI 10.1016/S0163-1047(85)90170-0; CRAGG BG, 1967, J ANAT, V101, P639; CRICK F, 1982, TRENDS NEUROSCI, V5, P44, DOI 10.1016/0166-2236(82)90020-0; Dailey ME, 1996, J NEUROSCI, V16, P2983; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; ECCLES JC, 1979, NATURWISSENSCHAFTEN, V66, P147, DOI 10.1007/BF00368708; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FAGG GE, 1984, P NATL ACAD SCI-BIOL, V81, P6876, DOI 10.1073/pnas.81.21.6876; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gilbert C D, 1993, Curr Opin Neurobiol, V3, P100, DOI 10.1016/0959-4388(93)90042-W; GILBERT CD, 1993, CEREB CORTEX, V3, P373, DOI 10.1093/cercor/3.5.373; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HERNDON RM, 1971, J NEUROPATH EXP NEUR, V30, P557, DOI 10.1097/00005072-197110000-00001; HIRANO A, 1983, J NEURAL TRANSM, P1; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Horch HW, 1999, NEURON, V23, P353; Hu S, 1999, NEURON, V22, P419, DOI 10.1016/S0896-6273(00)80696-0; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Kaech S, 1997, J NEUROSCI, V17, P9565; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim CH, 1999, J NEUROSCI, V19, P4314; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; KOCH C, 1993, J NEUROSCI, V13, P413; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Letourneau PC, 1996, PERSPECT DEV NEUROBI, V4, P111; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MATUS A, 1983, COLD SPRING HARB SYM, V48, P775, DOI 10.1101/SQB.1983.048.01.079; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; MOREST DK, 1969, Z ANAT ENTWICKLUNGS, V128, P290, DOI 10.1007/BF00522529; Muller D, 1997, REV NEUROSCIENCE, V8, P77; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; PARNAVELAS JG, 1974, NATURE, V248, P71, DOI 10.1038/248071a0; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; PETERS A, 1969, Z ZELLFORSCH MIK ANA, V100, P487, DOI 10.1007/BF00344370; Peters A., 1976, FINE STRUCTURE NERVO; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; Shepherd GM, 1996, J NEUROPHYSIOL, V75, P2197, DOI 10.1152/jn.1996.75.6.2197; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SOTELO C, 1990, J EXP BIOL, V153, P225; SPACEK J, 1983, ANAT EMBRYOL, V167, P289, DOI 10.1007/BF00298517; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; WU K, 1986, J NEUROCHEM, V46, P831, DOI 10.1111/j.1471-4159.1986.tb13047.x; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; ZADOR A, 1990, P NATL ACAD SCI USA, V87, P6718, DOI 10.1073/pnas.87.17.6718; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	95	613	633	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2000	290	5492					754	758		10.1126/science.290.5492.754	http://dx.doi.org/10.1126/science.290.5492.754			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11052932				2022-12-28	WOS:000090067600037
J	Sun, LG; Xie, ZQ; Zhao, JL				Sun, LG; Xie, ZQ; Zhao, JL			Palaeoecology - A 3,000-year record of penguin populations	NATURE			English	Article							LAKE-SEDIMENTS		Univ Sci & Technol China, Inst Polar Environm, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Sun, LG (corresponding author), Univ Sci & Technol China, Inst Polar Environm, Hefei 230026, Anhui, Peoples R China.		xie, zhouqing/P-9661-2019					CLAPPERTON CM, 1989, QUATERNARY RES, V31, P210, DOI 10.1016/0033-5894(89)90006-9; Hodgson DA, 1997, NATURE, V387, P30, DOI 10.1038/387030a0; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; STUIVER M, 1975, QUATERNARY RES, V5, P251, DOI 10.1016/0033-5894(75)90027-7; TAYLOR R H, 1990, Polar Record, V26, P293; TEDROW J. C. F., 1966, Publ. natn. Acad. Sci. natn. Res-Com., Wash., P161; UGOLINI FC, 1966, NATURE, V211, P440, DOI 10.1038/211440a0; WANG G, 1998, ACTA GEOGRAPH SINICA, V53, P538; XU ZB, 1994, ELEMENTS MATH GEOLOG, P226; ZHANG J, 1995, COMPUT MATH APPL, V30, P15, DOI 10.1016/0898-1221(95)00121-E; ZHAO JL, 1991, CHARACTERISTICS MODE	11	168	227	3	61	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2000	407	6806					858	858		10.1038/35038163	http://dx.doi.org/10.1038/35038163			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	364PZ	11057656	Bronze			2022-12-28	WOS:000089901900039
J	Davis, RJ				Davis, RJ			Signal transduction by the JNK group of MAP kinases	CELL			English	Review							N-TERMINAL KINASE; JUN NH2-TERMINAL KINASE; ACTIVATED PROTEIN-KINASES; KAPPA-B ACTIVATION; C-JUN; MICE LACKING; IN-VIVO; TRANSCRIPTIONAL ACTIVITY; LYMPHOCYTE DEVELOPMENT; SCAFFOLD PROTEINS		Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med,Dept Biochem & Mol Biol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Davis, RJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med,Dept Biochem & Mol Biol, Worcester, MA 01605 USA.	roger.davis@umassmed.edu						Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; ADLER V, 1992, J BIOL CHEM, V267, P17001; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bonny C, 2000, J BIOL CHEM, V275, P16466, DOI 10.1074/jbc.M908297199; Bonny C, 1998, J BIOL CHEM, V273, P1843, DOI 10.1074/jbc.273.4.1843; Bost F, 1999, MOL CELL BIOL, V19, P1938; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Chen CY, 2000, GENE DEV, V14, P1236; Chen YR, 2000, INT J ONCOL, V16, P651; Cheng JK, 2000, MOL CELL BIOL, V20, P2334, DOI 10.1128/MCB.20.7.2334-2342.2000; Chow CW, 2000, MOL CELL BIOL, V20, P5227, DOI 10.1128/MCB.20.14.5227-5234.2000; Constant SL, 2000, J IMMUNOL, V165, P2671, DOI 10.4049/jimmunol.165.5.2671; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Edwards DN, 1997, DEVELOPMENT, V124, P3855; Fanger GR, 2000, CANC DRUG DISC DEV, V5, P183; Faris M, 1998, MOL CELL BIOL, V18, P5414, DOI 10.1128/MCB.18.9.5414; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; Garay M, 2000, BIOCHEM PHARMACOL, V59, P1033, DOI 10.1016/S0006-2952(99)00412-8; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Ito M, 1999, MOL CELL BIOL, V19, P7539; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; Johnson R, 1996, MOL CELL BIOL, V16, P4504; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; KYRIAKIS JM, 1990, J BIOL CHEM, V265, P17355; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Leonardi A, 2000, J BIOL CHEM, V275, P271, DOI 10.1074/jbc.275.1.271; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; Merritt SE, 1999, J BIOL CHEM, V274, P10195, DOI 10.1074/jbc.274.15.10195; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Moriguchi T, 1999, J BIOL CHEM, V274, P30957, DOI 10.1074/jbc.274.43.30957; Negri S, 2000, GENOMICS, V64, P324, DOI 10.1006/geno.2000.6129; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; Nishina H, 1999, DEVELOPMENT, V126, P505; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Pellet JB, 2000, EUR J NEUROSCI, V12, P621, DOI 10.1046/j.1460-9568.2000.00945.x; Potapova O, 2000, MOL CELL BIOL, V20, P1713, DOI 10.1128/MCB.20.5.1713-1722.2000; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Sheikh MS, 2000, BIOCHEM PHARMACOL, V59, P43, DOI 10.1016/S0006-2952(99)00291-9; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Swat W, 1998, IMMUNITY, V8, P625, DOI 10.1016/S1074-7613(00)80567-1; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Teng DHF, 1997, CANCER RES, V57, P4177; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tournier C, 1999, MOL CELL BIOL, V19, P1569; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Waeber G, 2000, NAT GENET, V24, P291, DOI 10.1038/73523; Wang YB, 1998, J BIOL CHEM, V273, P5423, DOI 10.1074/jbc.273.10.5423; Weiss L, 2000, J EXP MED, V191, P139, DOI 10.1084/jem.191.1.139; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Yoshida BA, 1999, CANCER RES, V59, P5483; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; Zhang Y, 2000, J BIOL CHEM, V275, P25008, DOI 10.1074/jbc.M002491200	132	3479	3679	11	239	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 13	2000	103	2					239	252		10.1016/S0092-8674(00)00116-1	http://dx.doi.org/10.1016/S0092-8674(00)00116-1			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	11057897	Bronze			2022-12-28	WOS:000089864300008
J	Kiger, AA; White-Cooper, H; Fuller, MT				Kiger, AA; White-Cooper, H; Fuller, MT			Somatic support cells restrict germline stem cell self-renewal and promote differentiation	NATURE			English	Article							BAG-OF-MARBLES; EGF RECEPTOR; DROSOPHILA-MELANOGASTER; GENE; MORPHOGENESIS; PROLIFERATION; MAINTENANCE; ACTIVATION; OOGENESIS; FUSOME	Stem cells maintain populations of highly differentiated, short-lived cell-types, including blood, skin and sperm, throughout adult life(1). Understanding the mechanisms that regulate stem cell behaviour is crucial for realizing their potential in regenerative medicine(2). A fundamental characteristic of stem cells is their capacity for asymmetric division: daughter cells either retain stem cell identity or initiate differentiation. However, stem cells are also capable of symmetric division where both daughters remain stem cells(3-6), indicating that mechanisms must exist to balance self-renewal capacity with differentiation. Here we present evidence that support cells surrounding the stem cells restrict self-renewal and control stem cell number by ensuring asymmetric division. Loss of function of the Drosophila Epidermal growth factor receptor in somatic cells disrupted the balance of self-renewal versus differentiation in the male germline, increasing the number of germline stem cells. We propose that activation of this receptor specifies normal behaviour of somatic support cells; in turn, the somatic cells play a guardian role, providing information that prevents self-renewal of stem cell identity by the germ cell they enclose.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Stanford University; Stanford University; University of Oxford	Fuller, MT (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.		White-Cooper, Helen/A-4633-2010	White-Cooper, Helen/0000-0002-3373-8023; Fuller, Margaret T/0000-0002-3804-4987	NIGMS NIH HHS [R01 GM078176] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078176] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; BRAND AH, 1994, GENE DEV, V8, P629, DOI 10.1101/gad.8.5.629; CLIFFORD RJ, 1989, GENETICS, V123, P771; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Gabay L, 1997, DEVELOPMENT, V124, P3535; Golembo M, 1999, GENE DEV, V13, P158, DOI 10.1101/gad.13.2.158; Gonczy P, 1997, DEVELOPMENT, V124, P4361; GONCZY P, 1995, THESIS ROCKEFELLER U; GREEN H, 1991, Scientific American, V265, P96; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hime GR, 1996, J CELL SCI, V109, P2779; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; King FJ, 1999, DEVELOPMENT, V126, P1833; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEFFLER M, 1997, STEM CELLS, P1; LIN HF, 1994, DEVELOPMENT, V120, P947; LINDSLEY DL, 1980, GENETICS BIOL DROSOP, P00225, DOI DOI 10.1111/J.1601-5223.1952.TB02915.X; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Parreira GG, 1998, BIOL REPROD, V59, P1360, DOI 10.1095/biolreprod59.6.1360; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wessells RJ, 1999, DEV BIOL, V216, P243, DOI 10.1006/dbio.1999.9459; WHITELEY M, 1992, MECH DEVELOP, V36, P117, DOI 10.1016/0925-4773(92)90063-P; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	29	262	280	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2000	407	6805					750	754		10.1038/35037606	http://dx.doi.org/10.1038/35037606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362JB	11048722				2022-12-28	WOS:000089773900044
J	Allen, MR; Stott, PA; Mitchell, JFB; Schnur, R; Delworth, TL				Allen, MR; Stott, PA; Mitchell, JFB; Schnur, R; Delworth, TL			Quantifying the uncertainty in forecasts of anthropogenic climate change	NATURE			English	Article							GENERAL-CIRCULATION MODEL; FINGERPRINT METHOD; SULFATE AEROSOLS; GREENHOUSE-GAS; ATMOSPHERE; ATTRIBUTION; SURFACE; RECORD; GCM	Forecasts of climate change are inevitably uncertain. It is therefore essential to quantify the risk of significant departures from the predicted response to a given emission scenario. Previous analyses of this risk have been based either on expert opinion(1), perturbation analysis of simplified climate models(2-5) or the comparison of predictions from general circulation models(6). Recent observed changes that appear to be attributable to human influence(7-12) provide a powerful constraint on the uncertainties in multi-decadal forecasts. Here we assess the range of warming rates over the coming 50 years that are consistent with the observed near-surface temperature record as well as with the overall patterns of response predicted by several general circulation models. We expect global mean temperatures in the decade 2036-46 to be 1-2.5 K warmer than in pre-industrial times under a 'business as usual' emission scenario. This range is relatively robust to errors in the models' climate sensitivity, rate of oceanic heat uptake or global response to sulphate aerosols as long as these errors are persistent over time. Substantial changes in the current balance of greenhouse warming and sulphate aerosol cooling would, however, increase the uncertainty. Unlike 50-year warming rates, the final equilibrium warming after the atmospheric composition stabilizes remains very uncertain, despite the evidence provided by the emerging signal.	Rutherford Appleton Lab, Space Sci & Technol Dept, Didcot OX11 0QX, Oxon, England; Meteorol Off, Hadley Ctr Climate Predict & Res, Bracknell RG12 2SZ, Berks, England; Max Planck Inst Meteorol, D-20146 Hamburg, Germany; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Met Office - UK; Hadley Centre; Max Planck Society; National Oceanic Atmospheric Admin (NOAA) - USA	Allen, MR (corresponding author), Rutherford Appleton Lab, Space Sci & Technol Dept, Didcot OX11 0QX, Oxon, England.		Delworth, Thomas L/C-5191-2014; Stott, Peter/N-1228-2016; Allen, Myles R/A-5172-2012; Scott, Peter/GYA-5335-2022	Delworth, Thomas L/0000-0003-4865-5391; Stott, Peter/0000-0003-4853-7686; 				Allen M, 1999, NATURE, V401, P642, DOI 10.1038/44266; Allen MR, 1999, CLIM DYNAM, V15, P419, DOI 10.1007/s003820050291; Corti S, 1999, NATURE, V398, P799, DOI 10.1038/19745; COX PM, UNPUB NATURE; Cubasch U, 1997, CLIM DYNAM, V13, P757, DOI 10.1007/s003820050196; Delworth TL, 2000, SCIENCE, V287, P2246, DOI 10.1126/science.287.5461.2246; Forest CE, 2000, GEOPHYS RES LETT, V27, P569, DOI 10.1029/1999GL010859; HANSEN J, 1985, SCIENCE, V229, P857, DOI 10.1126/science.229.4716.857; Hasselmann K, 1997, CLIM DYNAM, V13, P601, DOI 10.1007/s003820050185; Hegerl GC, 1996, J CLIMATE, V9, P2281, DOI 10.1175/1520-0442(1996)009<2281:DGGICC>2.0.CO;2; Hegerl GC, 1997, CLIM DYNAM, V13, P613, DOI 10.1007/s003820050186; Johns TC, 1997, CLIM DYNAM, V13, P103, DOI 10.1007/s003820050155; Knutson TR, 1999, J GEOPHYS RES-ATMOS, V104, P30981, DOI 10.1029/1999JD900965; MEEHL GA, IN PRESS B AM METEOR; Mitchell JFB, 1997, J CLIMATE, V10, P245, DOI 10.1175/1520-0442(1997)010&lt;0245:OMOGWB&gt;2.0.CO;2; MITCHELL JFB, 1995, NATURE, V376, P501, DOI 10.1038/376501a0; Morgan MG, 1995, ENVIRON SCI TECHNOL, V29, P468, DOI DOI 10.1021/ES00010A003; Nakicenovic N., 2000, SPECIAL REPORT EMISS; North GR, 1998, J CLIMATE, V11, P563, DOI 10.1175/1520-0442(1998)011<0563:DCSITS>2.0.CO;2; RAPER SCB, 1996, RISING SEA LEVEL SUB, P11; RIPLEY BD, 1987, ANALYST, V112, P377, DOI 10.1039/an9871200377; Roeckner E, 1999, J CLIMATE, V12, P3004, DOI 10.1175/1520-0442(1999)012<3004:TCCSWA>2.0.CO;2; Santer BD, 1996, NATURE, V382, P39, DOI 10.1038/382039a0; SMITH SJ, IN PRESS TECHNOL FOR; Sokolov AP, 1998, CLIM DYNAM, V14, P291, DOI 10.1007/s003820050224; STOTT P, IN PRESS CLIM DYN; Stott PA, 1998, J CLIMATE, V11, P3282, DOI 10.1175/1520-0442(1998)011<3282:SDDOCC>2.0.CO;2; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; Van Huffel S, 1991, TOTAL LEAST SQUARES; Voss R, 1998, CLIM DYNAM, V14, P249, DOI 10.1007/s003820050221; Wigley TML, 1997, P NATL ACAD SCI USA, V94, P8314, DOI 10.1073/pnas.94.16.8314; Wood RA, 1999, NATURE, V399, P572, DOI 10.1038/21170	32	290	302	4	102	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					617	620		10.1038/35036559	http://dx.doi.org/10.1038/35036559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034207				2022-12-28	WOS:000089772800043
J	Gershon, D				Gershon, D			Western researchers reap rich rewards in eastern institutions	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					657	658		10.1038/35036757	http://dx.doi.org/10.1038/35036757			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034218				2022-12-28	WOS:000089772800056
J	Vokrouhlicky, D; Farinella, P				Vokrouhlicky, D; Farinella, P			Efficient delivery of meteorites to the Earth from a wide range of asteroid parent bodies	NATURE			English	Article							RAY EXPOSURE AGES; ORDINARY CHONDRITES; COLLISIONAL HISTORY; IRON-METEORITES; FRAGMENTS; BODY; RESONANCES; BELT; HOWARDITE; EUCRITE	Almost all meteorites come from asteroids, but identifying their specific parent bodies, and modelling their transport to the Earth, has proved to be difficult(1,2). The usual model(1,3,4) of delivery through orbital resonances with the major planets(5,6) has recently been shown(7-10) to deplete the supply of meteorites much too rapidly to explain either the observed flux at the Earth, or the length of time the meteorites have spent in space (as measured by cosmic-ray exposure ages). Independently, it has been found that a force arising from anisotropically emitted thermal radiation from asteroidal fragments (the 'Yarkovsky effect') influences the fragments' orbits in important ways(11-14). Here we report the results of a detailed model for the transport of meteorites to the Earth, which includes the Yarkovsky effect and collisional evolution of the asteroidal fragments. We rnd that the Yarkovsky effect significantly increases the efficiency of the delivery of meteorites to the Earth, while at the same time allowing a much wider range of asteroids to contribute to the flux of meteorites. Our model also reproduces the observed distribution(15,16) of cosmic-ray exposure ages of stony meteorites.	Charles Univ, Inst Astron, CR-18000 Prague, Czech Republic; Univ Trieste, Dipartimento Astron, Trieste, Italy	Charles University Prague; University of Trieste	Vokrouhlicky, D (corresponding author), Charles Univ, Inst Astron, Holesovickach 2, CR-18000 Prague, Czech Republic.		Vokrouhlický, David/Q-4359-2017	Vokrouhlický, David/0000-0002-6034-5452				BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; Bottke WF, 2000, ICARUS, V145, P301, DOI 10.1006/icar.2000.6361; FARINELLA P, 1993, ICARUS, V101, P174, DOI 10.1006/icar.1993.1016; Farinella P, 1999, SCIENCE, V283, P1507, DOI 10.1126/science.283.5407.1507; Farinella P, 1998, ICARUS, V132, P378, DOI 10.1006/icar.1997.5872; Gaffey MJ, 1998, METEORIT PLANET SCI, V33, P1281, DOI 10.1111/j.1945-5100.1998.tb01312.x; Gladman BJ, 1997, SCIENCE, V277, P197, DOI 10.1126/science.277.5323.197; GRAF T, 1995, J GEOPHYS RES-PLANET, V100, P21247, DOI 10.1029/95JE01903; GREENBERG R, 1983, ICARUS, V55, P455, DOI 10.1016/0019-1035(83)90116-1; Haack H, 1996, ICARUS, V119, P182, DOI 10.1006/icar.1996.0010; Hartmann WK, 1999, METEORIT PLANET SCI, V34, pA161, DOI 10.1111/j.1945-5100.1999.tb01761.x; Herzog GF, 1997, METEORIT PLANET SCI, V32, P413, DOI 10.1111/j.1945-5100.1997.tb01284.x; MARTI K, 1992, ANNU REV EARTH PL SC, V20, P221, DOI 10.1146/annurev.ea.20.050192.001253; Migliorini F, 1997, ICARUS, V128, P104, DOI 10.1006/icar.1997.5679; Migliorini F, 1997, METEORIT PLANET SCI, V32, P903, DOI 10.1111/j.1945-5100.1997.tb01580.x; Morbidelli A, 1998, METEORIT PLANET SCI, V33, P999, DOI 10.1111/j.1945-5100.1998.tb01707.x; Presley MA, 1997, J GEOPHYS RES-PLANET, V102, P6535, DOI 10.1029/96JE03302; Schmitz B, 1997, SCIENCE, V278, P88, DOI 10.1126/science.278.5335.88; SCHOLL H, 1991, ASTRON ASTROPHYS, V245, P316; Vokrouhlicky D, 1999, ASTRON ASTROPHYS, V344, P362; VOKROUHLICKY D, IN PRESS ICARUS; Welten KC, 1997, METEORIT PLANET SCI, V32, P891, DOI 10.1111/j.1945-5100.1997.tb01579.x; Wetherill G., 1988, METEORITES EARLY SOL, P35; WETHERILL GW, 1980, METEORITICS, V15, P386; WETHERILL GW, 1985, METEORITICS, V20, P1, DOI 10.1111/j.1945-5100.1985.tb00842.x; WISDOM J, 1985, NATURE, V315, P731, DOI 10.1038/315731a0; YOMOGIDA K, 1983, J GEOPHYS RES, V88, P9513, DOI 10.1029/JB088iB11p09513	29	88	88	1	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					606	608		10.1038/35036528	http://dx.doi.org/10.1038/35036528			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	362HP	11034203				2022-12-28	WOS:000089772800039
J	Grosset, C; Chen, CYA; Xu, NH; Sonenberg, N; Jacquemin-Sablon, H; Shyu, AB				Grosset, C; Chen, CYA; Xu, NH; Sonenberg, N; Jacquemin-Sablon, H; Shyu, AB			A mechanism for translationally coupled mRNA turnover: Interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex	CELL			English	Article							MYC MESSENGER-RNA; AU-RICH ELEMENTS; COLD SHOCK DOMAINS; DESTABILIZING ELEMENTS; BINDING SPECIFICITY; DECAY; DEGRADATION; REGION; DEADENYLATION; INITIATION	mRNA turnover mediated by the major protein-coding-region determinant of instability (mCRD) of the c-fos proto-oncogene transcript illustrates a functional interplay between mRNA turnover and translation. We show that the function of mCRD depends on its distance from the poly(A)tail. Five mCRD-associated proteins were identified: Unr, a purine-rich RNA binding protein; PABP, a poly(A) binding protein; PAIP-1, a poly(A) binding protein interacting protein; hnRNP D, an AU-rich element binding protein; and NSAP1, an hnRNP R-like protein. These proteins form a multiprotein complex. Overexpression of these proteins stabilized mCRD-containing mRNA by impeding deadenylation. We propose that a bridging complex forms between the poly(A) tail and the mCRD and ribosome transit disrupts or reorganizes the complex, leading to rapid RNA deadenylation and decay.	Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; Inst Rech Canc, CNRS, UPR Genet Mol & Integrat Fonct Cellulaires 9044, F-94801 Villejuif, France	University of Texas System; McGill University; Centre National de la Recherche Scientifique (CNRS)	Shyu, AB (corresponding author), Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.		Grosset, Christophe/P-9864-2019; Grosset, Christophe/I-5059-2016	Grosset, Christophe/0000-0002-0479-6291; Grosset, Christophe/0000-0002-0479-6291	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046454, R01GM059211] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 59211, GM 46454] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARUCCIO N, 1994, J BIOL CHEM, V269, P31814; CHEN CYA, 1995, MOL CELL BIOL, V15, P5777; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; CHEN CYA, 1994, MOL CELL BIOL, V14, P416, DOI 10.1128/MCB.14.1.416; CHEN CYA, 1992, MOL CELL BIOL, V12, P5748, DOI 10.1128/MCB.12.12.5748; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gao M, 2000, MOL CELL, V5, P479, DOI 10.1016/S1097-2765(00)80442-6; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; Greenberg ME, 1993, CONTROL MESSENGER RN, P199, DOI 10.1016/B978-0-08-091652-1.50013-X; Harris CE, 1999, J VIROL, V73, P72, DOI 10.1128/JVI.73.1.72-80.1999; Hassfeld W, 1998, NUCLEIC ACIDS RES, V26, P439, DOI 10.1093/nar/26.2.439; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HERRICK DJ, 1994, MOL CELL BIOL, V14, P2119, DOI 10.1128/MCB.14.3.2119; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hunt SL, 1999, GENE DEV, V13, P437, DOI 10.1101/gad.13.4.437; Jacobson A., 1996, TRANSLATIONAL CONTRO, P451; JACQUEMINSABLON H, 1994, NUCLEIC ACIDS RES, V22, P2643, DOI 10.1093/nar/22.13.2643; Korner CG, 1997, J BIOL CHEM, V272, P10448; LAIRDOFFRINGA IA, 1991, NUCLEIC ACIDS RES, V19, P2387, DOI 10.1093/nar/19.9.2387; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; MANLEY JL, 1994, GENE DEV, V8, P259, DOI 10.1101/gad.8.3.259; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Preiss T, 1998, NATURE, V392, P516, DOI 10.1038/33192; Preiss T, 1999, CURR OPIN GENET DEV, V9, P515, DOI 10.1016/S0959-437X(99)00005-2; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SCHIAVI SC, 1994, J BIOL CHEM, V269, P3441; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; SHYU AB, 1996, ANAL MRNA DECAY MAMM; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Triqueneaux G, 1999, NUCLEIC ACIDS RES, V27, P1926, DOI 10.1093/nar/27.8.1926; WELLINGTON CL, 1993, MOL CELL BIOL, V13, P5034, DOI 10.1128/MCB.13.8.5034; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; Yeakley JM, 1996, P NATL ACAD SCI USA, V93, P7582, DOI 10.1073/pnas.93.15.7582; Yeilding NM, 1998, J BIOL CHEM, V273, P15749, DOI 10.1074/jbc.273.25.15749; YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0; ZAPP ML, 1989, NUCLEIC ACIDS RES, V17, P2655, DOI 10.1093/nar/17.7.2655; Zhang SA, 1997, RNA, V3, P234	45	244	256	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 29	2000	103	1					29	40		10.1016/S0092-8674(00)00102-1	http://dx.doi.org/10.1016/S0092-8674(00)00102-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	359XB	11051545	Bronze			2022-12-28	WOS:000089636400006
J	Grimes, DA				Grimes, DA			Intrauterine device and upper-genital-tract infection	LANCET			English	Review							PELVIC INFLAMMATORY DISEASE; PRIMARY TUBAL INFERTILITY; INVASIVE CERVICAL-CANCER; ENDOMETRIAL CANCER; CONTRACEPTIVE DEVICE; CHLAMYDIA-TRACHOMATIS; IUD USERS; PROPHYLACTIC ANTIBIOTICS; ACUTE SALPINGITIS; NOVA-T	Concern about upper-genital-tract infection related to intrauterine devices (IUDs) limits their wider use. In this systematic review I summarise the evidence concerning IUD-associated infection and infertility. Choice of an inappropriate comparison group, overdiagnosis of salpingitis in IUD users, and Inability to control for the confounding effects of sexual behaviour have exaggerated the apparent risk. Women with symptomless gonorrhoea or chlamydial infection having an IUD inserted have a higher risk of salpingitis than do uninfected women having an IUD inserted; however, the risk appears similar to that of infected women not having an IUD inserted. A cohort study of HIV-positive women using a copper IUD suggests that there is no significant increase in the risk of complications or viral shedding. Similarly, fair evidence indicates no important effect of IUD use on tubal infertility. Contemporary IUDs rival tubal sterilisation in efficacy and are much safer than previously thought.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	dgrimes@fhi.org						ANDERSSON K, 1994, CONTRACEPTION, V49, P56, DOI 10.1016/0010-7824(94)90109-0; ANDOLSEK L, 1986, INT J GYNECOL OBSTET, V24, P217, DOI 10.1016/0020-7292(86)90100-1; [Anonymous], 1992, BMJ, V304, P809; Anwar M, 1993, Asia Oceania J Obstet Gynaecol, V19, P77; AVONTS D, 1990, SEX TRANSM DIS, V17, P23; BELHADJ H, 1986, CONTRACEPTION, V34, P261, DOI 10.1016/0010-7824(86)90007-7; BLUM M, 1988, Advances in Contraceptive Delivery Systems, V4, P233, DOI 10.1007/BF01849443; Brabin L, 1998, B WORLD HEALTH ORGAN, V76, P277; BROMHAM DR, 1993, BRIT MED BULL, V49, P100, DOI 10.1093/oxfordjournals.bmb.a072591; BUCHAN H, 1990, BRIT J OBSTET GYNAEC, V97, P780, DOI 10.1111/j.1471-0528.1990.tb02571.x; BURKMAN RT, 1976, AM J OBSTET GYNECOL, V126, P648, DOI 10.1016/0002-9378(76)90512-3; CASTELLSAGUE X, 1993, INT J CANCER, V54, P911, DOI 10.1002/ijc.2910540607; *CDCP, 1997, MMWR-MORBID MORTAL W, V47, P1; CRAMER DW, 1985, NEW ENGL J MED, V312, P941, DOI 10.1056/NEJM198504113121502; DALING JR, 1985, NEW ENGL J MED, V312, P937, DOI 10.1056/NEJM198504113121501; DALING JR, 1992, NEW ENGL J MED, V326, P203; DIAZ S, 1987, CONTRACEPTION, V35, P569, DOI 10.1016/S0010-7824(87)80017-3; Ebi KL, 1996, CONTRACEPTION, V53, P25, DOI 10.1016/0010-7824(95)00253-7; EDELMAN DA, 1988, AM J OBSTET GYNECOL, V158, P956, DOI 10.1016/0002-9378(88)90101-9; ESCHENBACH DA, 1992, FERTIL STERIL, V57, P1177; FARLEY TMM, 1992, LANCET, V339, P785, DOI 10.1016/0140-6736(92)91904-M; FARLEY TMM, 1992, LANCET, V340, P248; Faundes A, 1998, CONTRACEPTION, V58, P105, DOI 10.1016/S0010-7824(98)00064-X; Fortney JA, 1999, J REPROD MED, V44, P269; GAO J, 1986, CONTRACEPTION, V33, P443; GAYER M L, 1990, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V19, P155; Grimes DA, 1999, CONTRACEPTION, V60, P57, DOI 10.1016/S0010-7824(99)00071-2; GRIMES DA, 1987, CONTRACEPTION, V36, P97, DOI 10.1016/0010-7824(87)90063-1; GRIMES DA, 1992, FERTIL STERIL, V58, P670; GUPTA BK, 1989, INT J FERTIL, V34, P123; HAGER WD, 1983, OBSTET GYNECOL, V61, P113; Hill DA, 1997, INT J CANCER, V70, P278, DOI 10.1002/(SICI)1097-0215(19970127)70:3<278::AID-IJC5>3.0.CO;2-U; HUBACHER D, 1999, 36 ANN M ASS REPR HL; *IPPF INT MED ADV, 1991, IPPF MED B, V25, P1; James NJ, 1997, BRIT J FAM PLAN, V23, P16; LALOS O, 1988, EUR J OBSTET GYN R B, V29, P129, DOI 10.1016/0028-2243(88)90139-6; LASSISE DL, 1991, INT J EPIDEMIOL, V20, P865, DOI 10.1093/ije/20.4.865; LEE NC, 1988, OBSTET GYNECOL, V72, P1; LEE NC, 1983, OBSTET GYNECOL, V62, P1; MEHANNA MTR, 1994, AM J OBSTET GYNECOL, V171, P691, DOI 10.1016/0002-9378(94)90083-3; MISHELL DR, 1966, AM J OBSTET GYNECOL, V96, P119, DOI 10.1016/S0002-9378(16)34650-6; MORRISON C, 1999, 13 M INT SOC SEX TRA; Morrison CS, 1999, CONTRACEPTION, V59, P97, DOI 10.1016/S0010-7824(99)00006-2; PAAVONEN J, 1980, CONTRACEPTION, V22, P107, DOI 10.1016/0010-7824(80)90055-4; Palayekar V, 1996, ADV CONTRACEPT, V12, P145, DOI 10.1007/BF01849636; PAPAKESON M, 1992, BRIT J OBSTET GYNAEC, V99, P676, DOI 10.1111/j.1471-0528.1992.tb13854.x; PARAZZINI F, 1992, INT J EPIDEMIOL, V21, P1030, DOI 10.1093/ije/21.5.1030; PARAZZINI F, 1994, BRIT J CANCER, V70, P672, DOI 10.1038/bjc.1994.369; Peterson HB, 1996, AM J OBSTET GYNECOL, V174, P1161, DOI 10.1016/S0002-9378(96)70658-0; PLATT R, 1983, JAMA-J AM MED ASSOC, V250, P3205, DOI 10.1001/jama.250.23.3205; POTTS D M, 1991, Advances in Contraception, V7, P231, DOI 10.1007/BF01849413; PURRIER BGA, 1979, BRIT J OBSTET GYNAEC, V86, P374, DOI 10.1111/j.1471-0528.1979.tb10613.x; PYORALA T, 1982, CONTRACEPTION, V26, P113; RANDIC L, 1985, CONTRACEPTION, V32, P253, DOI 10.1016/0010-7824(85)90048-4; REES E, 1980, AM J OBSTET GYNECOL, V138, P1042, DOI 10.1016/0002-9378(80)91105-9; Richardson BA, 1999, AIDS, V13, P2091, DOI 10.1097/00002030-199910220-00012; RIVERA R, 1994, P 4 INT C IUDS, P171; Rosenblatt KA, 1996, CONTRACEPTION, V54, P329, DOI 10.1016/S0010-7824(96)00199-0; Rowe PJ, 1997, CONTRACEPTION, V56, P341; ROYLANCE D, 1993, J APPL BIOMATER, V4, P289, DOI 10.1002/jab.770040403; RYDEN G, 1979, CONTRACEPTION, V20, P149, DOI 10.1016/0010-7824(79)90087-8; SANDMIRE H F, 1986, Advances in Contraception, V2, P327, DOI 10.1007/BF02340049; Shrikhande S N, 1998, Indian J Public Health, V42, P42; SHU XO, 1991, INT J CANCER, V49, P38, DOI 10.1002/ijc.2910490108; Sinei SK, 1998, LANCET, V351, P1238, DOI 10.1016/S0140-6736(97)10319-1; SINEI SKA, 1990, BRIT J OBSTET GYNAEC, V97, P412, DOI 10.1111/j.1471-0528.1990.tb01828.x; SIVIN I, 1991, CONTRACEPTION, V44, P473, DOI 10.1016/0010-7824(91)90149-A; SKELDESTAD F, 1988, ADV CONTRACEPT, V4, P179; Skjeldestad FE, 1996, CONTRACEPTION, V54, P209, DOI 10.1016/S0010-7824(96)00190-4; SODERBERG G, 1981, CONTRACEPTION, V24, P137, DOI 10.1016/0010-7824(81)90086-X; SPRAGUE DS, 1990, BR J FAM PLANNING, V16, P54; STAMM WE, 1984, NEW ENGL J MED, V310, P545, DOI 10.1056/NEJM198403013100901; Sturgeon SR, 1997, INT J EPIDEMIOL, V26, P496, DOI 10.1093/ije/26.3.496; SUNDBY J, 1992, J PSYCHOSOM OBST GYN, V13, P135, DOI 10.3109/01674829209016712; SUNG S, 1984, CONTRACEPTION, V29, P229, DOI 10.1016/S0010-7824(84)80003-7; SVENSSON L, 1984, JAMA-J AM MED ASSOC, V251, P2553, DOI 10.1001/jama.251.19.2553; TATUM HJ, 1975, JAMA-J AM MED ASSOC, V231, P711, DOI 10.1001/jama.231.7.711; TIETZE C, 1970, STUD FAMILY PLANN, P1; TOIVONEN J, 1991, OBSTET GYNECOL, V77, P261, DOI 10.1097/00006250-199102000-00019; TRUSSELL J, 1995, AM J PUBLIC HEALTH, V85, P494, DOI 10.2105/AJPH.85.4.494; *US PREV SERV TASK, 1995, GUID CLIN PREV SERV; VESSEY MP, 1983, BRIT MED J, V286, P106, DOI 10.1136/bmj.286.6359.106; VESSEY MP, 1981, BRIT MED J, V282, P855, DOI 10.1136/bmj.282.6267.855; Walsh T, 1998, LANCET, V351, P1005, DOI 10.1016/S0140-6736(97)09086-7; WESTERGAARD L, 1982, OBSTET GYNECOL, V60, P322; *WHO, 1987, TECHN REP SER WHO, V753; WILSON JC, 1989, AM J OBSTET GYNECOL, V160, P391, DOI 10.1016/0002-9378(89)90455-9; World Health Organization, 1996, IMPR ACC QUAL CAR FA	88	221	230	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2000	356	9234					1013	1019		10.1016/S0140-6736(00)02699-4	http://dx.doi.org/10.1016/S0140-6736(00)02699-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041414				2022-12-28	WOS:000089293600039
J	Yasunari, T; Shiraki, K; Hattori, H; Miki, T				Yasunari, T; Shiraki, K; Hattori, H; Miki, T			Frequency of choroidal abnormalities in neurofibromatosis type 1	LANCET			English	Article							INDOCYANINE GREEN ANGIOGRAPHY; MALIGNANT-MELANOMA; DYE	Background Choroidal neurofibromatosis is thought to be a rare form of neurofibromatosis that involves the eyes. The development of infrared light examination with a scanning laser ophthalmoscope (SLO) and indocyanine-green fundus angiography has allowed examination of the choroid. We studied choroidal abnormalities in patients with neurofibromatosis 1 and compared their frequency with that of other ocular abnormalities. Methods We examined 33 eyes of 17 consecutive patients diagnosed with neurofibromatosis 1 by conventional ophthalmoscopy and by non-invasive infrared monochromatic light with confocal SLO. 76 eyes of 39 age-matched controls were examined similarly by confocal SLO. 21 digital fluorescein and indocyanine-green angiographies were obtained from 11 adult patients, and 77 angiograms were obtained from age-matched controls. Findings Infrared monochromatic light examination by confocal SLO showed bright multiple patchy regions at and around the entire posterior pole of all 33 eyes examined. All bright patchy regions seen in adult patients corresponded to hypofluorescent areas on their indocyanine-green angiograms. However, no abnormalities were noted in any patient at corresponding areas under conventional ophthalmoscopic examination or fluorescein angiography. In SLO and indocyanine-green studies, controls and control angiograms showed no choroidal abnormalities. Iris nodules were noted in 25 eyes (76%) of 14 patients (82%) and eyelid neurofibroma in five patients (29%). Interpretation The bright patchy regions noted under infrared fundus examination and the corresponding hypofluorescent areas seen on indocyanine-green angiograms are probably of choroidal origin. The high frequency (100%) of these abnormalities suggests that the choroid is one of the structures most commonly affected by neurofibromatosis 1.	Osaka City Univ, Sch Med, Dept Ophthalmol, Abeno Ku, Osaka 5458585, Japan; Osaka City Univ, Sch Med, Dept Pediat, Abeno Ku, Osaka 5458585, Japan	Osaka Metropolitan University; Osaka Metropolitan University	Yasunari, T (corresponding author), Osaka City Univ, Sch Med, Dept Ophthalmol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	taka@med.osaka-cu.ac.jp						ALBERT DM, 1982, PATHOLOGY OCULAR DIS, V1, P590; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; BISCHOFF PM, 1985, DOC OPHTHALMOL, V60, P235, DOI 10.1007/BF00157827; Chang AA, 1998, OPHTHALMOLOGY, V105, P1060, DOI 10.1016/S0161-6420(98)96008-0; DESTRO M, 1989, OPHTHALMOLOGY, V96, P846; FERRY AP, 1994, RETINA, V1, P650; FLOWER RW, 1994, RETINA-J RET VIT DIS, V14, P283, DOI 10.1097/00006982-199414030-00019; FLOWER RW, 1973, INVEST OPHTH VISUAL, V12, P248; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; HAYASHI K, 1985, OPHTHALMOLOGICA, V190, P20, DOI 10.1159/000309488; Kissel P, 1981, NEUROCRISTOPATHIES, P223; KLEIN RM, 1985, AM J OPHTHALMOL, V99, P367, DOI 10.1016/0002-9394(85)90376-9; KUROSAWA A, 1982, ARCH OPHTHALMOL-CHIC, V100, P1939; Rescaldani C, 1998, OPHTHALMOLOGICA, V212, P99, DOI 10.1159/000027287; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; SHIKISHIMA K, 1997, JPN J CLIN OPHTHAL, V51, P1090; Shiraki K, 1998, INT OPHTHALMOL, V21, P245; SHIRAKI K, 1996, FOLIA OPHTHALMOL JPN, V47, P629; TO KW, 1989, SURV OPHTHALMOL, V33, P373, DOI 10.1016/0039-6257(89)90014-3; VONRECKLINGHAUS.FD, 1982, MULTIPHEN FIBROME HA; Warwar RE, 1998, ARCH OPHTHALMOL-CHIC, V116, P1241, DOI 10.1001/archopht.116.9.1241; WOLTER JR, 1962, AM J OPHTHALMOL, V54, P217, DOI 10.1016/0002-9394(62)93279-8; WOLTER JR, 1965, ARCH OPHTHALMOL-CHIC, V73, P696, DOI 10.1001/archopht.1965.00970030698019; WOOG JJ, 1983, GRAEF ARCH CLIN EXP, V220, P25, DOI 10.1007/BF02307012	24	76	77	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 16	2000	356	9234					988	992		10.1016/S0140-6736(00)02716-1	http://dx.doi.org/10.1016/S0140-6736(00)02716-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353UJ	11041400				2022-12-28	WOS:000089293600013
J	Beckers, EAM; van Schijndel, RJMS; Weijmer, MC				Beckers, EAM; van Schijndel, RJMS; Weijmer, MC			A contrast crisis	LANCET			English	Article							ISOLATED ACTH DEFICIENCY		Vrije Univ Amsterdam, Acad Hosp, Med Instens Care Unit, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Beckers, EAM (corresponding author), Vrije Univ Amsterdam, Acad Hosp, Med Instens Care Unit, POB 7057, NL-1007 MB Amsterdam, Netherlands.							de Luis DA, 1998, HORM RES, V49, P247, DOI 10.1159/000023179; Kubo SI, 1997, AM J FOREN MED PATH, V18, P202, DOI 10.1097/00000433-199706000-00020; Nagai Y, 1997, ENDOCR J, V44, P453, DOI 10.1507/endocrj.44.453	3	1	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 9	2000	356	9233					908	908		10.1016/S0140-6736(00)02682-9	http://dx.doi.org/10.1016/S0140-6736(00)02682-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	353DP	11036897				2022-12-28	WOS:000089259800014
J	Aboulker, JP				Aboulker, JP			Viral load in treatment with antiretroviral therapy and interleukin 2	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									INSERM, SC10, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Aboulker, JP (corresponding author), INSERM, SC10, Villejuif, France.							Davey RT, 2000, JAMA-J AM MED ASSOC, V284, P183, DOI 10.1001/jama.284.2.183	1	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2055	2055		10.1001/jama.284.16.2055	http://dx.doi.org/10.1001/jama.284.16.2055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364QA	11042747				2022-12-28	WOS:000089902100017
J	Sobel, HL; Lurie, P; Wolfe, SM				Sobel, HL; Lurie, P; Wolfe, SM			Lead in candle wicks - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Prevent Med, Baltimore, MD 21205 USA; Publ Citizens Hlth Res Grp, Washington, DC USA	Johns Hopkins University	Sobel, HL (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Prevent Med, Baltimore, MD 21205 USA.		Sobel, Howard L/M-8800-2018					*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P141; HEHIR RM, 1973, MEMORANDUM COMMISSIO	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2189	2190		10.1001/jama.284.17.2189	http://dx.doi.org/10.1001/jama.284.17.2189			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056587				2022-12-28	WOS:000090052600025
J	McDermott, M				McDermott, M			Lead in candle wicks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Natl Candle Assoc, Washington, DC USA		McDermott, M (corresponding author), Natl Candle Assoc, Washington, DC USA.		Sobel, Howard L/M-8800-2018					Sobel HL, 2000, JAMA-J AM MED ASSOC, V284, P180, DOI 10.1001/jama.284.2.180	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2189	2189		10.1001/jama.284.17.2189	http://dx.doi.org/10.1001/jama.284.17.2189			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056587				2022-12-28	WOS:000090052600024
J	Luepker, RV				Luepker, RV		REACT Investigators	Barriers to patients seeking emergency care for acute coronary heart disease - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ACUTE MYOCARDIAL-INFARCTION; DELAY		Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Luepker, RV (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA.							FINNEGAN JR, IN PRESS PREV MED; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; Raczynski JM, 1999, AM J PREV MED, V16, P325, DOI 10.1016/S0749-3797(99)00023-9; Siepmann DB, 2000, ANN EMERG MED, V35, P573, DOI 10.1016/S0196-0644(00)70030-8; Simons-Morton DG, 1998, ACAD EMERG MED, V5, P726, DOI 10.1111/j.1553-2712.1998.tb02492.x; Zapka J, 1999, HEALTH EDUC BEHAV, V26, P714, DOI 10.1177/109019819902600511	6	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2184	2184		10.1001/jama.284.17.2184	http://dx.doi.org/10.1001/jama.284.17.2184			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056578				2022-12-28	WOS:000090052600012
J	Mackinnon, SE; Novak, CB; Landau, WM				Mackinnon, SE; Novak, CB; Landau, WM			Clinical diagnosis of carpal tunnel syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Washington Univ, Sch Med, Div Plast & Reconstruct Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Mackinnon, SE (corresponding author), Washington Univ, Sch Med, Div Plast & Reconstruct Surg, St Louis, MO 63110 USA.							Anderson J., 1978, GRANTS ATLAS ANATOMY, V7th; D'Arcy CA, 2000, JAMA-J AM MED ASSOC, V283, P3110, DOI 10.1001/jama.283.23.3110; KATZ JN, 1990, J RHEUMATOL, V17, P1495; KATZMAN PL, 1990, J CARDIOVASC PHARM, V15, P360, DOI 10.1097/00005344-199003000-00003; Rempel D, 1998, AM J PUBLIC HEALTH, V88, P1447, DOI 10.2105/AJPH.88.10.1447	5	11	13	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1924	1925		10.1001/jama.284.15.1924	http://dx.doi.org/10.1001/jama.284.15.1924			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362JC	11035885				2022-12-28	WOS:000089774000019
J	Davey, RT; Capra, WB				Davey, RT; Capra, WB			Viral load in treatment with antiretroviral therapy and interleukin 2 - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									NIAID, NIH, Bethesda, MD 20892 USA; Chiron Corp, Emeryville, CA 94608 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Novartis	Davey, RT (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2055	2056		10.1001/jama.284.16.2055	http://dx.doi.org/10.1001/jama.284.16.2055			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364QA	11042747				2022-12-28	WOS:000089902100018
J	Collins, JA				Collins, JA			Deficiencies in US medical care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter																		Starfield B, 2000, JAMA-J AM MED ASSOC, V284, P483, DOI 10.1001/jama.284.4.483	1	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2184	2185		10.1001/jama.284.17.2184-a	http://dx.doi.org/10.1001/jama.284.17.2184-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11058397				2022-12-28	WOS:000090052600013
J	Stafford, M				Stafford, M			Problems in pharmacoeconomic analyses	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Australian Pharmaceut Manufacturers Assoc, Hlth Econ Comm, N Sydney, Australia		Stafford, M (corresponding author), Australian Pharmaceut Manufacturers Assoc, Hlth Econ Comm, N Sydney, Australia.							*COMM DEP HUM SERV, 1995, GUID PHARM IND PREP; Hill SR, 2000, JAMA-J AM MED ASSOC, V283, P2116, DOI 10.1001/jama.283.16.2116; KASSIRER JP, 1994, NEW ENGL J MED, V331, P669, DOI 10.1056/NEJM199409083311009; RENNIE R, 2000, JAMA-J AM MED ASSOC, V283, P2156	4	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2000	284	15					1922	1923		10.1001/jama.284.15.1922	http://dx.doi.org/10.1001/jama.284.15.1922			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362JC	11035879				2022-12-28	WOS:000089774000015
J	Schlessinger, J				Schlessinger, J			Cell signaling by receptor tyrosine kinases	CELL			English	Review							EPIDERMAL GROWTH-FACTOR; PLECKSTRIN HOMOLOGY DOMAIN; HIGH-AFFINITY BINDING; SRC FAMILY KINASES; PROTEIN-KINASE; CRYSTAL-STRUCTURE; INOSITOL PHOSPHATES; INSULIN-RECEPTOR; PHOSPHORYLATION; ACTIVATION		NYU Med Ctr, Dept Pharmacol, New York, NY 10016 USA; NYU Med Ctr, Skirball Inst, New York, NY 10016 USA	New York University; New York University	Schlessinger, J (corresponding author), NYU Med Ctr, Dept Pharmacol, 550 1st Ave, New York, NY 10016 USA.	schlej01@popmail.med.nyu.edu		Lemmon, Mark/0000-0002-3379-5319	NCI NIH HHS [R01 CA125432-05, R01-CA096768, R01 CA096768-05, R01-CA079992, R01 CA125432, R01 CA096768, R01-CA125432, R01 CA079992-13, R01 CA079992] Funding Source: Medline; NIAMS NIH HHS [P50 AR054086, R01 AR051448, R01 AR051448-05, R01-AR051886, R01 AR051886-05, R01 AR051886, R01-AR051448, P50 AR054086-040003, P50-AR054086] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; CARR A, 1994, REV MED VIROL, V4, P5, DOI 10.1002/rmv.1980040104; Casci T, 1999, CANCER METAST REV, V18, P181, DOI 10.1023/A:1006313122373; COCHET C, 1984, J BIOL CHEM, V259, P2553; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DAVIS RJ, 1985, P NATL ACAD SCI USA, V82, P1974, DOI 10.1073/pnas.82.7.1974; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Edidin M, 1997, CURR OPIN STRUC BIOL, V7, P528, DOI 10.1016/S0959-440X(97)80117-0; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8; Gamett DC, 1997, J BIOL CHEM, V272, P12052, DOI 10.1074/jbc.272.18.12052; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; HONEGGER AM, 1990, MOL CELL BIOL, V10, P4035, DOI 10.1128/MCB.10.8.4035; Huang GC, 1998, BIOCHEM J, V331, P113, DOI 10.1042/bj3310113; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; Jin MH, 2000, MOL CELL BIOL, V20, P2098, DOI 10.1128/MCB.20.6.2098-2107.2000; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kossiakoff AA, 1999, ADV PROTEIN CHEM, V52, P67; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; LEMMON MA, 1994, TRENDS BIOCHEM SCI, V19, P459, DOI 10.1016/0968-0004(94)90130-9; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Margolis B, 1999, TRENDS ENDOCRIN MET, V10, P262, DOI 10.1016/S1043-2760(99)00168-X; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MASKI MD, 1998, FRONT BIOSCI, V3, pD781; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; QIAN XL, 1994, P NATL ACAD SCI USA, V91, P1500, DOI 10.1073/pnas.91.4.1500; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANOBBERGHEN E, 1994, DIABETOLOGIA, V37, pS125, DOI 10.1007/BF00400836; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; WANG F, 1995, J BIOL CHEM, V270, P10231, DOI 10.1074/jbc.270.17.10231; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhang ZJ, 1998, RNA, V4, P394; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	108	3805	4013	16	427	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 13	2000	103	2					211	225		10.1016/S0092-8674(00)00114-8	http://dx.doi.org/10.1016/S0092-8674(00)00114-8			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	20602996	Bronze			2022-12-28	WOS:000089864300006
J	Nitzkin, JL				Nitzkin, JL			Barriers to patients seeking emergency care for acute coronary heart disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ACUTE MYOCARDIAL-INFARCTION; MEDIA CAMPAIGN; DELAY TIMES; AMBULANCE		Engn Management & Econ Inc, New Orleans, LA USA		Nitzkin, JL (corresponding author), Engn Management & Econ Inc, New Orleans, LA USA.							BLOHM M, 1994, AM J EMERG MED, V12, P315, DOI 10.1016/0735-6757(94)90147-3; HERLITZ J, 1989, AM J CARDIOL, V64, P90, DOI 10.1016/0002-9149(89)90659-0; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; MOSES HW, 1991, AM J CARDIOL, V68, P249, DOI 10.1016/0002-9149(91)90753-8; *NAT HEART LUNG BL, 1997, NIH PUBL	5	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2000	284	17					2184	2184		10.1001/jama.284.17.2184	http://dx.doi.org/10.1001/jama.284.17.2184			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367GD	11056578				2022-12-28	WOS:000090052600011
J	Donnelly, B				Donnelly, B			Do increased 5-year survival rates in prostate cancer indicate better outcomes?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Interuniv Consortium, Los Angeles, CA USA; Amer Canc Soc, Los Angeles Reg Prostate Project Team, Los Angeles, CA USA	American Cancer Society	Donnelly, B (corresponding author), Interuniv Consortium, Los Angeles, CA USA.							Labrie F, 1999, PROSTATE, V38, P83, DOI 10.1002/(SICI)1097-0045(19990201)38:2<83::AID-PROS1>3.0.CO;2-B; Merrill RM, 2000, J UROLOGY, V163, P503, DOI 10.1016/S0022-5347(05)67912-8; Roberts RO, 1999, J UROLOGY, V161, P529, DOI 10.1016/S0022-5347(01)61941-4; Tarone RE, 2000, EPIDEMIOLOGY, V11, P167, DOI 10.1097/00001648-200003000-00014; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975	5	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2000	284	16					2053	2054		10.1001/jama.284.16.2053-a	http://dx.doi.org/10.1001/jama.284.16.2053-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	364QA	11042743				2022-12-28	WOS:000089902100014
